Clustering O 0 2.3392232151309145e-08
of O 0 5.9785878470108855e-09
missense O 0 3.047351171403534e-08
mutations O 0 3.339140422498055e-11
in O 0 2.001298432530163e-11
the O 0 9.055519001321954e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.473864040870467e-08
in O 0 2.6376309122944086e-11
a O 0 4.317263560538187e-11
sporadic B-Disease 1 0.9578458666801453
T I-Disease 1 0.9999959468841553
- I-Disease 0 0.000923196435905993
cell I-Disease 1 0.9999847412109375
leukaemia I-Disease 1 0.999990701675415
. O 0 1.869247157060272e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.002565214348495e-12
is O 0 1.1072211398600873e-13
a O 0 6.256727449506505e-13
recessive B-Disease 0 2.2001378496838697e-09
multi I-Disease 0 1.5243967027345207e-05
- I-Disease 0 0.0005854836199432611
system I-Disease 0 0.04704438894987106
disorder I-Disease 0 0.0001453465229133144
caused O 0 1.9984071689127525e-11
by O 0 3.396982605689651e-14
mutations O 0 1.0777503564075863e-13
in O 0 1.2539904011010794e-13
the O 0 6.58803697359267e-12
ATM O 0 7.516757882797265e-09
gene O 0 1.2638485744065342e-11
at O 0 1.1114015957547352e-10
11q22 O 0 8.06657629581764e-10
- O 0 3.9036440746542667e-10
q23 O 0 2.2956316847455582e-09
( O 0 2.0601914271778377e-12
ref O 0 1.6915815970186543e-10
. O 0 1.603777982812915e-12
3 O 0 8.742963991670294e-11
) O 0 1.665202047432257e-12
. O 0 1.3223468153800155e-10

The O 0 2.6608891090518227e-08
risk O 0 2.006691168787711e-08
of O 0 6.301953181520048e-09
cancer B-Disease 0 4.82752966490807e-06
, O 0 8.167326537300568e-11
especially O 0 1.9243520665845892e-10
lymphoid B-Disease 0 2.4457542167510837e-05
neoplasias I-Disease 0 0.0001127665163949132
, O 0 9.629553231194077e-12
is O 0 1.8792697161883892e-13
substantially O 0 1.3175747385490988e-12
elevated O 0 2.8178526179090113e-10
in O 0 6.961915072212221e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.1614395485112254e-08
and O 0 8.29896221188342e-12
has O 0 1.2723521238336422e-12
long O 0 1.8264080840161429e-13
been O 0 1.5601460553148205e-13
associated O 0 2.373519132972679e-12
with O 0 8.747729970948193e-12
chromosomal O 1 1.0
instability O 1 1.0
. O 0 9.22892979815515e-08

By O 0 3.1306890413418387e-10
analysing O 0 1.7756481440756033e-07
tumour B-Disease 1 1.0
DNA O 0 3.1337794581531853e-09
from O 0 3.315985507013064e-12
patients O 0 1.2100360318768877e-13
with O 0 3.813135991312909e-14
sporadic B-Disease 0 0.029569922015070915
T I-Disease 1 0.9920296669006348
- I-Disease 0 9.196419341606088e-07
cell I-Disease 0 0.16356056928634644
prolymphocytic I-Disease 0 0.03759950026869774
leukaemia I-Disease 1 0.9995856881141663
( O 0 6.667758012390834e-11
T B-Disease 0 3.3400505117242574e-07
- I-Disease 0 1.5291563570940525e-09
PLL I-Disease 0 1.5336851788561034e-07
) O 0 5.727777057989644e-14
, O 0 2.4481037721102092e-14
a O 0 3.966548769128442e-13
rare O 0 5.419618226421008e-11
clonal B-Disease 0 8.595022471524771e-09
malignancy I-Disease 0 4.647362494836216e-09
with O 0 3.795647810270718e-14
similarities O 0 1.879206209046136e-12
to O 0 1.0978594335714353e-12
a O 0 2.929700648746092e-10
mature B-Disease 0 1.8455502015513048e-08
T I-Disease 0 2.3269973098649643e-05
- I-Disease 0 6.91088359872083e-08
cell I-Disease 0 0.0006112371338531375
leukaemia I-Disease 0 0.0008651933167129755
seen O 0 7.504430410421037e-11
in O 0 4.75225206408858e-11
A B-Disease 1 1.0
- I-Disease 1 0.8532539010047913
T I-Disease 1 1.0
, O 0 4.3015209449936975e-12
we O 0 4.827370057511327e-13
demonstrate O 0 4.0987409321603663e-13
a O 0 7.899200228384667e-14
high O 0 4.309542360556723e-13
frequency O 0 2.9491862511138445e-12
of O 0 3.015235283676532e-11
ATM O 0 2.4742206505834474e-08
mutations O 0 4.4614929806119363e-11
in O 0 4.117521601454399e-10
T B-Disease 0 1.4614858628192451e-05
- I-Disease 0 1.0835676675924333e-06
PLL I-Disease 0 0.00013674031652044505
. O 0 1.6155061288714023e-08

In O 0 2.776315011221442e-10
marked O 0 4.706843803603533e-10
contrast O 0 9.12992077772845e-12
to O 0 5.746382102794767e-13
the O 0 3.432869960517948e-11
ATM O 0 3.650660929110927e-08
mutation O 0 4.278666830559441e-12
pattern O 0 2.431819155768178e-11
in O 0 1.2680337335702063e-10
A B-Disease 1 1.0
- I-Disease 1 0.9998142123222351
T I-Disease 1 1.0
, O 0 1.4400468664743649e-11
the O 0 9.041367481088525e-12
most O 0 1.0674151314357325e-13
frequent O 0 4.761865272755184e-13
nucleotide O 0 8.61301308052731e-12
changes O 0 1.1759031248725904e-12
in O 0 4.432607167599578e-13
this O 0 1.2761386999210478e-12
leukaemia B-Disease 0 2.0236402065165748e-07
were O 0 2.472925753060906e-10
missense O 0 5.347094855778778e-08
mutations O 0 5.167310135334446e-09
. O 0 4.287774579836423e-09

These O 0 1.3750789396027585e-09
clustered O 0 3.986519114818066e-09
in O 0 7.716521172040913e-11
the O 0 3.162075323803748e-10
region O 0 1.3656790975868915e-10
corresponding O 0 7.982666611061617e-11
to O 0 3.4364011636256464e-11
the O 0 1.7288162013073816e-09
kinase O 0 9.204784157113011e-10
domain O 0 2.6165569710911996e-10
, O 0 2.3508927009946445e-12
which O 0 4.186666475742423e-13
is O 0 1.1901654520859312e-13
highly O 0 1.286670206143703e-12
conserved O 0 1.880408329046901e-11
in O 0 2.6452538076648935e-11
ATM O 0 3.2697116125746106e-07
- O 0 3.981365237493151e-10
related O 0 8.582695665282358e-11
proteins O 0 2.060757380711875e-12
in O 0 8.67551690209023e-12
mouse O 0 6.480142533682454e-10
, O 0 2.143772572654745e-12
yeast O 0 6.016769860117677e-10
and O 0 2.4215635052726725e-10
Drosophila O 0 2.5404089498692883e-08
. O 0 1.3092246176071853e-09

The O 0 7.523917844309835e-08
resulting O 0 4.733515623911444e-08
amino O 0 4.5376484791859184e-08
- O 0 6.247131523196003e-08
acid O 0 3.5994462965760476e-09
substitutions O 0 4.630992922471933e-09
are O 0 4.026187803291004e-12
predicted O 0 1.265322985277706e-10
to O 0 4.773304689877078e-13
interfere O 0 1.550601140543062e-11
with O 0 5.722451050342581e-13
ATP O 0 3.54601041863134e-08
binding O 0 7.01932886815193e-11
or O 0 1.3824771405782088e-12
substrate O 0 6.098022087286381e-11
recognition O 0 1.295378665444602e-10
. O 0 3.7355271653716215e-10

Two O 0 1.3444600988066213e-10
of O 0 1.6252716950049262e-09
seventeen O 0 1.863679166547172e-08
mutated O 0 5.944407632796356e-09
T B-Disease 0 1.3200731530105259e-07
- I-Disease 0 2.4493616024301446e-09
PLL I-Disease 0 1.3372805085509754e-07
samples O 0 7.63730224895287e-12
had O 0 2.7374851517547594e-12
a O 0 6.73585644726804e-13
previously O 0 9.707527837132801e-11
reported O 0 1.953650796693296e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
T I-Disease 1 1.0
allele O 0 2.569543937624985e-07
. O 0 9.414648616257182e-09

In O 0 6.652035033916093e-10
contrast O 0 1.6583036333006618e-10
, O 0 1.4330926202676952e-11
no O 0 2.6714880307920907e-11
mutations O 0 3.979015467808766e-12
were O 0 1.4881943333905356e-12
detected O 0 7.592900266861768e-12
in O 0 2.0404817158842237e-12
the O 0 3.717939497938083e-11
p53 O 0 1.1978231774512071e-11
gene O 0 3.598308066440903e-12
, O 0 2.1889616313129634e-13
suggesting O 0 1.0371629770300483e-12
that O 0 4.8019571717398957e-14
this O 0 2.2631005142798033e-12
tumour B-Disease 1 1.0
suppressor O 0 5.934282754083142e-08
is O 0 2.327538931989198e-13
not O 0 6.172989772340945e-14
frequently O 0 1.174228357776752e-13
altered O 0 3.664019608551339e-12
in O 0 1.1231680733039817e-12
this O 0 1.934176083184802e-11
leukaemia B-Disease 0 2.1312263925210573e-05
. O 0 1.144211481118873e-08

Occasional O 0 1.4536185233282595e-07
missense O 0 1.2672508375999314e-07
mutations O 0 8.884542407328055e-11
in O 0 2.130464728244963e-11
ATM O 0 2.846024642622069e-07
were O 0 1.7136971008913093e-10
also O 0 2.2995286230731438e-12
found O 0 4.631548508431116e-13
in O 0 6.123438995447872e-12
tumour B-Disease 1 1.0
DNA O 0 1.8337105167631762e-09
from O 0 4.835230523261846e-13
patients O 0 8.291849466161155e-14
with O 0 5.4549226735037953e-14
B B-Disease 0 1.7843554815044627e-05
- I-Disease 0 7.483186692525123e-08
cell I-Disease 1 0.9999914169311523
non I-Disease 1 0.9999997615814209
- I-Disease 1 0.9998780488967896
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.2863863706588745
( O 0 4.043210644760764e-12
B B-Disease 0 2.1629975588410844e-09
- I-Disease 0 9.71222668261218e-12
NHL I-Disease 0 2.505838869737431e-10
) O 0 3.061861135185244e-14
and O 0 2.2661663127629406e-13
a O 0 2.864935025326254e-11
B B-Disease 0 2.5997454855541946e-08
- I-Disease 0 3.1441309555901853e-09
NHL I-Disease 0 1.4305597062502784e-07
cell O 0 2.1365929114836035e-07
line O 0 1.2580758657065871e-08
. O 0 1.2930292392354659e-09

The O 0 1.1616179129703141e-09
evidence O 0 7.835468385231081e-11
of O 0 3.2920211695541823e-11
a O 0 3.189268293901648e-12
significant O 0 2.6090989178190194e-12
proportion O 0 5.885417587309094e-12
of O 0 1.4944678827788493e-10
loss O 0 1.0512373194160318e-09
- O 0 1.5188654500786214e-10
of O 0 2.6905608407901127e-08
- O 0 1.098678148458987e-09
function O 0 9.877613393882712e-09
mutations O 0 3.249790193893265e-12
and O 0 2.545112016104356e-13
a O 0 8.609509047526054e-13
complete O 0 1.6115906387170753e-09
absence O 0 6.813837827301938e-10
of O 0 5.640792000161099e-11
the O 0 4.45857326752952e-12
normal O 0 1.8678854036419112e-12
copy O 0 8.23590241144645e-12
of O 0 4.9530700721445164e-12
ATM O 0 4.599827463369621e-10
in O 0 7.112555444784008e-13
the O 0 4.300889505648442e-12
majority O 0 3.5057672910510096e-12
of O 0 1.4578006857224324e-10
mutated O 0 3.035297169162732e-08
tumours B-Disease 1 1.0
establishes O 0 3.168851181456489e-09
somatic O 0 1.1482993445000034e-09
inactivation O 0 1.4606968079533544e-08
of O 0 7.578956212617172e-11
this O 0 1.8197630089009792e-13
gene O 0 3.047558678938994e-13
in O 0 3.116771977226124e-13
the O 0 1.0043621316568885e-11
pathogenesis O 0 2.0274429246569525e-08
of O 0 3.9153433273320104e-10
sporadic B-Disease 0 0.028430921956896782
T I-Disease 1 0.9846153855323792
- I-Disease 0 5.6273261179740075e-06
PLL I-Disease 0 0.0009248792775906622
and O 0 2.0756232843588407e-10
suggests O 0 3.630088937778275e-11
that O 0 1.1847077138749107e-12
ATM O 0 2.255813491558456e-08
acts O 0 9.108257481571513e-10
as O 0 4.947671786159624e-11
a O 0 8.982624644104931e-10
tumour B-Disease 1 1.0
suppressor O 0 6.335052603390068e-06
. O 0 6.38961816790129e-09

As O 0 3.344555521422876e-09
constitutional O 0 1.4697045003231324e-07
DNA O 0 1.8445709404346644e-09
was O 0 1.405112137753406e-10
not O 0 3.1660655000487203e-13
available O 0 6.529986512453234e-13
, O 0 8.496393692769555e-13
a O 0 3.89909528275556e-11
putative O 0 1.5995167856885928e-08
hereditary O 0 0.06175538897514343
predisposition O 0 3.6301710792940867e-07
to O 0 9.43737354930363e-09
T B-Disease 1 0.9992306232452393
- I-Disease 0 7.917246307442838e-07
PLL I-Disease 0 6.368310278048739e-05
will O 0 9.494230922280078e-12
require O 0 2.2455190918507784e-12
further O 0 4.3197959315524614e-13
investigation O 0 1.7705776081400337e-12
. O 0 2.6967000681110687e-12
. O 0 2.419356659455474e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 4.76029708806891e-06
kinase O 0 2.4587899716266293e-08
is O 0 2.4492179118151824e-12
involved O 0 4.3467213471171454e-14
in O 0 2.343905505883953e-14
the O 0 3.287656876339168e-13
modulation O 0 1.7243841987993336e-12
of O 0 4.3310684899600105e-12
the O 0 1.0176229650604718e-11
Ca2 O 0 4.210559331752073e-11
+ O 0 2.6639079830914625e-10
homeostasis O 0 1.6910412625747995e-08
in O 0 1.87898946402143e-10
skeletal O 0 4.378898665891029e-06
muscle O 0 9.087994499168417e-07
cells O 0 1.7235548455118987e-07
. O 0 2.1416424189624195e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999998927116394
DM B-Disease 1 1.0
) O 0 2.4443887886027582e-11
, O 0 1.648886512354772e-13
the O 0 9.817901699959997e-13
most O 0 3.4262876823926147e-12
prevalent O 0 0.000932239752728492
muscular B-Disease 1 1.0
disorder I-Disease 1 0.7754392027854919
in O 0 3.4343892313382085e-11
adults O 0 3.5443783324984324e-13
, O 0 3.463420481940489e-14
is O 0 5.879980747094948e-14
caused O 0 7.55806441737894e-12
by O 0 2.3633866131494985e-12
( O 0 1.642800478984796e-12
CTG O 0 1.25572165998733e-08
) O 0 1.6275570368967825e-14
n O 0 2.559806099727835e-12
- O 0 2.202309298468541e-12
repeat O 0 2.6938893823991172e-11
expansion O 0 7.736973388350332e-12
in O 0 3.361848831002351e-13
a O 0 5.437733054634852e-13
gene O 0 4.657309694150458e-13
encoding O 0 1.2135983407449147e-12
a O 0 4.1573397502325804e-11
protein O 0 1.555768430749893e-10
kinase O 0 4.293928768106525e-09
( O 0 2.0864923122587697e-09
DM B-Disease 1 1.0
protein O 0 4.340195758345544e-09
kinase O 0 3.2284047657427095e-10
; O 0 2.4909306388376518e-12
DMPK O 0 1.8798540679654252e-07
) O 0 1.11192793254139e-13
and O 0 6.98147797711067e-14
involves O 0 1.6042421839730647e-13
changes O 0 5.089342575842482e-13
in O 0 1.9119766533903793e-12
cytoarchitecture O 0 2.7187463391697975e-09
and O 0 1.188611015168206e-10
ion O 0 1.0916584614051317e-07
homeostasis O 0 7.746312803647015e-06
. O 0 2.723611025601258e-08

To O 0 2.9658298039692e-10
obtain O 0 3.004719251187282e-10
clues O 0 1.9211540691621565e-10
to O 0 7.013111879422551e-13
the O 0 3.870603056815858e-12
normal O 0 1.8775054427822013e-11
biological O 0 4.4850331781809416e-11
role O 0 6.980340350876135e-12
of O 0 1.3407698562506454e-10
DMPK O 0 3.9603716572855774e-07
in O 0 1.810501332188963e-10
cellular O 0 1.0545554651741895e-08
ion O 0 3.8451126727068186e-09
homeostasis O 0 1.4466347408870206e-07
, O 0 2.1374371023119565e-11
we O 0 1.1824734767740264e-11
have O 0 2.454810172410754e-13
compared O 0 4.528420281986467e-13
the O 0 4.767686245799041e-11
resting O 0 1.2639895796695555e-09
[ O 0 5.8321368567870735e-12
Ca2 O 0 9.012368759261924e-13
+ O 0 2.281059239064853e-12
] O 0 2.128826628866598e-12
i O 0 4.987784274143592e-13
, O 0 3.6736232274497266e-14
the O 0 3.136517738241973e-13
amplitude O 0 4.986826056263549e-12
and O 0 9.811012679356024e-13
shape O 0 5.43221301274599e-11
of O 0 4.50688340813965e-11
depolarization O 0 9.975760217884044e-10
- O 0 1.468741239740723e-10
induced O 0 1.797231807820765e-09
Ca2 O 0 1.1553238400685562e-11
+ O 0 8.282531778480706e-12
transients O 0 6.552275388926887e-11
, O 0 1.1646365905633622e-14
and O 0 2.1179177931828636e-14
the O 0 5.807335948931902e-13
content O 0 6.146182738100969e-13
of O 0 9.859415367463598e-12
ATP O 0 6.764117266300218e-09
- O 0 3.2460003435152984e-11
driven O 0 5.7818111409702055e-11
ion O 0 1.8382866062705006e-10
pumps O 0 1.5494606986354853e-10
in O 0 6.92000137747506e-11
cultured O 0 6.419571096927257e-09
skeletal O 0 4.4596061343327165e-05
muscle O 0 1.2508332147831425e-08
cells O 0 2.8976734900432177e-10
of O 0 1.1134236588272728e-10
wild O 0 6.799323326589501e-10
- O 0 4.622196722592342e-12
type O 0 1.8723914779750217e-11
and O 0 6.204867782771961e-12
DMPK O 0 9.283234447821087e-08
[ O 0 7.799712264944247e-11
- O 0 1.9728332856239206e-10
/ O 0 1.1457270687742493e-08
- O 0 8.801835704730365e-09
] O 0 4.090314753568691e-09
knockout O 0 0.00010212148481514305
mice O 0 3.9293456666200655e-07
. O 0 1.504622204606676e-09

In O 0 7.371946608714097e-09
vitro O 0 2.628625850320532e-07
- O 0 5.228961441616775e-08
differentiated O 0 1.1972224456258118e-07
DMPK O 0 8.491759217577055e-06
[ O 0 1.9002801554535154e-09
- O 0 1.384659054082249e-09
/ O 0 2.7459099882776172e-08
- O 0 4.082302496044576e-09
] O 0 3.991950103809927e-10
myotubes O 0 1.0450246001880714e-08
exhibit O 0 1.8001848622883898e-10
a O 0 4.59622929993575e-11
higher O 0 1.7236230498429705e-10
resting O 0 7.216585107272522e-10
[ O 0 9.954500765352314e-12
Ca2 O 0 4.9523900605419335e-12
+ O 0 1.6246873638103843e-11
] O 0 1.4358094574395963e-11
i O 0 2.2990461531063877e-12
than O 0 4.3877035116107396e-14
do O 0 4.3004770751420285e-13
wild O 0 1.8509560550938886e-10
- O 0 1.4083660453134694e-11
type O 0 3.4557714329030986e-11
myotubes O 0 6.703441135513799e-10
because O 0 2.927048794315601e-13
of O 0 3.6115648232443176e-12
an O 0 5.2784270959107746e-14
altered O 0 9.022848440620734e-12
open O 0 3.11621076165558e-11
probability O 0 3.136507329901117e-12
of O 0 3.829436767688321e-12
voltage O 0 8.798641815133124e-10
- O 0 8.880746832362618e-11
dependent O 0 7.061723428236633e-11
l O 0 1.2099794256814622e-11
- O 0 5.056592297658646e-12
type O 0 1.6704453792426577e-11
Ca2 O 0 2.8716900819097946e-12
+ O 0 3.1676137407510296e-12
and O 0 8.238663115438249e-13
Na O 0 3.5896949301950087e-10
+ O 0 2.369082360842434e-12
channels O 0 1.9098710460352386e-11
. O 0 8.211343410780003e-11

The O 0 1.7765137272363063e-07
mutant O 0 1.9213270263662707e-07
myotubes O 0 2.1580706288659712e-07
exhibit O 0 1.9971821973996384e-09
smaller O 0 5.289097285143818e-11
and O 0 1.586942730003038e-11
slower O 0 2.528794396106093e-10
Ca2 O 0 2.8886937980532323e-11
+ O 0 1.4842634066258853e-11
responses O 0 4.836272441549605e-13
upon O 0 2.2942539795040018e-12
triggering O 0 2.971853665933999e-11
by O 0 2.1164690280298798e-13
acetylcholine O 0 4.2959910628859177e-10
or O 0 4.866282290322266e-12
high O 0 4.22924251175516e-10
external O 0 3.08345904365126e-09
K O 0 2.4886739335983066e-09
+ O 0 3.5349451144028876e-10
. O 0 1.8358443931720814e-10

In O 0 5.625644949880382e-10
addition O 0 2.089931526449984e-11
, O 0 3.7674143318899844e-12
we O 0 9.5605175252228e-13
observed O 0 6.300353576522977e-13
that O 0 2.622996339850551e-15
these O 0 4.651214614468605e-15
Ca2 O 0 8.943649857165448e-13
+ O 0 2.1321883494906935e-11
transients O 0 8.569122078583291e-10
partially O 0 4.551631987981253e-11
result O 0 8.285751099991467e-13
from O 0 2.335694029680091e-14
an O 0 9.486541157385352e-15
influx O 0 1.1653793706954685e-13
of O 0 1.9646714810583887e-12
extracellular O 0 1.4656056316481036e-12
Ca2 O 0 2.40200952661071e-13
+ O 0 2.1971098172150066e-13
through O 0 4.445660893993668e-14
the O 0 2.1891338568280627e-12
l O 0 4.3803808779004083e-13
- O 0 3.241140808431936e-13
type O 0 1.6794279725576566e-12
Ca2 O 0 2.2579525055244076e-12
+ O 0 6.108984845765164e-12
channel O 0 9.21591761238183e-11
. O 0 1.169273011747407e-10

Neither O 0 2.1235752711845635e-08
the O 0 5.114144663309617e-10
content O 0 3.961970682087035e-11
nor O 0 1.3170081691882274e-10
the O 0 3.75725318912945e-12
activity O 0 5.689304062583833e-12
of O 0 1.3447492251683624e-11
Na O 0 2.607486004890802e-09
+ O 0 2.7310716188555517e-11
/ O 0 3.699478778873555e-10
K O 0 1.3314301050559862e-10
+ O 0 5.193129780367567e-12
ATPase O 0 2.5136788484036998e-11
and O 0 2.181198364287207e-12
sarcoplasmic O 0 5.521561541321773e-10
reticulum O 0 2.7305664673793473e-11
Ca2 O 0 1.3404700092978228e-11
+ O 0 2.3381491187635106e-11
- O 0 1.0425264818092472e-11
ATPase O 0 4.60851877492896e-11
are O 0 1.362063809179706e-13
affected O 0 8.049810817922776e-13
by O 0 4.9443860464237765e-12
DMPK O 0 2.13161256397143e-05
absence O 0 2.6823553866961447e-07
. O 0 6.151097409201611e-09

In O 0 1.888508016634205e-09
conclusion O 0 1.563211227129102e-09
, O 0 1.4395223728314033e-11
our O 0 1.526304950483226e-11
data O 0 7.590063126616808e-12
suggest O 0 1.6229211984714054e-12
that O 0 1.0353638112874444e-13
DMPK O 0 5.642306533104602e-08
is O 0 2.1495363811390583e-13
involved O 0 1.132703787265054e-14
in O 0 6.295581189610239e-14
modulating O 0 1.0493412562484483e-11
the O 0 7.405603907884029e-12
initial O 0 4.7256846873178215e-12
events O 0 8.485089800919221e-13
of O 0 1.588962815490813e-11
excitation O 0 1.6699859273217044e-08
- O 0 2.6430234001395547e-08
contraction O 0 1.3257449360537521e-08
coupling O 0 8.503219461886147e-09
in O 0 5.654841594981974e-10
skeletal O 0 3.5978893720312044e-05
muscle O 0 3.148396956476063e-07
. O 0 1.4209059484571185e-09
. O 0 1.465741972239698e-09

Constitutional O 0 0.00010463493526913226
RB1 O 0 0.00035976149956695735
- O 0 5.1741871232025005e-08
gene O 0 5.562862392949341e-10
mutations O 0 2.3168668372708368e-11
in O 0 9.393862424045274e-12
patients O 0 4.062163799778418e-12
with O 0 3.242867563021945e-12
isolated O 0 3.003954702762712e-07
unilateral B-Disease 0 0.0073721036314964294
retinoblastoma I-Disease 1 0.9960328936576843
. O 0 1.5000546227383893e-07

In O 0 2.2793533727138993e-09
most O 0 1.8869877882465858e-10
patients O 0 8.162775143316647e-12
with O 0 1.0586707292065123e-12
isolated O 0 7.22700548294597e-08
unilateral B-Disease 0 0.0012065351475030184
retinoblastoma I-Disease 1 0.9971290230751038
, O 0 9.506920251034501e-11
tumor B-Disease 0 5.0230447357080266e-08
development O 0 7.44980951927765e-11
is O 0 4.8715893786414194e-14
initiated O 0 1.4770722622445276e-12
by O 0 1.3619754467026485e-13
somatic O 0 6.331307700335742e-11
inactivation O 0 3.4038920571077824e-09
of O 0 3.4156927286588257e-11
both O 0 1.2497122477486688e-12
alleles O 0 4.551298032028084e-13
of O 0 4.737419484479588e-11
the O 0 2.4417770028151153e-09
RB1 O 0 1.891585952762398e-06
gene O 0 6.61453869454931e-09
. O 0 5.955461013229524e-09

However O 0 6.335143076796612e-09
, O 0 2.4550514399201973e-11
some O 0 4.716614468783242e-13
of O 0 1.0225928437357368e-10
these O 0 1.9369892842457936e-11
patients O 0 1.5566282637879958e-11
can O 0 1.828022759206571e-12
transmit O 0 9.063200190340126e-10
retinoblastoma B-Disease 0 7.773908237140859e-07
predisposition O 0 2.9166205561814706e-10
to O 0 4.484140923161073e-12
their O 0 1.504455032774743e-10
offspring O 0 1.0412552070571124e-10
. O 0 2.1461230015340504e-10

To O 0 2.6554702881043113e-11
determine O 0 9.758984419183658e-12
the O 0 3.6289380788562253e-12
frequency O 0 2.7275215072619652e-11
and O 0 4.648594334986933e-13
nature O 0 2.2474012234541263e-11
of O 0 1.3188231062777334e-10
constitutional O 0 4.578806169774907e-07
RB1 O 0 4.791259470948717e-06
- O 0 1.4415981741677797e-09
gene O 0 8.980993032592366e-11
mutations O 0 7.924455362740002e-12
in O 0 2.732414555034479e-12
patients O 0 1.324999138185845e-12
with O 0 3.8535553871163475e-13
isolated O 0 2.127921661099208e-08
unilateral B-Disease 0 2.3509510356234387e-05
retinoblastoma I-Disease 0 1.6963989764917642e-05
, O 0 2.0743635975595254e-11
we O 0 9.548931090286317e-12
analyzed O 0 3.403336640284138e-11
DNA O 0 9.616398649603397e-11
from O 0 5.410805484218351e-12
peripheral O 0 4.240797935040064e-08
blood O 0 5.672122493916021e-11
and O 0 1.1936563716619109e-11
from O 0 4.131057648737446e-11
tumor B-Disease 0 2.110658897436224e-06
tissue O 0 1.095799433414868e-07
. O 0 1.017436357386714e-08

The O 0 1.6431006555350791e-09
analysis O 0 1.0506816250366313e-10
of O 0 1.3769430928789461e-08
tumors B-Disease 1 1.0
from O 0 4.1351963520064317e-11
54 O 0 5.102218647579093e-10
( O 0 2.0813854112455843e-12
71 O 0 6.830441212635208e-10
% O 0 1.8864352354514002e-12
) O 0 5.868967285901569e-14
of O 0 2.45385760322403e-11
76 O 0 9.99709914850655e-09
informative O 0 6.113210493374766e-10
patients O 0 2.2183728812241732e-11
showed O 0 1.4951036242383253e-10
loss O 0 2.13466758158809e-10
of O 0 4.6104553508286017e-10
constitutional O 0 1.1351441031592913e-07
heterozygosity O 0 1.8862758111026778e-07
( O 0 1.529879001260781e-10
LOH O 0 0.2635391354560852
) O 0 3.9533799844893025e-11
at O 0 6.309253564040773e-09
intragenic O 0 5.76259651552391e-07
loci O 0 5.675940428773174e-08
. O 0 1.3984000624134296e-08

Three O 0 2.668542053996248e-09
of O 0 1.917370795467832e-08
13 O 0 7.321070256693929e-07
uninformative O 0 0.003937089815735817
patients O 0 9.04383412603238e-08
had O 0 6.715499267784253e-09
constitutional O 0 2.2129725039121695e-06
deletions O 0 1.8584013616873563e-07
. O 0 3.5750353788444045e-08

For O 0 5.518142831562045e-09
39 O 0 2.3721844044644058e-08
randomly O 0 1.0110461357015765e-09
selected O 0 7.859034312218682e-09
tumors B-Disease 1 1.0
, O 0 1.7847462396858305e-09
SSCP O 0 0.0007678563706576824
, O 0 7.651336231262462e-10
hetero O 0 8.231973325223407e-09
- O 0 9.654220478605424e-11
duplex O 0 4.4212827843281843e-10
analysis O 0 2.1889085596166202e-12
, O 0 6.636408951673708e-14
sequencing O 0 7.988751262073823e-13
, O 0 2.0009148960116463e-13
and O 0 4.1074904436923243e-13
Southern O 0 2.4243719878858094e-11
blot O 0 4.93273033530528e-10
analysis O 0 1.3820849846524208e-11
were O 0 1.934168797346203e-11
used O 0 1.154688757804001e-12
to O 0 5.806142892861299e-12
identify O 0 2.289369110952677e-10
mutations O 0 7.867054230281667e-10
. O 0 2.699534373817869e-09

Mutations O 0 7.275350322188956e-10
were O 0 3.8318133388504094e-11
detected O 0 1.4200592958479863e-11
in O 0 7.217579398727247e-13
21 O 0 2.3222657130617108e-10
( O 0 1.3085835583528937e-12
91 O 0 1.7073806257705826e-10
% O 0 2.2489007184267606e-12
) O 0 1.8942294022390727e-13
of O 0 1.474731725625844e-10
23 O 0 7.140900493141089e-07
tumors B-Disease 1 1.0
with O 0 2.618027394873934e-08
LOH O 1 1.0
. O 0 1.536477043373452e-07

In O 0 8.838573206659817e-10
6 O 0 9.537533429693212e-09
( O 0 8.59555048665639e-12
38 O 0 6.579702060971471e-11
% O 0 2.1034233382843937e-12
) O 0 2.6644477097749475e-13
of O 0 3.481787635983835e-10
16 O 0 3.405394579658605e-07
tumors B-Disease 1 1.0
without O 0 1.4758192889985366e-08
LOH O 1 0.9999957084655762
, O 0 4.5217939635688875e-12
one O 0 4.987708379991518e-13
mutation O 0 3.7121393741020026e-13
was O 0 4.892527789152057e-12
detected O 0 5.865223671325248e-12
, O 0 5.412224420259064e-14
and O 0 3.517250103364858e-14
in O 0 1.1217293370210935e-12
9 O 0 4.917549145666555e-10
( O 0 2.355361457088978e-13
56 O 0 1.8384014796590797e-11
% O 0 1.4091204331850848e-12
) O 0 1.5993326454855072e-13
of O 0 2.1650602144429598e-10
the O 0 1.4625484823227453e-07
tumors B-Disease 1 1.0
without O 0 6.4305512026408e-09
LOH O 1 0.9999672174453735
, O 0 5.508827335271027e-12
both O 0 2.1830712151199583e-12
mutations O 0 1.689652584513368e-11
were O 0 8.472483825627819e-11
found O 0 1.474346339458421e-10
. O 0 1.3591054948136616e-09

Thus O 0 1.6421669579713694e-09
, O 0 5.598151716496025e-12
a O 0 1.205399495496362e-12
total O 0 3.885500428346678e-12
of O 0 8.442270493791426e-11
45 O 0 1.1722363357780097e-10
mutations O 0 1.6027911636795622e-11
were O 0 1.3750461706762973e-11
identified O 0 2.980857227719014e-11
in O 0 2.478251770465789e-10
tumors B-Disease 1 1.0
of O 0 1.3233669449164154e-07
36 O 0 2.885136325403437e-07
patients O 0 1.154898132682547e-08
. O 0 1.0797345240121103e-08

Thirty O 0 3.745540055888341e-08
- O 0 1.0833129948650821e-09
nine O 0 3.3728625448148364e-10
of O 0 7.163075688154663e-10
the O 0 3.844545792830445e-10
mutations O 0 1.3272711055223319e-11
- O 0 8.713180871255943e-11
including O 0 6.097033294905074e-11
34 O 0 1.5253752705390866e-09
small O 0 4.9583847444578666e-11
mutations O 0 2.950093294651346e-11
, O 0 5.2761774983756116e-12
2 O 0 1.5625584159906225e-09
large O 0 6.31736329914645e-11
structural O 0 1.413750283063564e-06
alterations O 0 1.0084412593869274e-07
, O 0 4.597106029180509e-11
and O 0 4.334805778216655e-11
hypermethylation O 0 0.00018721367814578116
in O 0 9.223399821678413e-09
3 O 0 1.0557948371570092e-05
tumors O 1 1.0
- O 0 8.458505562636276e-10
were O 0 4.9100865734397203e-11
not O 0 1.364442955321954e-13
detected O 0 2.4563617199296894e-12
in O 0 2.0195181789882388e-13
the O 0 4.18071610316928e-12
corresponding O 0 7.763467646526578e-11
peripheral O 0 4.492274285894382e-08
blood O 0 3.3809782751248463e-10
DNA O 0 4.754995064359946e-09
. O 0 6.949208986029021e-10

In O 0 5.186166496251587e-10
6 O 0 6.32205843231759e-09
( O 0 3.2786035171483707e-12
17 O 0 4.854446705726545e-11
% O 0 5.687727849465474e-13
) O 0 1.3112330909644324e-14
of O 0 2.4101792610309314e-12
the O 0 1.7118152728645697e-10
36 O 0 7.386594669256397e-10
patients O 0 9.554579349924097e-12
, O 0 1.1716740858785935e-12
a O 0 4.505239497437641e-12
mutation O 0 2.2812418187106998e-12
was O 0 8.809749804661315e-12
detected O 0 3.54824915109464e-12
in O 0 5.64632975791346e-13
constitutional O 0 1.7586119227530617e-09
DNA O 0 8.170785575911665e-11
, O 0 4.902669524693704e-13
and O 0 1.3212338124610201e-12
1 O 0 3.0762908886927676e-10
of O 0 1.020955750496988e-10
these O 0 9.527205413473183e-13
mutations O 0 9.637007988491653e-13
is O 0 7.797974370176916e-14
known O 0 2.3952199815560626e-13
to O 0 7.221500009308227e-14
be O 0 2.9157931494619427e-13
associated O 0 2.015148031081493e-12
with O 0 2.1756927856553254e-12
reduced O 0 1.4230874256782045e-08
expressivity O 0 4.4580554003914585e-07
. O 0 5.6103139911556354e-09

The O 0 1.9288139974094065e-09
presence O 0 5.5527252934561844e-11
of O 0 4.870930325751033e-10
a O 0 1.9118255589756217e-10
constitutional O 0 4.29679865021626e-08
mutation O 0 8.854818267511888e-11
was O 0 3.3996257198243285e-11
not O 0 3.844215324213564e-14
associated O 0 9.115295595153033e-14
with O 0 2.6838266462323292e-15
an O 0 1.4400994977135755e-14
early O 0 1.8692915271234511e-10
age O 0 2.544654487124376e-10
at O 0 1.6967600657835646e-08
treatment O 0 3.069834875191191e-08
. O 0 4.256435648386514e-09

In O 0 3.671785009373707e-08
1 O 0 5.563641707340139e-07
patient O 0 7.479088459660943e-09
, O 0 6.744965697080829e-11
somatic O 0 2.862055659136331e-08
mosaicism O 0 3.054183252970688e-07
was O 0 2.952554867263757e-10
demonstrated O 0 1.0422038666108024e-12
by O 0 1.085577245772077e-14
molecular O 0 4.0187281670836517e-13
analysis O 0 3.6559385347637724e-14
of O 0 1.7001905525809713e-12
DNA O 0 1.1264166682734e-11
and O 0 2.7537609779276773e-12
RNA O 0 1.7175615096842733e-10
from O 0 2.8530254547742828e-11
peripheral O 0 3.6679639947578835e-07
blood O 0 5.305916594977589e-09
. O 0 1.052590192784919e-08

In O 0 3.0099862602384064e-09
2 O 0 8.630263437225949e-08
patients O 0 2.0910877196467226e-11
without O 0 2.3778012978731278e-12
a O 0 2.0309609029267595e-12
detectable O 0 5.488207222015262e-09
mutation O 0 2.7023793359309822e-12
in O 0 1.1125267374012537e-12
peripheral O 0 6.738633206992972e-09
blood O 0 1.1187108531207635e-11
, O 0 1.188949980135412e-12
mosaicism O 0 5.985081941162207e-08
was O 0 1.593415954737054e-10
suggested O 0 4.443207520660186e-12
because O 0 9.883204823112057e-14
1 O 0 2.063834346477389e-11
of O 0 4.7573286456048525e-12
the O 0 5.1654326649330784e-11
patients O 0 2.2687721493164226e-11
showed O 0 3.3919619113476074e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 2.1935989483190532e-11
the O 0 2.8314116676253498e-11
other O 0 1.7160297976440836e-13
later O 0 1.4468139360179766e-11
developed O 0 6.074270947342697e-11
bilateral B-Disease 0 3.5055720548626823e-09
retinoblastoma I-Disease 0 3.5420563904153823e-07
. O 0 9.925848587499786e-09

In O 0 3.9125816475582553e-10
conclusion O 0 7.816813307748305e-10
, O 0 1.590757907343754e-11
our O 0 1.9626574671027797e-11
results O 0 3.367613696583782e-12
emphasize O 0 9.904652618908383e-12
that O 0 3.123418068780824e-14
the O 0 9.959242631973897e-13
manifestation O 0 6.172931610315402e-10
and O 0 4.807827747033144e-12
transmissibility O 0 3.366514400582332e-09
of O 0 6.556450521388868e-11
retinoblastoma B-Disease 0 5.630142463353138e-10
depend O 0 2.0787115518478005e-12
on O 0 1.9820084809496485e-11
the O 0 2.3460907695727062e-12
nature O 0 6.617682964116245e-12
of O 0 1.988218097104255e-11
the O 0 2.6299599650836392e-11
first O 0 7.312100924750098e-11
mutation O 0 2.5707365923499648e-12
, O 0 7.279142566485319e-13
its O 0 3.6079294933599737e-12
time O 0 6.479691783134456e-12
in O 0 1.2625644453534424e-11
development O 0 1.8527998579820348e-10
, O 0 1.948705519866367e-12
and O 0 3.1435147453823253e-12
the O 0 4.910180248507423e-11
number O 0 5.451446585813535e-11
and O 0 9.843782039498095e-12
types O 0 1.2061182608213983e-10
of O 0 5.992124019194023e-10
cells O 0 8.972238750570849e-12
that O 0 1.915355623671039e-13
are O 0 1.5273226476944513e-13
affected O 0 1.4971140646635739e-12
. O 0 4.425175503808276e-12
. O 0 4.836584466261229e-10

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
of I-Disease 1 0.9408583045005798
the I-Disease 0 1.2656580565817421e-06
fifth I-Disease 0 1.7358205468553933e-06
component I-Disease 0 1.7127902651736804e-08
of I-Disease 0 3.1855160731453225e-09
complement I-Disease 0 1.8373795818149574e-09
in O 0 8.893532577047836e-10
man O 0 1.5104081541039704e-08
. O 0 6.847806766074882e-09

I O 0 0.00022198943770490587
. O 0 5.275735475152032e-07

Clinical O 0 3.5028231650358066e-05
, O 0 1.9284167596111956e-09
immunochemical O 0 2.434599309708574e-06
, O 0 4.1767825309513285e-10
and O 0 9.484823343397508e-11
family O 0 6.844313310550021e-11
studies O 0 7.278986302594603e-10
. O 0 3.4925244918326825e-09

The O 0 2.9883857610712994e-09
first O 0 2.1068785605038443e-10
recognized O 0 5.963665117292294e-10
human O 0 1.064899723957069e-09
kindred O 0 2.568149852777424e-07
with O 0 2.140494892444167e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9993135929107666
the I-Disease 0 5.024203801440308e-06
fifth I-Disease 0 4.291941593237425e-07
component I-Disease 0 5.03078956270997e-09
of I-Disease 0 5.9824203368918916e-09
complement I-Disease 0 8.365739212479184e-09
( O 0 4.0261460831914064e-10
C5 O 0 5.338146002031863e-05
) O 0 7.30755300021313e-12
is O 0 5.610465651090246e-12
described O 0 4.121481766983237e-10
. O 0 2.1353772083898548e-09

The O 0 4.416314425270684e-08
proband O 0 6.081560286474996e-07
, O 0 1.8037042692764516e-10
a O 0 1.971466739858485e-11
20 O 0 1.0691400022244668e-11
- O 0 1.4011418978179813e-12
year O 0 1.0582367230768663e-12
- O 0 2.2782513722785502e-11
old O 0 8.572110382631948e-11
black O 0 1.1096466627502632e-12
female O 0 4.39401831163911e-14
with O 0 1.1603943500526626e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 3.5606637993623735e-07
age O 0 1.8441629334731147e-09
11 O 0 2.3440187568724014e-09
, O 0 1.4610234896905716e-11
lacked O 0 1.436173704405519e-07
serum O 0 8.621884539650182e-09
hemolytic O 0 7.208899660327006e-06
complement O 0 3.5346214843912094e-10
activity O 0 1.0703463809713654e-10
, O 0 2.084920506639082e-13
even O 0 3.510114291241373e-13
during O 0 1.1307461217358039e-10
remission O 0 8.402027162901504e-08
. O 0 7.674487711994971e-10

C5 O 0 0.0008942882413975894
was O 0 7.846965388580429e-08
undetectable O 0 2.3855153585827793e-07
in O 0 9.178954818445106e-11
her O 0 6.49649735048885e-12
serum O 0 1.1707810936012475e-11
by O 0 3.729528838536389e-12
both O 0 3.620967761741589e-11
immunodiffusion O 0 2.435457986393885e-07
and O 0 2.111018693184974e-09
hemolytic O 0 0.07851415127515793
assays O 0 6.363034685819002e-07
. O 0 2.1740753197718732e-08

Other O 0 1.044740544076106e-10
complement O 0 4.3067199112512e-11
components O 0 5.723824192394034e-10
were O 0 1.4847191184830244e-11
normal O 0 1.5810181289155345e-11
during O 0 1.3698995063315955e-11
remission O 0 2.2685535672195556e-09
of O 0 5.673791436677789e-10
lupus O 0 9.846352213571663e-07
, O 0 1.0190919635943985e-10
but O 0 4.801179454005933e-10
C1 O 0 2.590697647519846e-07
, O 0 8.215572666614435e-11
C4 O 0 0.0007179938838817179
, O 0 2.5676324955092866e-10
C2 O 0 1.0572058783964167e-08
, O 0 7.546611772990541e-12
and O 0 9.954201352080361e-11
C3 O 0 0.0001486998808104545
levels O 0 6.229604565533009e-08
fell O 0 2.5631391054048436e-07
during O 0 5.6539093407081964e-08
exacerbations O 0 0.001746910740621388
. O 0 3.436773354792422e-08

A O 0 1.306638205278432e-05
younger O 0 3.621869471004402e-09
half O 0 1.5290601007578175e-09
- O 0 2.394320519627513e-09
sister O 0 2.0613266649149864e-09
, O 0 6.949894826302483e-11
who O 0 3.7849615802665326e-11
had O 0 2.3412563554536803e-10
no O 0 1.4755202615290841e-09
underlying O 1 0.9999146461486816
disease O 1 0.9687073230743408
, O 0 5.539446505664625e-12
was O 0 6.718724465670789e-10
also O 0 6.848018246213838e-12
found O 0 9.133504499589384e-13
to O 0 2.0035661497941337e-12
lack O 0 7.549289904318357e-08
immunochemically O 0 1.912249717861414e-05
detectable O 0 0.047515369951725006
C5 O 0 0.0002930217597167939
. O 0 1.5006049736143723e-08

By O 0 5.1169082304625135e-09
hemolytic O 1 0.9568184018135071
assay O 0 1.9761631619985565e-07
, O 0 1.0214641632533272e-10
she O 0 3.1836161311360467e-12
exhibited O 0 1.8373366716950557e-10
1 O 0 6.321765888550601e-10
- O 0 1.1968959677532975e-11
2 O 0 2.3702359519539584e-11
% O 0 1.0848161019656744e-13
of O 0 4.600682248362409e-12
the O 0 7.947512092876252e-11
normal O 0 5.197021923919465e-09
serum O 0 9.755979357706224e-10
C5 O 0 1.524158079746485e-07
level O 0 8.038223975326275e-10
and O 0 1.1138849852253621e-13
normal O 0 7.008008322956227e-12
concentrations O 0 9.38548197493283e-12
of O 0 6.225969826495481e-12
other O 0 6.102146240562212e-13
complement O 0 8.970909431971208e-11
components O 0 1.6528959534412024e-08
. O 0 5.2286197593787165e-09

C5 O 0 0.0003370334452483803
levels O 0 2.250209796272884e-08
of O 0 6.926214268787589e-09
other O 0 4.703664541194641e-11
family O 0 2.7166546789914037e-11
members O 0 8.981210740388601e-12
were O 0 4.4397704263010596e-11
either O 0 2.944376339963917e-11
normal O 0 6.028981203165529e-10
or O 0 1.555297991090443e-12
approximately O 0 7.390782864186152e-13
half O 0 6.687470455873923e-12
- O 0 2.3582500535690443e-11
normal O 0 3.0083835422800576e-10
, O 0 6.171697809927157e-13
consistent O 0 8.622632469146296e-11
with O 0 1.346129154325415e-12
autosomal O 0 5.5433231338497535e-09
codominant O 0 2.464400772339559e-08
inheritance O 0 1.2305867262696335e-11
of O 0 9.735039163683012e-12
the O 0 1.42944276207424e-11
gene O 0 6.222177217907188e-10
determining O 0 3.9897390280430045e-08
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.167910390151519e-07

Normal O 0 5.319098363543162e-06
hemolytic O 0 0.007184816058725119
titers O 0 5.083869041300204e-07
were O 0 1.0363256086609596e-10
restored O 0 2.264908927074316e-09
to O 0 5.895323834138877e-13
both O 0 1.0898734172093416e-11
homozygous O 0 5.739791959058493e-06
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 7.305625882025879e-09
C5D B-Disease 1 1.0
) O 0 1.3811382593154065e-12
sera O 0 9.710268700224844e-11
by O 0 7.644843688214137e-14
addition O 0 9.976353510660063e-13
of O 0 7.594338352623353e-11
highly O 0 5.238499634074856e-10
purified O 0 4.435144695946747e-09
human O 0 1.26332748706659e-08
C5 O 0 1.943678034876939e-05
. O 0 1.3908376672588929e-08

In O 0 3.407666149257693e-09
specific O 0 3.2882592204686034e-09
C5 O 0 2.747534608715796e-06
titrations O 0 4.175622070334839e-09
, O 0 3.3410498759961493e-12
however O 0 1.1773283086283226e-12
, O 0 1.473447286490931e-13
it O 0 2.927259468350242e-14
was O 0 9.379217888461078e-12
noted O 0 9.891507101247865e-13
that O 0 2.029835684030836e-14
when O 0 8.016832775967556e-14
limited O 0 9.730764371357337e-13
amounts O 0 6.178328248312992e-13
of O 0 4.8490236131959463e-11
C5 O 0 2.732357629042781e-08
were O 0 2.0323647278996937e-11
assayed O 0 5.146491913188278e-11
in O 0 9.223926960774675e-13
the O 0 4.884955721179418e-12
presence O 0 2.0300120091854e-12
of O 0 6.905392230249774e-11
low O 0 9.971047099099906e-09
dilutions O 0 7.396075574206407e-08
of O 0 2.7927182344456014e-08
either O 0 5.050627009950404e-07
C5D B-Disease 1 1.0
serum O 0 1.6365643062954405e-08
, O 0 3.758738806314277e-11
curving O 0 5.047741669095274e-10
rather O 0 4.5242244195789483e-13
than O 0 1.8520610866874614e-14
linear O 0 8.616150327933614e-12
dose O 0 4.728772928785929e-10
- O 0 2.3771085794210833e-11
response O 0 3.631042732113454e-12
plots O 0 3.7566959959489665e-11
were O 0 7.289691419942734e-12
consistently O 0 2.4379667121904314e-12
obtained O 0 5.410039278543055e-13
, O 0 2.528274356365656e-13
suggesting O 0 4.022810296683277e-12
some O 0 6.639248070587633e-13
inhibitory O 0 1.9675319151701842e-09
effect O 0 8.75375150144464e-09
. O 0 6.949897879415801e-10

Further O 0 6.035505428769739e-10
studies O 0 3.871712325742571e-11
suggested O 0 2.8640060809048684e-11
that O 0 9.363912640072969e-13
low O 0 5.182885676191518e-09
dilutions O 0 6.25985819624475e-07
of O 0 2.321281954209553e-06
C5D B-Disease 1 1.0
serum O 0 3.1018885238154326e-08
contain O 0 2.9219660024892846e-10
a O 0 1.2042144191537485e-11
factor O 0 3.822562492233894e-12
( O 0 7.125968245385098e-14
or O 0 2.04003697615307e-13
factors O 0 1.6710020953741855e-12
) O 0 4.7295480520240935e-14
interfering O 0 2.278563188823357e-12
at O 0 1.306176000692716e-10
some O 0 5.917561904898727e-13
step O 0 5.4731063431345817e-11
in O 0 4.078583824840276e-12
the O 0 3.6266584180211225e-10
hemolytic O 0 1.0672165444702841e-05
assay O 0 5.298617367088809e-08
of O 0 8.256050421096006e-08
C5 O 0 3.214956814190373e-05
, O 0 8.097648940275093e-11
rather O 0 1.2726148260200354e-11
than O 0 9.07200801026492e-13
a O 0 1.6098693211841208e-10
true O 0 7.079707486923326e-09
C5 O 0 2.8964201192138717e-05
inhibitor O 0 1.9775594495285986e-08
or O 0 4.322761593122948e-10
inactivator O 0 1.3866467725165421e-06
. O 0 2.5829752559047847e-08

Of O 0 1.3562754475060501e-06
clinical O 0 0.0001765882916515693
interest O 0 2.3604586729675248e-08
are O 0 2.636303154945896e-11
( O 0 1.5034466727126272e-12
a O 0 5.256449789325934e-12
) O 0 2.4204964272603498e-14
the O 0 9.825469431123945e-13
documentation O 0 3.445308482952214e-10
of O 0 5.911986455942042e-10
membranous O 1 0.9999998807907104
glomerulonephritis B-Disease 1 1.0
, O 0 1.9592492961351127e-08
vasculitis B-Disease 1 1.0
, O 0 1.6124207524725875e-09
and O 0 5.001461886422476e-06
arthritis B-Disease 1 1.0
in O 0 2.9135751589137726e-09
an O 0 5.369701645135949e-12
individual O 0 1.6185085216502415e-10
lacking O 0 0.035291098058223724
C5 O 0 0.019559264183044434
( O 0 8.944195210858208e-13
and O 0 7.910980356039266e-13
its O 0 1.7393279741831358e-12
biologic O 0 3.8167963234414515e-10
functions O 0 1.2503178830822193e-12
) O 0 9.381811039171515e-16
, O 0 2.3499654336984945e-15
and O 0 1.9786362693142816e-14
( O 0 2.913045577868957e-14
b O 0 4.4845516189440104e-12
) O 0 2.7674324827196492e-14
a O 0 6.74261753201566e-13
remarkable O 0 2.5518127541590552e-11
propensity O 0 1.7229788429329318e-10
to O 0 3.41688352958891e-12
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 6.78100327625164e-12
the O 0 1.3046217751944145e-11
proband O 0 3.6112051127190625e-09
, O 0 1.2315675822910377e-12
even O 0 1.4330035639012473e-13
during O 0 1.1747397759415135e-12
periods O 0 4.1499876451966955e-11
of O 0 4.4057403558728225e-11
low O 0 3.950050841972086e-10
- O 0 2.4842039883510303e-11
dose O 0 3.8953434922106567e-10
or O 0 9.163556198565903e-12
alternate O 0 6.584425782385495e-10
- O 0 3.75263908836132e-09
day O 0 9.889490115710942e-09
corticosteroid O 0 0.0005637835711240768
therapy O 0 3.150709915189509e-07
. O 0 1.1726729587380191e-09

Other O 0 1.4793603841933844e-10
observations O 0 5.040321979232765e-11
indicate O 0 9.424120338275e-12
that O 0 7.12632535447566e-13
the O 0 6.057567225603577e-10
C5D B-Disease 1 1.0
state O 0 4.388296323543095e-11
is O 0 2.21390695489751e-13
compatible O 0 1.4040934213921386e-11
with O 0 3.908299804123751e-14
normal O 0 2.0648737927841943e-11
coagulation O 0 4.845702398365015e-12
function O 0 2.1565855004568313e-11
and O 0 1.491936592714141e-13
the O 0 6.028431334854922e-13
capacity O 0 2.9782526271560084e-12
to O 0 4.109763202496397e-13
mount O 0 1.5819162868524472e-08
a O 0 1.3550003341578076e-09
neutrophilic O 0 8.944371074903756e-05
leukocytosis O 0 1.1311720300000161e-05
during O 0 1.0208987788473678e-07
pyogenic B-Disease 0 0.003987452015280724
infection I-Disease 0 7.116331062206882e-07
. O 0 4.3702147456414764e-10
. O 0 3.3223088724554373e-09

Susceptibility O 0 6.219789065653458e-05
to O 0 3.660429968022072e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0001560543751111254
twins O 0 2.1915369075031776e-07
: O 0 5.819155378915253e-13
the O 0 3.4206329175417993e-12
role O 0 2.643900506513197e-12
of O 0 2.8662029347148454e-11
genes O 0 4.854601963477645e-12
, O 0 5.6200838254028e-12
HLA O 0 1.6918995981995977e-08
, O 0 3.196693604268219e-11
and O 0 4.7796870628058485e-11
the O 0 7.326320439204892e-09
environment O 0 2.785221226986323e-07
. O 0 8.555115726949225e-09

OBJECTIVE O 0 2.5150313831545645e-06
To O 0 3.00724029012045e-11
determine O 0 2.40572579218723e-11
the O 0 5.949162169838207e-12
relative O 0 4.2972837094312766e-11
effects O 0 1.314343855973732e-09
of O 0 2.7155147921953393e-11
genetic O 0 1.0005749007113707e-10
and O 0 6.752785179989229e-13
environmental O 0 1.4294625205746314e-10
factors O 0 1.0646625725127534e-12
in O 0 1.2096234387401483e-12
susceptibility O 0 6.399060481498964e-08
to O 0 5.348755216516565e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 9.839932317845523e-06
AS B-Disease 1 1.0
) O 0 1.6429232974068952e-11
. O 0 1.860463033631632e-10

METHODS O 0 1.9928320398321375e-06
Twins O 0 5.065415820126873e-08
with O 0 2.3437481122545734e-11
AS B-Disease 1 0.9999979734420776
were O 0 2.2163682347753344e-11
identified O 0 2.081948166383213e-13
from O 0 3.908747037519901e-14
the O 0 1.5825408474987035e-12
Royal O 0 2.2291997137102726e-09
National O 0 3.866597637625091e-07
Hospital O 0 4.029277988593094e-05
for O 0 3.2116151960082107e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 3.66983883282046e-08
. O 0 2.654799269308228e-09

Clinical O 0 2.189398855989566e-06
and O 0 1.885052391958908e-10
radiographic O 0 1.700246627933666e-07
examinations O 0 1.9701916542658182e-08
were O 0 2.4309656718179973e-11
performed O 0 1.8973518936538092e-11
to O 0 3.6705152263970253e-13
establish O 0 3.4173868596054646e-11
diagnoses O 0 8.862882094895497e-10
, O 0 6.866508772164492e-13
and O 0 9.819704945013275e-12
disease O 0 2.1331052835193987e-07
severity O 0 2.034144053197906e-08
was O 0 7.604469831612448e-11
assessed O 0 4.59652498355223e-12
using O 0 7.066036937421888e-14
a O 0 2.7579493051300974e-13
combination O 0 2.8241452145610912e-12
of O 0 3.382034235999143e-11
validated O 0 1.6931965829414253e-09
scoring O 0 1.2949519234695117e-09
systems O 0 2.834647361282805e-08
. O 0 5.451711970749784e-09

HLA O 0 1.2959516197952325e-06
typing O 0 8.154819042260897e-09
for O 0 2.462072490327927e-10
HLA O 0 2.3110533931003374e-08
- O 0 7.977282723281576e-10
B27 O 0 5.8101838895652236e-09
, O 0 1.6051805717953727e-11
HLA O 0 3.626360878250523e-10
- O 0 2.5327077241010798e-11
B60 O 0 4.3483555645096317e-10
, O 0 7.166973178124314e-13
and O 0 1.1757752974364544e-12
HLA O 0 3.3245148856053675e-09
- O 0 1.8868806517247094e-09
DR1 O 0 2.020693318627309e-05
was O 0 1.2508058477855855e-10
performed O 0 6.764932364289322e-12
by O 0 1.0250757491100937e-12
polymerase O 0 3.162194464612078e-11
chain O 0 3.2572086694493407e-10
reaction O 0 3.024355668245632e-13
with O 0 1.6482765131074772e-13
sequence O 0 1.7944862609753365e-11
- O 0 7.060255158286566e-11
specific O 0 1.588050871359492e-11
primers O 0 1.360544177320122e-10
, O 0 1.1334354678774194e-12
and O 0 3.4434393270804664e-12
zygosity O 0 8.920583383087433e-09
was O 0 6.412678166256569e-10
assessed O 0 3.1735614136607637e-10
using O 0 1.941427747731428e-11
microsatellite O 0 1.3941948928675174e-08
markers O 0 8.390060202145833e-09
. O 0 4.896726579772803e-09

Genetic O 0 5.614738185499846e-08
and O 0 2.2239790564704265e-10
environmental O 0 4.2377049092046093e-10
variance O 0 4.488935959057194e-11
components O 0 4.91293672411075e-10
were O 0 3.236800757977498e-11
assessed O 0 7.952363767493864e-11
with O 0 8.462429975514274e-13
the O 0 1.0768253649873216e-10
program O 0 9.367351339051311e-11
Mx O 0 5.358760102325277e-10
, O 0 7.328258009101085e-14
using O 0 1.5101443790670015e-14
data O 0 2.0530823677429588e-13
from O 0 7.696985003568038e-15
this O 0 6.736903227524916e-15
and O 0 2.920589592110383e-14
previous O 0 4.4172322050117785e-12
studies O 0 7.920673123461286e-13
of O 0 3.938132805969552e-11
twins O 0 1.7820692699288543e-09
with O 0 1.5312365264641414e-10
AS B-Disease 1 1.0
. O 0 2.415559663404565e-08

RESULTS O 0 5.831570248915341e-08
Six O 0 8.03776434299408e-10
of O 0 2.0514583365383032e-09
8 O 0 2.434204020573816e-07
monozygotic O 0 3.6809538528359553e-07
( O 0 7.773161558866093e-10
MZ O 1 0.9538652896881104
) O 0 1.1970791025106564e-10
twin O 0 2.0415122037320543e-07
pairs O 0 6.569870342199025e-11
were O 0 4.5390896596941843e-10
disease O 0 1.113235794036882e-05
concordant O 0 5.1358505004373e-08
, O 0 9.33260196553376e-13
compared O 0 4.5402169437241957e-13
with O 0 2.9699349533493513e-13
4 O 0 1.7053570777747495e-09
of O 0 4.336759562573178e-10
15 O 0 4.919218921095592e-10
B27 O 0 2.3742383614688833e-09
- O 0 1.3435423606988905e-10
positive O 0 1.0828326950373945e-11
dizygotic O 0 9.86452874940369e-09
( O 0 1.202570942132608e-11
DZ O 0 7.97179723122099e-07
) O 0 2.4633288030900813e-12
twin O 0 5.585764073501309e-10
pairs O 0 6.948138353730926e-13
( O 0 3.2092815275934494e-13
27 O 0 2.5939922432272056e-10
% O 0 3.4337131662315334e-12
) O 0 6.825295943658702e-14
and O 0 1.6015007245698265e-12
4 O 0 7.484136088642401e-10
of O 0 1.7270002095060022e-09
32 O 0 8.510557591989709e-08
DZ O 1 0.998386025428772
twin O 0 2.4028776124396245e-07
pairs O 0 9.24684894626493e-12
overall O 0 9.781319088020268e-10
( O 0 7.727062913132077e-12
12 O 0 1.804172089503453e-10
. O 0 1.6378040416931139e-12
5 O 0 9.976706960568293e-11
% O 0 5.3885181906798696e-12
) O 0 4.001261127983824e-12
. O 0 5.131762237375881e-10

Nonsignificant O 0 1.3817914350511273e-06
increases O 0 1.0083647805636531e-10
in O 0 8.977198867089753e-13
similarity O 0 1.8820470355784824e-12
with O 0 6.804835693411185e-14
regard O 0 4.337028566142598e-12
to O 0 6.0165969970917e-14
age O 0 1.5470324674082825e-11
at O 0 4.828438537884949e-09
disease O 0 2.554856166625541e-07
onset O 0 3.455064856439094e-08
and O 0 1.558968069654415e-13
all O 0 9.077541642628015e-14
of O 0 1.7126366514200186e-12
the O 0 4.1099318393023054e-11
disease O 0 1.0420648344222627e-08
severity O 0 1.2559989714944209e-09
scores O 0 4.424730720709036e-11
assessed O 0 6.0464220436040605e-12
were O 0 1.7830208880534326e-13
noted O 0 7.184930276606105e-13
in O 0 1.0546304281267016e-11
disease O 0 2.155704532924574e-05
- O 0 3.25064661410579e-07
concordant O 0 0.001053147716447711
MZ O 1 0.9999997615814209
twins O 0 4.430370026398123e-08
compared O 0 6.733949509118986e-11
with O 0 6.598943613767005e-11
concordant O 0 0.0019608372822403908
DZ O 1 0.9999943971633911
twins O 0 5.887208772037411e-06
. O 0 3.607530629778921e-08

HLA O 0 1.0657491657184437e-05
- O 0 4.591294455735806e-08
B27 O 0 4.1709434128733847e-08
and O 0 2.7968079241436072e-11
B60 O 0 1.127989479599023e-09
were O 0 1.7588374333354917e-12
associated O 0 1.5262685321322522e-13
with O 0 2.132172849465385e-14
the O 0 1.2547621795755415e-11
disease O 0 8.857355959790425e-10
in O 0 2.6425630889233276e-13
probands O 0 9.798255540260925e-10
, O 0 9.460309732855013e-14
and O 0 2.942328523295075e-14
the O 0 1.0059394723455073e-12
rate O 0 1.2256815354327877e-11
of O 0 8.910502544146048e-12
disease O 0 3.520091329534125e-09
concordance O 0 2.184571794294765e-11
was O 0 1.4182727041400778e-11
significantly O 0 4.482992753060411e-13
increased O 0 2.2743254762119802e-12
among O 0 4.50179477029522e-12
DZ O 1 0.7762717008590698
twin O 0 8.082754732186004e-08
pairs O 0 1.9675966585197546e-12
in O 0 2.3989703452909072e-12
which O 0 3.8242542813038405e-12
the O 0 4.766761430019528e-10
co O 0 1.1268804556152645e-08
- O 0 6.541580166441463e-09
twin O 0 3.8477189434615866e-08
was O 0 1.4535589398789739e-09
positive O 0 6.4269123876969925e-12
for O 0 5.4584566033799575e-12
both O 0 5.687418938582489e-11
B27 O 0 8.141923757420955e-08
and O 0 6.331314139629285e-09
DR1 O 1 0.571216881275177
. O 0 3.321860120308884e-08

Additive O 0 9.843688530963846e-08
genetic O 0 5.640410360996384e-09
effects O 0 1.1059259286128054e-08
were O 0 9.909527191875878e-12
estimated O 0 1.8884754057844205e-13
to O 0 1.1691680474245833e-14
contribute O 0 2.904379753192188e-14
97 O 0 2.1543078085328737e-11
% O 0 2.0931605786752433e-13
of O 0 1.1120621567703437e-12
the O 0 2.505210448811024e-12
population O 0 5.2766652673804856e-14
variance O 0 8.658919067872084e-12
. O 0 4.189500690809922e-10

CONCLUSION O 0 4.789751528733177e-07
Susceptibility O 0 5.3081862461112905e-08
to O 0 3.380810631448128e-10
AS B-Disease 1 0.9999998807907104
is O 0 8.59638662337181e-12
largely O 0 5.608222219954939e-11
genetically O 0 1.5258683205843226e-11
determined O 0 8.591469549679154e-12
, O 0 1.8818091887268934e-13
and O 0 9.17502510598689e-13
the O 0 1.3612268257023885e-10
environmental O 0 2.0963502933568634e-08
trigger O 0 1.3655990782623917e-09
for O 0 6.101823039894594e-12
the O 0 1.2276574201663948e-09
disease O 0 7.593594659738301e-07
is O 0 2.872604931702938e-12
probably O 0 3.7268570174386895e-11
ubiquitous O 0 7.898617759849458e-09
. O 0 1.056997600556997e-09

HLA O 0 1.3835391655447893e-05
- O 0 3.427510364417685e-08
B27 O 0 2.3843551133495566e-08
accounts O 0 4.223627957794518e-12
for O 0 9.050628627625679e-13
a O 0 3.122980389916319e-12
minority O 0 5.97344602167732e-13
of O 0 8.520773496500933e-12
the O 0 5.583758455607324e-11
overall O 0 4.080885851465155e-09
genetic O 0 7.220651188077909e-09
susceptibility O 0 7.736188578633119e-09
to O 0 5.7929157998293235e-11
AS B-Disease 1 1.0
. O 0 6.234915694847132e-09

Cell O 0 2.9705501219723374e-05
cycle O 0 1.5490063560719136e-06
- O 0 4.195310054910806e-08
dependent O 0 3.730558972847575e-09
colocalization O 0 2.7741216968024673e-07
of O 0 2.7693735304978873e-08
BARD1 O 0 0.0007996396743692458
and O 0 4.034863554380763e-10
BRCA1 O 0 7.91991056070529e-11
proteins O 0 7.249173050033475e-13
in O 0 7.856051421374632e-13
discrete O 0 2.1320603060814847e-09
nuclear O 0 4.3218472001171904e-07
domains O 0 2.3954182637453414e-08
. O 0 1.0593050880913779e-08

Germ O 0 1.25028518596082e-05
- O 0 2.3548736294287664e-08
line O 0 2.8266606832971775e-09
mutations O 0 2.5976795367532723e-11
of O 0 2.160745055101998e-10
the O 0 1.405177196822649e-09
BRCA1 O 0 1.7463779311555072e-09
gene O 0 1.0888947729603693e-11
predispose O 0 1.7626659680469725e-12
women O 0 1.5159962755896973e-15
to O 0 6.0344308522796656e-15
early O 0 3.9440621435460343e-08
- O 1 0.9210660457611084
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.902526136632332e-08
compromising O 0 6.031816610629903e-07
the O 0 2.179754154951752e-09
genes O 0 2.8664763271346594e-11
presumptive O 0 7.151584657805188e-09
function O 0 3.2776314995430766e-10
as O 0 4.179049901270604e-12
a O 0 2.69051551871069e-11
tumor B-Disease 0 2.0880179363302886e-08
suppressor O 0 1.887404152967065e-07
. O 0 1.522782233642772e-09

Although O 0 2.8758657677485644e-09
the O 0 4.41196579270553e-10
biochemical O 0 2.32105334951882e-09
properties O 0 2.7771054345038237e-09
of O 0 2.1938534544574395e-08
BRCA1 O 0 4.192236779942959e-09
polypeptides O 0 4.456596480739705e-10
are O 0 3.4426102376791667e-13
not O 0 1.0436515204565594e-13
understood O 0 9.346478669139402e-13
, O 0 1.0299669916859905e-13
their O 0 3.0901881531084086e-13
expression O 0 1.5676518243246118e-12
pattern O 0 5.268454509460563e-12
and O 0 5.086111111267388e-13
subcellular O 0 2.5440019868483432e-08
localization O 0 1.2975585050867267e-08
suggest O 0 1.697588467367006e-12
a O 0 4.252020827447134e-13
role O 0 1.2419562990875765e-12
in O 0 3.3791049385695215e-12
cell O 0 2.58472478975591e-08
- O 0 7.489851405750869e-09
cycle O 0 1.0365879887785923e-07
regulation O 0 1.2351549685263308e-06
. O 0 4.815342347086471e-09

When O 0 1.1644495145901601e-07
resting O 0 8.754774171393365e-06
cells O 0 2.308844893050832e-09
are O 0 1.558731008849401e-12
induced O 0 4.611739601312337e-10
to O 0 2.0981250048977829e-13
proliferate O 0 2.5799221699956965e-12
, O 0 2.981432646338017e-14
the O 0 2.703971215770734e-13
steady O 0 5.014496196747986e-12
- O 0 1.4967763356868447e-13
state O 0 7.570607687837697e-14
levels O 0 2.3554257502778064e-12
of O 0 2.603674112248988e-13
BRCA1 O 0 1.0623779281423648e-13
increase O 0 4.19371136734935e-15
in O 0 8.752811572320524e-14
late O 0 6.322091183896816e-10
G1 O 0 1.9025349351498022e-10
and O 0 2.6226189189099136e-13
reach O 0 2.4214916096582106e-12
a O 0 8.400419574360052e-13
maximum O 0 1.3430503931211035e-10
during O 0 4.4335440874121446e-10
S O 0 2.9104441523486457e-08
phase O 0 1.2703250007461975e-08
. O 0 2.1158681473565366e-09

Moreover O 0 5.004502057204263e-08
, O 0 2.74342548678419e-10
in O 0 2.597670689663545e-10
S O 0 1.1104115316129537e-07
phase O 0 4.6588848334749855e-08
cells O 0 9.192169247995707e-10
, O 0 1.6110050793383124e-11
BRCA1 O 0 5.079168197141826e-10
polypeptides O 0 7.748585106881478e-11
are O 0 1.7478082783156657e-12
hyperphosphorylated O 0 2.0161432523480016e-09
and O 0 1.3074515428646016e-11
accumulate O 0 1.898860626028953e-12
into O 0 4.840840727403373e-13
discrete O 0 6.606339364445546e-10
subnuclear O 0 1.724057909768817e-07
foci O 0 2.3069340215897682e-07
termed O 0 4.349369309153417e-09
" O 0 4.558952326760846e-09
BRCA1 O 0 2.9005340351773157e-09
nuclear O 0 4.8717808454057376e-08
dots O 0 3.384386326743538e-09
. O 0 9.37476052342845e-09

" O 0 1.2569111049742787e-06
BRCA1 O 0 1.1957527590311656e-07
associates O 0 2.506796326073868e-09
in O 0 2.073888977216498e-11
vivo O 0 5.022024462952857e-10
with O 0 5.485111496950079e-12
a O 0 7.406006363730455e-10
structurally O 0 2.825767353442643e-08
related O 0 1.769041024779483e-09
protein O 0 7.135278679015755e-08
termed O 0 2.5948270376829896e-07
BARD1 O 0 0.0026636524125933647
. O 0 1.966377283224574e-08

Here O 0 1.4158585415202651e-08
we O 0 2.2470410948605135e-11
show O 0 1.7878244024105427e-11
that O 0 1.7325725543918674e-13
the O 0 8.994513467364129e-12
steady O 0 2.9446925453591177e-10
- O 0 5.8622039514344415e-12
state O 0 1.7265168244726126e-12
levels O 0 7.14394307599342e-11
of O 0 3.9965645376449643e-11
BARD1 O 0 7.857761943341757e-07
, O 0 5.109829660093768e-12
unlike O 0 5.467896968536223e-12
those O 0 7.745680724417781e-13
of O 0 2.018924333269112e-10
BRCA1 O 0 2.494717765699761e-10
, O 0 1.7316945403675343e-12
remain O 0 5.917669826382976e-11
relatively O 0 7.07013928739203e-13
constant O 0 2.0826573104981705e-11
during O 0 2.042286478820543e-10
cell O 0 2.753682792899781e-08
cycle O 0 2.825507161574592e-09
progression O 0 1.1990548109963584e-08
. O 0 5.010351578071948e-10

However O 0 1.540738914229678e-08
, O 0 4.0462694306242497e-10
immunostaining O 0 1.1083844242421037e-07
revealed O 0 1.894677748026652e-09
that O 0 1.4242039839129639e-11
BARD1 O 0 1.8207591665486689e-06
resides O 0 1.1619148976294014e-09
within O 0 1.4197620856748472e-10
BRCA1 O 0 5.975640121613779e-11
nuclear O 0 2.042630287135694e-09
dots O 0 1.6911227626592584e-11
during O 0 2.714371782897018e-10
S O 0 6.542590913483082e-09
phase O 0 1.279042871615843e-09
of O 0 1.6339396502473846e-10
the O 0 1.855084141855201e-10
cell O 0 1.26433918890001e-09
cycle O 0 8.487105462862132e-11
, O 0 2.1408416218168108e-13
but O 0 6.279200250036698e-14
not O 0 6.998944474109411e-14
during O 0 1.0915377976483676e-11
the O 0 1.1217626827431104e-10
G1 O 0 1.2925885251036107e-08
phase O 0 7.150711578418623e-09
. O 0 8.585416821915715e-10

Nevertheless O 0 7.757082585158059e-07
, O 0 5.471076480745296e-09
BARD1 O 0 2.3951404727995396e-05
polypeptides O 0 7.555105874246237e-09
are O 0 1.4548686691137624e-12
found O 0 9.379655255617458e-14
exclusively O 0 1.4398036799270764e-13
in O 0 2.1036628385442957e-13
the O 0 2.376391184527593e-12
nuclear O 0 1.5603389413865187e-10
fractions O 0 1.4664472977946041e-12
of O 0 1.5470560596475558e-11
both O 0 6.355939212443484e-12
G1 O 0 2.073246241351967e-09
- O 0 1.602394605892954e-10
and O 0 1.2430428908416502e-10
S O 0 6.569177202209175e-08
- O 0 3.18792303666271e-09
phase O 0 1.7758056003458478e-07
cells O 0 1.4547246074414488e-08
. O 0 2.025613676792659e-09

Therefore O 0 4.913641937775992e-09
, O 0 6.566162197296777e-11
progression O 0 1.4454308860933907e-09
to O 0 1.8212823610364026e-11
S O 0 7.530045031955979e-09
phase O 0 1.188212639391395e-09
is O 0 1.4419032374340945e-13
accompanied O 0 4.455918056409103e-13
by O 0 8.737132653653668e-14
the O 0 1.568671733308269e-12
aggregation O 0 1.3554867948559202e-12
of O 0 1.3922794341036937e-11
nuclear O 0 5.752768217348603e-08
BARD1 O 0 3.293339148058294e-07
polypeptides O 0 1.4406416060097627e-09
into O 0 1.0859645821481578e-10
BRCA1 O 0 2.3348536437595158e-09
nuclear O 0 1.6593689622368402e-07
dots O 0 9.731229155818255e-09
. O 0 1.7932299201106616e-08

This O 0 5.729361984840864e-10
cell O 0 3.4260789760764965e-08
cycle O 0 9.173993120725754e-09
- O 0 8.219683822474622e-10
dependent O 0 1.7901730098301982e-10
colocalization O 0 1.0365657665545314e-08
of O 0 2.171753221702488e-09
BARD1 O 0 0.00035763520281761885
and O 0 1.2956652417628334e-10
BRCA1 O 0 2.2518217845934885e-10
indicates O 0 9.767531401749796e-12
a O 0 6.803489520888772e-13
role O 0 1.4915048363040029e-12
for O 0 7.106999450751106e-12
BARD1 O 0 1.627936512704764e-06
in O 0 1.0103636816083394e-09
BRCA1 O 0 3.5355423477767545e-08
- O 0 1.7852714861987806e-08
mediated O 0 4.589290711010108e-06
tumor B-Disease 0 6.519140151795e-05
suppression O 0 0.0002971870417241007
. O 0 6.1098801573677974e-09

Ethnic O 0 1.5311293344311139e-09
differences O 0 2.5551938342971425e-10
in O 0 4.170024603400435e-10
the O 0 9.427694180885737e-09
HFE O 0 6.111639959271997e-05
codon O 0 4.388554231127273e-08
282 O 0 1.006448169249552e-08
( O 0 1.635783508646682e-09
Cys O 0 0.0003258052165620029
/ O 0 3.58185866389249e-06
Tyr O 0 1.0079389767270186e-06
) O 0 5.970365174468029e-11
polymorphism O 0 1.8320474026722877e-08
. O 0 5.414943160531038e-09

Recent O 0 6.493381388139596e-10
studies O 0 5.3209301548173826e-11
have O 0 5.50463374968807e-13
shown O 0 1.7181275499544846e-11
that O 0 1.9767354419997218e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.752622225126288e-08
HH B-Disease 0 0.07870127260684967
) O 0 1.7229506666868732e-12
is O 0 1.7640035753722222e-13
likely O 0 1.530384570154822e-13
to O 0 1.5760027153753284e-14
be O 0 1.5376525194180785e-13
caused O 0 2.373247431908254e-12
by O 0 3.127902938829946e-13
homozygosity O 0 2.4345412352744233e-09
for O 0 6.8865273726570475e-12
a O 0 2.5209865445185997e-11
Cys282Tyr O 0 3.1165467984095585e-09
mutation O 0 2.369448387495865e-12
in O 0 7.856111052494119e-13
the O 0 7.4135635130812e-11
HFE O 0 4.837493179365993e-07
gene O 0 6.419270670576793e-11
located O 0 1.8070168972261769e-10
4 O 0 2.1461824317725586e-08
. O 0 3.950467064584018e-09

5 O 0 2.748572342170519e-06
Mb O 0 3.379306508577429e-05
telomeric O 0 3.2270374958898174e-06
to O 0 2.986186631304122e-09
HLA O 0 7.805787390680052e-06
- O 0 1.791563875030988e-07
A O 0 2.993362215875095e-07
. O 0 6.947781461263958e-09

Population O 0 1.5822397211873174e-11
studies O 0 7.819907048289831e-12
of O 0 4.600088365780408e-11
this O 0 7.0969987699121e-13
polymorphism O 0 1.2481841948908112e-10
are O 0 8.096679522586608e-14
facilitated O 0 9.93503456586664e-13
by O 0 1.9140483469015646e-13
the O 0 6.641848095817471e-12
fact O 0 9.458401943607253e-13
that O 0 1.3944944645630925e-13
the O 0 2.915362395938814e-11
Cys282Tyr O 0 6.886987335974482e-08
mutation O 0 4.00995986415964e-10
creates O 0 1.0098834268834622e-10
a O 0 1.1623708939811905e-10
Rsal O 0 2.9727914352406515e-07
restriction O 0 2.121360864748567e-08
site O 0 1.2329591569937293e-08
. O 0 1.7363772641942887e-09

We O 0 1.1259194687696095e-09
have O 0 4.233596546249219e-12
studied O 0 8.69069191611338e-11
the O 0 1.3660803044324155e-10
codon O 0 1.0728180566133005e-09
282 O 0 1.5734686886759164e-09
( O 0 6.620214376695799e-10
Cys O 0 0.00011337678006384522
/ O 0 4.4948970412406197e-07
Tyr O 0 4.7365592337200724e-08
) O 0 2.945878675546243e-13
polymorphism O 0 3.315707300735604e-12
in O 0 1.2044611998312388e-13
different O 0 4.6567204980323476e-14
ethnic O 0 2.62651619203913e-11
groups O 0 5.7607418835203816e-11
. O 0 1.0938480121680527e-09

In O 0 1.43991291112755e-10
agreement O 0 3.5758637717542285e-10
with O 0 3.301124347834805e-12
previous O 0 1.1655040266234096e-09
observations O 0 3.4905914270133565e-10
the O 0 3.2899656332574523e-09
Tyr O 0 9.575907000680672e-08
allele O 0 2.9408420143539615e-10
appeared O 0 2.3062338150303674e-10
to O 0 7.001350996356515e-13
be O 0 6.004929084361954e-13
rare O 0 5.6503971640475825e-11
or O 0 8.474952510606482e-12
absent O 0 1.3277864363558933e-09
in O 0 6.343561526761521e-12
Asiatic O 0 3.6626202071232683e-09
( O 0 1.4395572407732704e-12
Indian O 0 1.0213057829999705e-11
, O 0 1.4056200864712154e-12
Chinese O 0 1.1702809728231234e-11
) O 0 9.156808341084788e-13
populations O 0 4.759618046912273e-11
. O 0 6.081565806503875e-10

The O 0 6.6209380200632495e-09
highest O 0 6.252541151496871e-09
allele O 0 1.3414931492039539e-11
frequency O 0 9.375734910666012e-11
( O 0 2.0799369171431437e-12
7 O 0 1.2884887601316564e-10
. O 0 1.7572571273539311e-13
5 O 0 6.71669274018849e-12
% O 0 2.6445699471445983e-13
) O 0 1.397662554133072e-14
was O 0 1.0851937404243728e-11
found O 0 3.0305992090862155e-12
in O 0 3.0039727649811e-11
Swedes O 0 1.454592108984798e-07
. O 0 2.6367095173895905e-08

Saamis O 0 4.815014108316973e-06
( O 0 5.825472326748127e-10
2 O 0 2.2591879478284227e-09
% O 0 6.240998169648737e-12
) O 0 1.485964129521733e-13
and O 0 2.508820625204966e-12
Mordvinians O 0 4.996735469831037e-09
( O 0 1.017106321041239e-12
1 O 0 2.191114997773802e-11
. O 0 6.722800213656427e-14
8 O 0 2.576701005341242e-12
% O 0 4.2097578136120195e-14
) O 0 5.027800380620184e-15
had O 0 1.394335601839769e-12
significantly O 0 4.892636859890609e-13
lower O 0 1.3752401994970853e-11
frequencies O 0 5.327162756058046e-12
of O 0 6.338617825063508e-11
the O 0 6.870423119309521e-10
Tyr O 0 9.190529226543731e-08
allele O 0 3.3784511299650433e-10
. O 0 3.936827808193044e-10

Comparisons O 0 6.048319622919962e-10
with O 0 6.824053475074088e-12
allele O 0 3.773003784401929e-11
frequencies O 0 1.0267864683499717e-11
based O 0 8.158910287832388e-13
on O 0 4.556530847077411e-11
prevalence O 0 3.1014002477292024e-10
estimates O 0 5.86396816520951e-13
of O 0 5.361575766693605e-12
HH B-Disease 0 1.9201219402020797e-05
showed O 0 5.484440013248104e-09
some O 0 9.971217644969e-13
disagreements O 0 1.6826487425625203e-10
with O 0 2.1574688650188856e-12
the O 0 1.452671316570786e-10
RFLP O 0 2.0737487282929123e-09
data O 0 3.208501520024498e-11
, O 0 1.3840496674091818e-12
particularly O 0 2.255899460290589e-12
in O 0 6.650458655999003e-11
Finns O 0 1.3643895613313362e-07
. O 0 2.8132049578744045e-08

The O 0 1.4102234047186357e-07
newly O 0 3.334976952373836e-07
described O 0 3.551939897761258e-08
HFE O 0 0.0010081293294206262
marker O 0 1.840722063661815e-07
provides O 0 2.7983126232866695e-11
a O 0 5.269569936655616e-12
new O 0 2.443679156596823e-12
approach O 0 2.517679207475476e-12
to O 0 7.23445893577486e-14
the O 0 1.835177409342803e-12
screening O 0 3.6397607150462363e-11
of O 0 1.72208428073084e-11
HH B-Disease 0 8.590131983510219e-07
as O 0 1.7989824907527208e-11
well O 0 4.753716409226783e-13
as O 0 9.556537419047606e-14
studies O 0 6.364253877589113e-14
of O 0 1.4548604291772516e-12
the O 0 1.1411644199044169e-12
relationship O 0 4.785827970358279e-14
between O 0 5.871222778786045e-12
the O 0 1.2709204799676854e-09
HFE O 0 1.4348897821037099e-05
Tyr O 0 2.391930031819811e-08
allele O 0 2.8397353912801293e-11
and O 0 2.4971337931473103e-12
different O 0 4.8669162450165615e-11
disorders O 1 0.9999982118606567
including O 0 6.085644486120145e-07
cancer B-Disease 1 0.9999986886978149

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9940738081932068
associated O 0 1.7595035151085625e-10
with O 0 8.461461240873158e-13
a O 0 2.6843541278687155e-11
missense O 0 5.522878265828979e-10
mutation O 0 4.8515007115834674e-12
encoding O 0 4.387858566073932e-12
Gly23 O 0 2.7543865854795513e-08
- O 0 1.0348037093876883e-08
- O 0 1.2606315991092742e-08
> O 0 2.6696328703224026e-08
Val O 0 6.6993792735559055e-09
in O 0 5.524332102879725e-10
neurophysin O 0 6.199300514708739e-06
II O 0 0.0019694415386766195
. O 0 3.2915174585923523e-08

Autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.746053662239234e-10
ADNDI B-Disease 1 0.5200765132904053
) O 0 6.372055118795961e-13
is O 0 7.440935752755715e-14
an O 0 8.969394237751116e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.985694511740803e-08
by O 0 7.034497550434393e-12
progressive O 0 0.08166996389627457
degeneration O 1 0.9999991655349731
of O 0 1.0224162849681306e-08
the O 0 4.3059664167621747e-10
magnocellular O 0 2.353921502162848e-08
neurons O 0 4.812736147108421e-12
of O 0 1.5455402582742472e-11
the O 0 3.6274240555744797e-11
hypothalamus O 0 1.9412360607873325e-10
leading O 0 1.0777499726000173e-10
to O 0 1.5123769207467386e-12
decreased O 0 9.354175767306572e-11
ability O 0 1.1012906081867002e-12
to O 0 6.10890027799571e-13
produce O 0 2.6529793986651562e-11
the O 0 3.9261424666925393e-10
hormone O 0 1.2085045186793764e-09
arginine O 0 3.9889819225535916e-10
vasopressin O 0 9.031311254403818e-10
( O 0 2.4452422725529388e-11
AVP O 0 6.709305466756632e-08
) O 0 1.2657664846815742e-11
. O 0 5.601511476882592e-10

Affected O 0 6.2047829096911755e-09
individuals O 0 4.115789740272158e-12
are O 0 6.021260963787189e-13
not O 0 3.397470022328819e-13
symptomatic O 0 1.7327139723022356e-10
at O 0 5.023113522351075e-11
birth O 0 7.569234128368407e-11
, O 0 1.3249073875769984e-13
but O 0 3.308857094569406e-13
usually O 0 3.612166121769178e-11
develop O 0 5.9540671060176464e-08
diabetes B-Disease 1 1.0
insipidus I-Disease 0 0.33602699637413025
at O 0 3.541251913929955e-08
1 O 0 3.0617127322329907e-07
- O 0 1.0808822281660468e-08
6 O 0 3.137435200528671e-08
yr O 0 1.0899712066247957e-07
of O 0 1.5032740607878736e-09
age O 0 3.348263666325124e-09
. O 0 4.399144604150251e-09

The O 0 1.900446910951814e-09
genetic O 0 3.8131434121346786e-10
locus O 0 2.0183006654850288e-10
of O 0 3.479782573201362e-10
the O 0 1.814553840517874e-09
disease O 0 1.3479581184583367e-06
is O 0 4.658128917311988e-12
the O 0 7.88229981285582e-10
AVP O 0 6.740539538441226e-05
- O 0 6.184675527265426e-08
neurophysin O 0 2.4876109819160774e-05
II O 1 0.9998088479042053
( O 0 1.3656061004230224e-10
NPII O 0 2.120322733389912e-06
) O 0 7.14867889276688e-13
gene O 0 2.1638153508557467e-12
, O 0 3.9094126698911713e-13
and O 0 6.900381416437285e-13
mutations O 0 5.419543286366846e-12
that O 0 1.2732284844496622e-12
cause O 0 6.4337415395243625e-09
ADNDI B-Disease 1 0.833154022693634
have O 0 3.4429993578388718e-12
been O 0 2.6413032459988994e-13
found O 0 7.992248830519626e-15
in O 0 9.14175639620549e-15
both O 0 2.6635111962671452e-14
the O 0 1.3580772791066398e-12
signal O 0 2.292471490417114e-10
peptide O 0 1.4221951741277827e-11
of O 0 6.166327171097663e-11
the O 0 7.564214810074077e-10
prepro O 0 8.299859473481774e-06
- O 0 3.117912638117559e-05
AVP O 0 0.0011228140210732818
- O 0 9.289398406053806e-08
NPII O 0 2.474540815455839e-05
precursor O 0 5.274950254374744e-08
and O 0 2.043131913653795e-10
within O 0 2.0094170771756126e-09
NPII O 0 4.25581238232553e-05
itself O 0 8.20145906743619e-09
. O 0 5.0768851345139865e-09

An O 0 1.7599868784579087e-10
affected O 0 5.517508672170379e-10
girl O 0 3.367527090514244e-10
who O 0 6.053137591860436e-12
presented O 0 1.5249468354738838e-10
at O 0 9.177296700357829e-10
9 O 0 3.2915331571459205e-10
months O 0 2.5646247278632295e-12
of O 0 3.346051213881651e-11
age O 0 5.1084778768251127e-11
and O 0 3.110088922508858e-11
her O 0 4.071963599638906e-11
similarly O 0 1.8564999537673543e-10
affected O 0 7.631539844510371e-11
younger O 0 2.778390191526814e-11
brother O 0 9.542677759100116e-10
and O 0 1.535137572616918e-10
father O 0 6.850507383582283e-10
were O 0 1.7024572029900042e-10
all O 0 5.112052274547363e-12
found O 0 1.214770146452937e-12
to O 0 1.8297798172473012e-13
have O 0 1.923828121547927e-13
a O 0 5.68486447152794e-13
novel O 0 3.121563120836446e-12
missense O 0 7.49601838934133e-11
mutation O 0 3.388849530855387e-13
( O 0 4.8439229108918416e-14
G1758 O 0 1.648470665527313e-10
- O 0 3.386005642536105e-10
- O 0 2.8303184240741075e-09
> O 0 3.565452599829655e-09
T O 0 2.3939814020046413e-10
) O 0 3.924926637361879e-15
encoding O 0 4.200629847759228e-14
the O 0 3.796231124592042e-12
amino O 0 1.692229342764584e-11
acid O 0 3.063768422989499e-12
substitution O 0 3.749273114195262e-11
Gly23 O 0 9.384851118454662e-09
- O 0 2.281232314160775e-09
- O 0 3.5316718438593853e-09
> O 0 1.2026370121986929e-08
Val O 0 1.2991607789558657e-08
within O 0 5.0559925135473804e-09
NPII O 0 2.945051164715551e-05
. O 0 9.594771199772367e-09

The O 0 4.089076810487313e-08
mutation O 0 1.2824090678265065e-09
was O 0 5.748166942431965e-10
confirmed O 0 4.618955912194522e-11
by O 0 9.685606483511577e-12
restriction O 0 2.269536114596349e-09
endonuclease O 0 8.836520848376495e-09
analysis O 0 1.7014574471563293e-10
. O 0 6.574737421161103e-10

A O 0 1.4413316193895298e-06
T1 O 0 8.410217446908064e-07
- O 0 2.7387203616058287e-10
weighted O 0 5.451488219176959e-11
magnetic O 0 2.1938123193065984e-11
resonance O 0 1.3628577433255629e-11
imaging O 0 3.214250421379461e-09
of O 0 3.041682239413035e-09
the O 0 5.983689277400117e-08
fathers O 0 7.61876677302098e-08
pituitary O 0 6.792070962546859e-06
gland O 0 8.179092247928565e-08
demonstrates O 0 3.288182504057602e-10
an O 0 3.9795241754680966e-12
attenuated O 0 8.491214487094112e-08
posterior O 0 3.5679917687048146e-08
pituitary O 0 0.0007662642747163773
bright O 0 1.598181484041561e-06
spot O 0 5.313516339811031e-06
. O 0 4.432464173476092e-09

This O 0 5.116271295513286e-10
mutation O 0 4.273728593240378e-10
may O 0 7.116399917267424e-12
be O 0 3.5160310535471695e-13
valuable O 0 1.087484919823356e-12
for O 0 2.684955935968597e-13
developing O 0 4.624313085233034e-12
models O 0 3.583958217007188e-12
of O 0 6.205368163758607e-11
dominantly B-Disease 0 8.625085570201918e-07
inherited I-Disease 0 1.5588668247801252e-05
neurodegeneration I-Disease 1 1.0
, O 0 6.905915509586302e-12
as O 0 2.5079583050070797e-13
the O 0 3.836906649606203e-13
early O 0 1.2288088081791049e-11
age O 0 2.713722042219091e-12
of O 0 2.088217966600414e-11
onset O 0 0.07103537768125534
of O 0 4.0584129123999446e-07
symptoms O 0 0.0010813751723617315
suggests O 0 1.2060302409522272e-11
that O 0 3.148792126561953e-14
this O 0 2.444577472306836e-13
mutation O 0 1.3611068001850857e-11
may O 0 2.2348668055061083e-12
be O 0 1.7741610047403156e-12
particularly O 0 6.433102748421016e-13
deleterious O 0 8.905800402692066e-11
to O 0 2.0730377050387494e-12
the O 0 6.421294607150685e-10
magnocellular O 0 1.7837101040640846e-07
neuron O 0 1.8975347959582223e-09
. O 0 3.728620190379672e-11
. O 0 8.18236201016731e-10

Frequent O 0 3.225298250697506e-09
inactivation O 0 1.4908102912158938e-06
of O 0 1.5599958658185642e-07
PTEN O 1 0.9486807584762573
/ O 0 4.5607714127982035e-05
MMAC1 O 0 0.03914039954543114
in O 0 1.1585252757129183e-08
primary O 1 0.9999982118606567
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.001473148993682e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.0483420798124143e-09
the O 0 1.6498830079925142e-10
most O 0 4.023853732854077e-12
common O 0 2.9695884640190684e-10
male B-Disease 0 2.7525742102296746e-12
cancer I-Disease 0 6.398608639462955e-12
in O 0 1.0152340123095738e-12
the O 0 4.5870859194385716e-11
Western O 0 3.278581850452156e-10
world O 0 9.516639212781008e-12
, O 0 7.201417874568364e-14
yet O 0 1.305675944966722e-13
many O 0 9.750038707716062e-15
of O 0 7.512183691944785e-13
the O 0 6.78710668396143e-13
major O 0 2.543998171844475e-11
genetic O 0 7.1338083010297204e-12
events O 0 4.1762185615072667e-13
involved O 0 1.745555333306295e-13
in O 0 4.88655665410731e-13
the O 0 1.0871743609530693e-11
progression O 0 2.200918558514786e-09
of O 0 9.599190886611098e-11
this O 0 3.3842411512052806e-11
often O 0 4.302239398068508e-10
fatal O 0 0.03157666698098183
cancer B-Disease 0 1.150429125118535e-05
remain O 0 1.7832430643238695e-08
to O 0 9.075334234109889e-12
be O 0 1.2672213278719369e-10
elucidated O 0 3.971820774495427e-07
. O 0 3.10973002903836e-09

Numerous O 0 3.2791338533399994e-09
cytogenetic O 0 1.595881826688128e-06
and O 0 6.210320591115703e-10
allelotype O 0 3.6525594282466045e-07
studies O 0 8.454888178466291e-11
have O 0 3.923194505806721e-13
reported O 0 6.419814766595033e-13
frequent O 0 4.426374197730176e-12
loss O 0 2.1778248648907095e-10
of O 0 3.282818183958369e-10
heterozygosity O 0 1.4511697088437359e-07
on O 0 6.407558483800813e-09
chromosomal O 0 0.000291618489427492
arm O 0 8.40528073808855e-08
10q O 0 4.1156255292662536e-08
in O 0 5.001243308377923e-10
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.8996967077764566e-07

Deletion O 0 1.0470936118167629e-08
mapping O 0 7.904626952992544e-10
studies O 0 8.147442442929531e-11
have O 0 6.480903053801557e-12
unambiguously O 0 3.114702940010261e-10
identified O 0 5.918019546635733e-11
a O 0 1.1945013554670592e-11
region O 0 6.97746860289783e-11
of O 0 3.0890734414867893e-10
chromosome O 0 3.2332068133911207e-09
10q23 O 0 3.132219594803587e-09
to O 0 1.4988368619156534e-12
be O 0 5.253400253875384e-13
the O 0 1.993419101661842e-12
minimal O 0 2.7166677796230942e-09
area O 0 1.9143432672397154e-10
of O 0 1.524118053986001e-10
loss O 0 1.903415203230452e-08
. O 0 1.4903305256552812e-08

A O 0 2.2425152224059275e-07
new O 0 1.6621106713188283e-09
tumor B-Disease 0 2.0685153145905133e-08
suppressor O 0 6.9311041350772484e-09
gene O 0 3.860356478924132e-11
, O 0 2.787773917961589e-12
PTEN O 0 5.346086027202546e-07
/ O 0 2.999534487457822e-08
MMAC1 O 0 2.6792492917593336e-06
, O 0 8.86540927474977e-12
was O 0 1.441289587678085e-10
isolated O 0 8.476691570891148e-10
recently O 0 6.234005672789422e-11
at O 0 5.84143636239709e-11
this O 0 1.173303804374165e-13
region O 0 1.078310704616392e-11
of O 0 2.105712305910945e-11
chromosome O 0 1.3489996897320111e-09
10q23 O 0 3.83779275026086e-09
and O 0 1.1184078836656841e-11
found O 0 7.03515099908375e-13
to O 0 4.342578000752356e-14
be O 0 2.7127619269852465e-14
inactivated O 0 3.415001961770692e-11
by O 0 1.3474154246777975e-13
mutation O 0 9.314042592745153e-12
in O 0 1.8374479021643353e-11
three O 0 1.6070945463297903e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.25856056809425354
lines O 0 1.4375179935299798e-09
. O 0 3.3469341187419843e-10

We O 0 4.68410057408164e-08
screened O 0 2.132567260559881e-06
80 O 0 8.764905601310602e-07
prostate B-Disease 1 0.9980942606925964
tumors I-Disease 1 0.9999998807907104
by O 0 7.88018695435655e-12
microsatellite O 0 1.4365779676950297e-09
analysis O 0 1.868875930746694e-12
and O 0 5.741838428330315e-12
found O 0 2.707977505428394e-12
chromosome O 0 1.9631823944266102e-10
10q23 O 0 3.752608501716992e-10
to O 0 1.2338763908173456e-12
be O 0 1.4551766909509656e-12
deleted O 0 2.8955327718849233e-12
in O 0 7.159226553601905e-13
23 O 0 2.3512089497579325e-10
cases O 0 3.756130129151103e-11
. O 0 9.311848514492738e-10

We O 0 2.0715504867041545e-09
then O 0 2.5146568854994555e-11
proceeded O 0 6.959415248947165e-12
with O 0 4.828773896036788e-15
sequence O 0 5.117998378074452e-14
analysis O 0 3.381100399115454e-14
of O 0 2.77177239493831e-12
the O 0 2.9793226913321647e-11
entire O 0 6.708685273970616e-10
PTEN O 0 5.141466772329295e-07
/ O 0 1.849539366105546e-08
MMAC1 O 0 1.5461888551726588e-06
coding O 0 4.1211141166286325e-09
region O 0 2.91365709337299e-10
and O 0 3.3995850839269037e-12
tested O 0 6.655671239835792e-12
for O 0 6.003577626353951e-13
homozygous O 0 1.0334042649384756e-10
deletion O 0 2.6034582475964463e-11
with O 0 2.4127539701400413e-13
new O 0 1.9664119291218363e-11
intragenic O 0 4.688835986144113e-09
markers O 0 1.3664601568319501e-11
in O 0 4.2522726334016936e-13
these O 0 5.3091825234123993e-14
23 O 0 1.93050506136494e-11
cases O 0 3.1804097658412467e-13
with O 0 6.167684635585702e-13
10q23 O 0 2.1840419250906962e-08
loss O 0 1.3998811887461216e-08
of O 0 2.2834404589389123e-08
heterozygosity O 0 1.2478527423809282e-05
. O 0 4.3155168327757565e-08

The O 0 1.710399710752597e-09
identification O 0 3.6546771164935876e-10
of O 0 2.3827387285457746e-10
the O 0 1.4542791970661995e-10
second O 0 8.665652639905375e-10
mutational O 0 2.4766571016243688e-08
event O 0 4.712358836478359e-10
in O 0 1.603503614611146e-11
10 O 0 3.0040185616808657e-11
( O 0 5.603832285358545e-13
43 O 0 7.892435316403379e-11
% O 0 7.848136723831445e-11
) O 0 2.1216177426008898e-10
tumors B-Disease 1 1.0
establishes O 0 1.03969874487575e-07
PTEN O 0 6.192906585056335e-05
/ O 0 6.256838247509222e-08
MMAC1 O 0 6.749530712113483e-07
as O 0 4.343145634799761e-12
a O 0 1.8720656535381464e-12
main O 0 9.23733450841624e-11
inactivation O 0 6.231872351492029e-09
target O 0 8.7287670147429e-11
of O 0 2.2336533664346625e-11
10q O 0 9.475358275778945e-09
loss O 0 1.6044137129966884e-09
in O 0 3.034807682933405e-10
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.9323269651039254e-09
. O 0 1.4675883841519521e-09

Risk O 0 1.4614910170962503e-08
reversals O 0 3.104951573629222e-10
in O 0 4.00138342598888e-12
predictive O 0 5.036508987643629e-10
testing O 0 5.838378225320184e-09
for O 0 4.772914063977396e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.649481973231559e-08

The O 0 1.5245715800915605e-10
first O 0 8.404013596141624e-12
predictive O 0 1.9495030589844475e-10
testing O 0 6.335538760282589e-10
for O 0 7.871436835671375e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.2609699525864548e-13
HD B-Disease 0 3.7620542792105027e-10
) O 0 4.226909129651088e-15
was O 0 1.3221054025874812e-13
based O 0 1.2375756140909668e-14
on O 0 3.7777255282311906e-12
analysis O 0 2.9376531047141385e-13
of O 0 1.074647835996867e-11
linked O 0 2.729125536671262e-10
polymorphic O 0 1.6166912253368082e-10
DNA O 0 1.9977935972192995e-11
markers O 0 1.0383704529895454e-12
to O 0 6.6216285655573e-14
estimate O 0 8.314088350072635e-13
the O 0 3.0533071188575123e-13
likelihood O 0 1.5849876749615688e-12
of O 0 1.0575269826507139e-11
inheriting O 0 3.101854190168396e-11
the O 0 2.119100901698534e-11
mutation O 0 4.1310631131163955e-12
for O 0 1.3178568479543795e-11
HD B-Disease 0 2.4255657535832142e-06
. O 0 9.181222893062113e-09

Limits O 0 6.678609221211218e-09
to O 0 1.1742697959837844e-11
accuracy O 0 2.520862685262415e-10
included O 0 4.53969110567054e-12
recombination O 0 7.337772967366818e-13
between O 0 6.808682307193892e-13
the O 0 4.066724387796761e-11
DNA O 0 2.7098235114153546e-11
markers O 0 1.0713896783642873e-11
and O 0 2.45325266177987e-12
the O 0 9.816263774053979e-11
mutation O 0 2.738520521461396e-11
, O 0 2.872440566653589e-12
pedigree O 0 6.683648773320172e-11
structure O 0 3.565022443918764e-10
, O 0 1.3006506678972518e-12
and O 0 1.556152559242796e-12
whether O 0 2.725133270084501e-12
DNA O 0 1.3798171806522763e-11
samples O 0 6.334199657842543e-13
were O 0 3.377275238983235e-12
available O 0 3.847402865048144e-12
from O 0 1.2333452835411318e-11
family O 0 1.2256798354037812e-10
members O 0 2.8344063207619286e-10
. O 0 6.233655369669577e-09

With O 0 1.6496241872498985e-11
direct O 0 1.1564752627757358e-10
tests O 0 2.245138970569105e-11
for O 0 8.946293684163054e-13
the O 0 1.7697445939268697e-11
HD B-Disease 0 4.850187451665988e-08
mutation O 0 2.6069999024130874e-12
, O 0 7.157078749098211e-14
we O 0 1.0733561527651383e-13
have O 0 8.128799011946491e-15
assessed O 0 2.874784828590937e-13
the O 0 7.573525546934398e-14
accuracy O 0 4.911620155728658e-12
of O 0 4.588343593958655e-12
results O 0 9.15174511693928e-13
obtained O 0 1.892546449416832e-13
by O 0 2.5907496092013316e-13
linkage O 0 2.659820974582061e-10
approaches O 0 5.635737362896798e-11
when O 0 1.8713515979873474e-12
requested O 0 1.1693259208134243e-11
to O 0 9.892564198366038e-13
do O 0 1.3571036655557478e-12
so O 0 3.171551901854676e-14
by O 0 2.298299625700523e-13
the O 0 4.2362967300757504e-11
test O 0 6.533882879189434e-10
individuals O 0 5.748490225498948e-12
. O 0 1.6756036558263077e-09

For O 0 2.9280373681217498e-09
six O 0 2.1298279806458709e-10
such O 0 8.351633620784504e-12
individuals O 0 1.377002624338569e-13
, O 0 5.047676686353864e-13
there O 0 7.406772135724882e-13
was O 0 4.66734498272281e-11
significant O 0 4.114675180438843e-12
disparity O 0 5.975933723562088e-12
between O 0 1.0769001792740318e-12
the O 0 9.539725259744003e-11
tests O 0 7.993976591791352e-10
. O 0 8.943612517242627e-10

Three O 0 3.182308305760273e-10
went O 0 1.8796848799684795e-10
from O 0 2.068306029917588e-12
a O 0 1.705804247853493e-11
decreased O 0 8.521660044280566e-10
risk O 0 1.1919977158103556e-11
to O 0 2.472934542958969e-14
an O 0 1.8042752147483417e-14
increased O 0 5.1843316965782815e-12
risk O 0 9.74672512837893e-12
, O 0 2.062398849248491e-14
while O 0 3.0115582201400634e-14
in O 0 8.037517320539506e-14
another O 0 4.678838696689502e-13
three O 0 3.951627165679067e-13
the O 0 4.589457980319622e-11
risk O 0 5.724162255305032e-10
was O 0 7.136156665588089e-10
decreased O 0 9.730876548985634e-09
. O 0 3.1339826289666917e-09

Knowledge O 0 1.3036485668749265e-08
of O 0 9.116709165368775e-09
the O 0 5.034127004144295e-10
potential O 0 2.6856447621348423e-11
reasons O 0 2.083988537293635e-11
for O 0 3.6482641452111053e-13
these O 0 2.237782272581767e-14
changes O 0 1.8390376840728834e-13
in O 0 1.2799724930130651e-13
results O 0 8.123196668270716e-13
and O 0 9.8235906442843e-14
impact O 0 4.228552837742816e-12
of O 0 2.8404268954257406e-12
these O 0 1.200530018279078e-13
risk O 0 2.2699049671143223e-12
reversals O 0 2.3982294015262307e-12
on O 0 4.208672299554905e-11
both O 0 5.8500071106748486e-12
patients O 0 1.3507457955960755e-12
and O 0 1.7386050281745224e-12
the O 0 9.559948388471184e-10
counseling O 0 1.6453012563477643e-10
team O 0 5.548614519235162e-12
can O 0 8.286536875515976e-14
assist O 0 1.0549356527222997e-12
in O 0 3.6154087536266477e-13
the O 0 5.899781531371051e-12
development O 0 5.1618253942009584e-12
of O 0 5.889122956653781e-12
strategies O 0 5.8948098138889016e-12
for O 0 6.415934949120794e-13
the O 0 1.3435928584992762e-11
prevention O 0 1.412361477770574e-10
and O 0 1.1552125358735288e-13
, O 0 6.867501223728131e-14
where O 0 4.648417067931732e-13
necessary O 0 6.337783770016259e-11
, O 0 3.3928224812962426e-12
management O 0 5.521548149256539e-11
of O 0 6.44061054488887e-11
a O 0 1.243189856614535e-10
risk O 0 7.554118441888136e-11
reversal O 0 9.848552529057031e-12
in O 0 2.296406608707363e-13
any O 0 1.4604208684390607e-12
predictive O 0 3.320727720579342e-11
testing O 0 1.1190357668278139e-10
program O 0 2.4231977535649207e-11
. O 0 2.3276157477131187e-12
. O 0 1.4907954037912674e-10

A O 0 2.3021136996703717e-08
novel O 0 2.8099414461912886e-10
common O 0 2.2429744173102506e-10
missense O 0 1.6098088417848544e-09
mutation O 0 1.940561426827525e-11
G301C O 0 1.7415671682563527e-10
in O 0 6.223666547400253e-12
the O 0 2.6812635445239152e-11
N O 0 5.020647453335414e-09
- O 0 3.5986205682014827e-10
acetylgalactosamine O 0 1.0043142850690856e-07
- O 0 7.724481498883051e-09
6 O 0 8.060262501885518e-08
- O 0 8.43905834102543e-09
sulfate O 0 5.959551963030663e-09
sulfatase O 0 2.1930434286332456e-06
gene O 0 7.896083231706541e-10
in O 0 1.9112567084533794e-10
mucopolysaccharidosis B-Disease 0 9.198382031172514e-06
IVA I-Disease 1 1.0
. O 0 2.8366656579237315e-07

Mucopolysaccharidosis B-Disease 0 0.17389588057994843
IVA I-Disease 1 1.0
( O 0 0.21195201575756073
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.3721386526999169e-10
is O 0 1.948374838203759e-12
an O 0 4.086472046166412e-12
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 2.8088178449792167e-09
by O 0 1.1218941357513113e-12
a O 0 1.4552455906979844e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 5.271070385726162e-11
N O 0 1.0263807581623041e-08
- O 0 1.6059684138092223e-10
acetylgalactosamine O 0 5.3648399500616506e-08
- O 0 4.83918860538779e-09
6 O 0 6.693277043723356e-08
- O 0 8.988662258957447e-09
sulfate O 0 3.096241929512189e-09
sulfatase O 0 5.333641638571862e-06
( O 0 1.9657192540378787e-10
GALNS O 0 5.6814378694980405e-06
) O 0 4.783754642412319e-11
. O 0 4.0941530721205766e-10

In O 0 2.259584519492819e-09
previous O 0 6.578026567893858e-09
studies O 0 7.941299701164084e-11
, O 0 2.1327049501418394e-11
we O 0 1.6470711947103034e-11
have O 0 1.0948859006931766e-12
found O 0 4.5438381789802973e-13
two O 0 6.932408342036692e-14
common O 0 1.5616175887134265e-12
mutations O 0 8.461009670668318e-13
in O 0 2.2523393740370157e-12
Caucasians O 0 2.350173111675957e-10
and O 0 6.4046897126079916e-12
Japanese O 0 5.873987518612012e-09
, O 0 4.835908409828171e-11
respectively O 0 1.749828948405252e-09
. O 0 8.490838254715527e-09

To O 0 5.851709117266068e-10
characterize O 0 1.6228061117118386e-09
the O 0 3.401897930022102e-10
mutational O 0 2.742664584332033e-08
spectrum O 0 1.4857283459068782e-10
in O 0 4.85835980820748e-13
various O 0 3.8265362558263794e-13
ethnic O 0 3.157630407146783e-12
groups O 0 4.777895743976468e-13
, O 0 1.3048743129854407e-13
mutations O 0 1.5611639856295129e-13
in O 0 8.325418262775108e-13
the O 0 5.1837905495899506e-11
GALNS O 0 2.3333795695634763e-07
gene O 0 4.2698157509679646e-11
in O 0 1.3549628433140448e-11
Colombian O 0 8.794553991720022e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.9387225336231495e-07
were O 0 5.296547575528443e-11
investigated O 0 1.1034448355040638e-10
, O 0 1.4060383716693603e-12
and O 0 3.1149256351364896e-12
genetic O 0 2.2264491639223394e-10
backgrounds O 0 6.978609964208848e-12
were O 0 4.172375552696783e-12
extensively O 0 2.994372111375654e-12
analyzed O 0 5.330913228213108e-12
to O 0 2.636330823785338e-13
identify O 0 8.656272313528612e-13
racial O 0 8.996602833370726e-13
origin O 0 4.813667571642276e-14
, O 0 1.6456620273311642e-14
based O 0 6.516545658120931e-14
on O 0 2.158042147759609e-11
mitochondrial O 0 1.3685154572062874e-11
DNA O 0 1.5135897743490112e-11
( O 0 2.306366631964901e-13
mtDNA O 0 8.387327291026203e-12
) O 0 3.318364680260366e-12
lineages O 0 4.0175848758927657e-10
. O 0 3.7159297860966944e-09

Three O 0 1.718368558556449e-09
novel O 0 1.1990083370605475e-09
missense O 0 1.2517186398497415e-08
mutations O 0 6.30850094385238e-11
never O 0 5.538825995077268e-11
identified O 0 4.594245990585666e-12
previously O 0 2.458955088158188e-11
in O 0 3.160309741765538e-13
other O 0 9.239505184164762e-14
populations O 0 3.551442993854348e-13
and O 0 9.285314758831348e-14
found O 0 2.8180902706884114e-13
in O 0 3.5505287403723995e-13
16 O 0 4.294620561950957e-11
out O 0 1.949493734845764e-12
of O 0 9.927391547703834e-11
19 O 0 1.7308165567442302e-08
Colombian O 0 1.3108492566971108e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 1.283799822004994e-08
alleles O 0 4.365969391573188e-12
account O 0 1.6786079904546058e-12
for O 0 1.3979793017648845e-11
84 O 0 4.2888071760671664e-08
. O 0 2.019592670876591e-08

2 O 0 3.4427632300548794e-08
% O 0 4.218485283313811e-11
of O 0 1.4540768589199615e-10
the O 0 5.5420595196364886e-11
alleles O 0 7.162900914764458e-13
in O 0 1.86525794809711e-12
this O 0 2.5582001794699494e-12
study O 0 3.758609742887664e-11
. O 0 4.142121368122531e-10

The O 0 8.974737397693389e-08
G301C O 0 1.9294209607778612e-07
and O 0 7.157776593658127e-10
S162F O 0 3.775327428456876e-08
mutations O 0 3.2131819427405617e-10
account O 0 9.005018952734645e-12
for O 0 2.7197497726172415e-11
68 O 0 1.4020326943864347e-07
. O 0 2.404041232750842e-08

4 O 0 2.02854991471213e-07
% O 0 5.604001152015314e-10
and O 0 2.003159443875191e-10
10 O 0 1.0984817500059307e-08
. O 0 1.5093483796135843e-08

5 O 0 1.4272817594473963e-08
% O 0 3.401532527869122e-11
of O 0 1.8141342594812926e-10
mutations O 0 2.0808108708303408e-11
, O 0 4.8576949754353116e-12
respectively O 0 4.1003561657149135e-11
, O 0 2.116559098125359e-12
whereas O 0 3.6109103988130054e-12
the O 0 8.668871870343153e-11
remaining O 0 1.1470215000031203e-08
F69V O 0 5.735693321184954e-06
is O 0 1.8538020511021935e-12
limited O 0 4.300684374597408e-12
to O 0 3.168204088833948e-13
a O 0 1.2550277657397135e-11
single O 0 7.663776557809143e-11
allele O 0 1.8721684202915867e-09
. O 0 2.3584953989796986e-09

The O 0 1.478913347341404e-08
skewed O 0 2.8552602504561264e-09
prevalence O 0 3.6251590618263663e-09
of O 0 1.8790431710602462e-10
G301C O 0 2.785152553030912e-09
in O 0 2.1883000619893345e-11
only O 0 1.2718675071465846e-11
Colombian O 0 8.287348585156451e-09
patients O 0 6.290474651587941e-12
and O 0 2.3680330699799024e-13
haplotype O 0 1.006124177027612e-11
analysis O 0 3.8051457601148697e-13
by O 0 9.616585278744358e-14
restriction O 0 2.4557667097774294e-12
fragment O 0 2.109593559953063e-13
length O 0 5.5204443989188834e-14
polymorphisms O 0 2.612266089205284e-12
in O 0 4.032351275801149e-12
the O 0 2.586043601482402e-10
GALNS O 0 1.4028233863427886e-06
gene O 0 7.885844061084057e-11
suggest O 0 1.7567250822428382e-12
that O 0 1.3060994614403493e-13
G301C O 0 1.2542937521953235e-10
originated O 0 3.337534242031648e-12
from O 0 1.0925120400365196e-12
a O 0 3.532463210831338e-11
common O 0 1.4839837692015578e-10
ancestor O 0 1.602963983771133e-09
. O 0 5.415852211143601e-09

Investigation O 0 2.6972493127885855e-09
of O 0 3.3126403842231866e-09
the O 0 6.27785989859575e-10
genetic O 0 4.188334401522553e-10
background O 0 1.0821306524466667e-11
by O 0 1.6206878504163025e-12
means O 0 2.0320583757338362e-11
of O 0 1.1289316703688712e-10
mtDNA O 0 2.1042589545827717e-11
lineages O 0 2.1577529259880768e-12
indicate O 0 1.224825687921871e-12
that O 0 5.129092680092318e-13
all O 0 8.21432019626478e-11
our O 0 2.90201707109361e-09
patients O 0 2.9811058135931212e-12
are O 0 4.928196590506424e-14
probably O 0 4.369683326115037e-13
of O 0 3.1157396541275917e-12
native O 0 1.4223443603467167e-11
American O 0 2.3973731888560224e-09
descent O 0 1.9042654741951992e-07

Low O 0 1.2759879375323635e-08
frequency O 0 2.1794466231739307e-09
of O 0 2.2875981109393706e-09
BRCA1 O 0 2.9312896554500867e-09
germline O 0 4.483256543785785e-10
mutations O 0 6.632008852681948e-13
in O 0 6.744698387035203e-14
45 O 0 3.6421286125909447e-11
German O 1 0.9992019534111023
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5988304014058485e-08
. O 0 7.447486627398803e-09

In O 0 1.5106572937018115e-10
this O 0 2.611070431049467e-12
study O 0 3.315806559444495e-13
we O 0 1.8544090958985682e-13
investigated O 0 6.304215396241153e-12
45 O 0 4.268569872567518e-11
German O 1 0.9633140563964844
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.748916289567859e-11
for O 0 7.81489716689121e-12
germline O 0 7.260836376588031e-10
mutations O 0 3.199722388089188e-13
in O 0 7.833009414703884e-13
the O 0 4.464413214111396e-11
BRCA1 O 0 3.180269381175549e-10
gene O 0 2.5488949839669317e-10
. O 0 3.9781772320779396e-10

We O 0 7.031499826837262e-10
identified O 0 8.307819016062368e-11
four O 0 8.892828314011059e-12
germline O 0 2.192003467627046e-09
mutations O 0 2.280580672225918e-12
in O 0 3.1064883738302074e-12
three O 0 4.587700774827397e-10
breast B-Disease 1 0.5965944528579712
cancer I-Disease 0 4.1560851968824863e-05
families O 0 1.679497469916913e-13
and O 0 1.4133680120362313e-12
in O 0 1.7501727844759785e-09
one O 1 0.9999377727508545
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.3116318768879864e-06
. O 0 8.958558721239296e-12
among O 0 1.6616666809882163e-13
these O 0 9.076883667434588e-14
were O 0 4.980732840054181e-12
one O 0 2.2789110008802904e-12
frameshift O 0 1.911571345658558e-09
mutation O 0 8.274131380048289e-12
, O 0 8.318720061753493e-13
one O 0 2.3798474042130424e-12
nonsense O 0 5.690569127025924e-10
mutation O 0 1.2588589025364083e-11
, O 0 4.3822530240017477e-13
one O 0 4.632096572629307e-13
novel O 0 7.25155525904686e-12
splice O 0 7.327587980832106e-10
site O 0 5.950493570106019e-11
mutation O 0 4.3351346817877e-12
, O 0 7.680157508224705e-13
and O 0 7.73732813930117e-12
one O 0 2.1804268113267966e-10
missense O 0 4.6018678290238313e-07
mutation O 0 6.117286943663203e-08
. O 0 3.3517284947492954e-08

The O 0 5.704593419864068e-08
missense O 0 3.250590623338212e-07
mutation O 0 1.1871208460689786e-09
was O 0 3.79425335594874e-09
also O 0 1.7474823671426165e-11
found O 0 2.8344306068905922e-12
in O 0 3.192349509739678e-11
2 O 0 5.397375346660738e-08
. O 0 7.212075825435704e-09

8 O 0 1.2243695834968094e-07
% O 0 1.501327534514374e-10
of O 0 2.798047349372723e-10
the O 0 1.5912351991609341e-10
general O 0 1.6039418404556471e-10
population O 0 5.748135799808762e-13
, O 0 4.695341337956904e-13
suggesting O 0 3.2400729235021464e-12
that O 0 7.212525525825478e-14
it O 0 2.905007235199514e-13
is O 0 4.2425831185861906e-13
not O 0 2.278502473501698e-12
disease O 0 6.748395620093106e-09
associated O 0 1.6421160264901147e-10
. O 0 3.6995773111669905e-10

The O 0 1.1070840910676338e-09
average O 0 2.676879377883079e-11
age O 0 1.6858162088517759e-10
of O 0 1.2278664307530107e-08
disease O 1 0.790815532207489
onset O 1 0.9080602526664734
in O 0 5.581951012523234e-10
those O 0 1.086140118816692e-11
families O 0 3.0091651826574806e-13
harbouring O 0 2.7180114159364166e-08
causative O 0 6.291408283232158e-09
mutations O 0 6.0313705418924e-11
was O 0 4.276142218095913e-10
between O 0 2.4848781365882644e-10
32 O 0 3.828407457717731e-08
. O 0 2.1530130567271044e-08

3 O 0 8.712710268810042e-07
and O 0 6.88246704072526e-09
37 O 0 1.1633162699808963e-07
. O 0 4.8198103286267724e-08

4 O 0 1.540454661608237e-07
years O 0 4.465778025153355e-10
, O 0 2.988542399662286e-11
whereas O 0 2.608831727035632e-11
the O 0 7.152941433608007e-11
family O 0 7.315459869816632e-12
harbouring O 0 1.3114046737427998e-08
the O 0 3.615731603012762e-10
missense O 0 7.648480071509312e-09
mutation O 0 4.666944261599859e-11
had O 0 3.5317068280277253e-12
an O 0 2.92899080369443e-14
average O 0 1.453143703457338e-12
age O 0 2.7359047319319707e-11
of O 0 2.4611255255990727e-09
onset O 1 0.9828150868415833
of O 0 2.058070776911336e-06
51 O 0 3.8201872598619957e-07
. O 0 4.6848064982896176e-08

2 O 0 1.5213901178867673e-06
years O 0 3.07499163909597e-08
. O 0 4.047770829629371e-08

These O 0 1.751818273776351e-10
findings O 0 2.4262222439452863e-11
show O 0 7.721512318425994e-11
that O 0 3.9947108121385355e-12
BRCA1 O 0 2.637571827612817e-10
is O 0 2.0766853135126967e-13
implicated O 0 1.5863427108367412e-12
in O 0 2.7816854722417794e-13
a O 0 6.710645494151235e-13
small O 0 8.7973655053461e-14
fraction O 0 2.4740836549602685e-12
of O 0 5.965012661590663e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3762400073724645e-11
suggesting O 0 5.47878582779493e-12
the O 0 1.0980522047177033e-12
involvement O 0 6.5755586739491e-12
of O 0 1.3299776210895509e-11
another O 0 3.2039865552335733e-12
susceptibility O 0 2.1286583606894283e-10
gene O 0 3.516852781215718e-11
( O 0 1.336135715956921e-11
s O 0 1.5539669107056397e-08
) O 0 1.3566606726911346e-09

Paternal O 0 4.2937426769640297e-07
transmission O 0 0.0001621482806513086
of O 1 0.968388557434082
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.2347274124622345

We O 0 5.249424450681772e-09
report O 0 6.602279833956004e-11
a O 0 6.299852133018202e-12
rare O 0 4.3437111546529295e-11
case O 0 3.1996263277767056e-12
of O 0 7.765599968623249e-11
paternally O 0 0.00010659483086783439
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8568139672279358
DM B-Disease 1 1.0
) O 0 1.6601264807292182e-10
. O 0 4.75815886691322e-10

The O 0 6.892032899941114e-08
proband O 0 6.446193197007233e-07
is O 0 1.6439734989992516e-11
a O 0 3.659905278147191e-12
23 O 0 5.608671513335217e-11
year O 0 9.964112000770964e-12
old O 0 7.056856432541281e-09
, O 0 4.339682835308167e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.5370464012676166e-08
who O 0 1.5337627834455247e-09
suffers O 1 0.9999998807907104
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 5.926900939812185e-06

He O 0 9.156542191135486e-10
presented O 0 6.112875983177446e-09
with O 0 6.59749976872348e-10
respiratory O 1 1.0
and O 0 4.3481089839758624e-09
feeding O 0 8.654573058208825e-09
difficulties O 0 2.3603146104278494e-08
at O 0 1.49089132150948e-07
birth O 0 1.2636677126920404e-07
. O 0 1.5113505114072723e-08

His O 0 3.1253701848754645e-08
two O 0 2.9114101351979116e-08
sibs O 1 0.9840062260627747
suffer O 0 7.55655094053509e-08
from O 0 4.981915990853736e-10
childhood O 1 0.992056667804718
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 4.375951448309934e-06

Their O 0 8.500654069543145e-10
late O 0 6.73363498293611e-09
father O 0 2.3521148917460266e-10
had O 0 8.428256703663095e-11
the O 0 1.673257886414259e-11
adult O 0 4.013177377221178e-12
type O 0 9.048652799270585e-11
of O 0 3.01586098316875e-08
DM B-Disease 1 1.0
, O 0 6.749135278427687e-11
with O 0 1.0517337868665155e-11
onset O 0 0.04599408805370331
around O 0 2.993667258532895e-10
30 O 0 1.129522364529123e-09
years O 0 4.663663344395275e-10
. O 0 3.190392838803291e-09

Only O 0 1.1934550014913725e-09
six O 0 1.006581554219288e-10
other O 0 4.004626220476676e-13
cases O 0 1.3889624585032567e-13
of O 0 1.1533027137466956e-11
paternal O 0 1.7788930051221286e-10
transmission O 0 9.037315606974516e-08
of O 0 2.713272579057957e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.6277784675722273e-09
been O 0 8.70053855350772e-12
reported O 0 7.278313368663802e-12
recently O 0 6.334426871923426e-10
. O 0 7.101342847093406e-10

We O 0 1.2151752937228366e-09
review O 0 8.158047154482873e-11
the O 0 1.1668595777114543e-11
sex O 0 4.3220049934789007e-13
related O 0 2.2155924826999102e-13
effects O 0 3.012556523684928e-11
on O 0 6.042620570578805e-11
transmission O 0 1.4946147430805468e-08
of O 0 4.0004756840517075e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 9.900806617224589e-06

Decreased O 0 8.500889236984221e-08
fertility O 0 4.016085242142253e-09
of O 0 2.707803252455232e-11
males O 0 2.4652346746552485e-14
with O 0 2.3451755470850662e-14
adult O 0 4.665887676225111e-10
onset O 1 0.9999982118606567
DM B-Disease 1 1.0
and O 0 6.149636355701205e-11
contraction O 0 4.49421555526186e-10
of O 0 1.7788184814016006e-10
the O 0 8.684659935642713e-11
repeat O 0 2.8411778485448735e-10
upon O 0 7.331872955984586e-12
male O 0 2.8015673006302755e-13
transmission O 0 9.501907724182579e-13
contribute O 0 2.0525332871052307e-14
to O 0 3.595224229544121e-14
the O 0 3.5389354207521206e-12
almost O 0 2.5546164576090158e-12
absent O 0 6.086317214104575e-12
occurrence O 0 7.51115662722679e-12
of O 0 6.270397829438723e-12
paternal O 0 7.608604718489786e-11
transmission O 0 6.924367568217349e-08
of O 0 1.631909640309459e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 3.17431622534059e-05

Also O 0 2.6371658190527114e-09
the O 0 2.5439023110251924e-10
fathers O 0 9.479289575509142e-11
of O 0 3.510432569631128e-11
the O 0 7.172327315396743e-11
reported O 0 4.188749624933763e-10
congenitally O 0 4.518406626630167e-07
affected O 0 4.506951756244604e-11
children O 0 5.163023871282424e-13
showed O 0 2.6130946365054974e-11
, O 0 4.930427268713677e-13
on O 0 1.4624348954050959e-10
average O 0 1.5738903236250934e-11
, O 0 1.7988865605444992e-11
shorter O 0 3.073524323937704e-09
CTG O 0 1.366021479043411e-06
repeat O 0 1.3869328796545233e-08
lengths O 0 1.7275141317441012e-09
and O 0 4.0661484596027364e-12
hence O 0 2.7274536795740545e-11
less O 0 2.8121422291499387e-12
severe O 0 5.340806978892942e-07
clinical O 0 0.010816571302711964
symptoms O 0 1.5360375300588203e-06
than O 0 5.640334119899615e-13
the O 0 2.2890798631602927e-11
mothers O 0 4.549613723953128e-13
of O 0 1.4312780561437366e-12
children O 0 5.0761799277876385e-12
with O 0 4.3051473497257575e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0018541665049269795

We O 0 7.969556681253209e-10
conclude O 0 5.096480459876318e-10
that O 0 1.4779816910268084e-13
paternal O 0 1.7639313620865238e-11
transmission O 0 5.394799718061449e-09
of O 0 5.0780062110789e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 4.485756210925729e-09
rare O 0 3.0264607486785167e-10
and O 0 4.904521884105395e-13
preferentially O 0 1.0193358743887382e-12
occurs O 0 5.808840143920954e-14
with O 0 2.0091934911062488e-14
onset O 0 0.008591088466346264
of O 0 1.999841333599761e-05
DM B-Disease 1 1.0
past O 0 2.408602428616291e-09
30 O 0 2.2981179459424794e-11
years O 0 6.01988294282596e-13
in O 0 1.2220300726201172e-12
the O 0 3.767430464818311e-11
father O 0 5.236708636169318e-11
. O 0 1.1613869588256165e-10
. O 0 1.6495630417168172e-09

The O 0 4.0001177126214316e-07
RB1 O 0 2.860880886146333e-05
gene O 0 1.1878931172049079e-09
mutation O 0 1.4029376271817995e-10
in O 0 8.733426308527026e-12
a O 0 1.955062639558136e-10
child O 0 1.1227864193941173e-09
with O 0 8.257900474539781e-10
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999998807907104
. O 0 5.42769498679263e-07

The O 0 2.2006452127243392e-07
RB1 O 0 7.419178928103065e-06
gene O 0 8.889428637637309e-10
mutation O 0 5.52591028490923e-11
was O 0 6.229263632695492e-11
investigated O 0 3.373446313958972e-11
in O 0 1.483770745158708e-11
a O 0 5.871632624554479e-10
child O 0 2.3096289325508224e-09
with O 0 8.630485215377348e-10
ectopic B-Disease 1 0.9999858140945435
intracranial I-Disease 1 0.9999568462371826
retinoblastoma I-Disease 0 1.638697176531423e-05
using O 0 9.725369815027918e-12
DNA O 0 2.9516059735223976e-12
obtained O 0 1.0154581304511537e-13
from O 0 9.0098379603408e-14
both O 0 6.194695364308833e-13
the O 0 9.623316032936202e-11
pineal B-Disease 0 6.296607170952484e-05
and I-Disease 0 4.640026418645249e-10
retinal I-Disease 1 0.9986761212348938
tumours I-Disease 1 1.0
of O 0 2.531113096893023e-08
the O 0 1.450065045816018e-08
patient O 0 2.730159209818339e-08
. O 0 6.010131947675745e-09

A O 0 1.5206532566480746e-07
nonsense O 0 1.65359601567161e-08
mutation O 0 1.2043389896465584e-10
in O 0 1.555972364841729e-11
exon O 0 1.4104482026766618e-09
17 O 0 4.619504223590809e-10
( O 0 3.9202191839948775e-12
codon O 0 8.643182003442718e-11
556 O 0 2.483408097220252e-11
) O 0 1.1141186985561685e-13
of O 0 5.0691003478098295e-11
the O 0 2.618975036838833e-09
RB1 O 0 8.366858423869417e-07
gene O 0 7.421641773364129e-11
was O 0 6.881689107451905e-10
found O 0 9.914626628373946e-13
to O 0 1.5090566871187733e-13
be O 0 4.4515690504447203e-13
present O 0 6.809578400289451e-13
homozygously O 0 3.19137249960022e-09
in O 0 1.0187104632075616e-11
both O 0 1.1120901942385242e-11
the O 0 3.5192032621367275e-10
retinal B-Disease 0 1.9722732247373642e-07
and I-Disease 0 3.600254538937975e-10
the I-Disease 0 9.69477369494598e-08
pineal I-Disease 1 0.9999997615814209
tumours I-Disease 1 1.0
. O 0 2.2862280957269832e-07

The O 0 3.1256488508546454e-09
same O 0 1.3062906312200084e-10
mutation O 0 3.450897206880299e-11
was O 0 9.552543478452691e-11
present O 0 6.552696753259202e-12
heterozygously O 0 2.0690629209951794e-09
in O 0 2.634483603491944e-11
the O 0 6.979039568477674e-11
DNA O 0 4.4042450242365305e-11
from O 0 7.752361578204636e-13
the O 0 4.219989982456873e-11
constitutional O 0 1.2445957153772724e-08
cells O 0 1.9324576661094994e-11
of O 0 3.45765673037679e-11
the O 0 8.281904328999445e-11
patient O 0 1.5921521046013964e-10
, O 0 3.973047585370537e-12
proving O 0 2.818970612494809e-10
it O 0 3.472934559291957e-13
to O 0 2.8954372536735273e-13
be O 0 2.921812531503365e-12
of O 0 5.504650207877049e-11
germline O 0 7.173552418748841e-09
origin O 0 3.3831437651343776e-11
. O 0 5.618888687664025e-10

The O 0 4.535110953440835e-09
initial O 0 1.0619627399677256e-09
mutation O 0 1.530526955173528e-10
was O 0 4.5598521486445165e-11
shown O 0 3.0914043026852855e-12
to O 0 4.328142661977341e-13
have O 0 4.293437079385537e-13
occurred O 0 2.8151328490544358e-11
in O 0 4.234969579880454e-12
the O 0 2.9524421796267575e-10
paternally O 0 3.732437914294451e-09
derived O 0 2.3022254935778363e-10
RB1 O 0 6.38222161342128e-07
allele O 0 1.7397553397913157e-09
. O 0 2.945671262466476e-09

The O 0 2.8365672477548287e-08
mutation O 0 1.640766689181561e-10
is O 0 2.840349754441168e-13
in O 0 2.8926055886495383e-13
an O 0 3.494228086671665e-14
area O 0 1.1698613432142846e-11
of O 0 2.958827974297584e-11
the O 0 1.4870976672298752e-10
gene O 0 8.54940944428062e-12
that O 0 3.8529525707084455e-13
encodes O 0 1.3766513970447924e-12
the O 0 8.858817325541057e-12
protein O 0 5.359551778078009e-12
- O 0 2.3636311657915243e-11
binding O 0 6.839902255695307e-11
region O 0 6.334798657858798e-11
known O 0 5.349389767955737e-12
as O 0 1.403632093367746e-12
the O 0 2.6754704354758907e-11
pocket O 0 1.2078454902919589e-09
region O 0 4.9243796540476836e-11
and O 0 1.4136591203195437e-12
has O 0 7.38517482844897e-13
been O 0 3.730081835854465e-13
detected O 0 5.426390673607395e-12
in O 0 3.369745075424563e-13
other O 0 2.3803821327245123e-13
cases O 0 3.52142712775963e-13
of O 0 2.693545039789136e-11
retinoblastoma B-Disease 0 1.2792582104736994e-08
. O 0 1.5980239354007608e-10
. O 0 2.340337701411954e-09

Low O 0 5.7043106238552355e-08
levels O 0 6.829881105119284e-10
of O 0 4.4980572044828193e-10
beta O 0 2.3566887108472656e-08
hexosaminidase O 0 2.4339951210095023e-07
A O 0 1.275875294304285e-09
in O 0 2.023204954265667e-12
healthy O 0 6.70303743066647e-12
individuals O 0 3.4099704159797854e-15
with O 0 3.187029091154814e-13
apparent O 0 2.6764735594042577e-05
deficiency O 0 0.2061798870563507
of O 0 3.7442907796503277e-06
this O 0 2.7888522602381727e-09
enzyme O 0 1.2200616072988169e-09
. O 0 1.3595981007696878e-09

Appreciable O 0 6.246804105103365e-07
beta O 0 2.4848316115821945e-07
hexosaminidase O 0 1.3934046592112281e-06
A O 0 3.860539266042906e-08
( O 0 1.0435729537461302e-11
hex O 0 1.503839897054604e-08
A O 0 1.051570275301117e-09
) O 0 2.985324593324061e-14
activity O 0 1.5932806289586932e-12
has O 0 3.85159874100819e-14
been O 0 8.427858562941315e-14
detected O 0 8.679290793012218e-12
in O 0 1.0042146801614305e-11
cultured O 0 5.6042420482071975e-08
skin O 0 1.4970653865020722e-05
fibroblasts O 0 0.0003976660664193332
and O 0 2.3888284683692973e-09
melanoma B-Disease 1 0.5689481496810913
tissue O 0 1.904060686896969e-09
from O 0 5.81587425788066e-12
healthy O 0 8.415386443250128e-12
individuals O 0 2.8099022064752115e-15
previously O 0 1.0245719203605397e-11
reported O 0 1.0246535607841278e-12
as O 0 3.4077389347852982e-12
having O 0 5.165339267421132e-09
deficiency B-Disease 0 1.1542193533387035e-05
of I-Disease 0 1.4108160030446015e-05
hex I-Disease 0 0.014016193337738514
A I-Disease 0 4.975385436978286e-09
activity O 0 3.645838405480495e-12
indistinguishable O 0 3.81098554406642e-13
from O 0 7.024588227180946e-16
that O 0 2.0787150702109052e-16
of O 0 1.2768100108011965e-13
patients O 0 2.2112483556453039e-13
with O 0 1.4096029898880147e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.331637662360663e-07
TSD B-Disease 1 0.9999841451644897
) O 0 3.650580671088477e-10
. O 0 5.399411584505742e-09

Identification O 0 3.8617763209458644e-08
and O 0 3.11746073400343e-10
quantitation O 0 3.7084023460920434e-06
of O 0 8.144113650132567e-08
hex O 0 2.492148723831633e-06
A O 0 3.853160990274773e-08
, O 0 1.3789963095034441e-11
amounting O 0 2.6802716296403517e-11
to O 0 2.052043257538827e-11
3 O 0 4.4961229406226266e-08
. O 0 8.347409874431833e-09

5 O 0 1.5020859223113803e-07
% O 0 3.219969180179305e-09
- O 0 3.563998873801211e-08
6 O 0 2.8491967896115966e-07
. O 0 3.800701975364973e-08

9 O 0 4.3817877326546295e-08
% O 0 6.0203945995152e-11
of O 0 1.4210950471937878e-10
total O 0 2.890337968963763e-10
beta O 0 8.884364355310481e-09
hexosaminidase O 0 1.1635609808990921e-08
activity O 0 1.7883369785032244e-10
, O 0 6.938285124387378e-13
has O 0 1.5520610241893246e-13
been O 0 1.1693761464790647e-13
obtained O 0 7.677931641164593e-13
by O 0 8.467504475362375e-12
cellulose O 0 1.9046810848522e-06
acetate O 0 3.2528351567862046e-08
gel O 0 8.903275339200434e-10
electrophoresis O 0 7.21972065464982e-11
, O 0 1.466182383835779e-11
DEAE O 0 4.0955012536869617e-07
- O 0 1.3489944716837954e-09
cellulose O 0 2.1694199858757202e-07
ion O 0 1.7499858229186316e-09
- O 0 3.1583080595254387e-10
exchange O 0 1.3734373360829721e-10
chromatography O 0 7.250190031671266e-11
, O 0 4.944480588853217e-12
radial O 0 3.8253669676358015e-10
immunodiffusion O 0 1.4088114674848384e-08
, O 0 2.7062749610728964e-11
and O 0 8.013298358200416e-11
radioimmunoassay O 0 3.694183874358714e-07
. O 0 1.7602436841457347e-08

Previous O 0 1.538418473501224e-05
family O 0 1.8136818713543335e-09
studies O 0 3.3405181398826755e-10
suggested O 0 1.3096386475286437e-10
that O 0 5.81602637144546e-13
these O 0 5.82619672992446e-13
individuals O 0 5.5508742269555836e-14
may O 0 1.570378896365021e-11
be O 0 1.016412561755109e-11
compound O 0 2.4773821882817515e-10
heterozygotes O 0 1.973934904420105e-11
for O 0 7.162299724659815e-13
the O 0 1.250709692063312e-11
common O 0 1.673088750875351e-11
mutant O 0 1.971690588575825e-09
TSD B-Disease 0 7.492312903423226e-08
gene O 0 2.1431632510338083e-12
and O 0 1.745069204157207e-13
a O 0 1.855216934937287e-12
rare O 0 2.5511847842607516e-11
( O 0 4.508082275533898e-13
allelic O 0 5.155887383700986e-10
) O 0 1.1140556793048928e-12
mutant O 0 2.1357926538456695e-09
gene O 0 3.0539248907501815e-09
. O 0 2.3549171501713317e-09

Thus O 0 3.875455067969824e-09
, O 0 3.797319403364696e-11
the O 0 7.800946694169753e-11
postulated O 0 4.50917247984961e-10
rate O 0 6.210602171430324e-11
mutant O 0 1.1526962717667288e-10
gene O 0 4.464631789269369e-12
appears O 0 1.3810953520144303e-13
to O 0 2.293366692162962e-15
code O 0 1.1495322990479236e-14
for O 0 1.082042238470006e-14
the O 0 1.888727618314795e-13
expression O 0 7.483696279862728e-13
of O 0 1.169425667413293e-12
low O 0 1.0963283232634513e-11
amounts O 0 8.608327267158045e-13
of O 0 3.861807748584134e-11
hex O 0 1.3841400914316182e-07
A O 0 1.0449333132100946e-07
. O 0 7.13060943624555e-09

Heterozygotes O 0 4.0237475218418695e-07
for O 0 9.893711405695171e-10
the O 0 1.3576286761463052e-09
rare O 0 1.8257882983263585e-09
mutant O 0 2.741690430241306e-09
may O 0 9.747227330825226e-12
be O 0 1.3198578514839188e-13
indistinguishable O 0 9.62444425371689e-13
from O 0 6.235898570520343e-14
heterozygotes O 0 8.641039273005191e-11
for O 0 1.4452824787652974e-12
the O 0 1.699984736314164e-10
common O 0 1.4019111427288067e-09
TSD B-Disease 0 3.6096482745051617e-06
mutant O 0 3.417600780153407e-08
. O 0 2.4872788273455626e-09

However O 0 7.258481593552801e-10
, O 0 4.16265372865654e-12
direct O 0 1.2255295736562921e-11
visualization O 0 8.124758643646146e-10
and O 0 4.267340300567746e-11
quantitation O 0 7.78275261836825e-06
of O 0 9.430143421695902e-08
hex O 0 9.464322943131265e-07
A O 0 9.352200125434251e-10
by O 0 5.351775337995857e-13
the O 0 4.3912746702789995e-12
methods O 0 3.214443294874414e-11
described O 0 8.97396740251466e-12
may O 0 1.0846759688348806e-12
prevent O 0 5.7847862784676796e-12
false O 0 1.0878049329365869e-11
- O 0 2.5419610860666353e-11
positive O 0 2.7193750723464305e-12
prenatal O 0 2.019453049229014e-09
diagnosis O 0 3.0727606570302157e-10
of O 0 5.943086300863598e-11
TSD B-Disease 0 3.433141955611063e-06
in O 0 2.8173569380229857e-11
fetuses O 0 1.3007214749727325e-10
having O 0 4.267102296506842e-12
the O 0 5.856529844416869e-11
incomplete O 0 4.796413044516612e-09
hex B-Disease 0 0.011403239332139492
A I-Disease 0 0.03551396727561951
deficiency I-Disease 0 3.832386028079782e-06
of O 0 1.0338000322462904e-07
the O 0 6.413451991704733e-09
type O 0 1.962068063576794e-09
described O 0 3.488074065693958e-11
in O 0 1.267868535853589e-11
the O 0 7.348288089126243e-10
four O 0 1.0725275112477561e-09
healthy O 0 3.825604366625157e-08
individuals O 0 1.3977780044527321e-09

The O 0 2.347817229519933e-07
tumor B-Disease 0 1.0089065654028673e-06
suppressor O 0 3.416109279896773e-07
gene O 0 1.563264961923494e-09
Smad4 O 0 1.412503678466237e-07
/ O 0 2.8459461987040413e-07
Dpc4 O 0 4.2085744667019753e-07
is O 0 5.8270554180450684e-12
required O 0 3.0500315814641077e-12
for O 0 1.277958208006913e-12
gastrulation O 0 7.074982821819731e-09
and O 0 6.714733370022374e-12
later O 0 5.368997607613224e-11
for O 0 4.088273122815345e-12
anterior O 0 2.8120204081938383e-11
development O 0 3.219984348601379e-11
of O 0 1.5056780822142457e-10
the O 0 2.863428660848655e-10
mouse O 0 4.553877275270679e-09
embryo O 0 1.9303303400164395e-09
. O 0 1.7564397714053825e-09

Mutations O 0 7.893316222862268e-09
in O 0 1.176304276206963e-09
the O 0 2.6894062088445025e-08
SMAD4 O 0 0.16258764266967773
/ O 0 5.489549948833883e-05
DPC4 O 0 0.0003211614675819874
tumor B-Disease 0 2.0526653088381863e-07
suppressor O 0 1.2766282253551253e-08
gene O 0 9.932424674397033e-12
, O 0 3.8161498700645113e-13
a O 0 5.037474343910775e-12
key O 0 2.897968087722802e-09
signal O 0 5.751832787836975e-09
transducer O 0 3.1647922060784595e-09
in O 0 2.3336403989770993e-11
most O 0 8.176659002656628e-12
TGFbeta O 0 1.0835284456334193e-06
- O 0 1.1468793914559683e-08
related O 0 2.079483918393521e-09
pathways O 0 3.678286564223754e-10
, O 0 1.816260764833308e-13
are O 0 2.9163907650875485e-15
involved O 0 3.6829382181772716e-15
in O 0 6.128643870607214e-14
50 O 0 7.750886737989404e-12
% O 0 1.0178830868456945e-11
of O 0 2.7796239976396464e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.443196081003407e-06

Homozygous O 0 2.037238346019876e-06
Smad4 O 0 1.3249255971459206e-05
mutant O 0 9.67507844507054e-07
mice O 0 2.749810050772794e-07
die O 0 4.959931576564713e-09
before O 0 2.3281108985084842e-10
day O 0 8.093407055653756e-10
7 O 0 6.821398557121938e-08
. O 0 6.944085306770376e-09

5 O 0 2.1761211144166737e-07
of O 0 3.4407019455784393e-08
embryogenesis O 0 4.12500003221794e-06
. O 0 6.46040376750534e-08

Mutant O 0 2.5815919002525334e-07
embryos O 0 1.602176169512859e-08
have O 0 4.660833177738688e-11
reduced O 0 8.502173270974467e-11
size O 0 2.305880660025128e-11
, O 0 1.333976332174025e-11
fail O 0 3.8854470751914505e-09
to O 0 6.536693929193316e-12
gastrulate O 0 9.697603076119776e-08
or O 0 6.042205624723351e-11
express O 0 6.906547816293296e-12
a O 0 1.3602763013209618e-11
mesodermal O 0 1.9018140395843375e-09
marker O 0 6.266004937138803e-10
, O 0 5.971805623790349e-13
and O 0 1.336688247068063e-12
show O 0 5.052664397986462e-10
abnormal O 0 2.2412402600480164e-08
visceral O 0 1.202402302169503e-07
endoderm O 0 1.0460794328537304e-06
development O 0 5.559629645546238e-09
. O 0 1.0834741992482577e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.775313359710708e-07
the O 0 1.062749532820817e-08
Smad4 O 0 5.714915823773481e-05
- O 0 1.2459216236493376e-07
deficient O 0 7.234257193289295e-09
embryos O 0 2.0780386092433822e-11
results O 0 5.512622042874726e-12
from O 0 1.6533971457580177e-12
reduced O 0 1.4567729245129613e-09
cell O 0 5.40800693116239e-09
proliferation O 0 1.1005012900966449e-08
rather O 0 2.5744938949787133e-13
than O 0 8.072096085358447e-15
increased O 0 2.554182559899587e-12
apoptosis O 0 7.56976081817129e-09
. O 0 1.7915051386818703e-10

Aggregation O 0 2.4858655134352148e-09
of O 0 3.5410609999786402e-09
mutant O 0 1.1028510016330983e-07
Smad4 O 0 3.434222662690445e-06
ES O 0 1.1693315173033625e-05
cells O 0 1.4890326818783883e-11
with O 0 6.373781168654558e-13
wild O 0 5.1951984936238205e-09
- O 0 1.0510569081745302e-09
type O 0 6.062621960012393e-09
tetraploid O 0 5.737629180657677e-07
morulae O 0 3.4055576634273166e-06
rescues O 0 1.3967452616725495e-07
the O 0 6.15912787438333e-09
gastrulation B-Disease 0 0.00021631334675475955
defect I-Disease 0 1.5566000001854263e-05
. O 0 1.6563106441935815e-08

These O 0 8.861631428658256e-10
results O 0 4.709151402160217e-10
indicate O 0 4.022090993593963e-11
that O 0 1.5191072141526596e-12
Smad4 O 0 5.2486861079614755e-08
is O 0 6.71200595103727e-12
initially O 0 3.805263829731453e-12
required O 0 6.515181731787945e-13
for O 0 1.405270892056512e-13
the O 0 7.86444748299836e-13
differentiation O 0 4.5767712536504135e-12
of O 0 5.681474388175012e-12
the O 0 6.114871629880891e-12
visceral O 0 1.3265681608753965e-10
endoderm O 0 9.078477969381993e-10
and O 0 5.928803455124143e-13
that O 0 7.987528146497988e-14
the O 0 1.578505035015887e-11
gastrulation B-Disease 0 1.5432763689204876e-07
defect I-Disease 0 2.495014195247336e-09
in O 0 4.4194255893748036e-11
the O 0 1.4987819874079378e-09
epiblast O 0 5.392741513787769e-06
is O 0 1.6129051219615498e-11
secondary O 0 1.387323034229837e-10
and O 0 4.749930049979811e-12
non O 0 4.328541436393607e-08
- O 0 8.630176573376502e-09
cell O 0 1.7167270698337234e-06
autonomous O 0 9.31775474555252e-08
. O 0 1.3449180435998187e-08

Rescued O 0 1.8086896034219535e-06
embryos O 0 3.1882287032658496e-08
show O 0 5.677792458413933e-08
severe O 0 0.00020734562713187188
anterior O 0 3.4881998089986155e-07
truncations O 0 0.00011369615094736218
, O 0 1.6344602060680558e-10
indicating O 0 8.368336579245295e-10
a O 0 3.285804614505672e-11
second O 0 1.2151468720134062e-10
important O 0 8.383392938182688e-12
role O 0 5.588933829625553e-12
for O 0 5.53715450227199e-12
Smad4 O 0 3.051364672046475e-08
in O 0 1.2216840039602772e-10
anterior O 0 3.578403795501117e-09
patterning O 0 1.8497509302051185e-08
during O 0 8.508334303769516e-08
embryogenesis O 0 5.785222583654104e-06
. O 0 2.651496266992126e-08

Prevalence O 0 2.300289224876906e-06
of O 0 2.26288072724401e-08
p16 O 0 1.698453466758565e-08
and O 0 1.2609219224302137e-09
CDK4 O 0 9.741201938595623e-05
germline O 0 3.862867572479445e-07
mutations O 0 1.2988174424855004e-10
in O 0 2.7631433599517585e-11
48 O 0 6.84530263583838e-08
melanoma B-Disease 1 0.9999996423721313
- O 0 0.0011036950163543224
prone O 0 4.283223802303837e-07
families O 0 2.98272105798969e-12
in O 0 2.886283156922076e-10
France O 0 1.495741253165761e-05
. O 0 3.56568619963582e-07

The O 0 8.469588408388518e-08
French O 0 4.126639396417886e-05
Familial B-Disease 1 0.9999911785125732
Melanoma I-Disease 1 1.0
Study O 0 3.244451818318339e-08
Group O 0 4.582965118515858e-08
. O 0 2.090149742173253e-08

Germline O 0 1.6492670056322822e-06
mutations O 0 3.1888092166809656e-10
in O 0 2.5406813805584072e-11
the O 0 2.7016142101210505e-10
p16 O 0 1.0433391928188485e-09
and O 0 1.2723509745793393e-10
CDK4 O 0 6.262518581934273e-06
genes O 0 1.6415452330775793e-11
have O 0 1.145990989820725e-13
been O 0 1.0780402449634546e-13
reported O 0 2.5446796904880775e-13
in O 0 5.838321904920452e-13
a O 0 8.031855562584678e-12
subset O 0 9.137743006704113e-08
of O 0 2.4042980939498193e-08
melanoma B-Disease 0 0.08492323756217957
pedigrees O 0 3.0055460342737206e-09
, O 0 1.0417036157284176e-11
but O 0 3.130005152632287e-12
their O 0 3.2434999130970255e-11
prevalence O 0 2.2335033378340086e-08
is O 0 3.677607263857796e-13
not O 0 1.8513275222738212e-13
well O 0 2.759271110208683e-12
known O 0 3.184554564494846e-10
. O 0 1.6747346842649335e-09

We O 0 1.5803593989005549e-09
searched O 0 3.272734028225699e-10
for O 0 1.2991878623261344e-12
such O 0 8.74464389788443e-12
germline O 0 3.1723947913064876e-09
mutations O 0 6.407646548772794e-12
in O 0 3.1886967025163138e-12
48 O 0 2.2071318106497984e-09
French O 0 0.0004036968166474253
melanoma B-Disease 1 1.0
- O 0 0.00018792082846630365
prone O 0 7.881931196607184e-08
families O 0 5.138845620734911e-13
selected O 0 1.8407300423489703e-12
according O 0 2.212243788764917e-13
to O 0 2.0126425753861504e-13
two O 0 5.043230373244501e-13
major O 0 3.0307933940321163e-10
criteria O 0 1.9635468806455947e-09
families O 0 7.845711283611684e-15
with O 0 3.201692722249773e-14
at O 0 4.420042942765434e-10
least O 0 5.1150758975659905e-12
three O 0 3.6300662996369137e-12
affected O 0 7.010949546609746e-12
members O 0 7.623007043308649e-13
( O 0 2.33619411793215e-13
n O 0 3.1731559047010194e-10
= O 0 2.3141387417435766e-10
20 O 0 1.3707045914967964e-11
) O 0 1.1208321122895167e-14
or O 0 4.0232204910227096e-14
families O 0 6.051047203485072e-16
with O 0 2.35432739926697e-14
two O 0 1.9031137343111793e-12
affected O 0 9.460500091651447e-12
members O 0 1.3131140055508417e-12
, O 0 1.0358068569527035e-12
one O 0 1.5927336489626742e-12
of O 0 2.902452722608473e-10
them O 0 3.876624715681842e-12
affected O 0 2.9187548645365213e-12
before O 0 1.952293014750861e-11
the O 0 1.1921341518117412e-11
age O 0 4.708976264478082e-12
of O 0 3.5929672431711523e-11
50 O 0 2.3154355169308083e-11
( O 0 1.735446638825855e-13
n O 0 3.734235490271409e-11
= O 0 7.002346619211508e-11
28 O 0 1.829894291649481e-10
) O 0 9.767353755223834e-14
, O 0 2.379905354819162e-13
and O 0 4.3595018545637687e-13
one O 0 9.86863043540842e-13
additional O 0 1.302677323650192e-11
minor O 0 2.0206366357911065e-08
criterion O 0 0.0006745600840076804
. O 0 2.222314954281046e-08

Sixteen O 0 2.4168875256691535e-07
different O 0 2.835536805356753e-10
p16 O 0 1.52575143630429e-08
germline O 0 8.083660851809782e-09
mutations O 0 1.3411708375821174e-11
were O 0 1.0900896504906221e-11
found O 0 4.617735230652564e-13
in O 0 9.47794251936196e-13
21 O 0 5.320983098577869e-10
families O 0 3.9427583919081355e-13
, O 0 7.618617108712256e-13
while O 0 8.35858205566753e-12
one O 0 2.0318607907299224e-11
germline O 0 1.0579723763726179e-08
mutation O 0 1.7760171805436542e-11
, O 0 9.684124162301355e-13
Arg24His O 0 2.450296188172274e-09
, O 0 2.80309759778663e-12
was O 0 9.696388136859468e-11
detected O 0 7.889665309956939e-11
in O 0 2.0536719894104216e-11
the O 0 1.9552537366962497e-09
CDK4 O 0 3.264493352617137e-05
gene O 0 1.7025305609763564e-08
. O 0 9.260753941475741e-09

The O 0 5.368222533164158e-10
frequency O 0 3.627024791619249e-10
of O 0 5.244558121120235e-10
p16 O 0 4.47341608200702e-10
gene O 0 1.3976593320197406e-11
mutation O 0 6.864911200263335e-13
in O 0 1.727728068034659e-13
our O 0 4.4057696401735014e-13
sample O 0 4.29734237561083e-14
( O 0 1.9348631312594844e-14
44 O 0 6.587455732808001e-13
% O 0 3.6892982158837073e-13
) O 0 1.9928393177738417e-14
is O 0 4.5001417143478856e-14
among O 0 2.8548828746996144e-14
the O 0 7.871324252117784e-12
highest O 0 1.866303334097097e-09
rates O 0 6.023737064708712e-11
yet O 0 5.494270403222368e-13
reported O 0 6.236913112703246e-13
and O 0 4.2128285452150416e-13
the O 0 8.956548003258291e-11
CDK4 O 0 1.949265652001486e-06
mutation O 0 6.775443921192004e-12
is O 0 4.396457766527202e-14
the O 0 3.311982578382139e-13
second O 0 3.5437445079083973e-12
mutation O 0 3.0773246364329543e-13
detected O 0 2.8351645575512563e-13
in O 0 9.186646940124304e-14
this O 0 2.78630525769874e-13
gene O 0 3.296840578315141e-11
worldwide O 0 8.470033008300959e-10
. O 0 5.126491231521868e-09

In O 0 1.0681586726235537e-09
summary O 0 4.0732977879542887e-08
, O 0 2.758420054871369e-11
our O 0 2.5253757418575162e-11
results O 0 1.1268266051148168e-12
show O 0 3.1450558303502962e-12
frequent O 0 9.200890917215876e-13
involvement O 0 4.1493206440201824e-12
of O 0 2.2243809225108713e-11
the O 0 4.723713434295895e-11
p16 O 0 5.98981281241251e-11
gene O 0 1.050306369654308e-11
in O 0 4.142978494992011e-12
familial B-Disease 0 4.355481664219951e-08
melanoma I-Disease 0 5.412041446106741e-06
and O 0 1.041487035502442e-11
confirm O 0 9.999853722852947e-11
the O 0 6.374663297226135e-11
role O 0 3.184990465809889e-11
of O 0 4.6307077616880576e-10
the O 0 7.60130181021168e-09
CDK4 O 0 0.0058752004988491535
gene O 0 1.2742604749149677e-09
as O 0 7.783483579881789e-11
a O 0 9.328665617758247e-10
melanoma B-Disease 0 0.0001180571416625753
- O 0 6.439955768655636e-08
predisposing O 0 5.862137868462014e-07
gene O 0 3.069786425058396e-09
. O 0 2.4488186478599516e-10
. O 0 2.424818346113966e-09

Progression O 0 6.924551598785911e-07
of O 0 9.743527584760159e-08
somatic O 0 1.1946999620704446e-06
CTG O 0 3.5783998555416474e-06
repeat O 0 1.424224405077723e-09
length O 0 3.045404423432374e-12
heterogeneity O 0 1.3938450393879975e-10
in O 0 1.1692763727741418e-12
the O 0 1.4959958619109592e-11
blood O 0 2.2158020210327756e-11
cells O 0 8.197263978715341e-10
of O 0 9.959057933883741e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.00024566278443671763
. O 0 6.36079944271728e-09

The O 0 2.2847276848203535e-10
genetic O 0 3.4608518828527224e-10
basis O 0 5.168273031763704e-10
of O 0 4.036115569761023e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999576807022095
DM B-Disease 1 1.0
) O 0 1.7566649090222652e-12
is O 0 1.7795206768648347e-14
the O 0 6.738436441862741e-14
expansion O 0 2.3148692164520757e-12
of O 0 1.6060156676767079e-12
an O 0 1.157418562033885e-12
unstable O 0 2.0876624873267247e-09
CTG O 0 7.846005587452964e-07
repeat O 0 2.955170330665169e-09
in O 0 3.3078890321336374e-11
the O 0 1.9690400698824106e-10
34 O 0 1.2216426759081855e-09
UTR O 0 2.795895170493168e-06
of O 0 1.3903019180361298e-08
the O 0 3.088591142841324e-07
DM B-Disease 1 0.9999995231628418
protein O 0 8.38254266000149e-09
kinase O 0 2.2430610702173226e-09
gene O 0 9.879431994708199e-11
on O 0 1.5036983880278854e-09
chromosome O 0 9.702613823492356e-09
19 O 0 2.979622415466565e-08
. O 0 7.909020105500986e-09

One O 0 7.624486597634927e-10
of O 0 1.6735212104990183e-09
the O 0 5.011938641885649e-10
principal O 0 6.713680722469917e-09
features O 0 2.0670580525017357e-10
of O 0 8.30903168491659e-09
the O 0 1.2535613677755464e-05
DM B-Disease 1 1.0
mutation O 0 1.0438690800640416e-08
is O 0 7.021932948297893e-13
an O 0 1.725152173079423e-14
extraordinarily O 0 2.5640633713464034e-11
high O 0 3.191011899161822e-10
level O 0 2.2106762642692956e-08
of O 0 8.754582614400874e-10
somatic O 0 5.28028579083184e-07
mosaicism O 0 6.30088334219181e-06
, O 0 5.838399967476871e-13
due O 0 6.834855598158995e-11
to O 0 6.284951942561734e-14
an O 0 3.7333539580110264e-14
extremely O 0 1.2276837532687601e-12
high O 0 7.396455843633465e-12
degree O 0 3.6846831141801317e-10
of O 0 2.400584175887843e-10
somatic O 0 1.0402358086025743e-08
instability O 0 7.346410146880089e-10
both O 0 6.552368782102025e-13
within O 0 5.64765768873432e-12
and O 0 1.1301837964843367e-13
between O 0 9.046641474136363e-13
different O 0 3.546503368756504e-12
tissues O 0 1.7782358918694285e-09
. O 0 1.6313155271063806e-09

This O 0 4.6147399790363863e-10
instability O 0 3.500689160773618e-08
appears O 0 6.485283837731615e-11
to O 0 6.638134052855404e-13
be O 0 5.14277747991343e-13
biased O 0 6.563663458233893e-13
towards O 0 5.2638686324265466e-14
further O 0 1.233428117264736e-14
expansion O 0 4.1004143982135977e-13
and O 0 5.915050875726592e-15
continuous O 0 7.326564355203402e-11
throughout O 0 2.027157608441854e-11
the O 0 1.5813407874820662e-11
life O 0 6.774019279537358e-13
of O 0 1.0289665820784055e-11
an O 0 1.3657396611202466e-13
individual O 0 2.2450938948637839e-13
, O 0 2.81839807568518e-12
features O 0 1.9980615773018684e-10
that O 0 2.1842417197853736e-12
could O 0 2.6033973154343526e-12
be O 0 6.149369072760633e-14
associated O 0 6.5833074397708e-14
with O 0 9.500810274414798e-15
the O 0 1.046407231697355e-11
progressive O 0 7.968466775309935e-09
nature O 0 1.1629763818632455e-10
of O 0 9.749352020138602e-11
the O 0 2.738606896812712e-09
disease O 0 1.0838673460966675e-06
. O 0 3.4780525126620887e-09

Although O 0 1.9950073537611246e-10
increasing O 0 4.106844725404457e-11
measured O 0 6.8606479004806875e-12
allele O 0 1.885618614375084e-12
size O 0 5.560233805497472e-13
between O 0 3.799708811480507e-12
patients O 0 5.431661630889151e-12
clearly O 0 1.0273457974087352e-13
correlates O 0 2.8345357880538505e-14
with O 0 4.0757528709004464e-16
an O 0 6.845079181647302e-16
increased O 0 9.904585967579829e-14
severity O 0 4.0016850944013527e-10
of O 0 1.6237401700980314e-10
symptoms O 0 2.0885757123778603e-08
and O 0 3.1876064288116623e-13
an O 0 6.224511821907109e-15
earlier O 0 5.317234933605031e-12
age O 0 8.411165861033076e-12
of O 0 1.2771797508470684e-10
onset O 0 4.13873249272001e-06
, O 0 1.0088062113097762e-12
this O 0 1.3867647129369928e-14
correlation O 0 4.066006971219227e-13
is O 0 3.6509908459122706e-14
not O 0 2.4710720869145462e-14
precise O 0 5.713336487939147e-12
and O 0 3.616063882789372e-13
measured O 0 5.39199327548312e-12
allele O 0 2.8519684443922833e-12
length O 0 1.9373209633744004e-12
cannot O 0 1.4558930233263268e-12
be O 0 1.8572825365875158e-14
used O 0 4.2963565139635205e-15
as O 0 6.5506872692357946e-15
an O 0 2.065570733526074e-15
accurate O 0 8.734391682141407e-12
predictor O 0 1.175790576013469e-09
of O 0 5.63345897708345e-11
age O 0 1.567345558894928e-10
of O 0 3.0212830015585723e-09
onset O 0 0.003840899793431163
. O 0 3.694863792702563e-08

In O 0 5.456868845676865e-10
order O 0 1.7008863761880377e-10
to O 0 1.9618330397708217e-12
further O 0 2.0170169787864234e-12
characterize O 0 1.0574947167940607e-11
the O 0 1.8132719284413845e-11
dynamics O 0 6.055819734562817e-11
of O 0 1.4029311046215298e-08
DM B-Disease 1 1.0
CTG O 0 0.008302049711346626
repeat O 0 4.735059633276251e-08
somatic O 0 4.353901683629147e-09
instability O 0 5.777228695436065e-10
, O 0 4.1224106918889836e-13
we O 0 1.198036759858176e-13
have O 0 1.1303599623967066e-14
studied O 0 7.418238115800002e-13
repeat O 0 2.9101716696178226e-12
length O 0 3.1836373679461e-14
changes O 0 3.123858864726575e-14
over O 0 2.7401358295548427e-14
time O 0 9.589587289396753e-14
in O 0 5.7886824673947235e-12
111 O 0 0.00037159561179578304
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 4.920232554717074e-10
with O 0 1.7806988996944655e-14
varying O 0 2.9985272077814873e-12
clinical O 0 2.8288074105375927e-09
severity O 0 1.7143690911325393e-08
and O 0 1.207959426929861e-11
CTG O 0 1.2907781865578727e-07
repeat O 0 1.8946189062063468e-10
size O 0 7.301864191414098e-13
over O 0 6.199103730342159e-13
time O 0 5.710217997230427e-13
intervals O 0 9.807313815224372e-12
of O 0 8.360499792470222e-11
1 O 0 4.544471465806055e-09
- O 0 6.024739596099948e-10
7 O 0 4.325642510849548e-09
years O 0 7.031191184836416e-10
. O 0 2.925140352161293e-09

We O 0 2.308382596183378e-09
have O 0 6.574918994667334e-12
found O 0 5.654045482673953e-13
a O 0 3.38419884563651e-13
direct O 0 4.888945585174165e-12
progression O 0 2.1783234938066443e-10
of O 0 3.4049339736608175e-11
the O 0 3.3058308694655647e-12
size O 0 6.16575583992085e-13
heterogeneity O 0 4.9496916981750516e-11
over O 0 6.1780611008976916e-12
time O 0 1.2793661095800157e-11
related O 0 1.1047035682054673e-11
to O 0 4.612350865823567e-12
initial O 0 2.024659773169901e-09
CTG O 0 5.280174946165062e-07
repeat O 0 1.0208491829644117e-09
size O 0 8.488152888896927e-12
and O 0 1.3014349797488278e-12
the O 0 4.9998074257151526e-12
time O 0 3.192189568235193e-12
interval O 0 6.585493261823672e-10
and O 0 1.4132285619528062e-11
always O 0 3.237535586841922e-11
biased O 0 1.0476734063624704e-11
towards O 0 2.796923933776063e-12
further O 0 5.9443300975958735e-12
expansion O 0 8.982385391043124e-10
. O 0 1.8166317339307625e-09

Attempts O 0 1.7051043244009634e-08
to O 0 1.1170739333543622e-10
mathematically O 0 8.421527919466598e-10
model O 0 2.6350174819889105e-10
the O 0 2.421129408070044e-10
dynamics O 0 7.763026887985802e-10
have O 0 2.4574828283441263e-11
proved O 0 1.0108514025830573e-09
only O 0 1.3627252104519982e-11
partially O 0 1.7774831606587327e-09
successful O 0 5.524940574486159e-11
suggesting O 0 4.044058924540517e-12
that O 0 5.737771369140887e-14
individual O 0 1.0971969284458063e-14
specific O 0 1.2744475342673506e-13
genetic O 0 8.683695255917723e-12
and O 0 1.7450368407223582e-12
/ O 0 3.0403655149058295e-09
or O 0 2.196027040768378e-11
environmental O 0 5.447969630978378e-09
factors O 0 5.371753389327161e-11
also O 0 1.6042583927955434e-12
play O 0 1.5341151959891164e-11
a O 0 1.0381848158935725e-11
role O 0 2.2771392410581015e-11
in O 0 5.821004789297035e-11
somatic O 0 3.2364599888978773e-08
mosaicism O 0 8.281945724775142e-07
. O 0 4.826576360805745e-10
. O 0 5.362003729914022e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.4412140814101804e-08
Palestinian O 0 1.8666644052700576e-07
Arabs O 0 5.809854641825041e-08
. O 0 2.9711213045402474e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.999681830406189
AGU B-Disease 1 1.0
) O 0 6.901811067105967e-11
is O 0 1.8960703233178444e-12
a O 0 1.2857238711194707e-11
rare O 0 1.123360902965942e-06
disorder B-Disease 1 0.9999990463256836
of I-Disease 0 0.008666615933179855
glycoprotein I-Disease 0 0.00495192501693964
metabolism I-Disease 0 0.3898855745792389
caused O 0 1.5376497852770399e-09
by O 0 2.968282954499135e-12
the O 0 4.457833924220722e-08
deficiency B-Disease 0 0.3804836571216583
of I-Disease 0 0.0015148513484746218
the I-Disease 0 1.435152535123052e-05
lysosomal I-Disease 0 0.020579835399985313
enzyme I-Disease 0 9.923794425104049e-11
aspartylglucosaminidase I-Disease 0 9.21520637575668e-09
( O 0 1.1951348764804859e-11
AGA O 0 6.109346628591084e-08
) O 0 5.418533330359132e-11
. O 0 1.689319129027922e-09

AGU B-Disease 1 1.0
is O 0 9.877124007573457e-09
inherited O 0 1.3837784251791163e-07
as O 0 1.2718147368584454e-10
an O 0 1.777806721281472e-11
autosomal O 0 2.3758395855111303e-06
recessive O 0 6.599858579647844e-07
trait O 0 2.4212401528167504e-10
and O 0 6.441242938332037e-13
occurs O 0 8.61712773619211e-14
with O 0 3.2366583693673725e-15
a O 0 7.183820595682566e-13
high O 0 9.63962416833386e-12
frequency O 0 1.9459951011713272e-11
in O 0 2.5820487241368095e-12
Finland O 0 9.57133261536569e-10
because O 0 1.2748134145534884e-11
of O 0 5.30502308748737e-10
a O 0 6.243076056122732e-10
founder O 0 1.9075367063692283e-08
effect O 0 3.451389574138375e-08
. O 0 3.1552089829745e-09

While O 0 3.191707342864447e-09
very O 0 6.555350012815708e-11
few O 0 8.227585279740879e-11
patients O 0 4.3653223397166485e-11
with O 0 1.483279193914555e-10
AGU B-Disease 1 1.0
have O 0 2.3132140734155593e-12
been O 0 1.512803147725797e-13
reported O 0 6.096396309865706e-14
from O 0 5.646811550253858e-14
non O 0 5.801853442122251e-10
- O 0 4.264069652926139e-11
Finnish O 0 1.9376342752508435e-09
origin O 0 6.08343930785793e-12
, O 0 1.6873199885913959e-12
we O 0 1.2549798873717766e-11
diagnosed O 0 5.4814384142787276e-09
the O 0 7.431898152443495e-11
disorder O 0 1.3671114018620756e-08
in O 0 9.998761367480125e-12
8 O 0 9.986845128651112e-09
patients O 0 8.602746878576262e-13
originating O 0 1.3811356572301925e-12
from O 0 1.2790994392136712e-12
3 O 0 7.667951607004397e-09
unrelated O 0 1.3486850525268324e-10
families O 0 4.100099573007762e-14
, O 0 8.72369396772571e-14
all O 0 5.392813474426605e-13
Palestinian O 0 1.5025823640879565e-10
Arabs O 0 9.614683181558004e-13
from O 0 6.729920711424225e-14
the O 0 1.2748565224318664e-12
region O 0 4.620953359540936e-12
of O 0 1.6049845480425873e-11
Jerusalem O 0 5.642909428615894e-08
. O 0 1.0461413957330024e-08

The O 0 2.775045748748539e-09
clinical O 0 9.07834510144312e-06
diagnosis O 1 0.9428874850273132
of O 1 0.9995943903923035
AGU B-Disease 1 1.0
is O 0 2.3782358304913487e-09
often O 0 7.812791212591375e-13
difficult O 0 8.597103606268475e-13
, O 0 3.440009168904738e-14
in O 0 3.978791241246969e-14
particular O 0 2.149507785306759e-13
early O 0 5.858079646370307e-12
in O 0 1.780261593524457e-13
the O 0 3.975472728789953e-12
course O 0 5.226300989202848e-11
of O 0 1.3865102642396376e-11
the O 0 1.508546759731999e-10
disease O 0 4.250148677442667e-09
, O 0 1.1180142369619089e-13
and O 0 1.5047740885374555e-13
most O 0 1.419028875524267e-13
of O 0 5.872133335138585e-11
the O 0 3.3799480991802966e-09
patients O 0 7.897841408643913e-11
are O 0 8.114153337950014e-13
diagnosed O 0 9.490939978373802e-11
after O 0 3.026234124403615e-11
the O 0 3.6814148951513914e-11
age O 0 2.60540044400015e-11
of O 0 1.7108328642656545e-10
5 O 0 4.62857308036746e-09
years O 0 6.252776629800394e-10
. O 0 4.966274058659792e-09

However O 0 9.842703319051793e-10
, O 0 1.285625859243078e-11
since O 0 7.01971744621055e-11
these O 0 7.805139347338841e-12
patients O 0 4.970435955181651e-12
excrete O 0 2.7648831141258157e-11
early O 0 2.6878381464978673e-11
large O 0 2.1306616410435297e-13
amounts O 0 9.775852545003405e-14
of O 0 2.9431509313004867e-12
aspartylglucosamine O 0 1.1771413843675305e-09
in O 0 1.1693617428532033e-11
urine O 0 4.727199100912349e-12
, O 0 2.776760754923807e-13
biochemical O 0 1.2876633093128476e-10
screening O 0 6.447423150923726e-10
is O 0 1.7288630379738712e-12
easy O 0 2.130444431980294e-11
by O 0 3.3215242622314234e-12
urine O 0 3.729602043867075e-11
chromatography O 0 7.375582089519384e-11
. O 0 6.814249164932562e-11
. O 0 1.4357287581034939e-09

Detection O 0 1.0001011929716697e-07
of O 0 1.5789493046369785e-09
heterozygous O 0 2.919281205659985e-10
carriers O 0 6.233170663644261e-12
of O 0 7.155002285097467e-11
the O 0 2.5371943479512993e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.8449059996660253e-08
ATM O 0 6.602946541534038e-06
) O 0 6.834548660523965e-13
gene O 0 6.943475200187066e-13
by O 0 6.823151527286797e-13
G2 O 0 7.661331835606688e-08
phase O 0 2.7883522157878815e-09
chromosomal O 0 1.1195796645324663e-07
radiosensitivity O 0 4.269716313842764e-08
of O 0 6.811969655018402e-09
peripheral O 0 1.2547741789603606e-05
blood O 0 3.77313691402037e-09
lymphocytes O 0 8.742588875065849e-09
. O 0 8.050007327398134e-10

In O 0 1.6752007923059864e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.831803458918202e-11
patients O 0 1.407352966803499e-12
, O 0 9.917642811055165e-15
mutations O 0 1.2041297558389782e-14
in O 0 4.932644529919046e-14
a O 0 3.671684809490594e-13
single O 0 2.1879486070131016e-12
gene O 0 8.387227002325248e-13
, O 0 6.536537668555206e-14
ATM O 0 1.7691142994991083e-10
, O 0 9.147860962656351e-15
result O 0 1.6290546927914817e-13
in O 0 9.972962532840343e-14
an O 0 2.535888513066631e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.425813964787807e-11
embraces O 0 4.6162518252401696e-11
a O 0 1.270132816196673e-13
variety O 0 5.762032561154595e-13
of O 0 4.771778024798001e-12
clinical O 0 1.3226805206656422e-09
features O 0 8.372180032578669e-11
and O 0 2.273740007038838e-12
manifests O 0 8.16470589054541e-12
extreme O 0 6.514934369761249e-09
radiosensitivity O 0 1.0885978696251186e-07
and O 0 2.1234706701345196e-11
a O 0 6.718336997835195e-11
strong O 0 3.3287386735914026e-10
pre O 0 0.2272748202085495
- O 0 1.7596247516848962e-06
disposition O 0 3.1564850360155106e-05
to O 0 4.941508979783293e-09
malignancy B-Disease 1 0.968845784664154
. O 0 1.9727787403667207e-08

Heterozygotes O 0 1.0152268004048892e-07
for O 0 2.5371862943934786e-10
the O 0 9.76405845065642e-10
ATM O 0 4.0501959119865205e-08
gene O 0 2.404262379462896e-11
have O 0 3.114381921299515e-14
no O 0 4.928318902064008e-14
clinical O 0 1.3246156775614804e-11
expression O 0 4.970768154727301e-12
of O 0 1.5497155780863636e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 7.264946283447316e-11
may O 0 6.456699064294469e-11
be O 0 1.5684301080121088e-11
cancer B-Disease 0 3.286749716835402e-08
prone O 0 1.5921512372396585e-11
with O 0 5.285600109721303e-14
a O 0 1.0263029141810431e-11
moderate O 0 2.3427482176430203e-10
increase O 0 8.009225878000126e-13
in O 0 1.9043774803634284e-12
in O 0 1.5351867346802273e-11
vitro O 0 8.299009124357326e-08
radiosensitivity O 0 4.023044311907142e-06
. O 0 2.3554125760938405e-08

We O 0 1.4713945617472746e-09
performed O 0 2.9873599149965457e-09
a O 0 2.2954600720215268e-10
blind O 0 2.210586602657827e-09
chromosomal O 0 8.125010886317341e-09
analysis O 0 1.1133254908257673e-11
on O 0 8.550868901835429e-10
G2 O 0 1.3568786094708685e-08
- O 0 9.806901818398828e-12
phase O 0 1.060217608150893e-10
lymphocytes O 0 4.451927975573922e-12
from O 0 4.361470901234274e-14
7 O 0 2.2743017191739767e-10
unrelated O 0 2.4087320582566463e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.355449473829708e-09
, O 0 5.630745977987239e-13
13 O 0 2.74878782929866e-11
obligate O 0 1.9735606482385037e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.1894967677505974e-08
( O 0 4.260591648908539e-14
parents O 0 2.8642406405909957e-15
of O 0 2.088721719455816e-13
the O 0 2.671236929568943e-12
patients O 0 6.401679181330597e-14
) O 0 1.4175559064048154e-15
, O 0 1.7064005576931073e-14
and O 0 2.4517313092914383e-13
14 O 0 6.206860025947947e-11
normal O 0 1.6710326178337453e-10
controls O 0 7.828973580537024e-10
following O 0 2.790887486392446e-11
X O 0 6.310962419320276e-09
- O 0 1.6308907349604773e-11
irradiation O 0 6.540288449707887e-11
with O 0 9.990826525460572e-13
1 O 0 6.394345053450934e-10
Gy O 0 3.366527057124813e-09
in O 0 7.734520489355301e-13
order O 0 1.924108008338754e-12
to O 0 3.9158083785066633e-13
evaluate O 0 5.225830185251468e-12
this O 0 5.426263821953214e-13
cytogenetic O 0 1.4414029969600506e-09
method O 0 4.340266340774335e-11
as O 0 5.78114682861508e-12
a O 0 6.7880943921405645e-12
tool O 0 2.594927328569696e-10
for O 0 3.7897779532614084e-12
detection O 0 5.35259259137888e-09
of O 0 2.0059554017848313e-09
ATM O 0 5.299059466778999e-06
carriers O 0 3.09610626025858e-09
. O 0 2.194977977154622e-09

Both O 0 3.212377066574845e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 6.064133799554838e-07
and O 0 3.6356928752312445e-12
heterozygotes O 0 5.020951432399556e-10
showed O 0 3.92285249423141e-12
significantly O 0 3.252173853027056e-14
increased O 0 2.197180087068311e-14
levels O 0 5.770347307615387e-13
of O 0 1.4935802161025746e-12
radiation O 0 1.2748538438245305e-06
- O 0 1.2080695555027887e-08
induced O 0 3.921000825357623e-06
chromatid O 0 1.771975121300784e-06
damage O 0 1.7670892304977315e-08
relative O 0 4.76296016516109e-11
to O 0 1.8544516508338382e-13
that O 0 8.253947113463778e-14
of O 0 3.088659536465421e-11
normal O 0 4.571491185600962e-09
controls O 0 2.386896937878191e-07
. O 0 2.1593784538254113e-09

These O 0 3.1897446489681514e-11
results O 0 1.638892320465768e-11
show O 0 3.0569172193573024e-11
that O 0 5.416791689673295e-13
the O 0 1.779867087048359e-10
G2 O 0 3.9914829130793805e-07
- O 0 1.0613653289581748e-09
phase O 0 1.0370740710641257e-08
chromosomal O 0 3.8023699744371697e-07
radiosensitivity O 0 6.660521734147551e-08
assay O 0 1.0610192724413992e-09
can O 0 1.0307098056994146e-13
be O 0 1.2372216390223092e-14
used O 0 3.316271419596278e-15
for O 0 6.168843546064135e-15
the O 0 2.0700691052803755e-13
detection O 0 3.227536848893209e-10
of O 0 1.5454473256681922e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 1.1809495845227502e-05
. O 0 1.0711051601219879e-08

In O 0 9.073647944113361e-10
combination O 0 4.982277368448251e-10
with O 0 2.1266757885968213e-12
molecular O 0 2.5883937215809283e-09
genetic O 0 1.539321586863096e-10
analyses O 0 8.733991828380194e-12
, O 0 3.5709239384895675e-13
this O 0 1.835246364600973e-13
test O 0 3.2074492367639706e-11
may O 0 2.2565822366087118e-13
be O 0 6.129132100398012e-15
of O 0 2.5815145106213716e-14
value O 0 8.894259975874771e-14
in O 0 1.2761665198711674e-14
studies O 0 3.919692058451142e-14
of O 0 4.3462428751459004e-13
familial B-Disease 0 1.350979050851464e-10
and I-Disease 0 2.0535035477609043e-11
sporadic I-Disease 0 5.776402758783661e-06
cancers I-Disease 0 7.376498842859291e-07
aimed O 0 3.321033448244748e-10
at O 0 1.0779267062277498e-10
determination O 0 2.049134334436431e-10
of O 0 1.5993746604880954e-10
the O 0 5.5179479041544965e-11
potential O 0 3.20033582967838e-11
involvement O 0 1.0116204401944273e-10
of O 0 1.378027469911558e-09
ATM O 0 6.963178020669147e-05
mutations O 0 6.728008705714217e-10
in O 0 1.7339173152830512e-10
tumor B-Disease 0 0.00014733521675225347
risk O 0 4.252256768921825e-09
or O 0 5.0782715706187975e-12
development O 0 1.872331595320631e-10
. O 0 5.029508406972916e-11
. O 0 1.3741272564260498e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.4869013398310926e-07
identification O 0 1.0430372121561504e-08
and O 0 3.8805677421427376e-12
detection O 0 1.2406677907250696e-09
of O 0 2.488254879917662e-10
founder O 0 9.864772998469107e-09
- O 0 2.5674562476041274e-10
effect O 0 1.3556673561510024e-09
mutations O 0 3.330291120998141e-12
in O 0 1.2468265352463814e-12
the O 0 2.7038706343351926e-11
ATM O 0 2.040275504100464e-08
gene O 0 9.132707610992608e-12
in O 0 1.259903097648729e-12
ethnic O 0 2.287892618413334e-11
populations O 0 1.41121433983038e-10
. O 0 7.034048343790289e-10

To O 0 1.1920937847964552e-10
facilitate O 0 8.835096543258203e-11
the O 0 3.79313525034064e-11
evaluation O 0 7.261732187791026e-11
of O 0 4.848980106331169e-10
ATM O 0 9.615688213671092e-06
heterozygotes O 0 1.265208382505989e-08
for O 0 6.591807828748575e-12
susceptibility O 0 4.776426476560403e-10
to O 0 2.313393888345866e-13
other O 0 1.833319520500032e-12
diseases O 0 0.0001034900124068372
, O 0 3.329546111475318e-13
such O 0 4.8586772626035835e-12
as O 0 1.6163806959568205e-09
breast B-Disease 0 0.00024563257466070354
cancer I-Disease 0 1.645863676458248e-06
, O 0 1.1043601796933977e-11
we O 0 1.0449133745760175e-11
have O 0 3.370053530942635e-13
attempted O 0 1.1811435510211687e-11
to O 0 9.530398659921696e-14
define O 0 4.894487592999042e-12
the O 0 3.5894789744694844e-12
most O 0 6.235898570520343e-14
common O 0 5.992089284609023e-14
mutations O 0 3.3832401737468078e-15
and O 0 5.119265115847071e-15
their O 0 1.4450246554886803e-14
frequencies O 0 2.472111708048952e-12
in O 0 1.9676735241169752e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999977350234985
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.877076599159926e-12
homozygotes O 0 6.365262761320878e-10
from O 0 2.9591802098993814e-13
10 O 0 4.972778699235958e-12
ethnic O 0 2.1415993978202152e-11
populations O 0 9.024177932692723e-11
. O 0 5.880194664520388e-10

Both O 0 1.1214209560961308e-09
genomic O 0 1.2038119834301142e-08
mutations O 0 5.991526719206774e-11
and O 0 1.0012273128634508e-11
their O 0 1.5135550798794917e-11
effects O 0 2.288322420440636e-09
on O 0 6.965770737998866e-10
cDNA O 0 3.187910824209439e-09
were O 0 1.4855243424261033e-10
characterized O 0 7.684364256022036e-09
. O 0 7.067147311801136e-09

Protein O 0 7.065219964630387e-09
- O 0 1.0307119602259718e-09
truncation O 0 4.776349626922638e-08
testing O 0 2.143089039563506e-09
of O 0 1.9794858807653526e-10
the O 0 1.1016153267373596e-10
entire O 0 1.5956512500192588e-10
ATM O 0 1.7040565625237036e-09
cDNA O 0 7.853857147965826e-11
detected O 0 6.005229733624384e-12
92 O 0 2.0050735377585838e-11
( O 0 6.482902864708706e-13
66 O 0 1.007499708660653e-10
% O 0 2.693697695455022e-12
) O 0 2.621268816154626e-13
truncating O 0 3.6893671451210253e-10
mutations O 0 1.819011087589306e-12
in O 0 3.745411099320695e-12
140 O 0 4.2615327933148706e-11
mutant O 0 8.054768518839239e-10
alleles O 0 3.042236254580111e-11
screened O 0 5.100761590881575e-09
. O 0 1.0875985667624377e-09

The O 0 1.4420533034353866e-07
haplotyping O 0 0.0017264154739677906
of O 0 1.46717229654314e-05
patients O 0 5.612828868351016e-09
with O 0 5.044803463860603e-11
identical O 0 1.4247500246256095e-07
mutations O 0 1.0892838020470919e-10
indicates O 0 8.718783334193958e-11
that O 0 2.408119547953752e-13
almost O 0 3.377693957862249e-12
all O 0 1.3531284382903297e-12
of O 0 1.273238892790518e-11
these O 0 2.6293139350876474e-14
represent O 0 2.1550948146268484e-13
common O 0 2.701280497029168e-13
ancestry O 0 4.088791683161917e-14
and O 0 1.6516279175479015e-13
that O 0 2.208188330538735e-13
very O 0 1.3051536847802359e-12
few O 0 5.962274424176073e-11
spontaneously O 0 1.1951947764821114e-10
recurring O 0 7.103351240544953e-09
ATM O 0 1.012074108075467e-06
mutations O 0 6.185165157823747e-10
exist O 0 1.714610009528883e-09
. O 0 3.3249205610985655e-09

Assays O 0 4.089489991088158e-08
requiring O 0 5.715271589323834e-10
minimal O 0 2.936930698638207e-09
amounts O 0 6.7793474826938205e-12
of O 0 1.4297017562892034e-11
genomic O 0 5.186304719018153e-10
DNA O 0 1.5815676546182544e-10
were O 0 7.652860983808907e-12
designed O 0 6.091845777822513e-12
to O 0 4.239008232972963e-13
allow O 0 4.5583719091024655e-12
rapid O 0 1.1270254174355898e-10
screening O 0 4.6940028253228405e-11
for O 0 6.04751437729284e-13
common O 0 1.0813219243621663e-11
ethnic O 0 3.2513106790199586e-11
mutations O 0 1.7521725736990845e-10
. O 0 7.371127597188831e-10

These O 0 2.00161637264884e-10
rapid O 0 1.4425252103933417e-09
assays O 0 1.908167929220994e-10
detected O 0 2.0582795884349636e-11
mutations O 0 3.677607263857796e-13
in O 0 3.805029750482414e-13
76 O 0 8.982483507002925e-11
% O 0 2.1043785203983534e-12
of O 0 2.224661982408449e-10
Costa O 0 2.6189416530542076e-05
Rican O 0 3.1448037134396145e-06
patients O 0 4.62300996095788e-11
( O 0 3.0434864155791386e-13
3 O 0 5.5139077331789466e-11
) O 0 1.7504754088837164e-14
, O 0 3.877700230684421e-14
50 O 0 5.743511135442025e-13
% O 0 8.576528430590674e-14
of O 0 9.9444428386386e-12
Norwegian O 0 1.6643025446683168e-07
patients O 0 3.897779321526684e-11
( O 0 5.551057118309555e-13
1 O 0 1.0912052511580228e-10
) O 0 9.815232292567384e-15
, O 0 1.8124738160514055e-14
25 O 0 6.774845983693878e-13
% O 0 2.3579686922632626e-13
of O 0 5.720841855794134e-11
Polish O 0 6.956561264814809e-07
patients O 0 5.696378369002275e-10
( O 0 1.4596188840920732e-12
4 O 0 6.769224625280401e-10
) O 0 5.583345065581988e-14
, O 0 4.8590986919880286e-14
and O 0 1.5448311575273765e-13
14 O 0 1.6156237805931006e-11
% O 0 6.971422137486138e-13
of O 0 1.318923581461462e-10
Italian O 0 7.544848017460026e-07
patients O 0 1.2928560999547756e-10
( O 0 5.188137788304792e-13
1 O 0 3.973862072736978e-10
) O 0 6.900351871928084e-14
, O 0 5.480180179551382e-14
as O 0 1.6106377570632852e-13
well O 0 2.010287010641154e-13
as O 0 1.8841760020694293e-13
in O 0 8.136097589921121e-13
patients O 0 2.4269328951012636e-13
of O 0 1.1047963759114321e-11
Amish O 0 4.7140695791370035e-09
/ O 0 1.1725774129445199e-08
Mennonite O 0 1.846050068365912e-08
and O 0 5.045352330368402e-11
Irish O 0 2.9122806388670597e-09
English O 0 1.6552897941224387e-09
backgrounds O 0 3.314839736034969e-09
. O 0 8.119928729399817e-09

Additional O 0 4.451034651964392e-09
mutations O 0 2.38265240870561e-10
were O 0 4.096400649244991e-11
observed O 0 1.235935746107808e-11
in O 0 4.0256808303551495e-12
Japanese O 0 1.252510983817956e-09
, O 0 8.6645864094681e-12
Utah O 0 7.625505227260021e-10
Mormon O 0 1.797421933513732e-11
, O 0 8.760281996339492e-13
and O 0 2.1702136615564527e-12
African O 0 1.2367146196012868e-10
American O 0 1.2129521831383272e-09
patients O 0 1.5021904831158395e-09
. O 0 3.5649354579447845e-09

These O 0 1.2719286734963475e-10
assays O 0 2.5998220243295123e-10
should O 0 2.7394594839108555e-12
facilitate O 0 1.1009148237137167e-12
screening O 0 6.572314220631981e-11
for O 0 1.9344943702481743e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999964237213135
T I-Disease 1 1.0
heterozygotes O 0 1.7200769697467422e-09
in O 0 3.103597023476623e-13
the O 0 1.2618271228240219e-12
populations O 0 1.4234800675434062e-13
studied O 0 6.533901458077862e-12
. O 0 5.0185910115130294e-12
. O 0 3.7139014086307043e-10

The O 0 1.8061385844703182e-06
von B-Disease 1 0.9999468326568604
Hippel I-Disease 1 0.9999986886978149
- I-Disease 1 0.994414210319519
Lindau I-Disease 0 0.0917016938328743
tumor I-Disease 0 1.032084310281789e-05
suppressor O 0 1.1499157182015551e-07
gene O 0 1.9077229379549365e-11
is O 0 9.17435479799375e-14
required O 0 4.489496339792065e-13
for O 0 5.264865691849419e-13
cell O 0 4.334377856629601e-10
cycle O 0 2.3179289043717688e-10
exit O 0 3.3027586221479055e-10
upon O 0 1.8604258758547765e-12
serum O 0 1.658818395144923e-11
withdrawal O 0 4.701980471644163e-10
. O 0 2.724288572508726e-10

The O 0 1.1958754875251998e-08
inactivation O 0 1.402373982273275e-06
of O 0 2.8918737626781876e-08
the O 0 4.651879237371759e-08
von B-Disease 1 0.99980229139328
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999873638153076
Lindau I-Disease 1 0.9999902248382568
( I-Disease 0 2.537395289436972e-07
VHL I-Disease 0 0.10138920694589615
) I-Disease 0 1.7293694254405523e-10
tumor I-Disease 0 5.725319738303369e-07
suppressor O 0 1.2168409284640802e-06
gene O 0 2.0380730436642125e-09
predisposes O 0 1.5058962410385845e-10
affected O 0 2.5618966583568215e-12
individuals O 0 5.677652528083155e-15
to O 0 4.1811264059289296e-14
the O 0 2.633620543868176e-10
human O 1 0.9992256164550781
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999986886978149
and O 0 7.346487133907953e-12
is O 0 2.3171915775055396e-13
associated O 0 3.4893431460208957e-12
with O 0 7.095919771910042e-12
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 2.164502882484598e-10
RCC B-Disease 0 0.0004805376520380378
) O 0 7.878533762883944e-12
and O 0 2.650755170918728e-10
brain B-Disease 0 0.03560088947415352
hemangioblastomas I-Disease 0 0.0025614809710532427
. O 0 3.346037047435857e-08

VHL O 0 0.06417032331228256
- O 0 6.005894874760997e-07
negative O 0 4.611928972053647e-08
786 O 0 3.3549572435731534e-06
- O 0 5.570645953412168e-06
0 O 0 6.16788065599394e-06
RCC B-Disease 0 0.04759218171238899
cells O 0 2.1719270826281445e-09
are O 0 1.1474305663602968e-12
tumorigenic O 0 2.242509067329479e-09
in O 0 2.1415341722175185e-11
nude O 0 1.0460511346011003e-09
mice O 0 3.3230022900010425e-11
which O 0 1.7728533417238172e-14
is O 0 9.799369906564152e-15
suppressed O 0 1.4553432244046594e-12
by O 0 1.3076746716716992e-13
the O 0 2.38421938442146e-11
reintroduction O 0 9.60802992722165e-09
of O 0 1.7176509103933313e-09
VHL B-Disease 0 1.310646712227026e-05
. O 0 2.6489587412470428e-08

Remarkably O 0 3.7099337646395725e-07
, O 0 6.06170252881455e-11
this O 0 2.043028506787392e-12
occurs O 0 3.584949611473709e-12
without O 0 3.5764468643562086e-12
affecting O 0 2.1716172696889524e-12
the O 0 5.099334149383239e-12
growth O 0 5.847623080201814e-11
rate O 0 5.994613139215232e-11
and O 0 3.245404596105561e-12
cell O 0 1.044516384496319e-08
cycle O 0 5.882191400630177e-10
profile O 0 1.126809930085404e-11
of O 0 2.2363349019838275e-11
these O 0 1.37296912120638e-13
cells O 0 3.8588438542631887e-13
in O 0 4.771183990427696e-13
culture O 0 1.1217497764004492e-10
. O 0 2.919448294225191e-10

The O 0 2.733359281137382e-07
786 O 0 4.2649872966649127e-07
- O 0 4.970085853983619e-08
0 O 0 2.3131260462605496e-08
cell O 0 2.0566464087323766e-08
line O 0 4.5502890344550906e-10
, O 0 9.267043512770079e-13
like O 0 1.8074838500914403e-12
many O 0 8.605470936534632e-13
cancer B-Disease 0 6.581273859218584e-10
cells O 0 9.120278317287234e-12
, O 0 5.658673941748293e-13
fails O 0 2.223685124924657e-11
to O 0 2.320960264257099e-13
exit O 0 4.0608669205077774e-10
the O 0 2.451733607800044e-11
cell O 0 9.411874057896341e-11
cycle O 0 1.7798153575943054e-11
upon O 0 7.429849378966236e-13
serum O 0 1.6340448091844983e-11
withdrawal O 0 4.119485030873449e-10
. O 0 3.319570729409804e-10

Here O 0 6.452568701575956e-09
, O 0 8.689063357714133e-12
it O 0 5.655089433840785e-14
is O 0 7.859130826595034e-15
shown O 0 2.375002118256732e-14
that O 0 5.358991110029562e-15
reintroduction O 0 1.2875103760912054e-11
of O 0 1.6675285284539765e-12
the O 0 1.2726027696918774e-11
wild O 0 1.6408518987987009e-09
- O 0 4.136003206589578e-10
type O 0 2.216788974607198e-09
VHL B-Disease 0 1.0426830385767971e-06
gene O 0 1.8117138345097317e-10
restores O 0 5.7111226858808095e-09
the O 0 4.25563612127533e-11
ability O 0 9.687028956761878e-12
of O 0 2.9206634888367944e-09
VHL O 1 0.9902684688568115
- O 0 2.3026641429169104e-06
negative O 0 1.5779572493102023e-07
RCC B-Disease 1 0.9999969005584717
cancer I-Disease 0 3.501064043121005e-07
cells O 0 2.2552076525683695e-11
to O 0 7.321974515410445e-13
exit O 0 4.778360818136207e-09
the O 0 2.0716355714212042e-11
cell O 0 8.606846346737029e-10
cycle O 0 6.84313855581209e-11
and O 0 7.194722248526908e-13
enter O 0 5.2886636042748236e-11
G0 O 0 1.8302911541923095e-07
/ O 0 3.0230914993545355e-10
quiescence O 0 5.4254156722777225e-09
in O 0 4.952921406342625e-11
low O 0 9.033779058142954e-09
serum O 0 3.607522280901776e-09
. O 0 3.9768135451367925e-09

Both O 0 1.0094650093606106e-07
VHL O 0 0.0006692907772958279
- O 0 4.243014828375635e-08
positive O 0 4.918205842585621e-10
and O 0 1.3659194886272985e-09
VHL O 0 0.0008348842384293675
- O 0 3.313090246592765e-08
negative O 0 7.508733190775274e-09
RCC B-Disease 0 0.000128032494103536
cells O 0 4.7303991834724e-09
exit O 0 2.5979659312724834e-08
the O 0 6.659470891401398e-11
cell O 0 3.370675960567837e-10
cycle O 0 1.321052989222693e-11
by O 0 4.3714839148729923e-13
contact O 0 1.345001332531126e-10
inhibition O 0 4.223497107602725e-09
. O 0 2.3467017218337105e-10

The O 0 2.3532150805749552e-07
cyclin O 0 1.8162174342251092e-07
- O 0 2.340758520347208e-08
dependent O 0 6.278880526622288e-09
kinase O 0 6.287341758337561e-09
inhibitor O 0 1.1042454728382722e-09
, O 0 2.2230479176238438e-12
p27 O 0 4.0138622980911975e-10
, O 0 2.6050101203760334e-13
accumulates O 0 2.016473603762628e-13
upon O 0 6.116032566462135e-14
serum O 0 2.0681354307057476e-13
withdrawal O 0 1.6351040530229732e-12
, O 0 1.9548609015178006e-14
only O 0 8.374015050176611e-15
in O 0 3.264491744959207e-14
the O 0 5.145936845044052e-13
presence O 0 8.229145988768172e-13
of O 0 1.5220787130676428e-10
VHL B-Disease 0 5.321801381796831e-07
, O 0 3.070496114310206e-12
as O 0 2.1105283319611257e-12
a O 0 4.750636516115403e-12
result O 0 1.2250177434947052e-11
of O 0 4.984489557213756e-11
the O 0 4.232210068511044e-11
stabilization O 0 5.1619249319401206e-08
of O 0 3.3217069095314855e-09
the O 0 1.1389595933053442e-08
protein O 0 4.6819927490560076e-08
. O 0 1.7143984010203894e-08

We O 0 2.099594498261581e-09
propose O 0 4.2148923240503677e-10
that O 0 6.144096733121107e-13
the O 0 1.4302199181914776e-11
loss O 0 1.3448653302106095e-10
of O 0 7.715083016890389e-10
wild O 0 6.79829170735502e-08
- O 0 4.187489466289662e-09
type O 0 4.74960444307726e-08
VHL B-Disease 0 4.921194886264857e-06
gene O 0 3.0934765166135136e-11
results O 0 2.1765770609472046e-12
in O 0 3.874101831436577e-13
a O 0 1.828043575888283e-12
specific O 0 2.0105729581221254e-11
cellular O 0 4.295860378533689e-07
defect O 0 5.3110625231056474e-08
in O 0 3.492487549161538e-11
serum O 0 7.76561870363679e-10
- O 0 2.461003401066364e-09
dependent O 0 3.804121184725062e-10
growth O 0 2.2666885035604878e-10
control O 0 8.124309003321173e-10
, O 0 3.869168982602311e-13
which O 0 7.429056285077063e-13
may O 0 1.2760590327454135e-11
initiate O 0 4.2503653374659223e-10
tumor B-Disease 0 1.8990201411384078e-08
formation O 0 5.11422237892134e-10
. O 0 1.0612459799830276e-09

This O 0 1.3690015787659604e-10
is O 0 3.583479650168253e-12
corrected O 0 3.540685800107468e-11
by O 0 1.510456121072909e-13
the O 0 6.56122638859058e-12
reintroduction O 0 1.481238687262021e-09
of O 0 6.904167515475734e-11
wild O 0 3.256354830227792e-08
- O 0 1.916434833049152e-08
type O 0 2.537126704282855e-07
VHL B-Disease 1 0.8976444602012634
, O 0 8.303340237603152e-10
implicating O 0 1.1297259305820262e-07
VHL B-Disease 0 5.433354090200737e-05
as O 0 1.591320131222318e-10
the O 0 3.202438036975508e-10
first O 0 1.6741653896534814e-10
tumor B-Disease 0 6.738568814057544e-09
suppressor O 0 4.246234919236258e-09
involved O 0 1.0836088970567204e-12
in O 0 1.4542334350609032e-12
the O 0 1.4877672704916023e-10
regulation O 0 1.2175863872698756e-08
of O 0 1.8492771758360504e-09
cell O 0 1.0906948944011674e-07
cycle O 0 1.1841701841319718e-08
exit O 0 1.3088808259453799e-08
, O 0 5.168837363331291e-13
which O 0 4.345809600852721e-14
is O 0 3.4976351919987006e-14
consistent O 0 5.154053399347713e-12
with O 0 5.145679414790723e-14
its O 0 2.5765597988502975e-11
gatekeeper O 0 2.0799360012091483e-09
function O 0 4.224967597998841e-11
in O 0 3.394991102481648e-12
the O 0 2.276124289046777e-10
kidney O 0 1.9652475202747155e-07
. O 0 9.663670558213155e-11
. O 0 1.1095701024643745e-09

Piebaldism B-Disease 1 1.0
with O 0 0.0005308864056132734
deafness B-Disease 1 1.0
: O 0 1.7287205000826589e-09
molecular O 0 7.798168777384262e-10
evidence O 0 1.7663856488603358e-11
for O 0 9.038983754192098e-13
an O 0 1.8896475096480403e-12
expanded O 0 1.0994170196454434e-07
syndrome O 1 0.6388230323791504
. O 0 7.511142285920869e-08

In O 0 3.5881889126621047e-10
a O 0 1.938468552342698e-10
South O 0 1.2115717318295083e-09
African O 0 4.6123552199794915e-10
girl O 0 1.6732970564703464e-10
of O 0 1.9066981327142685e-10
Xhosa O 0 2.926002196090849e-07
stock O 0 4.2724407345318127e-10
with O 0 1.4997156294604963e-11
severe O 0 0.003565907711163163
piebaldism B-Disease 0 0.001254672184586525
and O 0 1.4823805516428479e-09
profound O 1 0.9999921321868896
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 6.446967959483629e-10
identified O 0 4.327251176741015e-13
a O 0 4.123195112160777e-14
novel O 0 2.690179350985089e-13
missense O 0 1.4260794801990162e-11
substitution O 0 5.1610108547928135e-11
at O 0 2.1040272302208507e-10
a O 0 6.254869452243517e-12
highly O 0 9.615164567322587e-12
conserved O 0 3.3945197347451384e-11
residue O 0 9.815238621868616e-10
in O 0 3.735909498425727e-11
the O 0 1.826264556248347e-10
intracellular O 0 1.9351067970241331e-10
kinase O 0 4.942166120791569e-10
domain O 0 3.2881572464837916e-10
of O 0 1.8004604473986774e-09
the O 0 8.080363045337435e-09
KIT O 0 3.1791919354873244e-06
proto O 0 4.2801531208169763e-07
- O 0 5.295535743243818e-08
oncogene O 0 6.101626013332861e-07
, O 0 4.5174022855754004e-10
R796G O 0 2.238908223262115e-07
. O 0 1.4759599764602171e-08

Though O 0 2.6575467160228072e-08
auditory B-Disease 0 3.076404937019106e-06
anomalies I-Disease 0 1.2835104143960052e-06
have O 0 2.0647400456041964e-11
been O 0 2.4347880482611384e-12
observed O 0 1.6466064622910892e-11
in O 0 4.662831318974492e-12
mice O 0 1.6469779706707044e-10
with O 0 1.7524883454134166e-12
dominant O 0 8.966222821982228e-07
white O 0 5.026835059318557e-10
spotting O 0 1.1087285756161691e-08
( O 0 3.016247668297112e-11
W O 0 1.4788062799198087e-05
) O 0 3.3203652501090364e-12
due O 0 7.759596520884315e-09
to O 0 5.459510968308656e-11
KIT O 0 0.00015595857985317707
mutations O 0 1.099797697357019e-09
, O 0 7.406218416328159e-10
deafness B-Disease 1 1.0
is O 0 3.6395938346478474e-11
not O 0 2.5091926691804545e-13
typical O 0 6.6454597900944545e-12
in O 0 1.6128981830676459e-12
human O 0 3.142247018139699e-10
piebaldism B-Disease 0 7.743040697505421e-08
. O 0 5.904935207468043e-09

Thus O 0 3.1080088502832837e-10
, O 0 9.344696240767836e-13
the O 0 5.720824747083852e-13
occurrence O 0 4.386625229724217e-10
of O 0 2.7587136131046464e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 7.773729215898584e-09
this O 0 6.718230138869075e-12
patient O 0 4.3972783747570077e-11
extends O 0 1.486478041351491e-12
considerably O 0 1.827735825101623e-13
the O 0 2.8182355537795245e-13
phenotypic O 0 2.1677461214952842e-10
range O 0 2.3100759152794303e-11
of O 0 1.617396667985549e-11
piebaldism B-Disease 0 2.676485344466073e-08
due O 0 5.1274525958433514e-08
to O 0 1.1695117096977015e-10
KIT O 0 2.180326646339381e-06
gene O 0 7.757783304640498e-11
mutation O 0 2.3364671742492904e-12
in O 0 4.462024554095084e-13
humans O 0 1.1232988280859835e-12
and O 0 7.773149528558787e-13
tightens O 0 1.0884613349526617e-10
the O 0 3.334161939594349e-12
clinical O 0 1.1590236409508847e-10
similarity O 0 3.102178019673274e-12
between O 0 1.8225427677459605e-12
piebaldism B-Disease 0 1.4112911728147992e-08
and O 0 2.302609708806913e-12
the O 0 2.5850645408997952e-12
various O 0 8.081039635197962e-13
forms O 0 3.024999348233415e-11
of O 0 4.772941153419197e-09
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.8437840938568115
. O 0 2.7636839483591302e-09
. O 0 2.8420478415114303e-08

Cycloheximide O 0 3.5322573239682242e-06
facilitates O 0 1.1644307740255044e-09
the O 0 1.716019271125191e-10
identification O 0 6.637688176880374e-10
of O 0 8.762550685048609e-10
aberrant O 0 1.3396381781660693e-09
transcripts O 0 3.6409564252437576e-10
resulting O 0 1.685564535169881e-11
from O 0 4.321494063205117e-13
a O 0 6.982896899598856e-12
novel O 0 1.2959562242786937e-11
splice O 0 1.6163929084100914e-09
- O 0 3.0243949011854454e-10
site O 0 3.6570618755504825e-10
mutation O 0 6.0887558016309296e-12
in O 0 4.374105244675519e-12
COL17A1 O 0 2.174958126488491e-06
in O 0 8.931981543280898e-11
a O 0 2.6283367149382286e-10
patient O 0 1.7366786897454745e-09
with O 0 1.3270490262229373e-10
generalized O 1 0.9999947547912598
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999986886978149
. O 0 2.5303077677563124e-07

Patients O 0 4.98973840024064e-08
with O 0 3.8291778081678274e-10
generalized O 1 0.9997308850288391
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
often O 0 3.217657390530704e-11
show O 0 1.7193633669587705e-11
decreased O 0 7.45836795101873e-11
expression O 0 2.5086687935327312e-11
of O 0 1.1009809730566644e-10
type O 0 1.0398351513174475e-08
XVII O 0 6.385039910128398e-07
collagen O 0 1.398973648036872e-08
, O 0 5.617578971439663e-11
a O 0 5.11578071571428e-11
transmembrane O 0 9.984745252822336e-10
hemidesmosomal O 0 1.3384283015227538e-08
protein O 0 5.117322884884423e-11
encoded O 0 1.389872266756298e-12
by O 0 7.92008819638923e-12
COL17A1 O 0 1.5704943052696763e-06
. O 0 7.878425911655995e-09

This O 0 1.7331833190858958e-10
report O 0 1.8049286024113265e-11
documents O 0 1.0212668384579349e-11
a O 0 1.0249394215289254e-11
novel O 0 1.1327617663314804e-11
splice O 0 8.871981482805325e-10
- O 0 2.0782141285646816e-10
site O 0 2.261187070917714e-10
mutation O 0 1.2578244869276833e-11
in O 0 7.450260026964362e-12
COL17A1 O 0 4.510365670284955e-06
in O 0 8.547864499552915e-11
a O 0 3.02253805317676e-10
patient O 0 1.7188503953491363e-09
with O 0 1.2309817054578787e-10
generalized O 1 0.9999996423721313
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
, O 0 1.916246605837557e-10
and O 0 1.3362326002630542e-11
applies O 0 3.188710406831774e-11
a O 0 6.419891961789714e-12
new O 0 3.1167087140293592e-12
methodology O 0 7.627723105918527e-12
to O 0 3.5085617137303737e-13
define O 0 3.1143806283884246e-11
and O 0 3.4834049707221926e-12
characterize O 0 9.273559697930978e-11
the O 0 7.258547235489132e-11
resulting O 0 1.226032886325612e-10
mRNA O 0 1.9455953514935231e-10
splice O 0 1.2875025490188818e-08
variants O 0 3.932289605046435e-09
. O 0 6.044874822919155e-09

Mutational O 0 3.354087084517232e-06
analysis O 0 7.557365289123652e-10
of O 0 1.8185740913168047e-08
COL17A1 O 0 0.29894766211509705
identified O 0 1.9394061467892243e-08
a O 0 1.9754662350379704e-09
maternally O 0 2.2195856264062286e-09
inherited O 0 1.171057562032729e-08
G O 0 1.0971249366775737e-06
- O 0 5.648293921467484e-08
to O 0 1.0345333478767316e-08
- O 0 3.91471512557473e-05
T O 0 1.6378910004277714e-05
transversion O 0 2.0659965116465173e-07
at O 0 4.3479411737656903e-10
the O 0 1.7162148438498726e-11
- O 0 8.322390519788225e-12
1 O 0 8.058421985257525e-11
position O 0 2.12144659478275e-11
of O 0 1.3990415770326337e-10
exon O 0 1.69754343914974e-08
32 O 0 6.382334216681329e-09
. O 0 6.078901826356287e-09

This O 0 1.5347987325498025e-09
acceptor O 0 2.6277199860480493e-10
splice O 0 1.89381879067696e-08
- O 0 5.427206684061048e-09
site O 0 2.2179604819427823e-09
mutation O 0 7.190915224386529e-11
led O 0 9.789894589440351e-12
to O 0 6.32912721797857e-13
the O 0 2.7763664631197393e-11
formation O 0 2.5046622761926152e-11
of O 0 7.98552959868637e-11
aberrant O 0 1.6805351554793901e-10
transcripts O 0 1.4665718639506053e-10
present O 0 2.4956684288590658e-11
at O 0 3.856210017971762e-09
extremely O 0 4.159427802186144e-10
low O 0 4.377936235755442e-08
levels O 0 8.316994382084886e-08
. O 0 2.6005473330315e-09

Based O 0 9.636085263053928e-10
on O 0 6.360993509701984e-09
our O 0 1.5332735081585724e-10
recent O 0 1.3501334598930992e-11
finding O 0 6.771232446273201e-12
that O 0 3.084923538409362e-13
cycloheximide O 0 5.578143280615677e-09
stabilized O 0 1.0953602469498946e-08
mutant O 0 1.9252928140645054e-09
COL17A1 O 0 4.706345890781449e-08
transcripts O 0 1.410848382565888e-10
in O 0 1.7428148767900664e-12
keratinocytes O 0 2.679629018675911e-10
homozygous O 0 6.424648313352321e-11
for O 0 3.2176496710112357e-12
a O 0 3.919907107241549e-11
frameshift O 0 2.4249200425430217e-09
mutation O 0 9.148013943582889e-12
, O 0 4.197628843908424e-13
the O 0 7.35153344449957e-12
effects O 0 2.2351303030632153e-09
of O 0 1.04994690719451e-09
the O 0 2.8174496069510724e-10
splice O 0 1.7908432514701644e-09
- O 0 1.8062105977545428e-10
site O 0 1.3000021892306535e-10
mutation O 0 1.9250918133900674e-12
on O 0 2.816250010972965e-11
splicing O 0 8.673139290094056e-11
of O 0 1.3575555957157093e-10
COL17A1 O 0 1.5890051940914418e-07
transcripts O 0 4.838429656928156e-10
were O 0 1.0018424458080322e-11
determined O 0 4.6877736067929554e-12
using O 0 3.12108693924229e-12
reverse O 0 2.9205451945735206e-10
transcriptase O 0 5.853179746440063e-11
polymerase O 0 1.5320770693771912e-11
chain O 0 8.854260380442014e-11
reaction O 0 7.787276682866273e-13
of O 0 9.391229113808741e-12
total O 0 2.232771779964171e-11
RNA O 0 6.03506480900684e-11
from O 0 1.976360264679955e-12
keratinocytes O 0 5.484583343040583e-10
incubated O 0 1.0369365782691986e-10
for O 0 2.3599148676889392e-11
2 O 0 2.5649233847957476e-08
. O 0 3.1081763829376996e-09

5 O 0 5.2824010055019244e-08
h O 0 1.1979430780684197e-09
in O 0 2.8533956447640563e-11
the O 0 7.885182784495015e-11
presence O 0 4.3048311443305565e-11
or O 0 1.2057265776077575e-11
absence O 0 1.0863132615668292e-09
of O 0 2.4157058575724477e-09
10 O 0 4.781004481202444e-09
microg O 0 2.3701183238244994e-07
cycloheximide O 0 1.8215357044937264e-07
per O 0 1.0645910819562232e-09
ml O 0 3.946936644183552e-08
. O 0 5.575739425722759e-09

Using O 0 1.8037765725509303e-10
this O 0 7.848147479116996e-12
approach O 0 7.708578220189111e-11
, O 0 2.186496643463709e-12
an O 0 7.427326982611948e-13
abnormally O 0 1.974764657353134e-10
spliced O 0 6.353860770857978e-10
transcript O 0 1.7596419876753089e-09
was O 0 2.0053728122526593e-10
identified O 0 1.1940997236142836e-12
that O 0 1.5355650236602292e-14
contains O 0 1.46293472670124e-13
an O 0 1.707461889976017e-14
extra O 0 6.58318506045058e-13
264 O 0 4.65145012350926e-13
bases O 0 4.6632316064165735e-12
upstream O 0 5.785269182115305e-13
from O 0 1.4852764200837254e-12
exon O 0 6.454387024845687e-10
32 O 0 4.255749572190659e-11
, O 0 1.721498811557698e-12
resulting O 0 2.744313977454116e-11
in O 0 2.312571314999623e-11
a O 0 2.0505623865574307e-09
premature O 0 1.2940809313022328e-08
termination O 0 8.982886434694137e-09
codon O 0 5.0284678643208736e-09
27 O 0 9.163080072482899e-09
bp O 0 6.985594880326573e-10
downstream O 0 5.177999695682445e-11
from O 0 1.22411620770424e-11
the O 0 1.5297805244784968e-09
cryptic O 0 1.4555460836618295e-08
splice O 0 7.152706160695743e-08
site O 0 2.538582855038385e-08
. O 0 5.7810010112291366e-09

Three O 0 1.8489351161221634e-09
other O 0 7.863150408571329e-11
splice O 0 4.687449983720171e-09
variants O 0 2.736673387904176e-10
, O 0 4.327418631766555e-12
including O 0 8.955103368915585e-13
one O 0 1.560788851677833e-13
derived O 0 7.213075758428014e-14
from O 0 1.8199158814072997e-13
the O 0 2.8406020591287273e-11
skipping O 0 2.685431044202602e-10
of O 0 8.925390981850967e-11
exon O 0 8.986154598211726e-10
32 O 0 1.1391887433376269e-10
, O 0 1.1313259357104144e-11
were O 0 1.582524250531847e-10
also O 0 6.860572526745656e-11
identified O 0 1.3872760717958954e-09
. O 0 5.194286778475998e-09

These O 0 1.283906314597516e-10
results O 0 1.8584202232663216e-10
indicate O 0 1.1857278180149589e-11
the O 0 1.3030698915728056e-11
usefulness O 0 6.14120032604859e-10
of O 0 5.348566034513169e-11
cycloheximide O 0 1.9444323484663073e-08
treatment O 0 2.265390652844701e-11
in O 0 1.8532222197803483e-12
evaluating O 0 1.770085467089899e-11
the O 0 2.410157837196003e-11
abnormal O 0 9.708767817473429e-11
processing O 0 4.3011724737418433e-10
of O 0 4.4743209137720896e-10
mRNA O 0 2.295950374264777e-10
due O 0 1.0373861769608084e-09
to O 0 6.914983342876102e-12
splice O 0 2.0704957748307606e-09
- O 0 3.694042294277722e-10
site O 0 1.6117374102009308e-10
mutations O 0 1.243271653163236e-12
, O 0 3.123431418020073e-13
because O 0 9.14544590231714e-13
( O 0 2.9844266706373357e-13
i O 0 2.4244091109681953e-11
) O 0 4.164517851661803e-13
aberrant O 0 2.5528835989607757e-11
splicing O 0 2.0437437853182416e-10
often O 0 2.157624258295257e-13
generates O 0 1.7760695258245418e-13
a O 0 4.406813889495931e-12
premature O 0 4.528623656629982e-11
termination O 0 2.1655465615166847e-11
codon O 0 1.2866168200287298e-11
, O 0 1.040963715508332e-13
( O 0 1.4348683916379223e-14
ii O 0 1.1571217595207628e-10
) O 0 1.4248545648475747e-13
transcripts O 0 7.581543726153939e-11
with O 0 1.8017710587403535e-11
premature O 0 5.1902460107555726e-09
termination O 0 1.0048748499968951e-09
codons O 0 2.688670119876946e-10
can O 0 4.1246837217435994e-13
occur O 0 5.311960723716758e-13
at O 0 1.0163006547436737e-10
low O 0 2.0252930443831474e-09
or O 0 1.0013953208320991e-11
undetectable O 0 2.2347738592998212e-07
levels O 0 3.1277763712367346e-10
due O 0 3.054115571554661e-10
to O 0 9.087385791778368e-13
nonsense O 0 7.682128544406197e-11
- O 0 1.908995964777782e-12
mediated O 0 2.5700710656884063e-11
mRNA O 0 2.735167778031289e-12
decay O 0 4.7373015232832216e-11
, O 0 2.7015827861473843e-14
and O 0 4.584498403191299e-14
( O 0 2.6597239425533818e-14
iii O 0 3.196236678104647e-11
) O 0 5.738888097378547e-14
the O 0 4.8665333915454134e-12
levels O 0 3.139939003249381e-11
of O 0 8.783609256601821e-12
these O 0 3.579959950445605e-13
transcripts O 0 4.200235992346535e-11
can O 0 6.65777180022982e-14
be O 0 6.276721492819853e-14
increased O 0 7.273313353504951e-13
by O 0 6.3001288214126205e-12
cycloheximide O 0 2.77837386875035e-07
. O 0 1.0359985758157109e-08

A O 0 1.5151090337894857e-07
deletion O 0 3.0678957152474595e-09
mutation O 0 1.5334725156357365e-10
in O 0 2.656422477820275e-11
COL17A1 O 0 6.420590352718136e-07
in O 0 8.425846131920878e-11
five O 0 1.0858113713707596e-10
Austrian O 0 1.5698542910058677e-08
families O 0 6.84969051964468e-12
with O 0 1.386328551955529e-10
generalized O 1 0.9999963045120239
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999997615814209
represents O 0 3.1071925032932768e-09
propagation O 0 1.2583308262037463e-07
of O 0 2.1737425193180115e-09
an O 0 7.63861369990071e-12
ancestral O 0 4.473751147315852e-09
allele O 0 5.165447625188335e-09
. O 0 3.571462459106556e-09

Patients O 0 5.603333619319528e-08
with O 0 6.267714125485213e-10
generalized O 1 0.9997817873954773
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 6.464921376014843e-10
a O 0 7.969948312425146e-11
usually O 0 2.7345223307939648e-11
nonlethal O 0 8.638608939293135e-09
form O 0 2.1908864999975464e-10
of O 0 7.172895610807473e-09
junctional B-Disease 1 0.9999972581863403
epidermolysis I-Disease 1 0.9999985694885254
bullosa I-Disease 0 0.05240471661090851
, O 0 1.942324079351465e-11
have O 0 1.82640209379914e-12
generalized O 0 2.0640726905440943e-09
blistering B-Disease 0 2.0443702908323758e-07
, O 0 1.8318786487725447e-09
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.3103392976508985e-08
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.999997615814209
, O 0 1.6669196578611434e-10
and O 0 7.296240056575698e-09
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.6223044667640352e-06

Skin B-Disease 1 0.9964733719825745
fragility I-Disease 0 0.17546916007995605
in O 0 3.256720004785052e-09
most O 0 7.344301382328222e-12
cases O 0 5.508141685817147e-13
is O 0 5.629153962622216e-14
due O 0 6.028195997931363e-11
to O 0 3.4068012083263155e-13
mutations O 0 1.3678199740387031e-13
in O 0 3.9061481371498175e-13
the O 0 6.620435102910882e-12
gene O 0 5.828111430961069e-12
encoding O 0 1.3574304874586218e-11
type O 0 2.311537183885548e-09
XVII O 0 4.836220455217699e-07
collagen O 0 5.7089906135843194e-08
( O 0 4.1063216715819806e-10
COL17A1 O 0 1.1784406524384394e-05
) O 0 9.383516880179243e-11
. O 0 1.0241978376512861e-09

Recently O 0 4.4715612546042394e-08
, O 0 8.486312347288916e-11
we O 0 9.340388705536551e-12
reported O 0 2.0361282104808254e-11
five O 0 3.3794227832784074e-11
Austrian O 0 6.553756648486342e-09
families O 0 1.1311835149130367e-11
with O 0 1.2354178791085246e-10
generalized O 1 0.9999825954437256
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
who O 0 1.1258056709095854e-09
share O 0 5.141938957953229e-11
the O 0 1.3900253170717747e-09
same O 0 3.928309233458549e-09
COL17A1 O 0 0.08852998167276382
mutation O 0 2.3376710345246465e-08
. O 0 2.8978133226331693e-09

Affected O 0 7.527244605398664e-09
individuals O 0 1.5555768478892062e-12
in O 0 2.9346546026598475e-11
three O 0 4.460327593380775e-11
families O 0 3.4869527512811083e-13
are O 0 1.6149290292619828e-13
homozygous O 0 3.88399035156084e-11
for O 0 1.0435092893945619e-11
4003delTC O 0 1.604263832888364e-09
, O 0 3.226197737779546e-12
whereas O 0 1.6077995055110983e-12
those O 0 7.626639256111747e-14
in O 0 9.903400799080031e-13
two O 0 2.401204452287531e-12
others O 0 9.249052912441158e-12
are O 0 4.360826370147786e-12
compound O 0 4.64358773655249e-09
heterozygotes O 0 2.4491434658102662e-08
. O 0 1.8506111088001376e-09

To O 0 1.9394892636359629e-10
determine O 0 1.1214567469108871e-10
if O 0 1.1922609167297482e-12
the O 0 3.9033125689980075e-12
occurrence O 0 7.550977898507227e-11
of O 0 7.103425486709725e-11
4003delTC O 0 7.515377209443841e-10
in O 0 9.091742116107415e-12
these O 0 1.2720972279028908e-12
unrelated O 0 1.1065572069757224e-11
families O 0 1.5659467402255253e-14
signifies O 0 3.4962382381570345e-12
propagation O 0 1.6990163720365103e-09
of O 0 8.545729401898683e-11
an O 0 4.4103013342039477e-13
ancestral O 0 3.3615077388304826e-10
allele O 0 4.8888362108590044e-11
or O 0 2.0762279048791576e-11
a O 0 2.1890277090985677e-10
mutational O 0 8.810808139969595e-06
hot O 0 0.09918389469385147
spot O 0 6.65270226818393e-06
, O 0 2.221116519873778e-11
haplotypes O 0 8.186201716497976e-10
were O 0 2.6835658695212317e-11
determined O 0 4.2592415705478004e-11
for O 0 1.543189534491951e-11
polymorphisms O 0 2.562721590493311e-09
both O 0 6.544156883059316e-11
within O 0 1.37950273426668e-09
and O 0 1.962651818843142e-09
flanking O 0 2.5001778340083547e-05
COL17A1 O 0 0.08844900876283646
. O 0 4.034914411477075e-07

Five O 0 7.291596659797506e-08
intragenic O 0 1.108635501623212e-06
polymorphisms O 0 2.0163042790954933e-07
were O 0 7.863678597175294e-10
chosen O 0 1.319912061592543e-11
based O 0 1.753860251474393e-11
on O 0 6.2387464083712985e-09
their O 0 1.2185545905651907e-09
informativeness O 0 4.937385256198468e-07
. O 0 1.7818457820339972e-08

One O 0 8.847276244949853e-10
of O 0 1.160466389649173e-09
these O 0 6.0839033463877534e-12
, O 0 1.690560668884955e-12
not O 0 2.1697034902241896e-13
previously O 0 2.2798988391636854e-11
reported O 0 3.5640258105873457e-12
, O 0 1.5629704561842539e-12
was O 0 1.2822769512865761e-09
2988 O 0 4.446192463092302e-07
A O 0 1.8882143137943785e-07
or O 0 2.6900228572435125e-11
C O 0 7.761343567835866e-09
that O 0 2.8972672785204656e-12
introduces O 0 2.158396204821056e-11
a O 0 3.475321809845444e-12
new O 0 2.4638271024085556e-12
restriction O 0 3.739460130436356e-11
site O 0 1.497240352532625e-11
for O 0 2.3972596911031596e-12
Eco0109 O 0 1.8421458136685942e-08
I O 0 2.33410290206848e-07
. O 0 1.1278222800115145e-08

All O 0 2.713265390141828e-09
the O 0 5.980272388406149e-10
4003delTC O 0 1.4565119110798719e-09
alleles O 0 3.6834918795691785e-12
showed O 0 1.78236331943582e-11
the O 0 3.1227778609504986e-12
same O 0 1.4269167444846964e-12
haplotype O 0 3.2711597319767804e-11
for O 0 3.784562940811753e-12
these O 0 1.5582020266094454e-12
five O 0 5.2086373408810616e-11
polymorphic O 0 2.8913758054471828e-09
markers O 0 5.739690056572044e-09
. O 0 2.3413289085283395e-09

Fourteen O 0 2.6030898325757335e-08
microsatellite O 0 4.118499674632403e-08
polymorphisms O 0 6.7435577122409995e-09
were O 0 2.4669330467297357e-10
selected O 0 7.210661755185921e-12
based O 0 2.1834461322312038e-12
on O 0 2.5740671816265603e-09
their O 0 1.2736961485515508e-10
high O 0 1.2623151413038158e-09
heterozygosity O 0 4.594621128006793e-09
and O 0 1.0535365982389244e-11
their O 0 1.199272452179212e-11
location O 0 1.0925260696126315e-09
within O 0 6.669122476488099e-10
10q23 O 0 3.1687076074149445e-08
- O 0 4.7573745831641645e-08
q25 O 0 4.712930490313738e-07
near O 0 2.0059655980730895e-06
COL17A1 O 0 0.0002064769942080602
. O 0 8.349053359779646e-08

Three O 0 1.4528659386670029e-09
families O 0 6.1408191899536835e-12
shared O 0 9.14282052844051e-11
microsatellite O 0 1.9950284979586286e-08
polymorphisms O 0 3.4433611517670215e-08
covering O 0 1.1183119141833231e-07
at O 0 7.470266183418062e-08
most O 0 2.9101511131446323e-11
19 O 0 1.6638996847007093e-09
cM O 0 3.160248174260971e-10
, O 0 4.6632316064165735e-12
whereas O 0 1.8699644263597825e-11
the O 0 9.22694559646331e-11
others O 0 7.809204671804792e-12
shared O 0 5.495510296826822e-12
smaller O 0 1.069017053698107e-12
regions O 0 6.06837366814994e-12
consistent O 0 3.796160955027439e-11
with O 0 4.4017545684782444e-13
cross O 0 2.9035421636458558e-11
- O 0 4.8152155006364605e-12
over O 0 7.269461508446762e-12
events O 0 2.299484604464941e-12
during O 0 1.9407612669719576e-11
passage O 0 8.493383947538735e-12
of O 0 4.1243690320630355e-13
this O 0 3.146978798428471e-14
mutation O 0 3.553774028525192e-13
through O 0 7.510035345340005e-13
several O 0 1.085220802110598e-11
generations O 0 1.5345082149398337e-10
. O 0 1.711793373715409e-09

These O 0 1.0215834844728988e-09
results O 0 4.492963778801595e-10
indicate O 0 2.4993935740513784e-11
that O 0 6.200617276574949e-13
4003delTC O 0 5.282949633311773e-10
occurs O 0 3.0149231635551166e-12
on O 0 3.6177647683155456e-11
a O 0 5.205585962286818e-12
single O 0 1.0299601449492712e-11
ancestral O 0 1.0632796032528091e-10
allele O 0 4.036216152969452e-11
. O 0 2.363004757144349e-11
. O 0 7.010060865120238e-10

The O 0 1.4274074544573523e-07
haptoglobin O 0 1.2390364645398222e-06
- O 0 2.2917044262271702e-08
gene O 0 8.86227313756649e-10
deletion O 0 9.933078803925355e-10
responsible O 0 4.726203317595434e-10
for O 0 8.184105476649606e-11
anhaptoglobinemia B-Disease 0 1.7767706594895571e-06
. O 0 3.243183499535007e-08

We O 0 7.680964309031424e-09
have O 0 1.3402961900055299e-11
found O 0 1.3821502536232044e-12
an O 0 6.685946148934571e-14
allelic O 0 8.892515057645767e-10
deletion O 0 1.8149960701041579e-10
of O 0 3.033356676951371e-09
the O 0 4.598829317359332e-09
haptoglobin O 0 7.519542322143025e-08
( O 0 2.3616169783635677e-11
Hp O 0 5.013601755976538e-10
) O 0 1.0543363057613497e-12
gene O 0 5.4014631309384775e-12
from O 0 7.158612353071192e-13
an O 0 2.8722418323953725e-13
individual O 0 9.599364489062956e-13
with O 0 8.311401566984955e-11
anhaptoglobinemia B-Disease 0 0.0013745217584073544
. O 0 2.001122823003243e-07

The O 0 1.4460167108154565e-07
Hp O 0 1.8776836085976356e-08
gene O 0 2.6569763056372153e-10
cluster O 0 4.383045315581313e-10
consists O 0 3.4319780090746876e-12
of O 0 8.586964472812042e-12
coding O 0 1.993276654843612e-10
regions O 0 4.741948153585973e-11
of O 0 3.0254218574832237e-10
the O 0 9.588033700325127e-10
alpha O 0 6.780195294098235e-10
chain O 0 1.1282966921877247e-10
and O 0 1.4415960829586294e-12
beta O 0 2.1429080732104921e-10
chain O 0 1.5336186487413528e-10
of O 0 5.394629534749562e-11
the O 0 1.4163810402312293e-10
haptoglobin O 0 2.2358337403716178e-09
gene O 0 2.3579877200113897e-12
( O 0 6.816787667110122e-14
Hp O 0 4.601323228686782e-12
) O 0 1.812549879610069e-14
and O 0 1.668329374388683e-13
of O 0 1.9784214544404932e-10
the O 0 9.1569440918704e-10
alpha O 0 9.090728725347219e-10
chain O 0 1.8831765313809257e-10
and O 0 4.495908419860362e-12
beta O 0 4.4030376566972507e-10
chain O 0 5.081920440019871e-10
of O 0 1.1678109868018538e-10
the O 0 5.126674640365536e-10
haptoglobin O 0 1.9228350467415112e-08
- O 0 1.317648767873436e-10
related O 0 6.166080146474684e-11
gene O 0 1.7392360121548656e-11
( O 0 6.85209105167478e-13
Hpr O 0 6.230134186324676e-10
) O 0 1.7288686487201138e-13
, O 0 1.5611878380773075e-13
in O 0 1.2066277881375709e-12
tandem O 0 2.0976000103534176e-10
from O 0 2.8184315992163533e-11
the O 0 4.748723636538443e-09
5 O 0 2.0872501238500263e-07
side O 0 2.201369397880626e-07
. O 0 6.733326785024474e-09

Southern O 0 5.101017563902133e-08
blot O 0 1.0617247880873038e-07
and O 0 2.956984379576255e-10
PCR O 0 5.715339757017546e-09
analyses O 0 2.2550712686086882e-10
have O 0 1.922127170969623e-12
indicated O 0 2.278728421234444e-12
that O 0 2.7132120402934175e-14
the O 0 1.2785970199269414e-12
individual O 0 1.1895928916949051e-14
with O 0 1.7607731949993016e-13
anhaptoglobinemia B-Disease 0 2.119284969737123e-09
was O 0 9.243626697408303e-11
homozygous O 0 1.2751612266104217e-11
for O 0 1.2393484676020972e-12
the O 0 5.260782694888055e-12
gene O 0 9.477291998058468e-13
deletion O 0 1.3350550049154308e-12
and O 0 7.385875223052396e-14
that O 0 1.4858926399409847e-14
the O 0 2.1086290265953656e-12
gene O 0 1.2397883284234745e-12
deletion O 0 2.86677018929149e-12
was O 0 1.7309854938307723e-11
included O 0 6.3129996022426305e-12
at O 0 1.0110802473040081e-10
least O 0 7.026340772230133e-13
from O 0 4.168355927352402e-13
the O 0 7.3617237306145e-11
promoter O 0 6.030423804759266e-08
region O 0 2.003553989382567e-09
of O 0 4.240455986348479e-09
Hp O 0 1.0301897113151881e-08
to O 0 2.0434241798650277e-10
Hpr O 0 2.1404903804977948e-07
alpha O 0 3.6135339165355163e-09
but O 0 1.9378530898006563e-12
not O 0 1.0454571236495624e-12
to O 0 2.817731508189536e-12
Hpr O 0 8.820170371848235e-09
beta O 0 3.852960617223289e-09
( O 0 5.5921972781647344e-12
Hpdel O 0 1.6448730377760512e-08
) O 0 5.106908992913439e-11
. O 0 1.1665292065643484e-09

In O 0 7.855464057016093e-10
addition O 0 1.1425354412564204e-10
, O 0 1.6625560303462628e-11
we O 0 8.568526096985885e-12
found O 0 2.683375223411222e-12
seven O 0 1.1331911971279585e-12
individuals O 0 7.904682564432476e-15
with O 0 1.2754105768470608e-13
hypohaptoglobinemia B-Disease 0 2.095702633653218e-08
in O 0 4.179370738377486e-11
three O 0 9.535444482622335e-12
families O 0 9.11015105584459e-14
, O 0 4.70416186473116e-13
and O 0 3.781986442769059e-12
the O 0 1.4901473111006425e-10
genotypes O 0 6.671781460632076e-10
of O 0 1.490836010198393e-09
six O 0 1.3531607778727306e-10
of O 0 7.706318361222486e-10
the O 0 7.635678200834661e-10
seven O 0 2.2038117164502324e-10
individuals O 0 1.592508893852318e-12
were O 0 2.7252658463261525e-10
found O 0 3.573421072933236e-11
to O 0 1.1508372380064635e-11
be O 0 6.264284091450634e-10
Hp2 O 0 5.549215347855352e-05
/ O 0 5.607635830529034e-05
Hpdel O 0 0.0006065223715268075
. O 0 1.9200136591734918e-07

The O 0 7.785570410590026e-09
phenotypes O 0 9.733898131969454e-10
and O 0 8.404366612368985e-12
genotypes O 0 1.3410435262262155e-10
in O 0 4.387407104289309e-12
one O 0 5.143120629901021e-13
of O 0 3.1354800700267305e-11
these O 0 8.372123523961439e-13
three O 0 1.871030457303857e-12
families O 0 4.145329438325247e-14
showed O 0 1.6055518026192317e-10
the O 0 1.5494074079303033e-10
father O 0 3.8337652497055785e-11
to O 0 2.597470198997809e-12
be O 0 6.951057784920778e-12
hypohaptoglobinemic B-Disease 0 4.835424505245101e-09
( O 0 3.8791465699350436e-12
Hp2 O 0 1.4176690044109819e-08
) O 0 1.322585162048806e-12
and O 0 6.667512895963679e-12
Hp2 O 0 1.097135751138012e-07
/ O 0 7.402849888649143e-08
Hpdel O 0 1.2460396874303115e-06
, O 0 1.4524358105116875e-10
the O 0 5.446720297008767e-10
mother O 0 4.55997392623253e-11
to O 0 5.132960896603311e-12
be O 0 2.6476614303772017e-11
Hp2 O 0 2.0473241590934776e-07
- O 0 3.725950659116961e-09
1 O 0 1.0288268903480002e-08
and O 0 6.276239944424944e-11
Hp1 O 0 4.0091842379297304e-07
/ O 0 3.5594677427752686e-08
Hp2 O 0 2.974149992951425e-07
, O 0 7.2089014445386734e-12
one O 0 5.180681729964609e-13
of O 0 3.7312382350496165e-11
the O 0 1.5101243866499914e-10
two O 0 1.0932837968269382e-11
children O 0 3.328124180326103e-13
to O 0 1.0058205353671856e-12
be O 0 9.79938526157742e-12
hypohaptoglobinemic B-Disease 0 1.558086282216209e-08
( O 0 1.0458405842739271e-11
Hp2 O 0 5.00390093804981e-08
) O 0 2.6324127339744097e-12
and O 0 6.849089437960254e-12
Hp2 O 0 3.222969837679557e-07
/ O 0 2.0379114573643164e-07
Hpdel O 0 1.0267095831295592e-06
, O 0 4.1732610422950955e-11
and O 0 1.5183895807346914e-11
the O 0 2.294181788986549e-10
other O 0 5.819913561494472e-12
child O 0 1.9734908152102548e-11
to O 0 1.2489021318853877e-12
be O 0 1.4495706718298251e-11
Hp1 O 0 6.570330413069314e-08
and O 0 4.09472906970354e-11
Hp1 O 0 1.4224789310901542e-06
/ O 0 1.2527605974810285e-07
Hpdel O 0 3.026585204679577e-07
, O 0 1.6563807617164805e-11
showing O 0 4.819502019692834e-10
an O 0 1.3842872161051734e-12
anomalous O 0 1.6926023915786459e-09
inheritance O 0 3.21026621952214e-10
of O 0 2.516703734301018e-09
Hp O 0 1.693068263364239e-08
phenotypes O 0 6.488107828772627e-10
in O 0 3.863804068360288e-11
the O 0 9.448660742705783e-10
child O 0 2.1251979342995497e-10
with O 0 9.066792455714179e-11
Hp1 O 0 0.00046227226266637444
. O 0 4.1109188941845787e-07

The O 0 2.1604573419153894e-07
Hp2 O 0 3.7701935070799664e-05
/ O 0 1.3899983059673104e-05
Hpdel O 0 5.297614279697882e-06
individuals O 0 1.5092885274903267e-11
had O 0 2.634535090084711e-10
an O 0 1.0375507961471464e-12
extremely O 0 2.1101429631409374e-11
low O 0 5.883762366210021e-10
level O 0 1.226808432619464e-08
of O 0 3.7518071982489687e-10
Hp O 0 2.7009855463333565e-10
( O 0 2.036169084902728e-13
mean O 0 9.450900348775826e-13
+ O 0 4.145308228620248e-13
/ O 0 3.5210525901191447e-12
- O 0 1.5276730618365986e-12
SD O 0 2.421743638958418e-10
= O 0 6.914693644055614e-12
0 O 0 2.8049587392359188e-12
. O 0 3.274850280277769e-14
049 O 0 1.0499858794921213e-11
+ O 0 7.697208620266113e-14
/ O 0 3.1975643920850727e-12
- O 0 3.346802869563792e-12
0 O 0 1.9921963384517127e-11
. O 0 9.824082736545336e-13
043 O 0 6.358382709237276e-10
mg O 0 3.438453341497727e-11
/ O 0 1.2798566026428482e-11
ml O 0 2.2489607832271163e-12
; O 0 5.007549093400754e-15
n O 0 1.350379985783079e-12
= O 0 9.759426339989163e-13
6 O 0 8.663457321325674e-13
) O 0 2.3729167443164154e-16
, O 0 3.4358483313095883e-16
compared O 0 8.608018383888334e-16
with O 0 1.1437623529628746e-15
the O 0 6.24821266774489e-13
level O 0 3.559625511018183e-11
( O 0 5.3579691647787e-15
1 O 0 8.606061826718636e-13
. O 0 1.2352033289155916e-14
64 O 0 3.8013155448900215e-13
+ O 0 1.5415139054553856e-13
/ O 0 1.8128007775453092e-12
- O 0 8.80171695076537e-13
1 O 0 3.6739075323644066e-12
. O 0 1.540770278290332e-13
07 O 0 1.1048954286219104e-11
mg O 0 1.9549759380788068e-11
/ O 0 6.8245999129690205e-12
ml O 0 4.556848605050123e-13
) O 0 3.951395199353714e-16
obtained O 0 1.7892203899570226e-14
from O 0 1.0276358214898751e-13
52 O 0 3.3342207467201845e-11
healthy O 0 1.0859894927772729e-10
volunteers O 0 2.0516273142173747e-12
having O 0 3.804755555752992e-12
phenotype O 0 4.013401069813405e-11
Hp2 O 0 3.17232817792501e-09
, O 0 2.273700758920194e-12
whereas O 0 3.5055732188621347e-12
the O 0 2.354883475719216e-11
serum O 0 5.28861329729402e-11
Hp O 0 1.665839133302427e-10
level O 0 3.4805942572546655e-09
of O 0 6.995111434537904e-11
an O 0 1.1341853156524376e-13
individual O 0 7.195431723323528e-14
with O 0 2.320890441637191e-12
Hp1 O 0 1.9088124645350035e-06
/ O 0 6.904492693138309e-07
Hpdel O 0 2.15783916246437e-06
was O 0 6.627295334737937e-08
0 O 0 1.4238534618016274e-07
. O 0 4.767691130780349e-09

50 O 0 2.9257837041996027e-08
mg O 0 6.133245733508375e-08
/ O 0 2.2192311988078472e-08
ml O 0 1.2304682828201408e-09
, O 0 8.208766782633048e-13
which O 0 9.489459185888643e-14
was O 0 4.818973345366295e-12
approximately O 0 2.8442949628589356e-14
half O 0 2.56070826435556e-13
the O 0 2.1291839819026492e-12
level O 0 2.1544487027735926e-10
of O 0 5.714865039530004e-11
Hp O 0 1.5019778476510481e-10
in O 0 4.236884714597933e-12
control O 0 9.487524099682787e-10
sera O 0 1.6449255291206555e-09
from O 0 3.438267899558145e-12
the O 0 2.7124037391135225e-11
Hp1 O 0 4.329406166903027e-09
phenotype O 0 1.1845953905298412e-11
( O 0 3.219832102221813e-14
1 O 0 2.6522091814418225e-12
. O 0 3.19130979238233e-14
26 O 0 1.0151605034022793e-12
+ O 0 3.0114848332055133e-13
/ O 0 8.630888538585513e-12
- O 0 6.404054370134915e-12
0 O 0 1.429074567016464e-11
. O 0 3.379232386534897e-13
33 O 0 9.639384776494175e-12
mg O 0 6.713648387224325e-11
/ O 0 2.93549420882222e-11
ml O 0 3.744025488944258e-12
; O 0 9.926500234584603e-15
n O 0 2.6376750176387853e-12
= O 0 2.3489428718076466e-12
9 O 0 4.559432692508025e-12
) O 0 1.936800549719739e-15
, O 0 3.658615243580391e-15
showing O 0 1.4878027195658339e-12
a O 0 5.352380431228321e-12
gene O 0 1.5522876387064066e-11
- O 0 1.0536999744958919e-10
dosage O 0 1.0632969171808782e-08
effect O 0 1.191272236411578e-08
. O 0 3.7080830073144e-10

The O 0 4.7530029689824005e-08
other O 0 1.1694692436670096e-10
allele O 0 3.4519587188697187e-10
( O 0 1.177261500090454e-11
Hp2 O 0 3.7963111765293434e-08
) O 0 1.612682752095973e-12
of O 0 1.2640511033723545e-11
individuals O 0 1.0131288576088401e-13
with O 0 2.1462283339435118e-11
Hp2 O 1 0.5899614691734314
/ O 0 0.006467624567449093
Hpdel O 0 0.16279460489749908
was O 0 3.1422595725416613e-07
found O 0 2.3303310670019783e-11
to O 0 9.678806150645314e-13
have O 0 5.25614653797829e-13
, O 0 8.46975687827066e-14
in O 0 9.941099592819524e-13
all O 0 1.6425538013065122e-11
exons O 0 9.014140545104965e-09
, O 0 9.449769092229054e-12
no O 0 5.756392931766108e-11
mutation O 0 6.831763453563067e-12
, O 0 1.696898101633676e-13
by O 0 2.065928591393762e-12
DNA O 0 4.764107441879162e-10
sequencing O 0 1.505712499128009e-10
. O 0 1.0706634467894105e-09

On O 0 1.7120587614272154e-08
the O 0 1.0808460376710016e-10
basis O 0 6.709321292985848e-11
of O 0 1.3853082569958985e-10
the O 0 3.1015939816469995e-11
present O 0 2.2465770563306897e-12
study O 0 2.6665114886102737e-13
, O 0 2.474667335199826e-13
the O 0 7.811201338525642e-12
mechanism O 0 3.001511539313384e-10
of O 0 2.1335441746650474e-10
anhaptoglobinemia B-Disease 0 6.372739136395467e-08
and O 0 1.633300994452469e-10
the O 0 7.056570328067835e-10
mechanism O 0 4.3188164156049424e-09
of O 0 2.1817997408746237e-10
anomalous O 0 5.842366146424638e-09
inheritance O 0 9.622640462225718e-10
of O 0 6.836909705043581e-09
Hp O 0 4.6942698617158385e-08
phenotypes O 0 1.3088358841173431e-08
were O 0 9.76089209459019e-10
well O 0 6.984609002280706e-10
explained O 0 2.5630258804199002e-08
. O 0 1.7296448717729618e-08

However O 0 7.209792762807865e-09
, O 0 5.0080942864960676e-11
the O 0 1.3925217923205224e-10
mechanism O 0 8.254692929199337e-09
of O 0 2.9399798151530376e-09
hypohaptoglobinemia B-Disease 0 5.821551440021722e-06
remains O 0 1.7672581407168764e-06
unknown O 0 4.7796488615858834e-06

ATM O 0 4.546746822597925e-06
mutations O 0 1.0841068043276891e-09
and O 0 1.3998122973257754e-11
phenotypes O 0 2.313817581978128e-09
in O 0 1.3108870433597986e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.360123013163019e-10
in O 0 6.40091937786913e-11
the O 0 1.5561185673362843e-10
British O 0 4.2596662308547195e-10
Isles O 0 1.9769741399500163e-09
: O 0 3.693255011712193e-13
expression O 0 1.134222598654644e-12
of O 0 1.849355521152396e-12
mutant O 0 5.163856495182806e-11
ATM O 0 1.710960928491545e-09
and O 0 1.719227245376015e-13
the O 0 8.343159062923489e-13
risk O 0 1.731787976910759e-11
of O 0 3.802653678053325e-11
leukemia B-Disease 1 1.0
, O 0 6.677619694528403e-06
lymphoma B-Disease 1 1.0
, O 0 1.0733537010310101e-06
and O 0 8.213003638957161e-06
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00011815105972345918

We O 0 7.286626302338561e-10
report O 0 1.0033531297470866e-11
the O 0 3.742711869592075e-12
spectrum O 0 8.968376735696282e-11
of O 0 1.4592750618991346e-10
59 O 0 9.687556312698575e-10
ATM O 0 1.2549268291195403e-08
mutations O 0 2.822185193873672e-12
observed O 0 6.2129208028283145e-12
in O 0 1.1604968375156233e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999998807907104
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.0812119388979866e-11
patients O 0 4.0898560579871734e-12
in O 0 4.451526224458907e-13
the O 0 5.323397278544917e-11
British O 0 2.2693802392836915e-09
Isles O 0 2.0423534863311943e-07
. O 0 8.796381401054987e-09

Of O 0 7.703590085839096e-07
51 O 0 5.203472142056853e-07
ATM O 0 9.99750045593828e-06
mutations O 0 4.286398180841644e-10
identified O 0 1.6660542737079176e-11
in O 0 2.587723655148033e-12
families O 0 6.490001000806697e-14
native O 0 1.8107549964660463e-12
to O 0 5.389173265632485e-13
the O 0 5.0886586611120777e-11
British O 0 2.5327767660954237e-10
Isles O 0 1.2051582842786956e-08
, O 0 1.46815511137266e-11
11 O 0 3.123191982812301e-10
were O 0 1.70017278033896e-10
founder O 0 9.490986663251988e-09
mutations O 0 1.0458685133218903e-11
, O 0 1.788212373315945e-12
and O 0 3.1996629738101356e-12
2 O 0 2.689675426825744e-10
of O 0 4.9794151441018286e-11
these O 0 7.07472600468273e-13
11 O 0 1.6148266057669503e-10
conferred O 0 1.9044819055125117e-09
a O 0 3.3645849994989874e-11
milder O 0 4.5505058055006486e-10
clinical O 0 1.4900285449925832e-09
phenotype O 0 8.779187446461556e-12
with O 0 3.495567753981042e-14
respect O 0 1.8937644421374022e-12
to O 0 4.2979023660329185e-13
both O 0 2.6704437272595527e-11
cerebellar B-Disease 1 0.9999721050262451
degeneration I-Disease 1 0.9999998807907104
and O 0 3.2271119110305335e-10
cellular O 0 4.722702584558647e-08
features O 0 6.165827404203128e-09
. O 0 1.589361420251123e-09

We O 0 2.4409657628510217e-10
report O 0 3.38020085012547e-12
, O 0 7.124962647870117e-14
in O 0 6.221574362468008e-13
two O 0 1.37787697918057e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.8616753104383488e-12
, O 0 5.669239491919165e-13
an O 0 2.579664997240383e-13
ATM O 0 1.788065873142841e-08
mutation O 0 1.434799327959535e-11
( O 0 1.1896752571786962e-13
7271T O 0 3.8504607835498916e-10
- O 0 1.7109675898296928e-09
- O 0 3.86601994861735e-09
> O 0 1.0323415011725956e-08
G O 0 5.044779705087876e-09
) O 0 1.153208506742302e-14
that O 0 2.6438007395845377e-15
may O 0 1.4081302719985353e-14
be O 0 7.348630210273735e-16
associated O 0 2.2439186027681506e-15
with O 0 1.3566920098727228e-16
an O 0 1.0905490962383993e-15
increased O 0 1.0651418982932093e-12
risk O 0 2.6405504519044776e-11
of O 0 1.527429849268458e-10
breast B-Disease 0 6.765294074284611e-06
cancer I-Disease 0 2.819651179208904e-08
in O 0 5.897713567515339e-11
both O 0 2.9263150930214366e-11
homozygotes O 0 9.670798384320278e-09
and O 0 5.658806756514423e-12
heterozygotes O 0 4.918055962477297e-10
( O 0 3.403936746186609e-13
relative O 0 1.6668115498941205e-10
risk O 0 3.8020156467588606e-11
12 O 0 3.69693555282713e-12
. O 0 2.3077966946304096e-13
7 O 0 8.35305574709011e-11
; O 0 3.058121518604434e-13
P O 0 3.113118651754121e-09
= O 0 2.5138321979589762e-11
. O 0 1.114735799327693e-12
0025 O 0 2.6819196863314687e-10
) O 0 5.4018878230938355e-15
, O 0 3.231883856401937e-15
although O 0 1.4017872657730215e-14
there O 0 2.942508094279893e-14
is O 0 9.41501430718741e-15
a O 0 3.899121151819396e-13
less O 0 1.0007461873073886e-11
severe O 1 0.9999998807907104
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.2016578544478165e-11
in O 0 2.0735297092083597e-14
terms O 0 5.864480044160195e-14
of O 0 4.5425966997301656e-14
the O 0 3.211680257137438e-14
degree O 0 1.1023341267568654e-10
of O 0 2.1260655735932943e-10
cerebellar B-Disease 1 0.9999178647994995
degeneration I-Disease 1 1.0
. O 0 5.0077201052545206e-08

This O 0 2.1693591367721865e-10
mutation O 0 2.8258331438713036e-11
( O 0 1.886737511017089e-12
7271T O 0 8.525269379333622e-10
- O 0 1.7752164183093555e-09
- O 0 5.5298170487105835e-09
> O 0 1.2974075147553776e-08
G O 0 5.674876568662057e-09
) O 0 6.786560110541226e-14
also O 0 1.1905871389683922e-14
allows O 0 1.5194295118831557e-15
expression O 0 8.81212691792449e-14
of O 0 2.009949552714968e-13
full O 0 3.3699332387115977e-12
- O 0 7.737647870521835e-13
length O 0 8.930915360548519e-13
ATM O 0 2.97778002256166e-09
protein O 0 4.595560910980456e-12
at O 0 1.481522543533842e-11
a O 0 5.892648023177183e-13
level O 0 1.0153565488391081e-11
comparable O 0 3.743782627657621e-12
with O 0 9.238584120537918e-15
that O 0 1.1296859443992585e-13
in O 0 2.00602121719351e-12
unaffected O 0 1.0666602046072171e-09
individuals O 0 1.1525149324481676e-12
. O 0 4.579709944607657e-10

In O 0 2.346128846753004e-10
addition O 0 1.5238208264656272e-11
, O 0 6.362655628061598e-13
we O 0 1.075343901923119e-13
have O 0 1.5554091421419135e-14
studied O 0 1.201452045490603e-11
18 O 0 3.162223549679766e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5624534999147954e-10
, O 0 1.5870946118196234e-14
in O 0 2.430767379372166e-14
15 O 0 1.1458952276638401e-12
families O 0 6.5999998333590455e-15
, O 0 5.3632889552039306e-14
who O 0 3.95363472863175e-12
developed O 0 1.5125767731660744e-06
leukemia B-Disease 1 1.0
, O 0 0.00024392841442022473
lymphoma B-Disease 1 1.0
, O 0 4.344497028796468e-07
preleukemic O 1 0.9999997615814209
T O 1 0.9999889135360718
- O 0 4.136543552135663e-08
cell O 0 9.408007599631674e-07
proliferation O 0 7.244654989335686e-05
, O 0 1.0294843319838543e-12
or O 0 7.86586906720288e-10
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.580554658848655e-10
mostly O 0 1.5831778162750387e-12
in O 0 4.246520236145246e-12
childhood O 0 2.2734104376809228e-08
. O 0 5.651523693472882e-09

A O 0 3.8821897874186106e-07
wide O 0 4.062278513572437e-09
variety O 0 9.597841410524666e-10
of O 0 9.005977297249501e-09
ATM O 0 3.421918154344894e-05
mutation O 0 1.8181872674105648e-10
types O 0 3.04766073488949e-11
, O 0 1.0458799624968318e-12
including O 0 7.741992810728071e-12
missense O 0 2.6539030972827504e-09
mutations O 0 1.1999177693122753e-11
and O 0 7.303455583362872e-12
in O 0 5.1657969568630335e-11
- O 0 8.529416617442109e-10
frame O 0 6.805060959180764e-09
deletions O 0 2.6642077433081113e-10
, O 0 1.3087315085813511e-11
were O 0 6.790402962142394e-11
seen O 0 6.098266336351799e-11
in O 0 2.584395371318937e-11
these O 0 6.743808289577657e-11
patients O 0 2.5684063209574504e-10
. O 0 1.4906283984927882e-09

We O 0 9.68844338089525e-10
also O 0 2.74034787917099e-12
show O 0 1.9091670518806003e-12
that O 0 1.4438510066369648e-14
25 O 0 4.4955114934450147e-13
% O 0 6.680490579127896e-14
of O 0 1.0030315987508143e-11
all O 0 8.679750251872065e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.1237890618076563e-09
carried O 0 2.6377516490483366e-11
in O 0 5.401957527129131e-12
- O 0 9.28802104671611e-11
frame O 0 2.61625898723139e-09
deletions O 0 1.7546138153523572e-10
or O 0 2.1295588556458078e-11
missense O 0 9.723357674573663e-10
mutations O 0 3.766932946125401e-12
, O 0 3.7226756508142167e-13
many O 0 8.040001498767213e-14
of O 0 3.309138379981036e-11
which O 0 8.813678411233317e-13
were O 0 1.0208150297286167e-11
also O 0 2.494214416167567e-13
associated O 0 7.137792960854039e-13
with O 0 2.9163157349090807e-13
expression O 0 1.432678004009702e-10
of O 0 2.0505026843142815e-10
mutant O 0 1.463488352726472e-08
ATM O 0 6.436665103137784e-07
protein O 0 1.0004614026115632e-08
. O 0 7.771160381864206e-10

The O 0 1.5749376913731794e-08
DMPK O 0 7.1315075729216915e-06
gene O 0 1.5961786337115313e-09
of O 0 3.1181404125391055e-09
severely O 1 0.9997968077659607
affected O 1 0.9999910593032837
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999972581863403
is O 0 6.191465395932738e-11
hypermethylated O 0 6.786875506037404e-09
proximal O 0 1.0001265093873002e-10
to O 0 4.931320651303805e-13
the O 0 1.1868230356815168e-11
largely O 0 4.766795291821779e-11
expanded O 0 1.5236355233039234e-10
CTG O 0 3.2121107551574823e-07
repeat O 0 4.471296577435169e-08
. O 0 4.226647920546611e-09

Using O 0 1.7656296424917173e-09
methylation O 0 1.4594303365811356e-07
- O 0 3.3690721323864636e-08
sensitive O 0 2.193585757481742e-08
restriction O 0 2.147700683963194e-09
enzymes O 0 3.5386672758708215e-11
, O 0 7.77436546129523e-13
we O 0 4.998584554084806e-13
characterized O 0 2.0373082561253586e-12
the O 0 1.073983350169394e-12
methylation O 0 5.609184991484106e-11
pattern O 0 1.9955580590758082e-11
on O 0 3.8171871913350586e-11
the O 0 7.577174998552039e-12
5 O 0 4.253160670875111e-11
side O 0 2.420814070036581e-11
of O 0 1.517023312525012e-11
the O 0 1.1935545607411058e-10
CTG O 0 1.030064282758758e-07
repeat O 0 3.0263913597394776e-10
in O 0 7.038563742262083e-12
the O 0 7.044544114709339e-11
DMPK O 0 2.798082903154864e-07
gene O 0 6.9326801244162795e-12
of O 0 8.262257197855227e-12
normal O 0 3.100381409937292e-11
individuals O 0 1.2718146339947643e-14
and O 0 5.025638650894837e-13
of O 0 8.323478573046827e-10
patients O 0 1.6623231680057415e-09
affected O 0 5.93533266979307e-09
with O 0 1.9600847736001015e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.5608635495212297e-09
showing O 0 3.0406249740266844e-10
expansions O 0 6.778450023503524e-10
of O 0 2.03285818733967e-10
the O 0 5.44663703028192e-10
repetitive O 0 2.2068508798156472e-08
sequence O 0 2.738627769005575e-09
. O 0 2.8425559683853407e-09

The O 0 4.586357960079113e-08
gene O 0 3.3881181193962107e-10
segment O 0 1.6486971510243364e-10
analyzed O 0 7.836809326478011e-12
corresponds O 0 2.8606854298590667e-12
to O 0 8.419989423573415e-13
the O 0 4.4587795261508134e-11
genomic O 0 7.994879425154977e-09
SacI O 0 5.378209380069165e-07
- O 0 2.032529700102259e-09
HindIII O 0 2.698187095973026e-08
fragment O 0 1.3805055987248238e-09
carrying O 0 2.1240267877864483e-10
exons O 0 2.184033576213551e-08
11 O 0 1.054752729601205e-08
- O 0 2.3285927852612076e-08
15 O 0 6.716244627114065e-08
. O 0 2.672496179911832e-08

There O 0 5.0253996519700195e-09
is O 0 4.4425317591301194e-11
constitutive O 0 2.3688824235534867e-09
methylation O 0 3.3903435614490718e-09
in O 0 9.580570364819962e-11
intron O 0 4.2923402610028916e-09
12 O 0 3.633325584839753e-10
at O 0 6.242251160415435e-11
restriction O 0 6.3372245819037776e-12
sites O 0 7.769029018202256e-13
of O 0 5.8693870076675925e-12
SacII O 0 4.749103776902075e-09
and O 0 3.744313192832749e-11
HhaI O 0 4.297077182968678e-08
, O 0 1.0647645959371843e-11
localized O 0 1.2062615351027262e-09
1 O 0 1.5352349391761777e-09
, O 0 1.4982680894559675e-12
159 O 0 1.9855350003039618e-11
- O 0 1.2356771161847746e-10
1 O 0 8.538971751903546e-10
, O 0 6.1556302589915735e-12
232 O 0 8.9850488160792e-12
bp O 0 1.4789842961437927e-11
upstream O 0 1.6309925415444737e-12
of O 0 3.3689519923774114e-11
the O 0 6.640804017798985e-10
CTG O 0 2.323727358088945e-06
repeat O 0 4.5886481281343094e-09
, O 0 8.175521024056387e-12
whereas O 0 2.548143987479712e-12
most O 0 2.351205168060755e-13
, O 0 2.8467823259305247e-13
if O 0 1.1145395722870002e-13
not O 0 9.983124895328321e-14
all O 0 5.306128258129872e-13
, O 0 2.602363311822453e-13
of O 0 7.28267359612067e-12
the O 0 6.318637019858686e-12
other O 0 7.126321966343871e-14
sites O 0 4.335299480517918e-12
of O 0 2.1988518644766586e-11
SacII O 0 2.83573413639715e-08
, O 0 4.0617089552830166e-11
HhaI O 0 1.9159055852924212e-07
, O 0 1.0406873279800166e-10
and O 0 4.076906173766659e-11
HpaII O 0 1.1726314141924377e-07
in O 0 8.874617013487907e-11
this O 0 3.5210393628526404e-12
region O 0 1.6092369103937187e-10
are O 0 2.0767695289164445e-12
unmethylated O 0 2.4062616788000923e-08
, O 0 2.7666384808111566e-12
in O 0 3.847006914414752e-12
normal O 0 3.180766483534825e-10
individuals O 0 4.202441143013637e-14
and O 0 4.5178777711117613e-13
most O 0 1.0643133509929958e-12
of O 0 3.006920823445114e-10
the O 0 6.351149384187238e-09
patients O 0 2.99496955014078e-10
. O 0 9.44622824405883e-10

In O 0 1.9378401661107603e-10
a O 0 1.4707983095330057e-11
number O 0 7.925105016681755e-12
of O 0 5.164055849604665e-10
young O 0 3.319087713005153e-11
and O 0 6.719057532578177e-10
severely O 1 0.645401656627655
affected O 0 2.2352366624289743e-09
patients O 0 6.289205961573785e-11
, O 0 1.3530716260964915e-12
however O 0 1.2243846561621474e-11
, O 0 2.4318814648670306e-13
complete O 0 1.403124838539327e-10
methylation O 0 2.7598107132931204e-10
of O 0 1.1937679143814162e-11
these O 0 1.4212115100227518e-14
restriction O 0 4.3969046611101736e-13
sites O 0 2.763736234225739e-13
was O 0 4.8055630655352566e-12
found O 0 2.6068990716110463e-13
in O 0 1.2106205794781832e-12
the O 0 1.0340629047478345e-10
mutated O 0 3.4082103805843644e-10
allele O 0 8.020336061953515e-10
. O 0 2.4724455816027557e-09

In O 0 7.200718354916091e-10
most O 0 1.9218239846741092e-11
of O 0 2.9011576474502476e-10
these O 0 1.2845839843234064e-11
patients O 0 3.3633642745889425e-12
, O 0 7.968568161006648e-14
the O 0 1.80554041769726e-12
onset O 0 6.287859832809772e-07
of O 0 7.859960460265825e-10
the O 0 6.52846754434222e-09
disease O 1 0.7424697875976562
was O 0 1.359376710752258e-06
congenital O 1 1.0
. O 0 2.16752687265398e-06

Preliminary O 0 3.175562923729558e-08
in O 0 1.0132623629033333e-09
vivo O 0 5.755501319981704e-08
footprinting O 0 1.1424405101934099e-06
data O 0 7.67237995358272e-10
gave O 0 2.7747798503341414e-10
evidence O 0 8.962408593049531e-11
for O 0 1.4181050431161246e-11
protein O 0 1.5286532456526558e-11
- O 0 2.5308050793926284e-11
DNA O 0 1.2287572868918684e-11
contact O 0 4.239155901308855e-12
in O 0 2.7509366312683525e-12
normal O 0 8.66991339831813e-11
genes O 0 8.289829326463272e-13
at O 0 3.2933336613361064e-11
an O 0 1.026684163032976e-12
Sp1 O 0 2.0662717759023508e-08
consensus O 0 8.54757098434078e-11
binding O 0 5.642446145731617e-12
site O 0 6.503018176035047e-12
upstream O 0 2.1456736398490356e-13
of O 0 3.0997175312630354e-12
the O 0 1.686748934970339e-10
CTG O 0 4.5934845616102393e-07
repeat O 0 9.928646793611051e-10
and O 0 2.8795496802985765e-12
for O 0 1.4627569988601152e-12
a O 0 4.6067589846987556e-12
significant O 0 1.6819644635401865e-11
reduction O 0 2.1511650238892344e-09
of O 0 7.292880188636275e-11
this O 0 2.573453060893127e-13
interaction O 0 8.868820933725929e-13
in O 0 7.350071614710407e-13
cells O 0 5.935501656145759e-13
with O 0 1.0563243530749278e-13
a O 0 7.835183890581021e-11
hypermethylated O 0 6.175563527222039e-08
DMPK O 0 5.1727347454288974e-06
gene O 0 1.4186846142294485e-10
. O 0 3.75504141669758e-11
. O 0 4.017462473804301e-10

The O 0 4.7529306357319e-06
hemochromatosis B-Disease 1 1.0
gene O 0 2.046151470480595e-09
product O 0 2.3318885711276494e-10
complexes O 0 5.707040742763958e-12
with O 0 3.8645226341921246e-13
the O 0 1.6914913913979035e-10
transferrin O 0 9.796633726466553e-09
receptor O 0 5.330519359247887e-11
and O 0 1.0574497007198591e-12
lowers O 0 1.9634709136351347e-10
its O 0 4.646901353294597e-13
affinity O 0 8.490788367537805e-13
for O 0 3.516093449382196e-12
ligand O 0 2.502934526305012e-10
binding O 0 7.478884733735924e-10
. O 0 3.0938848705197586e-10

We O 0 1.171827745949372e-09
recently O 0 1.1156089940733693e-10
reported O 0 5.971193591663981e-12
the O 0 1.0087606097664015e-11
positional O 0 5.539592340397803e-09
cloning O 0 2.7389240875308474e-10
of O 0 3.1813961187676654e-11
a O 0 7.914531009733938e-12
candidate O 0 2.771604647178183e-11
gene O 0 3.4827174477669587e-10
for O 0 5.076071563081541e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9998944997787476
HFE O 1 0.8937129974365234
. O 0 7.232794363432049e-09

The O 0 5.99554539348901e-09
gene O 0 1.0827133634094821e-10
product O 0 1.1102638253213115e-10
, O 0 1.31011694548544e-12
a O 0 4.924846988552112e-12
member O 0 9.886740731657184e-12
of O 0 1.655377224185628e-10
the O 0 1.1175794734086253e-09
major O 0 8.799775486068029e-08
histocompatibility O 0 3.851306246360764e-06
complex O 0 1.1797093435461647e-07
class O 0 6.924252143880594e-11
I O 0 7.114198119495541e-09
- O 0 1.9167327447444649e-10
like O 0 8.305121347584876e-12
family O 0 1.550180339995877e-12
, O 0 6.074462222289967e-13
was O 0 5.302329408873874e-11
found O 0 6.043443740236243e-13
to O 0 1.4378990077605625e-13
have O 0 3.161997844548098e-13
a O 0 3.5420282158693528e-12
mutation O 0 3.730112139305186e-12
, O 0 1.4119561639672207e-12
Cys O 0 2.5091469524340937e-07
- O 0 2.4935440379181273e-09
282 O 0 3.7102074745831715e-09
- O 0 7.716429450965734e-08
- O 0 4.5410597948603026e-08
> O 0 5.2293305685680025e-08
Tyr O 0 2.43107134423326e-08
( O 0 4.211004917160921e-13
C282Y O 0 1.3093681520970346e-11
) O 0 3.891337969354983e-15
, O 0 2.1644518774808835e-15
in O 0 2.2819794353299595e-14
85 O 0 8.835563357345588e-12
% O 0 2.4936877649622824e-12
of O 0 1.4569445649925683e-10
patient O 0 7.147261893436507e-09
chromosomes O 0 7.031865756346178e-09
. O 0 4.455340540943098e-09

This O 0 9.280747836903913e-10
mutation O 0 1.48389955878514e-09
eliminates O 0 7.537057200579511e-09
the O 0 1.8854623418107508e-10
ability O 0 1.8288674394351112e-11
of O 0 1.7328404267047404e-09
HFE O 0 1.4807960724283475e-05
to O 0 2.8763783022078826e-11
associate O 0 5.769354993745424e-10
with O 0 4.649350349161807e-12
beta2 O 0 1.1223242836422287e-05
- O 0 5.143693329046073e-07
microglobulin O 0 2.7252843210590072e-05
( O 0 8.739929613366115e-11
beta2m O 0 1.0780763659568038e-07
) O 0 2.4961528070216454e-12
and O 0 6.101869877428445e-12
prevents O 0 3.5310754320505566e-11
cell O 0 2.7349855713509896e-08
- O 0 7.887653308280562e-10
surface O 0 1.414535155674912e-09
expression O 0 5.995351326504306e-09
. O 0 1.3662582176721116e-09

A O 0 3.3501473239994084e-07
second O 0 3.035394158246163e-09
mutation O 0 2.816142631589802e-11
that O 0 1.4812017714790904e-13
has O 0 1.661146941571781e-13
no O 0 8.044162124604126e-13
effect O 0 5.532617766701442e-11
on O 0 3.7300021404895745e-10
beta2m O 0 7.380560163028349e-08
association O 0 4.6802714481763985e-11
, O 0 7.496468181454607e-13
H63D O 0 2.7137327052173532e-08
, O 0 1.0730761982116754e-12
was O 0 1.6371489233724112e-11
found O 0 1.9230134791405756e-13
in O 0 2.7862946867275584e-13
eight O 0 5.538295082957445e-12
out O 0 2.1587163480385474e-12
of O 0 4.5441569951343297e-10
nine O 0 6.745963343490757e-09
patients O 0 1.2176472503899749e-11
heterozygous O 0 1.1316906613212385e-11
for O 0 8.077992268151757e-12
the O 0 2.4094787276496277e-10
C282Y O 0 3.7067149349923056e-08
mutant O 0 7.01686246884492e-08
. O 0 4.432134659282383e-09

In O 0 5.428631988380062e-10
this O 0 6.322675889791629e-12
report O 0 8.861386451008979e-12
, O 0 1.1572242730045756e-12
we O 0 1.6162332973704285e-12
demonstrate O 0 8.984585644911114e-12
in O 0 1.3517438904320223e-11
cultured O 0 4.88616258564889e-10
293 O 0 5.215231024813249e-10
cells O 0 4.795103203392159e-10
overexpressing O 0 6.66633042101239e-08
wild O 0 1.8454798578204645e-08
- O 0 3.7999728363935503e-10
type O 0 9.123071187389087e-10
or O 0 6.114385386890575e-11
mutant O 0 2.575374757896043e-08
HFE O 0 2.939543719548965e-06
proteins O 0 8.330406134869628e-13
that O 0 1.5570417134444514e-14
both O 0 7.474277680065075e-14
the O 0 2.6124317986653267e-11
wild O 0 8.251056726749084e-09
- O 0 6.366428495496734e-10
type O 0 2.782444719073851e-09
and O 0 2.584200631261524e-09
H63D O 1 0.8185474276542664
HFE O 0 0.00035302876494824886
proteins O 0 6.778511085769878e-11
form O 0 1.573947396027453e-11
stable O 0 1.4868709041770956e-10
complexes O 0 2.1797010810870043e-12
with O 0 1.6282843671479308e-13
the O 0 9.80758044222263e-11
transferrin O 0 4.213800863794859e-09
receptor O 0 4.395182134908637e-11
( O 0 1.578651814305998e-12
TfR O 0 6.72267574941543e-09
) O 0 9.534971770475131e-12
. O 0 6.05686223398294e-10

The O 0 9.979708437413137e-08
C282Y O 0 5.582786570812459e-07
mutation O 0 4.568911027291733e-09
nearly O 0 4.934198050143834e-10
completely O 0 2.288082612267317e-09
prevents O 0 1.4001781505068589e-11
the O 0 5.7355696581051774e-11
association O 0 3.841187090625198e-11
of O 0 3.253413510817538e-11
the O 0 1.7844799249377985e-10
mutant O 0 6.939173236020224e-09
HFE O 0 9.088687988878519e-07
protein O 0 3.6326310015599717e-11
with O 0 1.283018721646989e-12
the O 0 1.2243253078025873e-09
TfR O 0 1.4564286630047718e-06
. O 0 1.0138931472170043e-08

Studies O 0 1.5186865098826274e-09
on O 0 3.2794529314372767e-09
cell O 0 1.85755655301989e-09
- O 0 1.3709085949775712e-11
associated O 0 2.113715973084407e-11
transferrin O 0 5.702455729839073e-10
at O 0 1.9268972528685424e-10
37 O 0 2.4956684288590658e-11
degrees O 0 8.401586093498281e-10
C O 0 3.2992657494901323e-09
suggest O 0 3.0471476036852962e-12
that O 0 1.407223404643887e-13
the O 0 1.9919834878812104e-11
overexpressed O 0 2.369796625600884e-08
wild O 0 8.32197422084846e-09
- O 0 3.9670688956050526e-10
type O 0 1.9998620537364786e-09
HFE O 0 1.0067112725664629e-06
protein O 0 1.5656625301785354e-11
decreases O 0 1.5604444819627972e-12
the O 0 5.540816828790429e-13
affinity O 0 6.520987634421604e-13
of O 0 3.945199722465986e-11
the O 0 2.393739373385273e-10
TfR O 0 3.017161276375191e-08
for O 0 7.823208053592268e-11
transferrin O 0 2.9285649816301884e-07
. O 0 1.5707557921018633e-08

The O 0 6.594136721105315e-06
overexpressed O 0 0.0007781913154758513
H63D O 0 0.0073891193605959415
protein O 0 4.398951869433176e-09
does O 0 4.273153445671918e-12
not O 0 1.9007041220878845e-13
have O 0 8.440466478954606e-15
this O 0 1.7568899046899785e-15
effect O 0 9.169532537781078e-13
, O 0 1.3055257829658329e-14
providing O 0 5.070252824903622e-14
the O 0 6.153863090765585e-14
first O 0 4.6018276808525854e-14
direct O 0 2.796836926551721e-13
evidence O 0 3.391358374682518e-13
for O 0 1.281372198017744e-13
a O 0 7.067146347294884e-13
functional O 0 1.190212789436984e-10
consequence O 0 1.073570746190633e-10
of O 0 7.957856595908197e-11
the O 0 1.3309660040761173e-09
H63D O 0 5.358470298233442e-05
mutation O 0 1.0336378863939899e-08
. O 0 3.977632889728966e-09

Addition O 0 2.2878687833127742e-09
of O 0 1.6920802536901647e-08
soluble O 0 8.595715428327821e-08
wild O 0 3.1194379062071675e-06
- O 0 2.2078891959154134e-07
type O 0 6.291150384640787e-06
HFE O 1 0.9999992847442627
/ O 0 0.0002594136167317629
beta2m O 0 1.6909338000914431e-06
heterodimers O 0 1.210396760598087e-08
to O 0 2.692228601511304e-12
cultured O 0 1.1358945034567469e-11
cells O 0 2.5925997459985695e-12
also O 0 2.4989416731648756e-14
decreased O 0 2.0338751841562919e-13
the O 0 8.501738809479908e-14
apparent O 0 1.0923369413856632e-12
affinity O 0 1.1530815365035085e-13
of O 0 1.2862634568566733e-11
the O 0 5.5143497407206254e-11
TfR O 0 1.276737049415999e-09
for O 0 7.860607781004503e-13
its O 0 1.1238795267695667e-12
ligand O 0 1.8796901968959334e-12
under O 0 2.713366337170342e-11
steady O 0 2.0876067541308885e-09
- O 0 1.680781035184875e-11
state O 0 2.8434463984761127e-12
conditions O 0 2.1704280595002956e-09
, O 0 2.677233977045612e-13
both O 0 1.7907234668625843e-13
in O 0 2.935856419084004e-12
293 O 0 1.6260080087926454e-11
cells O 0 6.831528398532072e-12
and O 0 4.154745124329562e-12
in O 0 2.129364878866724e-10
HeLa O 0 6.008335162732692e-07
cells O 0 2.0777235487656753e-09
. O 0 1.2531753412758917e-09

Furthermore O 0 1.9826307262604814e-09
, O 0 1.8303924348428424e-11
at O 0 7.695385995099002e-11
4 O 0 2.364295148549189e-10
degrees O 0 1.743642119578226e-09
C O 0 1.2076341704414517e-08
, O 0 4.800524561199282e-12
the O 0 4.7659043378445176e-11
added O 0 3.858356689701026e-10
soluble O 0 1.908014995999352e-10
complex O 0 2.2852550407570504e-10
of O 0 7.193854956177859e-10
HFE O 0 0.00012820056872442365
/ O 0 6.34797956422517e-08
beta2m O 0 5.961987170621796e-08
inhibited O 0 1.3436346479878125e-10
binding O 0 2.1813658518388124e-11
of O 0 1.62546538728936e-11
transferrin O 0 5.893758814323746e-10
to O 0 1.653139430901618e-11
HeLa O 0 1.5066855496570497e-07
cell O 0 7.164992155139771e-09
TfR O 0 2.0454724580787342e-09
in O 0 8.177980319844236e-13
a O 0 1.3201839794974024e-11
concentration O 0 6.3229630420380545e-09
- O 0 4.7647641387982276e-09
dependent O 0 1.9023980168952903e-09
manner O 0 8.815645990978282e-09
. O 0 3.879441212717438e-09

Scatchard O 0 9.8711097962223e-06
plots O 0 3.769449108403933e-08
of O 0 9.653161825440293e-09
these O 0 1.5474279843608052e-11
data O 0 8.005263119059691e-11
indicate O 0 1.3894885242393684e-11
that O 0 1.0751762978197799e-12
the O 0 3.862848374502903e-10
added O 0 9.843491577399277e-10
heterodimer O 0 5.851709117266068e-10
substantially O 0 6.72230673903762e-12
reduced O 0 6.850370097566394e-12
the O 0 1.2900711315183555e-12
affinity O 0 2.8474353951091214e-12
of O 0 1.301542901233077e-10
TfR O 0 4.460538249873025e-08
for O 0 2.562744461087618e-10
transferrin O 0 2.358015933623392e-07
. O 0 1.0278736084501361e-08

These O 0 6.118191508974746e-10
results O 0 3.798842351798726e-10
establish O 0 2.949898103565829e-10
a O 0 7.72662142600744e-12
molecular O 0 1.7188027043313348e-11
link O 0 1.3924546411747674e-11
between O 0 8.948551101506386e-12
HFE O 0 3.1582626434101257e-06
and O 0 9.997006694684174e-12
a O 0 5.006490014225484e-11
key O 0 4.302717293569458e-09
protein O 0 2.1206576425458756e-11
involved O 0 1.0824872899092841e-12
in O 0 1.963810711269609e-11
iron O 0 1.26722795812384e-07
transport O 0 5.20791465508097e-10
, O 0 4.0500641035334795e-12
the O 0 1.254753106971762e-10
TfR O 0 1.4887940835706104e-07
, O 0 1.314733565072057e-11
and O 0 6.613014823242391e-12
raise O 0 4.289281169828074e-12
the O 0 9.673550155353539e-12
possibility O 0 1.0261385491316943e-11
that O 0 4.1655721705119095e-14
alterations O 0 2.2416346556752842e-11
in O 0 5.88285605125638e-13
this O 0 1.3546255046500977e-13
regulatory O 0 1.584136849475115e-10
mechanism O 0 1.4785112023574243e-10
may O 0 4.1859662437693235e-12
play O 0 1.1243410716343938e-11
a O 0 9.994676527375068e-13
role O 0 6.26621042380815e-13
in O 0 8.50443522028288e-13
the O 0 4.2091382462805527e-11
pathogenesis O 0 3.062360292460653e-06
of O 0 4.6792874286438746e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.3299081729201134e-06
. O 0 1.9631769987427106e-08

Genomic O 0 4.49746977437826e-07
organization O 0 2.1259378257809658e-08
of O 0 1.1234724262010332e-08
the O 0 2.7137016189726637e-08
UBE3A O 0 0.001157290069386363
/ O 0 2.925228272943059e-06
E6 O 0 6.354657216434134e-06
- O 0 2.845541047236111e-08
AP O 0 2.9003510348957207e-07
gene O 0 1.3560234879417266e-10
and O 0 1.0623790909491948e-11
related O 0 6.205762015376592e-10
pseudogenes O 0 6.83770764453584e-08
. O 0 7.767119392099175e-09

The O 0 2.38712004829722e-07
UBE3A O 0 1.7911803297465667e-05
gene O 0 1.4078518351112734e-09
encodes O 0 1.099925220349185e-10
the O 0 6.322019019400216e-10
E6 O 0 1.0778526302601676e-06
- O 0 4.6225938632460384e-08
AP O 0 3.849315817205934e-06
ubiquitin O 0 8.638905590885315e-09
- O 0 1.8339832985603266e-09
protein O 0 1.2901020529643148e-10
ligase O 0 3.334740469873587e-12
and O 0 6.933642028583709e-13
has O 0 2.542976679925646e-13
recently O 0 1.1726622277385967e-12
been O 0 1.0156402086534955e-13
shown O 0 7.151484265888186e-14
to O 0 1.5184742704768897e-14
be O 0 1.1816651715283732e-13
mutated O 0 2.0667889275016726e-11
in O 0 1.59732282956071e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 8.17556724541646e-08
who O 0 8.937570822320495e-11
lack O 0 1.2624656164916814e-07
15q11 O 0 2.120835489449746e-07
- O 0 7.415622338413641e-09
q13 O 0 2.30733174788611e-08
deletions O 0 1.1087026852152349e-09
or O 0 4.416922730343664e-11
chromosome O 0 1.2725220877030097e-08
15 O 0 2.678481969553559e-08
paternal O 0 1.1540289079903232e-07
uniparental B-Disease 0 0.0005628134240396321
disomy I-Disease 0 0.00010748844943009317
. O 0 1.5343479731200205e-07

Previous O 0 9.774946647667093e-07
UBE3A O 0 1.2177662028989289e-05
cDNA O 0 7.914844779577379e-09
analysis O 0 2.409224729438275e-11
has O 0 9.235070390703481e-13
shown O 0 1.1711869538424957e-12
a O 0 3.920473320984108e-12
coding O 0 1.8245305266617606e-10
region O 0 9.847731657908199e-11
of O 0 1.4163756278939843e-10
approximately O 0 3.592158862031347e-11
2 O 0 1.6713721961991723e-08
. O 0 3.836921891320344e-09

6 O 0 1.6914966636250028e-06
kb O 0 1.7069613704734365e-06
and O 0 3.233729395368812e-10
a O 0 8.458085898332968e-10
3 O 0 3.874096776712577e-08
- O 0 3.0696691855069957e-09
untranslated O 0 4.315093065088149e-07
region O 0 1.1884710993115277e-09
( O 0 4.325520410602968e-12
UTR O 0 8.765368164631582e-08
) O 0 3.052171688132377e-13
of O 0 2.1821398854537932e-11
< O 0 1.1011453970866114e-09
50 O 0 1.0031890596007287e-10
bp O 0 1.0832375794966875e-11
, O 0 3.342590689913577e-13
whereas O 0 1.007902311958575e-12
Northern O 0 8.240521980062976e-12
analysis O 0 3.798286284020097e-13
has O 0 1.9073863311274558e-13
indicated O 0 7.01002298743314e-13
mRNA O 0 1.019530380258482e-12
sizes O 0 3.2709317025758633e-13
of O 0 6.712466520120142e-12
5 O 0 2.566595824760043e-09
- O 0 6.302879107522585e-09
8 O 0 4.424762778398872e-08
kb O 0 2.0823920294787968e-06
. O 0 2.4279389165826615e-08

We O 0 5.288951498982897e-09
have O 0 3.311485200635511e-12
analyzed O 0 4.8106618515120214e-12
additional O 0 2.564204057420305e-12
cDNA O 0 1.0469832778525756e-09
clones O 0 1.2393267523336249e-09
and O 0 7.344694297195531e-12
provide O 0 2.711636904600967e-12
evidence O 0 4.726071964333833e-12
for O 0 5.083735082206386e-13
an O 0 5.028160505148038e-13
additional O 0 3.1146182855046334e-11
0 O 0 1.7025271858983615e-08
. O 0 2.9722759808947785e-09

5 O 0 1.2803522508875176e-07
kb O 0 4.943943849866628e-07
of O 0 4.985419366221322e-08
5 O 0 5.521082471204863e-07
- O 0 1.5108885520476178e-07
UTR O 0 1.64323046192294e-05
and O 0 3.387071179083989e-10
> O 0 2.141046007153591e-09
2 O 0 1.2575378516288538e-09
kb O 0 1.058359888617133e-08
of O 0 1.933403437348602e-09
3 O 0 9.687450983619783e-07
- O 0 7.103014922904549e-07
UTR O 0 0.00017441973614040762
. O 0 1.758213663549668e-08

We O 0 2.6190101198864113e-09
have O 0 5.1936844581990105e-12
established O 0 1.586391781827068e-11
the O 0 5.21998243241395e-12
genomic O 0 2.2592126780462962e-10
organization O 0 6.786855105689327e-11
of O 0 1.6062746965861407e-10
UBE3A O 0 1.5007942977263156e-07
and O 0 2.4091039493162603e-12
the O 0 8.017467766074926e-12
sequence O 0 4.8887404541231305e-12
of O 0 3.3905614427176545e-10
intron O 0 1.1939660282678233e-07
- O 0 1.8537866708356887e-07
exon O 0 2.922627686530177e-07
borders O 0 4.3861416720858415e-09
. O 0 6.592622447954e-09

We O 0 1.3114896724175651e-08
have O 0 2.542659312265716e-11
also O 0 8.061429995764868e-12
mapped O 0 2.1444984676932677e-10
two O 0 1.4065137943219952e-11
highly O 0 7.330813733830155e-11
homologous O 0 4.139299666916507e-11
processed O 0 1.0199942973576626e-10
pseudogenes O 0 9.309504278576242e-10
, O 0 9.423114198658933e-12
UBE3AP1 O 0 1.1952434988415916e-06
and O 0 1.3967060841224566e-10
UBE3AP2 O 0 3.461081405475852e-06
, O 0 9.302555253887235e-12
to O 0 1.013160367234478e-12
chromosomes O 0 1.833060829861677e-12
2 O 0 8.086783326310965e-11
and O 0 7.582418308678396e-13
21 O 0 5.7937113440154064e-11
, O 0 3.7969968965864687e-13
respectively O 0 2.1476195388031583e-12
, O 0 4.585445521551601e-13
and O 0 8.431560571259267e-13
determined O 0 6.20631532277649e-11
their O 0 7.045185615450755e-12
genomic O 0 2.5448207985334648e-09
organization O 0 2.1837116559453307e-09
. O 0 4.406509823695615e-09

These O 0 1.3956068523057752e-09
results O 0 2.5151189464445167e-10
will O 0 1.416901210075927e-12
form O 0 1.4261215906113955e-13
the O 0 2.575967596781664e-13
basis O 0 5.202128875239631e-13
for O 0 1.954618650094886e-14
studies O 0 5.6040648467245435e-14
of O 0 1.1361324207814771e-12
mutation O 0 6.889378390689815e-12
and O 0 3.767766480755608e-12
imprinting O 0 4.338261661018805e-08
of O 0 3.495318168234007e-08
UBE3A O 0 0.0019090180285274982
. O 0 1.3352720884540759e-07

Mutation O 0 2.681390398606709e-08
spectrum O 0 9.217860252874743e-09
and O 0 6.229679272440336e-11
genotype O 0 9.99988269967389e-09
- O 0 1.4071618315014689e-09
phenotype O 0 1.185007370008151e-10
analyses O 0 6.477813077609973e-12
in O 0 3.2792037314710587e-12
Cowden B-Disease 0 0.0001906516554299742
disease I-Disease 0 6.233717044779041e-07
and O 0 4.8586797779526236e-11
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.5967197836429534e-10
two O 0 1.2819296735244734e-09
hamartoma B-Disease 1 0.9999563694000244
syndromes I-Disease 0 0.0001256016839761287
with O 0 6.620546333380162e-09
germline O 0 0.4614247679710388
PTEN O 1 0.9914765954017639
mutation O 0 9.564826086716494e-08
. O 0 3.2934124316597035e-09

The O 0 6.748900887032505e-06
tumour B-Disease 1 1.0
suppressor O 0 3.825252497335896e-05
gene O 0 1.6976244410216168e-08
PTEN O 0 8.538130487067974e-07
, O 0 3.966762682217073e-12
which O 0 1.3894235154771062e-13
maps O 0 2.6479089754172236e-11
to O 0 1.4511254177451693e-11
10q23 O 0 5.324552532215421e-08
. O 0 6.181300360452724e-09

3 O 0 2.8675636087882594e-08
and O 0 7.208630220523204e-11
encodes O 0 3.36793683219927e-11
a O 0 1.7011914099640535e-10
403 O 0 5.7607200260045843e-11
amino O 0 4.994989422080209e-10
acid O 0 1.2858569764517824e-10
dual O 0 3.518782376588092e-09
specificity O 0 1.32661002183454e-08
phosphatase O 0 5.522437731997343e-06
( O 0 5.168450667447644e-10
protein O 0 2.2384623044047203e-09
tyrosine O 0 4.9542681068714955e-09
phosphatase O 0 4.427681776775216e-09
; O 0 1.1052025180452452e-12
PTPase O 0 1.5370632544531304e-09
) O 0 7.897693187364913e-14
, O 0 3.895023748521666e-14
was O 0 2.1292206279360792e-12
shown O 0 1.2819180396014818e-12
recently O 0 7.0079146478885246e-12
to O 0 2.1498562207799415e-13
play O 0 4.332838601794897e-11
a O 0 2.436317640686081e-11
broad O 0 6.917613010193335e-11
role O 0 7.975098879897669e-12
in O 0 9.820041481367614e-12
human O 0 1.3364812589955477e-09
malignancy B-Disease 0 2.810025080179912e-06
. O 0 6.458824142185904e-09

Somatic O 0 1.099330711440416e-05
PTEN O 0 6.485382073151413e-06
deletions O 0 2.032390256090366e-09
and O 0 3.203255022343754e-11
mutations O 0 2.9868085001799605e-12
were O 0 5.326712378475595e-13
observed O 0 2.62857823615098e-13
in O 0 2.3748358965111627e-13
sporadic B-Disease 0 1.966816398635274e-06
breast I-Disease 0 0.0003564937796909362
, I-Disease 0 4.795038810456731e-10
brain I-Disease 1 1.0
, I-Disease 0 8.796603623295596e-08
prostate I-Disease 1 1.0
and I-Disease 1 0.9843499064445496
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999321699142456
cell O 0 0.0025675115175545216
lines O 0 1.119197443055775e-11
and O 0 6.589864830035264e-14
in O 0 3.121073278294917e-13
several O 0 6.097798047749459e-12
primary O 0 9.254097221855773e-07
tumours B-Disease 1 1.0
such O 0 7.534046303492303e-11
as O 0 1.88490956176679e-09
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 3.074089909205213e-05
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9998840093612671
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 1.7180439044750528e-06

In O 0 9.167831493961387e-10
addition O 0 2.013340744122516e-10
, O 0 2.0347473705939478e-10
PTEN O 0 2.104095301547204e-06
was O 0 3.4875986543170256e-09
identified O 0 6.460369045280245e-11
as O 0 2.189860705964497e-12
the O 0 6.915432202575511e-12
susceptibility O 0 1.2230431944981746e-10
gene O 0 4.057355579983879e-12
for O 0 1.0169472685825354e-12
two O 0 1.2472274601993405e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9947669506072998
( O 0 8.561533426654222e-12
CD B-Disease 0 0.351739764213562
; O 0 1.0114892257107044e-10
MIM O 0 3.5389739423408173e-06
158350 O 0 1.2601988785831963e-08
) O 0 4.744033399624314e-13
and O 0 4.074346762750203e-12
Bannayan B-Disease 0 4.2291543422834366e-07
- I-Disease 0 1.1924541922780918e-06
Zonana I-Disease 0 0.0006409335765056312
( I-Disease 0 2.2209227512615115e-10
BZS I-Disease 0 9.907615776683087e-07
) I-Disease 0 2.5472111399305053e-12
or I-Disease 0 7.676441947379598e-12
Ruvalcaba I-Disease 0 6.78307330304051e-08
- I-Disease 0 1.0445805997960633e-07
Riley I-Disease 0 3.150945985908038e-06
- I-Disease 1 0.976109504699707
Smith I-Disease 0 4.216100205667317e-05
syndrome I-Disease 1 0.9999998807907104
( O 0 8.70553229503912e-09
MIM O 1 0.9783501625061035
153480 O 0 1.3539049177779816e-05
) O 0 5.919174039803465e-10
. O 0 4.872401149214056e-09

Constitutive O 0 8.085651757028245e-07
DNA O 0 2.6475024395011815e-09
from O 0 1.8470227083899893e-11
37 O 0 3.291325822996072e-10
CD B-Disease 0 1.1503163932502503e-06
families O 0 3.59817774533977e-12
and O 0 1.3558366235288943e-11
seven O 0 4.165755518314995e-10
BZS B-Disease 0 2.958225422844407e-06
families O 0 4.479507910437608e-12
was O 0 3.120101954579013e-10
screened O 0 9.026011937862677e-09
for O 0 4.119155294635135e-10
germline O 0 3.6899659789924044e-06
PTEN O 0 4.178490780759603e-05
mutations O 0 2.4958056954460517e-08
. O 0 4.020246802127758e-09

PTEN O 0 0.00016666548617649823
mutations O 0 3.4846194818527465e-09
were O 0 1.0794925370261055e-10
identified O 0 1.9590210530162633e-12
in O 0 1.4871047102071877e-12
30 O 0 2.363184994913503e-11
of O 0 1.4702239425901098e-10
37 O 0 4.1322495425433203e-10
( O 0 3.602139853758901e-12
81 O 0 2.9384533695164805e-10
% O 0 4.1394400927818875e-12
) O 0 4.4559692849617527e-13
CD B-Disease 0 1.7652305928095302e-07
families O 0 2.4169454957388703e-13
, O 0 3.189838530034267e-13
including O 0 3.6634393435486245e-12
missense O 0 1.6272134750749956e-09
and O 0 1.6953738413150177e-10
nonsense O 0 2.9035964743684417e-08
point O 0 2.761412876139957e-09
mutations O 0 4.250028714375409e-12
, O 0 1.2771954717785694e-12
deletions O 0 1.794910747809908e-11
, O 0 2.409232535693917e-12
insertions O 0 1.8290498282613754e-10
, O 0 4.3331442600713643e-11
a O 0 3.564981365666853e-10
deletion O 0 6.671043717432212e-10
/ O 0 2.4498194584055e-09
insertion O 0 3.441348317423376e-10
and O 0 5.724086205027845e-10
splice O 0 2.3695803008649818e-07
site O 0 2.6883141046596393e-08
mutations O 0 3.1459304050684977e-09
. O 0 5.55405454960578e-09

These O 0 5.940936076420655e-10
mutations O 0 1.2836369467361664e-10
were O 0 5.538445743691334e-11
scattered O 0 2.3927762549114107e-10
over O 0 6.01828170632146e-11
the O 0 4.3879971878268975e-10
entire O 0 3.347789545582458e-10
length O 0 9.679069178092359e-12
of O 0 4.142840515086732e-10
PTEN O 0 5.380666721066518e-07
, O 0 1.8057402361576491e-12
with O 0 7.677224741348132e-14
the O 0 9.313935039889643e-12
exception O 0 9.803385533913023e-12
of O 0 2.5305589221313873e-11
the O 0 1.7957189554773656e-11
first O 0 3.082903377027435e-11
, O 0 4.73715467894098e-12
fourth O 0 1.8087866759941562e-09
and O 0 1.0458969107451921e-10
last O 0 1.3213472982442909e-08
exons O 0 2.5215902041964e-06
. O 0 6.603850977171533e-08

A O 0 4.0049599192570895e-06
hot O 0 4.3754757825809065e-06
spot O 0 1.7413073294392234e-07
for O 0 1.2815916383690507e-10
PTEN O 0 3.467321505468135e-07
mutation O 0 5.2232294010801095e-12
in O 0 1.0191219613001068e-12
CD B-Disease 0 4.4181766156725644e-07
was O 0 7.696986104033243e-11
identified O 0 1.1646777292595445e-12
in O 0 1.6213804387640862e-12
exon O 0 1.7726339840429262e-10
5 O 0 4.788556356993823e-11
that O 0 2.4988954590472734e-13
contains O 0 7.338700827586031e-12
the O 0 7.844500049536407e-11
PTPase O 0 5.9149030562366534e-08
core O 0 1.3829763645389903e-07
motif O 0 7.667523282961497e-10
, O 0 5.166570296588624e-13
with O 0 1.574513089352969e-13
13 O 0 8.364231529611743e-11
of O 0 1.2514930758378284e-10
30 O 0 1.4150795812906125e-10
( O 0 7.180820608271299e-13
43 O 0 3.5943862469745014e-11
% O 0 3.849899132130075e-12
) O 0 7.634443749925113e-13
CD B-Disease 0 1.7234857807579829e-07
mutations O 0 1.3554228919798739e-11
identified O 0 5.353319350309693e-12
in O 0 4.508789609031227e-12
this O 0 2.553263329929667e-11
exon O 0 4.443690926336785e-08
. O 0 3.317040864203591e-09

Seven O 0 8.896200220931405e-09
of O 0 2.7580440153940344e-09
30 O 0 1.0629233049286313e-09
( O 0 6.470552392501272e-12
23 O 0 4.363260031059468e-10
% O 0 3.2365646621124178e-12
) O 0 1.1682546748569e-13
were O 0 4.127385065666456e-12
within O 0 2.655480349500472e-11
the O 0 1.037429239736376e-10
core O 0 8.506220616766313e-09
motif O 0 1.855636200254196e-10
, O 0 2.9887447768398023e-13
the O 0 2.861558429448352e-12
majority O 0 9.948648892546541e-13
( O 0 8.155732626790105e-14
five O 0 1.907503668907573e-12
of O 0 1.1659814780351496e-10
seven O 0 4.605021572401391e-11
) O 0 2.65774761139953e-13
of O 0 3.258282185725214e-11
which O 0 6.073259950500898e-12
were O 0 1.2371816071610198e-10
missense O 0 8.23465828858616e-09
mutations O 0 5.1212676460687945e-11
, O 0 2.063236213822872e-11
possibly O 0 1.2784397152021398e-10
pointing O 0 7.783780564540876e-11
to O 0 4.0244809438108597e-13
the O 0 1.4055349766006753e-11
functional O 0 3.21228738053847e-10
significance O 0 1.3441267543434776e-10
of O 0 6.154306925187925e-11
this O 0 6.6782933350051366e-12
region O 0 2.5405093584396354e-09
. O 0 4.477533011026935e-09

Germline O 0 0.00025770059437491
PTEN O 0 7.167336298152804e-05
mutations O 0 6.905079286134708e-10
were O 0 6.763645893359538e-11
identified O 0 4.558180655839239e-12
in O 0 1.2583325223816666e-12
four O 0 4.595946453272992e-12
of O 0 1.3408747723264725e-10
seven O 0 1.9911412796336236e-10
( O 0 3.3045007702403595e-12
57 O 0 1.0722533971829762e-09
% O 0 1.4680158477720084e-10
) O 0 6.906182570265429e-11
BZS B-Disease 0 7.68942481954582e-06
families O 0 2.2441798419592374e-11
studied O 0 1.3421222355702866e-08
. O 0 1.668136206944837e-08

Interestingly O 0 2.81296355097993e-08
, O 0 2.8517213590539825e-10
none O 0 9.159838859629232e-11
of O 0 1.0353772700311126e-10
these O 0 1.4248606634847949e-12
mutations O 0 2.529664845651869e-12
was O 0 5.7345631715444156e-11
observed O 0 7.115816182817758e-12
in O 0 7.933604294352303e-12
the O 0 5.187363316672133e-10
PTPase O 0 5.37056030225358e-06
core O 0 1.283156052522827e-05
motif O 0 8.960282116277085e-07
. O 0 4.299290523590571e-08

It O 0 4.1750222723457853e-10
is O 0 2.4413648186394354e-11
also O 0 4.938344871918687e-12
worthy O 0 1.771193261501658e-11
of O 0 5.725961718661132e-11
note O 0 8.124377906537639e-12
that O 0 2.0099343738845532e-13
a O 0 7.190678608104406e-12
single O 0 5.424592719460719e-11
nonsense O 0 8.977555365774492e-10
point O 0 4.056724955958657e-10
mutation O 0 1.7856049755113346e-12
, O 0 1.1345899941133178e-13
R233X O 0 2.7004277286524214e-11
, O 0 3.2880832388434977e-13
was O 0 1.7096086699086577e-11
observed O 0 4.4271006131857416e-12
in O 0 1.3890427436741293e-12
the O 0 1.9945840118440472e-11
germline O 0 4.975819756225519e-10
DNA O 0 1.4330105678472815e-11
from O 0 7.105640403327895e-13
two O 0 1.5879834339843635e-12
unrelated O 0 6.660614421116762e-11
CD B-Disease 0 2.281506749568507e-05
families O 0 4.119858100504192e-12
and O 0 8.408651552826996e-11
one O 0 1.878227351426176e-09
BZS B-Disease 0 0.001760598854161799
family O 0 4.357265659393761e-09
. O 0 3.2720816278697384e-08

Genotype O 0 4.680563847614394e-07
- O 0 5.5979388235982697e-08
phenotype O 0 1.29860011632843e-09
studies O 0 8.085854034944884e-12
were O 0 9.011565799132981e-12
not O 0 1.4915865309376997e-13
performed O 0 1.0604724737239835e-10
on O 0 3.087282651748069e-10
this O 0 9.27441608754298e-13
small O 0 4.490132224366228e-12
group O 0 2.746618210647256e-11
of O 0 1.8678738555877317e-09
BZS B-Disease 0 0.0009070382220670581
families O 0 2.7389970846947165e-10
. O 0 3.809786708330876e-09

However O 0 3.5365455008928848e-09
, O 0 4.7923116863746174e-11
genotype O 0 1.2717595865296971e-09
- O 0 6.951728082071895e-10
phenotype O 0 2.261299203443201e-10
analysis O 0 6.348789983318115e-12
inthe O 0 9.058401140293881e-09
group O 0 1.758536372076236e-11
of O 0 3.54764384535855e-10
CD B-Disease 1 0.9999881982803345
families O 0 1.7962044612102046e-12
revealed O 0 9.820116074477081e-12
two O 0 3.252888952122446e-13
possible O 0 1.41599683367577e-11
associations O 0 2.712226710582799e-12
worthy O 0 7.458311052088717e-11
of O 0 2.748385408146703e-10
follow O 0 2.6141313072547412e-11
- O 0 1.5070649589388196e-11
up O 0 3.3078871673059007e-12
in O 0 2.4092969373029627e-12
independent O 0 9.86762338506253e-11
analyses O 0 3.7123450979947847e-09
. O 0 7.808353075233754e-09

The O 0 3.2205342836988393e-09
first O 0 6.908372762737258e-10
was O 0 1.853748043956216e-09
an O 0 3.1153296088659577e-12
association O 0 5.6633010780959836e-11
noted O 0 6.923878571180042e-12
in O 0 3.3788729193046096e-12
the O 0 7.238832450129351e-11
group O 0 1.5556726046250802e-11
of O 0 1.745844163680843e-10
CD B-Disease 1 0.9999912977218628
families O 0 9.843331878756079e-12
with O 0 3.755043220809995e-10
breast B-Disease 1 0.9999985694885254
disease I-Disease 1 0.9999994039535522
. O 0 3.0049403676457587e-07

A O 0 5.942525582725011e-09
correlation O 0 9.104118847691467e-11
was O 0 1.0522499538367924e-10
observed O 0 1.060244882340744e-12
between O 0 7.169430522348252e-14
the O 0 2.045594162808362e-12
presence O 0 2.6155915541087316e-12
/ O 0 4.857987345729953e-10
absence O 0 3.3447195013636133e-10
of O 0 2.453184877460046e-10
a O 0 6.522701823108434e-10
PTEN O 0 2.4816727091092616e-06
mutation O 0 8.492801080450807e-12
and O 0 1.8995442968138682e-13
the O 0 3.321353175128605e-12
type O 0 2.573835033992111e-10
of O 0 8.752516045262837e-09
breast O 0 8.056271326495335e-06
involvement O 0 2.374058283294289e-08
( O 0 1.148754869007007e-09
unaffected O 1 0.7461431622505188
versus O 0 0.126646488904953
benign O 1 0.9999997615814209
versus O 0 2.142460652976297e-05
malignant O 0 5.4651052778353915e-05
) O 0 1.4544317139542073e-10
. O 0 2.957459832586551e-09

Specifically O 0 3.17399134752705e-10
and O 0 1.4334863157605682e-11
more O 0 7.001133207245117e-14
directly O 0 1.8657266758013297e-13
, O 0 1.6190681065807178e-13
an O 0 1.8080345163748457e-13
association O 0 5.193202118336515e-11
was O 0 3.310471896611489e-10
also O 0 5.763198078490017e-13
observed O 0 2.158179911908656e-13
between O 0 5.49573509259476e-14
the O 0 8.375141400708552e-13
presence O 0 6.322829087558601e-13
of O 0 7.887735603562263e-12
a O 0 2.714371782897018e-10
PTEN O 0 0.457698255777359
mutation O 0 3.64806460595446e-08
and O 0 3.3826696999028627e-09
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.9301252741097414e-07

Secondly O 0 7.472034013744633e-08
, O 0 3.155459782355763e-10
there O 0 5.397037677878913e-11
appeared O 0 1.3649681385174972e-10
to O 0 7.175399055307785e-13
be O 0 5.240270023465499e-13
an O 0 1.6494211595510788e-13
interdependent O 0 3.794115688293687e-09
association O 0 1.3678949639661653e-10
between O 0 2.7927991516629724e-11
mutations O 0 9.775714092385979e-12
upstream O 0 1.8148903603923405e-12
and O 0 1.0889482674955597e-12
within O 0 4.122296948239068e-11
the O 0 1.967403323588357e-10
PTPase O 0 2.9339935281313956e-07
core O 0 4.841665486310376e-07
motif O 0 7.948596447704404e-09
, O 0 1.487343928574525e-11
the O 0 2.3114565816939603e-10
core O 0 2.059755566108379e-08
motif O 0 4.810776776942305e-10
containing O 0 6.575282419235551e-12
the O 0 9.28077406592287e-12
majority O 0 2.0836455390943476e-12
of O 0 5.504524266952693e-11
missense O 0 3.064135389863054e-09
mutations O 0 3.549158189564139e-11
, O 0 3.611351235416338e-12
and O 0 3.0254073985630514e-12
the O 0 1.337293886738422e-10
involvement O 0 1.0791548904487414e-10
of O 0 3.5441405366043455e-10
all O 0 3.126260014751914e-11
major O 0 5.367805311351503e-09
organ O 1 0.9637507796287537
systems O 0 3.235391704947688e-05
( O 0 1.6450250883703887e-10
central O 0 0.05236499756574631
nervous O 0 0.013927169144153595
system O 0 0.438198059797287
, O 0 7.308344152079371e-09
thyroid O 1 1.0
, O 0 1.635240636232993e-07
breast O 1 1.0
, O 0 4.4548692130774725e-06
skin O 1 1.0
and O 1 0.9996386766433716
gastrointestinal O 1 1.0
tract O 1 0.9969275593757629
) O 0 6.870209956488793e-11
. O 0 2.0874555417549345e-09

However O 0 2.753661654253392e-08
, O 0 5.391954938094301e-11
these O 0 7.913153097192926e-13
observations O 0 9.937124040293455e-12
would O 0 6.1626554553884105e-12
need O 0 6.950126238414178e-13
to O 0 5.4160448776643597e-14
be O 0 9.003945321533341e-14
confirmed O 0 9.497191580257539e-14
by O 0 1.4467620894700883e-14
studying O 0 1.1036921159987556e-12
a O 0 4.755221823943279e-13
larger O 0 1.6533489529714507e-13
number O 0 2.390492968504243e-12
of O 0 1.464545151819152e-10
CD B-Disease 0 9.68760359683074e-05
families O 0 9.037199460992795e-11
. O 0 1.739184574134356e-09

Molecular O 0 0.0003656720509752631
defects O 1 0.9985401630401611
leading O 0 8.015767605229485e-09
to O 0 7.765477497145845e-12
human O 0 6.413864439558381e-10
complement B-Disease 0 5.538390368542423e-08
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.510587984871364e-11
an O 0 1.9056554023590827e-13
African O 0 3.4468185250435823e-11
- O 0 5.814812520377188e-11
American O 0 1.1593596221937119e-10
family O 0 1.6608645014848378e-10
. O 0 2.641973750883153e-09

Complement B-Disease 0 1.5485588846786413e-06
component I-Disease 1 0.9999983310699463
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.1177202496881478e-09
C6D B-Disease 0 2.686964398890268e-05
) O 0 5.975884934464326e-13
was O 0 2.4002806686684863e-11
diagnosed O 0 3.811250967600266e-11
in O 0 4.427503827973689e-13
a O 0 4.0671875589648465e-12
16 O 0 1.2645116724552263e-11
- O 0 2.1437560927817234e-12
year O 0 3.1174576808901122e-12
- O 0 3.3168981450337753e-11
old O 0 6.875090496905045e-10
African O 0 1.5396799113442938e-10
- O 0 1.7871971264016295e-11
American O 0 9.055658133083622e-12
male O 0 2.383014618967394e-11
with O 0 1.7064528956556302e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.990782377310097e-08

The O 0 1.1492819851355307e-07
patients O 0 3.3161723367314266e-10
father O 0 8.908196402757085e-11
and O 0 9.311399568057155e-11
two O 0 2.5316271301534243e-10
brothers O 0 1.2361596191112767e-07
also O 0 1.365130342101395e-09
had O 0 1.7955905651234616e-09
C6D B-Disease 0 0.007355150301009417
, O 0 1.7329247412045667e-11
but O 0 1.0106955420155495e-12
gave O 0 8.174990198672738e-12
no O 0 1.5047117198074833e-12
history O 0 4.240126479093664e-12
of O 0 2.2095231200225385e-10
meningitis B-Disease 1 1.0
or O 0 2.1499321420370698e-11
other O 0 8.51963638526243e-12
neisserial B-Disease 0 0.00012430391507223248
infection I-Disease 0 7.002466736594215e-05
. O 0 1.1376352304637294e-08

By O 0 1.2160841222907948e-09
using O 0 5.480076392672117e-10
exon O 0 2.196573811730218e-09
- O 0 1.1570577829189688e-10
specific O 0 4.588118773796168e-11
polymerase O 0 8.355269948134847e-11
chain O 0 4.959834765116966e-10
reaction O 0 4.00397943967068e-12
( O 0 1.678767259753744e-13
PCR O 0 2.3699738352367383e-11
) O 0 3.256227413899436e-14
/ O 0 3.892116663684053e-12
single O 0 1.5429952454626417e-11
- O 0 1.644698092995167e-11
strand O 0 3.617598928751242e-11
conformation O 0 8.295416437098524e-12
polymorphism O 0 4.981702116796383e-12
as O 0 3.5057986244937944e-13
a O 0 4.1669730274813965e-13
screening O 0 9.122104981107437e-12
step O 0 1.1338786897255315e-12
and O 0 3.2442252958500215e-14
nucleotide O 0 3.912314537005829e-13
sequencing O 0 2.8947138197739364e-13
of O 0 1.2374075722410005e-11
target O 0 4.873793035820029e-10
exons O 0 1.9085875102575756e-09
, O 0 6.046583372887326e-12
we O 0 1.5461673824948563e-12
determined O 0 3.0238322696468645e-12
that O 0 8.628673811702722e-14
the O 0 7.114567181915055e-12
proband O 0 2.5623794197571215e-09
was O 0 1.0273223383094887e-09
a O 0 7.199341817143434e-11
compound O 0 1.0671444838905586e-09
heterozygote O 0 2.387985587049002e-09
for O 0 1.228738465142154e-11
two O 0 5.953731951890973e-10
C6 O 0 9.56412623054348e-06
gene O 0 8.304183118923447e-09
mutations O 0 6.188047407817976e-09
. O 0 3.5759204486396357e-09

The O 0 1.3084713756938982e-08
first O 0 6.91501744753964e-10
, O 0 8.138367584009654e-12
1195delC O 0 2.9143185087399104e-10
located O 0 6.84180698207193e-11
in O 0 3.185002608874221e-11
exon O 0 3.934953252127116e-09
7 O 0 3.263846304335516e-09
, O 0 1.9871101292201487e-12
is O 0 1.0813682035318989e-13
a O 0 1.9780296920800938e-13
novel O 0 3.5343266941573193e-13
mutation O 0 9.856002868230754e-14
, O 0 1.7936075124040315e-14
while O 0 4.13867751918387e-14
the O 0 1.5922537810811321e-12
second O 0 1.708337464545462e-11
, O 0 4.1745383191904573e-13
1936delG O 0 8.574562587737589e-11
in O 0 1.9729074277052838e-11
exon O 0 6.311969835692821e-10
12 O 0 7.547464736523679e-11
, O 0 2.3731299043927567e-12
has O 0 4.2543331596305023e-13
been O 0 1.0911291401655143e-12
described O 0 4.514159011870245e-12
before O 0 1.4264712674960656e-11
to O 0 1.649780680991475e-12
cause O 0 5.886535148214023e-10
C6D B-Disease 0 3.040236151719e-06
in O 0 7.938857904399299e-12
an O 0 3.663870422332405e-13
unrelated O 0 1.3351836303243658e-10
African O 0 2.396558229644796e-10
- O 0 3.2960689733130266e-10
American O 0 8.963490505387028e-10
individual O 0 4.18684059644292e-10
. O 0 2.620515537898882e-08

Both O 0 1.244832570357346e-09
mutations O 0 8.389671735109516e-10
result O 0 2.1816413953157365e-10
in O 0 3.5982636314990657e-10
premature O 0 2.1401081795602295e-08
termination O 0 7.306448335242521e-09
codons O 0 6.141343877885674e-09
and O 0 2.849383506919878e-10
C6 O 0 4.844380782742519e-06
null O 0 4.937008313277147e-08
alleles O 0 7.216238023799448e-11
. O 0 3.5724961877647843e-10

Allele O 0 3.5514911012057837e-09
- O 0 5.613982612118207e-10
specific O 0 7.094678317054459e-11
PCR O 0 1.3773127083283043e-09
indicated O 0 2.327013234881825e-11
that O 0 5.75440777385132e-14
the O 0 5.055782181795365e-12
probands O 0 6.755942916214508e-09
two O 0 5.4702679885831884e-11
brothers O 0 1.8795531797621834e-09
also O 0 3.766935027793572e-11
inherited O 0 8.58081661281318e-10
the O 0 3.2720159914845226e-10
1195delC O 0 4.281024423846702e-09
mutation O 0 1.0850364877412755e-11
from O 0 6.016393438133816e-13
their O 0 3.7046507354865366e-12
heterozygous O 0 2.02163598361782e-11
mother O 0 3.3378397702038543e-12
and O 0 2.0214075639041207e-12
the O 0 4.854316948410542e-11
1936delG O 0 1.7659091966493179e-09
mutation O 0 8.567284034977085e-12
from O 0 7.202836959686876e-13
their O 0 4.0900043768443695e-12
homozygous O 0 4.82608786267491e-10
father O 0 1.7057921741781001e-10
. O 0 2.2387174059002035e-10
. O 0 2.33766983548378e-09

PAX6 O 0 0.011336973868310452
mutations O 0 3.965935206906579e-07
reviewed O 0 1.9778391902036674e-07
. O 0 5.437560446353018e-08

Mutations O 0 7.933495638212662e-09
in O 0 2.1360289093053098e-09
PAX6 O 0 0.001090713427402079
are O 0 1.7828663892438534e-11
responsible O 0 8.72477229352242e-11
for O 0 4.3164053060984475e-12
human O 0 1.6481540576762654e-09
aniridia B-Disease 1 1.0
and O 0 1.1273974115377783e-10
have O 0 1.263946738071231e-12
also O 0 1.8311064741306088e-13
been O 0 1.2086981263960406e-13
found O 0 3.5376497060533516e-14
in O 0 1.8191036784548364e-13
patients O 0 1.4356052425393978e-13
with O 0 2.890818552418739e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.650924504001068e-11
with O 0 1.4676875537134038e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.1656312359775711e-08
with O 0 2.1751815904025307e-09
autosomal B-Disease 1 0.9999479055404663
dominant I-Disease 1 0.9999066591262817
keratitis I-Disease 1 1.0
, O 0 1.8357558528858675e-11
and O 0 5.063647418035444e-12
with O 0 1.7170342925254545e-10
isolated B-Disease 1 0.9999946355819702
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 2.8761676730937324e-05

No O 0 1.693035933669762e-08
locus O 0 3.1241766951239924e-09
other O 0 1.4559383212930932e-11
than O 0 1.5173929820977428e-12
chromosome O 0 2.0346320184216893e-09
11p13 O 0 2.234129858891265e-08
has O 0 2.1381627371419576e-11
been O 0 8.291509839830624e-12
implicated O 0 1.9141233736919006e-11
in O 0 6.942634661610825e-11
aniridia B-Disease 1 1.0
, O 0 3.617386945542478e-10
and O 0 3.530545300556298e-10
PAX6 O 0 0.0015307989669963717
is O 0 5.956909271409572e-11
clearly O 0 9.757011171229735e-12
the O 0 1.347632682530131e-11
major O 0 3.1896488228433384e-10
, O 0 2.103086368249185e-12
if O 0 1.0041624649848035e-12
not O 0 5.791739158579612e-13
only O 0 1.291582834607452e-12
, O 0 2.3471378920308927e-12
gene O 0 1.5901703565024405e-10
responsible O 0 2.4633750594915682e-09
. O 0 2.591199477208761e-09

Twenty O 0 6.65336088445656e-08
- O 0 3.7055538637531527e-09
eight O 0 9.198483086336751e-10
percent O 0 1.152401715720508e-10
of O 0 1.313767317157044e-09
identified O 0 9.343289697483215e-09
PAX6 O 0 0.0006467300117947161
mutations O 0 5.208033448944605e-10
are O 0 2.167662230267986e-11
C O 0 6.424671937566018e-06
- O 0 1.5966466889949515e-05
T O 0 1.794955096556805e-06
changes O 0 6.119615370003828e-10
at O 0 1.4861457620085616e-09
CpG O 0 7.216289077405236e-08
dinucleotides O 0 2.3461299569760286e-09
, O 0 1.8453352994968197e-12
20 O 0 5.330801772229776e-12
% O 0 3.4204746240246164e-13
are O 0 5.790498831294288e-14
splicing O 0 2.4655405495010996e-10
errors O 0 3.5190861780165505e-08
, O 0 5.552065751590618e-12
and O 0 1.1452092529493085e-12
more O 0 1.2377597590536998e-14
than O 0 4.800290888526057e-14
30 O 0 9.166230274804121e-12
% O 0 1.3135798872243587e-12
are O 0 2.9791601585844874e-13
deletion O 0 1.163792326397406e-11
or O 0 1.8469269082860285e-12
insertion O 0 2.1704672781286405e-11
events O 0 1.311663555547682e-10
. O 0 2.099050044890305e-09

There O 0 2.862731163233434e-09
is O 0 2.4149756847058335e-11
a O 0 8.478077268003759e-11
noticeably O 0 1.4848339224826645e-09
elevated O 0 1.9921679861312214e-09
level O 0 7.658665923671037e-10
of O 0 4.788940077826709e-11
mutation O 0 4.293382056125283e-12
in O 0 3.5789442156403117e-12
the O 0 2.573259313964904e-11
paired O 0 9.442220443023341e-12
domain O 0 5.165469614543117e-12
compared O 0 1.9043801095536966e-13
with O 0 1.2002965082361788e-13
the O 0 7.020547337921457e-11
rest O 0 3.8233811949783814e-11
of O 0 8.299393811084244e-11
the O 0 3.0621707947098287e-10
gene O 0 1.3256482578327677e-09
. O 0 1.1531059440628155e-09

Increased O 0 7.188752371156681e-10
mutation O 0 2.648570598950961e-11
in O 0 4.925513989728625e-12
the O 0 4.2953089002262246e-11
homeodomain O 0 4.4218584349664525e-09
is O 0 4.950366288766772e-13
accounted O 0 4.0155738977032396e-12
for O 0 1.4432954885488375e-13
by O 0 1.1132293004090243e-12
the O 0 4.851394841409729e-10
hypermutable O 0 1.9030927944641007e-07
CpG O 0 2.6847942535823677e-06
dinucleotide O 0 2.0516496590516908e-07
in O 0 3.403833659376687e-09
codon O 0 3.877800835994094e-08
240 O 0 4.20227541653162e-09
. O 0 4.1136769546312735e-09

Very O 0 1.1570804314686711e-09
nearly O 0 1.5963848298827799e-10
all O 0 1.2887978878550754e-11
mutations O 0 8.666354960051859e-12
appear O 0 2.9883927363943963e-12
to O 0 4.066596235099973e-13
cause O 0 4.191994529278986e-10
loss O 0 3.4704900064852495e-10
of O 0 1.1209242561927013e-10
function O 0 4.6030460693069486e-11
of O 0 6.690315836055394e-12
the O 0 1.5824502081970837e-12
mutant O 0 1.0095074082228095e-11
allele O 0 6.505321997231361e-13
, O 0 2.431110427715804e-14
and O 0 3.032267498074073e-14
more O 0 1.6311051943853597e-15
than O 0 1.1494403112698517e-14
80 O 0 1.979196971244046e-12
% O 0 2.787729899353386e-13
of O 0 5.940740260834687e-11
exonic O 0 3.9899671122611835e-08
substitutions O 0 1.4966367034574546e-09
result O 0 3.272022375266914e-10
in O 0 7.547954622433295e-11
nonsense O 0 3.046131169526234e-08
codons O 0 1.1272222266711651e-08
. O 0 3.325979935908663e-09

In O 0 2.473110605194506e-09
a O 0 3.9429376430533125e-10
gene O 0 1.5913983672510845e-11
with O 0 5.751887139325562e-13
such O 0 1.3622813987979043e-10
extraordinarily O 0 1.0465559530103974e-09
high O 0 9.27002696826662e-10
sequence O 0 1.9248283522621534e-11
conservation O 0 2.719314010080076e-11
throughout O 0 2.25074055530336e-13
evolution O 0 1.3393193889002508e-12
, O 0 7.283860607764162e-14
there O 0 4.961407261590278e-13
are O 0 7.052011969169159e-13
presumed O 0 1.6202080788119133e-09
undiscovered O 0 4.073112052083161e-07
missense O 0 2.5469926612231575e-08
mutations O 0 1.5986945101076344e-10
, O 0 1.290485253380158e-11
these O 0 2.0862343970418085e-12
are O 0 3.447012098499458e-13
hypothesized O 0 1.0824108536561239e-12
to O 0 4.7021861773223483e-14
exist O 0 6.637403300591149e-12
in O 0 5.781995542075702e-12
as O 0 2.4928425643166996e-11
- O 0 1.9278054153026858e-10
yet O 0 1.4473253151514598e-10
unidentified O 0 5.687682547161899e-10
phenotypes O 0 9.708009396369732e-11
. O 0 1.6209854639126497e-11
. O 0 4.779014406430804e-10

Genetic O 0 3.920122537692805e-08
heterogeneity O 0 3.355182442987825e-08
and O 0 2.3425070216909205e-10
penetrance O 0 2.8892713999084663e-08
analysis O 0 2.786972388979514e-11
of O 0 1.323291143329186e-09
the O 0 6.073628711078527e-09
BRCA1 O 0 6.741937230714257e-09
and O 0 1.1084779621972629e-10
BRCA2 O 0 4.748180071345587e-09
genes O 0 9.267264039491963e-11
in O 0 1.1626908325013119e-09
breast B-Disease 1 0.9988914132118225
cancer I-Disease 0 0.07335138320922852
families O 0 1.7531387452862646e-10
. O 0 6.09181114441526e-08

The O 0 0.00041772410622797906
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0015910675283521414
Consortium O 0 5.098119260082967e-08
. O 0 1.905162250182002e-08

The O 0 4.1799066985426236e-10
contribution O 0 6.181223588530571e-11
of O 0 9.536491596406904e-10
BRCA1 O 0 2.7714277539558907e-09
and O 0 7.269437135581924e-11
BRCA2 O 0 3.640863255327531e-08
to O 0 1.2704020058151855e-09
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.155729271180462e-05
assessed O 0 6.942356411965278e-11
by O 0 1.4157117589775475e-13
linkage O 0 1.726880721752977e-10
and O 0 1.5837004017221767e-12
mutation O 0 6.933893021386639e-13
analysis O 0 6.102026707272695e-14
in O 0 1.3684775426563156e-13
237 O 0 1.616023721090487e-12
families O 0 1.0117032672772933e-14
, O 0 2.801576719636649e-14
each O 0 3.4341860291506017e-15
with O 0 5.882381577280646e-14
at O 0 2.2935474353058538e-10
least O 0 7.67640833711225e-13
four O 0 7.008993537470365e-13
cases O 0 1.3246553376769499e-12
of O 0 2.3727862341615946e-08
breast B-Disease 0 0.19943015277385712
cancer I-Disease 0 2.2385067666164105e-07
, O 0 1.3545538388864964e-12
collected O 0 4.851082101124671e-13
by O 0 2.25911563761505e-12
the O 0 3.7755725657007133e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.7397876440081745e-05
Consortium O 0 4.020223709488846e-09
. O 0 2.2571204905119657e-09

Families O 0 1.8783265220978507e-10
were O 0 2.2705914926035575e-10
included O 0 7.468844986924239e-11
without O 0 2.818152308736721e-11
regard O 0 1.918582480386899e-11
to O 0 8.2715986024582e-14
the O 0 1.0465344953483613e-12
occurrence O 0 2.556155509481073e-09
of O 0 4.9682565617104046e-08
ovarian B-Disease 1 0.9999997615814209
or I-Disease 0 2.7464126972631675e-08
other I-Disease 0 1.1815553868643747e-08
cancers I-Disease 1 0.9999918937683105
. O 0 2.2577144420665718e-07

Overall O 0 6.144662734186568e-07
, O 0 4.031611489097031e-09
disease O 0 0.0023627295158803463
was O 0 3.101190770848916e-08
linked O 0 3.3492344453378564e-09
to O 0 4.09668739903557e-12
BRCA1 O 0 1.7508921396069965e-11
in O 0 9.654739708446838e-14
an O 0 5.112824700832623e-15
estimated O 0 2.521585100011964e-13
52 O 0 1.1947240072252008e-12
% O 0 1.668389818659799e-13
of O 0 1.9343457391407526e-11
families O 0 1.9716602753672846e-13
, O 0 3.177129783218935e-13
to O 0 1.0112721207308772e-12
BRCA2 O 0 1.5099047012689937e-11
in O 0 4.880501927075065e-13
32 O 0 1.0864654662046114e-11
% O 0 7.60939542713418e-13
of O 0 2.9887134433970175e-11
families O 0 2.1828287061990276e-13
, O 0 4.517395301145005e-13
and O 0 7.753544442774818e-13
to O 0 4.468872646067046e-13
neither O 0 7.118531025057662e-12
gene O 0 2.7083017902981843e-13
in O 0 9.119747600323802e-14
16 O 0 5.587121910954895e-12
% O 0 1.3528773641722364e-13
( O 0 3.2077378269877374e-14
95 O 0 8.608073281957118e-11
% O 0 5.435174879608873e-12
confidence O 0 1.8306073323870464e-09
interval O 0 7.117727296446219e-09
[ O 0 1.5207910486481069e-09
CI O 0 1.2036877024002024e-06
] O 0 5.790783824677348e-11
6 O 0 8.115058625079996e-11
% O 0 1.0056786133028073e-12
- O 0 6.9097891471081585e-12
28 O 0 8.327555311993251e-11
% O 0 3.989677945653858e-12
) O 0 4.559847508259218e-13
, O 0 1.6427439920516096e-12
suggesting O 0 8.510155774521522e-11
other O 0 1.335391866530422e-11
predisposition O 0 1.1302470070972959e-08
genes O 0 6.44556630291504e-10
. O 0 1.7929587814435877e-09

The O 0 3.4234315382519753e-09
majority O 0 1.2314467501273185e-10
( O 0 2.7773926821600403e-12
81 O 0 1.3151957301005268e-10
% O 0 4.549249432023172e-13
) O 0 7.892509853947485e-15
of O 0 1.1245534017878533e-11
the O 0 1.3974281500850338e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.6568597322196297e-10
were O 0 1.9801682862863323e-11
due O 0 3.510490120817167e-09
to O 0 1.376425666152481e-12
BRCA1 O 0 2.1742461997487084e-11
, O 0 2.4248169729177045e-14
with O 0 9.886027306298898e-15
most O 0 2.1825454583814657e-13
others O 0 1.1191045377716147e-13
( O 0 9.369583695061426e-15
14 O 0 7.169000636186862e-12
% O 0 3.2874058835362374e-13
) O 0 9.731966073940265e-14
due O 0 1.7368906313208754e-09
to O 0 3.240434309770279e-10
BRCA2 O 0 1.719218545304102e-08
. O 0 3.6719933760309686e-09

Conversely O 0 8.603830536912938e-09
, O 0 2.154899696182877e-11
the O 0 9.760268981917619e-12
majority O 0 1.274209904256196e-12
of O 0 1.8128916770554504e-11
families O 0 1.698963439009625e-14
with O 0 5.496890919873265e-13
male B-Disease 0 7.198435597599584e-11
and I-Disease 0 1.2481277122944334e-09
female I-Disease 0 1.620882805752899e-08
breast I-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999973773956299
were O 0 6.313252498557631e-08
due O 0 9.175820741802454e-05
to O 0 1.4706082185345082e-10
BRCA2 O 0 2.6091065419286963e-10
( O 0 3.214102432553406e-13
76 O 0 4.766888550555848e-10
% O 0 1.268265267112545e-11
) O 0 8.10299050080232e-12
. O 0 6.090643545064722e-10

The O 0 3.1571774083971604e-09
largest O 0 5.930271274046106e-10
proportion O 0 1.6277425587962746e-11
( O 0 2.596029077470141e-12
67 O 0 1.1258272092362631e-09
% O 0 5.8265219905762056e-12
) O 0 1.3309810881472622e-13
of O 0 3.72931720227232e-11
families O 0 6.836135932504483e-14
due O 0 7.647864008752947e-10
to O 0 1.3626075094641532e-12
other O 0 3.52850696794596e-13
genes O 0 7.031059762185876e-13
was O 0 3.426995145994205e-11
found O 0 1.4478670270091226e-13
in O 0 7.464731957562698e-14
families O 0 2.343743553184438e-15
with O 0 2.8239698990698003e-14
four O 0 5.653390949822423e-12
or O 0 2.3175905639050143e-12
five O 0 3.591348789536153e-12
cases O 0 2.278006993108872e-12
of O 0 1.9944415008410488e-09
female O 0 6.9040031469569385e-09
breast B-Disease 0 0.0024322313256561756
cancer I-Disease 0 8.52415687404573e-05
only O 0 1.1594559090610801e-08
. O 0 4.8582425193899326e-08

These O 0 2.768541784714529e-10
estimates O 0 5.855393392373287e-10
were O 0 3.267754816738133e-11
not O 0 1.7245551774819345e-12
substantially O 0 5.562325773589283e-12
affected O 0 4.2473278583435303e-13
either O 0 7.980644817955421e-14
by O 0 5.5326304925244416e-14
changing O 0 2.4483024115007357e-12
the O 0 2.89465456812521e-12
assumed O 0 2.045045209564389e-11
penetrance O 0 5.101771227700169e-10
model O 0 2.5295585938389653e-12
for O 0 3.1144266852967117e-12
BRCA1 O 0 6.237118460594715e-12
or O 0 7.689300043044189e-14
by O 0 8.170071878147583e-14
including O 0 2.6598842486208474e-12
or O 0 1.2787097769528799e-11
excluding O 0 2.2528625631679233e-09
BRCA1 O 0 2.8274640406777962e-09
mutation O 0 8.467120754529489e-11
data O 0 4.287044330641976e-10
. O 0 1.366930679758127e-09

Among O 0 1.1654728293564176e-09
those O 0 2.723155034800584e-11
families O 0 9.139689872983414e-13
with O 0 1.7204033336826186e-11
disease O 0 0.1416805535554886
due O 0 1.4573206499335356e-06
to O 0 7.62673431353722e-12
BRCA1 O 0 1.1751481732158453e-11
that O 0 6.347836430895546e-15
were O 0 1.6777685740276133e-13
tested O 0 4.7164857875378954e-14
by O 0 1.6874985092553592e-14
one O 0 9.73372925772327e-14
of O 0 6.787472927455296e-12
the O 0 2.2901978924405597e-11
standard O 0 8.635107906496131e-11
screening O 0 8.634396149453938e-12
methods O 0 1.3320967592878041e-12
, O 0 8.474572091169211e-14
mutations O 0 7.355733047404583e-14
were O 0 3.4389678604807017e-13
detected O 0 1.479553567336478e-12
in O 0 8.250189268733943e-13
the O 0 9.750015898812858e-12
coding O 0 3.624353595022001e-11
sequence O 0 5.324135663592466e-12
or O 0 3.717963979223138e-13
splice O 0 1.3771274919027743e-11
sites O 0 2.1857824794926928e-13
in O 0 2.2372017161997187e-14
an O 0 5.147934216496314e-15
estimated O 0 3.468115551685802e-13
63 O 0 7.255277541945437e-12
% O 0 4.1903253870240187e-13
( O 0 2.1328491544517908e-13
95 O 0 3.492595934684317e-10
% O 0 2.0222724536611558e-11
CI O 0 4.3191400322939444e-07
51 O 0 1.3480704053048242e-10
% O 0 1.4283334931475267e-11
- O 0 6.174353389676313e-11
77 O 0 3.700480755153279e-10
% O 0 1.7546899697129525e-11
) O 0 5.981852166381252e-12
. O 0 3.3932268106440233e-10

The O 0 7.98130450618828e-09
estimated O 0 5.2650720588909294e-11
sensitivity O 0 6.455221079892937e-11
was O 0 6.116907536046767e-10
identical O 0 1.0564544031255174e-11
for O 0 3.586746513944278e-13
direct O 0 2.2176357972192307e-12
sequencing O 0 4.6331593075987776e-12
and O 0 1.638728866146244e-12
other O 0 3.914017981249129e-12
techniques O 0 1.3926479525139257e-08
. O 0 6.305548083673784e-09

The O 0 4.005484655067448e-08
penetrance O 0 3.7891604733886197e-06
of O 0 7.273497715232224e-08
BRCA2 O 0 1.944149508048554e-09
was O 0 8.389988009893656e-11
estimated O 0 7.783297660893251e-13
by O 0 1.8376703696081076e-13
maximizing O 0 1.383802933352385e-10
the O 0 1.9863390099406075e-10
LOD O 0 3.3732567317201756e-06
score O 0 8.501918058456681e-10
in O 0 1.37555036805459e-10
BRCA2 O 0 4.493754701684338e-09
- O 0 9.267057121675748e-10
mutation O 0 9.869035449971975e-11
families O 0 2.0350081754265392e-13
, O 0 3.421518439666177e-13
over O 0 3.807906680947104e-12
all O 0 2.528817086289159e-11
possible O 0 3.434471596008848e-09
penetrance O 0 1.3735956372329383e-06
functions O 0 3.417959248963598e-08
. O 0 3.2391200832648792e-09

The O 0 2.450547542665049e-10
estimated O 0 2.657745377943055e-11
cumulative O 0 2.932710074787792e-09
risk O 0 1.2886025579916804e-09
of O 0 6.693041121330623e-10
breast B-Disease 0 2.8582644517882727e-06
cancer I-Disease 0 2.1854754450600922e-08
reached O 0 1.2081358136128983e-09
28 O 0 1.6251344714390825e-10
% O 0 1.5439651510421037e-13
( O 0 1.2155152339027916e-14
95 O 0 5.006585424016663e-11
% O 0 2.3861197306213056e-12
CI O 0 6.422329335009636e-08
9 O 0 6.86688275686187e-11
% O 0 3.0999760592710646e-13
- O 0 4.2638866070733583e-13
44 O 0 3.0444329240757184e-13
% O 0 3.7134829038816194e-14
) O 0 4.167046081955515e-16
by O 0 9.770515729215935e-15
age O 0 4.831229817245375e-13
50 O 0 3.5399125037499646e-13
years O 0 4.2742417542601316e-14
and O 0 8.569824673032925e-14
84 O 0 1.0806146776010106e-11
% O 0 2.7518170576425194e-13
( O 0 1.9240692210060334e-14
95 O 0 2.6935041003151028e-11
% O 0 2.3242664303618765e-12
CI O 0 1.8661300060784924e-08
43 O 0 1.4165316489234137e-11
% O 0 5.37295685373862e-13
- O 0 9.568471232360154e-13
95 O 0 9.758016443484063e-12
% O 0 1.2810790568553582e-13
) O 0 1.891862487252583e-15
by O 0 5.3206377969910665e-14
age O 0 1.7650554628989568e-11
70 O 0 3.2054692233884907e-10
years O 0 1.930329507349171e-10
. O 0 1.296140417217373e-09

The O 0 7.626763220969224e-08
corresponding O 1 0.9999992847442627
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.38891416788101196
were O 0 4.161476940822695e-09
0 O 0 2.9751305419267737e-08
. O 0 8.005252016829445e-10

4 O 0 1.1335220762020981e-08
% O 0 3.055051697731237e-11
( O 0 2.0411432960498743e-12
95 O 0 4.760355998278953e-10
% O 0 2.8209917041222e-11
CI O 0 3.8709364957867365e-07
0 O 0 1.1366016461344941e-10
% O 0 3.495529603617098e-13
- O 0 2.4041454048905064e-13
1 O 0 1.1942363330880168e-12
% O 0 4.87891443486598e-15
) O 0 2.7471126400945403e-17
by O 0 6.204476633968347e-16
age O 0 6.769340269536725e-14
50 O 0 7.206557670492303e-14
years O 0 1.4861987576481224e-14
and O 0 1.742334405821066e-14
27 O 0 2.559459371873074e-12
% O 0 5.6652158821317994e-14
( O 0 1.052936407633159e-14
95 O 0 1.8592134776174163e-11
% O 0 1.9898141294383276e-12
CI O 0 2.7275152802985758e-08
0 O 0 1.751092500168472e-11
% O 0 1.5568553661960555e-13
- O 0 2.7503528426085777e-13
47 O 0 1.4188346678101205e-12
% O 0 7.162022711004745e-14
) O 0 1.6366085792019077e-15
by O 0 7.016400129086428e-14
age O 0 3.3913750280278876e-11
70 O 0 5.035356576144068e-10
years O 0 3.0207170098606184e-10
. O 0 2.217655836744825e-09

The O 0 1.920092751461766e-09
lifetime O 0 1.1234809527138623e-08
risk O 0 2.4645652629828874e-08
of O 0 8.172138166173681e-08
breast B-Disease 1 0.9999933242797852
cancer I-Disease 0 0.01171024702489376
appears O 0 8.785222549434479e-11
similar O 0 3.411261887114464e-13
to O 0 8.370506300895905e-14
the O 0 5.122215152031373e-11
risk O 0 4.756423380158914e-11
in O 0 8.568227507707582e-13
BRCA1 O 0 4.645406021658305e-12
carriers O 0 9.061241679404232e-15
, O 0 7.99057255231701e-15
but O 0 8.285237526974888e-15
there O 0 1.5935745832727083e-13
was O 0 1.3843935546542507e-11
some O 0 4.49445473514002e-14
suggestion O 0 2.9268046319863572e-12
of O 0 1.0066539615771752e-11
a O 0 5.240855319166293e-11
lower O 0 1.0803828942584914e-09
risk O 0 5.89645415827178e-11
in O 0 1.0557454216408857e-11
BRCA2 O 0 2.1759979929036888e-10
carriers O 0 1.205882399143987e-12
< O 0 1.9952013652346778e-10
50 O 0 1.588996122181552e-11
years O 0 6.2606460814185194e-12
of O 0 2.129844217657606e-10
age O 0 6.822632236946902e-09
. O 0 9.492181263226485e-09

Eye B-Disease 1 0.99542635679245
movement I-Disease 0 3.7154764868319035e-05
abnormalities I-Disease 0 0.00014101371925789863
correlate O 0 1.2621702294435266e-10
with O 0 1.6657039246179006e-12
genotype O 0 1.930853255061038e-09
in O 0 9.730179856282106e-11
autosomal O 0 5.347897968022153e-05
dominant O 1 0.9995890259742737
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999998807907104
I I-Disease 1 0.9992521405220032
. O 0 3.5261003006326064e-08

We O 0 4.763582861500026e-09
compared O 0 7.310403393745446e-10
horizontal O 0 1.3815600219402313e-08
eye O 0 3.711745932832855e-07
movements O 0 2.0845758896825828e-08
( O 0 1.197154597676331e-10
visually O 0 1.700938417892317e-10
guided O 0 4.561229172139747e-10
saccades O 0 1.1950163525398239e-07
, O 0 1.187029034094289e-11
antisaccades O 0 3.5618703542183994e-09
, O 0 2.5269114058146247e-12
and O 0 5.202565808715143e-13
smooth O 0 9.330725081468927e-11
pursuit O 0 4.171382683715308e-11
) O 0 2.7765104736285524e-14
in O 0 2.2890427075518416e-13
control O 0 1.2781324609800748e-10
subjects O 0 6.58384154486602e-12
( O 0 1.141627618177557e-13
n O 0 3.062654296837053e-11
= O 0 8.468413470463787e-11
14 O 0 6.189611323481614e-11
) O 0 2.4930112228066514e-13
and O 0 3.4297532262167474e-12
patients O 0 3.3261314167330747e-13
with O 0 5.95783188409027e-14
three O 0 1.4160528218759572e-12
forms O 0 2.4016453756270373e-11
of O 0 1.8893151487731075e-09
autosomal O 0 8.6481413745787e-06
dominant O 0 0.006489308085292578
cerebellar B-Disease 1 0.9999996423721313
ataxias I-Disease 1 0.9997232556343079
type I-Disease 0 0.02411513961851597
I I-Disease 0 0.0004759851726703346
spinocerebellar B-Disease 1 0.9996752738952637
ataxias I-Disease 0 1.5797384094184963e-06
1 I-Disease 0 3.2059492838243386e-08
and I-Disease 0 8.521260953797682e-12
2 I-Disease 0 3.6764208344308713e-10
( O 0 8.152035361856658e-13
SCA1 B-Disease 0 8.364957615469848e-09
, O 0 1.3162133058811087e-12
n O 0 2.6959606422294335e-11
= O 0 3.337605886111206e-11
11 O 0 3.09203114501333e-11
; O 0 1.8988994675717824e-13
SCA2 B-Disease 0 3.527134584402347e-09
, O 0 8.423780878570597e-13
n O 0 9.367239622859458e-12
= O 0 6.7035743275822846e-12
10 O 0 2.1183402254543182e-12
) O 0 9.73270807480206e-14
and O 0 1.4975118367566154e-11
SCA3 B-Disease 1 1.0
/ O 0 9.54401230046642e-07
Machado B-Disease 0 2.1015451068251423e-07
- I-Disease 0 2.1285833540218846e-08
Joseph I-Disease 0 8.075666357854061e-08
disease I-Disease 0 0.00011805962276412174
( O 0 6.078199749071089e-11
MJD B-Disease 1 1.0
) O 0 8.131009429125646e-13
( O 0 1.177727349237906e-13
n O 0 5.37929943644766e-11
= O 0 1.8690561598422306e-10
16 O 0 4.0433070780387936e-10
) O 0 5.698817719806959e-12
. O 0 2.7518420875338734e-10

In O 0 8.786856575682123e-09
SCA1 B-Disease 0 8.105454071483109e-06
, O 0 2.4922447439124085e-10
saccade O 0 2.887838945753174e-08
amplitude O 0 9.67732449730363e-10
was O 0 1.3929812858748392e-10
significantly O 0 1.472790639445165e-12
increased O 0 2.297108683824156e-12
, O 0 3.5938068384915034e-13
resulting O 0 1.2359593383470813e-11
in O 0 3.661003444843658e-11
hypermetria B-Disease 0 4.668198130275414e-07
. O 0 1.7070242108729872e-08

The O 0 2.7716247075204592e-08
smooth O 0 3.4428484951831706e-08
pursuit O 0 1.8378466748458777e-08
gain O 0 3.254205127589671e-09
was O 0 9.764510089382838e-09
decreased O 0 2.744862648285107e-08
. O 0 3.716674079612403e-09

In O 0 3.2967324870014636e-08
SCA2 B-Disease 0 1.5017240912129637e-05
, O 0 6.888767334345403e-10
saccade O 0 6.011980246967141e-08
velocity O 0 1.5108339024294537e-09
was O 0 3.8288288095600365e-09
markedly O 0 2.192856562999168e-09
decreased O 0 7.218048381218978e-09
. O 0 1.2031824425662307e-09

The O 0 1.7226149395810353e-09
percentage O 0 2.830360112948682e-10
of O 0 3.742887111357618e-10
errors O 0 1.4839237394426164e-07
in O 0 8.843783483314382e-10
antisaccades O 0 9.691941613709787e-07
was O 0 4.863524694087573e-09
greatly O 0 2.2186764144643822e-12
increased O 0 9.746441934771477e-13
and O 0 2.081042993094459e-13
was O 0 1.551751956097025e-11
significantly O 0 1.463794499024021e-13
correlated O 0 9.057220983410205e-14
with O 0 2.037259589000341e-14
age O 0 1.6328212393279529e-10
at O 0 3.4322081887694367e-07
disease O 0 0.049421414732933044
onset O 0 0.09432811290025711
. O 0 1.166111562866945e-08

In O 0 9.578291493284041e-10
addition O 0 6.73727670874591e-11
, O 0 3.5923488576200535e-12
a O 0 1.8637999130155514e-12
correlation O 0 6.42046745630287e-12
between O 0 1.5222666877034996e-11
smooth O 0 1.224764289986524e-09
pursuit O 0 2.98674335263982e-10
gain O 0 2.42451059229154e-11
and O 0 3.4977438155038565e-13
the O 0 2.8955327718849233e-12
number O 0 7.283479375175261e-12
of O 0 1.6406133396262845e-10
trinucleotide O 0 1.3324391545666003e-07
repeats O 0 3.454470043351421e-09
was O 0 4.624919558438023e-09
found O 0 1.002875782418755e-09
. O 0 4.5331134401749296e-09

In O 0 1.5264841124462691e-07
SCA3 B-Disease 1 1.0
, O 0 2.1927405668975553e-08
gaze B-Disease 0 1.2290448694329825e-06
- I-Disease 0 2.6869975044974126e-07
evoked I-Disease 0 6.965577625805963e-08
nystagmus I-Disease 0 4.74715416203253e-05
was O 0 1.6213704823186958e-09
often O 0 4.852506742779317e-13
present O 0 2.2260127497796683e-13
as O 0 2.06303832524235e-12
was O 0 3.213525279210927e-10
saccade O 0 3.057574815557018e-08
hypometria O 0 1.0094491464940347e-08
and O 0 1.5246581774874812e-11
smooth O 0 8.854028621385623e-10
pursuit O 0 4.6501180683833354e-10
gain O 0 5.62358493105819e-10
was O 0 1.4799058645209584e-09
markedly O 0 1.4063247233409015e-09
decreased O 0 1.1510782549351006e-08
. O 0 1.301963092892322e-09

Three O 0 1.523223658317363e-09
major O 0 1.1159229096335821e-08
criteria O 0 2.5280494142521093e-08
, O 0 3.634016698672582e-11
saccade O 0 6.889112835750666e-09
amplitude O 0 2.4626739536515174e-10
, O 0 4.320622418868547e-12
saccade O 0 8.229033565676502e-10
velocity O 0 1.240619239284424e-11
, O 0 4.1020729564869574e-13
and O 0 1.6840589795071026e-13
presence O 0 1.4500454873292434e-12
of O 0 1.771035262887466e-10
gaze B-Disease 0 1.0928793159337147e-07
- I-Disease 0 2.3609809218783084e-08
evoked I-Disease 0 9.786437438208395e-09
nystagmus I-Disease 0 4.1021775132321636e-07
, O 0 1.4630974383422757e-12
permitted O 0 8.096317886951976e-12
the O 0 4.745836536257375e-12
correct O 0 9.361006761410273e-12
assignment O 0 1.8119642071490194e-12
of O 0 5.2980202690233735e-12
90 O 0 1.3993931881339794e-11
% O 0 3.17410133550064e-13
of O 0 1.9379352289572438e-11
the O 0 2.7410876346500856e-10
SCA1 B-Disease 0 1.05135018202418e-06
, O 0 3.3422225490659097e-12
90 O 0 2.1774417338638052e-11
% O 0 4.4440018613818577e-13
of O 0 1.1273366788688843e-11
the O 0 2.390185549483448e-10
SCA2 B-Disease 0 1.325360244663898e-06
, O 0 2.560440791679608e-12
and O 0 6.065570138172327e-13
93 O 0 3.012337948526955e-11
% O 0 6.198264557860655e-13
of O 0 3.87304181781456e-11
the O 0 5.142510861588789e-10
patients O 0 3.563239286963338e-11
with O 0 7.939042478977143e-11
SCA3 B-Disease 1 1.0
to O 0 1.3921473696054676e-10
their O 0 8.919213284608318e-11
genetically O 0 2.5334917497232823e-10
confirmed O 0 4.5409318666367327e-11
patient O 0 3.704089257539067e-10
group O 0 3.361307412963477e-11
and O 0 1.8584475972027725e-11
, O 0 1.4029262994375014e-11
therefore O 0 1.0186838872439097e-10
, O 0 3.068470390971134e-12
may O 0 2.257170145236742e-11
help O 0 3.847953206070898e-12
orient O 0 2.594623360607784e-08
diagnoses O 0 2.3904600521262864e-09
of O 0 5.730006469306659e-10
SCA1 B-Disease 0 2.0145498638157733e-05
, O 0 5.1148054541760857e-11
SCA2 B-Disease 0 1.420234184479341e-06
, O 0 3.237430462599278e-11
and O 0 8.87092829748859e-11
SCA3 B-Disease 1 1.0
at O 0 7.097202825434579e-09
early O 0 1.264913396248346e-09
clinical O 0 1.42975302708237e-08
stages O 0 3.288606009732575e-08
of O 0 8.958500052891338e-10
the O 0 1.6504134947581406e-08
diseases O 0 0.001307224272750318
. O 0 3.822231142702748e-10
. O 0 3.589765373845921e-09

Genetic O 0 1.8708190552274573e-09
basis O 0 1.6055762275257734e-10
and O 0 4.5166396664408914e-12
molecular O 0 1.9653865201973986e-09
mechanism O 0 3.8296487758771036e-08
for O 0 2.9730429673691106e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 2.4743019366724184e-06

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 1.524739587921431e-07
more O 0 1.4694458757430473e-12
than O 0 7.508216054094574e-13
300 O 0 1.900958774073147e-12
, O 0 6.373319298529079e-13
000 O 0 3.503182119390935e-11
sudden O 0 1.2922989067742918e-10
deaths O 0 5.2323531792020095e-12
each O 0 1.5046041059656005e-14
year O 0 2.890443418467059e-13
in O 0 4.285756211724889e-12
the O 0 7.738205631824258e-10
USA O 0 5.654739609894932e-08
alone O 0 1.3595228276486182e-09
. O 0 2.0037758119428872e-09

In O 0 1.7072512292770625e-09
approximately O 0 2.602253135197685e-10
5 O 0 2.15348849863517e-09
- O 0 3.3737118654286746e-10
12 O 0 2.1949143891308864e-10
% O 0 5.012315649338683e-12
of O 0 5.251401744010842e-11
these O 0 1.1831992633923316e-12
cases O 0 6.097934115122106e-13
, O 0 1.1212474633655323e-13
there O 0 1.092294725263572e-13
are O 0 1.8093790964753172e-14
no O 0 2.5930943590296573e-12
demonstrable O 0 0.3488965332508087
cardiac O 1 1.0
or O 0 7.29175013702843e-08
non O 1 0.9999998807907104
- O 1 0.9971407651901245
cardiac O 1 1.0
causes O 0 2.1588076037915016e-07
to O 0 1.8022098570436018e-12
account O 0 1.335803212834663e-13
for O 0 3.967585266405338e-13
the O 0 3.057976831824516e-12
episode O 0 5.562920350060674e-12
, O 0 6.570762543008785e-14
which O 0 3.369433113190089e-15
is O 0 3.9403786359021656e-15
therefore O 0 3.196000322031045e-14
classified O 0 1.7623196738730806e-12
as O 0 7.058585660413286e-11
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 8.58156141703148e-08
IVF B-Disease 1 1.0
) O 0 5.921770851458064e-10
. O 0 3.806300608033553e-09

A O 0 6.044623290790696e-08
distinct O 0 1.6264998237147665e-09
group O 0 4.823079158278176e-10
of O 0 7.644962352060247e-06
IVF B-Disease 1 1.0
patients O 0 3.142964146718441e-07
has O 0 1.2235559787576733e-11
been O 0 5.241592750115931e-12
found O 0 2.5019523670725963e-13
to O 0 4.5203407396344694e-14
present O 0 1.5842683068201246e-12
with O 0 1.2241156439191103e-12
a O 0 2.648400110327742e-10
characteristic O 0 9.24039582628211e-08
electrocardiographic O 0 1.3375552043726202e-06
pattern O 0 1.9515798044267285e-07
. O 0 1.1330270943687992e-08

Because O 0 1.157139939422791e-09
of O 0 1.1526359422475707e-08
the O 0 1.5857338775404628e-09
small O 0 4.579338644394859e-12
size O 0 2.1687322077079685e-12
of O 0 5.561480095894744e-11
most O 0 1.933422822883446e-12
pedigrees O 0 3.646041801808053e-11
and O 0 1.641603953467241e-12
the O 0 3.08429740081273e-11
high O 0 1.7659259610169897e-09
incidence O 0 1.1828782930933812e-07
of O 0 9.298821157521786e-10
sudden B-Disease 0 4.9952895153637655e-08
death I-Disease 0 2.5181115859140846e-08
, O 0 1.9015173550324116e-12
however O 0 4.975849918729958e-13
, O 0 3.2169528678275064e-14
molecular O 0 8.177049315438722e-12
genetic O 0 4.697995898556018e-12
studies O 0 5.466789130756378e-13
of O 0 2.766060991366004e-10
IVF B-Disease 1 1.0
have O 0 7.250242073375546e-12
not O 0 3.862636122412e-13
yet O 0 3.9689120046038084e-12
been O 0 2.949073494087906e-12
done O 0 5.0933878642522856e-11
. O 0 6.706151745028421e-10

Because O 0 4.999407465788863e-08
IVF B-Disease 1 1.0
causes O 0 1.6014380889828317e-05
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.6942242383956909
, O 0 3.209479123439385e-12
we O 0 7.840931679978236e-13
investigated O 0 5.356781858367743e-12
whether O 0 6.877623470735728e-13
malfunction O 0 3.1162272762230714e-08
of O 0 4.1356064406361526e-11
ion O 0 1.0709978043310642e-10
channels O 0 1.0473182043835294e-10
could O 0 6.348793712973588e-11
cause O 0 4.3182787901052677e-10
the O 0 4.5550539035099646e-11
disorder O 0 4.040267426175248e-11
by O 0 5.0636039550808545e-14
studying O 0 7.387146992200722e-13
mutations O 0 2.3538962594968176e-14
in O 0 9.675312444669751e-14
the O 0 1.2951358735469043e-11
cardiac O 0 9.298179293182329e-07
sodium O 0 1.985999142917194e-09
channel O 0 7.828843351376236e-09
gene O 0 6.795592977226761e-09
SCN5A O 0 1.1072788765886799e-05
. O 0 6.507246741449535e-09

We O 0 7.640956312116032e-09
have O 0 1.8583058702947852e-11
now O 0 3.2148032066275922e-12
identified O 0 1.1312287911957597e-11
a O 0 1.3031941845098594e-11
missense O 0 1.3521088693124739e-09
mutation O 0 6.836742543619989e-12
, O 0 1.2146913249549973e-12
a O 0 9.846581015826583e-12
splice O 0 4.769364903012274e-09
- O 0 7.964572334984155e-10
donor O 0 5.749679621303017e-10
mutation O 0 6.791543022410806e-11
, O 0 7.819440082414142e-13
and O 0 1.4790259945593465e-12
a O 0 2.3373731769527062e-11
frameshift O 0 7.88936915796512e-10
mutation O 0 7.247182454844792e-13
in O 0 1.4889034016113412e-13
the O 0 1.1222450919945448e-12
coding O 0 2.4451022803684275e-11
region O 0 1.1599341279144859e-11
of O 0 1.2446792728437739e-11
SCN5A O 0 6.612548020257236e-08
in O 0 2.9344308233314464e-11
three O 0 2.9315788685480015e-10
IVF B-Disease 1 1.0
families O 0 1.5516846141316876e-10
. O 0 4.525890773265928e-09

We O 0 2.833849821470835e-10
show O 0 2.7291448614907843e-11
that O 0 9.148127269814968e-14
sodium O 0 7.067735746700901e-14
channels O 0 1.1376324686972195e-13
with O 0 2.6522619211012503e-14
the O 0 1.1953492015659428e-11
missense O 0 2.0052974836204385e-09
mutation O 0 1.9528963515758058e-11
recover O 0 5.5929462450254874e-11
from O 0 8.171961913584769e-13
inactivation O 0 1.5697194655217572e-08
more O 0 5.3681397434862665e-14
rapidly O 0 5.582602522619107e-13
than O 0 4.699798730257217e-15
normal O 0 1.8525860099455338e-12
and O 0 3.18192534495311e-14
that O 0 2.3363623386754746e-14
the O 0 1.0411393969178562e-11
frameshift O 0 1.5954360055303596e-09
mutation O 0 1.6089590597345715e-12
causes O 0 1.3091628475736528e-12
the O 0 1.5752018829931491e-12
sodium O 0 9.119543228214289e-13
channel O 0 1.6076645223406238e-12
to O 0 4.310775369477382e-13
be O 0 3.605143527457555e-12
non O 0 2.0780843712486785e-09
- O 0 5.223154686539999e-10
functional O 0 6.848946298987357e-08
. O 0 1.2867801268967582e-09

Our O 0 9.070295625690505e-09
results O 0 1.1296036328545256e-10
indicate O 0 3.517468434577342e-12
that O 0 6.317353324486463e-14
mutations O 0 9.112397251695437e-13
in O 0 1.38536231097941e-12
cardiac O 0 8.070600188148092e-08
ion O 0 2.6228630378710704e-10
- O 0 3.0103811110571144e-10
channel O 0 1.8874736495977373e-10
genes O 0 7.146429173258972e-13
contribute O 0 1.064580230745885e-14
to O 0 2.2373638383058232e-14
the O 0 3.473658426872417e-12
risk O 0 1.5102964018298692e-11
of O 0 6.839716293338682e-12
developing O 0 1.5002492581572824e-09
IVF B-Disease 1 1.0
. O 0 2.799638021411255e-10
. O 0 9.596944350320769e-10

Molecular O 0 6.205445934881482e-09
heterogeneity O 0 9.79510161869257e-09
in O 0 1.0706159569995322e-10
mucopolysaccharidosis B-Disease 0 3.755666512006428e-06
IVA I-Disease 1 1.0
in O 0 1.6662052848559483e-09
Australia O 0 2.2970060575833173e-10
and O 0 1.6532395027621383e-12
Northern O 0 6.091445681200014e-10
Ireland O 0 2.5623794197571215e-09
: O 0 3.5795177585895566e-12
nine O 0 4.075957626969995e-11
novel O 0 4.851972556368933e-12
mutations O 0 3.640619923583888e-12
including O 0 2.8477721483038954e-12
T312S O 0 2.2697830281970255e-09
, O 0 1.254089714020079e-11
a O 0 1.6441145320178485e-11
common O 0 9.656370321409202e-12
allele O 0 3.773080806124263e-12
that O 0 2.3660240433542867e-13
confers O 0 6.151892328887243e-10
a O 0 1.1689786638680033e-10
mild O 0 1.242283133251476e-06
phenotype O 0 1.7738667423827792e-08
. O 0 7.308590954657745e-10

Mucopolysaccharidosis B-Disease 1 0.768497109413147
IVA I-Disease 1 1.0
( O 0 0.0627535879611969
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.3424623352141793e-10
is O 0 2.953250274537189e-12
an O 0 3.5443666231149695e-12
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.946072440503713e-09
by O 0 2.3658176112606455e-12
a O 0 2.6155804189187393e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.651186628709894e-11
N O 0 1.018964645993492e-08
- O 0 1.272850991274055e-10
acetylgalactosamine O 0 6.044807321359258e-08
- O 0 2.4180846214250096e-09
6 O 0 2.5573418938051873e-08
- O 0 4.6882631110634065e-09
sulfate O 0 4.147016507971557e-09
sulfatase O 0 4.9094051064457744e-06
( O 0 1.3521443686936863e-10
GALNS O 0 3.606166274039424e-06
) O 0 7.887468456146962e-11
. O 0 5.705578232095831e-10

Previous O 0 1.064280930052064e-08
studies O 0 2.0045468063223382e-10
of O 0 1.5539868281067015e-09
patients O 0 9.850844966130534e-12
from O 0 1.2889300087318145e-12
a O 0 1.2223896374286003e-11
British O 0 2.0596276073536757e-10
- O 0 3.5898523043087494e-10
Irish O 0 7.253831979525671e-10
population O 0 1.187557810335832e-13
showed O 0 7.029937396096919e-12
that O 0 6.774610169721362e-14
the O 0 1.4265637282573351e-11
I113F O 0 8.303641108042825e-10
mutation O 0 2.3801607386408907e-12
is O 0 1.5948295472873603e-14
the O 0 8.172705811800365e-14
most O 0 5.8044948649015396e-15
common O 0 5.591145900213021e-14
single O 0 1.5643005554094591e-12
mutation O 0 1.3001404640389236e-11
among O 0 1.1234835978202184e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.2280811151631497e-07
and O 0 4.8859809427537204e-12
produces O 0 3.965508824088637e-11
a O 0 6.90801374436667e-11
severe O 1 0.5019065737724304
clinical O 0 0.03182185813784599
phenotype O 0 7.738892549014054e-08
. O 0 7.856422734597857e-10

We O 0 3.86319448653083e-10
studied O 0 2.232760226705821e-10
mutations O 0 2.446150703869221e-12
in O 0 1.4457732970887816e-12
the O 0 4.473840742313939e-11
GALNS O 0 3.218939426119505e-08
gene O 0 4.807799991457529e-12
from O 0 4.0145144153402867e-13
23 O 0 1.7675358399138474e-10
additional O 0 1.791219061964e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.2889460871720075e-08
( O 0 1.8137069537210726e-12
15 O 0 2.4108336854622436e-11
from O 0 1.5732652810726555e-12
Australia O 0 2.1958971099800273e-11
, O 0 5.38576182349676e-13
8 O 0 3.89208873463609e-11
from O 0 9.897962440982844e-13
Northern O 0 4.573023626441852e-10
Ireland O 0 7.26733395683965e-10
) O 0 1.7255611544676752e-13
, O 0 7.016881921426826e-14
with O 0 8.619198562341557e-14
various O 0 1.907981411752857e-11
clinical O 0 6.11565440067352e-07
phenotypes O 0 1.0413931939012855e-08
( O 0 2.457876610573173e-11
severe O 0 0.0004056016041431576
, O 0 4.475582057739125e-11
16 O 0 5.389099722030721e-10
cases O 0 2.0257380842214623e-12
; O 0 1.15516401782631e-13
intermediate O 0 6.040892092107342e-11
, O 0 1.595542274690498e-13
4 O 0 4.559365038292462e-11
cases O 0 5.524955493108052e-13
; O 0 2.476650612023845e-13
mild O 0 1.4807874926248132e-08
, O 0 5.861667488199496e-12
3 O 0 2.3040135077589952e-10
cases O 0 3.0422112311939697e-12
) O 0 1.0867509149525834e-12
. O 0 2.3062425580366863e-10

We O 0 7.760218245778105e-09
found O 0 1.1126594090526964e-10
two O 0 2.741393483746135e-12
common O 0 9.398845417230017e-12
mutations O 0 9.662574559921033e-13
that O 0 1.7171683793317828e-14
together O 0 5.628101947701726e-14
accounted O 0 3.0827842448927223e-12
for O 0 5.155072874650501e-13
32 O 0 1.47971235958666e-11
% O 0 7.140175495128076e-13
of O 0 2.9974137755184316e-11
the O 0 1.263261162343099e-10
44 O 0 6.116437911707351e-11
unrelated O 0 5.3956585727155115e-11
alleles O 0 8.526362125019227e-13
in O 0 2.8942956972061173e-12
these O 0 2.0367653744135517e-11
patients O 0 1.63891816784556e-10
. O 0 5.748660436566411e-10

One O 0 2.3601243182014287e-09
is O 0 1.600353356778772e-11
the O 0 8.252700606226071e-11
T312S O 0 4.7881867359933494e-09
mutation O 0 2.1784636594635032e-11
, O 0 5.0813308638889e-13
a O 0 1.1136349004417512e-12
novel O 0 1.152079733696132e-12
mutation O 0 1.2314195886944934e-12
found O 0 4.83369685152623e-14
exclusively O 0 4.26570860882422e-13
in O 0 5.472654881349959e-12
milder O 0 4.284866150783273e-08
patients O 0 1.072020250347805e-09
. O 0 9.000838407935419e-10

The O 0 4.680456555661294e-08
other O 0 2.577596990016584e-11
is O 0 1.1920993706060479e-12
the O 0 1.1758072814005427e-11
previously O 0 5.1199978284843795e-11
described O 0 3.624974018873184e-12
I113F O 0 2.9517552291302707e-10
that O 0 4.3744698076560173e-13
produces O 0 1.4957162244866318e-11
a O 0 1.2088127721021635e-10
severe O 0 2.975355710077565e-05
phenotype O 0 1.0130333549795978e-07
. O 0 2.4688735500433268e-09

The O 0 4.721333723978205e-08
I113F O 0 7.047201222576405e-08
and O 0 2.8678448504848575e-10
T312S O 0 5.071290942737505e-09
mutations O 0 6.25014666758017e-12
accounted O 0 8.782000300577852e-12
for O 0 1.3642718682191357e-12
8 O 0 2.1230626978674394e-10
( O 0 6.750078062689804e-14
18 O 0 7.56184177774788e-12
% O 0 2.1647101971188076e-13
) O 0 8.059726863229692e-15
and O 0 1.5886066333931081e-13
6 O 0 1.002676414119108e-10
( O 0 7.857845369394281e-14
14 O 0 7.40447373553943e-12
% O 0 1.9017338431012026e-13
) O 0 1.3371892297869142e-14
of O 0 6.175633789073931e-12
44 O 0 6.298630367274072e-11
unrelated O 0 2.2689029821609807e-10
alleles O 0 3.110626990363019e-12
, O 0 4.439581514914526e-12
respectively O 0 8.167985177109927e-10
. O 0 2.1595638610705237e-09

The O 0 2.8782707772734284e-08
relatively O 0 2.9243092392050585e-09
high O 0 5.781585432629299e-09
residual O 0 1.2859659364039544e-06
GALNS O 0 2.4393950297962874e-05
activity O 0 3.4462221965014805e-10
seen O 0 6.703740427355109e-12
when O 0 1.3556386915802854e-13
the O 0 1.5006504068895699e-12
T312S O 0 3.6780179596407336e-11
mutant O 0 2.3930579740039093e-11
cDNA O 0 2.7161947691034527e-10
is O 0 2.27947055762151e-13
overexpressed O 0 3.187360445022769e-11
in O 0 2.1986777090816922e-13
mutant O 0 6.884626202463551e-11
cells O 0 2.295234315108363e-12
provides O 0 3.465204333327407e-14
an O 0 7.768869725186195e-16
explanation O 0 3.072262022151169e-14
for O 0 5.676572899888585e-14
the O 0 1.9161103259612844e-11
mild O 0 7.349304098624998e-08
phenotype O 0 9.290979791076737e-11
in O 0 1.8005503771983955e-12
patients O 0 1.9470513255067518e-13
with O 0 1.8377394536152857e-14
this O 0 3.694454030894745e-12
mutation O 0 6.320475809395987e-10
. O 0 5.164962346704272e-10

The O 0 2.7559235449281516e-10
distribution O 0 1.699066581872799e-11
and O 0 6.380665852449841e-13
relative O 0 4.049199343880705e-12
frequencies O 0 1.8289783750014e-12
of O 0 8.592255379413771e-12
the O 0 1.426019632239095e-11
I113F O 0 3.6713543316579944e-10
and O 0 2.975629508419897e-12
T312S O 0 3.7223973903266483e-10
mutations O 0 1.331939224712142e-12
in O 0 9.050404197775974e-13
Australia O 0 3.4349773459646515e-12
corresponded O 0 1.6896507522116966e-13
to O 0 2.5519511634083947e-13
those O 0 1.310746080901079e-13
observed O 0 2.6848035513532542e-12
in O 0 1.4843304536882318e-12
Northern O 0 1.0744604095336285e-09
Ireland O 0 7.414122649151977e-09
and O 0 1.2622031891895702e-11
are O 0 2.7834050168873414e-13
unique O 0 2.0046863474787457e-12
to O 0 1.6486410760879755e-13
these O 0 2.7691393557523203e-13
two O 0 4.42022178408219e-13
populations O 0 2.8003386285183063e-13
, O 0 2.9844026826642694e-14
suggesting O 0 9.229113783967846e-14
that O 0 7.152955223304388e-15
both O 0 2.0324247927000494e-13
mutations O 0 6.287208709383763e-13
were O 0 5.02490323656124e-12
probably O 0 2.032747451266581e-12
introduced O 0 2.893721503735569e-12
to O 0 1.7436551334737427e-13
Australia O 0 3.982006998443088e-12
by O 0 6.194836852692343e-13
Irish O 0 3.6201411313108167e-10
migrants O 0 1.2858703902010604e-12
during O 0 8.315503667588597e-12
the O 0 5.403279559890173e-11
19th O 0 1.0751825207933052e-08
century O 0 7.179988870120724e-08
. O 0 3.4658892644756634e-08

Haplotype O 0 6.372556526912376e-08
analysis O 0 3.0454772037558087e-10
using O 0 2.8209287683544915e-10
6 O 0 2.5390672675484893e-08
RFLPs O 0 4.700120115330719e-08
provides O 0 3.65272222191404e-12
additional O 0 3.4796446865374697e-13
data O 0 1.8860574994145063e-12
that O 0 6.748172577371661e-14
the O 0 2.168687972259331e-11
I113F O 0 7.149944525330909e-10
mutation O 0 3.940625603604531e-12
originated O 0 5.190037852612073e-13
from O 0 2.4563651893766414e-13
a O 0 9.98393468593095e-12
common O 0 4.828857452787716e-11
ancestor O 0 2.3499098222856674e-09
. O 0 4.8228607774092325e-09

The O 0 4.8630262483584374e-08
other O 0 1.7645918060082977e-10
9 O 0 1.0503319991528315e-08
novel O 0 6.181458817033914e-11
mutations O 0 7.404134597099876e-12
identified O 0 1.6243519116582172e-12
in O 0 8.147714274098217e-13
these O 0 1.0805626142126878e-12
23 O 0 2.1984263298691076e-09
patients O 0 1.4163209667572563e-11
were O 0 1.0621216579853598e-11
each O 0 1.0352532904284867e-13
limited O 0 1.3665592095424284e-11
to O 0 1.9552731829464154e-12
a O 0 1.9291884756356126e-10
single O 0 1.8903243415024917e-09
family O 0 2.6625313065409273e-10
. O 0 2.5744404386074393e-09

These O 0 1.0519268095476875e-10
data O 0 9.921428262282816e-11
provide O 0 1.1415650326071503e-12
further O 0 1.6779093847847648e-13
evidence O 0 6.105964800613706e-13
for O 0 1.4885938618910965e-13
extensive O 0 4.382274057523894e-11
allelic O 0 4.996466573814473e-10
heterogeneity O 0 6.273227493025502e-10
in O 0 5.793493462746824e-10
MPS B-Disease 1 0.9999974966049194
IVA I-Disease 1 1.0
in O 0 3.916232338418979e-10
British O 0 1.5496040006723888e-08
- O 0 1.1875555827600692e-07
Irish O 0 1.0253284443706434e-07
patients O 0 3.046509572390832e-11
and O 0 3.180834502042318e-13
provide O 0 2.734634350562426e-13
evidence O 0 1.8022237348314096e-12
for O 0 6.031076788155787e-13
their O 0 1.901568095694084e-12
transmission O 0 5.782241352392248e-11
to O 0 1.2593595057844992e-13
Australia O 0 3.0017945594484896e-12
by O 0 2.1702499281191223e-13
British O 0 1.138654948107387e-09
- O 0 2.423121703287734e-09
Irish O 0 4.045700663368734e-09
migrants O 0 1.9963652259091802e-11
. O 0 1.1709217796751492e-11
. O 0 3.6236713629733686e-10

Identification O 0 1.4052636387873463e-08
of O 0 8.376692228750926e-09
constitutional O 0 4.672795512306038e-06
WT1 O 0 7.346604252234101e-05
mutations O 0 1.3036895174511898e-10
, O 0 6.54790837436442e-13
in O 0 1.0104392366219739e-12
patients O 0 8.41541354830444e-13
with O 0 9.590324411348772e-13
isolated O 0 7.058883966237772e-06
diffuse B-Disease 1 0.9999946355819702
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.4085621558024286e-11
and O 0 2.1696704220579288e-13
analysis O 0 4.862123616049263e-13
of O 0 3.279193236394029e-11
genotype O 0 1.1329098770218593e-09
/ O 0 1.3052003922098265e-09
phenotype O 0 4.744135206208311e-12
correlations O 0 7.752242858066749e-13
by O 0 5.149351133210481e-14
use O 0 1.1903703934015852e-12
of O 0 2.7366407751028277e-11
a O 0 7.017870312653329e-11
computerized O 0 2.1240126102384238e-08
mutation O 0 2.389848041683962e-10
database O 0 3.3736088922431406e-10
. O 0 5.364670929708382e-10

Constitutional O 0 4.152187784711714e-07
mutations O 0 2.1450835552272451e-10
of O 0 8.66570204482997e-10
the O 0 1.7962346055000467e-09
WT1 O 0 4.2445896042409004e-07
gene O 0 3.2305838559842925e-11
, O 0 1.3461676435025383e-12
encoding O 0 1.0933588236172742e-11
a O 0 2.142229588164568e-10
zinc O 0 2.777525232033895e-08
- O 0 9.176026338764132e-08
finger O 0 7.896284841990564e-06
transcription O 0 5.920851435803343e-07
factor O 0 5.130149638432613e-09
involved O 0 1.0316490717254823e-11
in O 0 1.6254289580963643e-10
renal O 1 1.0
and O 0 3.8215186570766946e-09
gonadal O 1 1.0
development O 0 6.625096915513495e-08
, O 0 1.3762759378324607e-12
are O 0 2.938660531820285e-14
found O 0 3.404746848497363e-14
in O 0 9.190222774414433e-14
most O 0 6.953480759935848e-13
patients O 0 1.2888605113725582e-13
with O 0 6.786485436116596e-13
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.272290195534879e-07
DDS B-Disease 1 1.0
) O 0 3.557833541667499e-11
, O 0 1.3631722486917575e-11
or O 0 2.2295738588695713e-09
diffuse B-Disease 1 0.9999984502792358
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.086894130253313e-08
DMS B-Disease 0 7.1585791374673136e-06
) O 0 6.007996563358459e-14
associated O 0 8.642760986055098e-13
with O 0 1.1601083592036043e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 5.562194038688517e-10
/ O 0 1.6509243039308785e-07
or O 0 1.965791529556782e-09
Wilms B-Disease 1 0.9990673661231995
tumor I-Disease 0 0.0002526181924622506
( O 0 1.102389401985704e-09
WT B-Disease 1 1.0
) O 0 1.1795006638060102e-10
. O 0 1.3743631788187827e-09

Most O 0 1.9109187565646835e-09
mutations O 0 3.240634205425863e-09
in O 0 1.3618776328883087e-08
DDS B-Disease 1 1.0
patients O 0 2.0939486589099943e-08
lie O 0 1.666303872660535e-09
in O 0 4.496253716568255e-11
exon O 0 6.333270796687884e-09
8 O 0 6.336919433636012e-09
or O 0 3.408839530094632e-11
exon O 0 2.9213766961078136e-09
9 O 0 1.3830120382252176e-09
, O 0 8.212780282235155e-12
encoding O 0 1.729979631770462e-10
zinc O 0 2.3504041379851515e-08
finger O 0 4.10163778497008e-07
2 O 0 2.1369201022025663e-06
or O 0 2.0736505845775355e-08
zinc O 0 2.9093962439219467e-07
finger O 0 1.4404109833776602e-06
3 O 0 5.219575172077384e-08
, O 0 7.442462444939846e-12
respectively O 0 8.98995114462231e-12
, O 0 2.398072517471872e-13
with O 0 3.3266645731513944e-13
a O 0 1.4933794478810825e-10
hot O 0 5.3354504814251413e-08
spot O 0 1.80102457392195e-08
( O 0 7.633686434707632e-13
R394W O 0 6.359095194863329e-11
) O 0 1.9778676038553072e-13
in O 0 6.6051487196405745e-12
exon O 0 7.3477033346591725e-09
9 O 0 1.873941180008387e-08
. O 0 5.28947596833973e-09

We O 0 8.105967563842853e-10
analyzed O 0 3.0895903890826304e-11
a O 0 8.452658711854966e-12
series O 0 3.462038988821803e-11
of O 0 2.1179664966286538e-10
24 O 0 8.946073215554406e-09
patients O 0 6.218496551024799e-11
, O 0 1.9066634122238968e-12
10 O 0 2.17751650044562e-11
with O 0 1.3981713356536751e-11
isolated B-Disease 0 2.348004636587575e-05
DMS I-Disease 1 0.7701946496963501
( O 0 5.522035606553288e-10
IDMS B-Disease 0 4.397177690407261e-05
) O 0 1.5190957216096312e-12
, O 0 9.216856878407897e-13
10 O 0 1.2561892498430538e-11
with O 0 2.536391582874664e-11
DDS B-Disease 1 1.0
, O 0 3.0729700034592966e-11
and O 0 4.547776651792068e-12
4 O 0 1.8158868853035415e-09
with O 0 7.649697542078115e-11
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9996287822723389
and O 0 2.3909252355736044e-09
/ O 0 3.0506273105856963e-05
or O 0 1.353022298644646e-06
WT B-Disease 1 1.0
. O 0 1.6536755254037416e-07

We O 0 9.039260895349344e-09
report O 0 8.470129597704101e-10
WT1 O 0 2.3373556814476615e-06
heterozygous O 0 3.2525218629508856e-10
mutations O 0 2.8163990237195513e-12
in O 0 3.4057895392791693e-12
16 O 0 1.910798408388814e-09
patients O 0 1.890279252569904e-11
, O 0 7.958820234799102e-13
4 O 0 1.8977808213804792e-09
of O 0 5.958094018154725e-10
whom O 0 7.326871748203345e-11
presented O 0 2.583441904846495e-09
with O 0 9.27441234921389e-10
IDMS B-Disease 1 0.6091889142990112
. O 0 8.26042878543376e-08

One O 0 1.0666851402163502e-08
male O 0 6.680567765648959e-10
and O 0 4.7620150878113776e-11
two O 0 5.017074533597565e-10
female O 0 7.67967467396602e-09
IDMS B-Disease 1 0.9999971389770508
patients O 0 6.957740605884055e-09
with O 0 3.6571595751766495e-10
WT1 O 1 0.9999955892562866
mutations O 0 1.4196069741956308e-07
underwent O 0 2.1174260837142356e-05
normal O 0 2.2337030713970307e-06
puberty O 0 5.15723877470009e-06
. O 0 1.04876207718263e-09

Two O 0 6.767485238867721e-09
mutations O 0 1.5671818287543715e-09
associated O 0 1.2926347769948165e-09
with O 0 3.413688220987865e-10
IDMS B-Disease 1 0.6803019642829895
are O 0 1.2412032122585681e-12
different O 0 1.5167085455950434e-14
from O 0 3.104496640229243e-13
those O 0 4.5137090137585545e-13
described O 0 5.963639304606971e-11
in O 0 4.6800439079675016e-09
DDS B-Disease 1 1.0
patients O 0 2.3162039042290417e-07
. O 0 8.971499987353582e-09

No O 0 4.957815917805419e-07
WT1 O 0 2.772556763375178e-05
mutations O 0 1.6386680901092632e-10
were O 0 1.8513787725105146e-11
detected O 0 2.362716272630294e-11
in O 0 5.1443107586257586e-12
the O 0 2.348027050569357e-10
six O 0 1.019636819421521e-09
other O 0 1.878191380200178e-09
IDMS B-Disease 1 1.0
patients O 0 6.932052154517976e-10
, O 0 1.6203694202382435e-12
suggesting O 0 1.6509682509990853e-11
genetic O 0 8.363146286605172e-11
heterogeneity O 0 4.5883308263938716e-10
of O 0 3.4840064166985485e-10
this O 0 2.5796786928822257e-10
disease O 0 6.943590506125474e-06
. O 0 2.4601867210094497e-09

We O 0 5.059165975040969e-09
analyzed O 0 1.2427520124091984e-09
genotype O 0 5.169518146885821e-09
/ O 0 8.500268044997483e-09
phenotype O 0 6.354245601913888e-11
correlations O 0 3.4015453648228444e-11
, O 0 3.7331707278438764e-13
on O 0 7.197141320414158e-12
the O 0 2.0284319471493284e-13
basis O 0 5.650218249005079e-13
of O 0 1.5659185103114592e-12
the O 0 2.4109243247638634e-12
constitution O 0 2.458054766674156e-11
of O 0 4.8711604194728864e-11
a O 0 2.619043593110604e-10
WT1 O 0 3.6860899399471236e-07
mutation O 0 2.5394119099186874e-11
database O 0 7.373384021402973e-12
of O 0 4.4922929959279045e-11
84 O 0 3.504435408530071e-09
germ O 0 1.0115297300217208e-05
- O 0 6.309484490429895e-08
line O 0 8.939677442754146e-09
mutations O 0 1.1399401388112462e-11
, O 0 2.3646072621653913e-13
to O 0 7.080472411722175e-14
compare O 0 5.491504603480357e-13
the O 0 2.5757625199407386e-12
distribution O 0 1.7331627452654708e-11
and O 0 4.2618214729853166e-13
type O 0 1.515716024913516e-11
of O 0 6.138784619524884e-11
mutations O 0 5.766541215888876e-13
, O 0 2.8990058373616276e-14
according O 0 1.2356462424437109e-14
to O 0 3.7683946945994e-14
the O 0 6.397657143636382e-12
different O 0 3.015751277174461e-12
symptoms O 0 1.072017141723336e-07
. O 0 1.4585411767242817e-09

This O 0 6.056050799729817e-11
demonstrated O 0 2.3611945731971673e-10
( O 0 2.733843099816946e-12
1 O 0 3.465356890330895e-10
) O 0 1.7872464304954233e-13
the O 0 4.291711517417918e-12
association O 0 1.0729330835249073e-12
between O 0 2.7260000355112946e-13
mutations O 0 1.0135681356715498e-12
in O 0 1.2320797593973198e-12
exons O 0 7.535817525550215e-10
8 O 0 6.246649308927488e-10
and O 0 7.133535949443992e-12
9 O 0 2.4933397568815963e-09
and O 0 6.771829624829806e-11
DMS B-Disease 0 3.7791025420119695e-08
; O 0 3.091225734587477e-13
( O 0 1.1226898588307527e-13
2 O 0 1.772298280355855e-11
) O 0 4.8025433185393956e-14
among O 0 1.4521261797184604e-13
patients O 0 7.58023472550301e-13
with O 0 6.481097125990432e-13
DMS B-Disease 0 7.246840141306166e-07
, O 0 9.574204493448257e-13
a O 0 6.062285547690782e-13
higher O 0 1.1992124957990735e-12
frequency O 0 4.670824924751793e-12
of O 0 1.9407687262829043e-11
exon O 0 3.7091582583137495e-10
8 O 0 2.1589365017948836e-10
mutations O 0 2.3058618816435006e-12
among O 0 1.0769201285940055e-13
46 O 0 2.9700967379975296e-11
, O 0 1.908774874270769e-11
XY O 0 1.2774047490893281e-06
patients O 0 7.42820995686122e-12
with O 0 4.1085719353593786e-13
female O 0 2.2284990693066664e-12
phenotype O 0 1.0949908514634732e-11
than O 0 8.87424831427612e-14
among O 0 1.7162654760913276e-13
46 O 0 1.2162204576782187e-10
, O 0 1.4144858895281942e-10
XY O 0 0.0021621983032673597
patients O 0 1.3799830202165797e-11
with O 0 3.2228996489809536e-13
sexual O 0 5.5323614613078664e-12
ambiguity O 0 2.041238844618931e-10
or O 0 3.194146336316095e-11
male O 0 6.138474060654597e-13
phenotype O 0 8.59166199556477e-13
; O 0 2.6354745751196174e-14
and O 0 1.4057004258521966e-12
( O 0 3.753547765574655e-13
3 O 0 1.153518877639037e-10
) O 0 3.618366524915824e-14
statistically O 0 1.5720173643721247e-12
significant O 0 8.73613681395824e-13
evidence O 0 4.974723324252528e-12
that O 0 3.0685611657980255e-14
mutations O 0 2.723510707323268e-13
in O 0 1.0999030462463533e-12
exons O 0 1.48921597276086e-09
8 O 0 1.754116296659447e-09
and O 0 5.14866170531203e-11
9 O 0 4.324768099195353e-09
preferentially O 0 5.175462142181786e-11
affect O 0 2.8320434539153005e-11
amino O 0 1.2155889142495546e-11
acids O 0 7.951168749017329e-14
with O 0 2.826567240899261e-14
different O 0 6.973692727885866e-14
functions O 0 2.458881431799398e-10
. O 0 2.013647061593904e-11
. O 0 4.299565148357942e-10

The O 0 2.1253099191653746e-07
185delAG O 0 2.389881501585478e-06
BRCA1 O 0 2.4312383217761635e-08
mutation O 0 2.9615438573715736e-11
originated O 0 5.7361788929899404e-12
before O 0 2.541135487796331e-12
the O 0 1.4053090288679293e-12
dispersion O 0 1.3273724133733289e-11
of O 0 7.979922278522622e-12
Jews O 0 1.1237359784019296e-12
in O 0 2.034931468122836e-12
the O 0 1.697748018558709e-11
diaspora O 0 9.431852000807428e-12
and O 0 7.817222563710757e-12
is O 0 3.3357901944169877e-12
not O 0 3.534833883933608e-12
limited O 0 2.4317925451100564e-10
to O 0 1.6101027455750483e-10
Ashkenazim O 0 1.0716364613472251e-06
. O 0 1.3865943948587756e-08

The O 0 1.8325227557625112e-08
185delAG O 0 1.609463424756541e-07
mutation O 0 7.135789181766938e-10
in O 0 3.505414708504517e-11
BRCA1 O 0 1.2503549584597096e-10
is O 0 8.516767884469631e-14
detected O 0 1.1177569286813238e-12
in O 0 3.088067182608484e-13
Ashkenazi O 0 1.2593175634234566e-11
Jews O 0 1.261460689594776e-13
both O 0 3.821771322803577e-14
in O 0 5.885192940618955e-12
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.6089583116117865e-07
in O 0 3.8385798012408046e-11
the O 0 8.69367633438145e-11
general O 0 1.3823783784339128e-10
population O 0 1.3584606529948307e-12
. O 0 6.002622010559122e-11

All O 0 2.461201731307483e-08
tested O 0 3.3896856876936e-08
Ashkenazi O 0 1.2185132902686746e-08
mutation O 0 6.166420846165366e-11
carriers O 0 1.8411515801536327e-12
share O 0 9.349724770443824e-13
the O 0 1.3262285367132698e-11
same O 0 1.4626517011451234e-11
allelic O 0 2.242316776701614e-09
pattern O 0 7.694685444370464e-10
at O 0 2.4008051102697436e-09
the O 0 1.079534239778468e-09
BRCA1 O 0 3.567234729828783e-09
locus O 0 3.380953961240607e-09
. O 0 1.954575168383599e-09

Our O 0 9.542355350333764e-09
previous O 0 8.396331963034243e-10
study O 0 6.123298916527187e-12
showed O 0 1.174856826408055e-11
that O 0 7.693084586252522e-14
this O 0 4.758379020669556e-13
Ashkenazi O 0 3.800560144373577e-10
mutation O 0 1.549814616919054e-11
also O 0 4.057817721159901e-13
occurs O 0 9.260253425614345e-14
in O 0 1.7815115431040612e-13
Iraqi O 0 9.986982595078242e-12
Jews O 0 1.3898270555257053e-12
with O 0 7.889202529101635e-14
a O 0 2.150268331446714e-11
similar O 0 1.0107410047810461e-10
allelic O 0 6.332077617798859e-08
pattern O 0 1.3454264546908234e-07
. O 0 2.6834113597828946e-08

We O 0 7.45794803691524e-09
extended O 0 9.275651358109371e-10
our O 0 7.861620382465517e-11
analysis O 0 2.2508405729537717e-12
to O 0 1.608173663680823e-12
other O 0 6.342665975767048e-12
non O 0 1.4453433117012082e-08
- O 0 5.757471721601348e-10
Ashkenazi O 0 2.732042092556952e-10
subsets O 0 1.3445717428339776e-08
354 O 0 1.2428841289491288e-10
of O 0 1.1029609170432053e-10
Moroccan O 0 1.395226956191209e-08
origin O 0 1.5073983727909024e-11
, O 0 1.1860423233811535e-11
200 O 0 8.058606559835368e-11
Yemenites O 0 3.950747640146801e-08
and O 0 5.109948922332741e-11
150 O 0 1.5604818826009392e-10
Iranian O 0 4.033339773279465e-10
Jews O 0 4.195052305533409e-09
. O 0 9.300315184646024e-09

Heteroduplex O 0 5.554191375267692e-06
analysis O 0 6.672977725941109e-10
complemented O 0 1.0911926917600567e-10
by O 0 3.506823954488314e-12
direct O 0 7.134207113956847e-11
DNA O 0 1.7549586783793814e-10
sequencing O 0 4.942804845975424e-11
of O 0 2.3082315225853023e-10
abnormally O 0 1.8816040392444222e-10
migrating O 0 1.7305587301716385e-12
bands O 0 1.583720932174515e-09
were O 0 4.992227187194942e-10
employed O 0 2.6113085027645866e-09
. O 0 7.478603514243787e-09

Four O 0 3.2500926394618546e-09
of O 0 2.8166342591617877e-09
Moroccan O 0 1.286094288843742e-07
origin O 0 4.4497738826976274e-11
( O 0 2.440804936637564e-12
1 O 0 7.593700668273584e-11
. O 0 2.086519704843498e-13
1 O 0 1.3068632113977241e-11
% O 0 1.3348557556611823e-13
) O 0 1.2016610783142055e-14
and O 0 2.2190350956480948e-13
none O 0 1.5874421568917718e-11
of O 0 1.795795040449022e-10
the O 0 1.991946468882233e-10
Yemenites O 0 9.399433231749299e-09
or O 0 5.3922708312392764e-12
Iranians O 0 3.715415822225232e-11
was O 0 3.9522135564240557e-10
a O 0 3.230669898268701e-11
carrier O 0 4.370821413135495e-11
of O 0 4.385211360702357e-10
the O 0 3.204321696870238e-09
185delAG O 0 4.233928621033556e-07
mutation O 0 2.1899401403402408e-08
. O 0 4.477072046427111e-09

BRCA1 O 0 8.377469384868164e-07
allelic O 0 1.5383552920411603e-07
patterns O 0 3.4292086947829148e-09
were O 0 9.844614012877173e-11
determined O 0 4.386670714173757e-12
for O 0 1.999237364200268e-12
four O 0 2.1989179140730064e-12
of O 0 1.1113734932344244e-11
these O 0 1.3311766511141243e-13
individuals O 0 3.985579702099444e-15
and O 0 4.1167297435557026e-13
for O 0 3.3268186382801046e-12
12 O 0 8.647897675739813e-11
additional O 0 1.51960354022318e-11
non O 0 4.883409943090555e-08
- O 0 1.539116945004082e-09
Ashkenazi O 0 1.7490848769341483e-09
185delAG O 0 4.66290073219966e-09
mutation O 0 9.502206660405577e-11
carriers O 0 1.931752934697384e-12
who O 0 6.162949491017589e-12
had O 0 1.783345204842135e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.08124140650033951

Six O 0 8.812882583697501e-07
non O 0 0.00023407286789733917
- O 0 2.849501186119596e-07
Ashkenazi O 0 1.0363172009419941e-07
individuals O 0 1.3496467832219139e-11
shared O 0 1.548911776616535e-09
the O 0 7.997488005173636e-09
common O 0 2.735881521331862e-09
Ashkenazi O 0 1.7397818741216042e-09
haplotype O 0 2.1102819491858327e-09
, O 0 1.6918914880204028e-10
four O 0 6.944756991700274e-10
had O 0 2.640321516977906e-09
a O 0 2.516678532238359e-10
closely O 0 1.932111241831347e-11
related O 0 6.864839946496559e-11
pattern O 0 5.984018169868932e-09
, O 0 1.0083951035300132e-11
and O 0 8.932692259489006e-12
the O 0 3.8222089382422553e-10
rest O 0 3.232533130059778e-10
( O 0 7.709981741585437e-13
n O 0 1.0124311805581598e-10
= O 0 1.1113698850095943e-10
6 O 0 1.4172160667236255e-10
) O 0 3.595786659421098e-14
displayed O 0 9.771127483515496e-12
a O 0 2.6914496673025035e-11
distinct O 0 1.8642497268128722e-10
BRCA1 O 0 1.2347218358854661e-08
allelic O 0 8.949080410047827e-08
pattern O 0 2.570222648046183e-07
. O 0 2.9291895131677848e-08

We O 0 1.6817448544870217e-09
conclude O 0 1.2123785309015034e-09
that O 0 1.2398544647559961e-12
the O 0 6.399795970946087e-11
185delAG O 0 4.237305262222435e-08
BRCA1 O 0 4.345099835489918e-09
mutation O 0 5.909151206545671e-12
occurs O 0 2.3328501673816615e-13
in O 0 2.8354350659932914e-13
some O 0 5.545394872463749e-13
non O 0 2.651615886861691e-07
- O 0 5.037657757611669e-08
Ashkenazi O 0 2.178026470289751e-08
populations O 0 4.8266474150793215e-11
at O 0 3.7021610777010494e-10
rates O 0 1.5141794762474348e-10
comparable O 0 9.825774742455717e-12
with O 0 2.4883602665372317e-13
that O 0 7.414238493985703e-12
of O 0 5.9129035001603825e-09
Ashkenazim O 0 9.374850833410164e-07
. O 0 8.459993594556181e-09

The O 0 6.8722614265936954e-09
majority O 0 2.744346694338873e-10
of O 0 5.601169528191008e-10
Jewish O 0 1.807141880583174e-09
185delAG O 0 1.1987671655333543e-07
mutation O 0 2.163517365261214e-09
carriers O 0 1.0190660815201369e-11
have O 0 7.924995295421899e-13
a O 0 3.3002303147233736e-12
common O 0 7.105644198035499e-12
allelic O 0 6.414550002276087e-10
pattern O 0 2.453999226048609e-10
, O 0 1.5004930891543422e-12
supporting O 0 5.201050094078008e-12
the O 0 9.937697192929917e-11
founder O 0 3.152093031033587e-09
effect O 0 1.247480230226472e-09
notion O 0 1.741892602380446e-10
, O 0 7.376967418003255e-13
but O 0 2.1424715842578712e-13
dating O 0 2.5673898770839365e-12
the O 0 8.839642559599348e-12
mutations O 0 3.396031828147017e-13
origin O 0 3.7977481131667296e-14
to O 0 1.800435275585259e-14
an O 0 2.3066250447764496e-14
earlier O 0 1.848922577540879e-11
date O 0 1.1585246095791035e-09
than O 0 1.5076075153899748e-12
currently O 0 5.491182595435129e-12
estimated O 0 8.34657343240508e-11
. O 0 1.4110750345963652e-09

However O 0 4.919728180396987e-09
, O 0 1.665717390408883e-11
the O 0 1.5103165246221906e-11
different O 0 3.310953128419364e-13
allelic O 0 1.809542515829321e-09
pattern O 0 1.6495125265691968e-09
at O 0 4.249378626752787e-09
the O 0 8.240058635422542e-10
BRCA1 O 0 9.097245179390256e-11
locus O 0 2.3226542217313906e-11
even O 0 6.848981017743005e-13
in O 0 8.446916668729265e-13
some O 0 8.395885982975804e-13
Jewish O 0 6.589774559362382e-11
mutation O 0 5.795026611354892e-11
carriers O 0 4.705681157235464e-12
, O 0 2.2998577868527104e-12
might O 0 2.0876594723773234e-12
suggest O 0 4.656332285891962e-13
that O 0 8.176791221111562e-14
the O 0 5.818848007599353e-12
mutation O 0 9.42763879116515e-13
arose O 0 1.9134131399537596e-13
independently O 0 1.2132928125727083e-12
. O 0 5.76186017300917e-12
. O 0 3.8351857800655864e-10

Crystal O 0 2.707250132516492e-06
structure O 0 1.4565979711278487e-07
of O 0 1.4776112777781236e-07
the O 0 1.4987219856266165e-06
hemochromatosis B-Disease 1 1.0
protein O 0 7.287633252417436e-07
HFE O 0 5.031812906963751e-05
and O 0 2.1323552298890824e-11
characterization O 0 2.594322499882562e-11
of O 0 6.826074427923601e-11
its O 0 1.0456252183543846e-11
interaction O 0 5.288691359850439e-12
with O 0 2.951166871642541e-12
transferrin O 0 5.230058519600789e-08
receptor O 0 5.638839617461144e-09
. O 0 8.019265251846264e-10

HFE O 1 0.999645471572876
is O 0 9.868950989755376e-09
an O 0 1.9731154210500534e-10
MHC O 0 9.652834620510475e-08
- O 0 6.66364563528532e-09
related O 0 9.964659319905422e-09
protein O 0 3.2440275465894786e-10
that O 0 3.1846590252057605e-13
is O 0 6.150120560391437e-14
mutated O 0 9.044911222994348e-14
in O 0 1.08147337114263e-13
the O 0 8.821137570391713e-11
iron B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.6559242794755846e-06

HFE O 0 4.7988003643695265e-05
binds O 0 3.0826932673200247e-10
to O 0 2.9746607954628246e-11
transferrin O 0 3.0127147443437252e-09
receptor O 0 4.076890561255375e-11
( O 0 1.9937690821231202e-12
TfR O 0 1.3003351728713142e-09
) O 0 9.514887792591575e-14
and O 0 2.2097640828711712e-13
reduces O 0 2.7472611859036267e-12
its O 0 6.846212507495564e-13
affinity O 0 3.311167800449516e-13
for O 0 2.632153002501969e-11
iron O 0 1.5038489209473482e-07
- O 0 2.2513719777350616e-09
loaded O 0 1.3204692894674963e-10
transferrin O 0 1.2918311975695929e-09
, O 0 1.1550374372226724e-11
implicating O 0 4.310455548051095e-09
HFE O 0 1.989512202271726e-05
in O 0 1.2571740093392236e-08
iron O 0 0.00013646690058521926
metabolism O 0 7.345334324782016e-06
. O 0 1.0380754034144957e-08

The O 0 1.2922491805511527e-06
2 O 0 7.491978976759128e-06
. O 0 1.7157992715510773e-07

6 O 0 2.9577337045338936e-05
A O 0 4.791519359059748e-07
crystal O 0 3.0665873396173993e-07
structure O 0 4.6578719548051595e-08
of O 0 5.1087486241385704e-08
HFE O 0 5.807941852253862e-05
reveals O 0 1.478375893926298e-10
the O 0 1.2913963301497411e-11
locations O 0 1.5005061082540294e-10
of O 0 9.211656326613138e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 4.081804227951125e-09
and O 0 2.331817239298317e-10
a O 0 1.7536345708890622e-09
patch O 0 0.00023458317446056753
of O 0 7.188359631982166e-06
histidines O 0 0.11280129104852676
that O 0 7.48513195869549e-11
could O 0 1.5616541046425958e-11
be O 0 8.680891834360327e-13
involved O 0 8.539920073186158e-13
in O 0 6.380048832993479e-12
pH O 0 8.148134611474234e-09
- O 0 7.283184277895316e-09
dependent O 0 1.7514083516800838e-09
interactions O 0 5.026585814249529e-10
. O 0 1.9911574611342076e-09

We O 0 1.5457723989698025e-08
also O 0 8.67039356977628e-11
demonstrate O 0 1.6398279956142403e-10
that O 0 3.4492651790341e-11
soluble O 0 1.644299096881241e-08
TfR O 0 5.364460662349302e-07
and O 0 4.139064924135738e-10
HFE O 0 1.126437564380467e-05
bind O 0 1.6109381884010787e-10
tightly O 0 2.2576718272659946e-09
at O 0 4.686973587020304e-10
the O 0 8.525655181834679e-11
basic O 0 3.1577134240734495e-09
pH O 0 2.8155264231166655e-10
of O 0 2.3092444623173947e-10
the O 0 5.697128324655409e-10
cell O 0 1.3902030637780172e-09
surface O 0 4.838535388324017e-12
, O 0 3.8785527524051733e-13
but O 0 6.944547476135654e-13
not O 0 2.295466334373275e-12
at O 0 8.56123172354728e-10
the O 0 4.957688148898853e-10
acidic O 0 8.190325084811434e-10
pH O 0 1.2895368106669025e-09
of O 0 1.889754797090859e-09
intracellular O 0 1.1479850314799478e-07
vesicles O 0 1.0818814644153463e-06
. O 0 1.0370523106928431e-08

TfR O 0 0.00032665496109984815
HFE O 0 0.00013348375796340406
stoichiometry O 0 7.113142430625885e-08
( O 0 4.160642108619328e-10
2 O 0 3.1541860234796104e-09
1 O 0 7.017404435316621e-10
) O 0 1.461456688089599e-13
differs O 0 2.7408167424004815e-13
from O 0 1.3015043686878669e-12
TfR O 0 1.389603876411627e-09
transferrin O 0 4.796895658465417e-10
stoichiometry O 0 1.1966089230597277e-10
( O 0 1.5276438967981587e-12
2 O 0 1.7238728500235112e-10
2 O 0 4.389367688761858e-11
) O 0 1.3464282416590905e-14
, O 0 2.867363396957638e-14
implying O 0 1.9970411771746271e-13
a O 0 1.1226384269901954e-13
different O 0 1.4728614403881272e-15
mode O 0 2.2123558193754e-11
of O 0 6.439866543674067e-13
binding O 0 4.4319669462167255e-12
for O 0 3.863183644509105e-12
HFE O 0 1.6948088443768938e-07
and O 0 5.003136793746421e-12
transferrin O 0 8.354796299236966e-10
to O 0 1.4016344508649414e-11
TfR O 0 2.440986790475108e-08
, O 0 2.4061878791531432e-12
consistent O 0 7.048966271794299e-11
with O 0 1.1656155641387445e-12
our O 0 1.145441866357011e-10
demonstration O 0 1.83991166746722e-09
that O 0 1.26545204436751e-12
HFE O 0 2.435016597246431e-07
, O 0 5.47024404939922e-12
transferrin O 0 1.0251319793042057e-09
, O 0 1.1387776138738204e-11
and O 0 2.0441912051971656e-11
TfR O 0 6.378077443969232e-08
form O 0 8.978817689353491e-11
a O 0 9.018332192134437e-10
ternary O 0 1.2387363312882371e-06
complex O 0 4.304033041080402e-07
. O 0 1.345980393807622e-08

Identification O 0 2.4189148462028243e-09
of O 0 7.631863474522049e-10
three O 0 6.368996909728031e-12
novel O 0 4.914112953363636e-12
mutations O 0 8.527565047329599e-13
and O 0 1.8298322655273952e-13
a O 0 8.409076386606262e-13
high O 0 6.483128270340366e-12
frequency O 0 2.5320412433416095e-11
of O 0 5.773237790607233e-11
the O 0 1.2908700497415992e-10
Arg778Leu O 0 1.0291255847505454e-07
mutation O 0 3.278542715090538e-11
in O 0 3.394026162548136e-12
Korean O 0 7.495339460206196e-09
patients O 0 2.6616907462806427e-12
with O 0 2.763295018151646e-12
Wilson B-Disease 0 1.1899855962838046e-06
disease I-Disease 0 0.09810855984687805
. O 0 6.96726232263245e-09

Four O 0 2.9446038940506014e-09
mutations O 0 2.569945090069581e-10
- O 0 2.264917586813908e-09
- O 0 4.2524592736015165e-09
R778L O 0 4.1776793580083904e-08
, O 0 3.0772516479427026e-11
A874V O 0 2.0816823820268837e-09
, O 0 2.680638480287434e-12
L1083F O 0 1.220754608510788e-10
, O 0 3.3715066329043086e-13
and O 0 1.0505377627924653e-13
2304delC O 0 7.162999794002589e-12
- O 0 1.5281392687707673e-12
- O 0 3.39444054461846e-12
in O 0 8.270818058209173e-12
the O 0 5.978447736865178e-10
copper O 0 2.5085482135978054e-08
- O 0 2.9744764429295856e-09
transporting O 0 2.078524241611035e-09
enzyme O 0 8.751839530862782e-11
, O 0 6.361254578646225e-11
P O 0 1.7172411617139005e-06
- O 0 5.791319868109213e-09
type O 0 1.989141740210698e-09
ATPase O 0 2.9304830784226965e-10
( O 0 1.4388436189033404e-12
ATP7B O 0 4.636554606918253e-08
) O 0 3.512563978287468e-14
, O 0 1.0310042682331981e-14
were O 0 5.950109654116742e-14
identified O 0 2.31159411273954e-13
in O 0 1.0403013086385249e-12
Korean O 0 3.692121275378213e-09
Patients O 0 1.0795454807865923e-11
with O 0 1.5802312583468314e-11
Wilson B-Disease 0 3.5710461361304624e-06
disease I-Disease 1 0.6383270025253296
. O 0 1.5491313121174244e-08

Arg778Leu O 0 4.533436822384829e-06
, O 0 5.739599351350932e-10
the O 0 2.5172783302274127e-10
most O 0 2.667906911016371e-12
frequently O 0 1.1888093591136406e-12
reported O 0 2.1277955526005643e-12
mutation O 0 1.0386833537365248e-12
of O 0 4.025375865968073e-11
this O 0 1.0810078960449276e-12
enzyme O 0 3.101028819580548e-13
, O 0 5.940765186642633e-14
was O 0 9.537173134566146e-12
found O 0 1.9896501709647935e-13
in O 0 1.152221899705999e-13
six O 0 2.0589027444756214e-12
of O 0 4.15979854728743e-11
eight O 0 8.589053357432874e-10
unrelated O 0 1.1940833877233104e-09
patients O 0 1.640208043170166e-12
studied O 0 1.5940230038702374e-11
, O 0 1.9425220709311936e-13
an O 0 2.2854683640397e-14
allele O 0 1.4141986193205724e-12
frequency O 0 1.9288277919304875e-10
of O 0 1.0293131902372465e-09
37 O 0 3.5263898467974286e-08
. O 0 1.3256286734986134e-08

5 O 0 4.671145958923262e-08
% O 0 2.0753818108509847e-10
, O 0 5.70223208928855e-12
which O 0 8.867179993737873e-13
is O 0 5.735847994486898e-13
considerably O 0 1.7709356116973884e-12
higher O 0 3.057411095130913e-12
than O 0 2.852477301129412e-14
those O 0 4.3040525706189783e-14
in O 0 8.440957893589285e-13
other O 0 1.835002419112164e-12
Asian O 0 1.3581201441237312e-10
populations O 0 2.5612723747459043e-11
. O 0 2.1524772242376145e-10

The O 0 3.5202658565935963e-09
novel O 0 1.2927869885714927e-10
single O 0 1.0282334012012839e-10
nucleotide O 0 4.593891655968463e-10
deletion O 0 1.8191827211300193e-10
, O 0 2.659544242819556e-12
2304delC O 0 6.610196279233094e-10
, O 0 9.631593266001826e-12
was O 0 2.730718706711599e-10
found O 0 4.539457351682152e-12
in O 0 8.5808079391958e-12
one O 0 5.755316709321612e-11
patient O 0 8.246415106327731e-09
. O 0 8.689142738660394e-09

Since O 0 7.000297230774777e-09
a O 0 2.418240052648457e-10
mutation O 0 4.769760281186919e-11
at O 0 3.1903787944820294e-10
cDNA O 0 5.525314872301124e-09
nucleotide O 0 7.954587211145281e-09
2302 O 0 3.317526875434851e-07
( O 0 2.8048945544673076e-12
2302insC O 0 3.3404290444849494e-10
) O 0 1.1339111073704888e-12
had O 0 1.6015626325138754e-11
been O 0 7.75282442411207e-12
previously O 0 8.170582960209671e-11
described O 0 1.0962238061740237e-11
, O 0 2.252110580273567e-13
this O 0 7.609637610794459e-14
region O 0 1.768431928672598e-11
of O 0 1.303970681432176e-10
the O 0 3.085224076215809e-09
ATP7B O 0 0.0013262672582641244
gene O 0 2.0198998029741233e-09
may O 0 7.291892784033749e-11
be O 0 8.570078674496884e-12
susceptible O 0 2.3014178063274215e-10
to O 0 3.841595444531443e-12
gene O 0 3.853827923450126e-09
rearrangements O 0 2.1380169528129045e-06
causing O 0 9.59524754762242e-07
Wilson B-Disease 0 7.196001661213813e-07
disease I-Disease 0 0.0004135027411393821
. O 0 1.0239093128916466e-08

Disruption O 0 1.020384274852404e-06
of O 0 2.1371549863147266e-08
splicing O 0 2.29875163348936e-09
regulated O 0 6.890604059561767e-11
by O 0 9.805175334859362e-13
a O 0 4.9363509807553996e-11
CUG O 0 5.919462182646384e-07
- O 0 1.1680253431123333e-09
binding O 0 6.6682352972691206e-09
protein O 0 1.28402506405223e-08
in O 0 6.6516583352438374e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.967324351426214e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999994039535522
DM B-Disease 1 1.0
) O 0 1.6331078156461842e-10
is O 0 1.5271777982842072e-12
caused O 0 1.0318320850521978e-11
by O 0 8.847194895092447e-13
a O 0 4.4396177706351736e-11
CTG O 0 1.6607836883508753e-08
expansion O 0 3.527978950645938e-11
in O 0 3.055917064537228e-13
the O 0 2.485871100979531e-12
3 O 0 1.2714461428142698e-10
untranslated O 0 1.1444712733066353e-08
region O 0 9.386559585156107e-11
of O 0 2.0253151933324887e-10
the O 0 1.720222186918363e-08
DM B-Disease 1 1.0
gene O 0 7.290415027227937e-08
. O 0 1.936445492844996e-08

One O 0 1.0269907146920332e-10
model O 0 4.922645069349585e-10
of O 0 1.6661972779274947e-07
DM B-Disease 1 1.0
pathogenesis O 0 0.4870409369468689
suggests O 0 6.065992846915336e-11
that O 0 1.6518957154845054e-13
RNAs O 0 3.100748130480113e-11
from O 0 3.192542801302989e-12
the O 0 3.444084947790138e-11
expanded O 0 2.342416365042066e-11
allele O 0 3.5517970942838817e-12
create O 0 1.4538147161818893e-12
a O 0 2.637503930535967e-12
gain O 0 8.020266742403415e-12
- O 0 5.7965381626556844e-12
of O 0 2.3045112484965102e-09
- O 0 4.453716007102315e-10
function O 0 1.4484224930555456e-09
mutation O 0 1.7294995730693374e-12
by O 0 1.0615575259109722e-13
the O 0 8.414728115690995e-12
inappropriate O 0 2.4307604540307892e-12
binding O 0 1.2182233520563468e-11
of O 0 4.7965454524900863e-11
proteins O 0 7.127167779563681e-13
to O 0 1.0042506106214266e-12
the O 0 4.3300399377166343e-10
CUG O 0 1.9648272427730262e-05
repeats O 0 6.18757738379827e-08
. O 0 1.1993886772643236e-08

Data O 0 1.840674102027151e-08
presented O 0 6.593050105863085e-09
here O 0 1.4837688022684148e-10
indicate O 0 4.713145672352592e-12
that O 0 1.8265926694360085e-13
the O 0 5.149985039115679e-12
conserved O 0 3.8688355297189503e-10
heterogeneous O 0 5.5204902871253125e-09
nuclear O 0 5.492984769261966e-07
ribonucleoprotein O 0 2.5591473828967537e-08
, O 0 9.308203513525015e-11
CUG O 0 4.387524938920251e-07
- O 0 4.859461166795143e-10
binding O 0 5.746051412458542e-10
protein O 0 5.7221512250738016e-11
( O 0 1.8323862392699564e-12
CUG O 0 2.1544596506828384e-07
- O 0 6.637030369738284e-10
BP O 0 7.155374071032838e-10
) O 0 7.842633335287952e-14
, O 0 1.0245337835491225e-13
may O 0 5.934833245506421e-13
mediate O 0 8.309689741858861e-11
the O 0 2.497250461974687e-10
trans O 0 1.2395844350976404e-09
- O 0 2.8204549806787327e-10
dominant O 0 1.0418437224046784e-09
effect O 0 9.748910567708435e-10
of O 0 3.671774273517059e-10
the O 0 5.229973676357247e-10
RNA O 0 7.532544366029015e-09
. O 0 6.966368037986115e-10

CUG O 1 0.5919835567474365
- O 0 6.829945959907491e-06
BP O 0 3.3596049320294696e-07
was O 0 3.350997923590171e-09
found O 0 6.249622347409556e-12
to O 0 1.4186662098975705e-13
bind O 0 2.714978578326893e-13
to O 0 2.1824080357561032e-13
the O 0 4.8948727016107085e-11
human O 0 1.6864031948671254e-08
cardiac O 1 0.9999997615814209
troponin O 0 0.001373574254103005
T O 0 5.299845611261844e-07
( O 0 5.015354451187726e-13
cTNT O 0 6.280024417160135e-11
) O 0 2.6554155941704675e-14
pre O 0 9.784523191669336e-11
- O 0 3.64725047038994e-12
messenger O 0 1.7858127086475828e-12
RNA O 0 2.6386863614252798e-12
and O 0 4.5466102806474354e-14
regulate O 0 3.954296471427726e-13
its O 0 9.33391927117333e-13
alternative O 0 6.500169152934276e-11
splicing O 0 1.4055497876697132e-09
. O 0 4.402038455975088e-10

Splicing O 0 3.4365307044481597e-08
of O 0 1.2422193940153647e-08
cTNT O 0 3.523842337926908e-07
was O 0 5.2470245037739005e-08
disrupted O 0 8.535080269211903e-06
in O 0 2.4863675207598135e-07
DM B-Disease 1 1.0
striated O 1 0.5999359488487244
muscle O 0 7.912566070444882e-05
and O 0 1.1335842264870166e-09
in O 0 6.513846406708268e-11
normal O 0 1.8571704174519255e-09
cells O 0 5.0440120830108626e-12
expressing O 0 1.548507009467917e-13
transcripts O 0 2.4234462093347675e-12
that O 0 5.711957870666723e-14
contain O 0 1.2077867352078275e-11
CUG O 0 1.606024255806915e-07
repeats O 0 7.239971733241646e-09
. O 0 2.4336497261856493e-09

Altered O 0 3.003186677119629e-08
expression O 0 1.3559414702157824e-09
of O 0 6.567968946491476e-10
genes O 0 2.791137633517682e-11
regulated O 0 1.1961981405406164e-10
posttranscriptionally O 0 4.266205611003215e-09
by O 0 9.961342167796872e-11
CUG O 0 0.22829124331474304
- O 0 6.634542160099954e-07
BP O 0 3.320371888548834e-08
therefore O 0 3.887340449537646e-11
may O 0 7.154602431336254e-12
contribute O 0 2.354388168798738e-12
to O 0 9.96672119835118e-11
DM B-Disease 1 1.0
pathogenesis O 0 6.693439354421571e-05
. O 0 2.76681011435187e-10
. O 0 1.0685743401239733e-09

Identification O 0 6.551344355898436e-09
of O 0 1.0834121377811812e-09
a O 0 7.589067568813945e-11
novel O 0 3.710260224054629e-11
nonsense O 0 5.02501373844666e-10
mutation O 0 1.454078068889586e-12
and O 0 1.3546512544516942e-13
a O 0 1.5736853009942764e-12
missense O 0 6.190992857257882e-11
substitution O 0 3.1579027587325115e-11
in O 0 2.4983962381569524e-12
the O 0 4.283438187480115e-11
vasopressin O 0 9.284217838967379e-10
- O 0 8.015274555184249e-10
neurophysin O 0 1.5298097366667207e-07
II O 0 3.175841811753344e-07
gene O 0 4.103890404588695e-12
in O 0 2.7725746503358406e-13
two O 0 1.625534965963779e-13
Spanish O 0 2.0252301224932268e-10
kindreds O 0 2.0902694686242285e-08
with O 0 3.7408583175579935e-11
familial B-Disease 1 0.9999986886978149
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 0 9.989039995161875e-08

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.3743736221604195e-07
FNDI B-Disease 1 1.0
) O 0 5.0720664647452285e-12
is O 0 6.125243541543757e-14
an O 0 6.042773025667289e-14
autosomal B-Disease 1 0.9991662502288818
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.1084199336153233e-08
by O 0 3.989007908711262e-12
deficiency O 0 8.49498889010647e-08
in O 0 7.86439524613769e-11
the O 0 8.483909574863446e-09
antidiuretic O 0 3.353730733124394e-07
hormone O 0 2.0843125003722207e-09
arginine O 0 8.954844088471248e-10
vasopressin O 0 3.001568715799152e-10
( O 0 1.0906382134218129e-12
AVP O 0 1.652793318873691e-10
) O 0 8.219784008887878e-16
encoded O 0 1.134389721643269e-15
by O 0 1.3690963510462617e-13
the O 0 6.78367473305741e-10
AVP O 0 1.822534727580205e-06
- O 0 2.8330580548185935e-08
neurophysin O 0 7.532399195042672e-06
II O 1 0.9994528889656067
( O 0 1.69317786458123e-08
AVP O 0 2.3685644919169135e-05
- O 0 1.7834064891530943e-08
NPII O 0 2.5040219497896032e-06
) O 0 8.183477333278955e-12
gene O 0 3.615998819817001e-11
on O 0 2.7808516600558164e-10
chromosome O 0 2.9096209885892677e-09
20p13 O 0 7.777335753189618e-08
. O 0 9.375332510330736e-09

In O 0 1.876494293284736e-09
this O 0 7.533740124798793e-12
study O 0 3.0747039029416223e-12
, O 0 1.03543540928841e-12
we O 0 2.1905873382604968e-12
analyzed O 0 8.64824011015397e-12
two O 0 1.203423862297659e-12
families O 0 3.517397825910859e-14
with O 0 2.5236889401175633e-12
FNDI B-Disease 1 1.0
using O 0 1.2155355715026683e-11
direct O 0 2.127500259296866e-11
automated O 0 9.785853238852837e-10
fluorescent O 0 6.522549167442548e-11
, O 0 4.946723369467221e-13
solid O 0 2.6972413885717472e-11
phase O 0 9.312731835686705e-11
, O 0 3.118360062358272e-13
single O 0 5.6483684916786014e-12
- O 0 6.749749630746704e-12
stranded O 0 3.5498892020369155e-11
DNA O 0 3.775701105934726e-12
sequencing O 0 5.857998548047805e-13
of O 0 2.9991006206264714e-11
PCR O 0 2.0402911360406506e-08
- O 0 2.4312367941092816e-07
amplified O 0 5.96570589550538e-06
AVP O 0 0.0005186193156987429
- O 0 1.2633945516427048e-06
NPII O 0 0.0002653403498698026
DNA O 0 9.574406476531294e-07
. O 0 2.490023653933804e-08

In O 0 8.845588705952423e-10
one O 0 2.6477623912835035e-11
of O 0 3.236876322532112e-10
the O 0 5.31450217167162e-10
families O 0 4.141301288441285e-13
, O 0 1.4285180026732403e-12
affected O 0 2.760955743544291e-12
individuals O 0 2.0334474325179284e-14
presented O 0 5.0232481368928106e-11
a O 0 1.709791336290678e-11
novel O 0 9.730286888720574e-12
nonsense O 0 1.0298094321736784e-10
mutation O 0 1.0955668880777147e-12
in O 0 7.477931576911623e-13
exon O 0 1.0660453769739675e-10
3 O 0 7.77220857117733e-11
of O 0 2.7626113202616764e-11
the O 0 1.9890108657327765e-11
gene O 0 1.818625870557422e-12
, O 0 1.9368690408038541e-13
consisting O 0 5.122454110190189e-13
in O 0 3.875922152674072e-12
a O 0 3.1114430476542054e-10
G O 0 3.8311391392653604e-08
to O 0 7.318843864290159e-10
T O 0 2.475385088018811e-07
transition O 0 6.49331122204444e-09
at O 0 6.819155240478381e-10
nucleotide O 0 1.8513161836875014e-10
2101 O 0 1.830817808468055e-08
, O 0 3.525177112023714e-13
which O 0 2.851960272218408e-14
produces O 0 4.611985299956059e-14
a O 0 4.0078126906616107e-13
stop O 0 7.695396403439858e-12
signal O 0 7.774136195903836e-11
in O 0 7.876024485375943e-12
codon O 0 3.9163219889282175e-10
82 O 0 9.57918633304189e-10
( O 0 6.886031328479092e-11
Glu O 0 3.910967052433989e-07
) O 0 3.6172335959872015e-11
of O 0 3.0926947669485116e-09
NPII O 0 0.00014234823174774647
. O 0 1.2597547538462095e-07

The O 0 3.7971227584421285e-07
premature O 0 2.0003024303605343e-07
termination O 0 1.5649982421095388e-09
eliminates O 0 2.7592648166319123e-09
part O 0 1.1904050661870613e-11
of O 0 1.5163587052668959e-10
the O 0 3.8886180386832336e-10
C O 0 5.62052413499714e-08
- O 0 3.1313940329624756e-10
terminal O 0 3.4387631631105364e-10
domain O 0 8.180699173632178e-12
of O 0 1.5244661435986906e-11
NPII O 0 2.3990310182853136e-07
, O 0 2.2622806405969698e-12
including O 0 2.189484704651079e-12
a O 0 2.055251281662951e-11
cysteine O 0 3.7175564709945874e-11
residue O 0 1.0753665735663276e-09
in O 0 8.586227215334752e-12
position O 0 1.2631792833950328e-10
85 O 0 1.9964577213649193e-10
, O 0 1.901996138711781e-12
which O 0 3.7977935141327024e-13
could O 0 5.719919438269827e-13
be O 0 1.8204017395058447e-13
involved O 0 4.0148646804046353e-14
in O 0 5.167457716066803e-13
the O 0 7.274958413461263e-11
correct O 0 1.0292463548111641e-09
folding O 0 4.6624561989006e-09
of O 0 8.715695942740354e-10
the O 0 2.2877649996644323e-08
prohormone O 0 5.733201760449447e-05
. O 0 5.7090346672339365e-08

In O 0 1.020450057787059e-09
the O 0 1.198651733425038e-09
second O 0 3.827894445862512e-09
family O 0 1.663904257431792e-11
, O 0 9.018013766293187e-12
a O 0 6.167633070930378e-11
G279A O 0 1.4635406220264713e-09
substitution O 0 7.218485253979168e-10
at O 0 1.2539547178391786e-09
position O 0 5.7182012597190024e-11
- O 0 3.287207095067912e-12
1 O 0 3.7395742752410754e-11
of O 0 9.301366100944453e-12
the O 0 1.934035917527943e-11
signal O 0 6.773628880019089e-10
peptide O 0 1.8179053748457186e-11
was O 0 8.839170714813882e-12
observed O 0 8.910158309956284e-13
in O 0 2.457161806922875e-13
all O 0 3.2797545061746813e-12
affected O 0 4.803357017690857e-11
individuals O 0 1.0676788446406515e-11
. O 0 3.606538401257353e-09

This O 0 6.534157104276517e-10
missense O 0 1.1018396151030174e-07
mutation O 0 8.388007510795603e-10
, O 0 3.056147696023359e-11
which O 0 5.0640654863931545e-11
replaces O 0 7.739482157376187e-07
Ala O 0 7.722524060227443e-07
with O 0 6.497045262898737e-11
Thr O 0 4.0254230952996295e-06
, O 0 6.3156853878643116e-12
is O 0 3.297623675860284e-13
frequent O 0 2.5271970280349443e-11
among O 0 1.6132997715523345e-10
FNDI B-Disease 1 1.0
patients O 0 4.53983020065607e-08
and O 0 1.2599806614721487e-11
is O 0 5.593327884190202e-12
thought O 0 6.239986392181374e-12
to O 0 5.06323932433772e-13
reduce O 0 6.821193609951592e-11
the O 0 2.353029056323397e-11
efficiency O 0 2.513718400098952e-10
of O 0 2.1943731554063817e-11
cleavage O 0 1.3844754336023168e-11
by O 0 8.331999153121661e-12
signal O 0 2.2603702021228855e-08
peptidases O 0 7.240416266540706e-08
. O 0 1.7588390466283244e-10
. O 0 1.1986287518084282e-09

Genetic O 0 2.198469317704621e-08
heterogeneity O 0 3.444707630251287e-08
of O 0 6.367879024082868e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.441031041859446e-10
due O 0 1.0258033853460802e-06
to O 0 2.0514649701208754e-10
TWIST O 0 1.4272103499024524e-06
and O 0 1.277950412159612e-09
FGFR O 0 0.0013965340331196785
mutations O 0 6.860291446031397e-09
. O 0 2.8128279705441628e-09

Thirty O 0 9.130161515713553e-07
- O 0 1.120233292795092e-07
two O 0 1.5391336816161783e-10
unrelated O 0 2.8724118639189555e-09
patients O 0 1.9733017303513734e-12
with O 0 1.782945231070584e-14
features O 0 7.170097848785417e-11
of O 0 3.95380661544209e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.6469588593778255e-11
a O 0 7.460929096758662e-11
common O 0 1.8404003654381995e-08
autosomal B-Disease 0 0.0006977713783271611
dominant I-Disease 1 0.5804727077484131
condition I-Disease 1 0.999626874923706
of O 0 6.195772130013211e-06
craniosynostosis B-Disease 1 1.0
and O 0 1.40909106605136e-08
limb B-Disease 1 0.9995875954627991
anomalies I-Disease 0 0.32807567715644836
, O 0 1.0894292412633177e-10
were O 0 4.3566220075952344e-11
screened O 0 1.4823176019973516e-10
for O 0 1.008321464518458e-12
mutations O 0 9.530150106573654e-13
in O 0 7.1812898509715506e-12
TWIST O 0 2.0050077154110113e-08
, O 0 3.932503281345312e-11
FGFR2 O 0 6.45353384243208e-06
, O 0 8.621991315349575e-11
and O 0 6.723980261469364e-10
FGFR3 O 0 0.00012489143409766257
. O 0 6.138196084748415e-08

Nine O 0 3.727345898596468e-08
novel O 0 6.858979495483197e-10
and O 0 1.434871110816971e-10
three O 0 1.5785930895795275e-10
recurrent O 0 1.1031513167836238e-05
TWIST O 0 3.749876441361266e-06
mutations O 0 3.739347720355113e-10
were O 0 2.4142939383797746e-11
found O 0 6.040563015063949e-13
in O 0 6.57254892871828e-12
12 O 0 2.55151344497051e-09
families O 0 5.40664041315253e-11
. O 0 4.342837645054942e-09

Seven O 0 1.7326430068465015e-08
families O 0 3.410699153660879e-11
were O 0 2.0801492472966032e-10
found O 0 1.9562440209397458e-11
to O 0 4.816298835447208e-12
have O 0 1.038909843570357e-11
the O 0 2.618953665045609e-10
FGFR3 O 0 2.754341039690189e-05
P250R O 0 2.5784418156149513e-08
mutation O 0 3.347187457758416e-11
, O 0 4.3466741165600065e-13
and O 0 4.022002728695101e-13
one O 0 1.4183631753903608e-13
individual O 0 3.6508190676305674e-13
was O 0 4.857607649455531e-10
found O 0 1.2289909758281259e-12
to O 0 3.5297117876101347e-13
have O 0 7.544003399403976e-13
an O 0 7.249159497506319e-13
FGFR2 O 0 1.1979046803389792e-06
VV269 O 0 3.4688124372905804e-08
- O 0 1.5288305732497065e-08
270 O 0 3.5579728052681503e-09
deletion O 0 5.562271088166426e-09
. O 0 1.8489456632408974e-09

To O 0 1.7792256556958819e-10
date O 0 1.4577966389595076e-08
, O 0 1.697696323799125e-11
our O 0 1.522141961085577e-11
detection O 0 4.509791706741595e-10
rate O 0 1.7846729302717357e-11
for O 0 2.5892196373056287e-12
TWIST O 0 3.0684048635265526e-09
or O 0 5.363542249225972e-11
FGFR O 0 8.496639338773093e-07
mutations O 0 3.7851327974736115e-12
is O 0 9.175719537478366e-14
68 O 0 6.84790115237921e-12
% O 0 6.69445781361494e-14
in O 0 2.861928088179061e-13
our O 0 2.868687509760548e-10
Saethre B-Disease 1 0.9999829530715942
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.158475981810625e-09
, O 0 1.3832077844222468e-12
including O 0 9.707448386797601e-12
our O 0 1.2488039491387326e-09
five O 0 4.2912493003477437e-10
patients O 0 1.4464800884850249e-11
elsewhere O 0 2.002401890133232e-11
reported O 0 6.724165928922998e-12
with O 0 7.821577586997197e-12
TWIST O 0 1.1647709925455274e-06
mutations O 0 1.1559185608689404e-08
. O 0 3.6594918206844795e-09

More O 0 2.791639697186099e-10
than O 0 4.020143246075136e-11
35 O 0 6.107395145171779e-10
different O 0 2.0759468796760494e-11
TWIST O 0 1.6764548860237483e-08
mutations O 0 2.1435037772521426e-11
are O 0 1.7013315398422407e-13
now O 0 7.22042529390475e-14
known O 0 1.2824798460622094e-13
in O 0 4.5431797972110555e-13
the O 0 1.081259994734074e-11
literature O 0 2.3664688264535272e-11
. O 0 2.4921878449823964e-10

The O 0 2.885691507970023e-08
most O 0 6.745763669879778e-11
common O 0 2.3668929663434035e-11
phenotypic O 0 4.386189744742808e-10
features O 0 3.029855533132064e-11
, O 0 3.0712737041083127e-13
present O 0 5.392710475220219e-13
in O 0 5.033658494364712e-13
more O 0 1.4716321626476007e-14
than O 0 7.758955289241878e-14
a O 0 1.4117305414951264e-11
third O 0 7.614415764578553e-10
of O 0 9.444179660533791e-09
our O 0 1.2043631869573801e-08
patients O 0 4.3315143138933365e-12
with O 0 8.646536720120779e-13
TWIST O 0 2.1391368676404454e-08
mutations O 0 1.0186638858822317e-11
, O 0 1.233095331572287e-12
are O 0 4.195475618393868e-13
coronal B-Disease 0 4.251517111697467e-07
synostosis I-Disease 0 2.5208035481227853e-07
, O 0 4.6950415777402554e-11
brachycephaly B-Disease 0 1.448610532861494e-06
, O 0 7.115673605895267e-10
low B-Disease 0 2.300685810041614e-05
frontal I-Disease 1 0.999984860420227
hairline I-Disease 1 0.9999991655349731
, O 0 1.3172631874169838e-08
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 0.9998807907104492
, O 0 7.174455696201676e-09
ptosis B-Disease 1 0.9999697208404541
, O 0 5.906047872983322e-10
hypertelorism B-Disease 0 3.775856748688966e-05
, O 0 2.118540343154507e-10
broad B-Disease 0 9.746928952836242e-08
great I-Disease 0 1.2125964303777437e-06
toes I-Disease 0 1.9946382963098586e-06
, O 0 2.0528896638172256e-10
and O 0 1.761710666237093e-09
clinodactyly B-Disease 0 8.721567428437993e-05
. O 0 3.066037379539921e-07

Significant O 0 1.3860073089233538e-08
intra O 0 3.6077897220820887e-06
- O 0 1.8984448502123996e-07
and O 0 7.72279795668851e-10
interfamilial O 0 8.726605642550567e-07
phenotypic O 0 9.806396406020212e-08
variability O 0 5.5634696849438114e-09
is O 0 7.754638944867942e-13
present O 0 9.207174953007602e-13
for O 0 9.191984846890211e-12
either O 0 7.636406507138815e-10
TWIST O 0 7.922943723315257e-08
mutations O 0 4.899760597254499e-10
or O 0 3.202352549802612e-10
FGFR O 0 9.623337246011943e-05
mutations O 0 1.3931422238044888e-08
. O 0 4.6853312340999764e-09

The O 0 1.983701203300825e-09
overlap O 0 6.142228392569393e-11
in O 0 1.1327920372561362e-11
clinical O 0 3.379709623274607e-09
features O 0 2.0108308074195946e-10
and O 0 8.369636581018192e-12
the O 0 1.4160022113185455e-11
presence O 0 1.6994966631905806e-12
, O 0 1.7813621942548014e-13
in O 0 2.346080415441959e-13
the O 0 4.5977176059419644e-12
same O 0 1.845377366541112e-12
genes O 0 1.2766761118328945e-13
, O 0 4.4984429050688723e-14
of O 0 2.1081185842125594e-12
mutations O 0 2.2394484541516518e-13
for O 0 1.8017588831499565e-13
more O 0 1.014756821052145e-14
than O 0 3.879172373946749e-14
one O 0 2.5706483382931244e-12
craniosynostotic B-Disease 0 5.211766165302834e-07
condition I-Disease 0 2.7215313821216114e-05
- O 0 2.500329387977729e-10
such O 0 6.71969563326158e-11
as O 0 1.197714011302864e-10
Saethre B-Disease 0 4.3702211769414134e-06
- I-Disease 0 2.4543576060409578e-08
Chotzen I-Disease 0 8.04654291641782e-07
, I-Disease 0 3.973928477951638e-11
Crouzon I-Disease 0 3.384195395028655e-07
, I-Disease 0 7.110880634320083e-11
and I-Disease 0 1.4286202776325752e-10
Pfeiffer I-Disease 0 2.662417728060973e-06
syndromes I-Disease 0 2.769919410638977e-05
- O 0 1.1402277095839963e-06
support O 0 2.6975337519274944e-08
the O 0 7.773124366394768e-08
hypothesis O 0 6.311464684216617e-10
that O 0 1.4263235774761296e-12
TWIST O 0 6.505459726469098e-09
and O 0 3.2158043589136653e-11
FGFRs O 0 6.511470473924419e-08
are O 0 5.20050148777873e-13
components O 0 6.122589241153165e-11
of O 0 1.5739422265514946e-10
the O 0 4.6883660148600015e-11
same O 0 2.3247096522099886e-12
molecular O 0 4.081543089617945e-11
pathway O 0 1.2721117562120021e-12
involved O 0 5.998397647186994e-15
in O 0 2.3920139279693872e-14
the O 0 1.0360281426161078e-12
modulation O 0 1.4372213141822243e-10
of O 0 1.597972865141628e-09
craniofacial O 1 1.0
and O 0 2.7062336016570043e-07
limb O 1 0.9332423210144043
development O 0 7.1790000610860716e-09
in O 0 7.911364618973238e-11
humans O 0 5.174267611596228e-11
. O 0 1.3673830297211698e-11
. O 0 7.021233594528553e-10

Mutation O 0 1.8749415353624954e-09
analysis O 0 4.5048891700316673e-11
of O 0 7.119869138705326e-10
UBE3A O 1 0.9989575147628784
in O 0 7.99396639195038e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.4715032850508578e-05
. O 0 1.5605845504751414e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0007286198670044541
AS B-Disease 1 1.0
) O 0 1.591361938058089e-11
is O 0 1.0255627727259742e-12
caused O 0 3.040217383398769e-11
by O 0 5.947664236116701e-12
chromosome O 0 4.0741037210523245e-09
15q11 O 0 2.5747363352479624e-08
- O 0 1.723893583438496e-09
q13 O 0 2.8104680804830195e-09
deletions O 0 2.4289265043719865e-11
of O 0 1.921761534628974e-11
maternal O 0 1.6808131275691807e-11
origin O 0 2.5976969056720756e-13
, O 0 8.2994124539406e-14
by O 0 1.7708443218744652e-12
paternal O 0 6.664281126944616e-09
uniparental B-Disease 0 0.0003765230067074299
disomy I-Disease 0 0.008441274985671043
( O 0 6.14296311596263e-08
UPD B-Disease 1 1.0
) O 0 1.4019846047985673e-11
15 O 0 8.398121087438426e-11
, O 0 8.673626595602502e-13
by O 0 1.077636330865106e-11
imprinting O 0 0.0031814947724342346
defects O 1 0.9963791966438293
, O 0 9.814799147023212e-12
and O 0 2.1958500556057414e-12
by O 0 1.10372583468632e-12
mutations O 0 5.92729120993396e-12
in O 0 1.1293101002951556e-11
the O 0 1.087718914938307e-09
UBE3A O 0 3.646330151241273e-05
gene O 0 1.0971291430905694e-08
. O 0 2.1292523300076027e-09

UBE3A O 0 0.003082600189372897
encodes O 0 4.9262379064884954e-08
a O 0 8.306432874860548e-09
ubiquitin O 0 1.5072481929223613e-08
- O 0 5.546496151254132e-09
protein O 0 5.93608828758363e-10
ligase O 0 1.0900376955225166e-11
and O 0 3.68122329494347e-12
shows O 0 3.6125330504788167e-10
brain O 0 1.1140539868392807e-07
- O 0 1.857159759310889e-09
specific O 0 9.696097258427017e-10
imprinting O 0 2.599210802145535e-06
. O 0 9.30038712709802e-09

Here O 0 6.603875846167284e-08
we O 0 5.485922827119794e-10
describe O 0 5.73620706489919e-10
UBE3A O 0 4.121000984014245e-06
coding O 0 2.4319525948612863e-08
- O 0 1.207882238674074e-09
region O 0 1.607850241835962e-10
mutations O 0 5.1321191220365936e-12
detected O 0 1.0590570087565254e-11
by O 0 1.3517045555772045e-12
SSCP O 0 1.6472002073442127e-07
analysis O 0 3.660478170575132e-12
in O 0 5.797632773169026e-12
13 O 0 2.5264283998183146e-09
AS B-Disease 1 0.9999990463256836
individuals O 0 1.0294961497875343e-12
or O 0 4.0414543239775114e-11
families O 0 8.896713227235509e-12
. O 0 1.8263036638543895e-09

Two O 0 3.5597784719954007e-09
identical O 0 6.92991442008406e-09
de O 0 1.7242517742488417e-06
novo O 0 2.279616069245094e-07
5 O 0 2.568085655241248e-08
- O 0 7.224228992797066e-10
bp O 0 4.155058797028488e-10
duplications O 0 2.5254840441135684e-09
in O 0 1.406989386110169e-10
exon O 0 2.7732799168234123e-08
16 O 0 4.626790062189912e-09
were O 0 1.1144292155762514e-09
found O 0 6.642957295355245e-10
. O 0 5.609960940233805e-09

Among O 0 3.6206468934096847e-09
the O 0 4.389489660638901e-09
other O 0 7.806646995511812e-11
11 O 0 2.8920599248749568e-09
unique O 0 2.045479341461487e-10
mutations O 0 1.205687546329548e-11
, O 0 4.378971577706503e-12
8 O 0 1.972348950829428e-09
were O 0 8.301356824169659e-11
small O 0 5.6914416755871056e-12
deletions O 0 2.93679906782085e-11
or O 0 1.4843877862991128e-11
insertions O 0 3.7768649319147585e-10
predicted O 0 1.958848416805381e-09
to O 0 7.308723938559414e-12
cause O 0 1.7184570433315116e-09
frameshifts O 0 6.16457143109983e-08
, O 0 7.713692531940985e-12
1 O 0 6.540054608983326e-10
was O 0 8.177863941583041e-11
a O 0 2.5000502969912963e-12
mutation O 0 1.8754133445861298e-13
to O 0 7.22571620050648e-14
a O 0 3.141776335618962e-12
stop O 0 1.3575547803956756e-11
codon O 0 1.0764571525823108e-11
, O 0 1.4278254143254565e-13
1 O 0 1.2157302942128467e-11
was O 0 1.7963902934625686e-11
a O 0 5.429683178764799e-12
missense O 0 2.697052581268622e-10
mutation O 0 3.137674148279146e-12
, O 0 2.2712204567152533e-13
and O 0 4.783831750870826e-13
1 O 0 9.335821005151956e-10
was O 0 6.611179936832912e-10
predicted O 0 4.0584816063393703e-10
to O 0 1.5293786202741355e-12
cause O 0 4.9563138315722455e-11
insertion O 0 5.116441992303322e-12
of O 0 1.0256948068665395e-10
an O 0 6.3545089329375415e-12
isoleucine O 0 3.945115523151799e-08
in O 0 7.987646655216452e-11
the O 0 5.906148903278563e-10
hect O 0 2.748786620543342e-08
domain O 0 4.929964769750939e-10
of O 0 8.750175584104625e-10
the O 0 1.809073002512207e-09
UBE3A O 0 9.244385523743404e-07
protein O 0 7.010846070354404e-11
, O 0 3.640520773295214e-13
which O 0 3.0796898234722314e-14
functions O 0 7.48644115450281e-12
in O 0 1.4729037434157988e-11
E2 O 0 5.151950688286888e-08
binding O 0 1.0286217710930856e-10
and O 0 1.9328188355371978e-11
ubiquitin O 0 4.5931203285221045e-10
transfer O 0 1.641669022944825e-09
. O 0 2.4552084809670305e-09

Eight O 0 4.725784563675006e-08
of O 0 6.153421328036757e-09
the O 0 1.0818882456575807e-09
cases O 0 2.8114947869806173e-11
were O 0 5.077460674129952e-11
familial O 0 8.267593276656271e-10
, O 0 2.680302160773529e-11
and O 0 1.806058080866535e-11
five O 0 2.2895263462885396e-10
were O 0 4.296958067140366e-10
sporadic O 0 1.4089721389609622e-06
. O 0 2.10645456633074e-08

In O 0 7.913210087195921e-10
two O 0 2.995019163232193e-11
familial O 0 6.1962439623641785e-09
cases O 0 2.120969198882161e-11
and O 0 4.237514852900581e-12
one O 0 6.126940317943697e-13
sporadic O 0 8.15889578120732e-09
case O 0 1.4162074291057536e-11
, O 0 1.2057167330520313e-12
mosaicism O 0 7.222538123130562e-09
for O 0 1.7740264118826232e-11
UBE3A O 0 1.8855942585105367e-07
mutations O 0 9.832968857551028e-13
was O 0 1.301271048380348e-12
detected O 0 3.646316376008235e-13
in O 0 8.92028828190436e-14
the O 0 3.650173479446961e-12
mother O 0 5.1832512891134e-13
of O 0 1.5528808794407212e-10
three O 0 5.726248364368303e-10
AS B-Disease 1 1.0
sons O 0 5.188689478075048e-10
, O 0 1.1574760247490268e-12
in O 0 2.130516466372634e-12
the O 0 9.80268019534769e-11
maternal O 0 1.860519932561644e-10
grandfather O 0 2.791980535654659e-10
of O 0 1.2519192793547518e-08
two O 0 1.3242228424914515e-09
AS B-Disease 1 1.0
first O 0 4.719665547270324e-09
cousins O 0 6.858979495483197e-10
, O 0 5.7043098543319015e-12
and O 0 2.82332642508043e-12
in O 0 4.360437705352993e-11
the O 0 1.8978099092237244e-09
mother O 0 1.0397707000953105e-10
of O 0 6.873638103144231e-09
an O 0 9.734251182891285e-10
AS B-Disease 1 1.0
daughter O 0 6.228547135833651e-07
. O 0 5.343150064618385e-07

The O 0 1.2920948755379413e-09
frequencies O 0 4.49227599563784e-11
with O 0 6.954289574756523e-13
which O 0 7.795063422869064e-13
we O 0 6.159232737550091e-13
detected O 0 2.6991236936474428e-12
mutations O 0 1.6215806095901814e-13
were O 0 1.4648985149912086e-12
5 O 0 1.4544061267829367e-11
( O 0 4.6565253416413e-14
14 O 0 3.8381602583681396e-12
% O 0 1.2338994572185652e-13
) O 0 4.050506048055907e-15
of O 0 1.4761767112500546e-12
35 O 0 1.5523876671988401e-12
in O 0 2.341886992489328e-13
sporadic O 0 5.472065578437935e-10
cases O 0 1.0670940043047694e-12
and O 0 1.3819709265838753e-12
8 O 0 4.769817318894809e-10
( O 0 3.227808645367425e-13
80 O 0 7.919664923861092e-12
% O 0 3.9848238098973143e-13
) O 0 2.2363228348136477e-14
of O 0 9.064297923355724e-12
10 O 0 3.016903393771031e-11
in O 0 1.991535235335018e-11
familial O 0 7.85702614081174e-09
cases O 0 1.1307375175073631e-10
. O 0 1.0974838399180342e-10
. O 0 2.8215541014731116e-09

The O 0 1.1936897408304503e-06
hemochromatosis B-Disease 1 1.0
845 O 0 1.5955941989886924e-07
G O 0 6.839911748102168e-08
- O 0 2.7463378238223868e-09
- O 0 1.8165208226506024e-09
> O 0 3.910770374204731e-09
A O 0 1.9897897218790206e-10
and O 0 4.778715400818867e-13
187 O 0 1.8994692971285865e-12
C O 0 1.469716431889978e-10
- O 0 2.0260183808407106e-10
- O 0 6.970129473593545e-10
> O 0 4.20538670553583e-09
G O 0 4.802812370030551e-09
mutations O 0 2.7397832266795596e-12
: O 0 1.5283069677417965e-14
prevalence O 0 8.041221334631476e-12
in O 0 2.3302310059834797e-13
non O 0 8.912041105091362e-10
- O 0 4.370857009661222e-10
Caucasian O 0 1.907150215529896e-09
populations O 0 5.328936181214772e-10
. O 0 1.0306451247998893e-09

Hemochromatosis B-Disease 1 0.996846616268158
, O 0 3.518614510866769e-09
the O 0 6.182635274853965e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999959468841553
, O 0 5.627315974310321e-11
leads O 0 1.8881327057407304e-10
, O 0 1.2050178563316472e-12
if O 0 3.4744204041592397e-12
untreated O 0 8.589331468300543e-10
, O 0 9.327329625894235e-14
to O 0 7.816353900930162e-13
progressive O 0 4.8649591917637736e-05
iron B-Disease 0 0.07135646790266037
overload I-Disease 0 8.01802525529638e-06
and O 0 1.1628216167736127e-09
premature B-Disease 0 4.7698947014396254e-08
death I-Disease 0 1.886313150123442e-08
. O 0 2.1786237258680785e-09

The O 0 9.291856258641928e-06
hemochromatosis B-Disease 1 1.0
gene O 0 1.0468823319342846e-07
, O 0 2.7864158202994815e-10
HFE O 0 0.00014534042566083372
, O 0 6.676055541721126e-11
recently O 0 1.5282720922105142e-10
has O 0 1.0646991101259662e-12
been O 0 1.1481049401115828e-12
identified O 0 2.6873447044051257e-12
, O 0 2.6694835578155995e-13
and O 0 7.463369115431884e-13
characterization O 0 1.69629796320514e-11
of O 0 2.782283847757583e-10
this O 0 4.462384455006241e-12
gene O 0 3.813241389316602e-12
has O 0 7.586609834277225e-14
shown O 0 1.6863860839450712e-13
that O 0 6.780165011789456e-15
it O 0 1.075999759534178e-14
contains O 0 1.0254663329427316e-13
two O 0 3.058720675830004e-14
mutations O 0 3.306432750749093e-14
that O 0 8.630743113192865e-15
result O 0 4.24627694117774e-12
in O 0 1.3240042742723723e-11
amino O 0 7.209290109333466e-11
acid O 0 2.2775290767912404e-12
substitutions O 0 1.746242907219031e-11
- O 0 6.168408839268835e-11
cDNA O 0 3.5200894976661345e-10
nucleotides O 0 2.141533044647259e-12
845 O 0 9.937351289068808e-12
G O 0 3.070510790070813e-10
- O 0 5.793382440444361e-10
- O 0 1.2189962372843866e-09
> O 0 3.8065763874328695e-09
A O 0 4.895341909616491e-10
( O 0 4.366631364762126e-14
C282Y O 0 9.686807779518691e-12
) O 0 5.108418435441006e-15
and O 0 2.419656339983263e-14
187 O 0 5.607617235142692e-13
C O 0 6.141197272935273e-11
- O 0 2.0730436811611241e-10
- O 0 7.644742616719213e-10
> O 0 4.408695630786497e-09
G O 0 1.888566814045589e-08
( O 0 7.15139622867178e-12
H63D O 0 2.626315449560934e-07
) O 0 6.60330947907517e-12
. O 0 7.668704560259698e-11

Although O 0 1.2778324389728368e-06
hemochromatosis B-Disease 1 1.0
is O 0 3.3053407233474275e-11
common O 0 3.9228368817201265e-12
in O 0 1.1900979333956396e-12
Caucasians O 0 5.009205272799022e-10
, O 0 1.2835082389278663e-12
affecting O 0 2.3861848261197416e-11
> O 0 3.8585479256170174e-10
= O 0 1.1112172293437084e-10
1 O 0 6.216364645261763e-10
/ O 0 1.3823994726713806e-10
300 O 0 7.403114037594916e-13
individuals O 0 2.3344812479062123e-15
of O 0 2.753960687967849e-12
northern O 0 8.505190302043886e-11
European O 0 2.2776691990800124e-11
origin O 0 4.856432638845887e-13
, O 0 2.698623117504406e-13
it O 0 9.012295711140553e-14
has O 0 8.728721277674253e-14
not O 0 2.1221433017435364e-14
been O 0 1.6520597010630939e-13
recognized O 0 7.413344027193403e-13
in O 0 3.5126526795777047e-13
other O 0 1.1484004936238024e-12
populations O 0 3.5850471896692326e-11
. O 0 2.3697760420660074e-10

The O 0 4.010176191115988e-09
present O 0 7.898579706955289e-11
study O 0 1.569231398469706e-12
used O 0 8.463172654002427e-13
PCR O 0 1.6110120182322163e-10
and O 0 4.667396243801525e-12
restriction O 0 3.448661634042338e-10
- O 0 3.541003254503572e-11
enzyme O 0 3.753333093544503e-13
digestion O 0 1.8053682463922693e-12
to O 0 3.441492154188791e-14
analyze O 0 1.9407926329408076e-13
the O 0 9.238343054961129e-14
frequency O 0 1.0221628231332769e-12
of O 0 1.4009521624377963e-12
the O 0 7.552501159191483e-12
845 O 0 2.0224960595172092e-11
G O 0 3.5841873913255995e-10
- O 0 3.2809965855307155e-10
- O 0 4.168887457467463e-10
> O 0 1.4763648081839165e-09
A O 0 2.2968833779390962e-10
and O 0 5.518426427625345e-13
187 O 0 2.671654781086219e-12
C O 0 7.29612203986818e-11
- O 0 4.1422535540514005e-11
- O 0 1.1963989521301954e-10
> O 0 1.0140047690399001e-09
G O 0 8.087512881616021e-10
mutations O 0 1.3169717053007624e-12
in O 0 6.985637654270682e-13
HLA O 0 3.0058525113396684e-11
- O 0 2.806162854168681e-12
typed O 0 1.0842995338405936e-12
samples O 0 4.507245949083097e-14
from O 0 1.0960784553202749e-13
non O 0 4.6787853591467865e-09
- O 0 3.5657568564495534e-10
Caucasian O 0 6.191275964129161e-11
populations O 0 3.658314103038851e-12
, O 0 1.822597519955671e-13
comprising O 0 2.286094273953876e-12
Australian O 0 1.3992390579531389e-10
Aboriginal O 0 1.92293958534151e-10
, O 0 2.6976671764489257e-12
Chinese O 0 2.255138957518721e-11
, O 0 5.930446238255893e-12
and O 0 1.0083224533108393e-10
Pacific O 0 2.0986226090258242e-08
Islanders O 0 1.919920293858013e-07
. O 0 2.0869787675792395e-08

Results O 0 6.929597340388227e-09
showed O 0 1.2663907700272148e-09
that O 0 1.658396727236e-12
the O 0 2.2931274934467893e-10
845 O 0 8.096480152985919e-10
G O 0 1.7518802408744705e-08
- O 0 1.7183070966098057e-08
- O 0 1.406389849023526e-08
> O 0 2.096674123208686e-08
A O 0 7.032076032587042e-10
mutation O 0 1.429578352397931e-12
was O 0 4.2321089124483513e-13
present O 0 9.011603854629235e-15
in O 0 2.0799348029489073e-14
these O 0 4.199298396669439e-15
populations O 0 1.761736542510873e-14
( O 0 6.002996083178519e-16
allele O 0 2.2714054148296157e-14
frequency O 0 1.034432630699078e-12
0 O 0 6.284406588868974e-12
. O 0 1.3531735038312554e-14
32 O 0 2.5358567242589336e-13
% O 0 3.290038936274754e-14
) O 0 4.0750238402306564e-15
, O 0 1.462080510914593e-14
and O 0 6.790289088388218e-14
, O 0 9.208452956318419e-14
furthermore O 0 1.0064500231485307e-12
, O 0 5.15349752889388e-14
it O 0 6.136504336357734e-14
was O 0 4.344374165965448e-11
always O 0 1.3834689687255985e-12
seen O 0 6.618841217297111e-13
in O 0 3.293749957023265e-14
conjunction O 0 4.408688691892593e-12
with O 0 2.8921767324802117e-12
HLA O 0 3.258585579146711e-08
haplotypes O 0 1.125818549496671e-09
common O 0 7.291458235803017e-12
in O 0 2.8022423791129736e-12
Caucasians O 0 1.3893886041671522e-10
, O 0 8.782198059054114e-13
suggesting O 0 6.054107302283507e-12
that O 0 7.677784731770221e-13
845 O 0 4.243625728594935e-10
G O 0 4.2234191255374753e-07
- O 0 4.69540373160271e-06
- O 0 1.3847165973857045e-05
> O 0 3.764239954762161e-05
A O 0 1.8853783956274128e-07
may O 0 2.144497426859182e-11
have O 0 1.4621703641696376e-13
been O 0 4.7635703161966886e-14
introduced O 0 2.0217227685807165e-13
into O 0 3.2120709087327115e-15
these O 0 1.0326096074264818e-15
populations O 0 7.252001326925675e-15
by O 0 2.1684778674308305e-14
Caucasian O 0 8.811602836278354e-11
admixture O 0 1.2415271033461295e-09
. O 0 3.86279097597253e-09

187 O 0 1.2749394429079075e-08
C O 0 2.1525533355770676e-08
- O 0 1.9987753674399755e-09
- O 0 2.5814617110597737e-09
> O 0 7.178972527555061e-09
G O 0 7.153262870929211e-09
was O 0 9.034787501471797e-11
present O 0 1.0257682290376602e-12
at O 0 2.6079199563766586e-12
an O 0 5.2868073857810245e-15
allele O 0 1.6807825205418514e-13
frequency O 0 4.2127360627697286e-11
of O 0 1.6840036309861972e-10
2 O 0 2.3139115512549324e-08
. O 0 1.488977385832868e-09

68 O 0 6.47666453801321e-08
% O 0 5.342285641640743e-11
in O 0 9.39755478296389e-12
the O 0 4.277641088568096e-11
two O 0 1.9838531858940023e-12
populations O 0 3.969979293222403e-12
analyzed O 0 4.826644726257934e-12
( O 0 1.6452996734125924e-12
Australian O 0 2.6917795770131647e-10
Aboriginal O 0 1.5364352845548268e-10
and O 0 1.057458374337239e-11
Chinese O 0 1.9568197062724835e-10
) O 0 1.728372653331256e-11
. O 0 9.255927690965393e-10

In O 0 1.41885780902129e-10
the O 0 1.2752615630162722e-10
Australian O 0 2.628722517439286e-10
Aboriginal O 0 6.721848772039962e-11
samples O 0 2.6270660993810147e-12
, O 0 2.4160846934240254e-12
187 O 0 1.8589227379628426e-11
C O 0 1.3432227552456766e-09
- O 0 4.974768597065804e-09
- O 0 2.8112257410839447e-08
> O 0 2.0492151975304296e-07
G O 0 1.2596073020176846e-06
was O 0 4.584431501086783e-09
found O 0 9.42792718894303e-13
to O 0 3.657180285064447e-14
be O 0 1.121211142592754e-13
associated O 0 1.1207819611627756e-12
with O 0 1.854583544028121e-12
HLA O 0 7.212257457922533e-08
haplotypes O 0 5.155140203605413e-10
common O 0 5.257311946893495e-12
in O 0 8.291474061158932e-13
Caucasians O 0 4.7235874933715394e-11
, O 0 8.603726319713831e-14
suggesting O 0 2.2385046561605032e-13
that O 0 1.3295595805145211e-14
it O 0 2.3591100861003467e-14
was O 0 5.202865915876487e-12
introduced O 0 9.311835157121973e-13
by O 0 4.566514809518918e-13
recent O 0 4.352792778994363e-11
admixture O 0 1.8254540101736438e-09
. O 0 2.7102553534774643e-09

In O 0 9.86042247852481e-10
the O 0 2.9222446684684655e-10
Chinese O 0 1.3578966076566168e-11
samples O 0 1.3872475217169278e-12
analyzed O 0 3.4801111645221816e-12
, O 0 5.544379517129217e-13
187 O 0 3.715095071854524e-12
C O 0 1.4361936639950557e-10
- O 0 1.3354153893807563e-10
- O 0 4.177037604691236e-10
> O 0 2.5810680259752417e-09
G O 0 4.049390600613378e-09
was O 0 1.0521596094381636e-10
present O 0 1.4041676892409538e-12
in O 0 2.1282663131838575e-12
association O 0 8.414840005355195e-12
with O 0 1.4940095872679332e-13
a O 0 9.003267749385646e-12
wide O 0 2.009415030201911e-11
variety O 0 1.6068438246641392e-11
of O 0 1.505008895286153e-10
HLA O 0 4.752239046723616e-09
haplotypes O 0 2.0963121516448524e-10
, O 0 8.311408744403337e-13
showing O 0 3.4573798685100243e-11
this O 0 3.5687178581191026e-13
mutation O 0 3.997368842184601e-13
to O 0 1.5079741112495465e-14
be O 0 4.1199797750929995e-14
widespread O 0 2.144043449725519e-11
and O 0 7.511869273314764e-13
likely O 0 8.737420509330462e-13
to O 0 1.3351204365165403e-13
predate O 0 5.165215824498581e-11
the O 0 1.1311015492287968e-11
more O 0 4.807134914739872e-14
genetically O 0 5.211526522830301e-12
restricted O 0 7.642573097814409e-13
845 O 0 1.167721214861972e-11
G O 0 3.829603301142015e-09
- O 0 5.47487957192061e-08
- O 0 1.6440206707102334e-07
> O 0 2.5390630753463483e-07
A O 0 2.4228688388916453e-08
mutation O 0 1.925344328412848e-09
. O 0 2.791916420274987e-10

Genotype O 0 4.679533958551474e-06
- O 0 2.322476859717426e-07
phenotype O 0 4.758300065077492e-08
correlations O 0 2.7034209537646348e-08
in O 0 8.56386606074011e-09
attenuated B-Disease 1 0.9999502897262573
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 6.383666914189234e-06

Germ O 0 0.00018351418839301914
- O 0 2.5683067406134796e-07
line O 0 1.2083300582332868e-08
mutations O 0 6.724695800208735e-11
of O 0 2.953506883507373e-10
the O 0 2.5737023623406685e-10
tumor B-Disease 0 1.2060451126671978e-07
suppressor O 0 1.8557838643573632e-07
APC O 0 1.5078110982003068e-09
are O 0 1.3158561967905463e-13
implicated O 0 6.4690223663954605e-12
in O 0 6.876345326478628e-11
attenuated B-Disease 1 0.9999932050704956
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.710187436605338e-05
AAPC B-Disease 1 1.0
) O 0 1.7223297441026908e-12
, O 0 1.836444001425755e-13
a O 0 1.7862862881565245e-12
variant O 0 3.7457672519281004e-09
of O 0 1.4939001857783296e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.0847743321137386e-07
FAP B-Disease 0 1.8356906821281882e-06
) O 0 1.0896786251102242e-10
. O 0 1.1972761670975274e-09

AAPC B-Disease 1 1.0
is O 0 7.600395313112074e-11
recognized O 0 1.6149860962433316e-11
by O 0 1.8064454825657966e-13
the O 0 2.529182375685113e-12
occurrence O 0 1.8529977552361743e-10
of O 0 7.170949944956817e-10
< O 0 7.091549747428871e-08
100 O 0 7.823077741164752e-10
colonic B-Disease 0 1.2157888704678044e-06
adenomas I-Disease 0 3.311243119696883e-07
and O 0 1.9799964348209825e-13
a O 0 1.7214846898244013e-13
later O 0 7.394989134934526e-12
onset O 1 0.9944961667060852
of O 1 0.9999446868896484
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.797425402960684e-11
age O 0 1.0452189114218413e-10
> O 0 9.006712042847198e-10
40 O 0 1.3629149024640963e-11
years O 0 6.087664226883671e-12
) O 0 1.5435948960002e-12
. O 0 1.2293345508229692e-10

The O 0 8.312281529754273e-09
aim O 0 4.996392632961033e-09
of O 0 7.602279916696375e-11
this O 0 8.159843785902898e-13
study O 0 6.713923037318659e-13
was O 0 1.820556552734054e-11
to O 0 4.693013555892578e-13
assess O 0 2.585313907399467e-10
genotype O 0 6.271580144101563e-09
- O 0 2.680448307756933e-09
phenotype O 0 8.754682534473091e-10
correlations O 0 1.2394685278138695e-09
in O 0 2.362092299534879e-09
AAPC B-Disease 1 1.0
families O 0 2.6171346340086998e-11
. O 0 1.4428801486943144e-09

By O 0 4.801051778358101e-10
protein O 0 1.2010202832257733e-09
- O 0 6.547681286050988e-10
truncation O 0 1.0176909626125052e-07
test O 0 3.908026791066277e-09
( O 0 3.792605552527251e-12
PTT O 0 1.1929178755920589e-09
) O 0 3.258364308618769e-14
assay O 0 3.590745973128251e-12
, O 0 6.688153177981937e-14
the O 0 1.2271640951674878e-12
entire O 0 4.142393893180607e-12
coding O 0 1.5933816766011688e-11
region O 0 7.1017961476849134e-12
of O 0 2.7085007847649223e-11
the O 0 2.608260829539688e-10
APC B-Disease 0 1.627027290673766e-09
gene O 0 3.857410918461923e-12
was O 0 6.589092552827802e-12
screened O 0 3.153641583986122e-11
in O 0 1.0776851416469113e-12
affected O 0 1.8239095130045957e-12
individuals O 0 1.330968484297007e-13
from O 0 5.040523554100673e-11
11 O 0 1.2828207218262833e-05
AAPC B-Disease 1 1.0
kindreds O 0 4.345294655649923e-06
, O 0 1.6439516414834543e-11
and O 0 5.951499709722086e-12
their O 0 1.3050447875140314e-11
phenotypic O 0 4.5804200432542075e-09
differences O 0 6.340443448049626e-11
were O 0 1.0791260940390401e-10
examined O 0 4.661531161076482e-09
. O 0 6.86238532665584e-09

Five O 0 1.0631428182250602e-08
novel O 0 2.843618673864512e-09
germ O 0 3.4377417250652798e-06
- O 0 1.0022264973486017e-07
line O 0 8.242959381732362e-08
APC B-Disease 0 1.5147413989780034e-08
mutations O 0 2.4648529745041614e-11
were O 0 1.4077672187695622e-11
identified O 0 1.012216265666721e-11
in O 0 2.1294653540504527e-11
seven O 0 1.8219059594315468e-09
kindreds O 0 2.960093752335524e-06
. O 0 3.31388037011493e-08

Mutations O 0 1.1647639519551944e-09
were O 0 3.285142158304666e-10
located O 0 5.834220606626417e-11
in O 0 2.50144783359163e-12
three O 0 2.1472999160027095e-12
different O 0 7.017871933535577e-14
regions O 0 2.988941386061761e-11
of O 0 9.063857997482216e-10
the O 0 1.2041426522557686e-08
APC B-Disease 0 4.330232172833348e-09
gene O 0 2.518103087156831e-11
( O 0 9.338495688543391e-13
1 O 0 2.570533508272632e-10
) O 0 1.4390184465036537e-13
at O 0 4.53001455791302e-11
the O 0 6.341580732760477e-11
5 O 0 1.163684149041444e-10
end O 0 1.1295821222834235e-10
spanning O 0 1.3961946876417386e-10
exons O 0 8.497054726497311e-10
4 O 0 6.260043594608078e-10
and O 0 6.463793042477128e-12
5 O 0 2.5929583480355234e-10
, O 0 4.1864931660251514e-12
( O 0 3.6293583698283893e-13
2 O 0 6.959312293108866e-11
) O 0 6.593109305036426e-14
within O 0 4.435095953686519e-12
exon O 0 7.455637496267542e-11
9 O 0 1.6597592744638234e-10
, O 0 1.073889133000605e-12
and O 0 1.2044709847558455e-12
( O 0 1.8909372223423204e-13
3 O 0 4.091480973467121e-11
) O 0 1.3952767164305407e-13
at O 0 1.0582821424742761e-10
the O 0 1.8934628864819558e-10
3 O 0 1.1226470864045268e-09
distal O 0 1.646588421166939e-10
end O 0 1.801314791771702e-10
of O 0 1.3657676378731054e-10
the O 0 4.6094092431836486e-10
gene O 0 1.864321808042746e-09
. O 0 1.4100527412352903e-09

Variability O 0 1.4278644933085616e-08
in O 0 1.6198480057294518e-11
the O 0 1.5226877050911192e-11
number O 0 1.5257352325992457e-10
of O 0 2.409835724392906e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.705905106064165e-06
most O 0 2.9618245789980735e-12
apparent O 0 3.2649261766382054e-11
in O 0 1.1910699206432729e-12
individuals O 0 3.882604636152318e-15
with O 0 7.150993664405136e-14
mutations O 0 1.6630149948099193e-12
in O 0 3.4558749091584406e-12
region O 0 1.5411841247647828e-10
1 O 0 6.501613913911797e-09
, O 0 5.890313844320039e-12
and O 0 2.2224991291786012e-10
upper O 1 0.9999542236328125
- O 0 0.060636188834905624
gastrointestinal O 1 0.9999959468841553
manifestations O 1 0.9201361536979675
were O 0 1.493541817998434e-10
more O 0 1.3434198686216453e-13
severe O 0 5.4291145801244056e-08
in O 0 1.2683287753390005e-10
them O 0 9.809038997721231e-11
. O 0 3.2968567875713006e-09

In O 0 4.203379866396517e-10
individuals O 0 7.054540870736481e-13
with O 0 1.0661826239585781e-12
mutations O 0 1.2776468251429751e-11
in O 0 2.2774431646110926e-11
either O 0 3.898180736539025e-11
region O 0 3.0679703222347143e-10
2 O 0 1.4648309232256906e-09
or O 0 2.249209716045919e-12
region O 0 3.759341102305136e-11
3 O 0 1.9792668892737453e-10
, O 0 2.488744887257921e-13
the O 0 1.3545151328689387e-12
average O 0 5.34570489003211e-13
number O 0 2.2941938279674723e-11
of O 0 2.723448577768295e-09
adenomas B-Disease 0 0.000324121443554759
tended O 0 2.405947108208295e-10
to O 0 4.355888479773418e-12
be O 0 1.199249553829329e-11
lower O 0 1.2896173018361878e-10
than O 0 2.884725200684099e-14
those O 0 3.5736336985317876e-14
in O 0 1.6052859996146251e-13
individuals O 0 3.600355046918819e-15
with O 0 2.2326319734492818e-14
mutations O 0 3.316154588341863e-13
in O 0 3.020251420921688e-13
region O 0 5.9975032752623836e-12
1 O 0 6.425763393602679e-11
, O 0 7.441730608473418e-14
although O 0 6.10890027799571e-13
age O 0 7.385149783378786e-12
at O 0 4.3057366005960773e-10
diagnosis O 0 4.424541177883157e-09
was O 0 3.3653824171864244e-10
similar O 0 9.380939774983332e-11
. O 0 8.662909278811526e-10

In O 0 1.230128621187987e-08
all O 0 7.266980617259833e-08
AAPC B-Disease 1 1.0
kindreds O 0 1.5396776689158287e-06
, O 0 1.1784611481102658e-11
a O 0 7.949326960576819e-12
predominance O 0 3.289601924194585e-09
of O 0 4.950102550083102e-09
right O 1 0.9995346069335938
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.6605086784693412e-05
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9865685701370239
sparing O 0 7.751091324337267e-09
was O 0 7.867759777013816e-10
observed O 0 4.129704356259367e-10
. O 0 1.9560771058468873e-10

No O 0 8.738024916965514e-06
desmoid B-Disease 1 0.9998944997787476
tumors I-Disease 1 1.0
were O 0 4.564616684632483e-09
found O 0 2.7039223290947767e-11
in O 0 3.308557594561279e-11
these O 0 1.8070339669051805e-10
kindreds O 0 2.9496277420548722e-06
. O 0 1.280224815047859e-08

Our O 0 4.3236234148480435e-08
data O 0 9.328914307715763e-10
suggest O 0 3.838740783579375e-11
that O 0 3.6071430673141613e-13
, O 0 3.190424270257952e-12
in O 0 5.211313047759347e-10
AAPC B-Disease 1 1.0
families O 0 1.3956819640975615e-12
, O 0 4.81199064969462e-13
the O 0 5.392003683823976e-12
location O 0 4.368731210124821e-10
of O 0 9.228041109032858e-10
the O 0 1.596112575441566e-08
APC B-Disease 0 3.3586951531106024e-07
mutation O 0 2.1188160115315213e-09
may O 0 3.781189805707186e-10
partially O 0 6.436490895822544e-09
predict O 0 7.328915807569558e-10
specific O 0 9.724317184822695e-11
phenotypic O 0 6.234287752704404e-08
expression O 0 3.4934573012179726e-09
. O 0 1.0543176331978543e-09

This O 0 1.522692194555475e-09
should O 0 4.1845554799024853e-11
help O 0 9.499515974190076e-13
in O 0 2.0501135511441504e-12
the O 0 5.4548480316052306e-11
design O 0 3.1040767733969687e-09
of O 0 9.12449782397573e-10
tailored O 0 1.9600854272994184e-09
clinical O 0 7.742442903690971e-06
- O 0 2.185241854135711e-08
management O 0 1.0358656155062818e-09
protocols O 0 1.0106682157839941e-09
in O 0 6.935453730413932e-13
this O 0 4.9513930959867516e-14
subset O 0 8.249635974344471e-10
of O 0 2.647788932552686e-10
FAP B-Disease 0 4.2127308574890776e-07
patients O 0 1.022953735607679e-10
. O 0 2.921362804442218e-11
. O 0 1.8434982429482716e-09

Wilms B-Disease 1 0.9998608827590942
' I-Disease 0 5.002869329473469e-06
tumor I-Disease 0 9.334902983937354e-08
1 O 0 1.0005529738066343e-08
and O 0 3.638427753527296e-11
Dax O 0 1.8410541088087484e-05
- O 0 1.1167512248277944e-08
1 O 0 1.67754556912314e-08
modulate O 0 3.671249138026411e-10
the O 0 2.0378078391392052e-10
orphan O 0 8.521509192727095e-11
nuclear O 0 2.073412330716451e-09
receptor O 0 1.3509499942332415e-11
SF O 0 2.4373841256419837e-07
- O 0 1.4902468148392245e-10
1 O 0 2.7522883971897727e-10
in O 0 9.14314305690278e-13
sex O 0 8.394524767148248e-13
- O 0 1.0684340781899615e-12
specific O 0 3.9311366661909375e-12
gene O 0 5.729818008948229e-11
expression O 0 4.462099578717016e-10
. O 0 2.8256458284303676e-10

Products O 0 9.559719416074586e-08
of O 0 4.17438137390036e-08
steroidogenic O 0 2.7265587050351314e-06
factor O 0 2.179093350207495e-09
1 O 0 1.3745316884694603e-08
( O 0 1.2139229725594003e-11
SF O 0 4.4489252104540356e-06
- O 0 4.079282689417596e-09
1 O 0 3.551504645926684e-09
) O 0 1.0948775523364485e-12
and O 0 2.0831182265257375e-11
Wilms B-Disease 0 1.319850798608968e-05
tumor I-Disease 0 1.4936308900814765e-07
1 O 0 1.0254024296330044e-08
( O 0 3.8678578569151245e-12
WT1 O 0 2.5190244556938524e-08
) O 0 7.692028166760706e-14
genes O 0 1.0366561802770471e-13
are O 0 7.66963939189888e-15
essential O 0 1.3989815165690866e-12
for O 0 6.11815882244765e-13
mammalian O 0 1.1604132099662934e-09
gonadogenesis O 0 9.500527031747197e-10
prior O 0 2.0721739601992084e-10
to O 0 5.1298097714091995e-12
sexual O 0 1.4463945666176592e-11
differentiation O 0 5.842608619133216e-10
. O 0 4.996704716653255e-10

In O 0 3.257072112017312e-10
males O 0 2.8342037917961083e-12
, O 0 1.5136936842852222e-11
SF O 0 0.0026125693693757057
- O 0 9.765724229282569e-08
1 O 0 3.559386385632024e-08
participates O 0 1.4826900124331743e-11
in O 0 8.938618616984029e-13
sexual O 0 5.261783847174129e-13
development O 0 3.227599394348135e-13
by O 0 3.59807805295001e-14
regulating O 0 1.4464001177327823e-11
expression O 0 9.576108135622707e-12
of O 0 1.66033142096067e-11
the O 0 4.114585339110022e-10
polypeptide O 0 2.716778624289873e-07
hormone O 0 3.226166001013553e-09
Mullerian O 0 3.148165106381384e-08
inhibiting O 0 5.089360044507885e-10
substance O 0 5.405529357460637e-10
( O 0 1.5709900394456078e-11
MIS O 0 1.5418904695252422e-06
) O 0 3.664796938140924e-11
. O 0 6.811823327623756e-10

Here O 0 2.4261149533799653e-08
, O 0 8.474876356245886e-11
we O 0 8.829078093630649e-12
show O 0 5.556899732028775e-11
that O 0 1.1448559981974693e-11
WT1 O 0 5.888645773666212e-06
- O 0 2.3928974357545485e-08
KTS O 0 2.69074098468991e-06
isoforms O 0 1.59282109724046e-09
associate O 0 7.097105125808412e-10
and O 0 3.7003147941583325e-12
synergize O 0 1.4602893338988565e-09
with O 0 1.4129131892248736e-11
SF O 0 0.0005799645441584289
- O 0 1.2438055030372652e-08
1 O 0 6.635931804055417e-09
to O 0 1.7204231095302447e-11
promote O 0 1.8494747955344337e-09
MIS O 0 2.1069719878141768e-05
expression O 0 6.137643726589204e-09
. O 0 6.286595133353501e-10

In O 0 1.2022740580874824e-09
contrast O 0 1.003943705946142e-09
, O 0 5.484960263757443e-10
WT1 O 0 3.445705078775063e-05
missense O 0 2.5724192553866487e-08
mutations O 0 2.943736227001281e-11
, O 0 1.6320156489245397e-13
associated O 0 3.4176459405566018e-12
with O 0 1.9399683682391755e-12
male B-Disease 0 5.913144973668238e-11
pseudohermaphroditism I-Disease 1 1.0
in O 0 6.51870890600037e-10
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.1899401403402408e-08
fail O 0 2.790280291264935e-07
to O 0 6.96100859245985e-12
synergize O 0 2.30951116009237e-08
with O 0 1.8663418033249002e-10
SF O 1 0.9999101161956787
- O 0 8.084232945293479e-07
1 O 0 4.0940952317214396e-07
. O 0 3.0627389513426806e-09

Additionally O 0 8.142292173829446e-09
, O 0 3.217700411672908e-11
the O 0 6.397977980743264e-11
X O 0 4.355191265403846e-07
- O 0 5.13042364147509e-09
linked O 0 2.242044239153529e-08
, O 0 1.0086643326134848e-11
candidate O 0 3.910677337515267e-11
dosage O 0 9.55123646839695e-10
- O 0 5.783355044863825e-11
sensitive O 0 5.926720780813355e-10
sex O 0 4.8148386319613046e-12
- O 0 9.407777508407822e-12
reversal O 0 3.098633016840324e-10
gene O 0 1.998613080589351e-11
, O 0 1.7939309976747198e-12
Dax O 0 2.3428410713677295e-06
- O 0 7.1599379758424675e-09
1 O 0 1.671847194018028e-08
, O 0 1.0076990457352775e-11
antagonizes O 0 3.277443871851915e-10
synergy O 0 4.884958410000806e-11
between O 0 3.155193814552426e-11
SF O 0 1.2252658962097485e-05
- O 0 1.2223232426222808e-09
1 O 0 9.505946030330392e-10
and O 0 9.343328194466594e-12
WT1 O 0 3.853852490465215e-07
, O 0 3.3458453022050527e-12
most O 0 5.93246860056823e-13
likely O 0 1.2858401951705567e-13
through O 0 1.7526670219314422e-14
a O 0 1.4018254330776247e-13
direct O 0 2.509470224936611e-13
interaction O 0 1.881867491698719e-12
with O 0 2.4462298506278124e-12
SF O 0 0.0015670679276809096
- O 0 1.5965606792178733e-07
1 O 0 1.559519944294152e-07
. O 0 3.0396405392707493e-09

We O 0 1.09650564183994e-08
propose O 0 2.0608470485683483e-09
that O 0 1.2331947962795908e-11
WT1 O 0 5.340246502782975e-07
and O 0 1.7678662700415515e-10
Dax O 0 0.00022069070837460458
- O 0 6.254869333588431e-08
1 O 0 4.4208992022731763e-08
functionally O 0 7.349549857593729e-10
oppose O 0 1.3010037491767434e-11
each O 0 1.2666412108628192e-14
other O 0 1.6224058907313502e-14
in O 0 1.7977527561226225e-13
testis O 0 9.889329632972732e-11
development O 0 9.20766718079391e-13
by O 0 2.118755203835837e-13
modulating O 0 4.27744728526136e-10
SF O 0 6.908497198310215e-06
- O 0 2.2368660257399142e-09
1 O 0 1.2440853680573127e-08
- O 0 6.718339773392756e-10
mediated O 0 4.5956049632422946e-08
transactivation O 0 4.381144265153125e-07
. O 0 1.4424611505248208e-10
. O 0 8.160588871319874e-10

A O 0 4.664433106427168e-08
mouse O 0 1.319568565527618e-09
model O 0 1.0503710401454924e-10
for O 0 2.3638591084562677e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9749201536178589
centre O 0 0.00020135790691711009
mutations O 0 5.345083931018735e-09
. O 0 2.3597461762392413e-09

Imprinting O 0 2.9921352506789844e-07
in O 0 1.7027699250604655e-09
the O 0 2.7582123252045676e-09
15q11 O 0 1.3575963464518281e-07
- O 0 2.36871215975043e-08
q13 O 0 5.262308633291468e-08
region O 0 8.352565861180494e-10
involves O 0 8.773094230252187e-12
an O 0 3.2773640030146767e-13
imprinting O 0 1.392940163214007e-08
centre O 0 1.60794158432509e-07
( O 0 8.23458315424297e-12
IC O 0 3.279986060533702e-08
) O 0 5.068466805112359e-13
, O 0 8.300521050661966e-14
mapping O 0 2.8386941235136742e-12
in O 0 1.0731028695851186e-12
part O 0 4.069756250751899e-12
to O 0 2.061425682930995e-12
the O 0 1.2488271527999473e-10
promoter O 0 1.4513046764363935e-08
and O 0 3.3720762293576456e-11
first O 0 4.688923138651546e-10
exon O 0 2.4554251965014373e-08
of O 0 4.978290224499915e-09
SNRPN O 0 0.00019767163030337542
. O 0 1.939362306302428e-07

Deletion O 0 8.009978813561247e-08
of O 0 1.904555624321347e-08
this O 0 8.251319072449803e-10
IC O 0 3.57553108187858e-06
abolishes O 0 1.2273471838852856e-07
local O 0 2.1430603958094707e-09
paternally O 0 7.89975446169322e-11
derived O 0 1.1293348661832806e-13
gene O 0 2.2885800242747334e-13
expression O 0 2.3100250011454104e-13
and O 0 2.382542913772958e-14
results O 0 2.0130353547281876e-12
in O 0 1.9708962240017058e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9988523721694946
PWS B-Disease 1 1.0
) O 0 2.2344397443418984e-09
. O 0 3.080120380971607e-09

We O 0 7.140953162121377e-09
have O 0 1.90124253146573e-11
created O 0 3.033041179323348e-11
two O 0 1.3811759028148352e-11
deletion O 0 2.74422123913709e-10
mutations O 0 1.249341168713114e-11
in O 0 1.6485264542343003e-11
mice O 0 7.726540518504521e-10
to O 0 1.1548347347845045e-11
understand O 0 5.9834928123336795e-09
PWS B-Disease 1 1.0
and O 0 9.425078079106086e-11
the O 0 5.870588737355575e-11
mechanism O 0 4.431202349497454e-10
of O 0 7.341784125092232e-11
this O 0 2.0064747086045998e-10
IC O 0 7.561930488009239e-06
. O 0 1.634480639722824e-08

Mice O 0 8.598995918873698e-06
harbouring O 0 3.5391865367273567e-06
an O 0 1.0753290619058831e-10
intragenic O 0 3.5710016277334944e-07
deletion O 0 8.84331630146562e-09
in O 0 3.776432777602423e-10
Snrpn O 0 6.083269909140654e-06
are O 0 7.673898322346773e-11
phenotypically O 0 1.2140915828240395e-08
normal O 0 1.5941888920067981e-09
, O 0 1.3602340824883652e-12
suggesting O 0 1.8294528218720796e-12
that O 0 3.413199559684603e-14
mutations O 0 2.3806770357154283e-13
of O 0 9.243397713909474e-11
SNRPN O 0 1.2651931683649309e-05
are O 0 1.125932897264037e-12
not O 0 3.3976386157666405e-13
sufficient O 0 1.4932599601280572e-10
to O 0 4.943596920714555e-11
induce O 0 3.545872459653765e-06
PWS B-Disease 1 1.0
. O 0 8.037694954055041e-08

Mice O 0 8.396916229003182e-08
with O 0 1.2569801970119254e-11
a O 0 1.1025864249392114e-10
larger O 0 1.3307389044869833e-11
deletion O 0 1.301493218752725e-10
involving O 0 4.583078274528196e-12
both O 0 1.505378460775475e-11
Snrpn O 0 1.1644051767234487e-07
and O 0 1.5106428608024913e-10
the O 0 1.038729013913553e-08
putative O 0 3.0285769753390923e-05
PWS O 1 1.0
- O 0 8.826276462059468e-05
IC O 0 0.04738687351346016
lack O 0 1.9694520858593023e-07
expression O 0 3.0016031327129156e-10
of O 0 2.3109981983626682e-10
the O 0 1.5391807273168467e-10
imprinted O 0 7.186750639043282e-10
genes O 0 8.534892410871908e-12
Zfp127 O 0 6.276617892098102e-09
( O 0 2.0643856415980544e-11
mouse O 0 2.5605522147031934e-09
homologue O 0 1.659058135317082e-08
of O 0 1.2546054195539114e-09
ZNF127 O 0 2.50978882831987e-06
) O 0 4.8916527078946004e-11
, O 0 8.111437910240937e-11
Ndn O 0 5.579620847129263e-06
and O 0 5.473912989550911e-10
Ipw O 0 3.1118682386477303e-07
, O 0 3.439213844269595e-11
and O 0 1.8267826487616823e-11
manifest O 0 1.928718296184684e-09
several O 0 1.524573696454201e-11
phenotypes O 0 1.842946240060428e-09
common O 0 6.575038291600777e-10
to O 0 4.467126224483309e-09
PWS B-Disease 1 1.0
infants O 0 2.1224359443294816e-05
. O 0 9.440253911918717e-09

These O 0 6.556601095386583e-11
data O 0 4.968808350880316e-11
demonstrate O 0 1.6758769719182887e-11
that O 0 1.9680909462901908e-13
both O 0 4.846642835329429e-13
the O 0 1.1944512219586034e-11
position O 0 3.514210797361805e-11
of O 0 4.077660431534014e-11
the O 0 1.3589232517041694e-10
IC O 0 7.868007401157229e-08
and O 0 5.81709463584601e-12
its O 0 6.484563320335868e-12
role O 0 4.524071655492845e-12
in O 0 1.7601596178848378e-12
the O 0 2.4227770831219964e-11
coordinate O 0 7.723088141231571e-11
expression O 0 4.6130066433391903e-10
of O 0 5.041564943297772e-10
genes O 0 1.8181541341921736e-12
is O 0 8.938955532809129e-14
conserved O 0 2.596063555099226e-12
between O 0 3.650033834207145e-12
mouse O 0 1.5327831226485955e-09
and O 0 8.091253361763862e-12
human O 0 1.0003210759723657e-10
, O 0 5.527063724232451e-13
and O 0 9.81202315578078e-13
indicate O 0 1.8363888968503383e-12
that O 0 2.669020061386862e-13
the O 0 4.690959773401282e-11
mouse O 0 6.806810115556061e-10
is O 0 2.9130747835649784e-13
a O 0 5.798558790244546e-13
suitable O 0 4.4196256897277575e-12
model O 0 6.262291032954614e-13
system O 0 3.308619220612763e-12
in O 0 2.2883005711647753e-13
which O 0 1.674871856873275e-13
to O 0 2.183278379050066e-13
investigate O 0 1.866197517699786e-12
the O 0 7.536183482814707e-12
molecular O 0 6.131248980745241e-11
mechanisms O 0 3.903016451700658e-11
of O 0 5.6474633997050105e-12
imprinting O 0 1.035013949546304e-10
in O 0 1.172366999487029e-12
this O 0 1.4782212997069277e-13
region O 0 1.4785500948577557e-11
of O 0 1.770706845038994e-11
the O 0 5.016832782533953e-11
genome O 0 6.071039504451647e-11
. O 0 7.525127743157611e-11
. O 0 2.525209374937276e-09

Mutations O 0 5.478791309521114e-10
of O 0 1.54666812690607e-09
the O 0 6.684978126614283e-10
ATM O 0 2.7953722891993493e-08
gene O 0 6.072658001454734e-12
detected O 0 4.200514502200603e-12
in O 0 2.6534588328658293e-12
Japanese O 1 0.5506210327148438
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999650716781616
: O 0 4.5654721322896386e-12
possible O 0 1.723747013182564e-11
preponderance O 0 2.3136719207172973e-09
of O 0 6.928929652261218e-11
the O 0 3.068255371996287e-11
two O 0 4.063775791568469e-12
founder O 0 3.435401740858879e-09
mutations O 0 1.94121024810201e-10
4612del165 O 0 8.408997054232259e-09
and O 0 1.3561844980358728e-09
7883del5 O 0 9.409783956471074e-07
. O 0 5.6275393234273e-08

The O 0 6.249610464692523e-07
ATM O 0 0.4385565519332886
( O 0 5.243331088422565e-06
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 9.660832550606457e-11
mutated O 0 1.0273624832801698e-11
) O 0 1.7663493145350304e-14
gene O 0 6.248617617256313e-13
on O 0 3.908767753912912e-11
human O 0 9.35353322573107e-11
chromosome O 0 2.5573405615375577e-09
11q22 O 0 5.663288149548862e-08
. O 0 5.6692512906408865e-09

3 O 0 4.182124087037664e-07
has O 0 1.0662040000886108e-10
recently O 0 8.4703188907298e-11
been O 0 6.321240839796127e-12
identified O 0 3.5969836050669945e-12
as O 0 5.623845031159369e-13
the O 0 5.097700039868869e-12
gene O 0 1.564509481168097e-12
responsible O 0 1.0710621842560664e-12
for O 0 4.5089227355054814e-14
the O 0 1.3372925813590064e-12
human O 0 1.6038875783053186e-09
recessive B-Disease 1 0.9999946355819702
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999939203262329
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.835437936838275e-10
. O 0 1.7946319985640002e-09

In O 0 8.990303501654751e-10
order O 0 7.253150163810673e-11
to O 0 4.097537196698364e-13
define O 0 1.0387315139970266e-11
the O 0 3.6079637541486242e-12
types O 0 8.242596709340244e-12
of O 0 1.8442569693633004e-10
disease O 0 3.373461652245169e-07
- O 0 1.3198850346007873e-10
causing O 0 2.0151426360914826e-10
ATM O 0 7.302310756074348e-09
mutations O 0 1.493571650905412e-12
in O 0 4.620272805837267e-13
Japanese O 0 6.5334174905729014e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.7086754172955807e-08
as O 0 5.842491421215179e-12
well O 0 4.932346306558977e-13
as O 0 1.9385912959548474e-13
to O 0 8.38797483077372e-14
look O 0 2.0106781365748783e-13
for O 0 1.0475064690434674e-13
possible O 0 7.793343227702199e-12
mutational O 0 2.0110351162117013e-09
hotspots O 0 9.498007935704322e-10
, O 0 1.4912716244167012e-12
reverse O 0 8.103520632296579e-11
- O 0 7.031493009374001e-12
transcribed O 0 6.864181532201252e-12
RNA O 0 1.9763377132747673e-12
derived O 0 8.121949056502046e-15
from O 0 2.4963550039505504e-14
ten O 0 6.519025770590492e-12
patients O 0 2.398804624988843e-13
belonging O 0 3.464851018944448e-12
to O 0 3.019963023143807e-13
eight O 0 6.261509366556339e-11
unrelated O 0 9.723506444458963e-10
Japanese O 0 0.11601126939058304
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.69670266620048e-12
was O 0 7.713239769113756e-11
analyzed O 0 2.490740469776598e-12
for O 0 3.567234127446056e-13
mutations O 0 8.423551569811116e-14
by O 0 1.6770775306679253e-13
the O 0 3.5038572737677853e-11
restriction O 0 2.0688722957018513e-10
endonuclease O 0 8.561673037199569e-10
fingerprinting O 0 7.122843426188297e-10
method O 0 2.0190436822442592e-10
. O 0 4.925866381455535e-10

As O 0 7.986508676616211e-10
has O 0 9.675322175384249e-12
been O 0 8.816503299993728e-13
reported O 0 3.5332817943135864e-13
by O 0 5.145544363857613e-13
others O 0 3.952066538609467e-12
, O 0 6.042613783473205e-13
mutations O 0 5.564275711196498e-13
that O 0 2.8579897237875074e-13
lead O 0 1.0996839550081461e-10
to O 0 8.711997269428284e-12
exon O 0 1.7498331672527456e-08
skipping O 0 3.792401503943665e-09
or O 0 5.3265451077644244e-11
premature O 0 1.6734374996829615e-10
protein O 0 3.340108745142345e-11
truncation O 0 1.9825030506126495e-08
were O 0 2.449323244224644e-10
also O 0 5.6557636178566906e-12
predominant O 0 3.91878057781625e-10
in O 0 4.550173779427347e-11
our O 0 1.0434784147861365e-09
mutants O 0 2.151814371131877e-08
. O 0 2.233685458818968e-09

Six O 0 5.1114259491669145e-09
different O 0 7.452987879630335e-12
mutations O 0 2.7619262779610132e-11
were O 0 1.627360746159212e-11
identified O 0 4.701114931365824e-12
on O 0 4.315396928689097e-10
12 O 0 2.737900461902143e-10
of O 0 2.6311605672013627e-10
the O 0 1.3225897044222279e-09
16 O 0 6.434035970670493e-09
alleles O 0 1.2669555682354172e-10
examined O 0 9.1078105057818e-09
. O 0 6.4212364314641945e-09

Four O 0 1.1417132128599405e-08
were O 0 8.14421474704119e-10
deletions O 0 1.1434647673169707e-09
involving O 0 1.3143280908067823e-10
a O 0 7.117655909105736e-10
loss O 0 8.161261888517402e-09
of O 0 4.127637609485646e-08
a O 0 4.69737537756032e-09
single O 0 4.505993800307806e-09
exon O 0 2.9806457746417436e-08
exon O 0 7.635041932019249e-09
7 O 0 9.63780077967158e-09
, O 0 2.7949946176941687e-11
exon O 0 2.983636004927348e-09
16 O 0 6.893393633689016e-10
, O 0 5.995573482131533e-11
exon O 0 1.230490020986963e-08
33 O 0 2.1055697185801137e-09
or O 0 9.688702062859988e-10
exon O 0 1.0046188236856324e-07
35 O 0 2.4481765947825807e-08
. O 0 1.1889954798505187e-08

The O 0 5.0473232704462134e-08
others O 0 1.4918714041911585e-09
were O 0 1.40702685613725e-10
minute O 0 5.224649046731145e-10
deletions O 0 1.490528117598089e-10
, O 0 8.412866757401272e-12
4649delA O 0 1.1203669103565517e-09
in O 0 7.111857630581753e-11
exon O 0 5.852761830738018e-09
33 O 0 5.268982472550476e-10
and O 0 4.190170085904832e-11
7883del5 O 0 6.208973335475321e-09
in O 0 8.038592014258938e-10
exon O 0 2.0493030206125695e-07
55 O 0 3.327510356143648e-08
. O 0 1.7923202477732048e-08

The O 0 3.0405818307599475e-08
mutations O 0 1.0564473740259928e-09
4612del165 O 0 3.2033315999768774e-09
and O 0 1.9481380050812014e-11
7883del5 O 0 1.3765589779168863e-09
were O 0 6.036193073155616e-11
found O 0 5.184022698959123e-13
in O 0 1.9129497790502936e-13
more O 0 6.67731488320205e-15
than O 0 2.2451013148724018e-14
two O 0 3.4393153472769833e-13
unrelated O 0 1.157154233544233e-11
families O 0 2.0719721850249485e-14
; O 0 1.016151206689915e-14
44 O 0 1.5269389485456086e-12
% O 0 8.911517899480581e-13
( O 0 3.038440267617848e-13
7 O 0 5.808762915116006e-10
of O 0 4.279846754773331e-10
16 O 0 3.5389391417339766e-10
) O 0 1.0556476076313895e-13
of O 0 3.813547134329243e-12
the O 0 1.3674613524861101e-11
mutant O 0 1.2340660437981654e-10
alleles O 0 5.669704614651161e-13
had O 0 2.732352104989344e-12
one O 0 1.4922295983512551e-13
of O 0 1.0138373647550214e-11
the O 0 8.543072499422877e-11
two O 0 4.516865700909811e-11
mutations O 0 8.362815440143834e-10
. O 0 4.577957124496379e-09

The O 0 1.8815054403376053e-08
4612del165 O 0 6.434183408288163e-09
mutations O 0 7.930154796720323e-12
in O 0 2.4797859078662388e-12
three O 0 6.698854795525455e-13
different O 0 9.04037586978157e-14
families O 0 3.60567627730006e-14
were O 0 2.0440691240325437e-12
all O 0 8.568472537398564e-13
ascribed O 0 2.6208611669797932e-11
to O 0 8.012281701823276e-13
the O 0 1.4179778878853355e-11
same O 0 1.9004377932452243e-11
T O 0 4.985205026564188e-10
- O 0 3.5323556579758275e-11
- O 0 1.0465155131367254e-10
> O 0 1.0035071662528594e-09
A O 0 3.932632830494498e-10
substitution O 0 5.7530889774337624e-11
at O 0 5.51085878319757e-11
the O 0 7.897400615408667e-12
splice O 0 3.8082736963929165e-10
donor O 0 2.5281613608152398e-11
site O 0 1.0221364726836768e-10
in O 0 4.001675379949887e-11
intron O 0 2.9590702865789353e-07
33 O 0 9.319621341319362e-08
. O 0 5.6399827030872984e-08

Microsatellite O 0 6.5276817622361705e-06
genotyping O 0 4.1629724023550807e-07
around O 0 2.536112153617154e-10
the O 0 7.874005336638845e-10
ATM O 0 1.7192094503570843e-07
locus O 0 1.2886443023774063e-09
also O 0 3.279254038451862e-12
indicated O 0 3.054450138997855e-12
that O 0 3.087388336523236e-14
a O 0 1.307904956213135e-12
common O 0 7.987837279642418e-13
haplotype O 0 2.1616508930066836e-11
was O 0 4.8373475364238416e-11
shared O 0 6.738324091412617e-13
by O 0 1.8064937295624722e-13
the O 0 3.738895044264057e-12
mutant O 0 2.2749859288073715e-11
alleles O 0 1.0114915768031155e-13
in O 0 5.265508623737702e-13
both O 0 6.8495860025552524e-12
mutations O 0 4.536440945113185e-10
. O 0 2.037342516914009e-09

This O 0 1.0052505494684283e-09
suggests O 0 9.009352985867025e-11
that O 0 4.945987738293189e-13
these O 0 1.0602934545980713e-12
two O 0 1.027484000659662e-11
founder O 0 2.099875828776021e-08
mutations O 0 7.361134618522058e-11
may O 0 3.144667512500199e-11
be O 0 7.958794213946963e-12
predominant O 0 6.36900310269084e-10
among O 0 1.790963536328627e-12
Japanese O 0 6.444807354455406e-09
ATM O 0 3.122284510936879e-07
mutant O 0 2.055152492630441e-08
alleles O 0 3.4026895190386597e-10
. O 0 4.278671306146009e-10

W474C O 0 9.314107956015505e-06
amino O 0 3.4867230169766117e-07
acid O 0 1.1263855403953471e-09
substitution O 0 1.7498547055794234e-10
affects O 0 3.876334203709725e-13
early O 0 1.5616474042731698e-12
processing O 0 2.3292544108766133e-12
of O 0 3.864981685391955e-12
the O 0 1.3784229833946338e-11
alpha O 0 1.8997780779073103e-11
- O 0 8.549731560746066e-13
subunit O 0 1.0756198015604568e-11
of O 0 4.0039811743941556e-11
beta O 0 8.300114373582801e-09
- O 0 3.3546305733267445e-09
hexosaminidase O 0 6.392107110286815e-08
A O 0 2.6276814057979436e-09
and O 0 1.1984145230001242e-12
is O 0 1.230317930867031e-13
associated O 0 6.038918930889592e-12
with O 0 6.553625003791197e-11
subacute O 1 0.9960014224052429
G B-Disease 0 0.286207914352417
( I-Disease 0 3.1028632996310535e-09
M2 I-Disease 0 4.840640485781478e-06
) I-Disease 0 4.175298995434673e-11
gangliosidosis I-Disease 0 1.5094096283974068e-07
. O 0 5.281320270000833e-09

Mutations O 0 3.7954672738038653e-10
in O 0 1.1689252343849432e-10
the O 0 9.982117354923048e-10
HEXA O 0 6.467047910518886e-07
gene O 0 1.2709822777567936e-11
, O 0 2.2004018615864873e-13
encoding O 0 1.0915866057196674e-13
the O 0 3.960819953269246e-12
alpha O 0 6.8073875529595096e-12
- O 0 7.709775743172664e-13
subunit O 0 9.793965985438469e-12
of O 0 3.3386054337780635e-11
beta O 0 2.1176362885455546e-09
- O 0 1.4226958500174192e-09
hexosaminidase O 0 2.447546876283013e-07
A O 0 2.1487956303190003e-08
( O 0 1.5066934245383523e-12
Hex O 0 3.474544874038088e-09
A O 0 3.227672018546457e-10
) O 0 3.162732594807864e-14
, O 0 3.630436744414198e-14
that O 0 1.5442123491374304e-13
abolish O 0 1.29374537749527e-08
Hex O 0 4.1089350588663365e-08
A O 0 6.480365688510403e-10
enzyme O 0 1.7329865840964853e-12
activity O 0 1.7285704118075174e-11
cause O 0 8.775410265116079e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.63404817349533e-09
TSD B-Disease 1 0.9964398741722107
) O 0 2.593875851955585e-12
, O 0 1.4011926384796536e-12
the O 0 8.224514402854766e-10
fatal O 0 0.025204353034496307
infantile B-Disease 0 5.4611609812127426e-05
form I-Disease 0 4.6075016024715865e-10
of I-Disease 0 2.187326941793799e-08
G I-Disease 0 4.57322045122055e-07
( I-Disease 0 1.5977975886816154e-11
M2 I-Disease 0 4.0969695191961364e-08
) I-Disease 0 9.541189453093901e-13
gangliosidosis I-Disease 0 2.7177042838388843e-09
, I-Disease 0 2.2019618767243898e-11
Type I-Disease 0 7.421395498141692e-09
1 I-Disease 0 2.1735037591952278e-07
. O 0 3.730331155082922e-09

Less O 0 3.558095151845464e-09
severe O 0 0.00010130520968232304
, O 0 1.1947075551077546e-09
subacute O 1 0.9999910593032837
( O 0 5.464537711219464e-09
juvenile O 1 0.9999580383300781
- O 0 7.912945676480376e-08
onset O 1 0.9999995231628418
) O 0 2.0333262851224276e-11
and O 0 6.112336192742873e-10
chronic O 1 1.0
( O 0 1.521736209264546e-10
adult O 0 1.996239404888911e-07
- O 0 7.1092878251022285e-09
onset O 1 0.9999147653579712
) O 0 7.754905116501287e-13
variants O 0 2.3407862453916906e-11
are O 0 2.2266271874796066e-14
characterized O 0 1.405034942558725e-13
by O 0 1.7510297072443996e-14
a O 0 8.651585307536958e-13
broad O 0 1.7573560662231813e-11
spectrum O 0 1.0396254170041974e-11
of O 0 2.2532889182996785e-12
clinical O 0 1.539428029495582e-09
manifestations O 0 8.410921736867749e-09
and O 0 3.3905368204863173e-13
are O 0 6.011087894802758e-15
associated O 0 7.375233101103093e-14
with O 0 7.22483393098862e-14
residual O 0 3.0310886245388247e-07
levels O 0 1.805499394436083e-08
of O 0 1.3885336214158883e-09
Hex O 0 2.2500139493786264e-06
A O 0 1.391558583918595e-07
enzyme O 0 4.507536358056008e-11
activity O 0 7.352943254268496e-10
. O 0 5.555821358527169e-10

We O 0 2.3024286921469184e-09
identified O 0 3.633894019028361e-10
a O 0 8.435590420630135e-11
1422 O 0 6.667396412751714e-09
G O 0 1.4403347847746772e-08
- O 0 1.576090813415476e-09
- O 0 8.839516896230748e-10
> O 0 2.5643496215366213e-09
C O 0 3.461646080893388e-09
( O 0 1.0823324658390532e-12
amino O 0 8.673067472542151e-12
acid O 0 3.655787153035439e-13
W474C O 0 2.0660823312618204e-12
) O 0 4.0347432413635374e-16
substitution O 0 1.8505567561731377e-14
in O 0 3.611083989745216e-15
the O 0 3.9785865980869126e-14
first O 0 2.68015671505209e-13
position O 0 3.646554846276073e-12
of O 0 2.3012059272020657e-11
exon O 0 6.228090265736341e-10
13 O 0 8.031997983382055e-11
of O 0 5.216663212515016e-10
HEXA O 0 0.0002036482037510723
of O 0 7.828544923427216e-09
a O 0 1.2146282868386038e-09
non O 0 1.161561371532116e-07
- O 0 2.8193001266885176e-09
Jewish O 0 5.459349861069995e-09
proband O 0 0.0007532444433309138
who O 0 2.068285542833337e-09
manifested O 0 1.952679440364591e-08
a O 0 4.392797681163074e-09
subacute O 0 0.002562045119702816
variant O 0 4.3486753042998316e-07
of O 0 1.9294573121442227e-06
G B-Disease 0 0.0013977906201034784
( I-Disease 0 1.680651284807766e-09
M2 I-Disease 0 4.5431102080328856e-06
) I-Disease 0 2.934934240084175e-11
gangliosidosis I-Disease 0 3.2004513172978477e-07
. O 0 1.3084863859091911e-08

On O 0 4.727452207475835e-08
the O 0 4.293781330488855e-09
second O 0 1.1017550427538936e-08
maternally O 0 2.87485657501918e-09
inherited O 0 1.8916372912514134e-09
allele O 0 8.327491474169335e-11
, O 0 1.5583386360831786e-12
we O 0 5.976522987442834e-13
identified O 0 6.968417813266181e-13
the O 0 3.640591734327403e-12
common O 0 3.4769980228332997e-09
infantile O 1 0.999975323677063
disease O 0 0.06269969791173935
- O 0 4.912461548656211e-09
causing O 0 7.880939278948063e-08
4 O 0 1.9260987471625413e-07
- O 0 2.2156265711004153e-09
bp O 0 8.618263880322274e-10
insertion O 0 3.6020267324410327e-10
, O 0 4.964649524819009e-11
+ O 0 5.994296170541702e-10
TATC O 0 1.5395279433505493e-06
1278 O 0 1.0457687693588014e-07
, O 0 2.2730775595114494e-11
in O 0 2.3220871406270938e-11
exon O 0 1.7997882295617273e-08
11 O 0 1.222125778355121e-08
. O 0 9.251026611423185e-09

Pulse O 0 0.029920998960733414
- O 0 2.3128761768020922e-06
chase O 0 3.1735467587168387e-08
analysis O 0 6.846741923416388e-11
using O 0 1.0571967606898269e-10
proband O 0 2.7083137510430788e-08
fibroblasts O 0 4.69728567153993e-09
revealed O 0 7.169824456365603e-11
that O 0 2.622458728038929e-13
the O 0 9.381651705497873e-12
W474C O 0 1.9221729763430062e-10
- O 0 1.6989076812023995e-11
containing O 0 3.451002331122943e-11
alpha O 0 1.0405007411229406e-10
- O 0 1.1388361607911346e-11
subunit O 0 5.038447437044624e-11
precursor O 0 7.957178249640151e-10
was O 0 6.852363121367944e-10
normally O 0 1.0963283232634513e-11
synthesized O 0 1.341115274389182e-10
, O 0 2.931184591922764e-12
but O 0 1.292598298362202e-12
not O 0 1.5762989871714872e-12
phosphorylated O 0 1.5647377837879617e-10
or O 0 7.719075487307159e-13
secreted O 0 2.847857583435087e-13
, O 0 1.7733853122960108e-13
and O 0 9.265170011416024e-13
the O 0 2.585708314128965e-10
mature O 0 2.8987848232908675e-10
lysosomal O 0 3.668627712727357e-08
alpha O 0 4.752617188685804e-10
- O 0 3.8471555802166435e-11
subunit O 0 1.386095821453992e-10
was O 0 5.787992862771318e-10
not O 0 4.282441068426124e-11
detected O 0 6.251611228691445e-09
. O 0 2.6843467448856018e-09

When O 0 5.001891678624304e-10
the O 0 5.375723199918525e-10
W474C O 0 1.931111048847356e-09
- O 0 2.947371166572843e-11
containing O 0 2.975983001696214e-11
alpha O 0 5.838083488862722e-11
- O 0 2.5699717961374935e-12
subunit O 0 3.753265406802875e-11
was O 0 2.2239239616528295e-10
transiently O 0 1.0687598583913882e-09
co O 0 9.457257199585456e-11
- O 0 3.673192826292304e-12
expressed O 0 1.3704214629414735e-12
with O 0 7.766743248972113e-14
the O 0 8.747997118363493e-12
beta O 0 1.9347958998827686e-11
- O 0 6.089321755164967e-13
subunit O 0 1.0169860830203103e-12
to O 0 1.0418654329026611e-13
produce O 0 5.9034960080139864e-12
Hex O 0 3.6241429857142293e-09
A O 0 7.933960155526165e-10
( O 0 7.388298414907901e-14
alphabeta O 0 7.008171820643838e-11
) O 0 2.641765488818875e-14
in O 0 8.300430113204749e-13
COS O 0 5.3905338859294716e-08
- O 0 6.996369039669048e-10
7 O 0 1.2422802786460352e-09
cells O 0 1.1374707599431932e-11
, O 0 1.9978640866235436e-13
the O 0 3.4241576588045497e-12
mature O 0 2.245403299058757e-12
alpha O 0 4.5911278251375975e-12
- O 0 3.258465545996625e-13
subunit O 0 2.1094740537686008e-12
was O 0 4.055127327678987e-12
present O 0 1.104757290423114e-13
, O 0 5.4019112859064744e-14
but O 0 3.131733899443788e-14
its O 0 2.2198563787937525e-13
level O 0 6.24671772642138e-11
was O 0 1.4631483524762956e-11
much O 0 7.331057961211529e-13
lower O 0 1.116845331494698e-11
than O 0 6.694479582361685e-15
that O 0 9.69677473489387e-15
from O 0 1.0268560090773149e-13
normal O 0 5.950663573006665e-11
alpha O 0 5.2812042933281234e-11
- O 0 2.7628574341548306e-12
subunit O 0 1.563203733123686e-11
transfections O 0 1.742045535602088e-10
, O 0 2.4683979361374286e-13
although O 0 3.569766010569353e-13
higher O 0 4.725537994763884e-13
than O 0 6.448587188323182e-15
in O 0 2.7314023438862467e-13
those O 0 4.1655107098012567e-13
cells O 0 3.596133156882897e-12
transfected O 0 7.225116772230367e-12
with O 0 8.979963785917498e-15
an O 0 9.126185728349293e-14
alpha O 0 4.821384264053208e-11
- O 0 1.3724782595148088e-11
subunit O 0 1.2964018747396722e-10
associated O 0 6.870131546987679e-11
with O 0 4.591675373255555e-10
infantile O 1 0.9998314380645752
TSD B-Disease 1 0.9786540865898132
. O 0 5.221427201718143e-08

Furthermore O 0 4.015640708843193e-09
, O 0 1.2386519761264925e-11
the O 0 9.864231827194647e-12
precursor O 0 2.4699450817955437e-11
level O 0 1.268106175622563e-10
of O 0 1.7463362353420386e-11
the O 0 4.639316361632062e-11
W474C O 0 8.529058570516668e-10
alpha O 0 1.460252474494439e-10
- O 0 1.3440747646809026e-11
subunit O 0 7.18597958915268e-11
was O 0 2.0754412077828022e-10
found O 0 2.100804990037841e-12
to O 0 1.0374691286185039e-13
accumulate O 0 1.133424137964717e-13
in O 0 2.670400250752436e-13
comparison O 0 3.256415319688455e-13
to O 0 2.8555266875021634e-13
the O 0 4.002805031877443e-11
normal O 0 7.98337118634862e-10
alpha O 0 4.115731366827191e-10
- O 0 2.7597884047492194e-11
subunit O 0 2.021625644665903e-10
precursor O 0 5.618267517881748e-10
levels O 0 7.559286530067766e-09
. O 0 7.492019782340265e-10

We O 0 2.4208073323706003e-09
conclude O 0 1.977004338016286e-09
that O 0 1.6600772406033526e-12
the O 0 7.563778076091765e-11
1422 O 0 4.0419383395828845e-08
G O 0 8.986506117025783e-08
- O 0 1.8658274925087426e-08
- O 0 1.3988909586259979e-08
> O 0 2.1230244229286654e-08
C O 0 1.3982001334511551e-08
mutation O 0 8.623352032444132e-12
is O 0 2.1824030890836912e-14
the O 0 3.4357092908512965e-13
cause O 0 1.554346755472391e-11
of O 0 2.392155640240645e-10
Hex B-Disease 1 0.652778148651123
A I-Disease 1 0.9987115859985352
enzyme I-Disease 1 0.9999988079071045
deficiency I-Disease 1 1.0
in O 0 2.4786678265442674e-10
the O 0 2.4791606545448985e-09
proband O 0 1.7069042996809003e-06
. O 0 6.89659307440138e-09

The O 0 1.2691480755222528e-08
resulting O 0 2.158472511837317e-09
W474C O 0 1.343149147459144e-08
substitution O 0 1.9018104868706587e-09
clearly O 0 1.731170588825659e-11
interferes O 0 1.010601108006326e-12
with O 0 8.373987945122299e-14
alpha O 0 2.2017141582120203e-11
- O 0 8.745790550102051e-13
subunit O 0 6.567736805795921e-12
processing O 0 1.7811601152328826e-11
, O 0 7.214285999103051e-14
but O 0 1.5523623646306398e-14
because O 0 2.1226535543909623e-14
the O 0 8.046311013309992e-13
base O 0 4.516691708145171e-12
substitution O 0 2.703819113047956e-11
falls O 0 4.387677027262171e-11
at O 0 1.8702891665944854e-11
the O 0 4.578910601377162e-12
first O 0 5.409628908020769e-12
position O 0 3.490842684361617e-11
of O 0 6.039808930768942e-11
exon O 0 1.4404877290985496e-09
13 O 0 3.5294342448644045e-10
, O 0 1.0635183705920426e-11
aberrant O 0 2.711256774645676e-10
splicing O 0 7.912576704960372e-10
may O 0 2.997630962897624e-11
also O 0 1.2127976574405341e-12
contribute O 0 1.1968856082015394e-13
to O 0 3.1458538031492456e-12
Hex B-Disease 0 7.973183528520167e-05
A I-Disease 0 0.00011207272473257035
deficiency I-Disease 0 1.5522537921697221e-07
in O 0 4.6933224667755624e-11
this O 0 1.6441835740121924e-11
proband O 0 4.727731450770989e-08
. O 0 2.585442138158811e-10
. O 0 1.5199617120487119e-09

Two O 0 4.377230522489839e-10
frequent O 0 1.2876345545365098e-09
missense O 0 1.466682988393586e-07
mutations O 0 6.2732308236945755e-09
in O 0 1.6303271621609383e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 9.173852959065698e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 8.511105598074664e-09
an O 0 3.311782492687598e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.274364500706952e-09
by O 0 6.112626816387814e-14
early O 0 3.0501932091198114e-09
childhood O 1 0.9999938011169434
deafness B-Disease 1 1.0
and O 0 6.1310870478337165e-06
goiter B-Disease 1 1.0
. O 0 1.1495977503273025e-07

A O 0 5.814196679665429e-09
century O 0 4.184150248498497e-10
after O 0 1.8557804598584582e-11
its O 0 7.675178851848652e-13
recognition O 0 9.525647631791756e-12
as O 0 4.1495362701482463e-11
a O 0 1.2512884062232388e-09
syndrome O 0 1.2388622394610138e-07
by O 0 1.345665245899852e-11
Vaughan O 0 4.6592759872510214e-07
Pendred O 0 3.180155181325972e-05
, O 0 8.553638353170356e-11
the O 0 8.209561919159114e-10
disease O 0 6.515072925594723e-08
gene O 0 2.1396559871100784e-11
( O 0 3.253424222735002e-12
PDS O 0 5.7293021882287576e-08
) O 0 2.2662830000217543e-13
was O 0 2.5029620737138103e-11
mapped O 0 2.2741529145942074e-11
to O 0 1.0341057003759868e-11
chromosome O 0 1.760190038169185e-08
7q22 O 0 6.153447316137317e-07
- O 0 8.802978754829383e-07
q31 O 0 1.2543163165901206e-06
. O 0 2.3041607732920966e-08

1 O 0 9.682389645604417e-07
and O 0 9.982231707894584e-10
, O 0 8.434384440869636e-11
recently O 0 5.34486732650663e-10
, O 0 6.508155125928283e-12
found O 0 2.8594088902211823e-12
to O 0 5.085024740690558e-13
encode O 0 1.4275436735489144e-11
a O 0 4.766197436723019e-10
putative O 0 1.7600523705141313e-08
sulfate O 0 7.479373564933667e-09
transporter O 0 8.849309551806073e-08
. O 0 3.801367221001328e-09

We O 0 1.9841286391653057e-09
performed O 0 3.035433016052025e-10
mutation O 0 4.273968765705627e-12
analysis O 0 2.738366174440121e-13
of O 0 1.6972300301287824e-11
the O 0 1.5926744645344826e-10
PDS B-Disease 0 5.477552349475445e-07
gene O 0 1.4101240140840243e-11
in O 0 8.27252242402432e-12
patients O 0 1.6513232838424874e-12
from O 0 8.918591234453876e-13
14 O 0 7.639567867201436e-10
Pendred B-Disease 0 1.7939299823410693e-07
families O 0 3.0609632124985187e-13
originating O 0 4.947442629188448e-12
from O 0 1.9977051696901116e-12
seven O 0 8.144112988162089e-12
countries O 0 1.3843558461026917e-12
and O 0 1.071581712253078e-11
identified O 0 1.4678842863435904e-10
all O 0 3.5524105879147783e-10
mutations O 0 1.7339677471639448e-09
. O 0 4.093639649482839e-09

The O 0 3.896030875694123e-08
mutations O 0 1.7123900908355694e-10
include O 0 7.961759029839754e-11
three O 0 2.4934892692285437e-11
single O 0 2.0302039216435475e-10
base O 0 4.0087211328199146e-10
deletions O 0 1.9499717118787174e-10
, O 0 1.1444940828386763e-10
one O 0 7.894934705987566e-11
splice O 0 1.0212294121458854e-08
site O 0 1.433859586619235e-09
mutation O 0 5.450541754048466e-11
and O 0 8.507619955744339e-12
10 O 0 1.3247534180749199e-09
missense O 0 1.284554684843897e-07
mutations O 0 1.1819881962082945e-08
. O 0 1.4494291100675127e-08

One O 0 4.702861655658808e-09
missense O 0 5.7699768518659766e-08
mutation O 0 1.2909782964865002e-10
( O 0 2.36386886627582e-12
L236P O 0 1.5918484586041615e-10
) O 0 2.314682462627865e-13
was O 0 1.0637131800383948e-11
found O 0 1.151277288563221e-13
in O 0 4.600537141454149e-14
a O 0 1.112405184785191e-13
homozygous O 0 2.472639931347387e-12
state O 0 2.370468730160391e-13
in O 0 4.63489815104301e-13
two O 0 5.401893667621172e-13
consanguineous O 0 3.1513536224991867e-09
families O 0 3.813848515428139e-14
and O 0 9.630609433845458e-14
in O 0 1.921408778610134e-12
a O 0 4.415412480085479e-12
heterozygous O 0 7.329240296269357e-13
state O 0 7.60035480731891e-14
in O 0 2.6232791980329573e-13
five O 0 1.8757469535946036e-12
additional O 0 1.7695959281249785e-11
non O 0 2.945741357507359e-07
- O 0 1.0457627297455474e-07
consanguineous O 0 6.932593805686338e-06
families O 0 2.2505808328077137e-10
. O 0 3.7149376908018894e-09

Another O 0 5.317425166850853e-09
missense O 0 3.1875355688271156e-08
mutation O 0 3.839333712063464e-11
( O 0 1.2434495707397408e-12
T416P O 0 2.2426664691987952e-10
) O 0 4.1594847141265823e-13
was O 0 1.6113861980859845e-11
found O 0 1.4099047721417152e-13
in O 0 7.183556321403023e-14
a O 0 2.364066245281321e-13
homozygous O 0 4.0628537860409875e-12
state O 0 3.665604061606209e-13
in O 0 2.3433000331807285e-12
one O 0 1.380169199413639e-12
family O 0 2.5434133423506144e-13
and O 0 2.2871269223130597e-13
in O 0 6.953083399839632e-13
a O 0 1.825458187387774e-12
heterozygous O 0 5.26724605771911e-13
state O 0 9.842121014664792e-14
in O 0 1.903055621074734e-12
four O 0 2.6462882232736185e-11
families O 0 1.870113439106369e-12
. O 0 1.6251415768664401e-09

Pendred B-Disease 0 0.14939096570014954
patients O 0 4.131968101006578e-09
in O 0 7.470982166246642e-11
three O 0 2.3182339381477846e-10
non O 0 1.3100144315103535e-05
- O 0 1.3044027014075255e-07
consanguineous O 0 8.175524271791801e-06
families O 0 3.050904581053393e-12
were O 0 2.2608323199668767e-11
shown O 0 1.2194205714632922e-11
to O 0 2.311749533120966e-12
be O 0 8.138864582285521e-12
compound O 0 6.703735344615325e-10
heterozygotes O 0 1.8096175946613613e-10
for O 0 4.8968971239071735e-12
L236P O 0 4.182205248781656e-09
and O 0 9.994934047075077e-11
T416P O 0 7.679473412736115e-08
. O 0 5.512062806189988e-09

In O 0 4.137218068134274e-10
total O 0 4.384032026294449e-10
, O 0 4.4711793295570956e-11
one O 0 4.523243325033066e-12
or O 0 2.305118769474479e-12
both O 0 5.257913895939659e-12
of O 0 1.3760700912079926e-10
these O 0 8.822003457614747e-13
mutations O 0 1.9954192107245888e-13
were O 0 7.617686863248263e-13
found O 0 5.3878142859719105e-14
in O 0 5.754473503608026e-14
nine O 0 7.319465346322662e-12
of O 0 5.894542493001254e-11
the O 0 4.561281075066148e-10
14 O 0 2.860646164393188e-09
families O 0 5.078039117673017e-12
analyzed O 0 3.167527573566531e-09
. O 0 1.3466224579872232e-08

The O 0 1.7404888641436855e-09
identification O 0 9.542495682524077e-10
of O 0 9.139826118165217e-10
two O 0 9.03751032343969e-11
frequent O 0 1.6851033901588153e-09
PDS B-Disease 0 6.494592071248917e-06
mutations O 0 1.6374642961003438e-11
will O 0 5.233558269916727e-13
facilitate O 0 8.189593751414814e-13
the O 0 1.2432598353595559e-12
molecular O 0 7.259409740001388e-10
diagnosis O 0 2.0966382408005302e-08
of O 0 9.806261580536102e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.826673034585838e-07

Insertional O 0 4.453909241419751e-06
mutation O 0 1.056294274270897e-09
by O 0 1.3154911188140161e-11
transposable O 0 8.092472825182995e-08
element O 0 6.690900278272238e-09
, O 0 9.450062954385885e-11
L1 O 0 5.783783407764531e-08
, O 0 1.2507376861634056e-12
in O 0 7.60607635902355e-12
the O 0 2.398763632172063e-09
DMD B-Disease 1 1.0
gene O 0 7.570561538772225e-11
results O 0 6.90997389515835e-12
in O 0 5.496013366634855e-12
X B-Disease 1 0.9999922513961792
- I-Disease 1 0.9998899698257446
linked I-Disease 1 0.9999982118606567
dilated I-Disease 1 0.9978996515274048
cardiomyopathy I-Disease 1 1.0
. O 0 6.384589141816832e-07

X B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999992847442627
linked I-Disease 1 0.9999980926513672
dilated I-Disease 1 0.9999886751174927
cardiomyopathy I-Disease 1 1.0
( O 0 5.188127705224588e-09
XLDCM B-Disease 0 0.37193000316619873
) O 0 6.593338613795907e-13
is O 0 3.6919567473732776e-14
a O 0 2.4347310192268656e-13
clinical O 0 2.105609908653605e-09
phenotype O 0 1.2952106054342494e-10
of O 0 2.397829157452236e-10
dystrophinopathy B-Disease 0 8.444954460173903e-07
which O 0 6.581653082780858e-13
is O 0 4.4072886074171536e-14
characterized O 0 7.375884300032942e-13
by O 0 3.7465809534648065e-13
preferential O 0 1.1568073610135343e-08
myocardial B-Disease 1 0.9997395873069763
involvement I-Disease 0 5.771985667202273e-10
without O 0 5.846705064538327e-12
any O 0 1.6457861549273867e-12
overt O 0 2.456781167392563e-10
clinical O 0 1.2969317708666495e-07
signs O 0 7.641264687663352e-07
of O 0 6.607983209505619e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.3360557204578072e-05

To O 0 7.400919460609501e-11
date O 0 4.469717040933574e-09
, O 0 3.234491017037322e-12
several O 0 2.6504278914825374e-13
mutations O 0 1.6763363700628142e-12
in O 0 4.319419388137957e-12
the O 0 1.2417886807725154e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 1.2379002782836324e-06
, O 0 4.352089244541446e-10
DMD O 1 1.0
, O 0 1.4554710518407954e-12
have O 0 4.4408978583246675e-14
been O 0 7.448475701238993e-14
identified O 0 2.0281341981277096e-13
in O 0 8.681570544920303e-13
patients O 0 6.618904101023115e-13
with O 0 9.096924602491896e-13
XLDCM B-Disease 1 0.9995784163475037
, O 0 2.6179735462816822e-11
but O 0 6.109086760769378e-13
a O 0 6.757809914957613e-13
pathogenic O 0 2.150111469076399e-12
correlation O 0 6.199020788875964e-13
of O 0 6.883191933093613e-12
these O 0 5.653603670288665e-13
cardiospecific O 0 3.4304383778049896e-09
mutations O 0 3.142017895862992e-11
in O 0 1.0013003620690242e-10
DMD O 1 1.0
with O 0 7.69000071954018e-11
the O 0 1.3537920118267266e-08
XLDCM B-Disease 1 0.7229592800140381
phenotype O 0 9.002765644083865e-09
has O 0 9.147037294265914e-12
remained O 0 4.512906437437181e-10
to O 0 1.816525012007797e-12
be O 0 3.057780070814253e-11
elucidated O 0 9.905218689709727e-08
. O 0 3.2653779680202888e-09

We O 0 3.1512394915722552e-09
report O 0 5.77334777207561e-11
here O 0 3.1690156141600534e-12
the O 0 2.1028697446551226e-12
identification O 0 1.1746417206970339e-11
of O 0 9.898042455103173e-12
a O 0 8.399430456718093e-12
unique O 0 1.608202113145829e-11
de O 0 5.0452442224013794e-08
novo O 0 6.375572070282942e-08
L1 O 0 2.597416148830689e-08
insertion O 0 1.7826556203415223e-11
in O 0 1.2945826702304153e-11
the O 0 1.4450855789771566e-10
muscle O 0 2.436724599874651e-09
exon O 0 4.387890939483441e-09
1 O 0 1.998859300300637e-09
in O 0 5.046016382515006e-11
DMD O 1 1.0
in O 0 6.015665049430297e-11
three O 0 8.222000857927014e-11
XLDCM B-Disease 0 0.026660040020942688
patients O 0 3.579034985046192e-11
from O 0 1.8518229484565385e-12
two O 0 8.507976441418652e-12
unrelated O 0 4.0965275616144936e-10
Japanese O 0 7.116074129953631e-08
families O 0 1.995276513455657e-11
. O 0 3.283740390713774e-09

The O 0 6.489695447697841e-09
insertion O 0 4.609699288948832e-10
was O 0 2.3555100092664816e-09
a O 0 7.397545770393421e-11
5 O 0 3.959774175221753e-10
- O 0 1.7712878039310986e-11
truncated O 0 1.959104406479284e-11
form O 0 1.3921936520278066e-12
of O 0 3.326642433743032e-11
human O 0 3.873175044577515e-11
L1 O 0 2.3407384364126926e-10
inversely O 0 4.0249647690303314e-13
integrated O 0 2.5861113597813734e-11
in O 0 8.508588798805672e-13
the O 0 1.9913909063418167e-11
5 O 0 1.6461455809579917e-10
- O 0 6.915634037651941e-11
untranslated O 0 1.8447195770932012e-08
region O 0 6.683584935496256e-11
in O 0 7.190842973153755e-12
the O 0 6.526929691164085e-11
muscle O 0 1.713900465993845e-09
exon O 0 2.0834538538849756e-09
1 O 0 7.928317447003508e-10
, O 0 2.7577861327031383e-13
which O 0 2.88396592035018e-14
affected O 0 4.6243526586123296e-14
the O 0 6.324372991452221e-13
transcription O 0 3.41935420949957e-12
or O 0 4.741753864556664e-13
the O 0 9.819255651632997e-12
stability O 0 4.108705820016212e-09
of O 0 1.333763377520114e-10
the O 0 1.4798146041883342e-10
muscle O 0 1.4684667370978843e-10
form O 0 4.251384660980406e-11
of O 0 7.760480591478824e-10
dystrophin O 0 4.765109640203491e-09
transcripts O 0 1.6563785065759618e-10
but O 0 8.863206934876799e-13
not O 0 6.012903255815313e-14
that O 0 1.8883989695312603e-14
of O 0 1.8589831063398066e-11
the O 0 6.865131241262645e-10
brain O 0 1.382997538712516e-07
or O 0 1.1037863956175897e-09
Purkinje O 0 0.1640629917383194
cell O 0 0.0002185135817853734
form O 0 1.2333231103056619e-09
, O 0 3.023735775653513e-11
probably O 0 9.161074676633518e-12
due O 0 2.700707435465688e-10
to O 0 3.98076726746896e-13
its O 0 1.4251378939802994e-12
unique O 0 1.3157364737656496e-12
site O 0 2.4909985532617362e-11
of O 0 3.711152218865976e-11
integration O 0 4.0314502847138556e-09
. O 0 6.611863945238383e-09

We O 0 2.3972359652901787e-09
speculate O 0 4.670996575639741e-11
that O 0 7.940195945405418e-14
this O 0 1.5059908683068453e-14
insertion O 0 2.539908116726969e-13
of O 0 2.9848380711516853e-12
an O 0 3.0725801677261577e-13
L1 O 0 7.94321675101628e-09
sequence O 0 3.56212490060237e-11
in O 0 1.112127390179296e-09
DMD O 1 1.0
is O 0 3.2408287858887164e-11
responsible O 0 1.73315268386931e-11
for O 0 5.91381598639279e-13
some O 0 6.42104845314205e-14
of O 0 2.0182562218695743e-12
the O 0 1.910234340499195e-12
population O 0 1.7677748709852593e-14
of O 0 2.257892440724052e-12
Japanese O 0 5.780615097705777e-09
patients O 0 8.239012770638876e-12
with O 0 5.240673346673663e-12
XLDCM B-Disease 0 0.025903688743710518
. O 0 1.8213710539782824e-09
. O 0 3.964363504138646e-09

Severe O 0 4.9418871640227735e-05
early O 0 6.407881301129237e-05
- O 1 0.9998158812522888
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 4.816952241526451e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.002122281352058053
red O 1 0.9370543360710144
hair O 0 0.004049253650009632
pigmentation O 0 0.00801978912204504
caused O 0 7.951840963471568e-09
by O 0 4.818194454525582e-11
POMC O 0 6.170669621496927e-06
mutations O 0 5.4457484528758204e-12
in O 0 1.732424642110486e-12
humans O 0 2.97753870170947e-11
. O 0 7.90174384257547e-11

Sequential O 0 1.3858328706817247e-08
cleavage O 0 1.567636354060653e-09
of O 0 2.4280395471976135e-09
the O 0 6.047304879075455e-10
precursor O 0 6.239528338447542e-10
protein O 0 1.759254200650595e-11
pre O 0 4.9202750318499966e-08
- O 0 5.251106660608684e-09
pro O 0 2.231956131026891e-07
- O 0 3.1753977225434937e-09
opiomelanocortin O 0 8.680780894110285e-08
( O 0 6.754595494040672e-11
POMC O 0 1.4120348623691825e-07
) O 0 2.0223166403206955e-13
generates O 0 1.4930646779695578e-12
the O 0 6.383788636599164e-11
melanocortin O 0 8.022537372198713e-07
peptides O 0 5.228507071741717e-10
adrenocorticotrophin O 0 2.25427356781438e-08
( O 0 4.9455963629929656e-11
ACTH O 0 4.081930526922406e-08
) O 0 6.220696158708294e-13
, O 0 2.9512343090176696e-12
melanocyte O 0 3.509299872916927e-08
- O 0 8.563980635756252e-09
stimulating O 0 8.417758046164181e-09
hormones O 0 4.2081046980335657e-10
( O 0 1.085868265963963e-12
MSH O 0 1.266855331749639e-08
) O 0 2.7202385174040708e-14
alpha O 0 8.855771476377894e-13
, O 0 5.747209603162258e-15
beta O 0 1.7702053473241108e-13
and O 0 4.961117711847589e-15
gamma O 0 3.509846764355312e-13
as O 0 4.479759729944695e-14
well O 0 3.24209721027334e-14
as O 0 7.628500695716633e-14
the O 0 1.0543643865976171e-12
opioid O 0 2.9683807495350933e-11
- O 0 3.060019251877044e-12
receptor O 0 2.4778853014578717e-12
ligand O 0 2.3468975027252093e-11
beta O 0 2.2396708931893272e-09
- O 0 1.7054351264533807e-09
endorphin O 0 2.1230208346878499e-07
. O 0 1.1173812985987297e-09

While O 0 2.1680615081010046e-09
a O 0 6.723938766883819e-11
few O 0 7.864930928747071e-12
cases O 0 1.8671837079958786e-12
of O 0 8.735334122711436e-10
isolated O 1 0.9814965724945068
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9072511196136475
have O 0 2.759988244893652e-11
been O 0 4.894002304106637e-12
reported O 0 1.766739532449435e-11
( O 0 1.1380979492159327e-11
OMIM O 0 6.795649824198335e-05
201400 O 0 2.7561419813082466e-08
) O 0 7.346679688213786e-13
, O 0 5.804102315952464e-13
an O 0 3.304494481867759e-12
inherited O 0 0.00015451300714630634
POMC O 1 1.0
defect O 0 0.02437441796064377
has O 0 5.743199665841914e-11
not O 0 2.7378455405568936e-12
been O 0 6.847966204509559e-12
described O 0 1.9525311922841126e-11
so O 0 2.8418252993878124e-12
far O 0 5.5317944669397434e-11
. O 0 5.698932437070425e-10

Recent O 0 1.9978060872283265e-10
studies O 0 4.35399459541852e-12
in O 0 1.8006637847456375e-12
animal O 0 1.1101108747524346e-11
models O 0 1.5811710664739853e-12
elucidated O 0 2.849557256823232e-10
a O 0 5.801139082994844e-12
central O 0 1.2848909436424805e-10
role O 0 4.250425966051408e-12
of O 0 7.874391416695659e-11
alpha O 0 1.7172119282093945e-09
- O 0 8.510712135034737e-10
MSH O 0 2.3986100927686493e-07
in O 0 5.48447311871092e-12
the O 0 4.4781265501336875e-11
regulation O 0 3.5816316579229124e-10
of O 0 3.753608882051118e-11
food O 0 2.334771091738741e-11
intake O 0 2.3865829559995e-13
by O 0 2.136846607861745e-14
activation O 0 6.885240207837873e-12
of O 0 7.348088110203932e-11
the O 0 1.5421074139876367e-10
brain O 0 6.760222159840623e-09
melanocortin O 0 5.116842416441614e-08
- O 0 6.877971803209704e-11
4 O 0 1.7035495236683573e-09
- O 0 8.735212553290239e-11
receptor O 0 6.501793547997181e-11
( O 0 5.5306414829814354e-12
MC4 O 0 3.2714256121835206e-06
- O 0 1.8249040056872445e-09
R O 0 8.706694032412088e-09
; O 0 6.040828102495122e-13
refs O 0 1.2510682767530312e-10
3 O 0 2.1111655826300257e-11
- O 0 6.35353531938665e-13
5 O 0 4.691044644747344e-13
) O 0 2.5220093661097493e-16
and O 0 8.905217363487043e-16
the O 0 4.971910605661503e-14
linkage O 0 1.4082351951216765e-10
of O 0 7.501596566150681e-11
human O 0 2.2073601613215033e-08
obesity B-Disease 1 1.0
to O 0 5.264313290842537e-13
chromosome O 0 1.877215397017018e-11
2 O 0 8.185541827687715e-11
in O 0 1.003693330704769e-12
close O 0 5.405091305088483e-12
proximity O 0 4.5010072058371264e-11
to O 0 1.213366863581089e-12
the O 0 1.5638426664743577e-10
POMC O 0 3.7178355682954134e-07
locus O 0 4.153123331351871e-11
, O 0 4.489496339792065e-13
led O 0 4.59221332835269e-12
to O 0 5.924993568690029e-13
the O 0 4.4853152442181354e-11
proposal O 0 3.906962427191463e-12
of O 0 5.5886779579128465e-12
an O 0 9.670687644777742e-13
association O 0 1.260885285070401e-10
of O 0 1.5595481572816539e-09
POMC O 0 0.09276889264583588
with O 0 4.626946603636384e-10
human O 0 2.804339055728633e-05
obesity B-Disease 1 1.0
. O 0 7.284674552465731e-08

The O 0 3.226879874418387e-09
dual O 0 6.612267622330137e-09
role O 0 4.40512099020296e-10
of O 0 5.662486035618031e-09
alpha O 0 1.5045748114062008e-07
- O 0 3.827224759334058e-08
MSH O 0 6.531984581670258e-06
in O 0 3.2143818856633644e-11
regulating O 0 1.5023796651192356e-09
food O 0 7.612440677817744e-10
intake O 0 2.0255817856362768e-10
and O 0 8.531344034001798e-12
influencing O 0 1.491678602860702e-08
hair O 0 4.1596131268306635e-06
pigmentation O 0 8.253545047409716e-07
predicts O 0 1.0203211886494756e-10
that O 0 3.3209444580146324e-14
the O 0 7.39153042158408e-13
phenotype O 0 3.677419913722391e-12
associated O 0 1.2735678397296502e-13
with O 0 5.225017602828244e-14
a O 0 3.8482196595968077e-11
defect O 0 9.527987288038275e-09
in O 0 1.6682842607362858e-10
POMC O 0 0.000834417762234807
function O 0 1.7654342432393832e-09
would O 0 3.1020479154125757e-12
include O 0 1.6935833291320534e-10
obesity B-Disease 1 1.0
, O 0 3.211602533394198e-13
alteration O 0 4.4613848726449135e-10
in O 0 7.360432402458983e-11
pigmentation O 0 0.07543689012527466
and O 0 8.422837538546446e-08
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999703168869019
. O 0 2.4585844471403107e-07

The O 0 5.120511126222027e-09
observation O 0 1.0293847196862771e-07
of O 0 2.5819100191171174e-09
these O 0 4.3313845565773335e-11
symptoms O 0 9.770307940470957e-08
in O 0 9.164784209314547e-11
two O 0 4.3502448171528485e-11
probands O 0 5.647937655339774e-07
prompted O 0 7.232018317537836e-10
us O 0 4.552150757036744e-12
to O 0 1.1188638990994315e-12
search O 0 1.2906625421194029e-11
for O 0 3.999765796347532e-12
mutations O 0 2.4343620869116123e-11
within O 0 5.573631556288206e-10
their O 0 5.320770490868654e-10
POMC O 0 5.082641564513324e-06
genes O 0 5.805196323649398e-10
. O 0 1.5064398617425923e-09

Patient O 0 2.408462478342699e-06
1 O 0 1.3063762480669538e-06
was O 0 2.014030364705377e-08
found O 0 1.1406492070320517e-11
to O 0 5.15302861145428e-13
be O 0 1.372283905433369e-12
a O 0 1.0799656308124739e-11
compound O 0 2.1578949738199071e-10
heterozygote O 0 1.3756344674487053e-10
for O 0 3.9780044492829236e-13
two O 0 2.2968096608649846e-13
mutations O 0 9.11196248662427e-13
in O 0 3.1285247829859752e-12
exon O 0 7.611569152743414e-10
3 O 0 1.0758629542806375e-09
( O 0 1.370675166249835e-12
G7013T O 0 6.705563881936882e-10
, O 0 3.612970382940728e-12
C7133delta O 0 6.040307143351242e-10
) O 0 7.481694300551234e-14
which O 0 1.5130735884051963e-14
interfere O 0 8.483207761473058e-14
with O 0 1.1579782339715856e-14
appropriate O 0 1.527588602487362e-12
synthesis O 0 3.382260096995715e-11
of O 0 2.4134388931784656e-10
ACTH O 0 3.116046514151094e-07
and O 0 4.268107811622457e-10
alpha O 0 2.6249105644637893e-07
- O 0 4.511173017363035e-07
MSH O 0 0.00041802984196692705
. O 0 2.101590723668778e-08

Patient O 0 1.4057239638987085e-07
2 O 0 1.7132673946207433e-08
was O 0 4.159356470356812e-10
homozygous O 0 1.4685171134676267e-10
for O 0 3.845972151861332e-12
a O 0 1.1271625126318963e-11
mutation O 0 2.866343664156834e-12
in O 0 3.1925915904007507e-12
exon O 0 5.372247646739936e-10
2 O 0 4.830370547992402e-10
( O 0 9.27238320846957e-13
C3804A O 0 2.0668886047126023e-10
) O 0 1.1512713525563267e-12
which O 0 7.102040310014157e-12
abolishes O 0 1.5515935558596539e-07
POMC O 0 3.6595051824406255e-06
translation O 0 4.547809684396498e-09
. O 0 1.958250672728923e-09

These O 0 3.439924178838538e-10
findings O 0 3.5989485697163204e-11
represent O 0 1.3736168235842228e-12
the O 0 3.940850683975539e-12
first O 0 1.354047624892163e-12
examples O 0 1.1228280458186468e-11
of O 0 1.7202467228472074e-10
a O 0 2.2699517820967685e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 5.3491400198169e-10
the O 0 2.0756352192563554e-10
POMC O 0 7.661667922320703e-08
gene O 0 5.662387876290143e-13
and O 0 2.096291856193335e-14
define O 0 7.050989024419418e-13
a O 0 1.9493005300186272e-12
new O 0 3.733041376019486e-10
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 2.825039700837806e-05
resulting O 0 4.2735450594966196e-12
in O 0 4.971748991775167e-14
early O 0 1.0570404995746685e-08
- O 1 0.5035889148712158
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 6.3639122345193755e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.00021086796186864376
red O 0 0.00040862898458726704
hair O 0 1.048890453603235e-06
pigmentation O 0 5.024002348363865e-06
. O 0 1.1831530200012708e-10
. O 0 5.543394632212539e-10

A O 0 5.3912536657207966e-08
European O 0 4.1439172093760135e-09
multicenter O 0 1.0620042445452782e-07
study O 0 3.900144096569136e-11
of O 0 9.844720949558905e-08
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.951367342329263e-10
classification O 0 1.7874988156307836e-09
of O 0 1.4220684352306279e-10
105 O 0 2.2173926583768377e-10
mutations O 0 5.777439616126701e-13
and O 0 1.8323362304447505e-13
a O 0 6.957978572648404e-13
general O 0 8.121000399929912e-12
system O 0 7.339428544084203e-12
for O 0 1.955578033492264e-13
genotype O 0 8.016565709867418e-12
- O 0 2.5077969215137053e-12
based O 0 4.555477522982798e-12
prediction O 0 6.3903979885537865e-09
of O 0 1.8745553997945308e-09
metabolic O 1 0.5997393131256104
phenotype O 0 2.296885526220649e-08
. O 0 5.891691023940382e-10

Phenylketonuria B-Disease 1 0.9994980096817017
( O 0 1.0336403022392915e-07
PKU B-Disease 0 0.0007353475084528327
) O 0 3.5698378281212584e-11
and O 0 1.2958284445474533e-10
mild B-Disease 1 0.9995899796485901
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.00016563713143114
MHP B-Disease 1 1.0
) O 0 5.529916455304651e-11
are O 0 3.065909678912071e-11
allelic B-Disease 1 0.6737399101257324
disorders I-Disease 1 0.9999954700469971
caused O 0 2.175696067752142e-09
by O 0 1.2324957677709025e-12
mutations O 0 4.624927827864833e-13
in O 0 5.017267525921076e-13
the O 0 1.1711875393116689e-11
gene O 0 1.0399725351717404e-11
encoding O 0 7.96065019459391e-11
phenylalanine O 0 1.6856441575896497e-08
hydroxylase O 0 1.005859360247996e-07
( O 0 1.9238273474275758e-10
PAH O 0 3.813627699855715e-06
) O 0 1.0779822867679201e-10
. O 0 1.1165185442862935e-09

Previous O 0 1.9234188641803485e-07
studies O 0 3.425624506281366e-10
have O 0 3.0310096880287185e-12
suggested O 0 2.9718404386674946e-12
that O 0 5.370833308258535e-14
the O 0 1.6771495650602652e-11
highly O 0 2.967674717080371e-10
variable O 0 9.250638477453776e-09
metabolic O 0 0.2148217111825943
phenotypes O 0 2.8319831812950724e-08
of O 0 3.417092955260159e-07
PAH B-Disease 1 1.0
deficiency I-Disease 0 7.693137013120577e-05
correlate O 0 5.72385694397326e-10
with O 0 4.298630340571208e-10
PAH O 1 0.9997966885566711
genotypes O 0 5.977005343993369e-07
. O 0 3.6635146027919063e-09

We O 0 2.93031687803591e-09
identified O 0 8.08366776294811e-11
both O 0 6.176894499360097e-12
causative O 0 8.303768228579145e-10
mutations O 0 1.113040996175707e-11
in O 0 1.1270377860139735e-11
686 O 0 2.95621904733423e-09
patients O 0 1.472926121348639e-11
from O 0 8.71803150503947e-12
seven O 0 1.4538805714892078e-09
European O 0 2.984679170481286e-08
centers O 0 1.7700713783597166e-08
. O 0 6.34190122639211e-09

On O 0 7.0308199262569815e-09
the O 0 6.21008106049814e-11
basis O 0 2.8895866602263176e-11
of O 0 2.3962507325614446e-11
the O 0 1.7914631583737517e-11
phenotypic O 0 4.4034682566973515e-09
characteristics O 0 1.0710795445012522e-10
of O 0 1.4335060916081943e-10
297 O 0 1.3084058281265243e-09
functionally O 0 5.5399226539520896e-08
hemizygous O 0 2.8432300496206153e-06
patients O 0 4.497917663326412e-11
, O 0 1.777422718556021e-12
105 O 0 2.8512101013511426e-10
of O 0 3.4134409188091297e-10
the O 0 2.3052133812928588e-10
mutations O 0 3.2507260772085544e-12
were O 0 4.381268785269565e-12
assigned O 0 2.801077512298855e-12
to O 0 5.305581278133853e-13
one O 0 1.6508067699275153e-12
of O 0 9.070546397316193e-11
four O 0 3.871003517730287e-11
arbitrary O 0 8.157993391932905e-09
phenotype O 0 3.9986125521807026e-09
categories O 0 4.8450625733664765e-09
. O 0 1.5196659486349517e-09

We O 0 1.4026921846266305e-09
proposed O 0 3.2168859243064674e-10
and O 0 6.26690669844332e-12
tested O 0 4.2606307371073626e-11
a O 0 4.564479436780511e-12
simple O 0 1.581140817233373e-12
model O 0 1.1004669669013173e-13
for O 0 1.5088834858217187e-14
correlation O 0 4.2778977517483885e-13
between O 0 6.888126137180595e-13
genotype O 0 1.2297098062052925e-10
and O 0 5.935900642545233e-12
phenotypic O 0 8.594695621866322e-09
outcome O 0 4.024382160849882e-09
. O 0 1.1078740147496546e-09

The O 0 2.821947120423829e-09
observed O 0 6.638220528820682e-10
phenotype O 0 2.0026093283664892e-10
matched O 0 2.7226460669327324e-11
the O 0 1.2595625931144383e-11
predicted O 0 1.672563060273191e-10
phenotype O 0 2.3838270767073677e-12
in O 0 1.2709180496200956e-13
79 O 0 7.297788241766856e-12
% O 0 1.879398736246915e-13
of O 0 5.03736852577874e-12
the O 0 1.9628821137929187e-11
cases O 0 4.4324380320606704e-13
, O 0 9.981887549598972e-14
and O 0 3.506238336237373e-14
in O 0 3.132703243948626e-13
only O 0 6.65326843098113e-13
5 O 0 2.3030237439325418e-11
of O 0 2.8238123644941382e-11
184 O 0 9.168158593420017e-11
patients O 0 2.9867514711456877e-12
was O 0 9.479433904502343e-11
the O 0 2.082069412712162e-11
observed O 0 2.441304276790124e-11
phenotype O 0 1.4868863518896491e-12
more O 0 2.3003761015597283e-15
than O 0 1.6771277766623564e-14
one O 0 1.687048802523003e-13
category O 0 2.074007632302255e-11
away O 0 6.47045394694401e-12
from O 0 6.23380904188342e-13
that O 0 1.5224488336684772e-12
expected O 0 6.58472720793668e-10
. O 0 1.4975618523038747e-09

Among O 0 2.180111868810286e-09
the O 0 1.9352923708026992e-09
seven O 0 1.843620395236556e-10
contributing O 0 3.8046562428339925e-11
centers O 0 6.336478564072934e-11
, O 0 6.917750335240502e-13
the O 0 6.1963168970780025e-12
proportion O 0 6.348088287672082e-12
of O 0 6.114082157226974e-11
patients O 0 7.183450340640662e-13
for O 0 5.38703576104943e-13
whom O 0 9.493104002541997e-13
the O 0 4.230819687645049e-12
observed O 0 1.0913795041311847e-11
phenotype O 0 1.5530835081531413e-12
did O 0 8.617785033759179e-14
not O 0 2.1421026167060472e-14
match O 0 5.432337565891565e-11
the O 0 3.5263220295178588e-12
predicted O 0 3.949792229396287e-11
phenotype O 0 1.2366283127715483e-12
was O 0 1.4520881242222061e-12
4 O 0 1.483244603528444e-11
% O 0 1.7490745180329115e-13
- O 0 2.428878929580658e-12
23 O 0 4.296169323070309e-11
% O 0 1.3192249376237086e-11
( O 0 9.589889646277605e-12
P O 0 2.9856047945031605e-07
< O 0 2.0499326680578633e-09
. O 0 2.7154669571954893e-12
0001 O 0 2.2084051920501224e-07
) O 0 3.536111494221138e-14
, O 0 8.315856073952237e-15
suggesting O 0 3.253483027150332e-14
that O 0 6.786061102256175e-16
differences O 0 3.417825037202969e-14
in O 0 2.8043248333307208e-14
methods O 0 8.033904487850241e-13
used O 0 4.2027938475328736e-14
for O 0 2.6009194255792456e-13
mutation O 0 7.029226159471769e-12
detection O 0 1.094659918265961e-09
or O 0 7.091292830718743e-12
phenotype O 0 5.212167919488309e-10
classification O 0 4.298966460591913e-10
may O 0 2.2978975493248566e-12
account O 0 3.601126355120589e-14
for O 0 2.288107210483576e-14
a O 0 1.0879407726267776e-13
considerable O 0 1.2620124129752996e-12
proportion O 0 3.1588169580043512e-12
of O 0 3.876131013380579e-11
genotype O 0 1.7424195419835087e-08
- O 0 1.5982547552084725e-07
phenotype O 0 6.47815951992925e-08
inconsistencies O 0 8.482619051619622e-08
. O 0 2.0306240244849505e-08

Our O 0 1.3166628676231085e-08
data O 0 5.536557878826898e-10
indicate O 0 1.7593817028260794e-11
that O 0 1.4056253990618606e-12
the O 0 1.202916322107228e-09
PAH O 0 1.6120444342959672e-05
- O 0 4.374036244314539e-09
mutation O 0 3.232136780439987e-11
genotype O 0 1.2050529844820357e-11
is O 0 3.509958504941714e-14
the O 0 3.0957219209967746e-13
main O 0 8.502595155723824e-11
determinant O 0 3.494616818144891e-09
of O 0 5.764350108350413e-10
metabolic O 0 0.46689102053642273
phenotype O 0 3.3978250768562646e-10
in O 0 3.006866023530508e-12
most O 0 7.1190739935056424e-12
patients O 0 3.889062960560352e-10
with O 0 1.9468371803554874e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.903451665290049e-07

In O 0 4.230162331531062e-10
the O 0 1.4290944816419682e-10
present O 0 8.071769815043428e-12
study O 0 9.61607746555182e-13
, O 0 3.9626844015351603e-13
the O 0 1.0518661462677326e-11
classification O 0 5.262825730767418e-10
of O 0 1.2903117463380909e-09
105 O 0 1.3661681919074908e-07
PAH O 0 6.21857907390222e-05
mutations O 0 4.970106617929737e-11
may O 0 9.14378815719541e-13
allow O 0 6.033651497264897e-14
the O 0 7.792699862133046e-13
prediction O 0 2.6824297991168145e-11
of O 0 6.7424668279136846e-12
the O 0 8.054576103311284e-12
biochemical O 0 4.911119289019439e-10
phenotype O 0 4.1082234836231635e-11
in O 0 5.553845144196101e-12
> O 0 6.565326060581356e-10
10 O 0 4.9438043936422815e-11
, O 0 2.0336122109193555e-12
000 O 0 3.033706619248733e-11
genotypes O 0 3.4254940550759727e-10
, O 0 3.217987074727313e-12
which O 0 8.650891960247653e-13
may O 0 1.7233550740972103e-12
be O 0 1.7401434026370621e-13
useful O 0 8.928543803821479e-14
for O 0 1.6747887798818084e-13
the O 0 1.1614838431317498e-11
management O 0 8.298032400100297e-11
of O 0 5.615050785445774e-11
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.93056845457329e-09
newborns O 0 1.4186861463372225e-08
. O 0 1.6828936022506014e-09

Somatic O 0 5.531496185540163e-07
instability O 0 7.091333031894465e-08
of O 0 5.2363442470948485e-09
the O 0 5.879480013959437e-09
CTG O 0 4.588564479490742e-06
repeat O 0 4.262122210718644e-09
in O 0 4.265663863800562e-11
mice O 0 1.3784191565946458e-09
transgenic O 0 1.7326057255573346e-09
for O 0 7.930971851477508e-12
the O 0 1.7011531099342392e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.20375980575227e-07
is O 0 2.67865027034353e-12
age O 0 3.4633710829790054e-12
dependent O 0 6.121287287816357e-13
but O 0 1.751604334395817e-14
not O 0 1.611930973085835e-14
correlated O 0 2.980899489919697e-13
to O 0 1.8007237750070938e-14
the O 0 2.121793626214119e-12
relative O 0 1.3864395742579916e-10
intertissue O 0 1.1239353447933809e-08
transcription O 0 1.6955103987470466e-09
levels O 0 3.1155662494342096e-09
and O 0 4.7677136544299614e-11
proliferative O 0 2.800800393742975e-05
capacities O 0 8.983889756564167e-07
. O 0 2.4009894517007524e-08

A O 0 3.3899525533342967e-06
( O 0 3.4518616853773665e-09
CTG O 0 2.544915332691744e-06
) O 0 9.921972098092535e-12
nexpansion O 0 7.302993321189888e-09
in O 0 5.592028923251391e-11
the O 0 5.791791490850073e-10
3 O 0 1.468235844015453e-08
- O 0 2.690980105413132e-09
untranslated O 0 3.5614581861409533e-07
region O 0 2.123614617488556e-09
( O 0 1.8056171141589417e-11
UTR O 0 3.0015263519089785e-07
) O 0 1.3472002376516135e-12
of O 0 3.92183868713758e-10
the O 0 1.1435715663310475e-07
DM O 1 1.0
protein O 0 8.759262648538879e-09
kinase O 0 1.8845427440794538e-09
gene O 0 9.026485114915772e-11
( O 0 3.3890065233299627e-12
DMPK O 0 9.791089183863733e-08
) O 0 2.304858235692431e-13
is O 0 6.206850761440383e-14
responsible O 0 7.558496363524458e-12
for O 0 3.438558118795676e-11
causing O 1 0.9999723434448242
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9915259480476379
DM B-Disease 1 1.0
) O 0 5.768529542926615e-10
. O 0 7.65559893256551e-10

Major O 0 6.075288183637895e-07
instability O 0 1.1297035598545335e-05
, O 0 5.131644553735271e-10
with O 0 4.690098569931633e-12
very O 0 2.100857248582555e-12
large O 0 1.296892823167417e-12
expansions O 0 1.684728918871503e-11
between O 0 2.4464165502419144e-12
generations O 0 5.273219794849071e-12
and O 0 1.0428242470938986e-12
high O 0 8.243575960742433e-11
levels O 0 5.000687364198342e-11
of O 0 1.8836713439052133e-11
somatic O 0 1.9999193412445493e-09
mosaicism O 0 1.851032038757694e-08
, O 0 4.3556537500030745e-13
is O 0 9.100459643675285e-14
observed O 0 6.514103926408277e-12
in O 0 4.026773706145015e-11
patients O 0 2.9534899526062475e-10
. O 0 2.0635531061685697e-09

There O 0 3.573206619478242e-09
is O 0 3.239821258493869e-11
a O 0 8.015617683487797e-12
good O 0 2.363949964598322e-12
correlation O 0 1.2044848625436533e-12
between O 0 6.271522363932025e-12
repeat O 0 4.121560037706473e-10
size O 0 5.754611197283932e-12
( O 0 1.5680397247568728e-13
at O 0 1.8255359029994978e-11
least O 0 2.35522701601959e-13
in O 0 1.6870230527214064e-13
leucocytes O 0 4.0857905947433437e-10
) O 0 6.081611857991151e-14
, O 0 8.802518176170837e-14
clinical O 0 5.634149813360523e-10
severity O 0 1.177088115866809e-08
and O 0 9.851070480182411e-12
age O 0 1.8335767626442845e-10
of O 0 1.960429596437052e-09
onset O 0 0.2933507263660431
. O 0 2.8233106519337525e-08

The O 0 1.1940404647248215e-06
trinucleotide O 0 0.00044554469059221447
repeat O 0 1.4797817584621953e-06
instability O 0 6.364965088323515e-07
mechanisms O 0 1.1840441516142164e-07
involved O 0 1.273822436420602e-10
in O 0 3.6024820904145827e-09
DM B-Disease 1 1.0
and O 0 5.281116099986605e-10
other O 0 3.240840928953048e-11
human O 0 3.730619209818542e-05
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.0489450454065352e-11
unknown O 0 1.4722029151315041e-09
. O 0 1.9690024610774515e-10

We O 0 1.31340149867043e-09
studied O 0 1.4828103189756803e-09
somatic O 0 3.9983607535987176e-09
instability O 0 2.437959834011849e-10
by O 0 3.756228401236017e-12
measuring O 0 8.843501042576918e-09
the O 0 1.2648602165654665e-09
CTG O 0 1.225790697390039e-06
repeat O 0 1.7612906688668772e-09
length O 0 4.5188800618101155e-12
at O 0 3.290182015724952e-11
several O 0 3.5987936263838505e-13
ages O 0 1.359108572213108e-12
in O 0 1.5601192213110515e-13
various O 0 1.7330161828157942e-12
tissues O 0 1.3564417818134888e-11
of O 0 5.0748950181089825e-11
transgenic O 0 1.4027919270631628e-08
mice O 0 8.77957706535426e-11
carrying O 0 2.3533063518710318e-12
a O 0 8.602751323805169e-12
( O 0 6.165241928091092e-12
CTG O 0 1.9270891016276437e-07
) O 0 2.553466769625312e-12
55expansion O 0 5.7670361819361915e-09
surrounded O 0 7.38721472881565e-10
by O 0 1.9830738613724197e-12
45 O 0 5.6972992296122626e-11
kb O 0 4.221855931518803e-08
of O 0 5.4556648088066595e-09
the O 0 1.76141252694606e-08
human O 0 7.589011943309742e-07
DM B-Disease 1 1.0
region O 0 3.176584995046028e-09
, O 0 9.577240042690782e-12
using O 0 8.010929419821622e-11
small O 0 6.399946128610168e-10
- O 0 6.410763830899668e-08
pool O 0 2.8583846756191633e-07
PCR O 0 1.197678557218751e-06
. O 0 2.6457069424168367e-08

These O 0 8.062453482615695e-10
mice O 0 2.0580266379965906e-09
have O 0 6.473240454947515e-13
been O 0 1.2503458554982694e-13
shown O 0 8.4613285616323e-14
to O 0 3.6166758471531044e-14
reproduce O 0 1.3170018461211574e-12
the O 0 1.378006975021051e-12
intergenerational O 0 1.5873422368195556e-11
and O 0 3.452157450959531e-13
somatic O 0 1.307442210052301e-10
instability O 0 1.979651997885412e-10
of O 0 9.806307849080653e-11
the O 0 9.68949698254562e-10
55 O 0 4.924986196641612e-09
CTG O 0 6.952715011721011e-06
repeat O 0 8.762504499770785e-09
suggesting O 0 4.2313708092933666e-11
that O 0 1.383383831750004e-13
surrounding O 0 2.897510356647537e-12
sequences O 0 3.3116623592704952e-12
and O 0 8.02721517728644e-12
the O 0 1.5165323163923716e-10
chromatin O 0 1.411866623612923e-09
environment O 0 3.6485894860938117e-10
are O 0 1.04961639423376e-13
involved O 0 2.5195898969640473e-13
in O 0 5.1314534219026875e-12
instability O 0 4.0785224086903327e-08
mechanisms O 0 5.354739869289915e-07
. O 0 3.0922421956347534e-08

As O 0 2.5917420987120465e-10
observed O 0 6.024759163780757e-11
in O 0 1.3979946757516903e-12
some O 0 2.4784558086410335e-13
of O 0 2.1758475229893826e-11
the O 0 1.0577372311360023e-10
tissues O 0 1.153999229508429e-09
of O 0 9.703079939527015e-08
DM B-Disease 1 1.0
patients O 0 7.339072127798829e-10
, O 0 5.635344621501837e-13
there O 0 1.2680106530743585e-12
is O 0 1.1561713771698207e-13
a O 0 1.004677786277386e-12
tendency O 0 9.760804360950392e-13
for O 0 5.606130793964215e-13
repeat O 0 2.555169409390601e-10
length O 0 4.045447570683036e-12
and O 0 1.9700825172608294e-12
somatic O 0 6.290108989226439e-10
mosaicism O 0 1.1577315772726138e-09
to O 0 6.511153785191889e-14
increase O 0 1.2148298317825323e-13
with O 0 5.296761971087041e-14
the O 0 1.3534594452135895e-11
age O 0 2.16654628265589e-11
of O 0 1.66543237534178e-10
the O 0 6.263172758202984e-10
mouse O 0 1.739669919231801e-08
. O 0 1.4188531460845866e-09

Furthermore O 0 2.205281290912353e-08
, O 0 3.860268354971552e-11
we O 0 1.286375736833656e-12
observed O 0 3.918335274299967e-12
no O 0 1.8319449689857548e-13
correlation O 0 3.2467648361511614e-13
between O 0 2.518408116596038e-13
the O 0 2.4782315088955897e-11
somatic O 0 2.8038396049367975e-09
mutation O 0 2.3171143823108586e-11
rate O 0 5.191092347645032e-11
and O 0 2.7447471379060673e-12
tissue O 0 5.358619326045755e-09
proliferation O 0 0.00014965249283704907
capacity O 0 1.8313766503297302e-08
. O 0 8.08595468360096e-10

The O 0 1.391115347360028e-07
somatic O 0 2.2710087250743527e-06
mutation O 0 1.8806720625264006e-09
rates O 0 5.1261342393083e-11
in O 0 2.074452670189006e-13
different O 0 1.787593239665347e-14
tissues O 0 2.9201596002392805e-11
were O 0 2.410603661129329e-11
also O 0 5.97253420765026e-13
not O 0 3.311583049881578e-14
correlated O 0 9.756727760781847e-13
to O 0 1.241652586954009e-13
the O 0 2.1419956086621283e-11
relative O 0 4.5007519933193407e-10
inter O 0 1.1364005558789358e-07
- O 0 6.678220476619146e-11
tissue O 0 2.0030019309835723e-11
difference O 0 1.9519121562117103e-12
in O 0 3.4329844197412973e-13
transcriptional O 0 2.0680665513417296e-11
levels O 0 1.3823934184864495e-11
of O 0 2.8231271487211274e-12
the O 0 6.142131074582391e-12
three O 0 2.346296551145044e-12
genes O 0 9.733289478217055e-13
( O 0 3.0346250685930887e-12
DMAHP O 0 1.812588607208454e-06
, O 0 2.0101061093402706e-10
DMPK O 0 4.816502041649073e-06
and O 0 1.894734646956664e-10
59 O 0 1.0627123625539525e-09
) O 0 1.1221402496444655e-12
surrounding O 0 5.2313476467391595e-11
the O 0 5.267736247205335e-10
repeat O 0 2.0945396528304627e-08
. O 0 9.113487742240522e-10
. O 0 7.881867603032333e-09

A O 0 7.211511388049985e-09
novel O 0 2.0084733876046812e-10
missense O 0 1.0821900708890553e-08
mutation O 0 3.961441591426862e-11
in O 0 6.5746305968894525e-12
patients O 0 3.435304775020742e-12
from O 0 2.0541097035114975e-12
a O 0 2.947164734479202e-10
retinoblastoma B-Disease 0 1.560967689329118e-06
pedigree O 0 1.1344234440713308e-09
showing O 0 1.38277139738463e-10
only O 0 2.690165364777064e-12
mild O 0 3.016618954632122e-09
expression O 0 6.433586996479335e-11
of O 0 6.024483689692772e-11
the O 0 1.4894879774018932e-10
tumor B-Disease 0 4.8267470020846304e-08
phenotype O 0 6.860366719152466e-10
. O 0 1.6242233946694995e-10

We O 0 1.3840305568280087e-09
have O 0 1.2816784309213625e-12
used O 0 1.852570831115119e-13
single O 0 1.574010366489631e-11
strand O 0 1.934843951723053e-11
conformation O 0 4.042778698615246e-12
polymorphism O 0 7.195422101029247e-13
analysis O 0 3.575229169791236e-14
to O 0 5.461603645875264e-15
study O 0 1.9758830734225262e-14
the O 0 8.337082109746707e-13
27 O 0 1.3976253487868462e-10
exons O 0 6.762952975414294e-10
of O 0 1.4697276728981024e-10
the O 0 7.869860874087919e-10
RB1 O 0 4.317286794730535e-08
gene O 0 2.4077810058253934e-12
in O 0 2.6017431481797915e-13
individuals O 0 5.03472868661225e-15
from O 0 5.82323035278054e-13
a O 0 4.290584207367054e-11
family O 0 7.112396609165739e-12
showing O 0 5.401213698519314e-09
mild O 0 7.23072787423007e-07
expression O 0 4.831137268013208e-09
of O 0 1.3427898792883752e-09
the O 0 1.041307373661482e-09
retinoblastoma B-Disease 0 7.62661670705711e-07
phenotype O 0 8.979031740352639e-09
. O 0 1.388340331587301e-09

In O 0 9.671567990920948e-10
this O 0 1.9001696049958383e-11
family O 0 5.4253971107365295e-12
affected O 0 2.3405841067386524e-12
individuals O 0 5.114134213769078e-14
developed O 0 7.958953496256527e-10
unilateral B-Disease 1 0.999998927116394
tumors I-Disease 1 1.0
and O 0 1.3168097168225756e-10
, O 0 1.5925696091739772e-12
as O 0 1.3610853980342008e-12
a O 0 1.478848293823276e-12
result O 0 3.166055308548299e-12
of O 0 5.553781393108359e-12
linkage O 0 5.176084214020271e-11
analysis O 0 9.059160214520967e-13
, O 0 8.561871914572472e-13
unaffected O 0 4.425112498651629e-10
mutation O 0 7.630487387777496e-12
carriers O 0 7.046955792337772e-13
were O 0 5.799192289573929e-12
also O 0 9.160127083934766e-13
identified O 0 9.506624654154194e-12
within O 0 3.101386855663968e-11
the O 0 2.933167320140484e-10
pedigree O 0 9.21754406135733e-09
. O 0 6.125691509595299e-09

A O 0 7.280090841277342e-08
single O 0 1.2473994059902793e-09
band O 0 2.313592650793339e-09
shift O 0 1.9351144298074274e-10
using O 0 8.646475896378902e-12
SSCP O 0 3.8253126888321276e-08
was O 0 8.676762780490677e-11
identified O 0 1.6269626704895623e-12
in O 0 2.6621426417461347e-12
exon O 0 4.566956812723788e-10
21 O 0 4.132373609966322e-11
which O 0 1.4330420530783705e-13
resulted O 0 2.591650418576341e-12
in O 0 1.1352225583183273e-12
a O 0 2.5053693494814233e-11
missense O 0 1.102814284337228e-09
mutation O 0 2.681468068421733e-11
converting O 0 9.626400371276489e-11
a O 0 8.326078021481109e-11
cys O 0 1.0073894145534723e-06
- O 0 5.475432729440399e-08
- O 0 5.3565681668032994e-08
> O 0 9.551244772865175e-08
arg O 0 9.30770127638425e-08
at O 0 4.244241069706334e-10
nucleotide O 0 7.723884032362349e-11
position O 0 8.962631331543847e-11
28 O 0 1.0434839103901083e-10
in O 0 1.5638091516168018e-11
the O 0 1.1864779159154182e-09
exon O 0 9.473301787465971e-08
. O 0 3.235341328178265e-09

The O 0 3.994696129439035e-08
mutation O 0 3.1475870798658434e-09
destroyed O 0 1.4049346930278261e-07
an O 0 2.976351803907207e-11
NdeI O 0 3.2881925449146365e-07
restriction O 0 6.44686295458996e-08
enzyme O 0 9.289350538788099e-11
site O 0 3.944035653624667e-10
. O 0 6.512805295066926e-10

Analysis O 0 4.003990750067743e-10
of O 0 1.0408312434151412e-08
all O 0 6.021924625621011e-10
family O 0 2.62997505717788e-11
members O 0 1.5644020367328038e-12
demonstrated O 0 8.765015623024563e-12
that O 0 7.966577294767421e-14
the O 0 1.1611050662607703e-11
missense O 0 1.0802268413101501e-08
mutation O 0 1.8596020279204595e-09
co O 0 2.741572302511486e-07
- O 0 2.6859397621592507e-05
segregated O 0 1.0165062121814117e-05
with O 0 7.9006585995689e-11
patients O 0 7.945049951274541e-09
with O 0 2.0462060934534065e-09
tumors B-Disease 1 1.0
or O 0 1.1940959154799202e-07
who O 0 5.257437818428912e-10
, O 0 8.615477255224935e-12
as O 0 4.36588655852721e-12
a O 0 1.9641619060373205e-12
result O 0 5.696883503131245e-12
of O 0 5.010461663623733e-12
linkage O 0 5.7800687847109344e-11
analysis O 0 1.196201557945864e-12
had O 0 5.777288803604508e-12
been O 0 4.092290742385707e-12
predicted O 0 4.176445994596989e-11
to O 0 3.966851261534565e-13
carry O 0 1.276867327149045e-11
the O 0 8.699680559276501e-11
predisposing O 0 6.646321537573385e-08
mutation O 0 1.8934205314735664e-09
. O 0 1.2892639178474496e-09

These O 0 1.207430266880749e-10
observations O 0 1.0716067616600711e-10
point O 0 5.252827062207643e-10
to O 0 1.0169821798924894e-12
another O 0 1.1131316137932834e-12
region O 0 2.2317670281268853e-11
of O 0 1.798448334699998e-10
the O 0 4.142352239000502e-09
RB1 O 0 2.742560809565475e-07
gene O 0 2.393939040057358e-11
where O 0 5.541623583626976e-12
mutations O 0 8.211742375495434e-13
only O 0 3.497343473851666e-13
modify O 0 1.820194385840357e-12
the O 0 1.1189791497903667e-12
function O 0 1.4534299978830045e-11
of O 0 1.8020973602261847e-11
the O 0 1.9070972231971517e-11
gene O 0 1.3785702614177442e-11
and O 0 4.20247777549454e-12
raise O 0 4.877721924284595e-12
important O 0 4.6991334434753895e-12
questions O 0 8.558655628827794e-13
for O 0 3.6214772500264836e-12
genetic O 0 8.235329640449152e-10
counseling O 0 7.1420313239867195e-12
in O 0 2.4377761094485084e-12
families O 0 1.7899576474343128e-14
with O 0 1.237444120696235e-13
these O 0 4.671261207706001e-12
distinctive O 0 7.141466862314871e-10
phenotypes O 0 9.81993930615488e-10
. O 0 1.1224218082750426e-10
. O 0 1.8219025177401704e-09

Maternal B-Disease 0 3.6953892958990764e-06
disomy I-Disease 0 0.0002551725192461163
and O 0 2.748508268268779e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9483465552330017
with O 0 1.4049138241656323e-10
gamete O 0 3.9067992929631146e-07
complementation O 1 0.7814428806304932
in O 0 5.456804105796742e-11
a O 0 2.2573507299505913e-11
case O 0 7.2234085032873985e-12
of O 0 7.176473998393718e-11
familial O 0 1.8482616548354258e-09
translocation O 0 6.572057564824263e-09
( O 0 3.935037191926671e-12
3 O 0 4.3378184377829143e-10
; O 0 2.2294842296106954e-13
15 O 0 1.971820276502889e-11
) O 0 3.8825479696481466e-14
( O 0 5.781714083191725e-14
p25 O 0 4.925488142348833e-11
; O 0 6.401580925508715e-14
q11 O 0 6.079452219420745e-11
. O 0 1.3852539991823787e-12
2 O 0 1.3472942206327332e-10
) O 0 2.971891613010036e-12
. O 0 1.313485986642604e-10

Maternal B-Disease 0 0.00033997168065980077
uniparental I-Disease 1 0.9984838366508484
disomy I-Disease 1 0.9950226545333862
( I-Disease 0 3.8934640542720445e-06
UPD I-Disease 1 1.0
) I-Disease 0 1.2346116316785949e-11
for I-Disease 0 5.26052205268579e-12
chromosome I-Disease 0 1.4353974675529457e-09
15 I-Disease 0 6.857723833242346e-10
is O 0 1.2637104904178464e-12
responsible O 0 1.1573352519389513e-11
for O 0 2.1845529942290942e-13
an O 0 2.8188682196284877e-14
estimated O 0 5.035310276374494e-13
30 O 0 1.9133813457250515e-12
% O 0 6.10544939800596e-14
of O 0 1.5547699846324425e-12
cases O 0 2.9934813308707398e-12
of O 0 6.898925164477987e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999893307685852
PWS B-Disease 1 1.0
) O 0 3.5361880090789555e-09
. O 0 7.260991807811479e-09

We O 0 9.276305834582388e-10
report O 0 1.1210775363590386e-11
on O 0 2.7466234148176838e-11
an O 0 3.4573036165712334e-13
unusual O 0 1.793548642936571e-11
case O 0 8.64055701987887e-12
of O 0 1.8939758095193326e-10
maternal B-Disease 0 2.330431181363224e-09
disomy I-Disease 0 3.5595297731561004e-07
15 I-Disease 0 8.454864364182413e-09
in O 0 1.5179171697354832e-08
PWS B-Disease 1 1.0
that O 0 2.2617727135632038e-11
is O 0 1.4960777842271122e-12
most O 0 1.3600673864043455e-13
consistent O 0 2.778188790131253e-11
with O 0 3.714958299750465e-13
adjacent O 0 2.085875472346288e-09
- O 0 6.227080517895445e-10
1 O 0 1.1972745461719114e-08
segregation O 0 1.6870490071596578e-07
of O 0 3.764365485992016e-10
a O 0 2.235542723161288e-10
paternal O 0 2.9217989139240785e-10
t O 0 3.0088539992867425e-10
( O 0 2.6226338266897853e-13
3 O 0 2.6605651709532552e-11
; O 0 2.7259414208313446e-14
15 O 0 2.1089510346405937e-12
) O 0 1.1131751038529272e-14
( O 0 3.2043869646483994e-14
p25 O 0 1.9657369482173337e-11
; O 0 1.7117336465356098e-14
q11 O 0 1.0456809897141373e-11
. O 0 4.250316122818808e-14
2 O 0 5.868846532884608e-13
) O 0 9.86466217075383e-16
with O 0 5.989206069159864e-15
simultaneous O 0 2.036129459481728e-10
maternal O 0 1.4337995235536027e-09
meiotic O 0 2.1906006963945401e-07
nondisjunction O 0 4.099165806792371e-08
for O 0 1.710001029664454e-10
chromosome O 0 1.7662470597201718e-08
15 O 0 4.501477590679315e-08
. O 0 8.039454435504467e-09

The O 0 4.191263158759284e-08
patient O 0 1.6550380621538352e-08
( O 0 1.1097303631579791e-10
J O 0 2.3569687073177192e-06
. O 0 7.811588181860785e-12
B O 0 1.3825840472492246e-10
. O 0 1.600213796919877e-14
) O 0 8.908955955157986e-16
, O 0 8.256336762814571e-15
a O 0 3.129054632587669e-13
17 O 0 5.6690047621488215e-12
- O 0 3.573759994532355e-12
year O 0 1.6188349272194813e-11
- O 0 4.261778707714825e-10
old O 0 5.3437996250238484e-09
white O 0 8.43004208106457e-11
male O 0 8.663474126459347e-13
with O 0 7.361551472573336e-12
PWS B-Disease 1 1.0
, O 0 9.262104277985017e-11
was O 0 1.4572453244099393e-09
found O 0 5.68886994803397e-12
to O 0 7.650040540277403e-13
have O 0 2.86982286892834e-12
47 O 0 4.0194528261316975e-11
chromosomes O 0 9.842205175858432e-12
with O 0 4.779629383250272e-12
a O 0 1.0086808055476126e-09
supernumerary O 0 2.6033785616164096e-06
, O 0 2.4528422695735408e-11
paternal O 0 7.630433784822088e-11
der O 0 3.5141601983923465e-07
( O 0 1.3061448624063221e-12
15 O 0 8.250335310766577e-12
) O 0 9.599134705965025e-15
consisting O 0 3.2590496599170515e-13
of O 0 1.9155330099884793e-11
the O 0 1.3957399680464277e-09
short O 0 2.811336941022091e-09
arm O 0 4.082491145140921e-08
and O 0 6.521096995726339e-10
the O 0 1.834091563068796e-07
proximal O 0 4.142392754147295e-06
long O 0 3.1192126215273674e-08
arm O 0 8.211542734670729e-08
of O 0 2.3370647639353592e-08
chromosome O 0 1.5235883665809524e-07
15 O 0 4.087711857891918e-08
, O 0 1.0119446947065569e-10
and O 0 3.1849678450157626e-10
distal O 0 9.256253719058805e-08
chromosome O 0 7.487964012398152e-06
arm O 0 0.00010447581735206768
3p O 0 0.00046991597628220916
. O 0 3.8042486494305194e-07

The O 0 4.184266515494528e-07
t O 0 1.2469196342124178e-08
( O 0 4.2883648021518894e-12
3 O 0 6.377557509873455e-11
; O 0 3.9450881390888995e-14
15 O 0 1.3291451272934296e-12
) O 0 5.365905439977999e-15
was O 0 5.000949199022997e-13
present O 0 5.218881696158334e-14
in O 0 1.2690285562839965e-13
the O 0 2.5156439431572863e-12
balanced O 0 4.296986377827494e-12
state O 0 5.73365817714902e-14
in O 0 3.654406963669865e-13
the O 0 4.3325409232464196e-11
patients O 0 1.6346331840194628e-12
father O 0 1.226453227171076e-11
and O 0 5.452330600896893e-11
a O 0 1.4903127620868872e-09
sister O 0 3.0715803234215855e-08
. O 0 6.572700073093074e-08

Fluorescent O 0 4.94186949140385e-08
in O 0 1.076330483074095e-10
situ O 0 1.4015849592041718e-09
hybridization O 0 7.489983459840754e-12
analysis O 0 7.804242820562413e-13
demonstrated O 0 5.066854488061656e-12
that O 0 1.5980519316692587e-13
the O 0 2.1456564303079517e-10
PWS B-Disease 1 1.0
critical O 0 2.4275892407388255e-10
region O 0 2.3425907047514016e-11
resided O 0 8.171253257360789e-11
on O 0 8.441417009841246e-11
the O 0 1.6431364949220928e-11
derivative O 0 1.4709834045278924e-11
chromosome O 0 3.637803600020639e-11
3 O 0 1.2245698899349122e-10
and O 0 1.9906218871618836e-13
that O 0 1.1193409107858755e-14
there O 0 3.7624791520210477e-13
was O 0 2.6386774709674654e-11
no O 0 3.5515397046881336e-12
deletion O 0 1.0887514848012536e-11
of O 0 7.834482368407336e-11
the O 0 4.369600237197346e-09
PWS B-Disease 1 1.0
region O 0 6.963432608309006e-10
on O 0 7.910493926566176e-10
the O 0 9.91221688062538e-11
normal O 0 4.332328384926143e-10
pair O 0 5.201697753087764e-11
of O 0 1.5342915826721537e-10
15s O 0 2.894399608877052e-09
present O 0 1.094661514211559e-10
in O 0 1.0633206537491446e-09
J O 0 0.00017638989083934575
. O 0 6.416550490939699e-08

B O 0 0.0010245713638141751
. O 0 5.507120590664272e-07

Methylation O 0 6.335206137464411e-08
analysis O 0 7.716113303857242e-10
at O 0 4.5943493454103645e-09
exon O 0 4.766964156743825e-09
alpha O 0 1.5375316297916441e-10
of O 0 4.0113655452866936e-11
the O 0 1.123424200888401e-10
small O 0 4.159862038166651e-11
nuclear O 0 4.1292675945214796e-08
ribonucleoprotein O 0 4.941678177772246e-09
- O 0 9.91093651592223e-10
associated O 0 4.979771706103975e-09
polypeptide O 0 7.327958684300029e-08
N O 0 6.008461355122563e-07
( O 0 8.879082365187418e-12
SNRPN O 0 2.1099414482250722e-07
) O 0 3.102170484468175e-13
gene O 0 3.217238541547429e-12
showed O 0 1.3013461835909013e-11
a O 0 8.317038464183968e-13
pattern O 0 1.8339815777146384e-11
characteristic O 0 2.522748399069741e-10
of O 0 7.372402688332613e-11
only O 0 3.4860766617156314e-12
the O 0 1.4477470437757045e-11
maternal O 0 1.475845140541665e-11
chromosome O 0 9.861151478718355e-11
15 O 0 5.300653804773958e-10
in O 0 6.666120988541024e-10
J O 0 0.0008299481123685837
. O 0 3.90936278904519e-08

B O 0 0.0016210373723879457
. O 0 9.443964472666266e-07

Maternal B-Disease 0 1.7611894236324588e-06
disomy I-Disease 0 4.149763299210463e-06
was O 0 2.2322215187386973e-08
confirmed O 0 2.541332144723185e-10
by O 0 9.567071093674606e-12
polymerase O 0 1.0387161963887337e-10
chain O 0 2.5343036003100394e-10
reaction O 0 9.213500188481882e-13
analysis O 0 3.2909883585646726e-13
of O 0 3.283622722685675e-12
microsatellite O 0 2.4850202451354164e-10
repeats O 0 9.487175628430933e-11
at O 0 3.902154988022488e-10
the O 0 2.4614152382973487e-10
gamma O 0 5.120081247866892e-09
- O 0 7.237444865637599e-09
aminobutyric O 0 1.9820159025130124e-07
acid O 0 8.722381150683134e-10
receptor O 0 4.593932872998252e-11
beta3 O 0 3.6391119007106454e-09
subunit O 0 1.747730016266047e-10
( O 0 4.6276303101999705e-12
GABRB3 O 0 5.4883667388594404e-08
) O 0 1.0503984834708824e-11
locus O 0 3.655892033549435e-09
. O 0 1.870333887765696e-09

A O 0 2.7104486434836872e-05
niece O 0 9.328519467999286e-07
( O 0 1.7295944676476438e-09
B O 0 1.2834735230171646e-07
. O 0 2.0741262873880117e-11
B O 0 7.210119168377105e-10
. O 0 2.299154790164071e-13
) O 0 4.513376942961913e-15
with O 0 4.6382294299806073e-14
45 O 0 3.744304345743021e-12
chromosomes O 0 5.361143928968304e-13
and O 0 4.884934687657272e-13
the O 0 8.209209353959857e-12
derivative O 0 7.256661417598398e-12
3 O 0 2.2562058124564466e-11
but O 0 1.343302097160659e-13
without O 0 2.674192247850704e-13
the O 0 2.7365869986750724e-12
der O 0 4.152691968073441e-09
( O 0 5.815114286367856e-14
15 O 0 1.828643356530102e-12
) O 0 3.8566270673962705e-14
demonstrated O 0 2.816033864427858e-12
a O 0 1.918007202714178e-12
phenotype O 0 1.6584926140761347e-11
consistent O 0 1.8366280718495887e-11
with O 0 2.8362069840587832e-14
that O 0 6.393405363501817e-14
reported O 0 1.9177400552988777e-12
for O 0 4.724612194528799e-12
haploinsufficiency O 0 1.810807646052126e-07
of O 0 2.867224502267618e-08
distal O 0 6.450897416243606e-08
3 O 0 1.251854428119259e-06
p O 0 2.9659065603482304e-06
. O 0 3.334804787868961e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 3.866463771373674e-08
with O 0 5.389898596885878e-11
unbalanced O 0 6.636124538772492e-08
segregation O 0 6.39546101410815e-07
of O 0 1.0816282314252135e-09
non O 0 2.228735809239879e-07
- O 0 1.3636651807757971e-09
Robertsonian O 0 6.982577360759024e-08
translocations O 0 6.399546670365908e-09
has O 0 2.974279026193849e-12
been O 0 6.963621302855105e-13
reported O 0 2.0156478482830087e-12
previously O 0 1.835634283464671e-10
but O 0 2.1718742256038315e-12
has O 0 2.1951045581919404e-12
not O 0 4.0498149538742423e-13
, O 0 2.0737880542572723e-13
to O 0 1.2998390070458749e-13
our O 0 2.991483579947718e-12
knowledge O 0 1.8610575320404665e-12
, O 0 5.769090581772204e-14
been O 0 5.887634536806338e-14
observed O 0 3.514918120017113e-13
in O 0 2.3543959750543797e-13
a O 0 1.0248456597250488e-11
case O 0 3.414135987811484e-11
of O 0 1.0168251129982764e-08
PWS B-Disease 1 1.0
. O 0 5.272606813377934e-07

Furthermore O 0 1.2542189153919026e-07
, O 0 7.951761471503005e-10
our O 0 2.43047082459924e-10
findings O 0 5.4190471554527164e-12
are O 0 1.1790309668250482e-13
best O 0 8.560974195173654e-13
interpreted O 0 1.356435905437714e-12
as O 0 5.755113182889793e-13
true O 0 1.557786712125253e-11
gamete O 0 2.457251069287736e-09
complementation O 0 2.4289176963065984e-06
resulting O 0 2.6949956155597476e-10
in O 0 2.088230977026484e-10
maternal B-Disease 0 1.1487728670545039e-06
UPD I-Disease 1 1.0
15 I-Disease 0 3.515133130349568e-06
and O 0 1.7465124528825982e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999814033508301
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.3177806067687925e-05
2 I-Disease 0 9.88305237115128e-06
and O 0 1.0655620830135604e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 6.245907263613404e-11
a O 0 1.6001274957821998e-11
case O 0 1.5290489143934827e-12
for O 0 1.2302762975036075e-12
" O 0 1.2044905350894197e-10
lumping O 0 1.6725767437719696e-09
" O 0 3.551653637856589e-09
. O 0 1.0528707905521628e-09

Recent O 0 4.734711511744649e-10
studies O 0 2.7446909328654456e-11
demonstrated O 0 2.6511988784894136e-11
the O 0 5.636508620954217e-12
existence O 0 1.9401320827672208e-11
of O 0 1.3857467950906255e-10
a O 0 5.4862548531930955e-11
genetically O 0 8.325982264745235e-11
distinct O 0 1.945237157116586e-12
, O 0 2.113694852826087e-12
usually O 0 1.977664993574324e-12
lethal O 0 3.458844322068444e-11
form O 0 1.0370977080592647e-12
of O 0 1.9807084791767515e-11
the O 0 2.8838564869460015e-10
Schwartz B-Disease 0 0.06518760323524475
- I-Disease 1 0.9999808073043823
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.536135438966028e-10
SJS B-Disease 1 0.9696677327156067
) O 0 6.665443891273881e-11
of O 0 1.3687947841845016e-07
myotonia B-Disease 1 1.0
and O 1 0.95563143491745
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.8025901599448844e-08
which O 0 1.622755679830945e-10
we O 0 1.8988588479373902e-10
called O 0 7.559141756985355e-09
SJS B-Disease 0 8.231594256358221e-05
type I-Disease 0 4.2151135914991755e-08
2 I-Disease 0 1.5762651628392632e-07
. O 0 1.6340558905980629e-09

This O 0 2.013875732842507e-09
disorder O 0 3.05975518131163e-05
is O 0 3.1975583205529068e-12
reminiscent O 0 9.037204318218528e-10
of O 0 1.809334487790082e-10
another O 0 2.458997241938654e-11
rare O 0 5.711947581588106e-10
condition O 0 2.1085769574824553e-08
, O 0 1.8432139495261346e-12
the O 0 2.46507980694588e-10
Stuve B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2584262520931588e-08
SWS B-Disease 1 1.0
) O 0 1.0554151302910597e-11
, O 0 3.5105115429173717e-12
which O 0 3.438989327683717e-12
comprises O 0 3.577050600167553e-10
campomelia B-Disease 0 1.7471072624175576e-06
at O 0 5.126993301018956e-07
birth O 0 9.287561510973319e-07
with O 0 1.1747913752913064e-08
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 3.1871385530735097e-09
contractures B-Disease 0 0.011911457404494286
, O 0 3.73250527707647e-11
and O 0 1.3016962507883534e-11
early B-Disease 0 4.221002924964523e-08
death I-Disease 0 1.0130584371381701e-07
. O 0 4.3945411754009456e-09

To O 0 5.668632230282356e-10
test O 0 1.3294007006336983e-09
for O 0 6.8210081680120105e-12
possible O 0 1.7936932494855284e-10
nosologic O 0 3.4281317340401074e-08
identity O 0 1.17987364670058e-11
between O 0 1.1372819352928332e-11
these O 0 2.0342106471504806e-11
disorders O 0 4.6774403017479926e-07
, O 0 3.111432552577176e-13
we O 0 1.5252905817726703e-13
reviewed O 0 4.701148324792737e-13
the O 0 2.3619252170412053e-13
literature O 0 2.2087475078091945e-14
and O 0 1.1309810916569282e-14
obtained O 0 2.1308000123457932e-13
a O 0 5.452262990049417e-13
follow O 0 3.630521447708923e-13
- O 0 6.294600257694682e-13
up O 0 1.6731930511243442e-12
of O 0 1.1190865074894862e-11
the O 0 1.2066376543773405e-11
only O 0 9.38139648430647e-13
two O 0 1.1100595269375457e-12
surviving O 0 2.2194077686776836e-09
patients O 0 3.2903059617173103e-12
, O 0 6.719046976785825e-13
one O 0 6.356420381367633e-13
with O 0 7.385769947021448e-12
SJS B-Disease 1 0.9934033751487732
type I-Disease 0 1.6951609040916082e-06
2 I-Disease 0 3.326435660255811e-07
at O 0 4.778650253278727e-10
age O 0 4.827657371087035e-12
10 O 0 2.2822427541563384e-12
years O 0 2.9711704017248985e-13
and O 0 1.9639660991249697e-13
another O 0 7.760276796164867e-13
with O 0 5.653089107937603e-12
SWS B-Disease 1 0.9831310510635376
at O 0 5.430582206145118e-09
age O 0 2.923292996559468e-10
7 O 0 1.524107950956477e-08
years O 0 7.938062429602155e-10
. O 0 2.4104498397292673e-09

Patients O 0 2.621303840655287e-09
reported O 0 5.7537141717745044e-11
as O 0 1.0049657286903546e-11
having O 0 7.240889138282469e-11
either O 0 1.0009743034444796e-09
neonatal O 1 1.0
SJS B-Disease 1 0.9999997615814209
or O 0 9.93584947650561e-09
SWS B-Disease 1 0.9999979734420776
presented O 0 1.1155919243943657e-10
a O 0 5.514060345476746e-13
combination O 0 1.541214963811377e-12
of O 0 9.698745712799495e-13
a O 0 1.242404074584813e-12
severe O 0 3.574494922276017e-09
, O 0 1.0275207334292658e-12
prenatal O 0 0.24624568223953247
- O 1 0.6842792630195618
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.5534539800354796e-12
with O 0 9.16786160876093e-11
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 4.691177650784084e-07
respiratory O 1 1.0
and O 0 2.9318165672975738e-08
feeding O 0 2.1028899510611154e-08
difficulties O 0 7.334488572041664e-08
, O 0 1.0350924110891224e-11
tendency O 0 6.164833921129542e-11
to O 0 2.148389756026492e-12
hyperthermia B-Disease 0 0.012446587905287743
, O 0 7.468752179218274e-13
and O 0 2.7246694483951117e-13
frequent O 0 6.089545968174237e-12
death O 0 4.5450906926980394e-11
in O 0 3.1000722822138727e-12
infancy O 0 5.4835556234644756e-11
) O 0 1.0076897710633182e-14
with O 0 1.9249868965010887e-14
a O 0 1.3371554731522739e-11
distinct O 0 7.682337543890583e-10
campomelic B-Disease 1 0.999539852142334
- I-Disease 1 0.999998927116394
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 8.642585271445569e-06

The O 0 4.917926954561835e-09
similarity O 0 1.2617135114467715e-09
of O 0 4.384569596282972e-09
the O 0 2.05053485302642e-09
clinical O 0 2.900730180499522e-07
and O 0 1.22942836466855e-10
radiographic O 0 5.146145213075215e-06
findings O 0 5.716743189942974e-10
is O 0 3.5448939790516665e-12
so O 0 6.320535457862708e-14
extensive O 0 6.96999333249515e-11
that O 0 1.6217670652587945e-12
these O 0 4.985459614581522e-11
disorders O 0 1.735926889523398e-05
appear O 0 2.726689013465844e-11
to O 0 1.5560983220291175e-13
be O 0 3.9511148801525675e-13
a O 0 9.174517699370166e-13
single O 0 1.0851193207872534e-11
entity O 0 1.3414382937781966e-09
. O 0 6.28568663785245e-09

The O 0 3.7963548749075926e-08
follow O 0 7.826808645639005e-10
- O 0 1.4236560541558418e-10
up O 0 1.0718557118261085e-11
observation O 0 1.0064745703530775e-09
of O 0 1.8017100311684686e-10
an O 0 8.257919630223765e-13
identical O 0 1.6893882126556292e-11
and O 0 8.819951062902232e-13
unique O 0 9.054863629731624e-12
pattern O 0 5.043683248828756e-09
of O 0 4.8155561671592295e-06
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 2.927847519984539e-09
the O 0 1.2957728223739196e-08
two O 0 1.8761638076458809e-10
patients O 0 1.3289582108388931e-11
( O 0 1.8631378720639774e-13
one O 0 2.416559573975574e-12
with O 0 8.703913284557885e-11
SJS B-Disease 1 0.9999872446060181
type I-Disease 0 3.4190759379271185e-06
2 I-Disease 0 3.399528054615075e-07
, O 0 1.0834767328118944e-12
one O 0 3.1661259443198364e-13
with O 0 2.3402538587569133e-12
SWS B-Disease 0 0.08767649531364441
) O 0 1.8116945660687223e-12
surviving O 0 8.950336027879757e-10
beyond O 0 3.1075719775230937e-09
infancy O 0 3.567792505876355e-09
adds O 0 6.292478690883563e-12
to O 0 2.0204505928565764e-13
the O 0 4.9657834268190815e-12
evidence O 0 5.7987716191310046e-12
in O 0 9.216944698783869e-13
favor O 0 1.5564769959008906e-11
of O 0 3.185476188383163e-11
identity O 0 3.049208663341574e-10
. O 0 5.4630162615865174e-09

The O 0 4.628196137446139e-08
hypothesis O 0 8.350435010129331e-09
that O 0 5.561225438488471e-11
SWS B-Disease 1 0.9999001026153564
and O 0 3.755734567789659e-08
SJS B-Disease 1 0.9999767541885376
type I-Disease 0 9.34414638322778e-05
2 I-Disease 0 5.5104039347497746e-05
are O 0 9.577843726460422e-12
the O 0 3.848505888970344e-11
same O 0 1.94173233047934e-10
disorder O 0 3.3332526072626933e-08
should O 0 1.572251335200947e-12
be O 0 3.7116417930674675e-14
testable O 0 1.4451971520543228e-12
by O 0 9.824522549932869e-15
molecular O 0 2.868881564602188e-12
methods O 0 6.444920118420239e-12
. O 0 4.2230637389839565e-12
. O 0 2.479272898092688e-10

A O 0 2.2871804006285856e-08
mouse O 0 2.0087914665012363e-10
model O 0 4.8986903943004645e-12
of O 0 2.759177608613328e-11
severe O 1 0.9998266100883484
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 1.1318323231535032e-05
defects O 1 0.9995923638343811
in O 0 4.380521501090584e-10
hemostasis O 1 0.9982714653015137
and O 0 2.3371182322762252e-08
thrombosis B-Disease 0 8.788458217168227e-05
. O 0 1.2831220885800576e-07

von B-Disease 0 0.0062318346463143826
Willebrand I-Disease 1 0.879718005657196
factor I-Disease 0 6.189762302710733e-07
( I-Disease 0 6.414651032571328e-09
vWf I-Disease 0 8.630329830339178e-06
) I-Disease 0 1.7320349599003748e-08
deficiency I-Disease 1 0.999998927116394
causes O 0 0.025235796347260475
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 9.542977608134606e-08
humans O 0 4.145559451274039e-10
. O 0 8.263489892357256e-11

We O 0 2.2861064152834842e-09
generated O 0 1.9251513577733803e-11
a O 0 3.0876228657161775e-11
mouse O 0 1.1671517918809826e-10
model O 0 2.4297777331816484e-12
for O 0 4.07893201636797e-13
this O 0 9.031434996566168e-13
disease O 0 3.952807178797535e-11
by O 0 2.256750016894904e-13
using O 0 4.2857644516614e-12
gene O 0 1.8067885729222688e-11
targeting O 0 5.509221967514577e-10
. O 0 4.823447197210839e-10

vWf B-Disease 0 0.0005954192019999027
- I-Disease 0 0.4624921381473541
deficient I-Disease 0 0.00012996798614040017
mice O 0 8.674673779296427e-08
appeared O 0 3.861566622020973e-10
normal O 0 1.0133004851864413e-10
at O 0 4.600965788914557e-11
birth O 0 1.1801886724838173e-11
; O 0 6.034549352188986e-14
they O 0 1.9388315822613245e-13
were O 0 3.3595301020261648e-12
viable O 0 6.266219765294068e-10
and O 0 2.454700158416312e-11
fertile O 0 4.8914152728229965e-09
. O 0 2.416549182981953e-09

Neither O 0 4.466397513169795e-06
vWf O 0 1.9893395801773295e-05
nor O 0 6.331099484668812e-07
vWf O 0 1.0474369673829642e-06
propolypeptide O 0 2.161301381420344e-06
( O 0 4.210410686766863e-09
von B-Disease 0 0.0005169312935322523
Willebrand I-Disease 1 0.5575682520866394
antigen O 0 1.3863241292710882e-06
II O 0 0.12654007971286774
) O 0 8.479690907781112e-12
were O 0 8.68240288692812e-12
detectable O 0 1.2580080310797825e-09
in O 0 1.7990056059430382e-12
plasma O 0 1.0345407863709966e-09
, O 0 1.871986940460424e-12
platelets O 0 1.109298694568217e-10
, O 0 4.7198564501194085e-12
or O 0 2.616040630648575e-12
endothelial O 0 5.4079192512990204e-11
cells O 0 4.705768110249697e-13
of O 0 6.918594928732869e-13
the O 0 1.4680312087483882e-12
homozygous O 0 1.7909619620670725e-10
mutant O 0 6.6368817108752864e-09
mice O 0 5.426026294941266e-09
. O 0 2.2527840704000823e-10

The O 0 5.305511141528996e-09
mutant O 0 1.1625033380369132e-07
mice O 0 1.1377003339418934e-08
exhibited O 0 6.069494240534823e-09
defects O 0 1.4639009577877005e-06
in O 0 1.1476784800290574e-11
hemostasis O 0 1.3029182355239755e-07
with O 0 5.181356212136112e-12
a O 0 7.786917222141199e-10
highly O 0 4.566628408753104e-09
prolonged O 0 0.002416945295408368
bleeding O 0 4.0669983718544245e-05
time O 0 1.5844452139202048e-10
and O 0 7.0817496831965254e-12
spontaneous O 0 2.805123466842474e-09
bleeding O 0 2.811529897783771e-09
events O 0 1.1355257012457542e-12
in O 0 1.8325948126628883e-13
approximately O 0 1.1493268088549197e-13
10 O 0 1.7530634062457029e-12
% O 0 1.962229640925517e-12
of O 0 7.703936932834665e-10
neonates O 0 7.68800276773618e-08
. O 0 1.8447195770932012e-08

As O 0 1.1992044857134232e-10
in O 0 9.167646676522256e-12
the O 0 7.45979042426903e-11
human O 0 9.821456981029542e-10
disease O 0 6.3254477211671656e-09
, O 0 2.686615578444129e-13
the O 0 4.342706749760339e-12
factor O 0 5.612435429597218e-12
VIII O 0 4.861537838962704e-10
level O 0 1.1383503167872178e-10
in O 0 2.069425766816277e-13
these O 0 1.4756240934027387e-13
mice O 0 3.9777580534972046e-11
was O 0 3.479787291649217e-11
reduced O 0 1.1808151678671663e-10
strongly O 0 5.640215941862814e-13
as O 0 1.6344765168055386e-13
a O 0 1.3345509593254423e-12
result O 0 7.416940325799537e-12
of O 0 2.522554561068535e-11
the O 0 2.5146568854994555e-11
lack O 0 2.4998528247444085e-10
of O 0 3.1294456609431975e-11
protection O 0 2.9449620519983455e-10
provided O 0 3.2748471903015774e-12
by O 0 4.824751362320079e-11
vWf O 0 1.2664463611145038e-07
. O 0 1.1099219321408782e-08

Defective O 0 0.0015169898979365826
thrombosis B-Disease 0 9.974094439257897e-08
in O 0 4.019125587895189e-10
mutant O 0 2.934043052960078e-08
mice O 0 9.822787028213043e-10
was O 0 4.3642069125215954e-11
also O 0 5.3407084120828466e-14
evident O 0 1.5492602589272514e-13
in O 0 8.027416791456677e-15
an O 0 1.3225377620850777e-15
in O 0 3.5061983562822627e-14
vivo O 0 3.525288047590003e-11
model O 0 1.355490112514568e-11
of O 0 4.7941544067953146e-09
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 2.1694074803235708e-07

In O 0 1.0367506853015129e-10
this O 0 1.4788821209310576e-12
model O 0 6.5849465637202176e-12
, O 0 2.0231047739849295e-12
the O 0 5.614601145120801e-11
exteriorized O 0 4.5044579621844605e-08
mesentery O 0 2.858738490374435e-08
was O 0 1.6825725257518798e-09
superfused O 0 2.265273124635314e-08
with O 0 1.1483709816406673e-10
ferric O 0 1.0092953743878752e-06
chloride O 0 2.4694906120004134e-09
and O 0 4.008032794544647e-10
the O 0 2.218269345988233e-09
accumulation O 0 1.9387959682148903e-08
of O 0 4.9203968899291795e-08
fluorescently O 0 6.457151471295219e-07
labeled O 0 1.6152311710371237e-09
platelets O 0 1.7090553972032296e-10
was O 0 3.003388163169696e-11
observed O 0 6.170053183651714e-12
by O 0 2.091118510988421e-12
intravital O 0 3.042211815795781e-08
microscopy O 0 1.0549175755159013e-08
. O 0 4.883938586885961e-09

We O 0 8.663227468730383e-09
conclude O 0 9.817266111156187e-09
that O 0 4.06700931612769e-12
these O 0 3.358908637340896e-12
mice O 0 6.540703534341219e-10
very O 0 2.8186331849262836e-13
closely O 0 1.0593924175406055e-11
mimic O 0 9.202032025257267e-09
severe O 0 0.00043471172102726996
human O 0 3.084077661696938e-06
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 4.0317825522606654e-08
will O 0 4.559782412760782e-11
be O 0 9.507780847350933e-13
very O 0 2.6124427328442362e-14
useful O 0 7.914190001045637e-14
for O 0 1.2111096630781915e-13
investigating O 0 4.1852450866942947e-13
the O 0 5.795208605531565e-13
role O 0 8.966794320941496e-13
of O 0 1.0903495988034972e-11
vWf O 0 1.2838008434101766e-10
in O 0 3.2606866425671788e-12
normal O 0 1.7635900517731784e-09
physiology O 0 1.1536470667650178e-09
and O 0 1.2277563948143166e-12
in O 0 3.016224423002534e-11
disease O 0 4.655447227719378e-08
models O 0 5.7708268719203204e-11
. O 0 2.3065846108116794e-11
. O 0 1.2704793883600018e-09

Oral O 0 1.8499436919228174e-05
contraceptives O 0 1.0854623724299017e-06
and O 0 2.8538961124868756e-11
the O 0 2.46924924951486e-10
risk O 0 4.1581071030805106e-08
of O 0 5.8057112255482934e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0001071715887519531

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999819993972778
Study O 0 4.8153168563658255e-08
Group O 0 1.0165187802613218e-08
. O 0 6.929041784786705e-09

BACKGROUND O 0 8.878574590198696e-06
Women O 0 2.235729310018364e-11
with O 0 8.857461205463713e-13
mutations O 0 2.757419292898078e-12
in O 0 5.617661717749467e-12
either O 0 5.7847233947416754e-11
the O 0 3.2383709602790134e-10
BRCA1 O 0 7.174420779687551e-11
or O 0 1.4563762522346035e-12
the O 0 8.263427442312121e-11
BRCA2 O 0 3.437016990459618e-11
gene O 0 4.662962724277797e-13
have O 0 2.6961726173066816e-14
a O 0 1.398927360670571e-13
high O 0 2.344660229858242e-11
lifetime O 0 1.6455649343161127e-10
risk O 0 7.237019872263772e-08
of O 0 9.517584112472832e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.605116787890438e-05

Oral O 0 0.005162668880075216
contraceptives O 0 0.443469375371933
protect O 0 5.286987629915529e-07
against O 1 0.9999992847442627
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.1111377595796057e-08
general O 0 1.6535770086534285e-08
, O 0 6.6179353663819995e-12
but O 0 5.203349144784764e-13
it O 0 9.687037413538824e-14
is O 0 3.632604471132811e-14
not O 0 1.5124965895615267e-14
known O 0 1.1271318080263715e-12
whether O 0 4.32796105811345e-13
they O 0 2.6208386589426924e-13
also O 0 1.5650517990947743e-13
protect O 0 9.471671493996303e-13
against O 0 2.778225913213639e-11
hereditary B-Disease 0 4.114058356208261e-06
forms I-Disease 0 1.1709994751640806e-08
of I-Disease 0 3.554042268660851e-05
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.633940756728407e-07

METHODS O 0 6.447527312047896e-08
We O 0 1.6170427497019801e-10
enrolled O 0 8.067341239481607e-11
207 O 0 3.0916669224723137e-10
women O 0 1.4037337915315251e-12
with O 0 2.920233221903601e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3779144492076512e-09
161 O 0 7.355604320080644e-11
of O 0 8.555013364386355e-10
their O 0 3.970884454584933e-10
sisters O 0 7.593762285651451e-10
as O 0 9.067063939938169e-12
controls O 0 4.230640282543163e-09
in O 0 1.105955865082775e-11
a O 0 3.7935404817446283e-11
case O 0 3.357853578522807e-11
- O 0 6.273586650173968e-10
control O 0 2.604882887169424e-08
study O 0 3.1743546680118584e-10
. O 0 7.79287523400285e-10

All O 0 7.707262383860325e-09
the O 0 4.795142061198021e-09
patients O 0 4.1366399888831396e-11
carried O 0 3.6543129633415106e-11
a O 0 1.2550349648421388e-11
pathogenic O 0 5.862900442910046e-11
mutation O 0 7.328699279385287e-12
in O 0 8.195160695889658e-12
either O 0 1.236327706877205e-10
BRCA1 O 0 1.442527208794786e-10
( O 0 8.793109469718008e-13
179 O 0 4.690020594111388e-11
women O 0 7.843534849394374e-13
) O 0 2.7063857340088593e-13
or O 0 1.9920252947169814e-11
BRCA2 O 0 3.221540256781452e-10
( O 0 2.0606786676341526e-12
28 O 0 9.215838758791506e-09
women O 0 1.1975398103714063e-11
) O 0 6.3186131674108914e-12
. O 0 7.841213234272004e-10

The O 0 7.475868102346794e-08
control O 0 2.3906313799670897e-06
women O 0 2.2621005763001634e-11
were O 0 2.4147269253593784e-11
enrolled O 0 1.469923315011723e-11
regardless O 0 7.550776670584014e-11
of O 0 1.384008879723453e-10
whether O 0 8.74476012435732e-12
or O 0 4.7117791439343915e-12
not O 0 1.0370541231319308e-12
they O 0 1.2387434827898502e-12
had O 0 1.4550194382678683e-11
either O 0 5.954750581516066e-11
mutation O 0 4.97678731559148e-10
. O 0 6.492044124506435e-10

Lifetime O 0 1.2863807796748006e-08
histories O 0 2.147327871071525e-09
of O 0 2.1587947429679843e-08
oral O 0 6.288163149292814e-06
- O 0 1.1085894868756441e-07
contraceptive O 0 5.102292277570086e-08
use O 0 1.7940688865070165e-11
were O 0 1.2865033474293575e-12
obtained O 0 1.3629498734051698e-13
by O 0 4.9204855413678e-14
interview O 0 1.4795147745827464e-11
or O 0 4.612610071457954e-14
by O 0 8.617058448897024e-15
written O 0 9.892704467022104e-15
questionnaire O 0 3.3946407078212586e-16
and O 0 5.335981460017399e-15
were O 0 7.362513376740765e-14
compared O 0 4.8555038841598813e-14
between O 0 7.872671698577749e-13
patients O 0 1.3352026732513234e-12
and O 0 7.986877760719768e-13
control O 0 1.0071607903228141e-06
women O 0 8.06280633621273e-14
, O 0 3.422273993055128e-14
after O 0 1.8764696827627825e-12
adjustment O 0 5.144273895751894e-11
for O 0 6.46983334962048e-13
year O 0 1.0586545745941423e-12
of O 0 2.1148008691462827e-11
birth O 0 3.214420396524531e-10
and O 0 6.470851632300878e-11
parity O 0 2.2237357200083352e-07
. O 0 5.458058893736961e-09

RESULTS O 0 1.9406828144497013e-08
The O 0 3.2004962569054385e-10
adjusted O 0 2.6464979097085006e-09
odds O 0 5.637132716174165e-08
ratio O 0 7.147790137551624e-10
for O 0 2.3624636469321558e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.067974014252627e-09
with O 0 1.3519437305764548e-13
any O 0 2.2043517185210693e-12
past O 0 2.1107336798525944e-12
use O 0 3.6093250241862884e-13
of O 0 3.665955993631398e-12
oral O 0 2.093460294005922e-09
contraceptives O 0 2.4314135149694494e-09
was O 0 7.860335160536636e-10
0 O 0 9.59085522111991e-09
. O 0 1.3496970208137782e-09

5 O 0 1.9802959272396947e-08
( O 0 3.5138291581970904e-11
95 O 0 1.508489999579865e-09
percent O 0 1.8983591087984308e-10
confidence O 0 3.4722924535657285e-09
interval O 0 4.498144967612916e-09
, O 0 9.722124147404365e-12
0 O 0 5.3236508951171047e-11
. O 0 1.7113883281436731e-13
3 O 0 4.474350577543529e-12
to O 0 1.0495984371352782e-13
0 O 0 1.0993792681768255e-11
. O 0 2.3980909489088043e-13
8 O 0 6.554899678601345e-11
) O 0 8.722234631601544e-13
. O 0 4.792905655692792e-11

The O 0 4.674024722817194e-08
risk O 0 2.5249735635668458e-09
decreased O 0 1.2152435308054876e-11
with O 0 5.016822410107294e-15
increasing O 0 3.928885483010097e-13
duration O 0 1.0195619522257449e-11
of O 0 1.582601237559711e-12
use O 0 4.509862264450576e-13
( O 0 1.395870181594705e-13
P O 0 6.835732535570571e-10
for O 0 7.192746290067553e-13
trend O 0 1.1278899342270776e-10
, O 0 2.7625452381392634e-13
< O 0 9.087494645676486e-12
0 O 0 6.9491357113093954e-12
. O 0 3.0160705340566765e-14
001 O 0 7.706409295427097e-13
) O 0 9.07209278026349e-17
; O 0 8.253557197728377e-17
use O 0 6.4764693953644255e-15
for O 0 3.104412343510332e-14
six O 0 3.0297482188010316e-13
or O 0 2.4959026883567166e-14
more O 0 8.327502247581391e-16
years O 0 8.850128204070107e-14
was O 0 9.02207388658871e-12
associated O 0 3.0904475484781757e-13
with O 0 1.699417279262764e-14
a O 0 1.3660398767018078e-12
60 O 0 2.2951467115728263e-12
percent O 0 4.304401887006426e-12
reduction O 0 1.994049814157961e-09
in O 0 1.9426139863387704e-10
risk O 0 3.2826399376517656e-08
. O 0 1.9098584935761664e-09

Oral O 0 0.00019840541062876582
- O 0 1.6991588154269266e-06
contraceptive O 0 1.6032146277211723e-06
use O 0 1.8210852270605926e-10
protected O 0 3.3259707379329484e-06
against O 0 0.015181930735707283
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 6.745412388375893e-12
for O 0 2.872986950338413e-13
carriers O 0 2.3316834980814313e-14
of O 0 3.296246197000141e-13
the O 0 1.689278751604295e-11
BRCA1 O 0 3.945884244349607e-11
mutation O 0 3.0898347032001783e-13
( O 0 2.0564440382227038e-14
odds O 0 3.686319305362673e-11
ratio O 0 1.4768911191665596e-13
, O 0 1.9016457177933703e-14
0 O 0 1.0413653446506022e-12
. O 0 9.055885043045796e-15
5 O 0 2.4129889709609276e-13
; O 0 7.192158872718632e-16
95 O 0 2.6444148520238242e-12
percent O 0 1.0069664286432856e-12
confidence O 0 4.670613548696245e-11
interval O 0 1.692133377861893e-10
, O 0 6.998066947976056e-13
0 O 0 5.16677022346923e-12
. O 0 2.1248246692413646e-14
3 O 0 9.60200126874644e-13
to O 0 2.0467084109335523e-14
0 O 0 8.229303198083182e-13
. O 0 1.0435514519841708e-14
9 O 0 7.48469591426576e-13
) O 0 4.584083018233966e-16
and O 0 2.488713665623485e-15
for O 0 1.246611338055802e-14
carriers O 0 2.2359902896785556e-14
of O 0 8.384955598773891e-13
the O 0 6.183876327670035e-11
BRCA2 O 0 8.644600313356676e-11
mutation O 0 1.6555588280495193e-12
( O 0 1.59496412388202e-13
odds O 0 1.6336998420740656e-10
ratio O 0 4.89024890460571e-13
, O 0 7.387791550392264e-14
0 O 0 7.099060055082429e-12
. O 0 7.284389156323248e-14
4 O 0 4.153660054795338e-12
; O 0 9.347485452500508e-15
95 O 0 1.4358998365326947e-11
percent O 0 2.429013370650046e-12
confidence O 0 3.0864702460497995e-10
interval O 0 1.0537627437301467e-09
, O 0 4.550119395846375e-12
0 O 0 2.2838028343463712e-11
. O 0 1.8970242043891972e-13
2 O 0 3.787704091345878e-12
to O 0 1.1051766056133228e-13
1 O 0 1.4396788448889364e-11
. O 0 3.445736805694072e-13
1 O 0 6.87022314038721e-11
) O 0 1.1195129025198813e-12
. O 0 5.5022254114023283e-11

CONCLUSIONS O 0 4.1855196286633145e-07
Oral O 0 2.0438534193090163e-05
- O 0 4.973633167537628e-07
contraceptive O 0 6.809230512772046e-07
use O 0 1.7508586594439102e-11
may O 0 1.3837856641801816e-12
reduce O 0 4.293209884820293e-12
the O 0 1.0895984635383993e-12
risk O 0 1.8514725308449442e-09
of O 0 1.7986889133680961e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.53906601194376e-09
women O 0 2.0349605721749035e-14
with O 0 3.4818718664986507e-15
pathogenic O 0 7.76410012670592e-12
mutations O 0 4.106761859832414e-13
in O 0 2.4095634341969596e-12
the O 0 3.467525433453744e-10
BRCA1 O 0 2.935945042636945e-09
or O 0 2.353820471867607e-10
BRCA2 O 0 4.8342464253892103e-08
gene O 0 1.2565558904498175e-07

A O 0 9.704696140033775e-07
Japanese O 0 2.6955154908137047e-07
family O 0 5.736425778835041e-10
with O 0 1.4135264070347375e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.9841173148904545e-09
a O 0 4.1834664621376305e-09
codon O 0 6.050815404279319e-09
291 O 0 2.850280289568019e-10
deletion O 0 7.256751866080435e-10
: O 0 2.2329070016591235e-12
a O 0 5.095338213856326e-12
clinical O 0 2.0095742847558995e-09
, O 0 1.21373722704321e-12
biochemical O 0 1.0630611946282897e-09
, O 0 4.654647760976571e-12
pathological O 0 1.322336515841016e-06
, O 0 3.431964998648618e-12
and O 0 3.110270938369575e-12
genetic O 0 1.0136026462603809e-09
report O 0 3.152993144350802e-10
. O 0 1.046973285845354e-09

We O 0 1.57144408596821e-09
report O 0 3.595750780460705e-11
a O 0 2.1057565413595825e-11
Japanese O 0 1.5216555793173825e-09
family O 0 2.0076183770978417e-11
with O 0 2.6769841898754976e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.003258208278566599
ALD B-Disease 1 1.0
) O 0 2.3324911880423516e-12
with O 0 8.815661959107879e-13
a O 0 5.799150742946679e-11
three O 0 3.755700264673756e-11
base O 0 1.6147906345409524e-09
pair O 0 1.588849163347561e-09
deletion O 0 9.363498865155861e-10
( O 0 1.861825277282847e-11
delGAG O 0 4.766254502186484e-09
291 O 0 7.854785571970169e-11
) O 0 2.0358506005145605e-13
in O 0 5.641284314683581e-12
the O 0 1.4374969659058934e-08
ALD B-Disease 1 1.0
gene O 0 1.5210970616408304e-07
. O 0 1.8856296080116408e-08

A O 0 1.0696886221239765e-07
variety O 0 9.504314002484193e-10
of O 0 9.614807838786987e-10
phenotypes O 0 5.757888610347095e-10
were O 0 2.8435942836524397e-11
observed O 0 6.080937142716181e-11
within O 0 3.549970387095591e-11
this O 0 8.250650163077466e-12
family O 0 1.3169176860117204e-10
. O 0 3.2472917688153302e-09

While O 0 5.266252323110621e-09
the O 0 3.27837690328181e-09
proband O 0 4.29231158705079e-06
( O 0 5.568084882057178e-10
patient O 0 3.163729944688498e-09
1 O 0 5.531736846364765e-09
) O 0 2.433050776910056e-13
was O 0 1.1979054033439684e-11
classified O 0 2.5412128998314465e-12
as O 0 1.1170855906961208e-12
having O 0 6.2323618488235866e-12
a O 0 7.84813273396745e-12
rare O 0 1.9403031958908912e-10
intermediate O 0 9.694981623065146e-11
type O 0 3.4348742600220916e-11
of O 0 7.981296179515596e-11
adult O 0 8.215232383257387e-10
cerebral O 0 4.4775498864169094e-09
and O 0 7.278455615988833e-11
cerebello O 1 0.9987016916275024
- O 0 0.00015607936074957252
brain O 0 0.004072040319442749
stem O 0 3.4838534834769064e-10
forms O 0 7.669811834254414e-12
, O 0 4.4658732007568647e-13
his O 0 7.037413013444294e-11
younger O 0 3.769090942129516e-11
brother O 0 1.0289912255601052e-09
( O 0 5.198888194946072e-12
patient O 0 3.695402595038644e-10
2 O 0 3.305306250922513e-09
) O 0 1.5854644799719736e-13
and O 0 2.8456002745119724e-12
nephew O 0 2.667951859436357e-09
( O 0 5.8883145755139754e-12
patient O 0 2.181800740075346e-09
3 O 0 1.204014132838438e-08
) O 0 1.828437574957764e-12
had O 0 3.0847280285684064e-10
a O 0 7.06201319644606e-09
childhood O 1 0.9999432563781738
ALD B-Disease 1 1.0
type O 0 0.00013356536510400474
. O 0 9.02932129065448e-08

Another O 0 1.1393548220439698e-06
nephew O 0 1.634880572964903e-05
( O 0 4.830556843415934e-09
patient O 0 2.159000622725671e-08
4 O 0 1.1342384453882914e-07
) O 0 2.1849540406126966e-12
of O 0 4.537332454201959e-10
patient O 0 1.0295905461532584e-08
1 O 0 1.7208891733844212e-07
was O 0 1.4529907277349707e-09
classified O 0 1.7452773601323024e-11
as O 0 2.710861266366771e-12
having O 0 1.0550207409087964e-11
an O 0 1.1267964642944217e-12
adolescent O 0 1.3800870446445401e-09
form O 0 7.760984077620492e-10
. O 0 3.82443499091778e-09

The O 0 1.5364015837349143e-08
tau O 0 1.886031553155476e-09
level O 0 1.8748116947797655e-10
in O 0 2.010188456663675e-12
the O 0 1.812193277384022e-11
cerebrospinal O 0 2.4946369969747195e-10
fluid O 0 1.664065261454406e-12
( O 0 1.657837062074563e-12
CSF O 0 1.0815972562028264e-09
) O 0 1.998248978394776e-13
in O 0 3.3035301924555505e-12
patient O 0 3.782488211534485e-10
1 O 0 4.871685721496988e-09
was O 0 4.3150760742349803e-10
as O 0 4.004467764329167e-12
high O 0 3.692723210546589e-11
as O 0 1.386299793492904e-13
that O 0 2.0908452649359005e-14
of O 0 1.4081081786687655e-11
patients O 0 2.5598804326287805e-11
with O 0 1.3687249944549507e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9993703961372375
( O 0 1.8358986206279404e-12
AD B-Disease 0 1.2553467987341804e-10
) O 0 4.8353430634473504e-12
. O 0 1.899105178670979e-10

His O 0 2.979400903768692e-08
brain O 0 1.0138891504141156e-08
magnetic O 0 1.7251952644237178e-10
resonance O 0 6.020072634838058e-11
image O 0 2.5447066329120638e-11
( O 0 1.8231260685147577e-13
MRI O 0 8.880480795170342e-10
) O 0 1.0040450729945777e-13
showed O 0 2.6416487053371185e-11
abnormalities B-Disease 0 1.4861125663401253e-08
in I-Disease 0 7.156537190113055e-13
the I-Disease 0 2.9531715614594667e-12
bilateral I-Disease 0 1.4612895338217413e-09
cerebellar I-Disease 0 8.249899110523984e-06
hemispheres I-Disease 0 3.263111780782424e-09
and O 0 6.700139748572198e-11
brain O 0 2.702054935355136e-08
stem O 0 2.6679896139580883e-11
, O 0 1.1095889696421599e-13
but O 0 4.994140815955603e-14
not O 0 6.804135705383574e-14
in O 0 1.5877835071037572e-12
the O 0 1.2466994103732532e-10
cerebral O 0 2.5206237097563644e-09
white O 0 2.2886944076039306e-12
matter O 0 9.485568932968494e-14
, O 0 4.434936609848481e-15
where O 0 1.1891845371110338e-14
marked O 0 7.047681665692251e-13
reductions O 0 1.8934583068119792e-11
of O 0 1.1711875393116689e-11
the O 0 7.413662739264026e-11
cerebral O 0 1.582264735899841e-10
blood O 0 5.179061389817829e-13
flow O 0 9.64186196161787e-13
and O 0 1.7985698650899162e-12
oxygen O 0 4.138462836311696e-11
metabolism O 0 2.0769588271463135e-09
were O 0 8.717747877751147e-12
clearly O 0 4.611415416189146e-13
demonstrated O 0 9.955515687005978e-14
by O 0 2.7165933958188566e-14
positron O 0 2.0365391231041974e-12
emission O 0 1.100007029908312e-10
tomography O 0 1.1576007513669495e-10
( O 0 1.003246010572445e-11
PET O 0 5.393729463065711e-09
) O 0 7.1382860560020855e-12
. O 0 3.387749525352035e-10

In O 0 3.3376028607534636e-09
patients O 0 3.307341622793558e-10
2 O 0 8.068914980619013e-10
and O 0 3.248389621526848e-12
3 O 0 6.045470790638774e-10
, O 0 6.81079921193567e-13
the O 0 8.08039659488946e-12
autopsy O 0 7.197536788794423e-09
findings O 0 1.9069881090905128e-11
showed O 0 1.0966677566059957e-10
massive O 0 1.185582654272821e-08
demyelination B-Disease 1 1.0
of I-Disease 0 1.654820920293787e-07
the I-Disease 0 1.5583886181502749e-07
cerebral I-Disease 0 5.01549152431835e-07
white I-Disease 0 1.0163510311134161e-10
matter I-Disease 0 1.1437814671083624e-12
with O 0 2.0152546894702111e-13
sparing O 0 1.7265482099571017e-10
of O 0 2.063671011853785e-09
the O 0 4.7053585916501106e-08
U O 1 0.7266392111778259
- O 0 4.5837516893243446e-08
fibers O 0 2.4862163439109963e-09
, O 0 8.051810954090577e-12
compatible O 0 1.2458348797039775e-09
with O 0 2.7134360296859894e-13
the O 0 3.205541040940396e-11
findings O 0 9.646392191975384e-12
of O 0 3.394728942396341e-10
childhood O 0 0.0003978556196670979
ALD B-Disease 1 1.0
. O 0 4.0762171238384326e-07

Oleic O 0 0.00010626528091961518
and O 0 4.43684768924868e-08
erucic O 0 4.105933112441562e-05
acids O 0 2.4880855153952552e-09
( O 0 2.5300232395220057e-11
Lorenzos O 0 3.402939441343733e-08
Oil O 0 2.2407423139192417e-10
) O 0 2.8085013156244065e-13
were O 0 2.1813438642187544e-12
administered O 0 2.5801893607790838e-11
to O 0 2.8034666602061442e-12
patients O 0 1.2272253525902332e-11
1 O 0 5.134669911477374e-10
and O 0 3.0114060117075736e-12
4 O 0 3.0629301872586723e-10
, O 0 2.1005915648401874e-13
but O 0 5.786745458898415e-14
sufficient O 0 6.3854663744089546e-12
effectiveness O 0 6.840734142338212e-12
was O 0 2.702138339472082e-11
not O 0 4.2352582487088786e-13
obtained O 0 1.108240669372984e-11
. O 0 2.983509272969087e-10

The O 0 2.811290045201531e-08
findings O 0 1.0152659962736621e-10
in O 0 1.960741638495911e-11
this O 0 2.9578785167710953e-12
family O 0 1.0411508894608845e-12
suggest O 0 1.6791011940228695e-12
that O 0 9.992173917710429e-14
delGAG291 O 0 3.4233124668325843e-10
is O 0 2.946643038077845e-13
part O 0 6.604515111890974e-13
of O 0 1.9078575524966723e-11
the O 0 4.966960870378401e-11
cause O 0 3.948777693718597e-10
of O 0 4.3759118550923404e-10
Japanese O 0 1.156064854512806e-06
ALD B-Disease 1 1.0
with O 0 2.0720712645694306e-10
phenotypic O 0 5.969634457869688e-07
variations O 0 5.533533453672135e-08
. O 0 1.540066030258913e-08

Moreover O 0 1.959032402965022e-08
, O 0 2.606116190906338e-11
although O 0 2.7937515582193706e-12
the O 0 4.702029564318533e-12
scale O 0 4.1493644631351856e-10
of O 0 1.3804496434843827e-10
the O 0 7.207063418279702e-11
study O 0 1.2405594130085462e-12
is O 0 4.4770265240304946e-14
limited O 0 1.2180321855292942e-12
, O 0 2.1983128750506509e-13
there O 0 2.3582353517875854e-12
is O 0 1.5328860143021261e-12
a O 0 8.10560386171888e-12
possibility O 0 6.524343287850343e-10
that O 0 1.4134441013446963e-11
PET O 0 1.5351632498550316e-07
can O 0 1.9509480836399362e-12
detect O 0 4.6238238238238694e-10
an O 0 5.637949308801016e-12
insidious B-Disease 0 5.079395748452953e-08
lesion I-Disease 0 1.7207822793352534e-06
which O 0 2.034589944438503e-12
is O 0 1.9936995305537553e-13
undetectable O 0 3.2345296580027494e-11
by O 0 9.723745788593752e-14
computed O 0 1.1260171614568826e-11
tomogram O 0 1.8562530401666777e-09
( O 0 9.126991697139264e-13
CT O 0 9.188036997898053e-09
) O 0 8.204161227329601e-14
or O 0 5.064357475590732e-14
MRI O 0 3.3645530805870294e-11
analysis O 0 1.4159008167313747e-13
, O 0 3.0841574140492295e-14
and O 0 4.0309630497869717e-14
that O 0 2.773218395375754e-14
the O 0 4.310210174884865e-12
higher O 0 1.2089182085950334e-11
level O 0 2.0585907978265539e-10
of O 0 2.506459102769032e-11
tau O 0 3.811120169450177e-11
reflects O 0 1.5898494001333197e-13
the O 0 3.5916069922835303e-13
process O 0 3.123540488758625e-12
of O 0 3.2011907014073415e-11
neuronal B-Disease 0 2.380722463612983e-07
degeneration I-Disease 1 0.9979665279388428
in O 0 3.040280205368617e-08
ALD B-Disease 1 1.0
. O 0 2.2874887406487687e-07

Lorenzos O 0 4.43497410742566e-05
Oil O 0 4.9893099429709764e-08
should O 0 3.840798859511274e-11
be O 0 2.2285744484627085e-13
given O 0 3.5097043950575377e-14
in O 0 7.050353952996885e-14
the O 0 2.5636855919414225e-12
early O 0 2.547266841901319e-10
stage O 0 1.4571676087982155e-09
. O 0 4.0968381465056325e-11
. O 0 5.336147634871224e-10

Nonsense O 0 1.696755703051167e-06
mutation O 0 3.2697655694136074e-09
in O 0 2.7717964035112175e-10
exon O 0 6.662247642452712e-09
4 O 0 3.4114444602550975e-09
of O 0 1.0288695451166063e-09
human O 0 7.611017927011687e-10
complement O 0 9.5326546656338e-10
C9 O 0 2.587764242889534e-07
gene O 0 2.067924477489047e-11
is O 0 2.977842039793288e-13
the O 0 2.5081508051028045e-12
major O 0 2.2119520104446622e-10
cause O 0 5.193412366821804e-10
of O 0 1.0085692281336378e-09
Japanese O 0 4.323892142110708e-07
complement B-Disease 0 5.330168733053142e-06
C9 I-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9328323602676392
. O 0 5.614738185499846e-08

Deficiency B-Disease 0 0.0011565153254196048
of I-Disease 0 4.350593826529803e-06
the I-Disease 0 4.612421662386623e-07
ninth I-Disease 0 4.74018770546536e-06
component I-Disease 0 1.9137319284823207e-08
of I-Disease 0 7.666182355592355e-09
human I-Disease 0 2.9656956890278252e-09
complement I-Disease 0 3.921344915447378e-10
( O 0 2.8894046877336876e-11
C9 O 0 3.2763477975095157e-07
) O 0 4.270169558662912e-13
is O 0 5.5951357642077676e-14
the O 0 1.632072298488052e-12
most O 0 1.9862271549708765e-12
common O 0 1.6255205181892052e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.488552279331316e-09
Japan O 0 5.156128963790252e-07
but O 0 1.6537756407364324e-12
is O 0 1.8333045585100516e-13
rare O 0 3.236218801619395e-12
in O 0 1.6354377704516643e-12
other O 0 2.2318169447949066e-12
countries O 0 2.4125999809054832e-11
. O 0 8.392408434865217e-10

We O 0 3.828841688147122e-10
studied O 0 1.5884422943646115e-10
the O 0 4.299568947402355e-12
molecular O 0 9.91374343728424e-12
basis O 0 2.9381941324402305e-11
of O 0 1.0736717070969348e-09
C9 B-Disease 0 0.10675926506519318
deficiency I-Disease 0 1.4122013780593079e-08
in O 0 8.396163105051091e-12
four O 0 1.695023808812035e-11
Japanese O 0 3.561756400927152e-08
C9 B-Disease 1 0.999994158744812
- I-Disease 0 0.10100666433572769
deficient I-Disease 0 0.0012883958406746387
patients O 0 1.3055932723826658e-10
who O 0 4.005522042521692e-12
had O 0 3.040329377146378e-10
suffered O 0 0.08258591592311859
from O 0 1.4584495033886924e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 4.335538150712637e-09

Direct O 0 1.6548667991500565e-09
sequencing O 0 6.116907536046767e-10
of O 0 2.4607358373174293e-09
amplified O 0 2.6805210495695064e-08
C9 O 0 4.2247000919815036e-07
cDNA O 0 3.2315732312326872e-09
and O 0 2.6510269673929443e-11
DNA O 0 1.5519095730720522e-10
revealed O 0 6.156208876006986e-11
a O 0 2.0231056413466675e-11
nonsense O 0 2.8079377711875964e-10
substitution O 0 1.46648776455649e-10
( O 0 6.448056064783936e-12
CGA O 0 9.507365561489678e-09
- O 0 2.5853680307719173e-10
- O 0 9.850704696390267e-10
> O 0 3.500434164749322e-09
TGA O 0 3.467542342150409e-08
) O 0 2.25452143932936e-13
at O 0 9.221450859853153e-12
codon O 0 1.3571327221739704e-11
95 O 0 1.567422407144914e-11
in O 0 1.855684009233194e-12
exon O 0 1.2268844273854995e-10
4 O 0 5.147768322721902e-11
in O 0 3.3542222818705447e-12
the O 0 9.156241043140056e-11
four O 0 7.417343961257927e-10
C9 B-Disease 0 0.00026782145141623914
- I-Disease 0 7.09055484549026e-07
deficient I-Disease 0 2.645379595378472e-07
individuals O 0 6.328217116990942e-11
. O 0 3.5530494102431476e-09

An O 0 1.1937867361311305e-10
allele O 0 8.597280665156859e-10
- O 0 5.120723289842033e-10
specific O 0 5.621376142350698e-10
polymerase O 0 3.466707365618049e-09
chain O 0 1.8778668220420514e-07
reaction O 0 9.61322549342114e-11
system O 0 1.6616565068350297e-10
designed O 0 8.092518842539587e-12
to O 0 1.5360285200889667e-13
detect O 0 4.447922065387022e-12
exclusively O 0 4.375588162196936e-13
only O 0 4.5891618277857024e-14
one O 0 1.2273593803075432e-14
of O 0 1.2435823855058703e-12
the O 0 1.9039268859405434e-12
normal O 0 4.38683768130832e-12
and O 0 3.9410721864793774e-14
mutant O 0 5.016830267184913e-12
alleles O 0 7.41531690245283e-15
indicated O 0 3.856670774296349e-14
that O 0 1.4028698374070835e-15
all O 0 4.249659502878096e-14
the O 0 1.1348545801009857e-12
four O 0 7.243492372750737e-13
patients O 0 4.256806428073849e-14
were O 0 8.54688973132671e-14
homozygous O 0 2.5687564055021372e-12
for O 0 2.9839599216020807e-13
the O 0 6.0096983812985005e-12
mutation O 0 1.1869718532717122e-12
in O 0 1.3615111642273359e-12
exon O 0 3.3100364116300796e-10
4 O 0 5.045855400176436e-10
and O 0 2.157135798111498e-12
that O 0 2.0689087379052729e-13
the O 0 2.8385384320817053e-11
parents O 0 6.244352365909756e-13
of O 0 7.298766452334959e-11
patient O 0 5.739402286764062e-10
2 O 0 2.101558749245669e-08
were O 0 6.497519744463887e-10
heterozygous O 0 3.990185959423798e-09
. O 0 1.5015660936867903e-09

The O 0 3.083354727095866e-08
common O 0 3.639667234267563e-09
mutation O 0 1.2029385820788718e-10
at O 0 4.236848372141111e-10
codon O 0 1.684273415181181e-10
95 O 0 6.753517189928004e-10
in O 0 7.011032726600419e-11
exon O 0 8.569519316381502e-09
4 O 0 2.892468042858809e-09
might O 0 5.15100635756216e-12
be O 0 1.876941256497705e-13
responsible O 0 1.7646303255430817e-12
for O 0 1.1752283174404354e-12
most O 0 9.611020312938479e-12
Japanese O 0 3.046918948257371e-07
C9 B-Disease 1 0.9998395442962646
deficiency I-Disease 0 3.2798909614939475e-06
. O 0 3.328002595726076e-10
. O 0 1.7458118284352508e-09

BRCA1 O 0 4.010200882476056e-08
required O 0 1.2266035409602694e-10
for O 0 1.7938428520380967e-11
transcription O 0 5.0764588088725304e-09
- O 0 6.803337981864388e-08
coupled O 0 1.7135459984274348e-07
repair O 0 5.964558340565418e-07
of O 0 5.1470987472157503e-08
oxidative O 0 5.1969607739010826e-05
DNA O 0 1.190174643284081e-07
damage O 0 7.411778710775252e-07
. O 0 2.1861827903535413e-09

The O 0 5.177299954084447e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999803304672241
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9995044469833374
gene O 0 1.2299550711247775e-08
BRCA1 O 0 4.955399979245101e-10
encodes O 0 1.2337405402851331e-11
a O 0 1.839468577458092e-10
zinc O 0 1.0832515329184389e-08
finger O 0 8.480903801455497e-08
protein O 0 2.4496513706395717e-09
of O 0 1.2222236556169719e-08
unknown O 0 1.202639765551794e-07
function O 0 6.741319946712565e-09
. O 0 4.037118972455289e-10

Association O 0 1.0985031906329823e-07
of O 0 1.1838563906962918e-08
the O 0 4.5304422435776814e-09
BRCA1 O 0 2.7862348539464676e-10
protein O 0 3.6130874767753562e-12
with O 0 4.750851947087076e-13
the O 0 1.504693175613525e-10
DNA O 0 1.1576498648580014e-09
repair O 0 8.324799516401526e-09
protein O 0 2.927153797127602e-10
Rad51 O 0 1.8823371750187334e-09
and O 0 7.30526316522484e-13
changes O 0 1.1572817357197174e-12
in O 0 2.5660861781816313e-13
the O 0 8.464302392666156e-13
phosphorylation O 0 6.944141008741189e-12
and O 0 1.6784607557995823e-12
cellular O 0 2.670969556639591e-10
localization O 0 4.337771031259763e-09
of O 0 4.320805865876132e-11
the O 0 3.95220384197259e-11
protein O 0 1.7789191994466158e-11
after O 0 4.401188094527164e-11
exposure O 0 2.7893937160072824e-10
to O 0 9.930094940768797e-12
DNA O 0 9.296307723616337e-09
- O 0 5.762506027906511e-09
damaging O 0 6.245571171348274e-08
agents O 0 3.6426219679475125e-11
are O 0 1.6133280692290364e-13
consistent O 0 9.696493608046808e-12
with O 0 7.060918147915041e-14
a O 0 1.0596834174037006e-11
role O 0 2.067277772577203e-11
for O 0 4.2133147665213144e-11
BRCA1 O 0 1.2994425535595155e-09
in O 0 1.8345946983799877e-10
DNA O 0 4.2573553571401135e-08
repair O 0 1.6913338640733855e-06
. O 0 9.200982731272234e-08

Here O 0 1.456193210458423e-08
, O 0 3.9350543656890835e-11
it O 0 4.1387745552783073e-13
is O 0 6.946319333536038e-14
shown O 0 3.462827626640047e-13
that O 0 2.400754291545515e-13
mouse O 0 1.0373584213851927e-09
embryonic O 0 4.4502090901232805e-10
stem O 0 2.2028398202755817e-11
cells O 0 7.538684954067065e-12
deficient B-Disease 0 1.0514106946191148e-11
in I-Disease 0 2.265519152486184e-12
BRCA1 I-Disease 0 3.8172600497210496e-11
are O 0 7.170879965127594e-14
defective O 0 1.2869383510250021e-11
in O 0 6.85211707252692e-13
the O 0 7.210937142537732e-12
ability O 0 5.75323642892922e-13
to O 0 2.3705232113195585e-13
carry O 0 4.4579075673956137e-13
out O 0 3.5401895174050346e-13
transcription O 0 3.6047759222057607e-10
- O 0 2.8886693037577515e-09
coupled O 0 8.748076929521176e-09
repair O 0 6.256539819560203e-08
of O 0 9.111024823482694e-09
oxidative O 0 6.868764899081725e-07
DNA O 0 5.136748804090985e-09
damage O 0 3.225306244303283e-08
, O 0 6.109346101929036e-12
and O 0 1.078713854352209e-11
are O 0 4.612614543791915e-12
hypersensitive O 0 2.4775439477764394e-09
to O 0 6.728108348230677e-11
ionizing O 0 5.353432470656116e-07
radiation O 0 3.7644701933459146e-07
and O 0 2.470963017531247e-11
hydrogen O 0 2.8818053499080065e-10
peroxide O 0 3.845471940877587e-09
. O 0 7.774173305108434e-09

These O 0 8.638242343650404e-10
results O 0 1.4271993586945086e-09
suggest O 0 1.6555257165151716e-10
that O 0 6.0975881462088655e-12
BRCA1 O 0 4.039468481931152e-10
participates O 0 2.2054031777879457e-12
, O 0 3.572095418936938e-13
directly O 0 1.2594219829346887e-13
or O 0 1.1336143476833524e-13
indirectly O 0 1.0973900688984392e-13
, O 0 9.5000538739929e-14
in O 0 2.9474933778417256e-12
transcription O 0 6.991663692446082e-09
- O 0 5.583670770192839e-08
coupled O 0 1.5225454319534037e-07
repair O 0 1.8053793837680132e-07
of O 0 4.172263956547795e-08
oxidative O 0 1.056683231581701e-05
DNA O 0 1.7358781079224173e-08
damage O 0 5.289145832421127e-08
. O 0 4.317181334645426e-11
. O 0 6.204412539290161e-10

Truncation O 0 6.421367970688152e-07
mutations O 0 2.46532461112281e-10
in O 0 2.4170125970113254e-11
the O 0 9.994075705899164e-11
transactivation O 0 3.299204465179173e-08
region O 0 4.798030306396583e-10
of O 0 9.594437466731165e-10
PAX6 O 0 1.2822421922464855e-05
result O 0 2.5499455325039833e-10
in O 0 1.879877503663252e-11
dominant O 0 2.958594036428508e-09
- O 0 2.0809398648680144e-09
negative O 0 7.410386748674114e-10
mutants O 0 3.477981280752829e-08
. O 0 1.6258671076130327e-09

PAX6 O 1 0.9950904846191406
is O 0 7.411266711443432e-09
a O 0 3.734814402189812e-10
transcription O 0 1.0738000766341571e-10
factor O 0 1.8183076572197976e-11
with O 0 1.4241922528454576e-12
two O 0 5.8946636634360505e-12
DNA O 0 7.592281664470235e-11
- O 0 1.9794320696431278e-11
binding O 0 7.37330335676134e-11
domains O 0 3.133590956161392e-11
( O 0 3.468313960683367e-13
paired O 0 2.9042400429002413e-11
box O 0 1.0584603193919406e-09
and O 0 4.201644240864333e-12
homeobox O 0 2.636374729636515e-10
) O 0 9.830376394631343e-14
and O 0 2.409416633222805e-12
a O 0 1.6325908680503431e-10
proline O 0 3.556644756486094e-08
- O 0 2.0142300272141256e-08
serine O 0 2.4862922600732418e-06
- O 0 1.8030564774562663e-07
threonine O 0 6.421229045372456e-05
( O 0 2.6277649500805467e-10
PST O 0 0.0004704953171312809
) O 0 6.696277646961457e-12
- O 0 1.6676510172786152e-10
rich O 0 1.2774233060230955e-10
transactivation O 0 4.2784145648511185e-07
domain O 0 1.3986374725050155e-08
. O 0 2.698293810610153e-09

PAX6 O 1 0.9990808963775635
regulates O 0 4.7068127173588437e-07
eye O 0 2.880173951780307e-06
development O 0 9.005183265742289e-10
in O 0 1.3461632850098049e-11
animals O 0 6.785906472156489e-12
ranging O 0 2.4841044152235092e-11
from O 0 3.243003738814809e-12
jellyfish O 0 2.183496005531138e-12
to O 0 8.950834864962509e-13
Drosophila O 0 1.671580929230032e-10
to O 0 6.2777695368498865e-12
humans O 0 6.530939677951153e-11
. O 0 3.055175834543178e-10

Heterozygous O 0 1.4595938679917708e-08
mutations O 0 1.0756039114934168e-10
in O 0 1.292976229555487e-11
the O 0 9.029825498441113e-11
human O 0 7.26119608884801e-10
PAX6 O 0 1.908907051983988e-06
gene O 0 3.1880900697167647e-11
result O 0 2.4995639238967193e-12
in O 0 1.9404409448611076e-13
various O 0 4.373669124351637e-13
phenotypes O 0 1.1281347384040075e-11
, O 0 1.1599285442732976e-13
including O 0 7.165323022417791e-12
aniridia B-Disease 1 1.0
, O 0 1.889524092746342e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.3559517952899114e-09
autosomal B-Disease 0 1.0790902706503402e-05
dominant I-Disease 0 5.288195097818971e-06
keratitis I-Disease 1 0.9999983310699463
, O 0 3.6504416156546426e-10
and O 0 2.647583485781979e-09
familial B-Disease 1 0.9999966621398926
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 8.484788850182667e-06

It O 0 1.5386053542343348e-10
is O 0 5.745694718617411e-12
believed O 0 8.241182042345585e-12
that O 0 9.863750848005878e-14
the O 0 1.2520080458489069e-11
mutated O 0 1.2574742462578836e-11
allele O 0 1.3618807470638927e-11
of O 0 1.0629471608458729e-10
PAX6 O 0 2.1411835859908024e-06
produces O 0 8.821015966276047e-12
an O 0 2.2406105833552847e-13
inactive O 0 4.031570910445481e-10
protein O 0 6.72798317058465e-10
and O 0 1.94563240518697e-10
aniridia B-Disease 1 1.0
is O 0 5.879844527933997e-11
caused O 0 3.264828130067343e-10
due O 0 1.7620029879594767e-09
to O 0 6.108612313898698e-12
genetic O 0 1.0975602648954919e-08
haploinsufficiency O 0 3.753522150873323e-07
. O 0 6.498638516205801e-09

However O 0 1.347580047550423e-09
, O 0 2.4911885054823557e-11
several O 0 1.3755235665768861e-11
truncation O 0 1.0032972674878238e-08
mutations O 0 1.7966782575595808e-11
have O 0 3.2892999847315696e-13
been O 0 2.2706053075076393e-13
found O 0 2.8201750220595116e-14
to O 0 7.068972753617071e-15
occur O 0 1.234299663345484e-13
in O 0 3.5871707080442627e-13
the O 0 2.4426691572210224e-11
C O 0 5.385197621166071e-09
- O 0 1.4320768182418675e-10
terminal O 0 5.205332831437204e-10
half O 0 9.53542258173845e-13
of O 0 4.310136449137136e-12
PAX6 O 0 3.468740317202901e-07
in O 0 8.243964538801052e-12
patients O 0 2.34443562653619e-12
with O 0 9.69253215014898e-13
Aniridia B-Disease 1 1.0
resulting O 0 8.469677181821567e-10
in O 0 6.519200110299828e-12
mutant O 0 4.4957929046240963e-10
proteins O 0 2.9341323207893177e-12
that O 0 3.762263666839266e-13
retain O 0 9.62759316713857e-11
the O 0 9.017295243829437e-11
DNA O 0 1.3017538436077558e-10
- O 0 9.968312633668042e-12
binding O 0 1.1030613054907601e-11
domains O 0 1.850805966818747e-12
but O 0 3.0180973822555024e-13
have O 0 3.823464440021185e-13
lost O 0 8.735879380994405e-11
most O 0 2.765159791678212e-13
of O 0 2.19980422766497e-11
the O 0 4.111149198848807e-10
transactivation O 0 1.8262042544847645e-07
domain O 0 8.978449095309315e-09
. O 0 3.691712713305151e-09

It O 0 1.87439688770219e-10
is O 0 4.4843291406582164e-12
not O 0 5.783426580523165e-13
clear O 0 6.058774575795622e-12
whether O 0 2.697264612182282e-13
such O 0 5.268304022199022e-12
mutants O 0 8.250143679333632e-09
really O 0 2.6714319992238167e-11
behave O 0 6.818429284724536e-13
as O 0 1.3087033626929534e-12
loss O 0 2.272184697338364e-11
- O 0 1.6074723149794856e-11
of O 0 1.468736465781717e-09
- O 0 4.3793185744434027e-10
function O 0 1.4368601863878894e-09
mutants O 0 4.1030179254164523e-10
as O 0 1.7750072245359405e-12
predicted O 0 3.788478905586423e-11
by O 0 4.261693428708746e-12
haploinsufficiency O 0 1.2656241210606822e-07
. O 0 6.306859035021262e-09

Contrary O 0 4.574249601319025e-08
to O 0 9.893097625834901e-12
this O 0 1.320593807918602e-12
theory O 0 1.3289334910293604e-10
, O 0 1.138551167408075e-12
our O 0 6.7680557339078184e-12
data O 0 1.4965665859345556e-11
showed O 0 3.812872587105609e-11
that O 0 1.1529628163656214e-13
these O 0 1.1875533380018705e-13
mutants O 0 1.3820515565310387e-10
are O 0 1.4020312959651254e-13
dominant O 0 3.2839123781380763e-11
- O 0 3.23876927880995e-12
negative O 0 6.306136710911014e-13
in O 0 2.8545046101141613e-12
transient O 0 1.3661539677300993e-09
transfection O 0 1.6167886585094493e-08
assays O 0 1.819814438031031e-10
when O 0 6.520281710387099e-12
they O 0 1.3962277514711907e-12
are O 0 7.631789894057411e-14
coexpressed O 0 2.2806090349547503e-10
with O 0 3.64620703421914e-12
wild O 0 3.434231530263787e-07
- O 0 6.466197532972728e-08
type O 0 4.94713219723053e-07
PAX6 O 1 0.7784908413887024
. O 0 7.195864526465812e-08

We O 0 1.9213677315832456e-09
found O 0 5.215344649200926e-12
that O 0 3.642421921804667e-14
the O 0 8.326042112705156e-12
dominant O 0 1.818916572915441e-09
- O 0 5.0937181556021116e-11
negative O 0 1.1786454624795883e-11
effects O 0 1.5768915062608357e-08
result O 0 3.38753469719677e-11
from O 0 2.652926164338487e-13
the O 0 2.3700178104768543e-12
enhanced O 0 3.477140103624876e-11
DNA O 0 2.581149009805994e-11
binding O 0 8.060631155604181e-12
ability O 0 8.729158346675037e-13
of O 0 9.948919292568359e-12
these O 0 1.7522710712980505e-12
mutants O 0 2.3876487453833306e-09
. O 0 2.8083341208073875e-10

Kinetic O 0 6.9348859987883316e-09
studies O 0 7.075245250787177e-11
of O 0 2.5911983669857364e-10
binding O 0 6.075618341760958e-10
and O 0 2.113413610782544e-11
dissociation O 0 5.4224517237466685e-11
revealed O 0 8.710518417665014e-12
that O 0 6.239206064772782e-14
various O 0 8.446723138641477e-13
truncation O 0 5.590008456124451e-09
mutants O 0 3.9308101218438196e-10
have O 0 2.5019966567313423e-12
3 O 0 7.26927060212823e-11
- O 0 1.6278698874994113e-11
5 O 0 3.2071204025818645e-10
- O 0 5.280851797517805e-11
fold O 0 4.732009922792102e-11
higher O 0 1.2928331148687189e-11
affinity O 0 4.171999117702496e-13
to O 0 3.7443095499134493e-13
various O 0 3.7069761323060835e-12
DNA O 0 1.0378244270914383e-11
- O 0 2.4279420162733045e-13
binding O 0 4.993971815941967e-13
sites O 0 7.953610914410852e-14
when O 0 5.03515135605293e-15
compared O 0 1.5845628303402803e-14
with O 0 8.602475082644147e-15
the O 0 5.962911414636451e-11
wild O 0 6.50540030733282e-08
- O 0 1.7799740348323212e-08
type O 0 7.669183332836838e-08
PAX6 O 0 0.002628735499456525
. O 0 3.899986111832732e-08

These O 0 2.3770735380068686e-10
results O 0 1.3046522195914179e-10
provide O 0 2.8219913385252315e-12
a O 0 4.477116160445105e-12
new O 0 5.863802932798423e-12
insight O 0 4.037230619258203e-12
into O 0 2.0772518091478204e-13
the O 0 2.530282624049751e-12
role O 0 1.8897051892036165e-12
of O 0 1.5265611691406278e-11
mutant O 0 3.169745799169732e-09
PAX6 O 0 4.549965069600148e-06
in O 0 2.7173607808350653e-10
causing O 0 2.4593434844177864e-08
aniridia B-Disease 1 0.9999994039535522
. O 0 3.562176109639381e-09
. O 0 1.1223630025369857e-08

Reversal O 0 1.4866375863675785e-07
of O 0 3.98693948966411e-08
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.5663399466347983e-08
excellent O 0 1.1219514206572967e-09
neuropsychologic O 0 9.739585138390794e-09
outcome O 0 4.795469021878773e-10
in O 0 2.077704544869996e-12
very B-Disease 0 1.1106144216094238e-12
- I-Disease 0 2.178639213479272e-10
long I-Disease 0 4.3689749595898775e-09
- I-Disease 0 4.4890548451803625e-06
chain I-Disease 1 0.9999998807907104
acyl I-Disease 1 1.0
- I-Disease 1 1.0
coenzyme I-Disease 1 1.0
A I-Disease 1 0.9999942779541016
dehydrogenase I-Disease 1 0.9999929666519165
deficiency I-Disease 1 0.9998507499694824
. O 0 7.609657792784219e-09

Very B-Disease 0 3.4025744444221573e-09
- I-Disease 0 1.6785858036882928e-08
long I-Disease 0 5.306556616346825e-08
- I-Disease 0 8.245575600085431e-07
chain I-Disease 1 0.9999101161956787
acyl I-Disease 1 0.9979045391082764
- I-Disease 1 0.9997878670692444
coenzyme I-Disease 1 0.9923075437545776
A I-Disease 0 5.224894152888737e-07
dehydrogenase I-Disease 0 4.349261839564633e-09
( I-Disease 0 2.2840108710592277e-12
VLCAD I-Disease 0 0.00019067384710069746
) I-Disease 0 1.4372342725665899e-11
deficiency I-Disease 0 1.5410680731520188e-08
is O 0 2.240644735723718e-13
a O 0 6.596209689568866e-12
disorder O 0 3.130088771285955e-06
of O 0 2.573460449184495e-07
fatty O 0 1.0951350049026587e-07
acid O 0 1.9986637345148495e-10
beta O 0 2.3635873813709907e-10
oxidation O 0 1.8153561986977707e-10
that O 0 1.0878827000479138e-13
reportedly O 0 1.1453184321080778e-12
has O 0 5.2565221462684206e-15
high O 0 8.133459726035464e-13
rates O 0 3.50648286448485e-12
of O 0 1.2153959479468956e-12
morbidity O 0 9.082695129336571e-08
and O 0 2.2051518597243636e-11
mortality O 0 2.0676166911925975e-07
. O 0 2.554688460776333e-09

We O 0 5.121563173560162e-10
describe O 0 2.1186928947369843e-11
the O 0 2.6861417604107096e-11
outcome O 0 9.929341376890832e-11
of O 0 3.876071685837701e-11
a O 0 9.423220884152705e-12
5 O 0 3.0949340312780294e-11
- O 0 2.4683894251503746e-12
year O 0 5.296040082175546e-12
- O 0 5.470333075408007e-10
old O 0 1.1647355968591455e-08
girl O 0 9.302528747312522e-10
with O 0 1.322743581333441e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.106196328455212e-09
was O 0 4.146674392746519e-10
first O 0 6.296800754423959e-12
seen O 0 7.543287175448832e-12
at O 0 8.716501478933658e-12
5 O 0 2.740055144584419e-12
months O 0 1.4069980261172815e-13
of O 0 2.0012594012519536e-12
age O 0 7.176688930632391e-12
with O 0 1.3341900501062653e-11
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 4.963260948898096e-07
hepatomegaly B-Disease 1 1.0
, O 0 3.482559804979246e-06
encephalopathy B-Disease 1 0.9999998807907104
, O 0 3.7132517061166936e-09
and O 0 2.4723061642362154e-07
hypotonia B-Disease 1 1.0
. O 0 3.4949364362546476e-06

Biochemical O 0 1.7943423245014856e-06
studies O 0 3.333729736709756e-08
indicated O 1 0.9575430750846863
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.00019642821280285716
by O 0 2.5991266430769322e-11
a O 0 2.599187531870939e-10
stable O 0 3.935375403329999e-08
yet O 0 4.761763205962666e-10
inactive O 0 1.909353031237515e-08
enzyme O 0 3.927542735482348e-10
. O 0 6.534506269417761e-10

Molecular O 0 2.5722576069142633e-08
genetic O 0 2.199693094340205e-09
analysis O 0 3.611256779723071e-11
of O 0 2.8499282933580616e-09
her O 0 2.337607440949796e-09
VLCAD O 1 0.9427602291107178
gene O 0 2.990495628907297e-09
revealed O 0 3.8687911207979653e-10
a O 0 2.338327448336841e-11
T1372C O 0 2.367481211074107e-10
( O 0 1.4815698581166492e-12
F458L O 0 4.625764216115158e-10
) O 0 1.1759076785217148e-12
missense O 0 9.426215363816937e-10
mutation O 0 8.599310152845874e-11
and O 0 2.942187118937234e-11
a O 0 2.2311987812884126e-09
1668 O 0 1.3025797670707107e-05
ACAG O 0 0.0016949936980381608
1669 O 0 4.103345872863429e-06
splice O 0 6.6111476826336e-07
site O 0 4.064535730208263e-08
mutation O 0 3.525473246668298e-09
. O 0 2.8016424735710643e-09

After O 0 8.176869736864489e-10
initial O 0 1.2867310550390698e-09
treatment O 0 4.897163230488388e-10
with O 0 1.7918732470034726e-11
intravenous O 0 2.929763764925042e-09
glucose O 0 4.629352758911409e-07
and O 0 7.20563018974385e-12
carnitine O 0 6.702737809227699e-10
, O 0 3.533456892964443e-13
the O 0 6.964142804100071e-12
patient O 0 3.170867388102572e-11
has O 0 3.9663067209934344e-13
thrived O 0 2.3002492272050645e-11
on O 0 2.209087947291355e-11
a O 0 1.5172982661959544e-11
low O 0 6.289860188246621e-09
- O 0 2.2016575229599766e-09
fat O 0 9.468023698389061e-09
diet O 0 1.0799997562926933e-09
supplemented O 0 2.3045868598886576e-12
with O 0 4.7202300119779383e-14
medium O 0 1.1777746555807767e-09
- O 0 9.479402818257654e-10
chain O 0 4.1962145758134284e-08
triglyceride O 0 2.8915977168253448e-08
oil O 0 2.2895350892948585e-10
and O 0 7.017585297586226e-12
carnitine O 0 1.807931360175985e-09
and O 0 1.3250805834530421e-11
avoidance O 0 8.775417725814805e-09
of O 0 9.568484893307527e-10
fasting O 0 3.66643853055848e-08
. O 0 2.92509017008058e-09

Her O 0 1.8217271644971333e-05
ventricular O 1 1.0
hypertrophy O 1 0.9999555349349976
resolved O 0 1.328567833525085e-07
significantly O 0 6.852382376798527e-12
over O 0 1.6691513622657528e-12
1 O 0 4.942352430092889e-11
year O 0 7.718898762353044e-13
, O 0 2.6228888852508625e-13
and O 0 2.7408496479364164e-12
cognitively O 0 1.3001771215215285e-08
, O 0 1.6788386002566935e-12
she O 0 6.534221948240049e-13
is O 0 3.6637153136591036e-14
in O 0 2.765550104460307e-13
the O 0 1.9477589680017005e-11
superior O 0 2.222672879081955e-10
range O 0 8.984059329808503e-11
for O 0 1.4558437788636525e-11
age O 0 2.0414967494275515e-09
. O 0 7.521002487465012e-09

Clinical O 0 5.124197173245193e-07
recognition O 0 9.552812230140262e-08
of O 1 0.9984233379364014
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 8.460091294182348e-09
important O 0 2.610555105420076e-10
because O 0 8.94627687902938e-13
it O 0 7.341464946814674e-14
is O 0 2.7756420954510273e-14
one O 0 3.5845699103203774e-14
of O 0 5.672801204475997e-12
the O 0 2.7395759272241804e-11
few O 0 1.4359217807846658e-11
directly O 0 2.9512468857628704e-11
treatable O 1 0.9996696710586548
causes O 0 1.685070416534984e-10
of O 0 6.798263285645589e-09
cardiomyopathy B-Disease 1 1.0
in O 0 1.5976162615061185e-09
children O 0 4.245629021959463e-12
. O 0 2.2956294851161907e-11
. O 0 2.232518392375482e-09

Cloning O 0 4.893079008638779e-08
of O 0 2.0116950327775385e-09
a O 0 3.904312290137213e-11
novel O 0 1.823827026903313e-11
member O 0 1.7572420948908096e-11
of O 0 1.4161270767143463e-10
the O 0 1.21274401632121e-09
low O 0 3.569461881625102e-08
- O 0 1.6899444066353908e-09
density O 0 9.937550782268545e-10
lipoprotein O 0 2.245854830107419e-06
receptor O 0 1.024600848609225e-08
family O 0 2.8693222797748774e-10
. O 0 4.011897480893367e-09

A O 0 5.6900969269690904e-08
gene O 0 9.628052521915009e-11
encoding O 0 1.6563838842187373e-11
a O 0 1.5227720126520516e-11
novel O 0 1.3067734394578423e-11
transmembrane O 0 1.2313833286370368e-10
protein O 0 2.4453541622171393e-11
was O 0 3.180971458460746e-11
identified O 0 1.7878840768981163e-13
by O 0 3.934522588918028e-14
DNA O 0 3.221031297587218e-13
sequence O 0 1.570253733355724e-14
analysis O 0 2.4720984790883816e-15
within O 0 6.713305313130885e-14
the O 0 1.8059124074626398e-12
insulin B-Disease 1 0.9999743700027466
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 7.878481200762621e-10
IDDM B-Disease 0 7.964556061779149e-06
) O 0 1.4718638634281245e-12
locus O 0 2.2489374251755123e-10
IDDM4 O 0 7.57681348773076e-08
on O 0 2.3518198499772325e-09
chromosome O 0 1.2299315343966555e-08
11q13 O 0 6.954758191568544e-08
. O 0 4.557248356462651e-09

Based O 0 2.710579816156411e-10
on O 0 2.861519243779753e-09
its O 0 4.458099167603535e-11
chromosomal O 0 2.1851169762499012e-08
position O 0 3.6674085990284766e-09
, O 0 4.154991021382282e-12
this O 0 6.550494738646884e-13
gene O 0 5.0185146836800865e-12
is O 0 4.625613721264202e-14
a O 0 1.0018490214942083e-13
candidate O 0 4.114798779486506e-13
for O 0 3.1429733490274947e-13
conferring O 0 1.849905229001081e-09
susceptibility O 0 3.4401350035295764e-07
to O 0 8.582502486476073e-10
diabetes B-Disease 1 0.9999988079071045
. O 0 3.240116441816099e-08

The O 0 2.124725995145127e-08
gene O 0 3.3422022926998807e-09
, O 0 9.730476840941193e-11
termed O 0 7.765237342027831e-09
low O 0 8.652361493943772e-09
- O 0 9.710342252500226e-11
density O 0 2.2836897303757375e-11
lipoprotein O 0 2.3600836840387274e-09
receptor O 0 2.4232624587505747e-11
related O 0 1.1202888443306858e-11
protein O 0 2.235955171014936e-11
5 O 0 1.7713326638801874e-10
( O 0 2.0550256646118675e-13
LRP5 O 0 5.023406579596212e-09
) O 0 2.693582051740799e-14
, O 0 2.3381275553375526e-14
encodes O 0 6.435136305120784e-14
a O 0 2.1569341365074157e-12
protein O 0 1.2660586121149286e-11
of O 0 7.44200145952334e-10
1615 O 0 1.0762395419305903e-07
amino O 0 9.998200045657768e-10
acids O 0 8.518401262147535e-12
that O 0 1.9561300279233307e-13
contains O 0 1.19644799709967e-12
conserved O 0 1.6463677643407948e-11
modules O 0 1.4667642100896217e-11
which O 0 6.061265448971745e-14
are O 0 3.515560103228496e-14
characteristic O 0 1.1173637015637894e-10
of O 0 1.3374930329934642e-10
the O 0 2.6429503030556134e-10
low O 0 4.6078909576863225e-09
- O 0 1.1768556962277188e-10
density O 0 5.109169684547332e-11
lipoprotein O 0 3.497832778975862e-08
( O 0 2.0186741167549371e-10
LDL O 0 1.45868614254141e-06
) O 0 3.7460708146586086e-11
receptor O 0 5.604075536957964e-10
family O 0 3.880110815979165e-11
. O 0 1.3807900378637328e-09

These O 0 2.4782187413308066e-10
modules O 0 1.0600179622954897e-09
include O 0 7.578319916046183e-11
a O 0 7.691644543506015e-11
putative O 0 3.4739863763455503e-10
signal O 0 1.2929700643482533e-09
peptide O 0 3.723048952464225e-11
for O 0 1.861046906859176e-12
protein O 0 9.220009304644616e-12
export O 0 2.5517166157840165e-10
, O 0 7.21010816155665e-13
four O 0 3.4101447794060435e-12
epidermal O 0 1.2920431391449938e-09
growth O 0 7.436322391196626e-11
factor O 0 3.797303183700196e-12
( O 0 2.703300636727052e-13
EGF O 0 4.5949868909822555e-10
) O 0 6.674822912271228e-14
repeats O 0 7.321224355927303e-12
with O 0 6.807409453843394e-13
associated O 0 1.5575438161441468e-10
spacer O 0 2.1683759232615785e-09
domains O 0 2.986766112211825e-10
, O 0 6.635153537715155e-11
three O 0 2.7117225132045064e-10
LDL O 0 9.509491150083704e-08
- O 0 9.906896636380225e-09
receptor O 0 1.8335767626442845e-10
( O 0 2.9514257791213305e-12
LDLR O 0 4.3507083091753884e-07
) O 0 5.167694072140405e-13
repeats O 0 3.3146339839529304e-11
, O 0 1.1468310025589123e-12
a O 0 6.0826968462102116e-12
single O 0 3.238702708796559e-11
transmembrane O 0 5.169266403814987e-11
spanning O 0 1.277072475547314e-10
domain O 0 1.1390974968827905e-10
, O 0 2.061763737168376e-12
and O 0 5.8132127583876425e-12
a O 0 3.9432004883543925e-10
cytoplasmic O 0 1.0985362841609003e-08
domain O 0 4.9694386383691835e-09
. O 0 1.8436775439667485e-09

The O 0 4.5191988817805395e-08
encoded O 0 1.2645370306429982e-09
protein O 0 6.941869856724736e-10
has O 0 4.1751220536401235e-12
a O 0 2.087770928360655e-12
unique O 0 3.5104712105965552e-12
organization O 0 6.558126958156052e-11
of O 0 1.3399551468395998e-09
EGF O 0 4.890270588475687e-07
and O 0 2.4523988395586116e-10
LDLR O 0 1.0227098755422048e-05
repeats O 0 1.8975201410142972e-09
; O 0 4.5514824548176236e-12
therefore O 0 3.7173153444314266e-11
, O 0 1.1738018543261397e-11
LRP5 O 0 4.316276317695156e-06
likely O 0 1.5176868095601037e-10
represents O 0 1.4910952247232379e-12
a O 0 8.600613710801897e-13
new O 0 1.9121956622292213e-12
category O 0 7.794625361823293e-11
of O 0 1.815408101624172e-10
the O 0 5.985524964557953e-09
LDLR O 0 0.001340624294243753
family O 0 2.8726421241742628e-09
. O 0 1.4623247501788228e-08

Both O 0 2.153464784271364e-08
human O 0 3.4355213784920124e-08
and O 0 1.8396099088491269e-09
mouse O 0 7.400223580589227e-07
LRP5 O 0 0.05998259782791138
cDNAs O 0 2.407851525276783e-06
have O 0 1.3794416997559011e-10
been O 0 1.9461175726487312e-11
isolated O 0 2.01988342718451e-10
and O 0 8.469216647433164e-12
the O 0 1.8260311318574196e-10
encoded O 0 2.4842135293301482e-11
mature O 0 6.748024881930714e-12
proteins O 0 1.5191759525703952e-13
are O 0 1.0313936492790509e-14
95 O 0 7.991955187913735e-12
% O 0 1.9887319872499698e-13
identical O 0 6.12322866022641e-12
, O 0 2.864527733938138e-13
indicating O 0 1.040452619893717e-11
a O 0 2.074774163238202e-12
high O 0 1.255743772854423e-11
degree O 0 4.4874801791161545e-11
of O 0 2.559748767116954e-11
evolutionary O 0 1.367788105000045e-10
conservation O 0 1.2545234295835428e-10
. O 0 3.311497777380712e-12
. O 0 2.078919814074709e-10

The O 0 2.5682234650048485e-07
APC B-Disease 0 3.4906688028968347e-07
variants O 0 2.2181763092987694e-09
I1307K O 0 1.0269721961719824e-08
and O 0 4.367770728430642e-11
E1317Q O 0 8.761702474657795e-09
are O 0 8.449962192631777e-13
associated O 0 2.551200639633322e-10
with O 0 3.876860773743829e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 7.447425454110146e-10
but O 0 1.8540494660379547e-12
not O 0 1.3768456860741018e-12
always O 0 1.1206152108686473e-12
with O 0 7.990636418601232e-14
a O 0 3.4185994313151724e-11
family O 0 4.285004642778922e-12
history O 0 1.6430025395752779e-10
. O 0 1.5159575816880988e-09

Classical O 1 0.8381058573722839
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.354802513262257e-06
FAP B-Disease 0 9.74451950241928e-07
) O 0 1.138987775622935e-12
is O 0 1.207359407763564e-13
a O 0 6.504159190401371e-12
high O 0 1.98583093151683e-05
- O 1 0.999988317489624
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
that O 0 5.552168967637439e-13
predisposes O 0 1.375475579788732e-12
to O 0 3.792333539754701e-14
hundreds O 0 1.9676968388004923e-13
or O 0 9.477394726214311e-14
thousands O 0 1.124074683160614e-12
of O 0 2.8754502778838287e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.039456408470869064
carcinoma I-Disease 1 1.0
and O 0 1.2652939807011876e-10
that O 0 6.059013967635307e-13
results O 0 4.362689896841854e-12
from O 0 5.229426917538471e-13
truncating O 0 1.2292643292166616e-10
mutations O 0 2.793158499631021e-13
in O 0 1.4261984605454248e-12
the O 0 2.651791841667972e-10
APC B-Disease 0 8.695708153538817e-09
gene O 0 1.6996872798102913e-09
. O 0 3.0700675335282313e-09

A O 0 4.3183245423961125e-08
variant O 0 1.06055448867437e-08
of O 0 3.087142985691571e-09
FAP B-Disease 0 7.786595688230591e-07
is O 0 3.389022673605524e-10
attenuated B-Disease 0 0.07083109766244888
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.499764644754322e-10
which O 0 8.180710883015641e-13
results O 0 3.152352727811558e-12
from O 0 2.647791491269813e-12
germ O 0 9.670890221968875e-07
- O 0 9.096555730891964e-10
line O 0 2.2773749552840172e-10
mutations O 0 4.4348230057895954e-13
in O 0 2.101958337203877e-13
the O 0 2.1805992341666913e-12
5 O 0 1.708314566195579e-11
and O 0 3.030360793028486e-13
3 O 0 3.780509932882481e-11
regions O 0 1.9701962283846797e-11
of O 0 1.0696137725529908e-10
the O 0 3.0969093955945937e-09
APC B-Disease 0 4.3859937903789614e-08
gene O 0 1.128460658250674e-09
. O 0 2.389238584754594e-09

Attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 1.171385247289436e-05
have O 0 7.303204915820594e-12
" O 0 1.5451458168502796e-10
multiple O 0 1.0063637922996804e-08
" O 1 0.9997144341468811
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 6.473444696952768e-11
typically O 0 2.744626574624487e-12
fewer O 0 7.052088676472862e-14
than O 0 9.199513031779918e-15
100 O 0 1.1310017592608412e-12
) O 0 8.860493176839068e-15
without O 0 2.942520630367512e-13
the O 0 6.747574287507829e-12
florid O 0 6.039984623562589e-10
phenotype O 0 1.5451038018476915e-11
of O 0 1.0184152132719504e-11
classical O 0 1.8807769563977672e-08
FAP B-Disease 0 3.816262221789657e-07
. O 0 5.2804041139609126e-09

Another O 0 3.474520227086941e-08
group O 0 7.845076588353095e-09
of O 0 1.6581060080511634e-08
patients O 0 3.7312686274049156e-10
with O 0 1.9995434127895173e-11
multiple O 0 3.4263149473190424e-07
adenomas B-Disease 1 0.9999915361404419
has O 0 1.1848621042642726e-11
no O 0 7.751715068449183e-12
mutations O 0 3.5884367851311827e-13
in O 0 1.6981877059077388e-12
the O 0 1.1731109139656581e-10
APC B-Disease 0 5.609915310067493e-10
gene O 0 2.5915812464777366e-12
, O 0 6.987023264647119e-13
and O 0 2.067615826814584e-12
their O 0 1.665793718241826e-11
phenotype O 0 4.091902511271783e-11
probably O 0 1.554731387035102e-12
results O 0 3.7304515487952827e-13
from O 0 1.7313039023247878e-13
variation O 0 7.815378205711099e-11
at O 0 3.4015149030786063e-10
a O 0 4.706300453516388e-12
locus O 0 2.3009864846823547e-11
, O 0 6.235402276975888e-13
or O 0 3.4862344673418366e-13
loci O 0 3.637204903580993e-12
, O 0 4.1432685732832597e-13
elsewhere O 0 1.4314855724395503e-12
in O 0 5.739284373272591e-13
the O 0 2.69467555907843e-11
genome O 0 2.4241883500586425e-10
. O 0 5.87299875398628e-10

Recently O 0 1.8448780281232757e-08
, O 0 2.3242763616537765e-11
however O 0 3.635831436268888e-12
, O 0 7.521518130548799e-13
a O 0 4.328012774557077e-12
missense O 0 3.5303432399658163e-10
variant O 0 4.382476881392705e-10
of O 0 5.292715599125586e-09
APC B-Disease 0 6.0864429052287505e-09
( O 0 2.779878107220246e-12
I1307K O 0 1.408614558329191e-09
) O 0 5.365808708815423e-13
was O 0 1.2165375477823925e-11
described O 0 3.6438899315462125e-13
that O 0 9.863802008795892e-15
confers O 0 1.1064195349838601e-12
an O 0 1.7760746715496964e-15
increased O 0 2.8816265779801897e-12
risk O 0 1.5637718897565378e-09
of O 0 6.390551425283775e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 7.450078748361122e-11
including O 0 2.1619806639394668e-11
multiple O 0 1.2846449237713387e-08
adenomas B-Disease 1 0.9912733435630798
, O 0 4.849976670273648e-11
in O 0 1.6484684728368393e-09
Ashkenazim O 0 3.9273927541216835e-06
. O 0 1.516753656005676e-08

We O 0 2.269094689921758e-09
have O 0 3.0115439222239138e-12
studied O 0 2.4663344283526456e-11
a O 0 4.013889047527197e-12
set O 0 1.0656997506686139e-10
of O 0 2.068745001693184e-11
164 O 0 7.097334941974509e-10
patients O 0 2.9636005455246917e-11
with O 0 1.86417044995002e-11
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 1.250105157168946e-07
/ I-Disease 1 0.997481644153595
or I-Disease 0 1.6331069900843431e-06
carcinoma I-Disease 1 1.0
and O 0 1.5109953288572342e-09
analyzed O 0 6.485088577257159e-10
codons O 0 2.7302290983577393e-10
1263 O 0 5.7211311244032e-09
- O 0 8.558962982796459e-10
1377 O 0 1.7032051324861186e-09
( O 0 9.128858259599415e-12
exon O 0 7.392486622848082e-10
15G O 0 3.6521146107304503e-09
) O 0 1.4279561962125126e-13
of O 0 1.1408558993342144e-11
the O 0 2.790117303863582e-10
APC B-Disease 0 1.0192946486853316e-09
gene O 0 1.3446133095840196e-11
for O 0 1.4123768994622754e-11
germ O 0 6.082221375436347e-07
- O 0 1.6247765799448644e-08
line O 0 2.3693354833653757e-08
variants O 0 1.2701020679628527e-08
. O 0 4.727846558694182e-09

Three O 0 3.2053012688493254e-08
patients O 0 6.087202963911409e-11
with O 0 2.819349788352188e-12
the O 0 9.193572569898834e-10
I1307K O 0 1.2814022731788555e-08
allele O 0 5.1088383523634207e-11
were O 0 5.717129894500239e-12
detected O 0 1.0437083489134302e-11
, O 0 2.224675521925179e-13
each O 0 7.719011925954797e-14
of O 0 2.031179946460071e-10
Ashkenazi O 0 2.5661025304657414e-08
descent O 0 1.6762504273515333e-08
. O 0 2.479369953789501e-08

Four O 0 7.824174730330924e-08
patients O 0 6.171542721311596e-10
had O 0 5.257057011931465e-10
a O 0 2.019359540694765e-10
germ O 0 1.0486104429219267e-06
- O 0 7.601649976152203e-09
line O 0 5.991407370231627e-09
E1317Q O 0 1.1611311911963185e-08
missense O 0 2.4036459489451545e-09
variant O 0 1.4586462593335625e-10
of O 0 3.012259053303268e-10
APC O 0 3.9889588854258307e-10
that O 0 2.3163873705440985e-13
was O 0 2.3120859393710447e-11
not O 0 6.074412755565847e-14
present O 0 1.5582427384010222e-13
in O 0 5.909801727849162e-13
controls O 0 8.822218511284063e-10
; O 0 6.921917330765179e-14
one O 0 1.6763547743946922e-13
of O 0 2.7522081835762435e-11
these O 0 5.456746166032644e-13
individuals O 0 1.5216960449950662e-13
had O 0 1.5446949275244037e-10
an O 0 1.2712094831640597e-12
unusually O 0 1.1225160384542576e-10
large O 0 1.4133039356878374e-11
number O 0 1.0706833336593391e-10
of O 0 9.477021833959043e-09
metaplastic B-Disease 0 4.3642798118526116e-05
polyps I-Disease 0 2.160959184038802e-06
of I-Disease 0 1.0019528318139237e-08
the I-Disease 0 2.7631319454712866e-08
colorectum I-Disease 0 5.1561664804467e-06
. O 0 1.1838613289683053e-07

There O 0 8.729625911030325e-09
is O 0 1.1910319085151055e-11
increasing O 0 1.3564417818134888e-11
evidence O 0 1.051950453828665e-11
that O 0 3.0739150916510305e-14
there O 0 1.9014438190200628e-13
exist O 0 1.7436361599357242e-12
germ O 0 7.054780093440627e-10
- O 0 5.44534339494418e-12
line O 0 9.522813960993748e-12
variants O 0 2.000763270337824e-12
of O 0 2.7153387177625277e-11
the O 0 2.7477775610407207e-10
APC B-Disease 0 1.2861274267805811e-09
gene O 0 2.913532045831224e-12
that O 0 5.6170129311694517e-14
predispose O 0 2.033409654848481e-13
to O 0 1.8664943587020852e-14
the O 0 4.363037166797701e-13
development O 0 1.2155210648776005e-12
of O 0 2.736306840833702e-11
multiple O 1 0.9998855590820312
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9959593415260315
carcinoma I-Disease 1 1.0
, O 0 9.376611292966075e-11
but O 0 4.165399579078577e-13
without O 0 2.675663076517898e-12
the O 0 5.441232100306115e-12
florid O 0 5.364640398575204e-10
phenotype O 0 2.8875411176715327e-12
of O 0 1.0012191813471571e-12
classical O 0 3.872927756276567e-09
FAP B-Disease 0 3.8680405545221674e-09
, O 0 1.3924957378581154e-13
and O 0 5.159162485245117e-14
possibly O 0 7.23200321785418e-14
with O 0 1.590945985927494e-15
importance O 0 4.061114777798025e-10
for O 0 2.6756419174489565e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 9.378730680964509e-09
in O 0 1.859928091532334e-13
the O 0 4.658517495370607e-13
general O 0 1.214457354126175e-12
population O 0 2.5685089973426396e-14
. O 0 1.1367696063982469e-12
. O 0 2.354161587891923e-10

Genomic O 0 4.4753495131999443e-08
structure O 0 4.699794775575583e-09
of O 0 3.93577670454448e-10
the O 0 3.305249407503652e-09
human O 1 0.776708722114563
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.716762017167639e-05
CLD B-Disease 1 0.9999986886978149
) O 0 5.2190689270315005e-11
gene O 0 2.0248218657314965e-09
. O 0 1.3324571446204914e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9993784427642822
CLD B-Disease 1 1.0
) O 0 3.3271881777485746e-11
is O 0 6.437164711860233e-13
caused O 0 4.593422430615446e-12
by O 0 1.3391245306648009e-13
mutations O 0 4.1523747873299655e-13
in O 0 9.837639600510095e-13
a O 0 2.4429566442690787e-12
gene O 0 8.094059276986254e-13
which O 0 1.813007345164222e-13
encodes O 0 1.1853949896320493e-12
an O 0 9.266124109327811e-13
intestinal O 0 2.193825821450446e-06
anion O 0 5.6542406312587445e-09
transporter O 0 1.1872045035943302e-07
. O 0 3.685697302913127e-09

We O 0 2.415447841741525e-09
report O 0 1.8461107642586683e-11
here O 0 2.7615774250699943e-12
the O 0 3.053821084897379e-12
complete O 0 1.0354760104913652e-10
genomic O 0 6.320258760794673e-10
organization O 0 1.242872194051614e-10
of O 0 1.4844905860122992e-10
the O 0 6.288657927733254e-10
human O 0 2.4112314367386034e-09
CLD B-Disease 0 8.614472903900605e-07
gene O 0 6.322486284515705e-11
which O 0 3.048740513517112e-12
spans O 0 1.653300239767841e-11
approximately O 0 3.762365852894023e-12
39kb O 0 3.2980389530479215e-09
, O 0 1.9747408569470437e-11
and O 0 6.728493456842344e-11
comprises O 0 1.5860787128119114e-09
21 O 0 6.998376989031385e-08
exons O 0 2.321414740436012e-06
. O 0 3.8530508561507304e-08

All O 0 4.05228242073008e-08
exon O 0 2.608997817787895e-07
/ O 0 4.464164149453609e-08
intron O 0 2.272127552771508e-08
boundaries O 0 7.071579988249255e-10
conform O 0 2.1397385252530654e-10
to O 0 6.431866324263513e-12
the O 0 4.891421712116539e-10
GT O 0 6.086341386435379e-07
/ O 0 1.0237495473575109e-07
AG O 0 5.20793764735572e-06
rule O 0 5.399157032570656e-08
. O 0 5.830232296943905e-09

An O 0 1.7917571940029298e-11
analysis O 0 2.04586833585374e-11
of O 0 1.134289329129956e-09
the O 0 1.3052502412236322e-09
putative O 0 3.532736325695396e-09
promoter O 0 3.6405506165237966e-08
region O 0 4.395024899572775e-10
sequence O 0 7.609417262965934e-11
shows O 0 8.239870452619869e-10
a O 0 3.3593303694345877e-09
putative O 0 7.813451929905568e-08
TATA O 0 1.7202397430082783e-05
box O 0 9.951936874585954e-08
and O 0 1.0289612217828648e-10
predicts O 0 1.1576587466421984e-09
multiple O 0 9.167442499569134e-11
transcription O 0 6.610044733790232e-10
factor O 0 2.90180518502936e-10
binding O 0 1.5266958530713026e-10
sites O 0 1.7499983406832342e-10
. O 0 3.971687423387493e-10

The O 0 1.1903887653375023e-08
genomic O 0 2.7509422295679542e-08
structure O 0 1.6028822713565205e-08
was O 0 1.835477658751472e-09
determined O 0 3.863192404862659e-11
using O 0 1.58464007974507e-12
DNA O 0 5.135957631408061e-12
from O 0 5.308007858121147e-14
several O 0 8.881919044646455e-14
sources O 0 3.8012578111243367e-13
including O 0 2.7121322765735756e-13
multiple O 0 5.9145973708985e-12
large O 0 3.575543194855868e-10
- O 0 3.0988178689739243e-09
insert O 0 4.178035695190374e-09
libaries O 0 2.4990828961790612e-08
and O 0 1.3490136958893562e-11
genomic O 0 1.6446526363012026e-09
DNA O 0 4.1327932742696305e-10
from O 0 3.075796214946358e-11
Finnish O 0 1.638286266825162e-05
CLD B-Disease 1 0.9999945163726807
patients O 0 9.011562163152576e-09
and O 0 4.273565668011514e-10
controls O 0 1.4692725926579442e-05
. O 0 5.8747076536747045e-08

Exon O 0 1.6048514908106881e-06
- O 0 6.187304002480687e-09
specific O 0 1.7231956139784899e-10
primers O 0 8.803577866700607e-10
developed O 0 2.7986968645365984e-11
in O 0 8.468194136364293e-13
this O 0 7.379003414157911e-14
study O 0 8.392119871204404e-14
will O 0 4.362985057330786e-14
facilitate O 0 1.3492626070241154e-12
mutation O 0 3.3817984220266273e-13
screening O 0 4.0719688905455076e-12
studies O 0 9.538036864226856e-14
of O 0 2.7962092277039607e-12
patients O 0 4.541611498768555e-13
with O 0 2.5754813321073045e-13
the O 0 5.870258501516901e-09
disease O 0 0.0002647954679559916
. O 0 2.201363535903056e-09

Genomic O 0 3.599116782382339e-09
sequencing O 0 3.84728943148005e-10
of O 0 4.161595956730935e-09
a O 0 3.53856464130331e-08
BAC O 0 7.580298552056774e-05
clone O 0 1.7420261428924277e-06
H O 1 1.0
_ O 0 1.8290742531679172e-10
RG364P16 O 0 8.013791852334862e-10
revealed O 0 7.600656215522861e-11
the O 0 6.906415543628253e-12
presence O 0 3.0139456468764037e-12
of O 0 3.477564763931795e-11
another O 0 1.3227523243397599e-11
, O 0 3.994901631720893e-12
highly O 0 1.3243125346340534e-11
homologous O 0 9.320083767250242e-12
gene O 0 2.7352734660590627e-11
3 O 0 2.64310795472511e-09
of O 0 3.1961606694608236e-09
the O 0 9.024017799674766e-08
CLD B-Disease 0 0.0002470700419507921
gene O 0 4.641159678797635e-10
, O 0 4.3029408161587845e-12
with O 0 4.320340201043049e-13
a O 0 1.2900054288667029e-11
similar O 0 3.76285417755251e-12
genomic O 0 1.8266346213380302e-09
structure O 0 3.1268236888593037e-09
, O 0 6.058670492387064e-12
recently O 0 7.761098014258394e-11
identified O 0 1.1769875872535973e-11
as O 0 2.02461103437912e-11
the O 0 1.349620593060763e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 4.328481573168119e-09
( O 0 4.358234259593807e-11
PDS B-Disease 0 1.1150829237749349e-07
) O 0 1.0923390013697909e-12
. O 0 1.5217471380224445e-11
. O 0 1.4641213796906527e-09

The O 0 2.937890464238535e-08
APCI1307K O 0 0.08742901682853699
allele O 0 1.2592623477303277e-07
and O 0 1.5973786737788487e-09
cancer B-Disease 0 3.704335540533066e-05
risk O 0 2.0347561413558424e-09
in O 0 8.732676907985404e-12
a O 0 1.5084539520260343e-11
community O 0 3.3007904135656796e-12
- O 0 1.456104854746787e-11
based O 0 1.1829652708794658e-11
study O 0 1.7137158012103804e-11
of O 0 3.1034833036791554e-10
Ashkenazi O 0 5.626656474078118e-09
Jews O 0 8.084536373687001e-10
. O 0 3.5592422342745067e-09

Mutations O 0 4.969315625658055e-09
in O 0 1.0738334665916227e-09
APC O 0 8.519587879618484e-08
are O 0 5.160939384185603e-12
classically O 0 2.011207644869728e-09
associated O 0 4.633340655590956e-10
with O 0 4.4177443925264015e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.2194132753838858e-08
FAP B-Disease 0 5.9039471977939684e-08
) O 0 1.3920681556263415e-13
, O 0 4.565275498673131e-14
a O 0 6.078255086749973e-12
highly O 0 1.0356710333780939e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.753262399821324e-08
by O 0 8.2188878099132e-13
multiple O 0 7.528002110568366e-10
intestinal O 1 0.9999954700469971
polyps B-Disease 0 1.1153769264637958e-05
and O 0 2.0725276963368122e-12
, O 0 2.3695872737941603e-13
without O 0 5.813079618360861e-12
surgical O 0 6.066382411518134e-06
intervention O 0 1.7258641182849033e-09
, O 0 1.1119046221946816e-13
the O 0 7.637065350778183e-13
development O 0 4.838039344146061e-11
of O 0 8.823320740702911e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.061162440725184e-08
CRC B-Disease 1 0.9964039325714111
) O 0 8.18018847104085e-11
. O 0 1.5142294085279673e-09

APC B-Disease 0 3.4189420148322824e-06
is O 0 2.086451428295888e-10
a O 0 1.0292797725242053e-09
tumour O 1 1.0
- O 0 2.9758398412127463e-08
suppressor O 0 2.8689310482832298e-08
gene O 0 2.1288967116950275e-11
, O 0 2.0547315747725808e-13
and O 0 1.3426546116232507e-12
somatic O 0 1.516945218327237e-07
loss O 0 4.803343500725532e-09
occurs O 0 4.4924672315538317e-10
in O 0 1.2984366914992052e-09
tumours B-Disease 1 1.0
. O 0 6.817873554609832e-08

The O 0 3.33340295810558e-07
germline O 0 1.0856808785320027e-06
T O 0 2.5400357372973303e-08
- O 0 3.817522339910617e-11
to O 0 8.002541337925884e-12
- O 0 1.8001848622883898e-10
A O 0 9.693988944903253e-10
transversion O 0 1.32156907639569e-08
responsible O 0 5.071191799821406e-10
for O 0 1.1189627349694753e-11
the O 0 2.819723621261261e-10
APC O 0 3.593053410355651e-09
I1307K O 0 1.940319016568992e-09
allele O 0 3.961093952842276e-11
converts O 0 2.0490550228791093e-11
the O 0 2.900995936527817e-11
wild O 0 4.426243815913722e-10
- O 0 2.0326204261400527e-11
type O 0 2.968556303550862e-11
sequence O 0 1.873259360130053e-11
to O 0 5.182522379992838e-12
a O 0 4.6332876424415304e-10
homopolymer O 0 2.706909526750678e-06
tract O 0 4.2308647607569583e-07
( O 0 4.4131920340362285e-11
A8 O 0 3.295374639833426e-08
) O 0 6.181378786650552e-14
that O 0 3.6543213794608745e-14
is O 0 1.1506829560373188e-12
genetically O 0 4.683113341563683e-10
unstable O 0 1.3464676040797485e-09
and O 0 1.936912574773686e-10
prone O 0 1.6284252168929925e-08
to O 0 1.5389986507408082e-10
somatic O 0 4.035071015096037e-06
mutation O 0 7.76215802744673e-09
. O 0 9.976826031987684e-10

The O 0 6.138477459671776e-08
I1307K O 0 1.2965917051133147e-07
allele O 0 1.6548572512320447e-09
was O 0 7.107901489611379e-10
found O 0 1.147015468716539e-11
in O 0 2.6299098315751834e-11
6 O 0 7.945189395286434e-08
. O 0 9.932249689370565e-09

1 O 0 1.2477157440571318e-07
% O 0 2.082706090922315e-10
of O 0 1.7869091761824052e-09
unselected O 0 8.333958248840645e-06
Ashkenazi O 0 9.990163363227111e-08
Jews O 0 5.897042298919075e-10
and O 0 1.1107044450842096e-10
higher O 0 1.4333182418724277e-09
proportions O 0 7.700253767950471e-09
of O 0 1.7027097953814518e-07
Ashkenazim O 0 9.275831689592451e-05
with O 0 3.811332915937271e-10
family O 0 2.1181038867279511e-10
or O 0 5.07182768005876e-11
personal O 0 7.76502584454164e-10
histories O 0 3.2968188179438584e-09
of O 0 4.789002559846267e-06
CRC B-Disease 1 0.9999959468841553
( O 0 3.226359457375594e-11
ref O 0 5.0169908227815085e-09
. O 0 1.728501196340826e-11
2 O 0 1.4449870189281455e-09
) O 0 7.726356013315616e-12
. O 0 2.2870473570524297e-10

To O 0 1.968262774987295e-10
evaluate O 0 2.16516346518425e-10
the O 0 7.247397126874944e-11
role O 0 3.2274797417963796e-11
of O 0 7.269534280096579e-11
I1307K O 0 1.18019496397892e-08
in O 0 2.351886185802954e-10
cancer B-Disease 0 1.9583488608532207e-08
, O 0 1.920369245567155e-11
we O 0 7.216967301548749e-11
genotyped O 0 9.730750605285721e-08
5 O 0 1.7439756305748233e-08
, O 0 3.1270963596341517e-10
081 O 0 2.1891025880904635e-06
Ashkenazi O 0 2.3883273136959815e-09
volunteers O 0 1.829732892977276e-11
in O 0 4.835287985976988e-12
a O 0 2.9103955356823974e-11
community O 0 3.578011151250671e-11
survey O 0 5.028896743475286e-10
. O 0 5.697174287888629e-09

Risk O 0 3.394628933506283e-08
of O 0 2.5923760915702587e-09
developing O 0 0.002883917884901166
colorectal B-Disease 1 1.0
, I-Disease 0 1.4373877377238387e-07
breast I-Disease 0 0.0010172748006880283
and I-Disease 0 3.858034336445826e-09
other I-Disease 0 1.8236965271256622e-09
cancers I-Disease 1 0.9994446635246277
were O 0 3.2426725193879236e-10
compared O 0 5.980722861398391e-12
between O 0 7.165312787549283e-11
genotyped O 0 8.638711733510718e-06
I1307K O 0 1.9678482843232814e-08
carriers O 0 5.209903689018525e-13
and O 0 1.1518462236532329e-13
non O 0 5.370093605905346e-11
- O 0 1.5758780998881283e-12
carriers O 0 2.229023782500568e-14
and O 0 1.3438445370600807e-14
their O 0 7.435629938374114e-14
first O 0 1.2162214594810261e-12
- O 0 8.428333551913081e-12
degree O 0 1.9211843227395775e-09
relatives O 0 5.2904214342675e-10
. O 0 1.1056343618420783e-09

Sperm O 0 7.343720631602935e-10
DNA O 0 1.7710523325664695e-10
analysis O 0 2.2516348594653346e-12
in O 0 1.4824412530867193e-11
a O 0 4.512116902333219e-09
Friedreich B-Disease 1 0.9999991655349731
ataxia I-Disease 1 1.0
premutation O 1 0.9999781847000122
carrier O 0 6.882593766022183e-07
suggests O 0 3.3579272695760665e-09
both O 0 8.671981188701494e-11
meiotic O 0 5.891358796361601e-07
and O 0 1.8279756874850506e-10
mitotic O 0 1.8669558343731296e-08
expansion O 0 1.6832050198090087e-09
in O 0 5.315371753855658e-11
the O 0 6.631576399129813e-10
FRDA B-Disease 0 1.0811401807586662e-05
gene O 0 2.878973681674779e-08
. O 0 7.179520977729226e-09

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 3.832506536127767e-06
usually O 0 4.788759944140963e-10
caused O 0 2.6758328192100223e-11
by O 0 4.4263360067086505e-14
an O 0 8.957929917860572e-15
expansion O 0 1.6617318632228262e-11
of O 0 2.0662853372765966e-10
a O 0 1.4564479622336535e-09
GAA O 0 1.3699452949822444e-07
trinucleotide O 0 8.597076117666802e-08
repeat O 0 1.4945542581301652e-09
in O 0 7.16331785555191e-11
intron O 0 7.77119346651034e-09
1 O 0 5.599356089902585e-09
of O 0 6.425079912553144e-10
the O 0 5.15666709333118e-09
FRDA B-Disease 0 2.7335825507179834e-05
gene O 0 2.0370871212094244e-08
. O 0 7.30778593194259e-09

Occasionally O 0 8.412557761516837e-09
, O 0 6.97237337310419e-11
a O 0 3.566047110381554e-11
fully O 0 7.49212983319758e-11
expanded O 0 1.1391315841990934e-11
allele O 0 9.862989765185848e-12
has O 0 6.623539065310491e-13
been O 0 1.0355934859651583e-12
found O 0 1.4886506469798805e-13
to O 0 1.0458394404406351e-13
arise O 0 4.671365833215646e-13
from O 0 1.9870711250469936e-13
a O 0 3.1044333770324783e-12
premutation O 0 6.97824409368053e-10
of O 0 2.7999477736351253e-10
100 O 0 1.7833129417610394e-10
or O 0 6.148929889565613e-12
less O 0 4.7752399257028344e-11
triplet O 0 9.417148305601586e-08
repeats O 0 5.349104981178243e-08
. O 0 1.5785706963811208e-08

We O 0 8.728609834918188e-09
have O 0 2.2602720042841362e-11
examined O 0 1.8522273992349625e-10
the O 0 4.678040246841597e-11
sperm O 0 8.744793951465102e-12
DNA O 0 7.180717825905347e-11
of O 0 1.495294860154317e-10
a O 0 2.498147466667433e-09
premutation O 0 9.75600300989754e-07
carrier O 0 1.2863813481089892e-07
. O 0 4.190543734239327e-08

This O 0 5.868340258174953e-10
mans O 0 1.4188842101248156e-07
leucocyte O 0 9.82026620022225e-08
DNA O 0 4.705631995172155e-10
showed O 0 8.789949323961821e-11
one O 0 1.0375666254988647e-12
normal O 0 6.476380629699685e-12
allele O 0 5.616865479673994e-13
and O 0 2.1727431865400243e-13
one O 0 9.472226469983344e-14
allele O 0 7.416639459696672e-13
of O 0 6.51985887153983e-12
approximately O 0 4.25932032699361e-12
100 O 0 2.8733804224856385e-10
repeats O 0 3.6563940764011704e-09
. O 0 8.242483140463719e-09

His O 0 3.1624285412590325e-08
sperm O 0 1.8961372749703997e-10
showed O 0 9.391180888496109e-11
an O 0 7.419210374098179e-14
expanded O 0 5.436460309704572e-12
allele O 0 5.562962417104966e-12
in O 0 2.9643904518594777e-12
a O 0 1.356802170615623e-10
tight O 0 9.115753485389178e-09
range O 0 3.574609219736402e-10
centering O 0 5.7204050524228833e-11
on O 0 1.3906584217515672e-10
a O 0 2.85762039031745e-12
size O 0 8.140381814805697e-13
of O 0 1.3478255837806596e-11
approximately O 0 3.570505349714814e-11
320 O 0 2.2322618753456425e-10
trinucleotide O 0 3.126193632851937e-07
repeats O 0 7.816343128297376e-08
. O 0 3.315328100939041e-08

His O 0 3.510907333748037e-07
affected O 0 4.106638940015728e-08
son O 0 6.310676070597765e-08
has O 0 6.477399727700117e-10
repeat O 0 1.243433089825885e-08
sizes O 0 1.2428846840606411e-09
of O 0 1.1710441505385916e-08
1040 O 0 2.8302064691843043e-08
and O 0 4.562864808210776e-10
540 O 0 8.859506017699914e-09
. O 0 7.003342350486719e-09

These O 0 9.767033709584538e-11
data O 0 6.439382360667878e-11
suggest O 0 1.0741391500215802e-12
that O 0 4.545289756282666e-15
expansion O 0 1.9903570978863083e-12
occurs O 0 1.0636344337569808e-14
in O 0 1.4327298028526947e-14
two O 0 9.461608742582922e-14
stages O 0 1.2209176725175297e-10
, O 0 3.7801670973135193e-13
the O 0 2.740023702721417e-12
first O 0 1.7254172266292778e-12
during O 0 5.86696923682295e-12
meiosis O 0 3.000878625453174e-12
followed O 0 1.7017738130134519e-12
by O 0 1.8032484143046257e-12
a O 0 6.463302809622817e-11
second O 0 3.693838290796947e-10
mitotic O 0 2.26900507271921e-08
expansion O 0 2.7712809824720352e-08
. O 0 8.260834682971563e-09

We O 0 1.5295938959880573e-09
also O 0 6.7999906920579445e-12
show O 0 4.789229776647197e-12
that O 0 3.241664545843882e-14
in O 0 1.5223607964520713e-13
all O 0 1.100908426920899e-12
informative O 0 3.0759533375251946e-12
carrier O 0 7.443385317829065e-12
father O 0 6.235595807063676e-12
to O 0 1.7201236095221173e-12
affected O 0 8.458367686814405e-12
child O 0 3.1884898367418035e-12
transmissions O 0 5.772466879494509e-11
, O 0 1.4977015667157895e-13
with O 0 4.8264005097185814e-14
the O 0 1.1491197750290727e-11
notable O 0 1.2772716044551213e-11
exception O 0 1.649032820016938e-11
of O 0 1.3070083904054286e-10
the O 0 3.1459049254500826e-10
premutation O 0 3.845605789365436e-08
carrier O 0 2.0675548773052554e-10
, O 0 5.072821503138147e-12
the O 0 1.5487921709023134e-11
expansion O 0 6.837215515975714e-11
size O 0 9.688433215415682e-12
decreases O 0 6.144829090004578e-11
. O 0 4.5944151261245736e-11
. O 0 2.344242355789561e-09

The O 0 7.062555340553445e-08
R496H O 0 3.45631775644506e-07
mutation O 0 2.684295674626469e-09
of O 0 5.367764455144197e-09
arylsulfatase O 0 7.309298325708369e-06
A O 0 2.081440015899716e-07
does O 0 2.0165102226910037e-11
not O 0 5.6252769803366576e-11
cause O 0 4.925543066747196e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 8.412176555339101e-08

Deficiency B-Disease 1 0.7698493599891663
of I-Disease 0 1.2412087926350068e-05
arylsulfatase I-Disease 1 0.9955136179924011
A I-Disease 0 0.001200206228531897
( O 0 2.9487967623254008e-09
ARSA O 0 0.015321742743253708
) O 0 3.432280501480811e-11
enzyme O 0 6.663181117971817e-11
activity O 0 7.871692742078551e-10
causes O 0 1.0084008295052627e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.5891160144483365e-08
MLD B-Disease 1 1.0
) O 0 3.0860816679911807e-10
. O 0 7.268290413975365e-10

A O 0 4.9135604029970636e-08
number O 0 6.450793232914975e-10
of O 0 1.2092845835809385e-08
ARSA O 0 0.0006086249486543238
gene O 0 3.85529830282394e-09
mutations O 0 8.109411753220996e-11
responsible O 0 2.76874245752623e-10
for O 0 3.580135909952986e-10
MLD B-Disease 1 1.0
have O 0 2.576521773711704e-10
been O 0 7.742409491307001e-11
identified O 0 7.26143145612923e-10
. O 0 2.048838210200188e-09

Recently O 0 2.2537662403010472e-08
, O 0 6.575850280965412e-11
the O 0 2.0961882229997286e-10
R496H O 0 9.923596167027426e-09
mutation O 0 2.262723064472283e-10
of O 0 2.2008346256541245e-09
ARSA O 0 0.00013824194320477545
was O 0 1.4190758790277869e-08
proposed O 0 9.912633214259614e-11
to O 0 1.257205060542499e-12
be O 0 1.3615371850794755e-12
a O 0 1.027864252045596e-11
cause O 0 3.6502392775084047e-10
of O 0 1.603399013561102e-08
MLD B-Disease 1 1.0
( O 0 1.0121608412516636e-10
Draghia O 0 9.372975995347588e-08
et O 0 2.250965280836681e-08
al O 0 1.1871842398036847e-09
. O 0 2.2386723551315324e-12
, O 0 7.231041395001914e-13
1997 O 0 1.19018780941893e-10
) O 0 9.150596946838618e-12
. O 0 6.335151847558507e-10

We O 0 1.6712181638567358e-09
have O 0 3.534429476523271e-12
investigated O 0 2.6050030188518036e-11
the O 0 1.7631106644100392e-11
R496H O 0 8.763704206771195e-10
mutation O 0 3.8401157254064344e-12
and O 0 1.4981272515937616e-13
found O 0 1.0861452660665058e-13
this O 0 1.8548610387979052e-14
mutation O 0 4.285190366611069e-13
at O 0 8.252727494439949e-12
a O 0 4.814579182381429e-13
relatively O 0 1.7147013789322457e-13
high O 0 1.1188291504198034e-13
frequency O 0 2.400461556958944e-13
in O 0 2.910712849132219e-14
an O 0 1.9665203947400508e-15
African O 0 1.366729808754269e-13
American O 0 1.160103371873611e-13
population O 0 1.0194437084591872e-14
( O 0 1.694193796483636e-14
f O 0 1.4210055354624274e-10
= O 0 9.903240727471285e-11
0 O 0 7.220354175663246e-11
. O 0 1.9911837749377742e-13
09 O 0 7.204282743283885e-12
, O 0 8.962549127335129e-14
n O 0 4.122483604485083e-12
= O 0 1.471825265830784e-11
61 O 0 3.3549728967186e-11
subjects O 0 7.15651704563669e-11
) O 0 8.429635461881801e-12
. O 0 2.2477196492953766e-10

The O 0 7.3513474490027875e-06
ARSA O 0 0.015886906534433365
enzyme O 0 1.947838002003266e-10
activity O 0 4.73340013018575e-11
in O 0 1.5254194392008702e-12
subjects O 0 1.2638268036269107e-11
with O 0 3.590552605670788e-13
and O 0 7.578099606164734e-12
without O 0 1.2046416815458816e-11
the O 0 2.7841194627509225e-11
R496H O 0 1.0531319150075547e-09
mutation O 0 7.660674178344706e-12
was O 0 3.552151281449589e-11
determined O 0 9.65088252369295e-12
and O 0 8.48292139657425e-13
found O 0 1.9232126741847155e-12
to O 0 5.94040550257191e-13
be O 0 2.1324730176131013e-11
normal O 0 2.5810826809191667e-09
. O 0 1.101918445378658e-09

It O 0 5.618653320382805e-10
is O 0 8.661066655535343e-12
therefore O 0 3.2386456797622865e-12
concluded O 0 1.1778140095175527e-11
that O 0 7.055007890822279e-14
the O 0 5.295373514679902e-12
R496H O 0 6.211682834766918e-10
mutation O 0 1.2263409038260065e-11
of O 0 3.0192076616586405e-10
ARSA O 0 5.002764282835415e-06
does O 0 4.472149213452514e-12
not O 0 6.885315343048426e-13
negatively O 0 3.6787843686039365e-14
influence O 0 2.1456777056071824e-13
the O 0 4.368868548182414e-12
activity O 0 1.478189098902405e-11
of O 0 1.0746626505353518e-10
ARSA O 0 4.108686334802769e-05
and O 0 3.7271626757151566e-11
is O 0 2.508638696080423e-12
not O 0 2.220852625064995e-12
a O 0 1.1989347015184393e-10
cause O 0 4.018976085262693e-08
of O 0 1.7247631376449135e-06
MLD B-Disease 1 1.0

Down O 0 7.758340530017449e-07
- O 0 2.16880700065758e-08
regulation O 0 3.554433902763776e-08
of O 0 4.25706936368897e-09
transmembrane O 0 1.8634801790540223e-06
carbonic O 0 1.1717477264028275e-06
anhydrases O 0 1.4042467228136957e-05
in O 0 1.1873505911808024e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.00017339344776701182
lines O 0 1.4090673940148069e-11
by O 0 1.7379617710255868e-12
wild O 0 1.1420921097737846e-08
- O 0 6.023774812291549e-10
type O 0 1.2287684647560582e-08
von B-Disease 1 0.9694874286651611
Hippel I-Disease 1 0.9999942779541016
- I-Disease 0 0.029245175421237946
Lindau I-Disease 0 0.0010179218370467424
transgenes O 0 2.588435336292605e-06
. O 0 8.238994375631137e-09

To O 0 4.616371285237619e-09
discover O 0 1.5700659661277427e-09
genes O 0 2.8979540989126917e-11
involved O 0 9.318199857555332e-12
in O 0 1.4743181675491712e-10
von B-Disease 1 0.9943935871124268
Hippel I-Disease 1 0.9999995231628418
- I-Disease 1 0.9999849796295166
Lindau I-Disease 1 0.9999836683273315
( O 0 1.0449252840771805e-07
VHL B-Disease 0 0.47498005628585815
) O 0 6.152088560806845e-11
- O 0 3.2841536157235396e-09
mediated O 0 5.446901809591509e-07
carcinogenesis O 0 0.0002916638331953436
, O 0 2.9689244118724645e-11
we O 0 2.551788294558044e-11
used O 0 1.2285663597566554e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.0016285959864035249
lines O 0 3.6329930730438775e-10
stably O 0 6.5586833741804185e-09
transfected O 0 1.7105097893654886e-10
with O 0 4.4987025714891826e-13
wild O 0 1.58683608475485e-08
- O 0 3.4426170802959177e-09
type O 0 1.3166308576728625e-07
VHL O 0 0.12380947917699814
- O 0 1.5678111253691895e-07
expressing O 0 1.744820643523326e-08
transgenes O 0 1.2680031886702636e-06
. O 0 6.21531270894593e-09

Large O 0 1.3404240917225252e-07
- O 0 1.1691448698059048e-08
scale O 0 1.5221448279589822e-07
RNA O 0 6.390763918062703e-09
differential O 0 9.843754700256113e-10
display O 0 8.328734368845403e-10
technology O 0 2.172821228496602e-10
applied O 0 1.6359379129138318e-11
to O 0 3.628223210153797e-13
these O 0 5.903020043260265e-13
cell O 0 5.385677459557314e-10
lines O 0 2.0177327690606983e-12
identified O 0 2.1523383661285755e-13
several O 0 3.4304688674132236e-14
differentially O 0 1.8639003535048104e-11
expressed O 0 1.1038136279572369e-13
genes O 0 3.321894828981452e-14
, O 0 2.591786309766135e-14
including O 0 5.021930679464937e-13
an O 0 4.323904082004226e-12
alpha O 0 1.2993566222974096e-08
carbonic O 0 1.603319432774697e-08
anhydrase O 0 2.0288355884190423e-08
gene O 0 2.1790215465333773e-10
, O 0 2.3194047377161908e-11
termed O 0 5.464999119908498e-08
CA12 O 0 6.029472206137143e-05
. O 0 7.28574391928305e-08

The O 0 3.0532973482877424e-08
deduced O 0 7.422580328153572e-10
protein O 0 1.2377576741329221e-10
sequence O 0 2.0359457175711526e-11
was O 0 2.963149725587755e-10
classified O 0 7.64126522473374e-12
as O 0 6.394948372928644e-12
a O 0 4.6718871826723074e-11
one O 0 6.425040360857892e-11
- O 0 1.289975415375011e-08
pass O 0 1.3625270689487934e-08
transmembrane O 0 2.2960365697599627e-07
CA O 0 8.383934755329392e-07
possessing O 0 2.167193091651143e-09
an O 0 8.338724676038023e-12
apparently O 0 1.734569016198506e-10
intact O 0 4.968631062141071e-10
catalytic O 0 2.0334969819124638e-11
domain O 0 7.446512850783904e-11
in O 0 2.5520363600151086e-11
the O 0 5.206325370821219e-10
extracellular O 0 2.9515611288388754e-08
CA O 0 9.095433597394731e-06
module O 0 6.870330366837152e-07
. O 0 7.670218238331472e-09

Reintroduced O 0 3.3662706755421823e-06
wild O 0 5.404840976552805e-06
- O 0 3.9603980894753477e-07
type O 0 1.3638552900374634e-06
VHL B-Disease 0 0.0027688750997185707
strongly O 0 2.144282751359583e-09
inhibited O 0 3.729482833669806e-10
the O 0 6.129845936397871e-11
overexpression O 0 1.5967968058916426e-09
of O 0 3.7197642188679936e-10
the O 0 3.5961092437197806e-10
CA12 O 0 3.702249955495063e-07
gene O 0 2.2592849466263054e-11
in O 0 1.7645428304277622e-12
the O 0 1.2712010610815838e-10
parental O 0 2.0360756025183946e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9432669878005981
lines O 0 1.261050108780637e-08
. O 0 1.8126098400017554e-09

Similar O 0 2.2466148941191477e-09
results O 0 2.924653574876146e-10
were O 0 1.2717437346265736e-11
obtained O 0 5.014123231200651e-12
with O 0 1.7537789796795433e-12
CA9 O 0 4.384857675177045e-06
, O 0 1.5657461438500775e-11
encoding O 0 4.948398288351363e-11
another O 0 5.708952199867667e-10
transmembrane O 0 1.3720196534450224e-08
CA O 0 1.1110810760328604e-07
with O 0 7.010789084688218e-12
an O 0 1.430509096594923e-11
intact O 0 3.060673492427668e-08
catalytic O 0 3.1285773971490016e-09
domain O 0 3.131361125952026e-08
. O 0 2.53024778906763e-09

Although O 0 3.361586342620626e-09
both O 0 4.4951559835526567e-11
domains O 0 3.437195805755522e-10
of O 0 1.0542438033667167e-08
the O 0 7.519283684587208e-08
VHL B-Disease 0 7.981999260664452e-06
protein O 0 4.056500690907683e-10
contribute O 0 5.230404325796967e-13
to O 0 1.8603547521922614e-12
regulation O 0 1.885563927217504e-09
of O 0 5.612012521361009e-10
CA12 O 0 4.494490895012859e-06
expression O 0 6.113805017804452e-10
, O 0 2.0781367078559487e-12
the O 0 2.5001755873943488e-11
elongin O 0 4.5129433523527496e-09
binding O 0 2.1933532767803854e-10
domain O 0 1.287729645138569e-10
alone O 0 6.953073533599863e-12
could O 0 8.316185413914656e-12
effectively O 0 1.7706132393602303e-10
regulate O 0 3.7066849589706408e-09
CA9 O 0 2.8748949262080714e-05
expression O 0 2.563749390560588e-08
. O 0 3.3861298209814095e-09

We O 0 6.862938306539945e-08
mapped O 0 1.3318623359737103e-07
CA12 O 0 3.604112134780735e-05
and O 0 7.472471530434177e-09
CA9 O 0 1.631094710319303e-05
loci O 0 5.863574070730238e-10
to O 0 3.3776505897753495e-11
chromosome O 0 3.12524961465499e-09
bands O 0 1.9793821692815072e-08
15q22 O 0 7.517792965927583e-08
and O 0 6.756403214680518e-10
17q21 O 0 1.8092849529693922e-07
. O 0 9.158153346788822e-09

2 O 0 6.901056792685267e-08
respectively O 0 1.2845804420180684e-09
, O 0 5.90570578551386e-11
regions O 0 1.0778512526954387e-09
prone O 0 6.355702630855831e-10
to O 0 1.6532552236936393e-12
amplification O 0 1.5933580843618955e-10
in O 0 9.8702539197415e-12
some O 0 7.977700097749896e-12
human O 0 1.2343191357899741e-08
cancers B-Disease 0 4.319364506955026e-06
. O 0 4.134585118720224e-09

Additional O 0 1.0421060681053973e-09
experiments O 0 4.243660089997547e-09
are O 0 5.734090285924864e-12
needed O 0 1.4704392217734785e-11
to O 0 4.505262536733806e-13
define O 0 2.94875998618771e-11
the O 0 1.9382493873787432e-11
role O 0 2.855284758629395e-11
of O 0 9.133761524893202e-10
CA O 0 1.4469561904206785e-07
IX O 0 7.916402466889849e-08
and O 0 3.8785144540476324e-10
CA O 0 7.662384149398349e-08
XII O 0 2.0189109051216292e-08
enzymes O 0 3.1212298370886238e-12
in O 0 7.201120125546745e-13
the O 0 6.1683353737296276e-12
regulation O 0 7.765289106176354e-11
of O 0 1.0121081923941677e-11
pH O 0 2.8190661610638656e-11
in O 0 8.664928583673737e-13
the O 0 1.3590626020409946e-11
extracellular O 0 5.5863577652637275e-11
microenvironment O 0 3.0787680738164624e-10
and O 0 4.938606489902908e-13
its O 0 8.149765584608559e-13
potential O 0 7.986256621295151e-12
impact O 0 3.8259509449467544e-10
on O 0 9.604731232570884e-09
cancer B-Disease 0 5.538474283639516e-07
cell O 0 8.958146509030485e-07
growth O 0 3.403082260433621e-08
. O 0 3.421904093414696e-09

A O 0 6.73543567586421e-08
gene O 0 2.6895627391887444e-10
encoding O 0 1.3970097301196915e-10
a O 0 2.54232107588237e-10
transmembrane O 0 1.4082250920921524e-09
protein O 0 1.2334588905815735e-10
is O 0 1.0024185664479421e-13
mutated O 0 3.672301178425652e-13
in O 0 6.275608152713982e-14
patients O 0 1.055423196755223e-11
with O 0 3.897603073621525e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.0001440962660126388
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 1.6451342332857166e-07
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 8.752069381723349e-12
. O 0 6.364446469842022e-11

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.3049497283645906e-05
WFS B-Disease 1 0.9998176693916321
; O 0 1.531684334921124e-09
OMIM O 0 0.2178071141242981
222300 O 0 2.4472802451214193e-08
) O 0 2.65946173503423e-13
is O 0 4.787927595627933e-14
an O 0 5.923728304754738e-13
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999945163726807
defined O 0 2.412028259415888e-12
by O 0 6.459494008068502e-15
young O 0 3.071014512026453e-14
- O 0 2.4177547117143483e-11
onset O 1 0.9999988079071045
non O 1 0.9999991655349731
- O 0 0.009040355682373047
immune O 1 0.9999973773956299
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 5.07723605380761e-08
progressive O 1 0.9944090247154236
optic B-Disease 1 0.9999940395355225
atrophy I-Disease 0 0.19580078125
. O 0 2.0024776503646535e-08

Linkage O 0 2.563178043146763e-07
to O 0 2.3862267717333907e-10
markers O 0 7.374642563284795e-10
on O 0 2.284241018557509e-09
chromosome O 0 4.921633323107244e-09
4p O 0 4.726280167233199e-07
was O 0 3.2560967810901786e-10
confirmed O 0 4.407169421072332e-11
in O 0 1.2177029350135538e-11
five O 0 1.3703602141923454e-10
families O 0 6.310735788106481e-12
. O 0 2.3189383746569092e-09

On O 0 5.143651282679684e-09
the O 0 5.178829587393352e-11
basis O 0 7.978221555626774e-11
of O 0 3.4712976937356643e-10
meiotic O 0 0.00025180159718729556
recombinants O 0 0.005055347923189402
and O 0 1.240968927618269e-08
disease O 0 4.097034252481535e-05
- O 0 6.088015508387556e-11
associated O 0 6.978546907010497e-11
haplotypes O 0 4.83645512527886e-10
, O 0 2.749971474494406e-12
the O 0 5.608610242902046e-10
WFS B-Disease 0 1.0424581887491513e-05
gene O 0 1.5510928652595624e-10
was O 0 1.1551701262213498e-10
localized O 0 5.29026045192893e-10
to O 0 7.720875154493267e-12
a O 0 7.119638212316204e-10
BAC O 0 2.9388654638751177e-06
/ O 0 1.5284106424928723e-08
P1 O 0 4.5153392136398907e-08
contig O 0 3.5569566847470924e-08
of O 0 3.5758226935023174e-10
less O 0 1.946440578159958e-11
than O 0 1.3797691288119918e-12
250 O 0 1.0570919140029389e-10
kb O 0 7.208763577182253e-07
. O 0 2.204440363584581e-08

Mutations O 0 4.527460073511236e-10
in O 0 3.2104607167182664e-11
a O 0 1.6186498322245946e-11
novel O 0 7.23296292651221e-12
gene O 0 2.270952956934247e-12
( O 0 5.658695625791743e-13
WFS1 O 0 1.187184839324118e-08
) O 0 3.302501501434296e-13
encoding O 0 4.647054008960483e-12
a O 0 4.2225424545794255e-11
putative O 0 6.913276617837028e-10
transmembrane O 0 1.6134105162990409e-10
protein O 0 6.22608006817238e-11
were O 0 1.0347962937917732e-11
found O 0 7.777594757465978e-14
in O 0 3.6657227817440963e-13
all O 0 2.001266990667161e-12
affected O 0 2.259817983782386e-12
individuals O 0 3.955666902973748e-14
in O 0 8.063833628613182e-11
six O 0 7.631492593418443e-08
WFS B-Disease 1 0.9731497168540955
families O 0 1.5628183426194542e-12
, O 0 2.2295704778935166e-12
and O 0 1.1231573397024741e-12
these O 0 6.142643902209977e-13
mutations O 0 2.149570235351894e-12
were O 0 8.01579722736756e-13
associated O 0 1.547557004419331e-12
with O 0 9.81799494134683e-13
the O 0 3.4093436962479018e-09
disease O 0 1.8917064153356478e-05
phenotype O 0 2.253743636160266e-09
. O 0 5.154638382798282e-10

WFS1 O 0 0.014347944408655167
appears O 0 5.6669589021396405e-09
to O 0 8.354756123041263e-12
function O 0 3.755114830195083e-10
in O 0 3.46538180096001e-11
survival O 0 9.243515819434833e-08
of O 0 1.5876404635406516e-09
islet O 0 1.2157414630564745e-08
beta O 0 4.2489083362795554e-09
- O 0 4.2930747845559836e-10
cells O 0 6.872005742231124e-11
and O 0 1.1958097706488147e-11
neurons O 0 3.742999313272044e-11
. O 0 1.0937113194275927e-11
. O 0 2.716546987358015e-10

Stable O 0 1.9481079505112575e-07
interaction O 0 5.4532250243211067e-11
between O 0 1.4128727701678834e-11
the O 0 2.3032445395365642e-10
products O 0 3.6100464284594125e-10
of O 0 1.101876478948327e-09
the O 0 4.584274293506496e-09
BRCA1 O 0 3.4440488239084743e-09
and O 0 1.4405530934791244e-10
BRCA2 O 0 1.1411552813811454e-09
tumor B-Disease 0 1.912110914048526e-09
suppressor O 0 1.0502834157932739e-09
genes O 0 3.3379861374971398e-12
in O 0 7.251195737606464e-12
mitotic O 0 2.6109862716339194e-08
and O 0 3.7793726481716305e-10
meiotic O 0 7.025914328551153e-06
cells O 0 4.036999712297984e-08
. O 0 3.3053819681327923e-09

BRCA1 O 0 1.0412800293124747e-06
and O 0 1.2992293907387875e-09
BRCA2 O 0 1.3344307880913675e-09
account O 0 7.923499096423869e-13
for O 0 4.820294554133686e-13
most O 0 7.74762673179212e-14
cases O 0 3.022578118783842e-14
of O 0 1.2213263169899569e-12
familial O 0 1.279054362424148e-10
, O 0 7.337409217537949e-13
early O 0 1.4049627017342914e-09
onset O 1 0.9999974966049194
breast B-Disease 0 0.0008902000263333321
and I-Disease 0 3.764821343565927e-08
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.474626499970327e-07
encode O 0 3.0018536267828466e-11
products O 0 2.0503071462840694e-10
that O 0 1.9702693795052573e-13
each O 0 2.063468990674052e-14
interact O 0 6.506882706258654e-14
with O 0 5.15110252629486e-13
hRAD51 O 0 1.0472673395156562e-08
. O 0 2.1197135158246283e-09

Results O 0 5.814773995638234e-09
presented O 0 1.2223559942015072e-09
here O 0 7.712754046540482e-11
show O 0 7.11061001745783e-11
that O 0 2.362967243749181e-12
BRCA1 O 0 9.346774049179274e-11
and O 0 5.617339926544673e-12
BRCA2 O 0 8.893833586265387e-11
coexist O 0 1.2949925853877886e-11
in O 0 1.6049683283780869e-12
a O 0 9.866489569798631e-12
biochemical O 0 1.4233906275862296e-09
complex O 0 3.2846922959350877e-09
and O 0 5.529156993366868e-11
colocalize O 0 5.133123295308906e-07
in O 0 2.074104665794607e-09
subnuclear O 0 2.131615701728151e-06
foci O 0 1.2253816521479166e-06
in O 0 2.2439157476572547e-10
somatic O 0 2.482908545431428e-09
cells O 0 1.7458033282902186e-11
and O 0 3.4199525806785647e-13
on O 0 3.54704668414918e-11
the O 0 1.953949588934245e-12
axial O 0 6.333019178517141e-12
elements O 0 8.405620643969769e-11
of O 0 3.249842894792465e-10
developing O 0 2.1622716950275844e-09
synaptonemal O 0 5.908948992328078e-07
complexes O 0 9.709855675055223e-08
. O 0 2.721985481457523e-08

Like O 0 1.9962241992743657e-07
BRCA1 O 0 3.1428260172106093e-07
and O 0 6.088718418340022e-09
RAD51 O 0 7.948919665068388e-05
, O 0 5.604933850378302e-09
BRCA2 O 0 9.356504904189933e-09
relocates O 0 6.771548877182454e-10
to O 0 2.707834304005452e-11
PCNA O 0 5.172717010282213e-08
+ O 0 3.3424010087435008e-12
replication O 0 3.977080817452183e-12
sites O 0 3.940758581000986e-13
following O 0 5.434511347879312e-12
exposure O 0 8.678351787194671e-11
of O 0 1.6113624323743636e-10
S O 0 1.632511370530665e-08
phase O 0 4.77491690631382e-09
cells O 0 4.1337770012583874e-11
to O 0 1.4481833267299127e-11
hydroxyurea O 0 1.347624412062487e-08
or O 0 1.1501377628064802e-10
UV O 0 2.211175342381466e-06
irradiation O 0 1.2533886817323037e-08
. O 0 4.6291975808188113e-10

Thus O 0 1.6877097053225043e-08
, O 0 7.220716247147152e-10
BRCA1 O 0 2.0710053671990636e-09
and O 0 4.725768040780842e-11
BRCA2 O 0 8.934367135005061e-11
participate O 0 9.45205393988735e-13
, O 0 2.0130495577766472e-13
together O 0 8.758155333778161e-14
, O 0 1.5559558849687072e-13
in O 0 1.0148989938382758e-12
a O 0 2.7776166783288758e-11
pathway O 0 5.921302510814019e-12
( O 0 5.871710317397957e-14
s O 0 2.0968738898008432e-12
) O 0 6.158803241023856e-15
associated O 0 1.745775019771495e-13
with O 0 4.0348241647737357e-14
the O 0 7.144456901087004e-12
activation O 0 1.254439000591967e-11
of O 0 3.293999448206186e-11
double O 0 8.366341508470043e-10
- O 0 2.024219458718335e-09
strand O 0 9.214678797775377e-09
break O 0 8.522953010015044e-08
repair O 0 8.686909325206216e-08
and O 0 2.9815125368592987e-10
/ O 0 1.5781221662791722e-08
or O 0 1.311163122519332e-10
homologous O 0 2.5817953330786736e-10
recombination O 0 1.837618057720647e-09
. O 0 6.653206430229375e-09

Dysfunction O 0 0.10239377617835999
of O 0 2.6868693225878815e-07
this O 0 1.8725639094885338e-10
pathway O 0 5.410016323814659e-10
may O 0 2.8831108507543224e-12
be O 0 6.910994671503745e-14
a O 0 8.378748270285868e-14
general O 0 6.818637451541654e-13
phenomenon O 0 3.6494631101835484e-12
in O 0 3.1263921708652234e-14
the O 0 1.896705855526301e-13
majority O 0 2.317871101217145e-14
of O 0 1.2436576833467494e-13
cases O 0 4.246540049939948e-14
of O 0 3.4301343015963326e-11
hereditary B-Disease 1 0.9999947547912598
breast I-Disease 0 0.25884342193603516
and I-Disease 0 5.278503749650554e-07
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00015513892867602408
. O 0 5.485603793431437e-08

A O 0 6.010558450952885e-08
novel O 0 3.798675818345032e-10
Arg362Ser O 0 1.772439617298005e-08
mutation O 0 4.317856489022276e-11
in O 0 6.769566244374525e-12
the O 0 1.4139032999960222e-10
sterol O 0 4.400943254267986e-08
27 O 0 9.49278202710957e-08
- O 0 1.2112097103056385e-08
hydroxylase O 0 1.2229621404458157e-07
gene O 0 2.36177133405846e-10
( O 0 2.3365161801874867e-12
CYP27 O 0 3.052377195444933e-08
) O 0 6.614848913847476e-14
: O 0 1.7136575971720032e-14
its O 0 3.143536863106644e-13
effects O 0 4.9231591026099863e-11
on O 0 2.0085808016823137e-10
pre O 0 4.726818492173379e-09
- O 0 5.418078485863731e-11
mRNA O 0 1.8495797948769876e-10
splicing O 0 3.051547625698703e-10
and O 0 4.4425907397283027e-11
enzyme O 0 2.0321010499313452e-11
activity O 0 6.847646338847824e-10
. O 0 1.2750142053263858e-09

A O 0 8.897985992462054e-08
novel O 0 5.06160557911528e-10
C O 0 7.0060410806149775e-09
to O 0 1.2921502409724006e-11
A O 0 6.249056827556387e-10
mutation O 0 5.3621282761207034e-12
in O 0 1.8442935980494957e-12
the O 0 6.520235046325595e-11
sterol O 0 1.2406494498407028e-08
27 O 0 2.4009619181697417e-08
- O 0 2.472945626053047e-09
hydroxylase O 0 2.373750440654021e-08
gene O 0 8.164523224163389e-11
( O 0 1.4791472083622303e-12
CYP27 O 0 1.6585550710601638e-08
) O 0 2.5725894938627425e-13
was O 0 6.117765148638821e-12
identified O 0 5.901883257282414e-13
by O 0 3.562052996314291e-13
sequencing O 0 9.86920475898323e-11
amplified O 0 2.0875590145408296e-09
CYP27 O 0 1.0038122582045617e-06
gene O 0 4.555522972737869e-11
products O 0 3.1388489030170774e-11
from O 0 8.469147150073908e-13
a O 0 1.643518827976198e-11
patient O 0 1.2656850567616118e-10
with O 0 9.865986499990598e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 9.043451321133489e-09
CTX B-Disease 0 4.376992001198232e-05
) O 0 1.2533611648546383e-10
. O 0 2.2635961993699993e-09

The O 0 1.0537552164180397e-08
mutation O 0 6.573157573797062e-10
changed O 0 6.756915166272748e-11
the O 0 2.71424743791826e-10
adrenodoxin O 0 4.430572886349182e-08
cofactor O 0 4.470996017857942e-09
binding O 0 9.045033055876672e-10
residue O 0 2.6666799879393466e-09
362Arg O 0 1.6957941995077164e-10
to O 0 3.515268588369369e-12
362Ser O 0 1.8215133845700393e-09
( O 0 5.713469974910623e-11
CGT O 0 5.928411042077641e-07
362Arg O 0 6.95162549746442e-09
to O 0 3.723119729182045e-11
AGT O 0 5.562199021369452e-07
362Ser O 0 3.183182328836409e-10
) O 0 6.542899224802265e-14
, O 0 2.4318802112582687e-14
and O 0 4.5108495660538955e-14
was O 0 1.4301762898960568e-11
responsible O 0 6.488178744268325e-11
for O 0 3.5410573778760224e-11
deficiency O 0 1.2794437509455747e-08
in O 0 1.2244157077123674e-10
the O 0 2.160012835261682e-09
sterol O 0 5.9381881101217e-07
27 O 0 2.991399128404737e-07
- O 0 2.9703830506377926e-09
hydroxylase O 0 1.5023662314206376e-08
activity O 0 2.496136353169476e-10
, O 0 2.0027705080298552e-13
as O 0 1.0648772174378512e-13
confirmed O 0 2.3801278873150644e-13
by O 0 6.646771213937239e-14
expression O 0 1.920536646382587e-12
of O 0 3.823291509774673e-12
mutant O 0 9.301423520291507e-11
cDNA O 0 6.572932198523063e-10
into O 0 4.3911513314398576e-11
COS O 0 4.899279701930936e-07
- O 0 1.9919484728347925e-08
1 O 0 5.483135012696039e-08
cells O 0 7.248566191719874e-09
. O 0 1.4672048020969441e-09

Quantitative O 0 2.3978852237149795e-09
analysis O 0 8.79387257457509e-11
showed O 0 1.2390355408342657e-10
that O 0 1.3935479560665126e-13
the O 0 4.5543304370843085e-12
expression O 0 8.82209236219289e-12
of O 0 2.022256841149872e-11
CYP27 O 0 6.051415368801827e-09
gene O 0 1.3835639448359083e-12
mRNA O 0 1.7157034256851111e-12
in O 0 3.363144181547928e-13
the O 0 2.1735205649187073e-11
patient O 0 1.2791495640485095e-10
represented O 0 1.0323621124630478e-10
52 O 0 4.3075317535112845e-08
. O 0 5.842480987894305e-08

5 O 0 1.4135999926168097e-08
% O 0 4.830883956752352e-11
of O 0 3.936602432919045e-10
the O 0 1.6958144888334914e-09
normal O 0 5.60908652857961e-08
level O 0 1.2062273526680656e-06
. O 0 3.945467064170316e-09

As O 0 3.423090422227659e-10
the O 0 1.3824733025025182e-10
mutation O 0 2.8830686102376823e-11
occurred O 0 5.3289941903678084e-11
at O 0 3.5844660573047804e-11
the O 0 1.5936764061197373e-11
penultimate O 0 1.4601054809659786e-09
nucleotide O 0 1.3857998082400513e-10
of O 0 6.870763957778081e-10
exon O 0 4.630224204049682e-09
6 O 0 4.54800952454093e-09
( O 0 3.744546773348789e-12
- O 0 1.3233485141039836e-10
2 O 0 1.3055614367374346e-09
position O 0 3.974294227049313e-10
of O 0 3.0676323703460184e-09
exon O 0 1.622766632181083e-08
6 O 0 8.113244831520205e-08
- O 0 5.681201731277952e-09
intron O 0 5.962225912981012e-08
6 O 0 1.414363204332858e-08
splice O 0 2.972911028464864e-09
site O 0 5.099434069455455e-11
) O 0 2.3834883719486832e-14
of O 0 1.8697959847102652e-12
the O 0 1.785009987043118e-11
gene O 0 1.3217637921669745e-11
, O 0 1.3484136767230592e-12
we O 0 8.929723822360958e-13
hypothesized O 0 3.1529360285803554e-12
that O 0 1.3661922308239646e-14
the O 0 3.2338556745642455e-12
mutation O 0 4.862478475420318e-12
may O 0 4.0750380500553796e-12
partially O 0 9.845703419220087e-11
affect O 0 4.0517312812141104e-13
the O 0 1.7631567863704567e-12
normal O 0 8.233641199395514e-12
splicing O 0 1.0816684353764927e-11
efficiency O 0 1.0979585296500005e-11
in O 0 6.744096925880017e-13
exon O 0 1.584402886667391e-10
6 O 0 5.350014875560305e-11
and O 0 8.067486565940807e-13
cause O 0 4.282539253774864e-11
alternative O 0 6.548676878548321e-11
splicing O 0 2.035507006004078e-11
elsewhere O 0 1.1227675690214656e-12
, O 0 5.330996671122808e-15
which O 0 2.949946610567738e-15
resulted O 0 2.648982378936071e-13
in O 0 4.779624639865768e-14
decreased O 0 5.4680327106482185e-12
transcript O 0 2.0904177694403003e-11
in O 0 2.9582621074997206e-12
the O 0 1.4485819488374574e-10
patient O 0 1.2502958668392239e-09
. O 0 2.3260702253224963e-09

Transfection O 0 3.7466093090188224e-06
of O 0 2.863536110453424e-07
constructed O 0 2.8618873670893663e-07
minigenes O 0 5.954213975201128e-07
, O 0 3.2546174089098656e-11
with O 0 1.4148785225029381e-12
or O 0 5.385518420109037e-12
without O 0 2.6915112499859006e-11
the O 0 3.026390249516453e-11
mutation O 0 2.8241989909888465e-12
, O 0 5.119328897427999e-13
into O 0 2.5904248364405635e-12
COS O 0 9.47105888826627e-07
- O 0 8.986056343474047e-09
1 O 0 4.780475570953513e-09
cells O 0 4.684501918317263e-12
confirmed O 0 2.3615345789984588e-12
that O 0 8.738345096614367e-15
the O 0 6.074462222289967e-13
mutant O 0 6.723874929059903e-11
minigene O 0 9.996521388444535e-10
was O 0 1.692966461463996e-10
responsible O 0 2.9317846761411914e-11
for O 0 1.5274195753686715e-12
a O 0 1.5293384614256667e-11
mRNA O 0 5.1296942388256994e-11
species O 0 1.734179342011491e-13
alternatively O 0 1.840379194525954e-12
spliced O 0 1.626790507858189e-10
at O 0 5.137001379829087e-10
an O 0 2.180883078295448e-11
activated O 0 2.539236731990968e-08
cryptic O 0 4.618819549051523e-09
5 O 0 1.856465536853591e-09
splice O 0 6.6610530424782155e-09
site O 0 1.3419654276702886e-09
88 O 0 6.104413641239148e-10
bp O 0 3.8702652194189113e-11
upstream O 0 1.1799899165415573e-12
from O 0 3.2714060410263257e-13
the O 0 4.4178913999326497e-11
3 O 0 7.595326589893148e-10
end O 0 1.2017008499398685e-09
of O 0 1.4043518570261426e-09
exon O 0 1.0762786217810572e-07
6 O 0 7.555426151384381e-08
. O 0 1.0313633502789799e-08

Our O 0 7.071961238835911e-09
data O 0 2.3230851964317623e-10
suggest O 0 5.588635457187685e-12
that O 0 7.462226772917899e-14
the O 0 9.845735338132044e-12
C O 0 4.26314455959087e-10
to O 0 6.217363321230074e-13
A O 0 1.285886397361935e-10
mutation O 0 9.072648231647773e-13
at O 0 1.1181007508742624e-11
the O 0 6.155054764478418e-12
penultimate O 0 4.0329400929906e-10
nucleotide O 0 3.857398081508201e-11
of O 0 1.2934084359095266e-10
exon O 0 7.61740837074143e-10
6 O 0 3.5235755979634575e-10
of O 0 8.787065519655357e-11
the O 0 4.747724990927793e-10
CYP27 O 0 1.6299778735628934e-06
gene O 0 4.384932694723176e-11
not O 0 3.1331336722111025e-13
only O 0 3.294121973893699e-13
causes O 0 1.3661316869417739e-11
the O 0 1.92854454628133e-10
deficiency B-Disease 0 7.438088811539956e-09
in I-Disease 0 8.67666286041846e-11
the I-Disease 0 2.810591537283358e-09
sterol I-Disease 0 2.7423675419413485e-07
27 I-Disease 0 1.4000178794049134e-07
- I-Disease 0 1.5062330271931046e-09
hydroxylase I-Disease 0 8.048721689135618e-09
activity I-Disease 0 1.281774963945992e-10
, O 0 5.052820141460135e-13
but O 0 4.4274024550705615e-13
also O 0 3.3621456313470688e-12
partially O 0 2.792465148004908e-10
leads O 0 1.088796587611629e-12
to O 0 9.968854084232981e-14
alternative O 0 2.0243563769728468e-11
pre O 0 5.610578668324706e-10
- O 0 5.895844142761453e-12
mRNA O 0 1.547324594841637e-11
splicing O 0 4.146537974092368e-11
of O 0 2.426361195295712e-11
the O 0 1.3923651120961722e-10
gene O 0 7.323187056762492e-10
. O 0 8.328607803420596e-10

To O 0 3.4169977958242725e-10
our O 0 2.2778615105245592e-10
knowledge O 0 7.63372282053254e-11
, O 0 7.411265611628748e-13
this O 0 2.2028953571766145e-14
is O 0 1.2873758997852466e-14
the O 0 8.71642574741191e-14
first O 0 2.7675816282810017e-13
report O 0 2.4535825506196395e-14
regarding O 0 4.0779344148440116e-14
effects O 0 2.6267000727275835e-12
on O 0 1.3769384070438928e-11
pre O 0 1.04592882965715e-10
- O 0 1.2658140594729028e-12
mRNA O 0 5.928274798144839e-12
splicing O 0 1.196893625876605e-11
of O 0 2.480718928887793e-11
a O 0 9.069797864136309e-12
mutation O 0 2.3104315769600925e-12
at O 0 1.5714314571813048e-10
the O 0 2.5223056976386715e-10
- O 0 7.744629382244739e-10
2 O 0 9.47788958427509e-09
position O 0 2.228697892903142e-09
of O 0 2.100836171692322e-09
a O 0 3.897143940889691e-09
5 O 0 2.5146992044255967e-08
splice O 0 2.6915265038951475e-07
site O 0 7.592799278199891e-08
. O 0 7.0719066158630994e-09

ATM O 0 1.4458638588621398e-06
germline O 0 1.378172775901021e-08
mutations O 0 8.418452566993917e-12
in O 0 1.2043516140966548e-12
classical O 1 0.9999778270721436
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.2604983150959015
in O 0 8.500746634387824e-11
the O 0 2.1518942183718082e-10
Dutch O 0 6.138640884501001e-08
population O 0 5.24407253732484e-12
. O 0 2.2983381864349894e-10

Germline O 0 6.775649694645836e-07
mutations O 0 1.3269983722974388e-10
in O 0 2.3378370420101824e-11
the O 0 1.217167339140346e-10
ATM O 0 5.748040976527591e-08
gene O 0 1.756454530432716e-11
are O 0 4.947793460070805e-15
responsible O 0 1.1406306942799566e-13
for O 0 7.775933217636644e-14
the O 0 1.5182472168362438e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.001037483918480575
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.7221540860035134e-10
. O 0 6.706126209898855e-10

In O 0 5.153668158897062e-09
our O 0 9.800292799511112e-10
study O 0 9.029752640055122e-12
, O 0 2.680546539943207e-12
we O 0 1.7451499230089484e-12
have O 0 9.558889460135542e-14
determined O 0 2.1874936757815266e-12
the O 0 6.294700004294551e-12
ATM O 0 1.7234068616645004e-09
mutation O 0 5.649895156757678e-13
spectrum O 0 3.9863896688849265e-13
in O 0 4.470447449722581e-14
19 O 0 2.245318687921216e-11
classical O 0 0.0006559854373335838
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5646729467633236e-09
, O 0 9.779153940618623e-14
including O 0 1.0834802293639006e-13
some O 0 2.8938182687794634e-14
immigrant O 0 7.992759557505502e-13
populations O 0 8.253459222486159e-14
, O 0 2.183193879043248e-14
as O 0 8.233600704444372e-14
well O 0 3.621806901697028e-13
as O 0 1.2826077006033998e-12
12 O 0 1.9133566259155188e-11
of O 0 1.1659541387931682e-11
Dutch O 0 4.111010198926124e-09
ethnic O 0 1.4363600586708714e-11
origin O 0 2.3976451032914348e-11
. O 0 1.115583958544164e-09

Both O 0 2.52505039100015e-09
the O 0 2.0783577081573412e-09
protein O 0 2.0654578047896166e-10
truncation O 0 1.4231796185981693e-08
test O 0 3.2004490169157407e-09
( O 0 6.899490527512153e-12
PTT O 0 5.852470952305566e-09
) O 0 1.4693555074919706e-13
and O 0 4.151107897091416e-13
the O 0 9.682503063213055e-12
restriction O 0 2.9634988907289994e-11
endonuclease O 0 1.0583366127914218e-10
fingerprinting O 0 1.1064586052933478e-10
( O 0 5.291291493500494e-13
REF O 0 4.796070138257669e-11
) O 0 4.771442894518354e-15
method O 0 1.2487585835177506e-13
were O 0 1.4778492828364936e-13
used O 0 2.423332632380936e-14
and O 0 6.889739565538525e-14
compared O 0 3.45117001383094e-13
for O 0 9.808168817057594e-13
their O 0 2.295059324877724e-12
detection O 0 1.1541394923098025e-10
efficiency O 0 7.945295463218649e-12
, O 0 5.0227420692657704e-14
identifying O 0 3.860942056517491e-13
76 O 0 5.587292781217279e-12
% O 0 2.8198968225583154e-13
and O 0 4.0384530572076804e-13
60 O 0 5.325374689835183e-12
% O 0 8.111305680943981e-13
of O 0 2.6966087349200585e-11
the O 0 1.4507109402650542e-10
mutations O 0 2.2593796625280937e-11
, O 0 9.831230447787664e-12
respectively O 0 3.768043377316843e-10
. O 0 2.2872317373412443e-09

Most O 0 3.9701085086107923e-08
patients O 0 8.40989111683399e-10
were O 0 2.0742697837139445e-10
found O 0 6.491840051636721e-12
to O 0 3.720945426777256e-12
be O 0 1.2224858625398127e-10
compound O 0 3.544792903653615e-08
heterozygote O 0 1.5369357697636588e-07
. O 0 1.46837231262964e-09

Seventeen O 0 9.484547547344846e-08
mutations O 0 2.1712467934698054e-10
were O 0 5.963275012677016e-11
distinct O 0 1.0698050084689825e-11
, O 0 1.748308312357616e-12
of O 0 8.715159149907947e-11
which O 0 8.410170997119604e-12
10 O 0 8.561930331385526e-11
were O 0 2.2216841213951177e-11
not O 0 3.993857328188355e-12
reported O 0 1.1153961781973365e-10
previously O 0 3.0285296492849056e-09
. O 0 2.3429862494595e-09

Mutations O 0 8.674508222838995e-08
are O 0 1.2778497704424296e-10
small O 0 5.013761975036779e-11
deletions O 0 2.5113125468045894e-10
or O 0 3.1275437795130756e-10
point O 0 3.820747807026237e-08
mutations O 0 2.473656834922622e-10
frequently O 0 1.3471983077717464e-11
affecting O 0 5.465157840167656e-11
splice O 0 2.1024395557844855e-09
sites O 0 1.0853791199139096e-09
. O 0 1.3456665781674815e-09

Moreover O 0 2.153381331027049e-07
, O 0 2.0527497479605472e-09
a O 0 2.6415405418589444e-09
16 O 0 1.6920422751809383e-07
. O 0 4.362981442795899e-08

7 O 0 8.504373454343295e-07
- O 0 7.400615675834388e-09
kb O 0 5.716443851611075e-08
genomic O 0 2.5849105078634693e-09
deletion O 0 1.5735668323912932e-10
of O 0 8.060946909971278e-10
the O 0 1.9018854546803965e-10
3 O 0 5.884188691851477e-10
end O 0 7.292810105807845e-11
of O 0 2.6553335918944043e-11
the O 0 1.6251585147064596e-11
gene O 0 6.152367244133261e-12
, O 0 7.7717856022258e-13
most O 0 9.049125923414614e-13
likely O 0 5.5990702525765546e-12
a O 0 2.6169437710582555e-12
result O 0 1.1324378067223417e-11
of O 0 6.829574666217253e-12
recombination O 0 2.356457856535904e-13
between O 0 1.0684340781899615e-12
two O 0 3.1221527099778434e-12
LINE O 0 8.859603051192266e-10
elements O 0 7.855580075322166e-11
, O 0 7.091644112222628e-12
was O 0 1.8750774266607095e-09
identified O 0 1.632815882501859e-09
. O 0 4.927974028845483e-09

The O 0 1.502744417791746e-08
most O 0 2.520332727240504e-11
frequently O 0 2.5473666145220397e-12
found O 0 5.22743306974327e-13
mutation O 0 2.509408154362236e-13
, O 0 2.715091267590196e-14
identified O 0 3.1573094833037274e-13
in O 0 5.004689696518072e-13
three O 0 2.53673362697604e-12
unrelated O 0 2.658547826328572e-10
Turkish O 0 1.4456443864219182e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 9.191703821687103e-12
, O 0 8.754840602476222e-12
was O 0 1.1603644711755123e-09
previously O 0 2.940617471747231e-10
described O 0 2.8506088548679864e-12
to O 0 8.667799957602293e-14
be O 0 1.641994374669553e-13
a O 0 6.988836050679514e-13
Turkish O 0 6.028314514239241e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
founder O 0 1.573036024637986e-05
mutation O 0 8.353178770903469e-08
. O 0 3.738907849992756e-09

The O 0 4.47352110910515e-09
presence O 0 3.0684502161371086e-10
of O 0 4.477378912071117e-09
a O 0 8.16923506619105e-09
founder O 0 2.2274552975432016e-06
mutation O 0 1.822319628530522e-09
among O 0 1.941041728389936e-12
relatively O 0 1.955683445048484e-12
small O 0 1.258139778340453e-13
ethnic O 0 6.195427742876347e-13
population O 0 9.489654003466512e-15
groups O 0 1.7937306709945623e-14
in O 0 4.1519153566593747e-13
Western O 0 3.412217453035993e-10
Europe O 0 3.156170325091523e-10
could O 0 6.654947426465441e-12
indicate O 0 3.4523306522565855e-12
a O 0 6.667322076381321e-12
high O 0 4.1430595065783393e-11
carrier O 0 6.067398645136224e-13
frequency O 0 1.4452695117073144e-11
in O 0 1.1783437723830725e-12
such O 0 6.227869782382545e-12
communities O 0 1.7260238377447834e-11
. O 0 3.397268022453659e-10

In O 0 1.49010324079768e-08
patients O 0 7.385890232747272e-10
of O 0 7.272575319738905e-10
Dutch O 0 1.641163436261195e-07
ethnic O 0 4.911078835267979e-11
origin O 0 5.1971925027483046e-12
, O 0 9.11928193549072e-13
however O 0 2.8801210548434764e-12
, O 0 5.769731480781415e-13
no O 0 7.073326299678051e-12
significant O 0 1.1423022944212491e-10
founder O 0 7.85048026585855e-09
effect O 0 7.650770683653718e-09
could O 0 6.918364492403128e-11
be O 0 7.866011661472605e-12
identified O 0 1.0006989681343725e-10
. O 0 9.006334011907313e-10

The O 0 9.89580639654264e-10
observed O 0 2.419190403557536e-10
genetic O 0 1.144005168374207e-10
heterogeneity O 0 3.9546943497725806e-10
including O 0 1.353010412041833e-11
the O 0 1.0080859758065941e-10
relative O 0 1.2331160537115693e-09
high O 0 4.3715755460027594e-09
percentage O 0 2.4249097174688927e-10
of O 0 3.424234895632594e-09
splice O 0 1.678536847293799e-07
- O 0 2.249780628460485e-08
site O 0 4.508899476007855e-09
mutations O 0 1.3416415547973237e-11
had O 0 1.722826742378558e-11
no O 0 4.843576928426074e-12
reflection O 0 1.2705872812213137e-11
on O 0 5.294994998017444e-10
the O 0 1.482170636224467e-10
phenotype O 0 1.2114631520177e-09
. O 0 7.227082265970353e-10

All O 0 1.9788148897248448e-09
patients O 0 3.8148217224032166e-11
manifested O 0 1.5107697037830548e-10
classical O 0 0.0001406158844474703
A B-Disease 1 1.0
- I-Disease 1 0.9999969005584717
T I-Disease 1 1.0
and O 0 4.696205924137331e-11
increased O 0 2.9332289375183507e-10
cellular O 0 7.581146377333425e-09
radioresistant O 0 4.1926863758590116e-08
DNA O 0 2.06013162085128e-09
synthesis O 0 1.7243473315886604e-09
. O 0 4.766707029091322e-10

Determination O 0 3.755505062486009e-08
of O 0 6.632300930675683e-09
the O 0 2.4545704357947784e-10
genomic O 0 5.190184393377706e-10
structure O 0 1.102273716746538e-09
of O 0 7.596572260126777e-10
the O 0 9.521151644875658e-10
COL4A4 O 0 7.38958817692037e-07
gene O 0 1.078958797307017e-11
and O 0 1.1686960806663732e-13
of O 0 3.861621526018988e-12
novel O 0 4.7405919467724544e-11
mutations O 0 9.563340119811414e-10
causing O 0 9.826916880228964e-08
autosomal B-Disease 1 0.9999991655349731
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.771390760855866e-07

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.834455170575012e-10
a O 0 1.3690598654747532e-09
progressive O 1 0.9999339580535889
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 1.4208245602276293e-07
by O 0 1.1515997877520334e-10
glomerular B-Disease 1 0.9998668432235718
basement I-Disease 1 1.0
membrane I-Disease 0 2.188968892369303e-06
abnormalities I-Disease 1 0.8060663342475891
and O 0 2.9352462301013293e-12
associated O 0 2.3822012071295084e-11
with O 0 1.7289882633247933e-12
mutations O 0 5.441346592055529e-12
in O 0 2.8386086883824824e-11
either O 0 9.784896504161367e-11
the O 0 2.7064430696555064e-09
COL4A3 O 0 0.0007462489884346724
or O 0 4.391076044441e-11
the O 0 3.2716979125879675e-10
COL4A4 O 0 2.673259018592944e-07
gene O 0 4.238217849589221e-12
, O 0 1.2580846195549278e-13
which O 0 2.5236962110483825e-14
encode O 0 4.1591675849911303e-13
the O 0 4.48277526210461e-11
alpha3 O 0 3.713132912253059e-08
and O 0 5.125589397358965e-10
alpha4 O 0 3.1072975161805516e-06
type O 0 5.881394827156328e-06
IV O 0 0.07243374735116959
collagen O 0 9.329470231023151e-06
chains O 0 1.5135623243622831e-06
, O 0 5.394629534749562e-11
respectively O 0 1.1258937115954382e-09
. O 0 1.5125638519464246e-09

To O 0 2.07995884404788e-10
date O 0 1.7231482019042232e-08
, O 0 1.7055570497581662e-11
mutation O 0 3.3519901264378316e-12
screening O 0 1.6388610954432004e-11
in O 0 1.3758430159049873e-12
the O 0 8.337341234065931e-12
two O 0 1.7991393964911229e-12
genes O 0 3.4119924767483933e-12
has O 0 2.5111664050253557e-12
been O 0 6.02972272806257e-12
hampered O 0 3.9474751245549555e-10
by O 0 1.8588297134164433e-12
the O 0 1.1986442394196217e-10
lack O 0 1.0368560454665499e-09
of O 0 4.730457692225798e-11
genomic O 0 1.8462639195249153e-09
structure O 0 1.0736900257768411e-09
information O 0 6.625099774337784e-11
. O 0 1.4717707053080176e-09

We O 0 2.777969188016982e-09
report O 0 1.6324592719274555e-11
here O 0 3.672184084591024e-12
the O 0 3.845627375570482e-12
complete O 0 8.185776362301667e-11
characterization O 0 1.779903481546885e-11
of O 0 2.0454157464988576e-11
the O 0 4.236377568189731e-11
48 O 0 3.3149960554368363e-10
exons O 0 2.8641073956947594e-09
of O 0 1.5482916060349794e-09
the O 0 3.863380726443211e-09
COL4A4 O 0 1.0835246030183043e-05
gene O 0 1.5993410762416005e-10
, O 0 1.422622978621002e-12
a O 0 1.4540808878152345e-12
comprehensive O 0 1.6484258402726937e-11
gene O 0 1.916788261316707e-13
screen O 0 7.69308878753594e-13
, O 0 1.284418535071885e-13
and O 0 9.32035888355151e-14
the O 0 1.766344340757564e-12
subsequent O 0 6.741412983402029e-12
detection O 0 4.4230855089644194e-11
of O 0 2.022911785998227e-12
10 O 0 2.1190878912724642e-12
novel O 0 3.405476042220995e-13
mutations O 0 4.56738596596451e-13
in O 0 5.241929936991574e-13
eight O 0 4.4913958663350684e-10
patients O 0 2.5451412088983716e-09
diagnosed O 0 2.5682136310933856e-06
with O 0 1.5544708631409776e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.471007209374875e-07

Furthermore O 0 8.93574352289761e-08
, O 0 3.9887382285996864e-10
we O 0 6.171328031934209e-11
identified O 0 9.840671333360973e-11
a O 0 1.2848051789138282e-10
glycine O 0 1.3901579887232174e-09
to O 0 1.777043963369085e-11
alanine O 0 3.739347720355113e-10
substitution O 0 9.245975651772653e-10
in O 0 2.4373449439285544e-11
the O 0 1.0265755606697624e-10
collagenous O 0 5.892649479477541e-09
domain O 0 1.4246548385443703e-11
that O 0 4.347036443373524e-14
is O 0 6.872375390119811e-14
apparently O 0 6.336084543319409e-13
silent O 0 1.717911403409378e-11
in O 0 3.0414670890328843e-13
the O 0 5.0075187052467385e-12
heterozygous O 0 5.446444944351425e-12
carriers O 0 3.6711248190685053e-13
, O 0 1.297874432709331e-13
in O 0 7.643933229439792e-12
11 O 0 1.2511696567685249e-08
. O 0 1.1689798462555245e-08

5 O 0 1.0507728909203706e-08
% O 0 5.3294417490246104e-11
of O 0 1.7660295448251873e-10
all O 0 3.668125525546628e-11
control O 0 2.4533359788136977e-09
individuals O 0 1.2506917159912923e-13
, O 0 5.044269038925742e-13
and O 0 1.751782312958694e-13
in O 0 1.4429990405698256e-12
one O 0 9.208509605881932e-13
control O 0 7.374371946422542e-11
individual O 0 3.804069689458678e-14
homozygous O 0 5.6530786995967475e-12
for O 0 1.1513899642739966e-12
this O 0 2.2389798348676493e-12
glycine O 0 2.3837216645006265e-09
substitution O 0 8.432800235880222e-09
. O 0 1.3241976404287925e-09

There O 0 2.2519948128518763e-09
has O 0 2.2398524007760656e-11
been O 0 2.9842688650111304e-12
no O 0 3.044370528240692e-12
previous O 0 9.177746757016436e-11
finding O 0 5.538973793517421e-11
of O 0 2.2074844729935705e-10
a O 0 1.7997831003313536e-10
glycine O 0 9.83178316538158e-10
substitution O 0 3.955946681344358e-10
that O 0 1.495306835167312e-13
is O 0 5.251794347170026e-14
not O 0 5.7951364213838005e-15
associated O 0 5.972987675208902e-14
with O 0 1.9556516914773572e-14
any O 0 1.1404012283111609e-11
obvious O 0 6.371454058795578e-11
phenotype O 0 1.3884023271348855e-11
in O 0 4.265464663335411e-13
homozygous O 0 3.722496755287352e-10
individuals O 0 7.270737831244212e-12
. O 0 1.7816816910709576e-09

Founder O 0 0.00014782845391891897
BRCA1 O 0 2.0729198979552166e-07
and O 0 2.454841885324299e-10
BRCA2 O 0 2.605188009763282e-10
mutations O 0 3.6926348480695315e-13
in O 0 1.3686655162079703e-13
French O 0 1.5871923775279129e-09
Canadian O 0 7.636019176970876e-07
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.273818111575565e-08
. O 0 3.3318102055091003e-08

We O 0 2.416019162509997e-09
have O 0 3.8253046563685444e-12
identified O 0 3.0143595952658586e-12
four O 0 1.2222491898791765e-12
mutations O 0 2.951975686463215e-13
in O 0 3.5621007012098804e-13
each O 0 6.225440762940362e-14
of O 0 2.37346725606713e-10
the O 0 1.1883083743668976e-06
breast B-Disease 1 0.9999774694442749
cancer I-Disease 1 0.8355871438980103
- O 0 5.134039042786753e-07
susceptibility O 0 1.8468974758434342e-06
genes O 0 2.702225943007619e-11
, O 0 1.8917933625878236e-12
BRCA1 O 0 3.481839122576602e-11
and O 0 7.975186266592771e-13
BRCA2 O 0 3.4750104269815063e-12
, O 0 3.425393827158102e-15
in O 0 2.0977877163781862e-14
French O 0 5.936246494364639e-10
Canadian O 0 9.153176883103242e-09
breast B-Disease 1 0.987589418888092
cancer I-Disease 1 0.9994511008262634
and O 0 0.0045606703497469425
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.917789343470645e-10
from O 0 1.4386199176374959e-10
Quebec O 0 2.934634437679051e-07
. O 0 1.0706537878490963e-08

To O 0 1.418379635964584e-09
identify O 0 3.3295024515211935e-09
founder O 0 8.656530781081528e-07
effects O 0 6.593375474039931e-06
, O 0 3.8829685994334895e-11
we O 0 2.099030801602786e-12
examined O 0 2.0742756470792933e-12
independently O 0 3.7465809534648065e-13
ascertained O 0 1.680227484923691e-10
French O 0 7.976278526555802e-10
Canadian O 0 6.709888200617797e-10
cancer B-Disease 0 3.1231044417268095e-09
families O 0 1.3833461726651692e-14
for O 0 7.540805002995143e-14
the O 0 8.826447060218678e-13
distribution O 0 1.1214411343996034e-11
of O 0 2.2606470514996424e-11
these O 0 2.557931731012042e-12
eight O 0 2.8202720714354257e-10
mutations O 0 2.6507451789115066e-10
. O 0 2.040920543677771e-09

Mutations O 0 4.167744815930519e-09
were O 0 2.560448242316937e-10
found O 0 2.7625467018121963e-12
in O 0 4.2471516754905014e-12
41 O 0 4.388415741907181e-10
of O 0 2.5135951098320675e-09
97 O 0 4.421523556175089e-07
families O 0 2.169980028998708e-10
. O 0 7.654960221259444e-09

Six O 0 1.388451464912066e-09
of O 0 3.827967276492927e-09
eight O 0 2.099890705764551e-09
mutations O 0 1.20220000621174e-10
were O 0 7.894843806477425e-11
observed O 0 2.101019497269263e-10
at O 0 8.717008781466973e-10
least O 0 5.993481405619505e-11
twice O 0 7.84040921075757e-09
. O 0 2.7120963252968977e-09

The O 0 2.993864995914919e-07
BRCA1 O 0 1.1094376617393209e-07
C4446T O 0 2.6201105285394988e-08
mutation O 0 1.8419683833759137e-10
was O 0 2.0559265401232096e-10
the O 0 2.181548865165528e-11
most O 0 1.2138090012270286e-12
common O 0 6.1723837846416885e-12
mutation O 0 2.119314272686079e-12
found O 0 6.415295405364299e-14
, O 0 1.3065620430735038e-14
followed O 0 6.437005334140877e-13
by O 0 2.557365994318439e-12
the O 0 7.885126440676515e-10
BRCA2 O 0 3.040986129576595e-09
8765delAG O 0 1.0369652692077125e-08
mutation O 0 3.2850935305361872e-09
. O 0 1.9307133669599352e-09

Together O 0 2.61930988010306e-09
, O 0 9.890084584629477e-11
these O 0 1.6987124597592218e-12
mutations O 0 2.2211069788946602e-12
were O 0 3.624171926105979e-12
found O 0 1.8575456927835687e-13
in O 0 4.867078419977522e-13
28 O 0 3.363367639952486e-10
of O 0 6.085859594051612e-10
41 O 0 1.2544618677168273e-09
families O 0 1.1154887777364841e-12
identified O 0 1.41735330069781e-11
to O 0 7.509952729134461e-12
have O 0 5.2408150735816506e-11
a O 0 3.8626127296659263e-10
mutation O 0 6.139306396590882e-09
. O 0 3.7168088606875926e-09

The O 0 2.4638978857183247e-08
odds O 0 7.138886104485209e-08
of O 0 3.1528610278108715e-10
detection O 0 1.5750390991442487e-09
of O 0 9.02268051938826e-11
any O 0 4.4094731338484294e-11
of O 0 7.32616300958e-10
the O 0 1.0994999355418145e-09
four O 0 3.04520991756263e-10
BRCA1 O 0 8.819123209491408e-10
mutations O 0 1.0923589116584864e-10
was O 0 5.308143258275777e-09
18 O 0 5.478723252849704e-08
. O 0 2.9434486847890184e-08

7x O 0 6.096866854932159e-05
greater O 0 1.6451084050572717e-08
if O 0 3.0897791269968167e-11
one O 0 1.5864576362670246e-12
or O 0 2.217863073099638e-13
more O 0 4.014525782522439e-15
cases O 0 6.519308747357511e-13
of O 0 9.12704399524955e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.070578458164164e-08
also O 0 4.940198640793203e-13
present O 0 1.1240612390536753e-13
in O 0 1.6118217871508023e-12
the O 0 2.689767852892544e-10
family O 0 1.8502077647752913e-10
. O 0 2.5615729537520338e-09

The O 0 6.493548454500342e-08
odds O 0 7.554100989182189e-08
of O 0 8.618591951226051e-10
detection O 0 3.4637530621495216e-09
of O 0 1.613155165003377e-10
any O 0 2.9263431955417474e-11
of O 0 3.2765690161085104e-10
the O 0 8.815104202142265e-10
four O 0 1.8512420763006077e-10
BRCA2 O 0 8.299809728384844e-10
mutations O 0 3.1340451067674024e-11
was O 0 5.511032519223136e-09
5 O 0 6.068315627771881e-08
. O 0 1.3792352149266662e-08

3x O 0 9.932231250786572e-07
greater O 0 1.6427181837030957e-09
if O 0 3.404237395449039e-12
there O 0 2.244846669663403e-12
were O 0 4.888236950634228e-12
at O 0 1.2436446837627013e-11
least O 0 1.5925261597719148e-13
five O 0 1.816510266858251e-13
cases O 0 1.776116959669588e-13
of O 0 5.299500838162885e-10
breast B-Disease 0 5.233914271229878e-05
cancer I-Disease 0 1.2923441090606502e-06
in O 0 2.313045532886804e-09
the O 0 4.9205567620447255e-08
family O 0 5.405488279208726e-10
. O 0 6.669468977094084e-09

Interestingly O 0 1.5637718897565378e-09
, O 0 1.1638478375486372e-11
the O 0 2.9332428413270106e-12
presence O 0 4.721314918881836e-12
of O 0 4.876154480193406e-10
a O 0 1.6156700155534054e-07
breast B-Disease 1 0.8952991962432861
cancer I-Disease 0 2.107534783135634e-05
case O 0 2.2160651091951422e-10
< O 0 1.4473537923720414e-09
36 O 0 7.227556660799328e-12
years O 0 7.003568189799247e-13
of O 0 2.0045074974883725e-11
age O 0 1.5744067508038917e-11
was O 0 7.597091011835033e-11
strongly O 0 1.1813315083097908e-13
predictive O 0 2.004453027171227e-12
of O 0 7.51115662722679e-12
the O 0 3.698430450782553e-12
presence O 0 7.523684366489425e-13
of O 0 2.2833315099779483e-12
any O 0 4.610811298738637e-12
of O 0 2.7267410551701232e-11
the O 0 8.262544815007544e-11
eight O 0 1.5058675140178224e-10
mutations O 0 8.473518414708892e-11
screened O 0 5.7694265365171304e-08
. O 0 9.024117453293456e-09

Carriers O 0 4.85577356101885e-10
of O 0 1.0092696678398738e-09
the O 0 1.6223410115312475e-10
same O 0 1.9173900314695125e-11
mutation O 0 2.789837588376698e-12
, O 0 4.825020184827736e-14
from O 0 1.0942167277241868e-14
different O 0 1.7181380626497995e-14
families O 0 1.4790386187383923e-14
, O 0 1.0688676912963199e-13
shared O 0 2.5073376534734404e-12
similar O 0 3.2564291974762627e-12
haplotypes O 0 3.0700643416370355e-11
, O 0 6.193478347370218e-13
indicating O 0 8.958935156233583e-12
that O 0 6.369451949379823e-14
the O 0 3.309325903588789e-12
mutant O 0 6.721835588141545e-11
alleles O 0 2.5675110908868204e-13
were O 0 1.3500090802198716e-12
likely O 0 9.587721106407363e-14
to O 0 2.583938210696645e-14
be O 0 1.1196446737414198e-13
identical O 0 7.188933693128008e-13
by O 0 1.163340664035381e-13
descent O 0 4.298691611004379e-12
for O 0 8.655496566874199e-13
a O 0 4.3299448228284465e-12
mutation O 0 5.568002114063331e-13
in O 0 5.272442638731833e-13
the O 0 2.8732311668777655e-11
founder O 0 3.1856011162290088e-09
population O 0 1.3654441292920705e-11
. O 0 7.798198753405927e-10

The O 0 1.8338224272440584e-09
identification O 0 1.895776646776426e-09
of O 0 2.1565875751861086e-09
common O 0 2.2611366112812448e-09
BRCA1 O 0 1.920869241445189e-09
and O 0 5.876290426476416e-11
BRCA2 O 0 3.627357025859368e-10
mutations O 0 2.0832838492496064e-12
will O 0 1.0248113393052788e-13
facilitate O 0 3.055812439027583e-13
carrier O 0 1.274253055502661e-13
detection O 0 5.0161988278396574e-12
in O 0 2.919809644172551e-14
French O 0 3.493828559797407e-10
Canadian O 0 1.1205619543375178e-08
breast B-Disease 1 0.996542751789093
cancer I-Disease 1 0.9996436834335327
and O 0 4.408719905768521e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.405709905900949e-09
. O 0 6.174748268250596e-09

Are O 0 1.6619047249477603e-09
Dp71 O 0 7.424739010275516e-07
and O 0 1.3195231574059108e-09
Dp140 O 0 4.5027829287391796e-07
brain O 0 2.858101311176142e-07
dystrophin O 0 2.8725121836714607e-08
isoforms O 0 7.5668950272334e-11
related O 0 4.596551438085239e-12
to O 0 1.0630838657293973e-12
cognitive B-Disease 0 0.09345607459545135
impairment I-Disease 1 0.9999908208847046
in O 0 1.0915612165263155e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 0.0006258865469135344

Molecular O 0 2.2407274258284815e-08
study O 0 5.4278220806835975e-11
and O 0 3.9394377517043555e-12
neuropsychological O 0 1.7540493502110621e-09
analysis O 0 5.785699068276695e-13
were O 0 4.0214657775691776e-13
performed O 0 2.214571191358483e-12
concurrently O 0 2.9592383231358266e-12
on O 0 1.9553860267085277e-11
49 O 0 2.2119940601417198e-10
patients O 0 2.418008328286536e-11
with O 0 4.170479961373985e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.3220880329608917
DMD B-Disease 1 1.0
) O 0 4.2714890327068267e-13
in O 0 7.883185207044341e-14
order O 0 7.856890593856136e-13
to O 0 6.26814342075642e-14
find O 0 1.284644049123762e-13
a O 0 1.3239120899826567e-13
molecular O 0 1.1533152904918964e-12
explanation O 0 3.0166803977786996e-14
for O 0 1.643156165060007e-14
the O 0 4.454646287260777e-12
cognitive B-Disease 0 1.2216764844197314e-07
impairment I-Disease 0 1.2232941770662364e-08
observed O 0 1.2752269726301613e-11
in O 0 6.7709735387944114e-12
most O 0 6.099735161413378e-10
DMD B-Disease 1 1.0
patients O 0 6.885122161293111e-08
. O 0 2.9443343319002224e-09

Complete O 0 1.5071563552737643e-08
analysis O 0 1.1711277780879215e-10
of O 0 1.4406086323859313e-09
the O 0 1.5657595220375242e-09
dystrophin O 0 3.289333605493994e-08
gene O 0 2.2184840076100443e-10
was O 0 3.7595074275920126e-10
performed O 0 7.52633302902872e-11
to O 0 1.48064893679134e-12
define O 0 5.854262907778462e-11
the O 0 4.31013835733296e-11
localization O 0 3.659561764735031e-09
of O 0 1.0661547165946583e-11
deletions O 0 1.047110054913647e-11
and O 0 1.5680585085595111e-12
duplications O 0 1.4268965176089665e-10
in O 0 3.4702544657316814e-12
relation O 0 4.660477559426113e-11
to O 0 4.1278495378771485e-12
the O 0 2.397939069531674e-10
different O 0 1.0070890787972075e-09
DMD B-Disease 1 1.0
promoters O 0 2.9942330002086237e-05
. O 0 3.39046160036105e-08

Qualitative O 0 5.065355246358649e-09
analysis O 0 5.972734112846823e-11
of O 0 8.04300903656241e-10
the O 0 1.8446905114544165e-09
Dp71 O 0 2.6574687694846943e-07
transcript O 0 5.088974130984525e-09
and O 0 1.5596121616390235e-11
testing O 0 6.175567002220106e-11
for O 0 9.206823671503717e-13
the O 0 8.001320092598796e-12
specific O 0 1.4030539967693767e-12
first O 0 1.8520074362982086e-11
exon O 0 2.9787669553194007e-10
of O 0 6.002976588037612e-11
Dp140 O 0 1.942418670353163e-09
were O 0 1.779636299437115e-10
also O 0 1.5532828495645745e-11
carried O 0 1.0295678892768834e-10
out O 0 2.255750863877637e-10
. O 0 3.644071044917041e-09

Neuropsychological O 0 3.134333383059129e-05
analysis O 0 2.06944572589407e-09
assessed O 0 6.584981893098529e-09
verbal O 0 2.1320401000224365e-09
and O 0 2.3609783572631216e-10
visuospatial O 0 3.785144713219779e-07
intelligence O 0 4.990799440385274e-10
, O 0 2.6440986553022405e-11
verbal O 0 1.431302187882011e-09
memory O 0 4.9149526603287086e-05
, O 0 1.138411170886755e-10
and O 0 1.4681222904044944e-10
reading O 0 4.5570420326157546e-08
skills O 0 3.4608422794235594e-08
. O 0 9.002147471903754e-09

Comparison O 0 1.9481214419414528e-09
of O 0 2.2719355285971687e-09
molecular O 0 5.417050807920987e-09
and O 0 5.407898434617309e-11
psychometric O 0 3.8100725419099035e-07
findings O 0 4.482877957734388e-11
demonstrated O 0 1.7242599709144102e-11
that O 0 7.584540363380493e-14
deletions O 0 2.30916718038654e-12
and O 0 2.1236760180259884e-12
duplications O 0 2.5916332968556333e-10
that O 0 2.36710282451591e-13
were O 0 3.1050728394738103e-12
localized O 0 4.718114787749528e-10
in O 0 2.644501978510405e-11
the O 0 1.0818587692362769e-10
distal O 0 5.4842252267262026e-11
part O 0 1.3713426227912606e-11
of O 0 4.233697836752981e-10
the O 0 3.3060548743080176e-10
gene O 0 1.1428624019371725e-10
seemed O 0 2.0259941294065165e-11
to O 0 7.878165350985733e-14
be O 0 1.2851048350470684e-13
preferentially O 0 4.2011129275897063e-13
associated O 0 3.6044492043862952e-12
with O 0 2.4648106472513476e-11
cognitive B-Disease 1 0.9997311234474182
impairment I-Disease 1 0.9997376799583435
. O 0 1.560233364727992e-08

Two O 0 9.144224932811085e-09
altered O 0 1.568965224407748e-08
Dp71 O 0 2.0009242973628716e-07
transcripts O 0 2.214688654689212e-09
and O 0 2.5248313856307547e-11
two O 0 7.469610867338883e-12
deleted O 0 9.084084873212106e-11
Dp140 O 0 4.004808151769623e-10
DNA O 0 1.5319894658416544e-11
sequences O 0 4.033087882757136e-13
were O 0 2.523331478661295e-13
found O 0 1.676667329552229e-14
in O 0 4.652920708230965e-14
four O 0 1.0444650352936513e-11
patients O 0 1.568017417297174e-11
with O 0 7.500480792010933e-11
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
. O 0 2.333999837844658e-08

These O 0 1.3848518998216264e-09
findings O 0 1.4648972312958364e-10
suggest O 0 4.829094155806013e-12
that O 0 4.3039211111055645e-14
some O 0 2.007890923839961e-14
sequences O 0 1.1110035824267103e-13
located O 0 3.121444075437907e-12
in O 0 1.3583519075169304e-12
the O 0 2.0818867463301416e-11
distal O 0 2.8625534234660854e-11
part O 0 7.737121707207528e-12
of O 0 1.5768297778606666e-10
the O 0 9.026863978522925e-11
gene O 0 2.004483601672491e-12
and O 0 4.0361350329629064e-13
, O 0 6.556891531464548e-14
in O 0 1.7469107215471735e-13
particular O 0 2.6007323464943832e-12
, O 0 1.1767355753006248e-12
some O 0 4.587643633036098e-12
DMD B-Disease 1 1.0
isoforms O 0 7.174831562206663e-11
expressed O 0 6.662322603323556e-13
in O 0 1.505406476559612e-12
the O 0 1.1044175990404526e-10
brain O 0 6.333463531404959e-09
may O 0 1.3966033191037397e-12
be O 0 2.6262415771813666e-14
related O 0 3.1868937014085247e-14
to O 0 1.3805258070606966e-14
the O 0 1.2766505734507216e-11
cognitive B-Disease 0 0.0022569249849766493
impairment I-Disease 0 1.5407484852403286e-06
associated O 0 8.205863766264088e-11
with O 0 6.295687582369425e-11
DMD B-Disease 1 1.0
. O 0 1.0365357461239455e-09
. O 0 2.5764002042905076e-09

I1307K O 0 9.64597893471364e-06
APC O 0 4.196959366709052e-07
and O 0 1.4245171708893167e-10
hMLH1 O 0 1.163303675610905e-08
mutations O 0 2.7960024920337112e-11
in O 0 5.400886335382715e-12
a O 0 2.1175615080859522e-11
non O 0 5.800351310369933e-09
- O 0 8.604937595801943e-11
Jewish O 0 1.5147456899899936e-10
family O 0 6.659616976802119e-13
with O 0 3.2953553080750098e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3524160067390767e-06

We O 0 1.104527691531132e-09
describe O 0 8.276439950050118e-11
a O 0 6.819239183747383e-12
French O 0 9.774455689282036e-10
Canadian O 0 3.788901636880837e-09
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.075337673408285e-08
HNPCC B-Disease 0 0.0011363967787474394
) O 0 1.026439458602646e-12
kindred O 0 2.56041410295893e-10
which O 0 4.1847661403845993e-13
carries O 0 2.5912635210310897e-13
a O 0 8.015782048537146e-13
novel O 0 2.966052967470767e-12
truncating O 0 9.121331467909499e-10
mutation O 0 1.2665053901461665e-11
in O 0 1.1801864173432985e-11
hMLH1 O 0 3.473857645985845e-08
. O 0 7.754921149683014e-09

Interestingly O 0 2.8051876377332974e-09
, O 0 2.526608956776588e-11
the O 0 1.302558616522731e-10
I1307K O 0 1.1297836444157383e-08
APC O 0 2.5630537692222788e-09
polymorphism O 0 8.778053284252962e-11
, O 0 1.2524749575144878e-13
associated O 0 1.2287326917655855e-13
with O 0 4.2822851791272584e-15
an O 0 3.9507789299450275e-15
increased O 0 1.0539788659891247e-11
risk O 0 8.221397784780038e-09
of O 1 0.5518554449081421
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 9.23555953935562e-10
is O 0 1.1795759681521023e-12
also O 0 1.6762716974032255e-13
present O 0 1.8100253826140722e-13
in O 0 1.6035456382873514e-12
this O 0 5.367387957699865e-12
family O 0 7.370645760396144e-11
. O 0 1.7175461053398067e-09

The O 0 1.7744218538950918e-08
I1307K O 0 7.282409342224128e-08
polymorphism O 0 5.201524100328925e-09
has O 0 3.6764747496365047e-11
previously O 0 7.67492319697638e-11
only O 0 7.803156449985582e-13
been O 0 1.0387031946362812e-12
identified O 0 5.185505887531083e-13
in O 0 8.587626595078779e-14
individuals O 0 4.792237976889921e-15
of O 0 4.9477096031314005e-11
self O 0 1.8416258740217017e-08
- O 0 5.678374215278836e-09
reported O 0 1.3659352537942482e-09
Ashkenazi O 0 4.669272968271798e-09
Jewish O 0 7.189383532946181e-10
origins O 0 1.583676478844609e-08
. O 0 2.401704080057243e-08

In O 0 6.87703116675209e-10
addition O 0 4.706284667532756e-11
, O 0 2.538228958612332e-12
in O 0 3.361158140008369e-12
this O 0 2.5585954795820376e-12
family O 0 2.9944235025586297e-12
, O 0 1.973090961449042e-12
there O 0 1.5070217643242678e-11
appears O 0 9.705597436848734e-12
to O 0 1.5109402173429237e-13
be O 0 2.1110425961565898e-13
no O 0 4.046301867784846e-13
relationship O 0 3.508190027202789e-15
between O 0 2.2184299753105763e-13
the O 0 4.0075013620077815e-12
I1307K O 0 3.896998695962495e-11
polymorphism O 0 4.254213301080334e-12
and O 0 3.4709545350744553e-13
the O 0 4.530876108327364e-12
presence O 0 8.05174937140718e-12
or O 0 5.629803914719567e-12
absence O 0 2.844334767715395e-09
of O 0 3.0201308121036163e-09
cancer B-Disease 0 1.1754687534448749e-07
. O 0 1.6488764520428134e-10
. O 0 3.106825019472126e-09

Identification O 0 1.5421266041926174e-08
of O 0 1.5426847577160174e-09
a O 0 3.070316223485747e-11
novel O 0 8.517393387807992e-12
mutation O 0 2.4208406546738503e-12
of O 0 3.290972702685302e-11
the O 0 9.887693996901703e-10
CPO O 0 1.5898609490250237e-05
gene O 0 4.1293322927682397e-11
in O 0 6.3052137296015776e-12
a O 0 1.753526490677615e-10
Japanese O 0 1.9776619808453688e-07
hereditary B-Disease 1 0.9999817609786987
coproporphyria I-Disease 1 0.999769389629364
family O 0 2.0752413121272184e-08
. O 0 6.019656240141558e-08

Hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.9999961853027344
( O 0 5.7322372413182165e-06
HCP B-Disease 1 0.9999997615814209
) O 0 2.5692085611761506e-11
is O 0 8.213339947396592e-13
an O 0 1.894909793312416e-12
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 3.0837239428649355e-09
by O 0 1.5249569185540879e-12
a O 0 2.6729418678428374e-10
deficiency B-Disease 0 2.0891320673399605e-07
of I-Disease 0 5.8393613500129504e-08
coproporphyrinogen I-Disease 0 0.03792194649577141
oxidase I-Disease 0 8.106713522693099e-09
( O 0 2.2519742147453226e-12
CPO O 0 6.775212114007445e-06
) O 0 2.681075440868e-14
caused O 0 7.616699697170215e-13
by O 0 6.832277528023151e-14
a O 0 1.8328687092367124e-12
mutation O 0 1.3905005619152533e-12
in O 0 2.6577895700236054e-12
the O 0 5.916171441633367e-10
CPO O 0 5.666120341629721e-05
gene O 0 5.353246290695779e-09
. O 0 2.1206760791869783e-09

Only O 0 1.7965806620168223e-09
11 O 0 3.4119977954105707e-09
mutations O 0 2.0962231950250043e-11
of O 0 2.6733701363745865e-10
the O 0 2.626998618637799e-10
gene O 0 3.296362835469857e-11
have O 0 4.1832100392165394e-13
been O 0 6.991649555317114e-13
reported O 0 6.6659490427500856e-12
in O 0 1.6798525070971237e-10
HCP B-Disease 1 0.9999996423721313
patients O 0 2.3138586158211183e-08
. O 0 8.14841349949802e-09

We O 0 3.1336837569284626e-09
report O 0 3.538289453097754e-11
another O 0 5.474596904281315e-12
mutation O 0 1.1263501416280963e-11
in O 0 9.734760740565118e-12
a O 0 3.375243695646901e-10
Japanese O 0 1.1568531022021489e-07
family O 0 1.1126853882714727e-09
. O 0 1.1120028453603936e-08

Polymerase O 0 1.8628725229064003e-08
chain O 0 7.884051456130692e-08
reaction O 0 3.208282806088647e-10
- O 0 3.755336597244252e-10
single O 0 1.3324920333790402e-10
strand O 0 5.156356591706768e-11
conformational O 0 6.46248592833798e-12
polymorphism O 0 1.1315562202518503e-12
and O 0 1.9746172673861494e-14
direct O 0 8.776432271900836e-14
sequence O 0 1.3648647099670508e-13
analyses O 0 4.3151352174634894e-13
demonstrated O 0 3.102876462712789e-12
a O 0 3.5389759699133716e-12
C O 0 5.611734410493341e-10
to O 0 1.2133952696780081e-11
T O 0 6.443734990035921e-10
substitution O 0 1.1539759599277222e-11
in O 0 6.475315075804566e-13
exon O 0 1.6690185691836668e-11
1 O 0 6.351333955295635e-12
of O 0 2.071729289856994e-12
the O 0 2.2489791279278748e-11
CPO O 0 7.690496772738697e-08
gene O 0 5.203064541714486e-12
at O 0 3.757506111812248e-11
nucleotide O 0 6.28424187687493e-11
position O 0 1.7144555219950064e-10
85 O 0 2.4247712171465707e-10
, O 0 3.2612400193560154e-12
which O 0 4.813018473354136e-13
lies O 0 1.1777601463536236e-11
in O 0 2.609318143498296e-12
the O 0 9.939327139107945e-11
putative O 0 2.217520611580426e-09
presequence O 0 5.670138136792957e-09
for O 0 4.785999721534928e-11
targeting O 0 5.777029965514657e-10
to O 0 4.822377566715552e-11
mitochondria O 0 4.07008826641686e-09
. O 0 4.381459639546392e-09

This O 0 3.7290042581572536e-11
mutation O 0 2.06068374170032e-11
changes O 0 7.902976016660457e-12
the O 0 1.6502410549179558e-11
codon O 0 4.005562201370161e-11
for O 0 3.2922896180120897e-12
glutamine O 0 1.4757944866161665e-11
to O 0 9.74175818138634e-13
a O 0 3.1771574954264636e-11
termination O 0 6.501238436484869e-10
codon O 0 1.8928210110402688e-09
at O 0 7.567133586405816e-09
amino O 0 6.358203741285706e-09
acid O 0 5.357246868342713e-10
position O 0 1.2675313021404122e-09
29 O 0 7.016127057113408e-08
. O 0 7.915871513830552e-09

MaeI O 0 4.23317942477297e-06
restriction O 0 4.3092880375183995e-09
analysis O 0 2.2738580116032914e-11
showed O 0 7.442068489238451e-11
two O 0 8.947727541536166e-13
other O 0 7.112894800063996e-13
carriers O 0 1.067794398908195e-12
in O 0 3.764246726822851e-12
the O 0 7.913935062831001e-10
family O 0 4.74026873309441e-10
. O 0 5.064930252984823e-09

The O 0 2.802376457111677e-06
C O 1 0.9994169473648071
- O 0 0.27518534660339355
T O 0 2.3463919660571264e-06
mutation O 0 3.9706703203190585e-11
is O 0 4.599116158981835e-14
located O 0 1.8837986997134043e-13
within O 0 1.2053988991851672e-13
a O 0 4.2966563466861896e-13
recently O 0 3.402231621429941e-12
proposed O 0 1.401598889033684e-12
putative O 0 5.530082902022171e-12
alternative O 0 2.3074339314255177e-11
translation O 0 1.4277287685438012e-11
initiation O 0 2.5232812367326218e-11
codon O 0 6.707632366209637e-11
( O 0 1.195384936869548e-12
TIC O 0 2.3735396981194867e-10
- O 0 2.3502674806330504e-10
1 O 0 4.533681763341235e-10
) O 0 6.493517203977339e-14
, O 0 1.1080788793037949e-13
supporting O 0 1.1380235946309436e-12
that O 0 8.141717551882199e-13
TIC O 0 4.212073800857752e-09
- O 0 3.499779799298608e-09
1 O 0 1.3651752617249713e-08
is O 0 3.2646569909228207e-12
the O 0 3.803422854442573e-11
real O 0 1.4603124043333082e-08
TIC O 0 2.2257761855826175e-08
rather O 0 3.8506791505410476e-11
than O 0 9.993913249045638e-13
TIC O 0 1.1038833180876395e-09
- O 0 5.619424925384919e-10
2 O 0 1.6055281548688072e-09
. O 0 2.9323942579706497e-11
. O 0 2.889703754060946e-10

Human B-Disease 0 4.9506785337882775e-09
complement I-Disease 0 3.239002843713479e-09
factor I-Disease 0 3.9119294115153025e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.9998437166213989
associated O 0 1.8425042824787852e-08
with O 0 1.5159616850723978e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.125932794820983e-05

This O 0 4.934929548339184e-11
study O 0 4.353596042699914e-12
reports O 0 2.6920438534611124e-12
on O 0 7.191436335318713e-11
six O 0 6.987773640970696e-12
cases O 0 1.6185500205725956e-12
of O 0 6.901550997362449e-10
deficiency B-Disease 0 1.3634682716201496e-08
in I-Disease 0 1.0861551935636982e-10
the I-Disease 0 1.8625437303576575e-10
human I-Disease 0 3.07204400806782e-11
complement I-Disease 0 6.60347341044365e-12
regulatory I-Disease 0 1.7245767314211236e-10
protein I-Disease 0 4.3644646924301256e-11
Factor I-Disease 0 1.261481891168259e-10
H I-Disease 1 0.9999426603317261
( O 0 6.439829680800202e-13
FH O 0 3.2901584234856784e-10
) O 0 4.164821296979992e-16
in O 0 4.899652024876252e-16
the O 0 1.3160411887862267e-14
context O 0 7.716421360388914e-14
of O 0 9.055445737878032e-13
an O 0 1.5087013235937086e-11
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.512148959496699e-07

Five O 0 4.056100344485003e-09
of O 0 1.2465194432209614e-09
the O 0 9.22488613275263e-11
cases O 0 6.141425258968103e-13
were O 0 3.4183352220877594e-13
observed O 0 3.831012655546029e-13
in O 0 7.113583268443524e-14
children O 0 3.946638548195554e-14
presenting O 0 2.2742916924722856e-11
with O 0 1.5731947689001657e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.656003774376586e-05
HUS B-Disease 1 1.0
) O 0 5.768029609498626e-08
. O 0 1.6879131692348892e-07

Two O 0 9.313656096354705e-11
of O 0 2.500901707946923e-10
the O 0 1.1648655651175233e-10
children O 0 1.4031984124987518e-12
exhibited O 0 6.035758004507841e-10
a O 0 2.1031856256570336e-09
homozygous O 0 0.024510884657502174
deficiency O 1 0.7214744687080383
characterized O 0 1.7124228424147958e-10
by O 0 8.980469905044142e-13
the O 0 6.520409906451974e-11
absence O 0 3.948785187724013e-10
of O 0 1.3596959669293085e-10
the O 0 3.441458229502814e-11
150 O 0 3.3543692996851338e-12
- O 0 3.1326571111461865e-12
kD O 0 6.756270543029075e-11
form O 0 7.1846604186853735e-12
of O 0 6.748726577576747e-10
Factor O 0 4.2383372367282846e-09
H O 1 1.0
and O 0 2.42670362970987e-11
the O 0 3.2865567906048554e-11
presence O 0 4.617050665400857e-12
, O 0 1.9488681772972943e-13
upon O 0 1.4951279147037977e-12
immunoblotting O 0 5.428114624450586e-10
, O 0 9.111806361511432e-13
of O 0 1.9658793690147114e-11
the O 0 1.789261655504859e-10
42 O 0 4.2899564456355677e-10
- O 0 5.309943040820997e-10
kD O 0 3.8609644370524165e-09
Factor O 0 3.211872323660714e-09
H O 1 0.9999344348907471
- O 0 5.841809258555486e-09
like O 0 1.9110744930994628e-10
protein O 0 4.5202636078656155e-10
1 O 0 8.680727248133735e-09
( O 0 3.214232916284865e-12
FHL O 0 1.4681545756900505e-08
- O 0 1.579357478131982e-11
1 O 0 5.864656676957125e-11
) O 0 1.659714642739292e-14
and O 0 1.0984706118885926e-13
other O 0 6.671160477332572e-13
FH O 0 8.311825183682231e-08
- O 0 7.832420129139095e-11
related O 0 1.1686755729822806e-10
protein O 0 7.194318057957005e-11
( O 0 3.003845002597094e-12
FHR O 0 2.0983289061859978e-07
) O 0 3.736691945449566e-12
bands O 0 6.73209399337793e-09
. O 0 1.1644574193780954e-09

Southern O 0 1.8800417223019394e-08
blot O 0 2.3092908918442845e-08
and O 0 6.374031163991489e-11
PCR O 0 2.9577346127851456e-10
analysis O 0 7.60846626587236e-13
of O 0 6.64878178555095e-12
DNA O 0 1.9000100104360484e-11
of O 0 1.807277938414842e-11
one O 0 1.8910574061531404e-12
patient O 0 1.6815122211299993e-11
with O 0 1.2872200050653704e-12
homozygous O 0 8.69300663453032e-07
deficiency O 0 2.3144220904214308e-05
ruled O 0 1.760767531777674e-08
out O 0 2.7936290433738797e-12
the O 0 2.93260489676872e-12
presence O 0 8.414884457644267e-13
of O 0 5.793344103055542e-12
a O 0 1.625839762299519e-12
large O 0 7.541212663011998e-13
deletion O 0 2.6366638906927253e-12
of O 0 4.117959445659736e-11
the O 0 1.1079205330943864e-09
FH O 0 1.2507650808402104e-06
gene O 0 2.056180399556684e-11
as O 0 1.808932344193881e-12
the O 0 1.757738225804939e-11
underlying O 0 2.4645987650728785e-07
defect O 0 1.6901634580790414e-07
for O 0 1.9702385556374935e-10
the O 0 5.045764055466861e-07
deficiency O 1 0.9997166991233826
. O 0 2.4433256839984097e-07

The O 0 9.778133858162619e-09
other O 0 2.992603734264243e-11
four O 0 1.4518008323305409e-11
children O 0 3.342998620980975e-13
presented O 0 5.370667452431199e-11
with O 0 3.8417585085381845e-11
heterozygous O 0 8.120612164930208e-07
deficiency O 0 3.341800947964657e-06
and O 0 2.4529498224290514e-11
exhibited O 0 1.0073085476847154e-08
a O 0 2.5775934164862235e-10
normal O 0 5.54925794205019e-09
immunoblotting O 0 1.6877031328021985e-08
pattern O 0 2.8614197122855956e-10
of O 0 4.4541127730557406e-11
proteins O 0 5.332863057400106e-13
of O 0 4.350659763008302e-11
the O 0 2.551946431950114e-09
FH O 0 1.8481185179552995e-05
family O 0 3.55651924577316e-10
. O 0 4.426583988248467e-09

Factor B-Disease 0 0.05763213708996773
H I-Disease 1 1.0
deficiency I-Disease 1 0.9984502792358398
is O 0 2.800587366180718e-11
the O 0 1.11418423098808e-10
only O 0 1.9895013414483742e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.7204143644185024e-08
with O 0 8.010353491627598e-10
HUS B-Disease 1 1.0
. O 0 8.095406656138948e-08

These O 0 1.0830438629261252e-10
observations O 0 1.8066446949571713e-10
suggest O 0 4.7587010720828715e-11
a O 0 7.039745522630092e-12
role O 0 9.202474719749443e-12
for O 0 1.7484826086988647e-11
FH O 0 3.248331381655589e-07
and O 0 6.005702879452457e-11
/ O 0 2.800612897146948e-08
or O 0 4.2963763102754626e-10
FH O 0 1.085739995687618e-06
receptors O 0 4.38337517325027e-12
in O 0 4.4611224978875763e-13
the O 0 1.2595625931144383e-11
pathogenesis O 0 1.7427693421723234e-07
of O 0 1.130841642549285e-09
idiopathic O 1 0.9999905824661255
HUS B-Disease 1 1.0
. O 0 8.841072762777458e-09
. O 0 1.4026956485224673e-08

Further O 0 2.35256814029583e-10
evidence O 0 6.236336447251745e-11
for O 0 2.173822103226919e-12
a O 0 2.484524955562173e-12
major O 0 9.652876414856237e-11
ancient O 0 8.215483293660952e-10
mutation O 0 9.89222712632909e-07
underlying O 1 0.9999806880950928
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.616841743297016e-10
linkage O 0 1.3682460497932425e-08
disequilibrium O 0 8.470909307334296e-09
studies O 0 5.403089000516337e-13
in O 0 1.6865340775416154e-13
the O 0 2.992647796240533e-12
Japanese O 0 4.47409054249448e-10
population O 0 5.932618545728685e-12
. O 0 5.433770655649539e-10

The O 1 0.8792921304702759
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999970197677612
DM B-Disease 1 1.0
) O 0 1.0608083161889326e-10
mutation O 0 1.1518693984746697e-11
is O 0 6.907752907008013e-14
an O 0 3.1861398420854684e-14
unstable O 0 1.8012563662850312e-10
( O 0 3.900008354457141e-12
CTG O 0 2.0067528794243117e-07
) O 0 2.074717622094907e-13
n O 0 3.4863046477484616e-11
repeat O 0 1.712559954958337e-10
, O 0 1.737271351082148e-13
present O 0 1.6924149256504484e-13
at O 0 3.840569789276271e-12
a O 0 1.6056410758261142e-13
copy O 0 1.840105325057184e-12
number O 0 9.854936961969929e-13
of O 0 5.747942052880539e-12
5 O 0 1.6385680312591688e-10
- O 0 9.623939839498163e-11
37 O 0 1.2095693890934456e-10
repeats O 0 2.1640693403934819e-10
on O 0 8.618624702805278e-10
normal O 0 5.639253647382603e-11
chromosomes O 0 1.7353813698550713e-12
but O 0 3.526804499484615e-13
amplified O 0 1.9320153116231253e-11
to O 0 1.638078886943839e-12
50 O 0 4.80948093850575e-11
- O 0 4.084931351511223e-11
3000 O 0 5.077712902923359e-11
copies O 0 2.490800066201615e-10
on O 0 3.518871238838983e-08
DM B-Disease 1 0.9994269609451294
chromosomes O 0 2.3810000637780604e-09
. O 0 3.570549633735709e-09

Previous O 0 3.120962333014177e-08
findings O 0 5.435457639535457e-11
in O 0 9.940175418887698e-12
Caucasian O 0 2.644846563981673e-10
populations O 0 9.108874245156162e-12
of O 0 1.4691230454388915e-09
a O 0 1.6427916307293344e-06
DM B-Disease 1 1.0
founder O 1 0.7793962359428406
chromosome O 0 8.104682365228655e-07
raise O 0 8.146653907026291e-10
a O 0 3.602162318427915e-11
question O 0 2.662152833246556e-12
about O 0 5.1033349672080595e-15
the O 0 4.920750764324244e-13
molecular O 0 2.0994152596931492e-12
events O 0 2.987143139180498e-13
involved O 0 8.000732373706146e-14
in O 0 2.5590236852300607e-13
the O 0 1.820584134837322e-11
expansion O 0 3.7575671463230265e-09
mutation O 0 8.091879388771872e-10
. O 0 9.176508997121857e-10

To O 0 4.241003936922283e-10
investigate O 0 2.5195459607552095e-10
whether O 0 2.965511516905828e-11
a O 0 1.7662081519542738e-10
founder O 0 6.043606504135823e-09
chromosome O 0 6.053467171973637e-10
for O 0 1.5059019309315858e-10
the O 0 2.1220209589500882e-07
DM B-Disease 1 1.0
mutation O 0 7.2293115938038e-11
exists O 0 9.05789874529328e-13
in O 0 1.0058622635982992e-13
the O 0 7.515193979276691e-13
Japanese O 0 5.469892247478292e-11
population O 0 2.1198940904553973e-14
, O 0 3.5854332740628547e-13
we O 0 1.3386764786960104e-11
genotyped O 0 4.244550488863297e-09
families O 0 1.7110880041418947e-13
using O 0 1.091920282490777e-12
polymorphic O 0 2.160859512156943e-11
markers O 0 1.8091195208569388e-11
near O 0 1.615246603137166e-09
the O 0 9.542309303833818e-11
( O 0 5.083621024137841e-12
CTG O 0 2.9424494840668558e-08
) O 0 3.9351253375632944e-13
n O 0 7.214848163350496e-11
repeat O 0 4.121293029069051e-10
region O 0 2.1440199615696542e-10
and O 0 3.2517134818110804e-11
constructed O 0 9.006338785866319e-09
haplotypes O 0 3.157353845040234e-08
. O 0 6.915944261720597e-09

Six O 0 4.838450085031809e-09
different O 0 1.0544976350446156e-11
haplotypes O 0 3.028425510365196e-09
were O 0 3.318399721674581e-10
found O 0 5.094631660984561e-11
and O 0 7.676361768460538e-10
DM B-Disease 1 1.0
alleles O 0 3.8642483657369553e-10
were O 0 3.654189173474265e-10
always O 0 1.60532517834433e-10
haplotype O 0 1.9154883901251196e-08
A O 0 1.1045582226643091e-07
. O 0 5.592002416676678e-09

To O 0 2.8785751560178596e-10
find O 0 6.390120203814131e-12
an O 0 9.204075998266777e-15
origin O 0 1.357304974794124e-13
of O 0 4.971232626937994e-12
the O 0 4.90331039659786e-11
( O 0 4.558841151802717e-12
CTG O 0 3.313564178597517e-08
) O 0 4.431119371168385e-13
n O 0 1.4868369035969664e-10
repeat O 0 1.2541030436352685e-09
mutation O 0 1.3686825978131978e-11
and O 0 2.6195790870688074e-13
to O 0 1.1466795937255247e-13
investigate O 0 2.01607849338592e-12
the O 0 3.904771905122173e-12
mechanism O 0 1.8691442491003407e-11
of O 0 3.927718827262394e-12
the O 0 1.7354441451608582e-12
expansion O 0 8.832396619640193e-12
mutation O 0 9.541603211747976e-14
in O 0 7.196282822028929e-14
the O 0 8.497689856466761e-13
Japanese O 0 4.2454290083426827e-11
population O 0 1.867755251947368e-14
we O 0 3.461586215152551e-13
have O 0 1.1821521138290908e-13
studied O 0 1.7385691844507e-11
90 O 0 1.2893965894988924e-09
Japanese O 0 2.6586525336824707e-07
DM B-Disease 1 1.0
families O 0 7.54012303982865e-12
comprising O 0 1.1524808884999516e-10
190 O 0 2.907389606843225e-10
affected O 0 1.220957224212782e-10
and O 0 5.4252238118612794e-11
130 O 0 3.220816946480909e-09
unaffected O 0 8.383191811844881e-07
members O 0 1.3675123256007282e-09
. O 0 8.150186303623741e-09

The O 0 6.047275036280553e-08
results O 0 3.4883369526284014e-09
suggest O 0 6.229037424754225e-11
that O 0 5.862983709636893e-13
a O 0 1.74979718214896e-11
few O 0 5.379974243879815e-12
common O 0 7.0991689089805465e-12
ancestral O 0 1.998689408422294e-11
mutations O 0 1.807344963793145e-13
in O 0 1.0086556427330723e-13
both O 0 3.5680369791547817e-13
Caucasian O 0 4.0473326079482064e-11
and O 0 1.3474322352324819e-11
Japanese O 0 6.507395511334835e-09
populations O 0 4.742877531688228e-12
have O 0 3.6098050546981564e-14
originated O 0 2.8408143350720783e-14
by O 0 8.432903321768572e-15
expansion O 0 4.894338406780108e-12
of O 0 1.3844351012815004e-12
an O 0 9.397061443870355e-14
ancestral O 0 8.925914694868364e-12
n O 0 6.281653669448772e-11
= O 0 1.0884904089181191e-10
5 O 0 1.6281254122674227e-10
repeat O 0 1.4260530256660076e-10
to O 0 4.127456189328971e-12
n O 0 2.391617459629458e-10
= O 0 2.3261489956460935e-10
19 O 0 7.991902695181352e-10
- O 0 1.8471893459270916e-10
37 O 0 2.8082164371667773e-10
copies O 0 4.837026890136542e-10
. O 0 9.247633769859931e-10

These O 0 7.718626432451359e-11
data O 0 4.011196930164829e-11
support O 0 4.4505015991958e-12
multistep O 0 2.5218918620062425e-10
models O 0 7.417792768915632e-11
of O 0 5.673639891234927e-10
triplet O 0 7.172515381625999e-08
repeat O 0 5.258573576583103e-09
expansion O 0 2.070143362287169e-10
that O 0 1.60492170768467e-13
have O 0 3.202449969704618e-14
been O 0 2.4667774604653775e-14
proposed O 0 5.872942242116444e-14
for O 0 8.446428913276918e-14
both O 0 6.705201671675098e-11
DM B-Disease 1 1.0
and O 0 5.3587418946676735e-09
Friedreichs B-Disease 0 0.07905097305774689
ataxia I-Disease 1 0.9999996423721313
. O 0 3.539172155342385e-08
. O 0 2.119835862401942e-08

The O 0 2.2023788348590756e-10
molecular O 0 2.3589888376029933e-10
basis O 0 1.117291814622945e-09
of O 0 8.639345651317853e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.909854744994391e-10
the O 0 9.148280744053494e-11
western O 0 1.223313950138305e-10
Cape O 0 1.833549645446908e-09
, O 0 2.754790753151104e-12
South O 0 3.7062869440163126e-10
Africa O 0 7.775756150074642e-10
. O 0 8.859079581036156e-10

Deficiency B-Disease 0 5.280649565975182e-05
of I-Disease 0 6.442364792746957e-07
the I-Disease 0 3.974351514557384e-08
sixth I-Disease 0 2.67989065605434e-07
component I-Disease 0 2.7001163527273775e-09
of I-Disease 0 1.1144292155762514e-09
human I-Disease 0 3.159145445241762e-10
complement I-Disease 0 9.010590190650092e-11
( O 0 1.6844591693709887e-11
C6 O 0 4.2324344917687995e-07
) O 0 1.6043859762861906e-13
has O 0 5.4232192467276036e-14
been O 0 2.2371761358047117e-14
reported O 0 2.7741601266065112e-14
in O 0 8.33110097293692e-14
a O 0 5.454093123316572e-13
number O 0 1.4487738266011352e-12
of O 0 1.275672102674097e-11
families O 0 1.0021122285122381e-14
from O 0 7.087499397052596e-14
the O 0 1.704327824703089e-11
western O 0 1.9691565045221182e-10
Cape O 0 6.128448859499258e-09
, O 0 1.0579183362668942e-11
South O 0 1.4148049398698959e-09
Africa O 0 2.180319702560496e-09
. O 0 1.5588940138755447e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.999958872795105
is O 0 1.2439957050580652e-11
endemic O 0 2.4043357582659297e-11
in O 0 1.7378821905861264e-12
the O 0 8.155869729575826e-11
Cape O 0 2.7208317820992534e-09
and O 0 2.2312028255793565e-13
almost O 0 1.3108961073766967e-13
all O 0 9.530580941411945e-14
pedigrees O 0 8.05946281934311e-12
of O 0 4.0922695787593e-11
total O 0 2.3661546322273352e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.772091805576139e-10
C6Q0 O 0 1.430070278729545e-05
) O 0 4.4396468923055266e-13
have O 0 9.251497137818809e-14
been O 0 1.0544764659971978e-13
ascertained O 0 2.4348544014340945e-11
because O 0 2.3515729836477706e-13
of O 0 3.046021768149387e-11
recurrent O 1 0.9999483823776245
disease O 1 0.999853253364563
. O 0 1.375438962725184e-08

We O 0 1.6777400579925938e-09
have O 0 2.6891392758410237e-12
sequenced O 0 3.381892335618808e-11
the O 0 7.529832660169156e-12
expressed O 0 4.56496689407726e-12
exons O 0 2.708632651504672e-09
of O 0 1.2321004216886422e-09
the O 0 4.112421958524237e-09
C6 O 0 2.4276532712974586e-06
gene O 0 3.253127975333392e-11
from O 0 8.234264507224476e-13
selected O 0 3.2125903499935493e-12
cases O 0 4.347519523204002e-13
and O 0 7.943472810946484e-13
have O 0 4.548173903468067e-13
found O 0 3.3530564934845797e-13
three O 0 4.611565578190036e-13
molecular O 0 1.800679996222243e-07
defects O 0 5.017074727220461e-05
leading O 0 2.144119326530358e-09
to O 0 9.315622925831768e-12
total O 0 7.015324143821999e-08
deficiency O 0 0.0030977230053395033
879delG O 0 9.199120540870354e-07
, O 0 6.6112740282342486e-12
which O 0 1.252121372080986e-13
is O 0 3.674870737574443e-14
the O 0 1.1044501901577575e-12
common O 0 1.1299133503839265e-11
defect O 0 9.624985530809482e-11
in O 0 1.3192142690743314e-12
the O 0 6.799474872032363e-11
Cape O 0 2.538552479336431e-09
and O 0 1.3509726106905595e-12
hitherto O 0 8.783010430057914e-11
unreported O 0 2.5706889741905492e-11
, O 0 5.448749090808391e-13
and O 0 6.285398091755712e-13
1195delC O 0 4.0883704754968164e-10
and O 0 1.3199246383377439e-11
1936delG O 0 1.916426572989849e-09
, O 0 2.653787996645396e-12
which O 0 1.1336878701431741e-13
have O 0 6.554415484753134e-14
been O 0 9.797525068805032e-14
previously O 0 6.738901971170552e-13
reported O 0 2.3738167464690263e-13
in O 0 1.59501968924336e-12
African O 0 4.702070399709157e-10
- O 0 2.560464062995038e-09
Americans O 0 7.357839337807093e-10
. O 0 8.047954302980997e-09

We O 0 3.5546763310634333e-09
also O 0 1.5614873977165544e-11
show O 0 1.8176557481375255e-11
that O 0 2.5907298225116837e-13
the O 0 1.0546103053343803e-11
879delG O 0 9.65376445449806e-10
and O 0 2.94791656363369e-11
1195delC O 0 8.207994710573985e-07
defects O 0 0.00034147987025789917
are O 0 3.5677919494638e-13
associated O 0 1.6719212819760187e-11
with O 0 2.328389564487665e-11
characteristic O 1 0.9983478784561157
C6 O 1 1.0
/ O 1 0.9944905042648315
C7 O 0 0.030159348621964455
region O 0 2.1732544652763863e-08
DNA O 0 4.0588861160983924e-09
marker O 0 1.150188833065613e-09
haplotypes O 0 6.887371922781327e-11
, O 0 7.879101017460588e-13
although O 0 8.024149378803302e-13
small O 0 8.177917978219318e-13
variations O 0 8.81170345023996e-11
were O 0 4.0993883287931965e-10
observed O 0 3.7228964355762173e-09
. O 0 3.067526899158679e-09

The O 0 4.490895122444272e-08
1936delG O 0 1.0768283118522959e-06
defect O 0 8.524625059180835e-07
was O 0 2.459989767444881e-09
observed O 0 1.282068340380249e-10
only O 0 1.4691740662584052e-12
once O 0 2.0605489970543234e-12
in O 0 5.915101850169358e-13
the O 0 3.125234446232916e-11
Cape O 0 4.9816146763248526e-09
, O 0 5.48360185384511e-13
but O 0 1.0964401722700703e-13
its O 0 5.717410594442696e-13
associated O 0 8.132222326096006e-12
haplotype O 0 2.783563102237707e-10
could O 0 3.8971548210753326e-11
be O 0 2.018079973964415e-11
deduced O 0 3.361565470427763e-10
. O 0 8.50831016752096e-10

The O 0 7.598329965219364e-09
data O 0 5.467401531511484e-10
from O 0 8.404238242831763e-12
the O 0 2.695426173926485e-11
haplotypes O 0 4.0244162169411624e-11
indicate O 0 8.295603245132843e-13
that O 0 4.039359856799693e-14
these O 0 6.160510605335637e-14
three O 0 1.8118363797128834e-12
molecular O 0 1.4745081600153753e-08
defects O 0 6.353502612910233e-08
account O 0 2.5161128605968863e-13
for O 0 3.928782646434037e-12
the O 0 1.7893204695695886e-09
defects O 0 6.809581805100606e-07
in O 0 1.067163805240634e-11
all O 0 5.3578776831875174e-11
the O 0 7.917558275671865e-10
38 O 0 3.813261706397952e-09
unrelated O 0 1.620801604040878e-09
C6Q0 O 0 2.4160910925274948e-06
individuals O 0 6.2034681861875e-13
we O 0 5.689824913307495e-12
have O 0 1.875767472120718e-13
studied O 0 2.1805130617780222e-11
from O 0 6.8246519546733e-12
the O 0 4.422699706463362e-10
Cape O 0 1.0575087827646712e-07
. O 0 2.7382829337341263e-09

We O 0 1.90500526464632e-09
have O 0 4.858788718586915e-12
also O 0 5.141512215978139e-13
observed O 0 4.299905050075825e-12
the O 0 8.639765985973824e-12
879delG O 0 1.0961140883836151e-09
defect O 0 1.4248248136894404e-09
in O 0 8.920808536316827e-12
two O 0 1.7679607777765227e-10
Dutch O 1 0.9999866485595703
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 2.9052225727355108e-05
, O 0 6.282081625730296e-12
but O 0 3.7130454960676573e-13
the O 0 1.0200093374101993e-11
879delG O 0 7.800463386331558e-09
defect O 0 1.7917461292427106e-08
in O 0 1.690603386450551e-11
the O 0 1.9515875582243325e-09
Cape O 0 1.2007201632968645e-07
probably O 0 2.932047313275454e-11
did O 0 1.244616931218856e-12
not O 0 1.6811609071000488e-13
come O 0 2.11762397439412e-13
from O 0 1.7599505566009283e-13
The O 0 1.498071632022313e-11
Netherlands O 0 1.1014756218230559e-08
. O 0 8.732530670796379e-11
. O 0 1.462558296694283e-09

Complement B-Disease 1 0.9999960660934448
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.3154624056710418e-09
seven O 0 6.660004492342608e-11
further O 0 7.949933246431673e-12
molecular O 0 3.9113690064596085e-08
defects O 0 1.4728415408171713e-05
and O 0 1.790984895111425e-11
their O 0 9.115690841055013e-11
associated O 0 8.575417043132916e-10
marker O 0 3.3933211796011165e-08
haplotypes O 0 1.4011072302366756e-08
. O 0 2.27277641151602e-09

Seven O 0 2.7906719157755333e-09
further O 0 3.2365724683680597e-11
molecular O 0 1.2444764108110462e-09
bases O 0 9.212429041838277e-09
of O 0 0.02232005074620247
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.021751572238827e-08
described O 0 2.953209454759076e-09
. O 0 1.917406677875988e-09

All O 0 1.6602001995380533e-09
these O 0 1.646499603324969e-11
new O 0 1.7768041205012963e-10
molecular O 0 6.613304748270821e-08
defects O 0 2.2376829633685702e-07
involve O 0 1.847230701734759e-11
single O 0 4.242298734524752e-10
- O 0 5.411595060955676e-10
nucleotide O 0 1.4793808400526132e-09
events O 0 3.7850428347141474e-10
, O 0 1.0977512301946213e-11
deletions O 0 5.989527623873059e-11
and O 0 9.191178200473882e-12
substitutions O 0 1.7176501887483653e-10
, O 0 1.6657428908439798e-11
some O 0 2.4672599033270792e-12
of O 0 1.8643778187943383e-10
which O 0 9.195070919953974e-12
alter O 0 2.300518109343841e-10
splice O 0 6.509526806475208e-10
sites O 0 5.6423629657409435e-11
, O 0 7.730630371960423e-12
and O 0 4.3163743412844013e-11
others O 0 6.787790884921208e-10
codons O 0 2.0481163431895766e-08
. O 0 8.525761430178136e-09

They O 0 5.075729836434562e-10
are O 0 5.375827278990275e-13
distributed O 0 6.855894974996946e-13
along O 0 7.922414460570515e-12
the O 0 3.058388542420687e-10
C7 O 0 2.1061379129605484e-07
gene O 0 2.531278311956875e-11
, O 0 4.834124094944825e-13
but O 0 6.348154152954061e-14
predominantly O 0 1.1147032868150455e-13
towards O 0 6.156249013171411e-13
the O 0 7.263529621520659e-12
3 O 0 1.0542814399272515e-09
end O 0 5.973207706233552e-09
. O 0 2.8565458887186423e-09

All O 0 7.852202443814349e-09
were O 0 5.080117992939392e-10
found O 0 1.2864057909178772e-11
in O 0 2.1205525183032314e-11
compound O 0 7.701090432021829e-09
heterozygous O 0 7.168733939799665e-10
individuals O 0 4.578517686509853e-12
. O 0 2.5468263054051477e-09

The O 0 1.2118807717342861e-05
C6 O 1 0.9997655749320984
/ O 1 0.9909055233001709
C7 O 0 0.0009577061864547431
marker O 0 1.145204251429277e-07
haplotypes O 0 1.688545969713573e-09
associated O 0 2.8124226905679173e-11
with O 0 1.3992650788052785e-11
most O 0 1.5248291518332735e-08
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999916553497314
are O 0 5.7529682406798344e-11
tabulated O 0 3.009125393305112e-09
. O 0 9.08375527575167e-11
. O 0 1.1154095425069954e-09

A O 0 6.956031484151026e-08
genome O 0 5.293197546940576e-10
- O 0 1.969640978094489e-10
wide O 0 6.791801843153422e-11
search O 0 6.147675250811613e-12
for O 0 5.731101899476843e-13
chromosomal O 0 4.096016326116114e-08
loci O 0 8.883326851893969e-10
linked O 0 2.156785194884492e-09
to O 0 2.7222824688921676e-11
mental O 1 0.9999994039535522
health O 0 3.7180343497311696e-06
wellness O 0 2.4609934712316317e-07
in O 0 1.1541559808564417e-12
relatives O 0 6.050917687912272e-13
at O 0 2.850039475255084e-11
high O 0 3.2610834033164338e-09
risk O 0 1.7689734121972833e-09
for O 0 1.1205613104081635e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 2.0243343112902323e-10
the O 0 9.054043070833018e-10
Old O 0 2.5702320272102952e-08
Order O 0 4.234685047066478e-09
Amish O 0 3.8152425219095676e-08
. O 0 1.6044749973076478e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.7160792253889667e-07
BPAD B-Disease 1 1.0
; O 0 2.8757589461747557e-05
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 9.325454471131867e-12
is O 0 2.9240339668870977e-14
characterized O 0 1.608313905231834e-13
by O 0 1.993394463167472e-14
episodes O 0 6.21674101086711e-11
of O 0 3.285856309265256e-10
mania B-Disease 0 2.818478961330584e-08
and O 0 7.647917715791763e-11
/ O 0 6.77208475963198e-08
or O 0 2.656981301640826e-10
hypomania B-Disease 0 7.791203097440302e-05
interspersed O 0 5.907602185217797e-10
with O 0 1.1804401857037905e-12
periods O 0 2.669205301231159e-08
of O 0 4.008082754580755e-08
depression B-Disease 0 0.07815971225500107
. O 0 2.878138971595945e-08

Compelling O 0 1.6724371221243928e-08
evidence O 0 1.3266827636471135e-09
supports O 0 2.7007279745916435e-10
a O 0 3.664166192685059e-12
significant O 0 1.0546063154703855e-11
genetic O 0 7.698351678353532e-11
component O 0 2.2854598769050938e-10
in O 0 2.181790338673384e-11
the O 0 1.9985609001071936e-10
susceptibility O 0 6.92245061273411e-09
to O 0 9.346613066840703e-11
develop O 0 5.8871357566658844e-08
BPAD B-Disease 1 1.0
. O 0 1.2043085462210001e-07

To O 0 1.3403940457568098e-10
date O 0 6.814802944177245e-09
, O 0 5.619247688687379e-12
however O 0 4.2380157543042696e-12
, O 0 5.419974907251712e-13
linkage O 0 2.9249103139505905e-10
studies O 0 4.873509148323185e-12
have O 0 6.581151097174998e-13
attempted O 0 4.027165059761195e-11
only O 0 6.860958199142453e-13
to O 0 3.8655989758988596e-13
identify O 0 6.1506190765503455e-12
chromosomal O 0 1.24086483310748e-08
loci O 0 4.461553002044205e-11
that O 0 5.700619555397413e-13
cause O 0 1.1152062780184213e-11
or O 0 8.431443884000453e-14
increase O 0 1.7417505968325003e-13
the O 0 9.389706893958571e-12
risk O 0 9.563919101118756e-11
of O 0 8.834068893071034e-11
developing O 0 2.4978200841019316e-08
BPAD B-Disease 1 1.0
. O 0 8.776643767305359e-08

To O 0 2.1790008686295437e-10
determine O 0 1.2901955892541395e-10
whether O 0 8.075588808775791e-12
there O 0 1.996612770949202e-11
could O 0 8.464209368119757e-12
be O 0 2.972673756457267e-12
protective O 0 1.1647456610308637e-10
alleles O 0 8.828176498209064e-14
that O 0 1.1106597548127609e-14
prevent O 0 2.895886004952719e-12
or O 0 4.1358388068457597e-13
reduce O 0 1.772338872885193e-11
the O 0 1.7986221886867604e-11
risk O 0 2.7975869884566684e-11
of O 0 1.1312245411232436e-11
developing O 0 3.066321863087751e-09
BPAD B-Disease 1 1.0
, O 0 5.180032184443073e-12
similar O 0 3.209501891685007e-13
to O 0 2.7733137712856147e-14
what O 0 3.1266605109029136e-14
is O 0 2.6293577690426678e-15
observed O 0 2.938122496492189e-14
in O 0 4.439475181786459e-14
other O 0 5.896924008125248e-12
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.8836414632933396e-12
we O 0 2.507816003471941e-12
used O 0 3.2013738882064047e-11
mental O 1 0.9999643564224243
health O 0 7.05147670032602e-07
wellness O 0 8.263139505970685e-08
( O 0 3.304194889702447e-14
absence O 0 1.1363951446519138e-11
of O 0 2.719272723661348e-11
any O 0 8.338370882654544e-09
psychiatric B-Disease 1 1.0
disorder I-Disease 0 3.117960295639932e-05
) O 0 8.39183120237598e-14
as O 0 4.3726095877785753e-13
the O 0 1.2629666409913476e-11
phenotype O 0 1.5238208264656272e-11
in O 0 2.427433904925169e-12
our O 0 1.065581390485848e-11
genome O 0 4.467818042613869e-12
- O 0 2.6669517289024114e-11
wide O 0 4.487309135381423e-11
linkage O 0 7.718935213230083e-11
scan O 0 2.7745469810547263e-10
of O 0 7.30418725503057e-10
several O 0 5.987528528539343e-11
large O 0 2.061073950399006e-10
multigeneration O 0 1.0486228774198025e-07
Old O 0 1.5434456202001456e-07
Order O 0 4.085901395001201e-09
Amish O 0 8.853628052918339e-09
pedigrees O 0 2.951304756138029e-10
exhibiting O 0 4.896303917867328e-10
an O 0 3.6351104418241853e-12
extremely O 0 2.0067426886871687e-10
high O 0 1.809764249571799e-08
incidence O 0 0.0008388150599785149
of O 0 1.7852560631581582e-05
BPAD B-Disease 1 1.0
. O 0 6.212776952452259e-06

We O 0 6.981975886333203e-09
have O 0 1.3725202398229275e-11
found O 0 1.2930273171618545e-12
strong O 0 1.4638175654252406e-12
evidence O 0 2.792382427715956e-12
for O 0 6.252087064208267e-13
a O 0 2.032828983269952e-12
locus O 0 1.5579589701664176e-11
on O 0 3.3316477354716767e-10
chromosome O 0 8.874909140921261e-10
4p O 0 1.5532103248006024e-07
at O 0 1.2501075730142475e-09
D4S2949 O 0 1.2688859962750598e-09
( O 0 2.059232775616926e-12
maximum O 0 1.0282810158912525e-09
GENEHUNTER O 0 2.1208636269420822e-07
- O 0 2.030149659493219e-10
PLUS O 0 2.387474384857313e-10
nonparametric O 0 5.590432006208346e-10
linkage O 0 2.8076044961133917e-11
score O 0 3.85057645491127e-11
= O 0 1.0966713648308257e-11
4 O 0 2.0470470804556662e-11
. O 0 2.500087268285378e-13
05 O 0 1.906203667134676e-10
, O 0 2.872867959149983e-12
P O 0 7.175026128791728e-10
= O 0 1.2075655579646405e-11
5 O 0 3.707683465803413e-12
. O 0 5.286002958591017e-14
22 O 0 6.388191299729062e-13
x O 0 8.889521931065847e-12
10 O 0 1.6850793330136504e-11
( O 0 1.990971271311967e-13
- O 0 5.948254475779402e-12
4 O 0 4.557191429777063e-11
) O 0 6.837491862846448e-14
; O 0 1.7313899608722289e-13
SIBPAL O 0 1.6815979719808638e-08
Pempirical O 0 3.912687951412863e-09
value O 0 3.28071320110368e-11
< O 0 8.168292431331992e-11
3 O 0 1.427037221030103e-11
x O 0 2.0284959476035702e-11
10 O 0 7.536787166584347e-12
( O 0 1.034499227817523e-13
- O 0 1.2842013693767362e-12
5 O 0 6.502968302735113e-12
) O 0 8.345250658320803e-15
) O 0 2.2869281829726454e-15
and O 0 4.30480778519475e-14
suggestive O 0 1.6128243488996996e-12
evidence O 0 1.2547686414204895e-12
for O 0 1.9254579484637158e-13
a O 0 1.5098809789254597e-12
locus O 0 2.6884021050999074e-11
on O 0 4.628350203095266e-10
chromosome O 0 7.047481265232136e-09
4q O 0 1.8291213876864276e-08
at O 0 5.139687009325655e-10
D4S397 O 0 8.875705170829917e-10
( O 0 1.6607612637539737e-12
maximum O 0 5.719436591000715e-10
GENEHUNTER O 0 1.196521566271258e-07
- O 0 1.7370421767637367e-10
PLUS O 0 2.3095791945593191e-10
nonparametric O 0 5.762074706261444e-10
linkage O 0 6.965036186690199e-11
score O 0 3.277004709256737e-11
= O 0 1.0105245633329485e-11
3 O 0 7.7798722325495e-12
. O 0 1.347510563418433e-13
29 O 0 5.0437740789499586e-11
, O 0 3.2332760600828347e-12
P O 0 8.614450264232687e-10
= O 0 1.4800171505013893e-11
2 O 0 8.236703853692351e-12
. O 0 6.247708920310499e-14
57 O 0 6.212775519737201e-13
x O 0 9.543870034545154e-12
10 O 0 1.248369289885698e-11
( O 0 1.3249731173337054e-13
- O 0 3.795616165119808e-12
3 O 0 1.9847550686291626e-11
) O 0 6.497395259623048e-14
; O 0 1.3982284568451325e-13
SIBPAL O 0 7.071057073204656e-09
Pempirical O 0 2.177867441943704e-09
value O 0 7.181046729476392e-11
< O 0 1.4738486819876329e-10
1 O 0 4.1369789538503454e-11
x O 0 6.121293749661305e-11
10 O 0 3.1618204582306575e-11
( O 0 3.546867118585373e-13
- O 0 5.854784539127689e-12
3 O 0 1.5303452949311236e-11
) O 0 4.356729634312018e-15
) O 0 6.911831730638046e-16
that O 0 5.36717471884946e-15
are O 0 3.314882073804544e-14
linked O 0 3.862654640585106e-11
to O 0 2.676230938247759e-11
mental O 1 0.9999998807907104
health O 0 0.031687311828136444
wellness O 0 9.045911428984255e-05
. O 0 1.7470975777200692e-09

These O 0 6.218570658411693e-10
findings O 0 9.0654261875045e-11
are O 0 8.756589745841092e-13
consistent O 0 3.3629425633119325e-11
with O 0 2.146299766603646e-13
the O 0 5.325377291920397e-11
hypothesis O 0 5.06547321449391e-12
that O 0 7.400960541029816e-15
certain O 0 1.7069230143912373e-12
alleles O 0 8.674354095260239e-13
could O 0 1.6609768031458638e-12
prevent O 0 2.3908316298948407e-11
or O 0 1.061325398225843e-12
modify O 0 5.716639401437407e-12
the O 0 1.0630433165681463e-12
clinical O 0 4.134804165722983e-10
manifestations O 0 2.0253247967616517e-08
of O 0 2.5832447292373217e-09
BPAD B-Disease 1 1.0
and O 0 2.4622403074769927e-11
perhaps O 0 2.221606796096176e-12
other O 0 6.614019770236068e-13
related O 0 2.9276703727987297e-08
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 4.305322534037259e-07

Segregation O 0 0.0021375336218625307
distortion O 1 0.9926992058753967
in O 0 6.010936886013951e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.0511189834214747e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 3.268255110988605e-10
is O 0 1.439046689970247e-12
an O 0 7.363485906089484e-13
autosomal B-Disease 1 0.9961615800857544
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
which O 0 6.673361949843803e-13
, O 0 2.3198524806873622e-14
in O 0 2.0170159758994138e-13
the O 0 1.8619815758680325e-11
typical O 0 2.669394566501282e-11
pedigree O 0 6.106573580133556e-12
, O 0 4.0526101626001815e-14
shows O 0 1.370293418664903e-12
a O 0 3.360824856260547e-12
three O 0 1.7467417486385917e-12
generation O 0 5.726376664516586e-11
anticipation O 0 1.3864455139511733e-09
cascade O 0 2.0781248721846168e-08
. O 0 1.4378972679196522e-08

This O 0 2.0113698033508154e-12
results O 0 8.279341622008385e-12
in O 0 8.519895726422089e-12
infertility B-Disease 0 0.17189908027648926
and O 0 0.11560177803039551
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.75756507209735e-06
CDM B-Disease 0 8.31821216706885e-06
) O 0 4.9217594789204705e-15
with O 0 2.445433034875869e-15
the O 0 1.3180321634456704e-12
disappearance O 0 6.864957907692926e-11
of O 0 1.5832798405668314e-09
DM B-Disease 1 1.0
in O 0 6.111799955021979e-10
that O 0 5.4613959188376526e-11
pedigree O 0 2.384395969556863e-08
. O 0 7.527015455366382e-09

The O 0 7.46902040216213e-10
concept O 0 2.822435618554664e-10
of O 0 1.2987728947866373e-10
segregation O 0 1.2295156182062783e-07
distortion O 0 4.864937253046264e-08
, O 0 3.1248021206166376e-13
where O 0 7.277556649757516e-14
there O 0 3.9875434632843584e-14
is O 0 7.291113073265142e-15
preferential O 0 9.150418053480158e-13
transmission O 0 4.4399627203983716e-12
of O 0 5.745245425237133e-12
the O 0 1.2490171223678015e-11
larger O 0 1.1713344053379537e-12
allele O 0 2.775692653153583e-12
at O 0 1.1147071460326785e-10
the O 0 7.770078469526709e-10
DM B-Disease 1 1.0
locus O 0 2.6121491081276815e-10
, O 0 2.500870604354999e-12
has O 0 3.787073465152252e-13
been O 0 1.2773587526257457e-12
put O 0 3.4356340689045695e-11
forward O 0 7.22628814425752e-12
to O 0 3.446407384737754e-13
explain O 0 9.435847068972603e-12
partially O 0 4.749381998792046e-10
the O 0 1.4422569041827593e-11
maintenance O 0 4.7130473745937707e-08
of O 0 2.1328139254706002e-08
DM B-Disease 1 1.0
in O 0 2.8314509070703764e-10
the O 0 6.092037985183651e-10
population O 0 1.4819832860890614e-11
. O 0 5.540138903192826e-10

In O 0 2.707092050524551e-10
a O 0 5.965470478708212e-11
survey O 0 4.814317694501469e-11
of O 0 5.09343145438379e-09
DM B-Disease 1 1.0
in O 0 1.7161969623202822e-09
Northern O 0 2.1997779597882072e-08
Ireland O 0 2.2958431600272888e-08
, O 0 1.092138046665525e-10
59 O 0 5.150189164027097e-09
pedigrees O 0 4.350597659907862e-09
were O 0 2.3691852923946044e-09
ascertained O 0 1.1617719053447217e-07
. O 0 7.693808257158707e-09

Sibships O 0 3.1352778933069203e-06
where O 0 8.850044030950244e-10
the O 0 8.058114592257581e-11
status O 0 9.980018200739238e-11
of O 0 4.7864014834919644e-11
all O 0 7.756891483301498e-12
the O 0 4.781164006373295e-11
members O 0 3.8184963004062045e-12
had O 0 1.3822880340352839e-11
been O 0 2.016855432662723e-12
identified O 0 2.482511808968302e-12
were O 0 3.87594427039839e-12
examined O 0 4.023469925285017e-12
to O 0 1.7113296457010874e-13
determine O 0 2.500546211064991e-12
the O 0 5.65572068345066e-12
transmission O 0 1.1582324682679612e-10
of O 0 2.0822255031305303e-10
the O 0 1.2785507763624082e-08
DM B-Disease 1 1.0
expansion O 0 5.073341746708593e-09
from O 0 4.7085741555763505e-11
affected O 0 1.3158431289017614e-10
parents O 0 6.8925850270351585e-12
to O 0 1.6632823590656542e-11
their O 0 9.10395037134748e-10
offspring O 0 2.5865778408018514e-09
. O 0 1.766175206086018e-09

Where O 0 2.1926183091380835e-09
the O 0 9.515778165436473e-10
transmitting O 0 5.7991154989167626e-08
parent O 0 1.548377204230178e-09
was O 0 1.503286384263447e-08
male O 0 1.6393401913727956e-10
, O 0 9.066827150183698e-11
58 O 0 1.3676302756948644e-08
. O 0 3.454761809962292e-08

3 O 0 2.5018778160301736e-08
% O 0 4.7903833677587215e-11
of O 0 2.427973655461102e-10
the O 0 2.473227456167848e-10
offspring O 0 4.9409948355005895e-11
were O 0 1.1531443334933389e-11
affected O 0 1.0483244047149176e-12
, O 0 1.263743612794216e-13
and O 0 3.2266515305988397e-13
in O 0 2.121724670955949e-12
the O 0 4.104581605157698e-11
case O 0 2.908307492402451e-12
of O 0 1.4418690200135309e-11
a O 0 2.1042749140387507e-11
female O 0 1.0050419697871238e-12
transmitting O 0 2.5664881331266542e-09
parent O 0 3.368889334165459e-10
, O 0 7.786100097995075e-10
68 O 0 1.0096418918692507e-06
. O 0 1.2002863059024094e-07

7 O 0 8.768208203946415e-07
% O 0 3.2187041920650472e-09
were O 0 5.600509833669776e-09
affected O 0 2.2216790185325408e-08
. O 0 3.124738512383374e-08

Studies O 0 2.2251300801912066e-09
on O 0 5.241960199242612e-09
meiotic O 0 9.679711183707695e-07
drive O 0 6.51054898881398e-09
in O 0 2.9560032199782427e-10
DM B-Disease 1 0.9999998807907104
have O 0 1.1000982026374007e-12
shown O 0 1.0407670683392975e-13
increased O 0 2.1976714339403541e-13
transmission O 0 3.2903937820932816e-12
of O 0 2.700117473358743e-12
the O 0 3.5350090910046816e-12
larger O 0 2.3232145916242397e-13
allele O 0 2.0711473443409123e-13
at O 0 3.190000000263815e-11
the O 0 1.0859645821481578e-10
DM B-Disease 1 0.9999407529830933
locus O 0 4.1738040801320153e-10
in O 0 6.765555476961893e-11
non O 0 3.160913820465794e-06
- O 0 2.5012175683514215e-05
DM O 1 1.0
heterozygotes O 0 2.809853640428628e-06
for O 0 9.218787400122608e-10
CTGn O 0 9.8103719210485e-06
. O 0 1.962533069388428e-08

This O 0 2.1109812509134684e-10
study O 0 1.6943772773725385e-11
provides O 0 1.4793221985928695e-12
further O 0 6.04325942586692e-13
evidence O 0 9.37092070607548e-12
that O 0 2.2411504076169653e-12
the O 0 1.688678885614081e-08
DM B-Disease 1 1.0
expansion O 0 1.0995932342439119e-07
tends O 0 2.579893937371125e-11
to O 0 4.310103489391093e-12
be O 0 3.09867305425815e-11
transmitted O 0 1.977961128218908e-10
preferentially O 0 9.066831729853675e-10
. O 0 6.301769661654077e-10

Diagnosis O 1 0.8773711919784546
of O 0 0.0006227359990589321
hemochromatosis B-Disease 1 1.0
. O 0 2.546431278460659e-05

If O 0 7.2854633437202665e-09
untreated O 0 4.277479092706926e-05
, O 0 3.1005618073010055e-09
hemochromatosis B-Disease 1 1.0
can O 0 1.7408631480808623e-10
cause O 0 1.2981996810879082e-08
serious O 0 3.242693765059812e-06
illness O 0 7.464482791874616e-07
and O 0 1.7541862602256375e-13
early B-Disease 0 1.197083682180633e-10
death I-Disease 0 3.7132196623046454e-11
, O 0 3.083827748826158e-14
but O 0 4.92418436484187e-14
the O 0 1.1921205342324548e-11
disease O 0 7.531308909847212e-09
is O 0 9.538345861846015e-14
still O 0 2.0001059456657005e-13
substantially O 0 3.5320841303837502e-12
under O 0 5.331440178224511e-09
- O 0 3.0053130103624426e-05
diagnosed O 0 9.958950613508932e-06
. O 0 1.9078495228086467e-08

The O 0 1.5906177708302494e-08
cornerstone O 0 4.229346359352348e-06
of O 0 5.6951972027263764e-09
screening O 0 3.4448832675337826e-09
and O 0 1.391735164613106e-11
case O 0 3.421899048838828e-12
detection O 0 1.7375591243595778e-10
is O 0 6.56004384928105e-14
the O 0 1.7450591752871114e-13
measurement O 0 1.0640357518687527e-11
of O 0 2.5962133484713767e-11
serum O 0 1.464455119670749e-11
transferrin O 0 1.0118288845673007e-10
saturation O 0 3.934829198581902e-11
and O 0 1.0177816705744802e-12
the O 0 1.4632489664379023e-11
serum O 0 1.3899716100329584e-10
ferritin O 0 1.152972828322163e-07
level O 0 1.757272514169017e-07
. O 0 2.46796028058327e-09

Once O 0 7.586256600689012e-08
the O 0 1.6031107552549884e-09
diagnosis O 0 1.2696254714228417e-07
is O 0 7.75010351034e-12
suspected O 0 5.1044506399477996e-09
, O 0 1.9461992781244497e-11
physicians O 0 9.647758286712715e-11
must O 0 8.113665989073482e-11
use O 0 4.002316533746608e-11
serum O 0 4.997772196091432e-10
ferritin O 0 8.4018502377603e-08
levels O 0 1.5676003828346552e-09
and O 0 9.586396780558726e-12
hepatic O 1 0.9999769926071167
iron O 0 0.0004881047934759408
stores O 0 3.493882729799225e-07
on O 0 1.1099139385351009e-07
liver O 0 1.2166865417384543e-06
biopsy O 0 2.4664510434035947e-08
specimens O 0 6.199946805951484e-12
to O 0 3.337112216336008e-13
assess O 0 1.1938368349451167e-10
patients O 0 4.4852337989509383e-13
for O 0 3.333778565706158e-13
the O 0 1.5299133487856054e-11
presence O 0 2.7032723282083282e-11
of O 0 1.2410014127439695e-09
iron B-Disease 0 1.1359513337083627e-05
overload I-Disease 0 3.510485839797184e-07
. O 0 1.5409741038752145e-08

Liver O 1 0.999992847442627
biopsy O 1 0.9993777275085449
is O 0 8.208830060141281e-09
also O 0 3.4940134119310073e-11
used O 0 7.75540818630932e-13
to O 0 1.8166142147415382e-13
establish O 0 1.4599342568200058e-11
the O 0 6.886054660509844e-12
presence O 0 1.5550931853000605e-12
or O 0 6.044758335370382e-13
absence O 0 2.569817691977505e-10
of O 0 4.192418356918637e-10
cirrhosis B-Disease 1 0.9980942606925964
, O 0 2.2908955548545107e-12
which O 0 2.3745233752349437e-13
can O 0 4.2842178372623496e-13
affect O 0 2.545396012021417e-11
prognosis O 0 2.6540565301047536e-08
and O 0 2.7005205363583862e-11
management O 0 2.6195159819053515e-08
. O 0 3.776938761745896e-09

A O 0 1.0260601612799292e-07
DNA O 0 8.589904898492762e-10
- O 0 5.2630635960504435e-11
based O 0 1.7001750701739482e-11
test O 0 4.916845819380455e-10
for O 0 1.873605957880553e-11
the O 0 4.444033752104559e-10
HFE O 0 1.1774977792811114e-06
gene O 0 1.1426568892469735e-11
is O 0 6.977511152412089e-14
commercially O 0 2.236529971638701e-12
available O 0 1.0660254553011492e-13
, O 0 3.11141900005002e-14
but O 0 1.1626745234443424e-14
its O 0 2.2347548074216905e-13
place O 0 1.702469415443275e-11
in O 0 2.740315027845164e-13
the O 0 7.299987871134395e-12
diagnosis O 0 6.432894661401178e-09
of O 0 7.034213211909446e-09
hemochromatosis B-Disease 1 1.0
is O 0 1.422917617066588e-10
still O 0 2.045798079552963e-11
being O 0 1.97378433042239e-11
evaluated O 0 5.838887706666185e-10
. O 0 8.184874999983549e-10

Currently O 0 2.2667241417195783e-09
, O 0 1.2336982997684931e-11
the O 0 2.7190237908425452e-11
most O 0 5.748925641091418e-13
useful O 0 6.727613258150633e-13
role O 0 7.032951152875777e-13
for O 0 1.45702026832506e-13
this O 0 4.3367507528884255e-14
test O 0 2.65094478486827e-12
is O 0 3.3392609525759436e-15
in O 0 4.554262799809404e-15
the O 0 1.9200594347963673e-13
detection O 0 1.9257141714579262e-10
of O 0 2.5628568711688615e-10
hemochromatosis B-Disease 1 1.0
in O 0 4.850460033622994e-10
the O 0 1.5402797926000744e-09
family O 0 8.115209892967101e-12
members O 0 2.2038894147147214e-12
of O 0 4.836399614127629e-10
patients O 0 1.0751890697213717e-11
with O 0 1.6916702413882767e-12
a O 0 3.656824842934725e-10
proven O 0 2.3904098700455734e-09
case O 0 2.8561724166320523e-11
of O 0 5.702977534660647e-10
the O 0 2.6704274347366663e-08
disease O 0 0.00023076664365362376
. O 0 3.2748774803081915e-09

It O 0 1.0524846966175616e-10
is O 0 1.490075424159798e-11
crucial O 0 1.7300135768394398e-09
to O 0 1.7444860833659703e-10
diagnose O 1 0.9999984502792358
hemochromatosis B-Disease 1 1.0
before O 0 0.00018374565115664154
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 1.099701218976179e-09
because O 0 7.445717653542516e-11
phlebotomy O 1 0.9999996423721313
therapy O 0 4.496389180985716e-07
can O 0 1.3489847260073073e-12
avert O 0 6.380279842232994e-07
serious O 1 0.9999969005584717
chronic O 1 1.0
disease O 1 0.9999973773956299
and O 0 1.3542799694177265e-12
can O 0 5.0371521325776394e-14
even O 0 1.9522723010683557e-13
lead O 0 7.282298895849859e-12
to O 0 5.4286006164480996e-14
normal O 0 9.215653934413481e-11
life O 0 2.3313169970895498e-12
expectancy O 0 1.5804753339399014e-11
. O 0 8.334998815272276e-13
. O 0 8.531348544282835e-11

Prevalence O 0 1.0936702210528892e-06
of O 0 2.1948579842501204e-08
the O 0 1.3987415670158043e-08
I1307K O 0 3.8696185811204487e-07
APC B-Disease 0 2.4277351684531823e-08
gene O 0 9.29016065465138e-12
variant O 0 1.161204812860639e-11
in O 0 1.2307005187086467e-13
Israeli O 0 6.0436547259790085e-12
Jews O 0 4.607300868944564e-13
of O 0 4.830593932671212e-13
differing O 0 9.159039087054677e-14
ethnic O 0 5.648731807826601e-13
origin O 0 7.005892719257056e-13
and O 0 4.715879162869863e-12
risk O 0 4.6702730571723805e-08
for O 0 1.1496276783873327e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.588849595980719e-06

BACKGROUND O 0 2.039511309703812e-05
& O 0 2.495364060450811e-05
AIMS O 0 7.950297487013813e-08
Israeli O 0 2.6712003720064104e-09
Jews O 0 2.719694192077071e-10
of O 0 1.5234793426799342e-09
European O 0 1.9764545555744917e-08
birth O 0 2.765947471061736e-08
, O 0 1.352211398408798e-10
i O 0 7.329611223516608e-11
. O 0 8.909376600189922e-13
e O 0 4.439215108790334e-13
. O 0 1.1756985359226424e-13
, O 0 1.640372950320601e-13
Ashkenazim O 0 4.726218721939901e-11
, O 0 6.592782011505607e-14
have O 0 6.43794777687931e-14
the O 0 6.5011082454879965e-12
highest O 1 0.999994158744812
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.11291110515594482
of O 0 1.8668117052200728e-10
any O 0 2.14438709844611e-11
Israeli O 0 1.3119344499656904e-09
ethnic O 0 1.19725329650322e-09
group O 0 4.816710585942019e-09
. O 0 1.7771720095538512e-08

The O 0 1.3512682528471487e-07
I1307K O 0 1.0768488891699235e-06
APC B-Disease 0 8.80664288160915e-08
gene O 0 1.3289055966758667e-10
variant O 0 3.6728181607159627e-10
was O 0 3.240286094996492e-10
found O 0 4.984914824673892e-12
in O 0 8.96659396038002e-12
6 O 0 5.3390543541809166e-08
. O 0 1.0501237213134118e-08

1 O 0 7.861463480196562e-09
% O 0 6.455353179085632e-12
of O 0 1.139249024978417e-11
American O 0 5.3476858358214585e-12
Jews O 0 5.400587529263978e-12
, O 0 1.7703065847019667e-13
28 O 0 2.43806086430709e-11
% O 0 8.149982967144143e-13
of O 0 5.043254702741251e-11
their O 0 1.9570313725125743e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 4.485242843799142e-09
, O 0 6.04462009959339e-13
but O 0 3.3569006678123986e-14
not O 0 4.4380189627435396e-14
in O 0 6.984198375886708e-13
non O 0 4.2662704480278535e-09
- O 0 2.4214480420781115e-10
Jews O 0 3.426304240328193e-10
. O 0 2.1700223840070976e-09

We O 0 2.2360087115202987e-09
assessed O 0 6.441867039796989e-10
the O 0 7.515976035987748e-11
I1307K O 0 4.246007989650025e-09
prevalence O 0 2.8079805147740444e-10
in O 0 1.4816624218771252e-13
Israeli O 0 3.1829725487264593e-12
Jews O 0 4.379495626826574e-13
of O 0 3.190812414635702e-13
differing O 0 5.182260396090384e-14
ethnic O 0 4.720799489169036e-13
origin O 0 5.500037274577818e-13
and O 0 3.158413417955752e-12
risk O 0 5.119663626373949e-08
for O 0 1.6856897673278581e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2110316674807109e-05

METHODS O 0 1.9857317568039434e-07
DNA O 0 8.076428970049676e-10
samples O 0 8.828623596079943e-12
from O 0 8.110505322900252e-12
500 O 0 1.0298049739343451e-11
unrelated O 0 3.517644509010154e-11
Jews O 0 1.1143366611399141e-11
of O 0 8.729305056576209e-10
European O 0 1.431734286683195e-08
or O 0 5.2010524359547006e-11
non O 0 3.161198236512064e-08
- O 0 1.9224882796819998e-10
European O 0 4.872027226099362e-10
origin O 0 3.780609072329133e-12
, O 0 2.1903273194744804e-13
with O 0 8.868782580074078e-14
or O 0 3.1796475175038807e-12
without O 0 1.660515128176776e-11
a O 0 3.807216694684534e-12
personal O 0 1.2079133700215738e-11
and O 0 5.963252114327133e-11
/ O 0 2.8665299467434124e-08
or O 0 1.8011730995581843e-11
family O 0 8.293498808716049e-13
history O 0 1.1643895916901847e-11
of O 0 3.552315663846173e-10
neoplasia B-Disease 0 6.638175022999349e-07
, O 0 2.6907105016293897e-11
were O 0 2.2986659450885405e-11
examined O 0 3.4542028959361204e-11
for O 0 2.9942808215527306e-12
the O 0 7.024981291126053e-11
I1307K O 0 4.4931353082589e-10
variant O 0 1.63650273887761e-11
by O 0 4.816011955552368e-13
the O 0 1.277744316602325e-11
allele O 0 8.920400008938234e-12
- O 0 5.835300298517865e-11
specific O 0 6.998768231625263e-11
oligonucleotide O 0 3.2379791292669324e-08
( O 0 3.3749156247431245e-10
ASO O 0 0.02289470285177231
) O 0 3.349620927850516e-11
method O 0 1.6538980185387686e-09
. O 0 3.936259318493285e-09

RESULTS O 0 5.528846269697851e-09
In O 0 7.693620913962196e-12
persons O 0 1.5423589055235665e-12
at O 0 1.2400395814349263e-11
average O 0 7.555815348392336e-12
risk O 0 3.147407001691249e-09
for O 0 1.4759466182567849e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1130372318257642e-10
I1307K O 0 1.1224009499599674e-09
was O 0 1.1739546834643733e-10
found O 0 1.489216519198755e-12
in O 0 1.5699737516972068e-12
5 O 0 2.573188329080267e-09
. O 0 1.7549327546717564e-09

0 O 0 2.459507619789747e-08
% O 0 3.8442360406065745e-11
of O 0 2.530487763774403e-10
120 O 0 3.0459651467751314e-10
European O 0 3.737809617376797e-09
and O 0 3.0008129314751386e-10
1 O 0 2.1184177967370488e-07
. O 0 9.559697922156829e-09

6 O 0 2.2844932345833513e-07
% O 0 1.6538277691768855e-10
of O 0 5.581269890697627e-10
188 O 0 6.220207682261503e-10
non O 0 4.9537320023773646e-08
- O 0 6.531117313635093e-10
European O 0 1.057007703586521e-09
Jews O 0 1.166715613010183e-10
( O 0 6.423946010553072e-12
P O 0 7.597478202114871e-08
= O 0 5.321866836105471e-10
0 O 0 4.177252710402257e-10
. O 0 2.1506570396095936e-12
08 O 0 3.031647502482748e-11
) O 0 9.209845342958434e-13
. O 0 5.3959055973384906e-11

It O 0 3.7542555175740233e-10
occurred O 0 3.6124314650720635e-09
in O 0 1.7122300799421453e-10
15 O 0 1.912374436585651e-08
. O 0 1.5036103917509536e-08

4 O 0 2.661122699976204e-08
% O 0 3.891650543486058e-11
of O 0 2.4150689781343715e-10
52 O 0 1.4628764866131405e-09
Ashkenazi O 0 2.2044475134208597e-09
Israelis O 0 4.783392015816901e-10
with O 0 5.5488821870675054e-11
familial O 1 0.7880562543869019
cancer B-Disease 1 0.999933123588562
( O 0 4.010525800346443e-10
P O 0 0.0002888911112677306
= O 0 2.0075017204135293e-09
0 O 0 8.193726946936764e-11
. O 0 8.421848694773956e-14
02 O 0 6.251386994865493e-12
) O 0 1.5632601846508952e-15
and O 0 6.925083455218721e-15
was O 0 1.310396994906593e-12
not O 0 1.858338447859563e-14
detected O 0 5.254442172163143e-13
in O 0 1.6641152160695033e-13
51 O 0 3.0173641363262504e-11
non O 0 8.78932127079679e-09
- O 0 1.0101820768770864e-10
European O 0 6.311245276391375e-11
Jews O 0 6.007039917571566e-12
at O 0 1.8053943062756872e-10
increased O 0 1.5800488695205672e-09
cancer B-Disease 0 9.077945719582203e-07
risk O 0 7.127375312165896e-08
. O 0 2.2661277299107496e-09

Colorectal B-Disease 1 0.9999992847442627
neoplasia I-Disease 1 0.9996665716171265
occurred O 0 3.1499090255238116e-05
personally O 0 3.2486795475961117e-09
or O 0 1.065743934075547e-11
in O 0 7.387855084639572e-12
the O 0 3.803016582204499e-11
families O 0 4.560236669076505e-14
of O 0 2.7963598450697624e-11
13 O 0 1.1019226642261515e-09
of O 0 3.201132692254305e-09
20 O 0 6.53560672247977e-09
Ashkenazi O 0 1.0379209491873098e-08
I1307K O 0 6.568360522152261e-09
carriers O 0 2.022982129035178e-11
, O 0 1.7376633985877188e-12
8 O 0 2.9899463460658637e-10
of O 0 4.751040116879324e-10
whom O 0 2.0152117474747655e-10
also O 0 3.4821329153444935e-10
had O 0 4.678399334601124e-10
a O 0 5.880012449166472e-11
personal O 0 3.922826230517984e-10
or O 0 8.850782606817376e-11
family O 0 2.856476123344609e-12
history O 0 7.08951092276422e-11
of O 0 3.3847997737979085e-09
noncolonic O 0 2.8937807655893266e-05
neoplasia B-Disease 0 0.007238570135086775
. O 0 4.121977781323949e-07

CONCLUSIONS O 0 8.275220864106814e-08
The O 0 1.0957718288295837e-08
I1307K O 0 7.121083740457834e-07
APC O 0 2.486545440660848e-07
variant O 0 3.8422753867450865e-09
may O 0 5.1512450555124545e-11
represent O 0 7.619928993340963e-12
a O 0 3.197980769087394e-11
susceptibility O 0 2.7685429504487047e-09
gene O 0 1.1155876916690843e-10
for O 0 1.9137737228280827e-10
colorectal B-Disease 1 1.0
, I-Disease 0 5.54859880264047e-10
or I-Disease 0 2.690577101394087e-11
other I-Disease 0 1.574436761520026e-11
, I-Disease 0 6.7494954070213e-11
cancers I-Disease 0 1.5848297607590212e-06
in O 0 7.250591099738912e-11
Ashkenazi O 0 1.8449781979956725e-10
Jews O 0 1.982703281069864e-12
, O 0 1.3861676563531322e-13
and O 0 4.1527070952958323e-13
partially O 0 6.790704110137824e-10
explains O 0 7.595894399581304e-13
the O 0 9.291751396078851e-13
higher O 0 9.115030258355361e-11
incidence O 0 0.00042907631723210216
of O 0 0.4567321538925171
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.4075493537955026e-09
European O 0 1.0594424892929055e-08
Israelis O 0 4.21204937595121e-09
. O 0 4.749076687460274e-09

Systematic O 0 3.551599458972987e-09
analysis O 0 1.3946668819819763e-10
of O 0 1.3546360699834281e-09
coproporphyrinogen O 0 3.8763691918575205e-06
oxidase O 0 1.7932319451574585e-06
gene O 0 9.184676486029275e-08
defects O 0 1.6817490177345462e-05
in O 0 2.588027292471651e-10
hereditary B-Disease 1 0.9997184872627258
coproporphyria I-Disease 1 0.964408814907074
and O 0 2.707155388748106e-09
mutation O 0 2.867950543716802e-09
update O 0 2.177253932700296e-08
. O 0 4.553842192223101e-09

Hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.999891996383667
( O 0 8.190801281671156e-08
HC B-Disease 1 0.9999955892562866
) O 0 2.507267136964142e-11
is O 0 3.009119375115693e-13
an O 0 3.643966367799373e-13
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 5.99366174469651e-08
autosomal O 1 0.9990745782852173
dominant O 0 0.0011831569718196988
inheritance O 0 1.0436337349872815e-09
caused O 0 2.8361462484083333e-11
by O 0 1.6729051141323864e-13
deficient B-Disease 0 2.3111028715772086e-11
activity I-Disease 0 5.848835304966826e-12
of I-Disease 0 1.052456212458086e-11
coproporphyrinogen I-Disease 0 5.908903943918631e-08
III I-Disease 0 1.0316141469957074e-06
oxidase I-Disease 0 2.1076673739628404e-09
( O 0 1.5247192397538356e-11
CPO O 0 2.309204091943684e-06
) O 0 1.934124388425218e-11
. O 0 3.32672056568839e-10

Clinical O 0 9.264020263799466e-06
manifestations O 0 0.00041908081038855016
of O 0 2.2356520901212207e-07
the O 0 1.2638545854315453e-07
disease O 0 0.012606393545866013
are O 0 3.166559489663559e-14
characterized O 0 2.096396786634841e-13
by O 0 3.737700253469978e-14
acute O 0 3.765123892662814e-07
attacks O 0 5.542146741532861e-10
of O 0 5.5334453463729005e-06
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.4295763357818903e-11
precipitated O 0 1.1577768257997612e-11
by O 0 5.025619677356818e-13
drugs O 0 4.933913347326957e-11
, O 0 1.2959154149089214e-13
fasting O 0 5.083315990361825e-10
, O 0 5.7138811911106036e-12
cyclical O 0 4.567677024169825e-06
hormonal O 0 5.753864797952701e-07
changes O 0 8.682180530072969e-10
, O 0 1.4018990829312017e-11
or O 0 2.720862868343943e-09
infectious B-Disease 1 1.0
diseases I-Disease 1 0.9999995231628418
. O 0 1.3831182421597532e-08

Skin O 1 1.0
photosensitivity O 1 0.9999970197677612
may O 0 1.6189908365049632e-06
also O 0 5.803579838925543e-10
be O 0 2.6710448089439787e-11
present O 0 1.5768297778606666e-10
. O 0 2.622844164079652e-09

The O 0 1.9281126029113693e-08
seven O 0 4.232214134702872e-09
exons O 0 3.418631067120259e-08
, O 0 6.699973215118504e-11
the O 0 6.445848854674807e-10
exon O 0 7.437180649105812e-09
/ O 0 1.207541400205514e-09
intron O 0 7.839612847782007e-10
boundaries O 0 3.136089998800884e-11
and O 0 7.024893904430951e-13
part O 0 1.9846706743320564e-12
of O 0 2.28532800322645e-11
3 O 0 3.0907471026964117e-10
noncoding O 0 4.729212854659437e-11
sequence O 0 2.781633864218369e-12
of O 0 1.432606949736126e-10
the O 0 1.0440458497740224e-09
CPO O 0 3.561873199942056e-06
gene O 0 2.6546397025040136e-11
were O 0 4.1731713570913875e-12
systematically O 0 2.6246769514737256e-12
analyzed O 0 1.976532544405163e-13
by O 0 8.396954735267331e-14
an O 0 1.3547340603926178e-13
exon O 0 3.831469863602166e-11
- O 0 1.735481550135809e-11
by O 0 2.3702642626410864e-10
- O 0 1.0812496498147084e-07
exon O 0 3.556208127974969e-07
denaturing O 0 3.4315576158405747e-06
gradient O 0 5.813487469197298e-09
gel O 0 6.489580539614792e-10
electrophoresis O 0 3.051906991013986e-11
( O 0 7.217596745962007e-12
DGGE O 0 8.980491372767574e-08
) O 0 4.4648852215271873e-13
strategy O 0 1.6312942750090764e-12
followed O 0 7.198726342675169e-14
by O 0 6.680550549060561e-15
direct O 0 1.5650637253186717e-13
sequencing O 0 4.0800679891941916e-13
in O 0 6.022363597396607e-13
seven O 0 3.475124701890486e-11
unrelated O 0 1.255500703400969e-09
heterozygous O 0 4.6468329628623906e-08
HC B-Disease 1 1.0
patients O 0 3.7839315014664976e-10
from O 0 2.6102440521535986e-12
France O 0 4.646812712394421e-09
, O 0 5.230587230703465e-12
Holland O 0 4.4479941951891533e-10
, O 0 2.7828225834802822e-12
and O 0 4.183061015627931e-12
Czech O 0 5.840736889695108e-07
Republic O 0 1.336285208708432e-06
. O 0 2.306645825456144e-07

Seven O 0 1.4193980213406121e-08
novel O 0 2.0039618575662388e-10
mutations O 0 9.286617481951698e-12
and O 0 3.668340804729997e-12
two O 0 2.142791369688646e-12
new O 0 6.411574049458579e-11
polymorphisms O 0 9.226989838850841e-09
were O 0 4.2130938737727774e-09
detected O 0 8.161762821146112e-08
. O 0 2.3971367113517772e-08

Among O 0 2.5095134859043355e-09
these O 0 4.109109233429997e-11
mutations O 0 2.8723105491290646e-11
two O 0 1.1121623587351248e-11
are O 0 2.918287139719311e-12
missense O 0 1.550235828595703e-09
( O 0 9.92208658984195e-12
G197W O 0 7.09222280903532e-09
, O 0 3.335690057504337e-11
W427R O 0 1.9589829758359656e-09
) O 0 7.275727871743076e-13
, O 0 8.135880207385537e-13
two O 0 1.7815940779944417e-12
are O 0 5.652460921198865e-13
nonsense O 0 2.7424473802994953e-10
( O 0 2.38241826440444e-12
Q306X O 0 1.6365262478501563e-09
, O 0 8.338565081478233e-12
Q385X O 0 3.368940404424592e-10
) O 0 4.166710650555655e-13
, O 0 3.554194427917573e-13
two O 0 3.7378945967093957e-13
are O 0 1.0571345909109534e-13
small O 0 6.011048321423462e-13
deletions O 0 2.15225441635436e-11
( O 0 5.5228517072125616e-12
662de14bp O 0 2.1442869702070766e-09
; O 0 3.0695491287646703e-11
1168del3bp O 0 3.5673016895998444e-07
removing O 0 2.0240396736426192e-07
a O 0 1.3544370069951128e-09
glycine O 0 4.71396166545901e-09
at O 0 1.8410419855285909e-09
position O 0 1.7595705448236743e-10
390 O 0 6.980952708263155e-12
) O 0 8.19449624258825e-14
, O 0 1.472065199771555e-13
and O 0 3.5347915458387724e-13
one O 0 1.394609579728756e-12
is O 0 6.890478313793802e-13
a O 0 1.2144649869094692e-11
splicing O 0 7.359650111560256e-10
mutation O 0 2.4878266113859127e-11
( O 0 9.96422128834995e-13
IVS1 O 0 4.9136257729287536e-08
- O 0 2.5503832379314417e-10
15c O 0 2.1509105607719903e-09
- O 0 4.573285639075664e-10
- O 0 2.761116613125836e-10
> O 0 3.134644765978578e-10
g O 0 6.238489586030127e-11
) O 0 5.066115577176053e-14
which O 0 5.2876973632987045e-14
creates O 0 9.505115878410964e-13
a O 0 6.470022000798492e-12
new O 0 3.3558815448753165e-11
acceptor O 0 5.658550017439978e-11
splice O 0 1.2908565771851954e-08
site O 0 3.967896233803003e-09
. O 0 1.0151155471760376e-09

The O 0 6.98296087620065e-09
pathological O 0 1.9075190493822447e-07
significance O 0 2.2269810440178617e-09
of O 0 1.1493598295331253e-09
the O 0 2.936693943578206e-10
point O 0 1.1063747695772008e-09
mutations O 0 2.6493978452085676e-12
G197W O 0 3.391350533732407e-10
, O 0 3.114628346900794e-12
W427R O 0 6.253516038334794e-10
, O 0 2.966641472409992e-12
and O 0 1.1468047648663382e-12
the O 0 2.889096253899659e-11
in O 0 6.956499265520222e-11
- O 0 8.522798022880806e-10
frame O 0 1.1447375491968614e-08
deletion O 0 6.720095591106201e-10
390delGly O 0 2.130625453844459e-09
were O 0 3.1943107881016175e-11
assessed O 0 4.108325138418856e-11
by O 0 7.777806176889612e-13
their O 0 1.1982023880030557e-11
respective O 0 8.534441209295807e-11
expression O 0 6.12274120292966e-11
in O 0 2.502254263167525e-12
a O 0 2.7200700459389937e-12
prokaryotic O 0 1.925209340905565e-12
system O 0 9.616430048098312e-12
using O 0 5.55045321769948e-13
site O 0 3.7720254003614784e-11
- O 0 1.6974048902551608e-11
directed O 0 3.529318157169392e-11
mutagenesis O 0 9.381844634503977e-09
. O 0 3.415761229419445e-09

These O 0 5.4706853630515084e-11
mutations O 0 8.548349528236798e-12
resulted O 0 8.04143557298076e-12
in O 0 1.9983567751957754e-12
the O 0 2.5668477759976938e-11
absence O 0 5.259533919499404e-10
or O 0 2.1011296001682833e-12
a O 0 6.783745440386291e-12
dramatic O 0 3.659448299941914e-10
decrease O 0 4.002997933127972e-10
of O 0 1.0200925437686692e-08
CPO O 0 0.17177678644657135
activity O 0 4.052977686797021e-08
. O 0 3.787456570591985e-09

The O 0 5.90147886114778e-09
two O 0 1.8224255438070713e-11
polymorphisms O 0 1.2009264693801924e-09
were O 0 4.391168331729922e-11
localized O 0 3.2599062338434237e-10
in O 0 6.337345145185358e-12
noncoding O 0 6.519414869066154e-11
part O 0 2.258120556861143e-12
of O 0 3.1654470711295346e-11
the O 0 1.002522891091484e-11
gene O 0 4.485199646582505e-13
1 O 0 1.707360294811444e-11
) O 0 6.379612871911791e-15
a O 0 5.304944309357518e-13
C O 0 3.6550676374424995e-10
/ O 0 4.1266573491682834e-10
G O 0 8.584533084388113e-10
polymorphism O 0 8.847170218651002e-11
in O 0 7.443782569505064e-12
the O 0 4.748500898044128e-11
promotor O 0 1.986242459395271e-08
region O 0 1.2220266465412521e-10
, O 0 1.754240741384805e-12
142 O 0 1.6433496924372903e-11
bp O 0 1.7956915468464452e-11
upstream O 0 5.311089025170079e-13
from O 0 3.0296671746886383e-13
the O 0 1.31833953476157e-11
transcriptional O 0 1.178198788531759e-10
initiation O 0 1.3931241577003206e-11
site O 0 1.1441072048090639e-11
( O 0 8.277564424912301e-14
- O 0 1.0005590973805045e-11
142C O 0 7.288100123403751e-10
/ O 0 2.6387507734426663e-09
G O 0 2.3487178868464298e-09
) O 0 2.1598064862179273e-13
, O 0 1.170132513019645e-13
and O 0 2.592494632597947e-13
2 O 0 4.9744885294300545e-11
) O 0 5.181291390398725e-14
a O 0 3.03814070255759e-12
6 O 0 8.667582623855807e-11
bp O 0 2.713789262753785e-12
deletion O 0 1.1101907154004165e-12
polymorphism O 0 1.1032627719384513e-12
in O 0 4.655480102984388e-13
the O 0 5.7450042986739724e-12
3 O 0 8.20517473409943e-11
noncoding O 0 2.6716051246267192e-11
part O 0 4.282128471255753e-12
of O 0 6.373982591734162e-11
the O 0 9.00662600056279e-10
CPO O 0 1.9063020317844348e-06
gene O 0 3.78764797304143e-11
, O 0 5.77726625219932e-12
574 O 0 4.086716035023308e-11
bp O 0 2.312959372641199e-11
downstream O 0 1.7264739984867994e-12
of O 0 1.569187141337025e-11
the O 0 3.4851409952407764e-11
last O 0 4.4695167705777195e-11
base O 0 2.7899934099129275e-11
of O 0 7.163509369023657e-11
the O 0 3.721261632172457e-10
normal O 0 3.6618588161729804e-09
termination O 0 4.649026996705885e-10
codon O 0 1.2397138871023117e-10
( O 0 1.2096857803650662e-12
+ O 0 2.8945732963303605e-11
574 O 0 2.844100233101443e-10
delATTCTT O 0 5.020935223143397e-09
) O 0 3.878009371960367e-11
. O 0 1.1265081090172657e-09

Five O 0 1.2175055985608196e-07
intragenic O 0 4.59352895632037e-06
dimorphisms O 0 7.312749858101597e-06
are O 0 4.3494152723866364e-11
now O 0 2.573012766390881e-12
well O 0 2.5949630898941534e-13
characterized O 0 2.1328462000008708e-12
and O 0 1.3664144414473472e-13
the O 0 1.2106990757154712e-12
high O 0 3.713139604816229e-12
degree O 0 3.319252511735371e-11
of O 0 1.1774859733082454e-11
allelic O 0 7.350419162222011e-10
heterogeneity O 0 3.3183489289712043e-10
in O 0 2.475675740798433e-11
HC B-Disease 0 0.11748058348894119
is O 0 2.1136354819151215e-11
demonstrated O 0 1.582734811267361e-11
with O 0 1.5268332659388456e-13
seven O 0 6.9631865377839386e-12
new O 0 1.1121681917428128e-12
different O 0 6.485471746231139e-14
mutations O 0 3.916301148394058e-13
making O 0 9.860238710593383e-13
a O 0 6.213415199018968e-13
total O 0 3.1780103722234276e-12
of O 0 9.358993441344055e-11
nineteen O 0 1.2647481639760372e-07
CPO O 1 0.9997949004173279
gene B-Disease 0 2.143525961173509e-07
defects I-Disease 0 1.161286036222009e-06
reported O 0 8.186790828590418e-11
so O 0 3.543906704553401e-12
far O 0 1.3607641922985803e-11
. O 0 2.7867864266228892e-11
. O 0 1.199127241946485e-09

Coincidence O 0 1.4368637835104892e-08
of O 0 2.653427477739001e-09
two O 0 1.7800394838674016e-11
novel O 0 3.8259635043447204e-11
arylsulfatase O 0 8.59538307196317e-09
A O 0 5.265727298642275e-10
alleles O 0 1.4073260785896213e-12
and O 0 2.768227270674717e-12
mutation O 0 8.32202987077757e-11
459 O 0 9.798142297512413e-10
+ O 0 8.37001667974846e-09
1G O 0 0.0028201548848301172
> O 0 2.004608745664882e-07
A O 0 3.537874437853361e-09
within O 0 4.8586336343081626e-11
a O 0 1.3689331786193026e-11
family O 0 1.2658188299624618e-12
with O 0 1.593871042093742e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 5.570224836937143e-12
molecular O 0 5.334798575118427e-12
basis O 0 3.703372244284742e-12
of O 0 1.170263018435147e-11
phenotypic O 0 1.5663220054307203e-08
heterogeneity O 0 4.1182168786235707e-08
. O 0 8.416987995474301e-09

In O 0 5.053871099391927e-09
a O 0 1.1275764766338625e-09
family O 0 6.658870937287231e-12
with O 0 1.7138620167153618e-12
three O 0 4.936247244291536e-11
siblings O 0 5.4416707251370156e-11
, O 0 1.3377161791477965e-12
one O 0 3.7323448368389855e-13
developed O 0 1.8061545314917993e-11
classical O 0 6.934016028026235e-08
late O 0 0.007256131153553724
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.1052906367936544e-09
MLD B-Disease 1 1.0
) O 0 1.800433717044636e-12
, O 0 1.4005139279196777e-12
fatal O 0 7.098909016178823e-09
at O 0 1.4186095631529838e-09
age O 0 3.111591539983749e-10
5 O 0 1.3624744665818866e-09
years O 0 1.176992010798461e-11
, O 0 7.272009600392537e-13
with O 0 5.084144910627586e-12
deficient O 0 2.7673812041939527e-07
arylsulfatase O 0 1.564604099257849e-05
A O 0 2.0192388205941825e-07
( O 0 4.3010699168899436e-12
ARSA O 0 1.0200754729794426e-07
) O 0 9.233304225364503e-14
activity O 0 1.7224545357727439e-12
and O 0 1.2264309305533988e-13
increased O 0 1.2639859645058316e-11
galactosylsulfatide O 0 2.4236824103240906e-08
( O 0 4.715002277499991e-10
GS O 1 0.9999998807907104
) O 0 7.258242618046751e-11
excretion O 0 1.7736087043473958e-09
. O 0 6.323538359609415e-10

The O 0 2.2390739928823677e-08
two O 0 2.7205812602737467e-10
other O 0 6.82919970573792e-11
siblings O 0 2.3932202886101095e-09
, O 0 1.7833433341163385e-10
apparently O 0 5.321767915233977e-09
healthy O 0 7.333782470198003e-10
at O 0 6.51362963566271e-09
12 O 0 8.865232437038628e-10
( O 0 9.04736626328867e-13
1 O 0 1.6715179240733846e-09
/ O 0 7.176422789356707e-10
2 O 0 1.0201946926136074e-10
) O 0 8.987675173869301e-15
and O 0 5.476147286282915e-14
15 O 0 1.920361005630644e-12
years O 0 7.141047193674754e-13
, O 0 1.914318448767785e-13
respectively O 0 2.900795055549299e-12
, O 0 9.497015803980324e-13
and O 0 2.513380345861571e-12
their O 0 2.8378834004971765e-11
father O 0 8.800047496260177e-11
, O 0 4.4859227443794225e-11
apparently O 0 2.0299949221591618e-10
healthy O 0 1.2293947977692898e-11
as O 0 5.148410994401664e-13
well O 0 5.194603427960409e-13
, O 0 8.603665739917443e-13
presented O 0 1.4888126287360137e-09
ARSA O 0 5.4582091252086684e-05
and O 0 3.823129812730031e-09
GS O 1 0.9998902082443237
values O 0 2.6402596775554343e-10
within O 0 4.757639421315574e-11
the O 0 1.0366434273489933e-11
range O 0 6.048758161014689e-10
of O 0 4.81741802005331e-09
MLD B-Disease 1 1.0
patients O 0 1.0065637212619549e-07
. O 0 8.742805590600256e-09

Mutation O 0 9.55732382124097e-10
screening O 0 2.300733076276984e-10
and O 0 7.782866690529688e-13
sequence O 0 7.409781338854615e-13
analysis O 0 2.2563499462932568e-13
disclosed O 0 4.691038356374744e-12
the O 0 5.072385653864808e-12
involvement O 0 8.11137268463824e-12
of O 0 4.5906396739514577e-11
three O 0 1.3342714953734625e-11
different O 0 7.91440957909062e-12
ARSA O 0 1.750377668940928e-05
mutations O 0 7.227326376257892e-11
being O 0 6.3053698547144155e-12
the O 0 1.7688459204301399e-12
molecular O 0 2.730321697896887e-11
basis O 0 5.224257831892842e-11
of O 0 2.949335220492344e-10
intrafamilial O 0 5.063644152869529e-07
phenotypic O 0 1.0655625146682723e-06
heterogeneity O 0 4.770431587530766e-07
. O 0 2.9723343786258738e-08

The O 0 2.8437179722118344e-08
late O 0 5.232391231402289e-06
infantile O 1 0.9979398846626282
patient O 0 1.8006295121608673e-08
inherited O 0 6.667332463905495e-09
from O 0 3.786860755528032e-11
his O 0 7.233011412033363e-10
mother O 0 8.226314074377683e-11
the O 0 2.852450220469649e-10
frequent O 0 1.9790706573541428e-10
0 O 0 4.04929823005773e-09
- O 0 5.434848127094938e-10
type O 0 1.6286481052674162e-09
mutation O 0 7.852258288032488e-10
459 O 0 5.547498571623066e-10
+ O 0 4.709502232635998e-10
1G O 0 5.455216978589306e-06
> O 0 7.123893919214197e-09
A O 0 3.1838864877897777e-10
, O 0 1.1076013560094508e-13
and O 0 9.78443332757227e-14
from O 0 3.5939095666473464e-13
his O 0 1.937240472205115e-11
father O 0 2.937370485733837e-11
a O 0 6.044830434814852e-12
novel O 0 1.946848064704465e-12
, O 0 3.111444478801073e-13
single O 0 1.3140316959536769e-11
basepair O 0 6.120786100183295e-09
microdeletion O 0 1.9250368410439478e-08
of O 0 1.3097940509965156e-09
guanine O 0 1.7406448504786454e-09
at O 0 7.7815025534278e-09
nucleotide O 0 1.8850891958521743e-09
7 O 0 9.384260479805562e-09
in O 0 2.4701723999598357e-10
exon O 0 4.672623177270907e-09
1 O 0 2.1378550041362132e-09
( O 0 4.935369387476518e-12
7delG O 0 3.0868134714978623e-09
) O 0 3.5789326363611096e-11
. O 0 8.23399459726204e-10

The O 0 5.096327360121222e-09
two O 0 3.8464750828914873e-10
clinically O 0 9.707936214908841e-07
unaffected O 0 9.562637615090352e-08
siblings O 0 1.4796057434818266e-10
carried O 0 3.8390554624179174e-11
the O 0 1.1569495361740678e-10
maternal O 0 8.05939426307134e-10
mutation O 0 1.4779810708631658e-10
459 O 0 1.630509061101293e-10
+ O 0 1.1800503907366533e-09
1G O 0 1.0928352821792942e-05
> O 0 5.9172808875018745e-09
A O 0 4.29042273930591e-10
and O 0 2.603073193194888e-13
, O 0 6.924030847375168e-14
on O 0 1.3518960256808654e-11
their O 0 1.3247438085742247e-12
paternal O 0 1.5085683353552315e-12
allele O 0 6.206971785507887e-13
, O 0 6.056711799847306e-14
a O 0 2.317386191795501e-13
novel O 0 2.4983617605278674e-13
cytosine O 0 7.720021670543087e-12
to O 0 6.576282487319451e-13
thymidine O 0 2.7156560333807533e-10
transition O 0 3.6871650177516813e-10
at O 0 3.888432631438121e-10
nucleotide O 0 5.90741067174605e-10
2435 O 0 5.705964412072717e-08
in O 0 1.6226433391386408e-11
exon O 0 1.712586961133411e-09
8 O 0 4.0262992939688047e-10
, O 0 9.534585577661292e-13
resulting O 0 1.3308371332038105e-12
in O 0 1.11495697657088e-12
substitution O 0 8.337758955478947e-11
of O 0 1.2898854206966348e-10
alanine O 0 3.397708780994435e-10
464 O 0 1.4050746677263248e-10
by O 0 9.273135037624058e-11
valine O 0 3.581827172638441e-07
( O 0 4.4472116961236097e-11
A464V O 0 1.741343069738832e-08
) O 0 1.2093386014822016e-10
. O 0 2.2057682347309537e-09

The O 0 1.6873434560693568e-07
fathers O 0 2.6993197010938275e-08
genotype O 0 3.026381589776861e-09
thus O 0 1.6090283272429673e-10
was O 0 5.781461420717449e-10
7delG O 0 3.8662722801063865e-08
/ O 0 2.822476687924791e-07
A464V O 0 6.097112077441125e-07
. O 0 1.67971325737426e-08

Mutation O 0 2.8144931718543376e-08
A464V O 0 6.182339973292983e-08
was O 0 1.889920442366133e-09
not O 0 2.075526165865038e-12
found O 0 5.168778274312891e-13
in O 0 9.293257352896434e-13
18 O 0 9.116808974418689e-10
unrelated O 0 6.039317099748587e-07
MLD B-Disease 1 1.0
patients O 0 2.481445493529577e-09
and O 0 4.1487212970592324e-11
50 O 0 2.0500188213645743e-09
controls O 0 8.62840067838988e-07
. O 0 1.61159761091767e-08

A464V O 0 3.325747002236312e-07
, O 0 1.4461470909665763e-10
although O 0 9.51940401505702e-11
clearly O 0 4.423878277592941e-11
modifying O 0 4.708783363227553e-10
ARSA O 0 3.469776129350066e-05
and O 0 4.085013216581501e-09
GS O 1 1.0
levels O 0 6.728810575395983e-08
, O 0 1.1720679114757271e-11
apparently O 0 5.241135303535316e-11
bears O 0 1.2397321016988094e-11
little O 0 2.2098401125485168e-13
significance O 0 4.538037480517065e-12
for O 0 3.803897572363796e-13
clinical O 0 4.6483708548983316e-10
manifestation O 0 1.6272204916845112e-08
of O 0 1.0531364225130346e-08
MLD B-Disease 1 1.0
, O 0 1.665038523723794e-10
mimicking O 0 5.0626507430706624e-09
the O 0 3.1399001176879437e-09
frequent O 0 7.934618651006531e-08
ARSA O 0 0.007006846833974123
pseudodeficiency O 0 1.7141655916930176e-05
allele O 0 1.8692296066546987e-07
. O 0 2.1662520666154705e-08

Our O 0 3.442224993932541e-08
results O 0 2.424872802553324e-10
demonstrate O 0 2.1712374953519742e-11
that O 0 5.799440788711863e-14
in O 0 2.9609585725128007e-13
certain O 0 8.116634100940878e-12
genetic O 0 3.495603584369178e-09
conditions O 0 5.349336333893007e-06
MLD B-Disease 1 1.0
- O 0 2.6802229058375815e-07
like O 0 2.1764889890363293e-09
ARSA O 1 0.9977760910987854
and O 0 7.891645559254812e-09
GS O 1 1.0
values O 0 6.110762451605467e-10
need O 0 2.8193120581165854e-12
not O 0 2.015053942661712e-14
be O 0 7.693579931120076e-15
paralleled O 0 1.1282539843799483e-13
by O 0 2.8301925419135093e-14
clinical O 0 3.1394469601764285e-07
disease O 0 7.848492344919578e-08
, O 0 1.524845516780865e-13
a O 0 5.14423898444194e-13
finding O 0 1.1873182558658213e-12
with O 0 1.257477737388879e-13
serious O 0 4.648914142535432e-09
diagnostic O 0 4.670629039082996e-08
and O 0 1.0005786477140788e-10
prognostic O 0 0.00011357825860613957
implications O 0 3.338852394563219e-08
. O 0 2.486391759148887e-09

Moreover O 0 3.484049670987588e-08
, O 0 3.37239292047542e-10
further O 0 8.957543040644111e-10
ARSA O 0 2.778310954454355e-05
alleles O 0 4.088362703935644e-10
functionally O 0 6.459756618504287e-10
similar O 0 5.661700275272352e-12
to O 0 2.733884516339935e-12
A464V O 0 1.465342291950833e-09
might O 0 1.3272653375667742e-12
exist O 0 7.932359738678507e-13
which O 0 2.610002261516607e-14
, O 0 2.2145901716727652e-14
together O 0 5.2457773639259103e-14
with O 0 7.749523136917069e-13
0 O 0 2.1073938150095728e-09
- O 0 7.409901858768109e-11
type O 0 3.3713622171749336e-11
mutations O 0 2.885993961171396e-12
, O 0 1.5211070521648634e-13
may O 0 4.673515914543902e-12
cause O 0 1.9272795859226477e-10
pathological O 0 0.01396052073687315
ARSA O 1 0.5078983902931213
and O 0 1.03912878302026e-09
GS O 1 1.0
levels O 0 3.3853293501806547e-09
, O 0 7.072859957218611e-14
but O 0 1.0191987465308413e-14
not O 0 1.9433883484670095e-14
clinical O 0 4.918165874556735e-11
outbreak O 0 4.963475463970468e-11
of O 0 8.828977479669042e-12
the O 0 9.627501573739039e-11
disease O 0 1.0049921783661375e-08
. O 0 9.1589782633128e-12
. O 0 2.3162141649102352e-10

Human O 0 0.020261645317077637
MLH1 O 1 1.0
deficiency O 1 0.9999994039535522
predisposes O 0 3.5490322147779807e-07
to O 0 3.759588640406264e-09
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 4.542939890939124e-08
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.00257163611240685
1 I-Disease 0 0.2404782623052597
. O 0 1.5488446081235452e-08

Heterozygous O 0 3.534065839971845e-08
germ O 0 7.81680398631579e-07
- O 0 3.607653065174077e-09
line O 0 7.623163766901087e-10
mutations O 0 8.712280029354869e-12
in O 0 8.553482900262865e-13
the O 0 5.7593579211312473e-11
DNA O 0 2.7459032825305485e-09
mismatch O 0 4.523347172380454e-07
repair O 0 5.447224538102091e-08
genes O 0 5.435592254077193e-11
lead O 0 3.390574487838194e-10
to O 0 7.821731456969516e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1542478972614845e-07

The O 0 1.033882426781929e-06
disease O 0 0.00020780735940206796
susceptibility O 0 2.0486204732605984e-08
of O 0 2.203661475519425e-09
individuals O 0 3.3226585545442777e-12
who O 0 5.953867954211489e-10
constitutionally O 0 0.00020329123071860522
lack O 0 1.4049924175196793e-06
both O 0 1.1435034169560154e-10
wild O 0 1.6522529122653395e-08
- O 0 5.181774107021475e-11
type O 0 7.778823418735925e-11
alleles O 0 2.2940789892733626e-12
is O 0 7.817397445521179e-13
unknown O 0 6.653164685843649e-10
. O 0 4.686821486465931e-10

We O 0 6.459682233561637e-10
have O 0 7.844088334603427e-13
identified O 0 1.1553937060565511e-12
three O 0 2.0503900226981342e-13
offspring O 0 8.89609729198132e-13
in O 0 1.9741513653838416e-13
a O 0 3.2260411009232826e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 4.405761977466227e-09
who O 0 6.748337305628738e-11
developed O 0 7.154998371561305e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999992847442627
at O 0 2.7186390028077767e-08
a O 0 2.4380516702726673e-11
very O 0 2.1847988370717053e-13
early O 0 9.644705173394996e-11
age O 0 1.6867545554744012e-11
, O 0 6.751781208777508e-13
and O 0 1.1140471141077302e-12
at O 0 2.1353313561789378e-10
least O 0 1.0009365298407902e-12
two O 0 1.947589902935934e-13
of O 0 1.6638820529712994e-11
them O 0 8.142773022697114e-13
displayed O 0 9.181148064030253e-10
signs O 0 3.2248138381874014e-08
of O 0 3.5793321639943088e-09
neurofibromatosis B-Disease 0 0.00015560799511149526
type I-Disease 0 3.0478975787673335e-08
1 I-Disease 0 1.8750108665699372e-07
( O 0 9.257830613229601e-11
NF1 B-Disease 0 4.156331954163761e-07
) O 0 4.2900363816933407e-11
. O 0 1.0890350843340002e-09

DNA O 0 9.027797953642391e-10
sequence O 0 1.3915174568168709e-11
analysis O 0 3.5100559611644933e-12
and O 0 1.4561874926363738e-12
allele O 0 1.5801158124995052e-12
- O 0 2.556127184916157e-12
specific O 0 1.8513532720754178e-12
amplification O 0 1.571008080569758e-11
in O 0 1.4857750446628515e-12
two O 0 2.9615533116145176e-12
siblings O 0 3.001200676866489e-11
revealed O 0 2.037761209772171e-10
a O 0 9.053607169517974e-11
homozygous O 0 2.6754644721904697e-08
MLH1 O 0 2.151656553905923e-05
mutation O 0 1.5553885956975932e-10
( O 0 1.5604385188508485e-12
C676T O 0 3.182686114655553e-09
- O 0 4.350367532879318e-08
- O 0 1.2908459723348642e-07
> O 0 1.8616475472299499e-07
Arg226Stop O 0 1.3055243925919058e-06
) O 0 5.241245285003693e-11
. O 0 4.3769135538163084e-10

Thus O 0 2.0797614741496773e-09
, O 0 1.290596102210273e-11
a O 0 1.2127797030525578e-11
homozygous O 0 1.2546484962072668e-09
germ O 0 1.1997810361208394e-05
- O 0 1.0482670376177339e-07
line O 0 5.786034407151419e-08
MLH1 O 0 4.1787538066273555e-05
mutation O 0 1.2952032502067112e-10
and O 0 1.2060710503219996e-12
consequent O 0 6.239034178179281e-08
mismatch O 1 0.9999347925186157
repair O 1 0.9999995231628418
deficiency O 1 0.9999936819076538
results O 0 4.927748431526879e-09
in O 0 6.60971347099526e-11
a O 0 2.433555579273161e-10
mutator O 0 5.3240437409840524e-05
phenotype O 0 2.29770702464549e-10
characterized O 0 4.438497746422909e-12
by O 0 2.7541063505297225e-13
leukemia B-Disease 0 0.014332064427435398
and O 0 1.1206832128962674e-09
/ O 1 0.9999991655349731
or O 1 0.7366573214530945
lymphoma B-Disease 1 1.0
associated O 1 0.628559947013855
with O 0 1.353120171465605e-09
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 7.111078957677819e-06
1 I-Disease 0 3.3522962894494412e-06
. O 0 4.775021350544861e-11
. O 0 3.155231353968446e-10

Missense O 0 1.6935790654315497e-06
mutations O 0 1.6593486584781658e-09
in O 0 1.7769770377373817e-10
the O 0 5.47507206238862e-10
most O 0 6.664651903270924e-12
ancient O 0 1.3311710067576144e-10
residues O 0 5.357577048670237e-09
of O 0 2.729137360546474e-09
the O 0 1.0585658571926615e-08
PAX6 O 0 0.00027058570412918925
paired O 0 4.136541331689614e-09
domain O 0 1.4466223774434184e-09
underlie O 0 8.493911130003085e-10
a O 0 4.940238756273585e-12
spectrum O 0 4.1131179018272235e-10
of O 0 5.525765400804517e-10
human O 0 0.00033371595782227814
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 7.720771009189775e-07

Mutations O 0 1.2596023113431443e-09
of O 0 5.997177754402117e-10
the O 0 3.8908215538313584e-10
human O 0 3.050129482318198e-09
PAX6 O 0 9.169559052679688e-05
gene O 0 8.442053278656658e-09
underlie O 0 5.076537490822375e-06
aniridia B-Disease 1 1.0
( O 0 7.968956924742088e-05
congenital B-Disease 1 1.0
absence I-Disease 1 0.9834255576133728
of I-Disease 0 1.5060726582305506e-05
the I-Disease 0 1.3233474760454556e-08
iris I-Disease 0 3.832248296475882e-09
) O 0 6.637741029567878e-13
, O 0 1.0247005067381965e-12
a O 0 3.8635684929122505e-11
rare O 0 8.866625194059452e-07
dominant O 1 0.9999825954437256
malformation B-Disease 1 1.0
of I-Disease 1 0.9998903274536133
the I-Disease 1 0.7442313432693481
eye I-Disease 1 0.9999988079071045
. O 0 3.206356495866203e-07

The O 0 2.3805322157954834e-09
spectrum O 0 1.13899005782514e-08
of O 0 5.702392780193577e-09
PAX6 O 0 0.0002500346163287759
mutations O 0 5.680722003909011e-10
in O 0 5.66282909453264e-10
aniridia B-Disease 1 1.0
patients O 0 3.166736650683788e-09
is O 0 1.925833624516482e-12
highly O 0 4.339866573749296e-12
biased O 0 9.61274029126491e-13
, O 0 1.3007982379773225e-14
with O 0 1.3908386873034018e-14
92 O 0 7.459818873734037e-11
% O 0 2.721947558841087e-13
of O 0 5.567240245196725e-12
all O 0 6.0357981633563096e-12
reported O 0 2.1753163506610385e-11
mutations O 0 8.353098594759967e-12
leading O 0 4.4364031892563105e-10
to O 0 1.5470914480064657e-11
premature O 0 2.1003154770937726e-09
truncation O 0 4.6611422277464953e-08
of O 0 2.296719259220481e-08
the O 0 1.4596432951208271e-09
protein O 0 3.93883120564098e-11
( O 0 1.9170964728892903e-12
nonsense O 0 4.2802222877114104e-10
, O 0 6.790295756231579e-12
splicing O 0 1.1474361738539329e-10
, O 0 1.059214131335362e-12
insertions O 0 3.0428611019761576e-12
and O 0 3.2388601891621127e-13
deletions O 0 1.907387225594248e-12
) O 0 1.293337453193294e-13
and O 0 1.9565640340529766e-12
just O 0 2.0355925278714437e-11
2 O 0 1.569250979160941e-10
% O 0 1.1892403294772036e-12
leading O 0 1.8209940499946953e-11
to O 0 6.175135815016108e-13
substitution O 0 2.149031230747056e-10
of O 0 1.2925926995421833e-09
one O 0 5.986614676212199e-11
amino O 0 1.827836076939704e-10
acid O 0 6.449925229329301e-12
by O 0 6.430170523645529e-13
another O 0 1.6807265648677294e-11
( O 0 1.982578380979594e-12
missense O 0 3.5804177400677872e-09
) O 0 2.2604097413281288e-11
. O 0 1.965746454501982e-09

The O 0 6.1810290219455055e-09
extraordinary O 0 1.7964676413129155e-09
conservation O 0 2.5811073278703134e-09
of O 0 2.6085442139667236e-10
the O 0 7.932643986130472e-10
PAX6 O 0 1.914632093757973e-06
protein O 0 4.3733586196914587e-10
at O 0 1.7353277703691106e-09
the O 0 2.6092124016940943e-09
amino O 0 3.2755849588284036e-08
acid O 0 1.342416067195984e-09
level O 0 1.3934349851751904e-07
amongst O 0 5.422444160352313e-10
vertebrates O 0 8.317923572143116e-10
predicts O 0 2.6276900100263845e-10
that O 0 6.590245384997806e-13
pathological O 0 5.1915235417254735e-06
missense O 0 9.786026211600074e-09
mutations O 0 1.177908291738472e-11
should O 0 5.406284686419738e-13
in O 0 4.002770608458467e-13
fact O 0 1.4033002190827482e-12
be O 0 2.581123249162376e-12
common O 0 2.6422217278693205e-12
even O 0 3.767161008052383e-13
though O 0 5.642550771241261e-13
they O 0 2.1826288064234756e-13
are O 0 3.831113418585434e-14
hardly O 0 7.45773755250756e-12
ever O 0 2.653787996645396e-12
seen O 0 2.1702271923995653e-11
in O 0 7.095192489092739e-11
aniridia B-Disease 1 1.0
patients O 0 1.9531748662870996e-08
. O 0 2.9400695211734273e-09

This O 0 4.0309998394771895e-11
indicates O 0 9.232397832348305e-12
that O 0 5.0540897422041153e-14
there O 0 5.418537797272083e-13
is O 0 1.3501835283494246e-13
a O 0 1.3968164732508503e-12
heavy O 0 3.7005813968704615e-09
ascertainment O 0 1.0425303997863011e-07
bias O 0 5.1125423339293263e-11
in O 0 6.609757229394941e-13
the O 0 4.24422042649697e-12
selection O 0 3.462472713058884e-12
of O 0 2.1950052886410276e-11
patients O 0 1.8044731290786653e-12
for O 0 3.1289667037914803e-12
PAX6 O 0 1.7506730500826961e-06
mutation O 0 4.722035696486104e-12
analysis O 0 1.5274858201214103e-13
and O 0 2.216987579845356e-13
that O 0 2.1061359036997351e-13
the O 0 1.364569846007413e-10
missing O 0 5.207340780799541e-09
PAX6 O 0 0.00018520384037401527
missense O 0 7.511099653356723e-08
mutations O 0 3.301391937604592e-10
frequently O 0 1.6208371450554537e-11
may O 0 2.462080712917203e-11
underlie O 0 1.5174647094440274e-09
phenotypes O 0 1.0279275347579997e-10
distinct O 0 5.418199743034702e-12
from O 0 6.503405453051059e-11
textbook O 0 3.360935079399496e-05
aniridia B-Disease 1 1.0
. O 0 1.9066551715241076e-07

Here O 0 5.701870975372003e-09
we O 0 2.0186153096291015e-11
present O 0 5.095882049666045e-12
four O 0 2.4214640709230295e-12
novel O 0 4.469320399880239e-11
PAX6 O 0 7.76267711444234e-07
missense O 0 1.5644461281993927e-09
mutations O 0 1.4491939549429733e-12
, O 0 2.2910433316106205e-13
two O 0 1.6631505471865343e-13
in O 0 1.1597173742161626e-11
association O 0 2.2238136332397573e-10
with O 0 7.764648299324328e-12
atypical O 0 2.2214254613572848e-07
phenotypes O 0 1.9043376653371524e-08
ectopia B-Disease 0 4.1942703887798416e-07
pupillae I-Disease 0 9.603214579101405e-08
( O 0 5.050202010054017e-12
displaced B-Disease 0 2.9922956473749096e-11
pupils I-Disease 0 2.135709144257536e-11
) O 0 4.228496025548978e-12
and O 0 3.474758614174789e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 1.5341745929209338e-10
searching B-Disease 0 3.442536533615481e-10
gaze I-Disease 0 5.522520218903537e-10
) O 0 6.502837954528926e-14
, O 0 8.180831907083144e-14
and O 0 1.6268036180308587e-13
two O 0 7.552324651077802e-13
in O 0 2.895059018903634e-11
association O 0 1.9937634876399102e-10
with O 0 9.423940794395236e-12
more O 0 3.786297317343035e-11
recognizable O 0 3.589333573472686e-06
aniridia B-Disease 1 1.0
phenotypes O 0 7.354449849117373e-07
. O 0 5.938469271882241e-09

Strikingly O 0 2.844890616415796e-07
, O 0 1.9746073665061203e-09
all O 0 6.298320753828079e-10
four O 0 1.8515562694165766e-10
mutations O 0 3.154405556204942e-11
are O 0 2.093600900282544e-12
located O 0 1.1969923663368576e-10
within O 0 6.118798245857704e-10
the O 0 3.7914031913999224e-09
PAX6 O 0 5.105066884425469e-05
paired O 0 3.1278197809569974e-09
domain O 0 9.453258176250756e-10
and O 0 4.1503994685498924e-11
affect O 0 2.7494290177898506e-10
amino O 0 6.024118981429183e-10
acids O 0 5.396273705660093e-12
which O 0 4.911168043422731e-13
are O 0 8.867666529462775e-14
highly O 0 4.773923769317567e-13
conserved O 0 2.827724165932466e-12
in O 0 3.142903038516609e-12
all O 0 1.4599425834926905e-11
known O 0 1.5344789328075592e-10
paired O 0 9.405275447349482e-10
domain O 0 1.2972632967844788e-09
proteins O 0 1.2452118502981335e-10
. O 0 8.048257615911325e-10

Our O 0 1.2965293727518201e-08
results O 0 2.1333243505061716e-10
support O 0 4.9339320823404975e-11
the O 0 6.240905708887468e-11
hypothesis O 0 7.851322023078033e-12
that O 0 8.926955617045377e-15
the O 0 1.7210580562695282e-13
under O 0 1.541464872412135e-12
- O 0 1.0095107258814573e-12
representation O 0 5.841143541074345e-12
of O 0 4.3600300453361385e-11
missense O 0 1.0544288109315403e-08
mutations O 0 5.43920151974131e-11
is O 0 5.456861091462928e-13
caused O 0 8.805130236044789e-12
by O 0 3.0474847905609392e-12
ascertainment O 0 5.6089538702508435e-06
bias O 0 1.8780124122486086e-09
and O 0 4.221799559250838e-12
suggest O 0 1.7153435789840632e-12
that O 0 3.293297641429431e-14
a O 0 1.1442309773290749e-12
substantial O 0 4.298562547577767e-11
burden O 0 5.80265002714242e-10
of O 0 5.577178185944831e-08
PAX6 B-Disease 1 1.0
- I-Disease 1 0.999991774559021
related I-Disease 0 0.48363399505615234
disease I-Disease 1 0.9999980926513672
remains O 0 1.0672264849631574e-08
to O 0 7.047076680880004e-13
be O 0 4.5728620542973e-12
uncovered O 0 1.4053970209815247e-09
. O 0 4.8921942885638003e-11
. O 0 1.0451157717028536e-09

The O 0 3.23988160744193e-08
chromosomal O 0 5.25921336702595e-07
order O 0 2.0360255703621988e-09
of O 0 1.4501474465689057e-09
genes O 0 2.4814856766641746e-11
controlling O 0 1.5905835537566304e-09
the O 0 1.011945194306918e-09
major O 0 4.6002877951423216e-08
histocompatibility O 0 8.830019737615658e-07
complex O 0 8.829579734026538e-09
, O 0 6.0785907557425745e-12
properdin O 0 1.0448073517466128e-08
factor O 0 4.4309320101909577e-10
B O 0 7.837004289967808e-08
, O 0 3.1964667458056484e-12
and O 0 4.342319559480501e-11
deficiency B-Disease 0 3.091328082405198e-08
of I-Disease 0 5.133108516020002e-08
the I-Disease 0 1.4958439820134117e-08
second I-Disease 0 2.9081341779146896e-09
component I-Disease 0 2.7580859818243653e-09
of I-Disease 0 3.9388430295161925e-09
complement I-Disease 0 3.090644185022029e-08
. O 0 2.4506153550873933e-08

The O 0 1.9797097294826926e-09
relationship O 0 1.137225556779864e-11
of O 0 4.6133052933328145e-10
the O 0 4.240389428478153e-10
genes O 0 7.0133035663666465e-12
coding O 0 1.3192784364957078e-10
for O 0 1.0359713954743999e-11
HLA O 0 1.5961534871600236e-10
to O 0 3.868652631317665e-13
those O 0 1.559363532396829e-13
coding O 0 3.86391439677336e-11
for O 0 1.6789026766050874e-12
properdin O 0 1.5215163573500945e-09
Factor O 0 7.15097703274381e-11
B O 0 1.0864831256895968e-09
allotypes O 0 2.453545422387293e-10
and O 0 1.5468841485510865e-12
for O 0 2.1880913747551745e-11
deficiency B-Disease 0 3.5103426831994966e-09
of I-Disease 0 3.5630867145641787e-09
the I-Disease 0 6.093618387659205e-10
second I-Disease 0 2.254374603660736e-10
component I-Disease 0 2.9196708939416283e-10
of I-Disease 0 7.480240316048992e-10
complement I-Disease 0 2.8852609190721523e-09
( O 0 1.6576552630542807e-10
C2 O 0 1.9829067277044032e-09
) O 0 6.145804758118587e-14
was O 0 2.6911094880288644e-12
studied O 0 6.5410463503945415e-12
in O 0 4.660437075316992e-13
families O 0 5.9624932758056e-14
of O 0 5.8044184042538305e-11
patients O 0 5.131497449184508e-10
with O 0 3.7101650640636308e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 4.469354280445259e-06

Patients O 0 2.442915025824277e-08
were O 0 4.469152270480947e-10
selected O 0 4.022566654771076e-11
because O 0 4.066955106019066e-12
they O 0 6.597338777711292e-13
were O 0 1.1895714448206807e-12
heterozygous O 0 3.78677211115841e-12
or O 0 9.931755938497044e-13
homozygous O 0 2.157321077334018e-08
for O 0 3.961516483741434e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.8909793548546077e-08

12 O 0 6.595643498030768e-08
families O 0 8.705021078969644e-12
with O 0 5.789754092822008e-12
15 O 0 1.1011662692794744e-09
matings O 0 6.656557527406903e-09
informative O 0 6.5175314034604526e-09
for O 0 1.0283265510224737e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.4743742105547426e-08
found O 0 1.4354351041134805e-10
. O 0 8.771865456225214e-10

Of O 0 5.907585318709607e-07
57 O 0 8.992866185053572e-08
informative O 0 1.857811682270949e-09
meioses O 0 2.7949136338634162e-08
, O 0 6.681121367951848e-12
two O 0 4.3330161507426634e-13
crossovers O 0 2.760703124438102e-12
were O 0 7.80226360949654e-13
noted O 0 1.2483590550171897e-12
between O 0 4.116576871049382e-11
the O 0 0.0013862678315490484
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.0533116873444612e-11
and O 0 3.326804164181102e-13
the O 0 8.946571782020296e-12
HLA O 0 3.06703551444798e-09
- O 0 1.3660523823233461e-09
B O 0 7.444163063752285e-09
gene O 0 4.0968829891074865e-12
, O 0 3.0992535740483745e-14
with O 0 1.0650879422944692e-14
a O 0 1.5023258245067117e-12
recombinant O 0 1.089017331173947e-11
fraction O 0 7.314134541080985e-12
of O 0 2.6254257101676615e-10
0 O 0 4.496706296208686e-08
. O 0 1.666933258093195e-09

035 O 0 0.008316706866025925
. O 0 3.93169511880842e-06

A O 0 8.203481627333531e-08
lod O 0 5.921184538237867e-07
score O 0 1.0063824218420336e-09
of O 0 1.96570038024646e-10
13 O 0 1.7840373622846073e-10
was O 0 3.964359396313455e-11
calculated O 0 2.0303528823484296e-12
for O 0 7.574540495693116e-13
linkage O 0 4.6788681373755026e-08
between O 0 1.4063962225918658e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.6868646757206562e-10
HLA O 0 3.067505360832001e-08
- O 0 5.174231043625355e-10
B O 0 5.8329132635037695e-09
at O 0 2.2107151179118212e-11
a O 0 1.5076584728920817e-13
maximum O 0 1.6958829089294691e-12
likelihood O 0 2.697099813452064e-13
value O 0 2.046779493938486e-13
of O 0 3.0152321069641663e-13
the O 0 8.15520773741335e-13
recombinant O 0 4.260198097072454e-12
fraction O 0 1.4639907125121865e-12
of O 0 9.277274087837739e-11
0 O 0 2.3699321616277302e-08
. O 0 3.1540055012158064e-09

04 O 0 0.0010771142551675439
. O 0 2.142082166756154e-06

18 O 0 5.164287841807891e-08
families O 0 5.7407325421143796e-12
with O 0 2.4097748536205943e-12
21 O 0 1.3249707997431415e-09
informative O 0 1.1860852577871839e-11
matings O 0 2.4561800510136678e-11
for O 0 1.1357856929267163e-12
both O 0 2.6011538842990456e-12
properdin O 0 6.765407789544042e-09
Factor O 0 6.811732289335737e-10
B O 0 9.213851903666637e-09
allotype O 0 1.5295005262316863e-09
and O 0 1.858866012505178e-11
HLA O 0 3.142298155012213e-08
- O 0 2.180491520675787e-08
B O 0 5.558391649174155e-07
were O 0 4.1202868894529843e-10
found O 0 2.0502913256059685e-10
. O 0 6.910810812499335e-10

Of O 0 9.373349030283862e-07
72 O 0 1.153695848188363e-06
informative O 0 8.445000254653223e-09
meioses O 0 2.814515198679146e-07
, O 0 1.2771357582597176e-10
three O 0 4.850550169854806e-11
recombinants O 0 6.527013596269171e-08
were O 0 6.023130882937267e-10
found O 0 1.6864135088390242e-11
, O 0 1.710175295648042e-12
giving O 0 1.4334261208559518e-11
a O 0 1.1651916410893026e-11
recombinant O 0 8.286343833319165e-11
fraction O 0 4.641599604671143e-11
of O 0 1.0413926387897732e-09
0 O 0 1.3325751524462248e-07
. O 0 5.762549992738286e-09

042 O 0 0.0020001381635665894
. O 0 4.643449756258633e-06

A O 0 1.4887005761465844e-07
lod O 0 8.526193369107204e-07
score O 0 2.1074542111421124e-09
of O 0 4.709672651870278e-10
16 O 0 3.60950935807125e-10
between O 0 3.622287192417417e-11
HLA O 0 9.365756881152265e-08
- O 0 5.738354680318025e-09
B O 0 1.3523648867419524e-08
and O 0 1.7474883302545652e-12
Factor O 0 2.530129578071083e-11
B O 0 1.0726972643482213e-09
allotypes O 0 1.9715805377185092e-10
was O 0 7.887465854061748e-12
calculated O 0 7.828558222684745e-13
at O 0 5.10685764509855e-12
a O 0 2.2739554922206195e-13
maximum O 0 2.9918717243254678e-12
likelihood O 0 8.302298735649027e-13
value O 0 7.728444620380692e-13
of O 0 7.877673665300511e-13
the O 0 7.463653718502161e-13
recombinant O 0 1.959301427698068e-12
fraction O 0 1.651587937592791e-12
of O 0 5.2245173465248484e-11
0 O 0 2.4979296853189226e-08
. O 0 2.028122558783707e-09

04 O 0 0.001089718658477068
. O 0 2.9134739634173457e-06

A O 0 1.3135675658304535e-08
crossover O 0 1.3145443622519792e-09
was O 0 2.652824071525117e-10
shown O 0 2.6950132663711157e-12
to O 0 1.6114151300209573e-13
have O 0 8.59336134694487e-14
occurred O 0 8.784928622225519e-13
between O 0 2.4058229367018846e-14
genes O 0 2.2642207119644153e-14
for O 0 1.1570068565876744e-14
Factor O 0 7.407859590503885e-13
B O 0 1.4265182091133255e-10
and O 0 1.894313482117549e-12
HLA O 0 1.850999353791849e-09
- O 0 1.5253198704101578e-09
D O 0 9.705926728997838e-09
, O 0 3.6598057483877566e-13
in O 0 2.4245362661989844e-13
which O 0 4.875012611475771e-13
HLA O 0 3.785492364016818e-09
- O 0 8.544287055656241e-09
D O 0 4.164917655202771e-08
segregared O 0 7.877915209064668e-09
with O 0 4.25988931629373e-12
HLA O 0 6.766610027852948e-08
- O 0 3.48718587339647e-09
A O 0 1.0151799401114658e-08
and O 0 9.254687988180521e-11
B O 0 3.127720447082538e-07
. O 0 1.985825059946933e-09

These O 0 1.2464569654202506e-10
studies O 0 2.0229899352908198e-11
suggest O 0 2.1636709351263717e-12
that O 0 2.6452244325622827e-14
the O 0 2.8928923601241607e-13
genes O 0 4.4074651290833614e-14
for O 0 1.5669663646061122e-13
Factor O 0 1.0095470015514252e-09
B O 1 0.9997506737709045
and O 0 0.002006086753681302
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.242638695934939e-12
located O 0 2.5452246647100774e-12
outside O 0 3.909168561772036e-12
those O 0 2.1313027772219655e-14
for O 0 4.1777323787905996e-13
HLA O 0 4.665691721861265e-10
, O 0 2.5464325743504435e-13
that O 0 1.5743682806003065e-14
the O 0 9.240672463328714e-13
order O 0 1.6573279207343639e-12
of O 0 3.1727292234412507e-12
genese O 0 5.399614644296946e-10
is O 0 2.084292347005398e-13
HLA O 0 2.3684285435643382e-11
- O 0 1.0239937370259966e-11
A O 0 5.399553026919079e-10
, O 0 1.939032484923886e-12
- O 0 4.3863381676834123e-11
B O 0 7.3135590916706406e-09
, O 0 9.48691732810536e-12
- O 0 6.210829628372494e-10
D O 0 3.701767559149971e-09
, O 0 7.342728855497249e-13
Factor O 0 9.646636267568454e-11
B O 0 7.353930868703173e-07
allotype O 0 0.00014191018999554217
, O 0 1.648229385864397e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.249223028623389e-13
that O 0 1.2684224152717766e-15
the O 0 6.6276811241852e-14
genes O 0 3.052421867783678e-13
coding O 0 1.9380408389224613e-09
for O 0 9.358702612871639e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.4786757715777874e-11
Factor O 0 1.102809440989283e-10
B O 0 2.4142134957827466e-09
allotypes O 0 2.2078801287239713e-10
are O 0 4.378221401282701e-15
approximately O 0 1.9386411523141227e-15
3 O 0 7.801816918201476e-13
- O 0 8.283538785458511e-13
- O 0 7.605090168727457e-12
5 O 0 2.5648020166024743e-11
centimorgans O 0 1.305359154102348e-10
from O 0 2.473657671926699e-13
the O 0 5.111662395446137e-12
HLA O 0 2.418193978392935e-10
- O 0 2.8171525875975156e-11
A O 0 3.4803071535804975e-10
and O 0 3.569264024963492e-12
HLA O 0 6.063662461031072e-09
- O 0 1.3008950860982083e-10
B O 0 3.886867772084912e-10
loci O 0 2.1601824062161823e-12
, O 0 2.4245762461540948e-14
and O 0 7.85709286532394e-15
that O 0 1.6352543852774849e-15
the O 0 5.304346913960478e-13
apparent O 0 4.7935641567242726e-11
lack O 0 4.185457189165298e-11
of O 0 1.9391988015371453e-12
recombinants O 0 5.092629790093284e-11
between O 0 5.653064279707853e-13
the O 0 1.9457874547712528e-11
Factor O 0 6.206484215454111e-10
B O 0 3.441822627792135e-06
gene O 0 1.016015744426113e-06
and O 0 0.022979050874710083
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.45397274617676e-09
suggests O 0 5.8210680199677345e-12
that O 0 4.8125752379534967e-14
these O 0 7.177639965673041e-14
two O 0 3.204791846397187e-13
genes O 0 1.0397279825297145e-12
lie O 0 1.1167239875875534e-11
in O 0 1.0686277166979674e-12
close O 0 2.9439943538545066e-11
proximity O 0 4.909733175573194e-10
to O 0 3.1217953569417922e-12
one O 0 3.730626571551987e-11
another O 0 5.994753027316335e-10
. O 0 9.612649343182511e-09

Distribution O 0 2.8433422283313803e-09
of O 0 5.223864452119642e-09
emerin O 0 1.9418719432451326e-07
and O 0 1.9463786138373962e-10
lamins O 0 2.1283990747633652e-07
in O 0 4.2130413741015005e-11
the O 0 5.80085701695765e-10
heart O 0 7.42428625244429e-08
and O 0 6.768623855846201e-12
implications O 0 9.286781760264873e-11
for O 0 1.6274601458143856e-11
Emery B-Disease 1 0.999103844165802
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.090294194407761e-05

Emerin O 0 0.00028414331609383225
is O 0 2.448296676504924e-09
a O 0 7.437687132849646e-10
nuclear O 0 7.502437426865072e-08
membrane O 0 1.514185304918314e-10
protein O 0 1.9868988399007748e-11
which O 0 1.7984421731790518e-13
is O 0 6.731309845457722e-13
missing O 0 2.95451371701283e-11
or O 0 7.583854551296287e-12
defective O 0 3.923291913565663e-09
in O 0 3.2825114848478165e-10
Emery B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.907475032377988e-06
EDMD B-Disease 1 1.0
) O 0 4.0912337406773247e-10
. O 0 7.011892733110869e-10

It O 0 4.550262944214012e-10
is O 0 2.824879219431864e-11
one O 0 1.2826670281462782e-11
member O 0 3.812648807777208e-10
of O 0 3.342930554595114e-08
a O 0 5.614459652747428e-08
family O 0 1.5800631636420093e-10
of O 0 8.29563830961888e-08
lamina O 1 0.9999722242355347
- O 0 1.558864141770755e-06
associated O 0 5.750892384526196e-08
proteins O 0 1.1718473413857566e-10
which O 0 2.7934265144080594e-12
includes O 0 1.2839299935729631e-11
LAP1 O 0 5.226775556366192e-06
, O 0 1.588233433658104e-10
LAP2 O 0 1.8409311451250687e-05
and O 0 2.0995905014586924e-09
lamin O 0 6.077981197449844e-06
B O 0 1.5323679747325514e-07
receptor O 0 5.058796714862979e-10
( O 0 2.390243385164137e-11
LBR O 0 1.3883864369290677e-07
) O 0 4.089936375684111e-11
. O 0 1.8335636342570183e-09

A O 0 6.974882580834674e-06
panel O 0 6.790412498958176e-08
of O 0 6.100494331917616e-09
16 O 0 1.4057998320993192e-08
monoclonal O 0 8.057626788016137e-10
antibodies O 0 4.315073645622114e-11
( O 0 1.0408217690494048e-11
mAbs O 0 1.0379996862042162e-09
) O 0 3.916166978375213e-13
has O 0 6.119127557088766e-13
been O 0 4.664430191918256e-13
mapped O 0 5.55896387949284e-12
to O 0 6.493966605777834e-13
six O 0 4.265857198731959e-12
specific O 0 1.3228729093053837e-12
sites O 0 3.6411356568732955e-11
throughout O 0 8.886338886959777e-11
the O 0 2.4847074397982283e-10
emerin O 0 5.788901358272369e-09
molecule O 0 8.452174724005168e-12
using O 0 4.616055801487384e-12
phage O 0 5.421117374448947e-11
- O 0 8.857533630168835e-12
displayed O 0 6.95745475121079e-11
peptide O 0 1.7062566637360277e-11
libraries O 0 6.730414836564336e-12
and O 0 2.9495221369468805e-13
has O 0 1.7166845202309933e-13
been O 0 3.0764033356368847e-13
used O 0 1.5274858201214103e-13
to O 0 4.609630277312149e-13
localize O 0 1.0010450246511482e-09
emerin O 0 6.3902767521994974e-09
in O 0 9.366811146160892e-12
human O 0 1.1985938630498794e-10
and O 0 4.1517456139672504e-11
rabbit O 0 2.1658188131823408e-07
heart O 0 2.6681096642278135e-05
. O 0 6.463632473696634e-08

Several O 0 3.638801260308355e-08
mAbs O 0 2.9937731937934586e-07
against O 0 4.666815378584488e-09
different O 0 4.7984123618949326e-11
emerin O 0 2.3263027060238528e-07
epitopes O 0 2.2699317980823253e-07
did O 0 2.9603576534587006e-11
not O 0 5.000548586320264e-13
recognize O 0 4.706372010859772e-12
intercalated O 0 1.1946500733106546e-10
discs O 0 6.129509677599287e-10
in O 0 2.4957147893439613e-12
the O 0 4.78117302693537e-11
heart O 0 1.3944368326690437e-08
, O 0 9.3695580807851e-13
though O 0 3.608774249482666e-13
they O 0 9.07890977024442e-14
recognized O 0 1.6343650608222071e-12
cardiomyocyte O 0 9.974980841320757e-10
nuclei O 0 4.416897403380915e-11
strongly O 0 5.321465490482069e-12
, O 0 6.993063354950035e-13
both O 0 7.87785808809005e-12
at O 0 2.1279134898577468e-08
the O 0 5.268301794814079e-09
rim O 0 6.048692213767026e-09
and O 0 1.1498279758881402e-11
in O 0 4.491281999086105e-11
intranuclear O 0 3.12152153014722e-08
spots O 0 5.934642111071753e-09
or O 0 6.869869950687502e-11
channels O 0 2.8054125689180864e-09
. O 0 1.1155611545632382e-08

A O 0 1.6579531347815646e-06
polyclonal O 0 1.529929477328551e-06
rabbit O 0 8.59286330978648e-08
antiserum O 0 2.1923291626535502e-07
against O 0 1.9390769878668834e-08
emerin O 0 6.073480562918121e-07
did O 0 2.1725642118664013e-10
recognize O 0 1.930830217933277e-10
both O 0 1.2099563538592317e-11
nuclear O 0 3.2172986497158718e-09
membrane O 0 1.1860966202259515e-11
and O 0 1.9973764666964683e-13
intercalated O 0 1.9337628720528244e-11
discs O 0 2.3331298004691803e-10
but O 0 1.542231647293571e-13
, O 0 3.500592014610976e-14
after O 0 3.1919931108015387e-13
affinity O 0 1.1466206402323958e-13
purification O 0 1.3817871326315956e-11
against O 0 2.804029404501751e-11
a O 0 1.604081797945689e-11
pure O 0 1.7520900286172036e-09
- O 0 1.0046601328639326e-09
emerin O 0 1.1675541600197903e-07
band O 0 1.6112226219888726e-08
on O 0 1.4217165222873973e-09
a O 0 1.1877537148263784e-11
western O 0 3.600349185450824e-11
blot O 0 1.8535890600190896e-09
, O 0 1.2535660010026817e-11
it O 0 3.1124016124789433e-12
stained O 0 2.5975001705091927e-08
only O 0 4.029493405610651e-11
the O 0 6.964415155685799e-10
nuclear O 0 2.628673598792375e-07
membrane O 0 6.9314474160364625e-09
. O 0 6.145324804585073e-10

These O 0 5.533601910023833e-10
results O 0 3.238457280119178e-10
would O 0 1.1416634998484554e-11
not O 0 5.320833292195293e-13
be O 0 3.154624456623567e-13
expected O 0 1.9278474216316566e-12
if O 0 6.726587060794376e-13
immunostaining O 0 4.963440214389436e-10
at O 0 2.6491265778250117e-11
intercalated O 0 5.46980863380675e-11
discs O 0 1.047786302166287e-09
were O 0 6.250957650805189e-12
due O 0 4.614693696614047e-11
to O 0 2.277849404323101e-13
a O 0 1.19489032383846e-12
product O 0 3.689208227103391e-12
of O 0 1.5942358544407398e-11
the O 0 4.012811610776268e-11
emerin O 0 4.278200016472056e-09
gene O 0 3.4839366634675795e-12
and O 0 1.1928751172604612e-12
, O 0 2.484187443425878e-13
therefore O 0 2.7577861327031383e-13
, O 0 5.727471448502275e-14
cast O 0 9.453190183764115e-13
some O 0 6.467164992548721e-14
doubt O 0 3.1216585306276246e-12
upon O 0 1.8127514734515154e-13
the O 0 6.10081917710309e-13
hypothesis O 0 1.6645922921304512e-12
that O 0 1.14385958387489e-13
cardiac B-Disease 1 0.9999998807907104
defects I-Disease 1 0.9893465638160706
in O 0 5.007376202570413e-08
EDMD B-Disease 1 1.0
are O 0 6.25117527186525e-11
caused O 0 1.4191446628952775e-10
by O 0 1.502096515747231e-12
absence O 0 4.579519874425841e-09
of O 0 2.4510440344016615e-09
emerin O 0 1.1831118484906256e-07
from O 0 7.290877623855607e-11
intercalated O 0 2.824565470405105e-08
discs O 0 1.6450258044642396e-06
. O 0 1.869232768569873e-08

Although O 0 8.65615756850957e-09
emerin O 0 2.7701403837454563e-07
was O 0 3.2198588240106574e-09
abundant O 0 1.1169247471354282e-10
in O 0 4.271034914626881e-12
the O 0 3.808010157202446e-11
membranes O 0 3.5347478416491995e-11
of O 0 2.6057098145848556e-10
cardiomyocyte O 0 2.5918435397898065e-08
nuclei O 0 1.2882921118784196e-10
, O 0 3.9813230837126845e-12
it O 0 1.3922203234012498e-12
was O 0 2.3150756867096334e-09
absent O 0 2.6566686628370917e-09
from O 0 5.553845144196101e-12
many O 0 6.829561655791183e-12
non O 0 4.8774062122447503e-08
- O 0 2.123537568010647e-09
myocyte O 0 9.308923267781211e-07
cells O 0 2.388553799193005e-10
in O 0 1.0771965784639459e-11
the O 0 1.3554061206733081e-09
heart O 0 3.28980308950122e-06
. O 0 1.7729602674876332e-08

This O 0 5.132255731510327e-12
distribution O 0 8.035951071239111e-11
of O 0 5.758130638966463e-10
emerin O 0 1.5931537689084507e-07
was O 0 5.3872111216435314e-09
similar O 0 5.420887697060728e-12
to O 0 3.043974035506214e-13
that O 0 2.1684210145794108e-13
of O 0 5.693022719910346e-10
lamin O 0 5.402586111813434e-07
A O 0 4.815764675925038e-09
, O 0 2.7228002838497467e-12
a O 0 8.228851627878342e-12
candidate O 0 9.07727365495603e-12
gene O 0 2.559952683861555e-12
for O 0 1.2530108244382387e-12
an O 0 7.47730436595484e-13
autosomal O 0 2.642004170994028e-09
form O 0 4.207408199619067e-09
of O 0 2.2638430891674943e-05
EDMD B-Disease 1 1.0
. O 0 2.0310044135385397e-07

In O 0 1.9978987353397315e-09
contrast O 0 9.975098969050578e-09
, O 0 5.299321870211315e-09
lamin O 0 0.008702585473656654
B1 O 0 0.000313614058541134
was O 0 3.9061056611444656e-08
absent O 0 1.5970503142170855e-08
from O 0 2.9849307053853025e-11
cardiomyocyte O 0 2.7319197570818687e-08
nuclei O 0 2.861381409591246e-10
, O 0 2.09639011879148e-12
showing O 0 8.813204055435619e-10
that O 0 2.4698615375129407e-10
lamin O 0 0.0014482877450063825
B1 O 0 5.897548476241354e-07
is O 0 7.462572226835107e-13
not O 0 4.4557629477358016e-14
essential O 0 1.9975155210461004e-11
for O 0 1.3487120491609272e-12
localization O 0 4.458545976859796e-09
of O 0 5.689274051867699e-11
emerin O 0 2.7846001060538583e-09
to O 0 8.132967389828938e-12
the O 0 1.3907520690636943e-09
nuclear O 0 4.922105290461332e-06
lamina O 0 3.0364893973455764e-05
. O 0 7.916433020227487e-08

Lamin O 1 0.9999573230743408
B1 O 0 0.05290248245000839
is O 0 6.838940525000226e-10
also O 0 3.4119096437024155e-11
almost O 0 6.440217109604518e-11
completely O 0 3.59664120708203e-08
absent O 0 3.912607837719406e-08
from O 0 4.944957776586989e-10
skeletal O 0 0.00023302496992982924
muscle O 0 5.055062865721993e-05
nuclei O 0 1.2991157518627006e-06
. O 0 1.586424502875161e-08

In O 0 1.3627584394271253e-08
EDMD B-Disease 1 1.0
, O 0 1.378407943342097e-10
the O 0 2.5312300866442428e-11
additional O 0 4.115742469057437e-12
absence O 0 1.056395082521533e-09
of O 0 1.516525216516129e-08
lamin O 0 0.462747186422348
B1 O 0 0.010430916212499142
from O 0 8.730070555351688e-10
heart O 1 0.9999909400939941
and O 0 1.136017431235814e-06
skeletal O 1 1.0
muscle O 1 0.9999709129333496
nuclei O 0 2.734333975240588e-06
which O 0 1.4765583200571086e-10
already O 0 3.148808991326746e-11
lack O 0 1.4665368475164087e-08
emerin O 0 1.2112471381442447e-07
may O 0 1.5069700695646837e-11
offer O 0 4.201014400717282e-14
an O 0 8.583266916499261e-15
alternative O 0 6.97766497359531e-12
explanation O 0 8.558819343355839e-13
of O 0 9.605412819302384e-12
why O 0 1.77000363150992e-12
these O 0 2.561099119238741e-13
tissues O 0 1.941124171123132e-11
are O 0 1.56030665276162e-13
particularly O 0 3.68900927600474e-13
affected O 0 1.3553343560304687e-12
. O 0 5.263211741435292e-12
. O 0 1.009452632594332e-09

Genetic O 0 9.574017134639234e-10
mapping O 0 4.5908168933017635e-10
of O 0 2.4338446813487735e-09
the O 0 5.670029779025754e-09
copper B-Disease 0 2.4640203832859697e-07
toxicosis I-Disease 0 8.437704309471883e-06
locus O 0 4.997545932639014e-09
in O 0 3.988829544443462e-10
Bedlington O 0 2.1032533936704567e-07
terriers O 0 1.6309366301925365e-08
to O 0 1.4811410778414746e-11
dog O 0 5.949997161636134e-10
chromosome O 0 1.4548730276064958e-10
10 O 0 2.4866405809453873e-11
, O 0 2.4331806101202114e-13
in O 0 7.185204579755744e-13
a O 0 1.0245876196079973e-11
region O 0 1.0254092713823937e-10
syntenic O 0 2.5034039285998233e-09
to O 0 5.9689388848260805e-12
human O 0 4.1225800551103475e-11
chromosome O 0 2.7624019738325956e-10
region O 0 1.3462134740294118e-09
2p13 O 0 6.185312173556667e-08
- O 0 3.3341557070798444e-08
p16 O 0 2.681206190402463e-08
. O 0 5.998690877362378e-09

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9478586912155151
accumulation I-Disease 0 2.479756062712113e-07
is O 0 3.3069675470231985e-11
recognized O 0 7.372740612465734e-11
as O 0 8.873428034017472e-12
an O 0 1.600768649578921e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 5.145790460403532e-09
man O 0 2.1079636647325373e-10
, O 0 1.2014675278976261e-12
mouse O 0 1.7920391837122907e-09
, O 0 4.473064280086092e-11
rat O 0 1.9684112118056873e-08
and O 0 2.9521773914353844e-10
dog O 0 2.5645059054113517e-07
. O 0 1.4611426735200439e-08

The O 0 5.1864784467170466e-08
major O 0 2.2707200741933775e-07
cause O 0 1.0170190307690063e-06
of O 0 1.6851974578457884e-05
hepatic B-Disease 1 1.0
copper I-Disease 0 0.04472567141056061
accumulation I-Disease 0 3.9076712710084394e-07
in O 0 2.914521601837805e-08
man O 0 1.3337239757049701e-08
is O 0 1.773255153825204e-11
a O 0 8.255596900541562e-11
dysfunctional O 0 2.1179675790961028e-09
ATP7B O 0 9.084425073524471e-06
gene O 0 9.312944859729555e-11
, O 0 1.1825698840312038e-12
causing O 0 4.3587353171226084e-10
Wilson B-Disease 0 1.9030732545388673e-09
disease I-Disease 0 3.9103403537410486e-07
( O 0 4.121149255187362e-11
WD B-Disease 1 0.9999938011169434
) O 0 6.465167290414797e-10
. O 0 7.842817062453378e-09

Mutations O 0 3.3429161661047146e-09
in O 0 7.318327610583708e-10
the O 0 5.651793255623261e-09
ATP7B O 0 1.5870193237788044e-05
genes O 0 9.680643786591503e-11
have O 0 3.2431394809268044e-12
also O 0 1.1513964694870316e-12
been O 0 7.381794828176247e-13
demonstrated O 0 9.646244740479926e-12
in O 0 7.143012310112384e-12
mouse O 0 7.036950133709752e-09
and O 0 9.606265782835521e-10
rat O 0 4.0077392782222887e-07
. O 0 7.683865987928584e-09

The O 0 1.1920580078594867e-07
ATP7B O 0 5.540670463233255e-05
gene O 0 3.5959582533884316e-10
has O 0 2.3731027993384446e-12
been O 0 5.647180314517775e-13
excluded O 0 4.073141997296137e-12
in O 0 1.145422732357071e-13
the O 0 9.261741764146625e-13
much O 0 2.0111700933106436e-12
rarer O 0 4.3418912909487517e-10
human O 0 4.1647090220919836e-09
copper B-Disease 0 2.620416125864722e-06
overload I-Disease 0 0.0005774220917373896
disease O 1 0.9999936819076538
non B-Disease 0 3.462471067905426e-05
- I-Disease 0 4.722637392262641e-09
Indian I-Disease 0 1.8157923775685703e-10
childhood I-Disease 0 2.151615035472787e-06
cirrhosis I-Disease 1 0.9999586343765259
, O 0 2.698646341114941e-11
indicating O 0 8.910749915713723e-10
genetic O 0 5.080604825735691e-09
heterogeneity O 0 1.1792053555836901e-07
. O 0 1.0114555415441373e-08

By O 0 1.0227884095215245e-09
investigating O 0 5.0230806181161824e-09
the O 0 3.818531268962033e-09
common O 0 9.503452957915215e-08
autosomal O 0 0.00011605139297898859
recessive O 0 0.0005615537520498037
copper B-Disease 0 0.0016287604812532663
toxicosis I-Disease 1 0.999474823474884
( O 0 1.1327839360975034e-10
CT B-Disease 0 6.0789843701059e-06
) O 0 2.474791422138467e-12
in O 0 1.183157044559735e-11
Bedlington O 0 2.4541982668324636e-08
terriers O 0 4.995773128513292e-09
, O 0 4.4297191782727285e-12
we O 0 1.81487659102475e-12
have O 0 5.176312869547943e-14
identified O 0 7.062466524142622e-14
a O 0 6.058630160066247e-14
new O 0 8.528667003312659e-14
locus O 0 7.031573240334765e-12
involved O 0 1.3970076451989138e-13
in O 0 6.122694712340504e-11
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.4238833045965293e-07

We O 0 4.2798160571067e-09
examined O 0 5.311867612434185e-10
whether O 0 1.0111877481178144e-11
the O 0 4.3182624143156545e-10
WD B-Disease 1 0.9964743256568909
gene O 0 2.846941526968294e-08
ATP7B O 0 8.298603643197566e-05
was O 0 1.2199482313235421e-08
also O 0 1.1567040728022171e-11
causative O 0 6.246932138243011e-11
for O 0 4.433226789141154e-12
CT B-Disease 0 1.6834272642540782e-08
by O 0 2.266478454568399e-12
investigating O 0 3.676053905721233e-11
the O 0 8.343931101606472e-11
chromosomal O 0 6.3369925555889495e-06
co O 0 1.2189594826850225e-06
- O 0 1.3278015842388413e-07
localization O 0 5.812507151858881e-05
of O 0 5.705823014068301e-08
ATP7B O 0 7.584709237562492e-05
and O 0 1.7625735593274072e-10
C04107 O 0 1.3627576844754685e-09
, O 0 5.221513325881499e-13
using O 0 1.644304402923305e-13
fluorescence O 0 3.657365642978361e-12
in O 0 2.397836052978053e-12
situ O 0 3.6403663417061694e-10
hybridization O 0 2.581045620286826e-11
( O 0 2.043699931508769e-11
FISH O 0 1.0278893292081648e-08
) O 0 6.263465007066982e-12
. O 0 3.7489886195452016e-10

C04107 O 0 2.324290107935667e-06
is O 0 1.2395436066459098e-10
an O 0 1.655675596623496e-12
anonymous O 0 3.5610653315032437e-11
microsatellite O 0 3.051661323638655e-08
marker O 0 2.0781605769570888e-08
closely O 0 3.246658220046328e-10
linked O 0 3.102076373551199e-09
to O 0 3.4258990089242047e-10
CT B-Disease 0 0.4798610508441925
. O 0 3.1803331523860834e-08

However O 0 3.64246055539752e-08
, O 0 3.75198805357968e-09
BAC O 0 2.0060767838003812e-06
clones O 0 1.7927034079434634e-08
containing O 0 5.22162091343148e-10
ATP7B O 0 4.552568100280041e-07
and O 0 7.761246506587938e-11
C04107 O 0 2.6211537385023576e-09
mapped O 0 1.8146222025006153e-10
to O 0 1.1001680469413522e-11
the O 0 4.633800287923151e-10
canine O 0 1.2653290859532262e-08
chromosome O 0 2.4901933848298086e-09
regions O 0 9.403696710208465e-10
CFA22q11 O 0 5.104930664856511e-07
and O 0 2.900499285196645e-10
CFA10q26 O 0 1.74909658312572e-07
, O 0 1.2614017469436689e-11
respectively O 0 2.015410581479582e-11
, O 0 1.093679508935852e-12
demonstrating O 0 2.8621494063685304e-11
that O 0 4.2265934675767e-12
WD B-Disease 1 0.547168493270874
cannot O 0 6.461259860479629e-10
be O 0 3.4672310595534883e-12
homologous O 0 1.0892147427055132e-11
to O 0 3.0621810642728065e-11
CT B-Disease 0 2.0527922970359214e-05
. O 0 1.2566177431949654e-08

The O 0 2.3483525524170545e-07
copper O 0 2.2030916113635612e-07
transport O 0 4.392135988240398e-09
genes O 0 2.224225109648259e-10
CTR1 O 0 1.0217593171546469e-06
and O 0 1.3752461669458427e-10
CTR2 O 0 4.116083073313348e-05
were O 0 3.120554370461548e-10
also O 0 3.620966157122374e-12
excluded O 0 1.9228542369464918e-11
as O 0 9.953963651596065e-13
candidate O 0 3.660422225743032e-12
genes O 0 1.5177915619214027e-13
for O 0 2.9683381945998233e-13
CT B-Disease 0 4.7184261831034746e-08
since O 0 9.939099543387897e-11
they O 0 6.083041514080845e-13
both O 0 3.248362950153405e-13
mapped O 0 4.288211799541308e-11
to O 0 2.2221460782567704e-11
canine O 0 1.671429394889401e-08
chromosome O 0 1.362456902853637e-08
region O 0 1.3567079015786021e-08
CFA11q22 O 0 4.956405973643996e-06
. O 0 3.750966826032709e-08

2 O 0 5.289330147206783e-06
- O 0 2.212992740169284e-07
22 O 0 1.5464866010006517e-07
. O 0 4.5028169637362225e-08

5 O 0 2.3497228539781645e-05
. O 0 6.040509106242098e-07

A O 0 2.3457330300402646e-08
transcribed O 0 6.18828946419292e-11
sequence O 0 4.87354601119705e-12
identified O 0 2.5358192108637656e-12
from O 0 4.507101885719428e-13
the O 0 2.1300950586722323e-11
C04107 O 0 1.0483860446441895e-09
- O 0 3.1611346873461343e-10
containing O 0 6.349620274015422e-10
BAC O 0 1.1291668755575301e-07
was O 0 2.1106190406516845e-10
found O 0 7.387260291327746e-13
to O 0 6.339780724050684e-14
be O 0 1.455387053277482e-13
homologous O 0 7.272204214682498e-13
to O 0 1.595228804737378e-13
a O 0 2.8213510087221616e-12
gene O 0 2.2978932125161666e-12
expressed O 0 2.457011644921986e-13
from O 0 1.5435940828485706e-13
human O 0 4.864760504152965e-12
chromosome O 0 6.446509992485971e-11
2p13 O 0 1.2375078739523815e-09
- O 0 4.3263498339385364e-10
p16 O 0 9.490541685863718e-11
, O 0 9.322177361645312e-13
a O 0 1.7284278392218355e-12
region O 0 2.0962870328489203e-11
devoid O 0 2.412381627792115e-09
of O 0 2.1754740370250047e-11
any O 0 3.55791507367087e-11
positional O 0 1.0009350859263577e-07
candidate O 0 8.927596439889385e-09
genes O 0 1.2521431669298977e-09
. O 0 4.178840384838622e-09

Molecular O 0 1.3261842735090568e-09
analysis O 0 3.4153797845437595e-11
of O 0 6.303163546661494e-10
the O 0 2.2326378523729318e-09
APC B-Disease 0 6.07957373333079e-09
gene O 0 9.272440454344277e-12
in O 0 4.5077405350091304e-12
205 O 0 2.4618928423647546e-11
families O 0 1.189598143299178e-13
: O 0 5.465214869201929e-13
extended O 0 2.256422132473901e-10
genotype O 0 1.109210390204396e-09
- O 0 4.670633324543871e-10
phenotype O 0 7.63381094448512e-11
correlations O 0 2.986411465344396e-11
in O 0 1.961369001240998e-12
FAP B-Disease 0 1.4279691318286325e-10
and O 0 7.37652668982014e-14
evidence O 0 2.470734120768592e-13
for O 0 1.6560971344281583e-14
the O 0 3.889517017924976e-13
role O 0 1.2865573406975472e-12
of O 0 1.0722855936506903e-10
APC B-Disease 0 2.8533563067867362e-08
amino O 0 2.432702927990249e-09
acid O 0 3.2173888553366226e-10
changes O 0 2.0590698590616796e-10
in O 0 2.39700682413968e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.003218284109607339
. O 0 2.4581428448300358e-08

BACKGROUND O 0 1.1406645228362322e-07
/ O 0 9.05077044421887e-08
AIMS O 0 3.113029611867546e-09
The O 0 1.1772569898094165e-11
development O 0 9.314472804167195e-11
of O 0 3.052375063816726e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.525877757480032e-10
a O 0 4.5321207724213775e-12
variable O 0 2.5142540827083337e-11
range O 0 2.1790744555993946e-11
of O 0 8.371984529242926e-12
extracolonic O 0 4.506683737304229e-08
manifestations O 0 8.665082532388624e-06
in O 0 1.4845062068502557e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.0359431534823216e-08
FAP B-Disease 0 8.099700465891146e-08
) O 0 3.7667013063312493e-13
is O 0 5.557463465658864e-14
the O 0 1.0301561036499263e-12
result O 0 4.6577737326802815e-12
of O 0 4.218211890893997e-11
the O 0 3.4997779674306173e-10
dominant O 0 3.634784917494471e-08
inheritance O 0 1.0332713351601797e-08
of O 0 3.5798120734398253e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 9.810583456726363e-09
APC B-Disease 0 2.3978223850917857e-08
) O 0 1.5266427011439987e-11
gene O 0 7.747185115647426e-10
mutations O 0 2.269233023710626e-09
. O 0 7.55225304516216e-09

In O 0 1.5674442299662417e-10
this O 0 1.2391122199487126e-12
study O 0 2.0271516399088946e-13
, O 0 1.710760913898983e-14
direct O 0 1.095967663410774e-13
mutation O 0 5.354417132114389e-14
analysis O 0 1.3065471352936321e-14
of O 0 1.964686443048369e-12
the O 0 3.7690048998451076e-11
APC B-Disease 0 1.9840973308760113e-10
gene O 0 2.583329600583384e-12
was O 0 2.0877400502827825e-11
performed O 0 8.563329732813596e-12
to O 0 6.100481990227447e-13
determine O 0 1.7349982561754018e-11
genotype O 0 1.3440293322730668e-10
- O 0 9.309251286504505e-11
phenotype O 0 1.906846208710178e-11
correlations O 0 7.776267477166421e-12
for O 0 1.10267372489814e-12
nine O 0 2.696145910696668e-11
extracolonic O 0 3.5922176344627132e-09
manifestations O 0 3.8670542323870905e-08
and O 0 6.481913530226313e-13
to O 0 1.0370576738940457e-13
investigate O 0 9.065883894293636e-13
the O 0 1.8139904725891776e-12
incidence O 0 2.5501121214688283e-09
of O 0 1.411944033913315e-10
APC B-Disease 0 2.231913986960876e-09
mutations O 0 1.550601140543062e-11
in O 0 9.257195010548003e-11
non O 1 0.9999984502792358
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8084980385756353e-06

METHODS O 0 4.1630124769653776e-07
The O 0 2.441890245563627e-08
APC B-Disease 0 1.7876702784747067e-08
gene O 0 2.821282270304426e-11
was O 0 4.05018969751314e-11
analysed O 0 8.728296731208562e-12
in O 0 2.6720318666018095e-12
190 O 0 3.718776328542894e-11
unrelated O 0 7.120897621559763e-11
FAP B-Disease 0 1.537855065514293e-09
and O 0 2.719011864618648e-12
15 O 0 1.3291953093741427e-09
non O 1 0.999963641166687
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.336902754114135e-09
using O 0 4.59484429671253e-11
denaturing O 0 1.0235777381240041e-07
gradient O 0 1.6575857353373635e-10
gel O 0 3.0769817249698406e-11
electrophoresis O 0 4.6146914414735285e-12
, O 0 7.376165108395616e-13
the O 0 7.916916254513406e-12
protein O 0 1.0024770076555445e-11
truncation O 0 1.5146425225154303e-09
test O 0 4.078920534666963e-11
, O 0 1.8128344149177106e-13
and O 0 2.5303584639917165e-13
direct O 0 1.5124065194660474e-11
sequencing O 0 1.7605776558848873e-10
. O 0 1.1585246095791035e-09

RESULTS O 0 3.907753125531599e-07
Chain O 0 7.405024149420569e-08
terminating O 0 1.6778616274137903e-09
signals O 0 1.6467704977429776e-10
were O 0 1.0664434613172347e-11
only O 0 2.1030330526073532e-13
identified O 0 1.899288018525347e-12
in O 0 4.812212694299545e-12
patients O 0 3.2273671582427887e-12
belonging O 0 1.4252038785245169e-11
to O 0 1.3502331848089244e-12
the O 0 1.1437548685933052e-09
FAP B-Disease 0 1.5739713887796825e-07
group O 0 8.773852477883537e-11
( O 0 5.272797389682671e-12
105 O 0 8.041325827434775e-09
patients O 0 3.1657504395710134e-10
) O 0 7.702739487913668e-12
. O 0 5.046567608246733e-10

Amino O 0 3.709134261953295e-07
acid O 0 6.281872244606745e-10
changes O 0 1.2148912084675167e-11
were O 0 3.193115260050061e-12
identified O 0 9.399055969291914e-13
in O 0 1.5060153644996799e-12
four O 0 1.3371453250199394e-11
patients O 0 1.459245810124521e-12
, O 0 3.21882060935752e-13
three O 0 1.7915784958008607e-12
of O 0 2.2282131695305907e-09
whom O 0 1.8540299850933195e-10
belonged O 0 7.674477053853934e-09
to O 0 7.120880274325003e-12
the O 0 6.114073691776412e-10
non O 0 2.469879291311372e-06
- O 0 2.0242211462573323e-07
FAP O 0 2.563060888860491e-06
group O 0 7.363276210980985e-09
of O 0 0.0386619046330452
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.241093483869918e-05
. O 0 4.453667212800383e-09

Genotype O 0 4.192533651803387e-06
- O 0 3.624988664796547e-07
phenotype O 0 6.012505160413184e-09
correlations O 0 5.647447509637971e-10
identified O 0 2.504012622250862e-11
significant O 0 3.214367791035122e-12
differences O 0 2.366223536554024e-12
in O 0 1.8469548807020786e-12
the O 0 9.154297979374615e-12
nature O 0 1.6066538724435198e-11
of O 0 1.1559498150348624e-11
certain O 0 8.663462308655667e-12
extracolonic O 0 1.3826277012185528e-08
manifestations O 0 8.379493010579608e-08
in O 0 6.313113920519697e-10
FAP B-Disease 0 3.708271378854988e-07
patients O 0 2.42304978165242e-11
belonging O 0 2.7576205208212912e-11
to O 0 3.753034341635875e-12
three O 0 1.7629164794641383e-10
mutation O 0 1.8550577962628267e-08
subgroups O 0 1.0591882926291873e-07
. O 0 1.089014833866031e-08

CONCLUSIONS O 0 4.6918978569010505e-07
Extended O 0 1.9866707390292504e-08
genotype O 0 1.951476846784317e-08
- O 0 2.170328805561894e-09
phenotype O 0 1.2293063789137193e-10
correlations O 0 3.428315964448814e-11
made O 0 1.9462318041896243e-12
in O 0 2.3805818969747927e-13
this O 0 7.897617970839196e-14
study O 0 2.40595276991204e-13
may O 0 4.879087043239971e-13
have O 0 6.526247912311961e-14
the O 0 6.260022339908689e-13
potential O 0 4.364868384267029e-13
to O 0 2.110083416047119e-14
determine O 0 5.085965828176275e-13
the O 0 2.2965303703853523e-12
most O 0 9.487342281146866e-14
appropriate O 0 5.923953818806615e-13
surveillance O 0 1.7548482111884312e-10
and O 0 1.1237922051265947e-11
prophylactic O 0 7.627475042681908e-07
treatment O 0 2.9052678041097124e-09
regimens O 0 4.958132238108703e-10
for O 0 4.812543159121718e-12
those O 0 5.445613578125563e-12
patients O 0 3.406762448098649e-13
with O 0 1.7761228889002188e-14
mutations O 0 1.4108577587462756e-12
associated O 0 1.403632093367746e-12
with O 0 3.3707222126325154e-13
life O 0 7.299184173747975e-11
threatening O 0 1.5119242746663986e-08
conditions O 0 5.60905334623385e-07
. O 0 2.494604967040459e-09

This O 0 7.348508607174509e-11
study O 0 8.61049946621062e-12
also O 0 3.425985352616817e-13
provided O 0 4.523048534560252e-14
evidence O 0 3.7005175399645873e-13
for O 0 1.5475797455598989e-13
the O 0 1.318524933333065e-12
pathological O 0 1.972762841973008e-09
nature O 0 1.8488275146943955e-11
of O 0 2.267932890098745e-11
amino O 0 2.39440030302962e-11
acid O 0 1.149024994075154e-12
changes O 0 4.0576087411911543e-13
in O 0 1.394878245027098e-12
APC O 0 1.0044182152668668e-10
associated O 0 7.515738248767279e-13
with O 0 6.654889855330082e-14
both O 0 5.5880816467179795e-12
FAP B-Disease 0 7.981487470942739e-09
and O 0 3.1841401043619655e-11
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.155663227336845e-07
. O 0 4.7761510024724174e-11
. O 0 5.986777185107428e-10

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 6.742267578374594e-05
cancer B-Disease 1 0.999974250793457
risk O 0 2.673218091331364e-07
of O 0 2.5004512238524512e-08
the O 0 7.576581850798902e-08
APC O 0 5.263523803478165e-07
I1307K O 0 1.6218297105297097e-07
polymorphism O 0 7.321531825255079e-08
. O 0 3.416569471781372e-09

Germ O 0 0.000252534169703722
- O 0 1.8899817177953082e-07
line O 0 1.1480961958909575e-08
and O 0 3.8375476407725984e-11
somatic O 0 3.0659945693400914e-09
truncating O 0 1.996123488723356e-09
mutations O 0 4.3695186358050364e-12
of O 0 1.1715411973867162e-10
the O 0 9.034240022742779e-10
APC B-Disease 0 4.042599588416351e-09
gene O 0 3.789982216950705e-11
are O 0 3.4002512719517874e-13
thought O 0 2.2153526842844107e-12
to O 0 2.0881293655988786e-12
initiate O 0 8.049293853673589e-08
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.4860010821848846e-07
formation O 0 6.871783003736809e-11
in O 0 7.335205359781938e-11
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.726027759081262e-08
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 0.9999873638153076
, O 0 1.6081047604643572e-10
respectively O 0 1.6055771157041931e-09
. O 0 6.567496324549893e-09

Recently O 0 9.021433378109123e-09
, O 0 3.2527435606111155e-11
an O 0 8.458755397511286e-12
isoleucine O 0 5.703939791601442e-07
- O 0 7.555023273653205e-08
- O 0 1.9060969691508944e-07
> O 0 5.340531288311468e-07
lysine O 0 5.234609261606238e-07
polymorphism O 0 4.842436451824028e-10
at O 0 2.8332661217156385e-10
codon O 0 5.2120259497190347e-11
1307 O 0 1.0481655127181355e-10
( O 0 1.1505003221813637e-13
I1307K O 0 1.4325514732793643e-11
) O 0 2.2057837395267517e-14
of O 0 1.989218468764764e-12
the O 0 1.1590677723161136e-10
APC B-Disease 0 1.2657821457651153e-09
gene O 0 4.4004812814468774e-12
has O 0 1.1945182527579173e-13
been O 0 1.22660643578007e-13
identified O 0 1.1920716150304322e-13
in O 0 3.480268644887735e-13
6 O 0 3.6304856343427616e-10
% O 0 3.2965876122642568e-12
- O 0 8.309055526956044e-11
7 O 0 4.429599353983349e-09
% O 0 2.9510782706410055e-11
of O 0 1.1184944082032189e-09
the O 0 3.5971332579265436e-09
Ashkenazi O 0 1.6564077887082362e-09
Jewish O 0 1.358130413686709e-10
population O 0 1.4093737461806644e-11
. O 0 1.20921928026263e-09

To O 0 2.077009259027207e-10
assess O 0 1.9669539330635644e-09
the O 0 2.9803698398112033e-10
risk O 0 1.152854617325616e-10
of O 0 1.1595846678702504e-11
this O 0 1.4336277390919472e-12
common O 0 1.0253485560607345e-10
APC B-Disease 0 4.294453237463358e-09
allelic O 0 1.4331604347717075e-08
variant O 0 2.0703982528402776e-08
in O 0 1.4306197337887738e-09
colorectal O 1 1.0
carcinogenesis O 1 0.6533217430114746
, O 0 7.356474457376194e-11
we O 0 1.2975813132309888e-11
have O 0 1.887366538012511e-13
analyzed O 0 2.004143379030765e-12
a O 0 2.1451141644229788e-12
large O 0 8.88077632266171e-12
cohort O 0 6.866070906275112e-11
of O 0 1.1848491632271418e-10
unselected O 0 1.234672140526527e-06
Ashkenazi O 0 9.333849249060222e-09
Jewish O 0 2.3818116923202126e-10
subjects O 0 7.315634209525967e-10
with O 0 4.638767495124263e-11
adenomatous B-Disease 0 0.0006673965253867209
polyps I-Disease 0 7.798949081916362e-05
and O 0 1.829981444156914e-10
. O 0 2.28672569768662e-09
or O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.9394301442599016e-10
for O 0 3.353296459951416e-11
the O 0 2.6270599029487585e-09
APC O 0 4.088694538495474e-08
I1307K O 0 2.802280008040725e-08
polymorphism O 0 1.9895107783440835e-08
. O 0 3.1855038606920516e-09

The O 0 3.7281427012203494e-07
APC O 0 2.4428226197414915e-07
I1307K O 0 1.4144117876924156e-08
allele O 0 1.2902275081660974e-10
was O 0 1.2316486719399222e-10
identified O 0 2.386229018200292e-12
in O 0 1.5839601765627043e-12
48 O 0 4.9896638903978996e-11
( O 0 3.610385373910979e-13
10 O 0 2.4528924898181703e-12
. O 0 1.4695964714248055e-13
1 O 0 1.1772277597188463e-11
% O 0 1.8573401009466112e-13
) O 0 1.662115981144758e-14
of O 0 1.4461903896645367e-11
476 O 0 5.665151681100156e-10
patients O 0 1.7660708451217033e-09
. O 0 3.3902787244244337e-09

Compared O 0 2.1514744846795608e-11
with O 0 6.172309842053525e-13
the O 0 4.159225047706272e-12
frequency O 0 3.986239723724472e-12
in O 0 1.4624298950646764e-13
two O 0 1.2250953459428272e-14
separate O 0 8.258577334366649e-14
population O 0 1.6739512337035634e-14
control O 0 3.408806570348588e-11
groups O 0 8.799299722021814e-13
, O 0 1.599778794679485e-12
the O 0 3.5790026498006e-10
APC O 0 1.5553544230328953e-08
I1307K O 0 1.6257182267054304e-09
allele O 0 3.375177567987997e-11
is O 0 3.246230731055941e-14
associated O 0 4.567845057821922e-14
with O 0 1.683100311852565e-15
an O 0 5.3392183964253315e-15
estimated O 0 2.5082453475322453e-13
relative O 0 7.957735859154269e-11
risk O 0 3.7520361817477976e-10
of O 0 3.0938260286994534e-10
1 O 0 7.179029353210353e-07
. O 0 1.2405855898123264e-08

5 O 0 3.1024235340737505e-06
- O 0 5.673461487276654e-07
1 O 0 8.667683459862019e-07
. O 0 3.3101027696602614e-08

7 O 0 3.882799774146406e-06
for O 0 1.754584815216731e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.1654960662126541
( O 0 3.846020169007147e-10
both O 0 2.4461671577213906e-10
P O 0 9.395374149789859e-07
= O 0 2.384188679815935e-10
. O 0 2.9603166706165807e-12
01 O 0 1.153061868208738e-09
) O 0 1.4389862999092395e-12
. O 0 7.47634176789802e-11

Furthermore O 0 1.71339709087448e-09
, O 0 6.569866612543551e-12
compared O 0 2.3863291984810298e-12
with O 0 1.511217691783917e-12
noncarriers O 0 1.8295790482625307e-07
, O 0 4.0900632880536136e-10
APC O 0 1.4552297145087323e-08
I1307K O 0 3.3934097753984815e-09
carriers O 0 8.441638880973823e-12
had O 0 7.588335884135822e-13
increased O 0 2.9446654533152317e-13
numbers O 0 1.4829545198161848e-13
of O 0 2.740004230450399e-11
adenomas B-Disease 1 0.9999837875366211
and O 0 2.7599405711953295e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999057054519653
per O 0 5.921700629851756e-11
patient O 0 1.3022909417514938e-09
( O 0 6.676548203188304e-12
P O 0 6.981497904234857e-07
= O 0 1.6171693151267874e-10
. O 0 7.252976431254554e-13
03 O 0 4.395282748870244e-11
) O 0 4.950587821763797e-15
, O 0 5.084893365880439e-15
as O 0 1.5984047039511312e-14
well O 0 6.518957330328354e-14
as O 0 3.2174331016272817e-13
a O 0 4.2939714284262465e-12
younger O 0 1.752902944324175e-12
age O 0 4.783544740871726e-11
at O 0 1.4106426249327342e-08
diagnosis O 0 4.0613591067995003e-07
. O 0 2.459435988200198e-09

We O 0 1.0910725656287923e-09
conclude O 0 1.0543679263008698e-09
that O 0 1.8345368626992986e-12
the O 0 1.3345166638423223e-10
APC O 0 1.7500735083331165e-08
I1307K O 0 1.1424233115064908e-08
variant O 0 7.278365465879233e-09
leads O 0 4.084790838909669e-11
to O 0 2.5526486306659546e-12
increased O 0 3.909920387457078e-09
adenoma B-Disease 1 1.0
formation O 0 3.1057570404335877e-10
and O 0 3.3372475789772427e-12
directly O 0 3.199965113850553e-14
contributes O 0 1.2252683100706565e-14
to O 0 7.119987006931356e-15
3 O 0 5.907956849432461e-12
% O 0 8.488662653653375e-14
- O 0 5.999548731080995e-13
4 O 0 8.043337697272168e-12
% O 0 1.190274414404266e-13
of O 0 3.6486352134046385e-12
all O 0 2.8618656056078606e-11
Ashkenazi O 0 1.221026479925058e-07
Jewish O 0 4.187426748103462e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.809244155192573e-07

The O 0 1.3932370812597128e-09
estimated O 0 7.504716292849878e-11
relative O 0 8.763253456223197e-10
risk O 0 1.2472774202354486e-10
for O 0 2.5070507735786007e-12
carriers O 0 4.855360904998385e-12
may O 0 1.2453483340044147e-12
justify O 0 2.378422545717962e-12
specific O 0 1.0689023857658395e-13
clinical O 0 1.838162955181133e-11
screening O 0 1.723788971806639e-12
for O 0 4.998600952642665e-14
the O 0 6.088706470432081e-13
360 O 0 1.834092556649014e-12
, O 0 1.0045029451245455e-13
000 O 0 1.4988281882982735e-12
Americans O 0 8.226631317354363e-14
expected O 0 6.434758867239487e-13
to O 0 4.1418542315492524e-13
harbor O 0 2.9082769525956564e-10
this O 0 3.091825772727312e-14
allele O 0 3.051147117079378e-13
, O 0 2.6518219721884465e-14
and O 0 3.838632360651621e-14
genetic O 0 2.8244576816272016e-12
testing O 0 9.668422312758551e-12
in O 0 2.7277060276297005e-13
the O 0 3.191008655228922e-12
setting O 0 2.6596383428945103e-10
of O 0 2.0973269995727684e-11
long O 0 7.449180161600566e-12
- O 0 1.4463118203078551e-11
term O 0 6.567489607700594e-11
- O 0 2.609916623097508e-11
outcome O 0 7.746264740760012e-11
studies O 0 5.028592017612687e-13
may O 0 1.60492170768467e-13
impact O 0 1.0810125364302259e-11
significantly O 0 2.1931513896622512e-11
on O 0 4.713120142696425e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 2.888343715312658e-07
in O 0 3.979362683554505e-13
this O 0 1.5783498097908522e-13
population O 0 6.10920331250292e-13
. O 0 1.2903898782834489e-10

Localization O 0 1.426761286893452e-06
of O 0 6.403624741579961e-09
human O 0 2.0780128728858926e-09
BRCA1 O 0 2.2089499673860757e-10
and O 0 9.008759992330806e-13
its O 0 6.320686161964684e-12
loss O 0 1.2171742780342498e-10
in O 0 1.5021203031428954e-11
high O 0 3.916326107855639e-08
- O 0 5.4049551501123005e-09
grade O 0 7.014908192104485e-07
, O 0 4.1636744052553354e-10
non B-Disease 1 0.9999932050704956
- I-Disease 1 0.9999475479125977
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.3723590200243052e-05

Although O 0 1.4906446910156745e-10
the O 0 3.343869625638263e-11
link O 0 2.462090080423973e-11
between O 0 6.178991780042553e-12
the O 0 1.1900634921957476e-09
BRCA1 O 0 6.0708371663054095e-09
tumour B-Disease 1 1.0
- O 0 1.1008324252159696e-09
suppressor O 0 3.5792913077870026e-09
gene O 0 2.264846470090287e-11
and O 0 1.6521809961811407e-11
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.2995690079620204e-09
established O 0 6.135952163033309e-11
, O 0 5.3363299293718996e-14
the O 0 7.7023386583705e-13
role O 0 8.149904904587724e-13
, O 0 5.94808964994413e-14
if O 0 2.444646183619517e-14
any O 0 6.986463816326116e-13
, O 0 1.3980098545821051e-13
of O 0 9.068587027150077e-12
BRCA1 O 0 7.129024454100019e-11
in O 0 5.1680149742994175e-11
non B-Disease 0 0.06701598316431046
- I-Disease 0 8.615191472927108e-05
familial I-Disease 1 0.9999604225158691
cancers I-Disease 1 1.0
is O 0 2.7136486391299286e-09
unclear O 0 9.208458884302217e-09
. O 0 5.186613805108209e-09

BRCA1 O 0 3.8020763781787537e-07
mutations O 0 2.907677709718115e-10
are O 0 4.1170910539296834e-13
rare O 0 6.688643996305421e-12
in O 0 2.059115031260994e-12
sporadic B-Disease 0 4.770040504809003e-06
cancers I-Disease 0 0.005532810464501381
, O 0 1.0950075915450164e-11
but O 0 1.1880618884518857e-11
loss O 0 6.318960465989676e-09
of O 0 4.1351235324782465e-08
BRCA1 O 0 1.041811970026174e-09
resulting O 0 1.7567997404044355e-11
from O 0 4.745825043714347e-13
reduced O 0 1.0811863210280492e-10
expression O 0 2.0670727282623425e-11
or O 0 2.3153284844923405e-12
incorrect O 0 8.494295544725361e-11
subcellular O 0 4.0500179210312126e-08
localization O 0 4.610407344785017e-08
is O 0 1.2103405571620846e-13
postulated O 0 9.449819399209858e-13
to O 0 9.513503910162351e-15
be O 0 1.1285418061754253e-14
important O 0 5.441060809915389e-14
in O 0 2.7647854708781616e-13
non B-Disease 0 2.898788409311237e-07
- I-Disease 0 1.818497935346386e-06
familial I-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9934731125831604

Epigenetic O 0 5.6235330703202635e-06
loss O 0 5.784841619060899e-07
, O 0 5.27603932765075e-11
however O 0 8.259719297409873e-12
, O 0 4.242081404030873e-13
has O 0 4.9889806912409296e-14
not O 0 8.745147618213767e-15
received O 0 2.1162743798586008e-14
general O 0 2.103254636426355e-12
acceptance O 0 7.383178270148338e-12
due O 0 2.3327770271031056e-11
to O 0 8.512448016438634e-14
controversy O 0 3.1197163992760513e-13
regarding O 0 8.194687875322237e-13
the O 0 2.140528422914234e-12
subcellular O 0 1.0678068207425895e-08
localization O 0 1.962136231270506e-08
of O 0 3.3195959869836145e-10
BRCA1 O 0 5.679700459948478e-11
proteins O 0 4.0565329415855056e-13
, O 0 3.143920670675704e-13
reports O 0 1.8123374979570062e-12
of O 0 9.846247428502153e-11
which O 0 7.200409105762029e-12
have O 0 1.1296154983631013e-12
ranged O 0 2.5635108619193048e-11
from O 0 8.998267083705491e-13
exclusively O 0 1.7666316326492293e-11
nuclear O 0 7.374407751115086e-09
, O 0 5.943896633567314e-13
to O 0 3.478821777088553e-13
conditionally O 0 1.4774915735316085e-09
nuclear O 0 3.6402780789757117e-09
, O 0 3.037142748667926e-13
to O 0 4.228800740569555e-13
the O 0 1.070136132486077e-10
ER O 0 5.288802995551123e-08
/ O 0 2.5366357903067183e-09
golgi O 0 6.815140896065941e-09
, O 0 2.217213912469873e-11
to O 0 1.2734330950836537e-11
cytoplasmic O 0 3.3218017225777885e-09
invaginations O 0 2.5578396289915872e-08
into O 0 3.243685528508955e-11
the O 0 3.328192721419043e-10
nucleus O 0 9.102751885592397e-10
. O 0 1.4381845714339647e-09

In O 0 1.345302091948497e-09
an O 0 2.127788396866226e-11
attempt O 0 1.0065898115030336e-09
to O 0 1.0420017279577642e-11
resolve O 0 5.077153142352131e-10
this O 0 2.545710387283351e-12
issue O 0 7.734996670949457e-12
, O 0 5.005701799246087e-13
we O 0 1.043795366979794e-12
have O 0 5.400718934567283e-13
comprehensively O 0 1.4402735670770994e-09
characterized O 0 1.9129126060946078e-10
19 O 0 7.592840134407197e-09
anti O 0 7.813762863406737e-07
- O 0 1.737680861424451e-07
BRCA1 O 0 3.173473928086423e-08
antibodies O 0 1.842050179057253e-09
. O 0 1.6234066313458584e-09

These O 0 5.848208584069425e-09
reagents O 0 1.3046113522818814e-08
detect O 0 7.104408172864396e-09
a O 0 5.565239380445064e-10
220 O 0 1.0730200755704189e-10
- O 0 2.2318362435935768e-10
kD O 0 1.0168110797792451e-09
protein O 0 1.9295405551122968e-11
localized O 0 5.952275478060542e-11
in O 0 7.157574229491037e-13
discrete O 0 1.491554796340111e-10
nuclear O 0 7.505642685146086e-08
foci O 0 1.487487910623031e-08
in O 0 8.734291935541538e-12
all O 0 8.839879349353819e-12
epithelial O 0 1.799499216303957e-09
cell O 0 1.0487266166592235e-08
lines O 0 5.163341976199831e-12
, O 0 2.199234311371992e-14
including O 0 1.399965755301269e-13
those O 0 2.450207192087467e-13
derived O 0 7.450141848927561e-13
from O 0 2.234186100014135e-11
breast B-Disease 0 2.0351342300273245e-07
malignancies I-Disease 0 3.592268285501632e-06
. O 0 5.3240650998986894e-08

Immunohistochemical O 0 8.102247193164658e-06
staining O 0 7.206948566818028e-07
of O 0 2.483360503902077e-07
human O 0 7.838959845685167e-07
breast O 0 2.6296362420907826e-07
specimens O 0 1.122058557179173e-09
also O 0 1.4684667370978843e-10
revealed O 0 2.8962936493570623e-09
BRCA1 O 0 3.845119778134176e-09
nuclear O 0 5.850146749253327e-07
foci O 0 5.351539016373863e-07
in O 0 2.8215205172266167e-10
benign O 1 1.0
breast O 1 0.9709208011627197
, O 0 4.729253433310987e-09
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 2.1418536562123336e-06
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 9.139779422184802e-07

Conversely O 0 8.764025949403731e-09
, O 0 1.37613309636464e-10
BRCA1 O 0 4.5571421636303455e-10
expression O 0 7.702934123887673e-11
was O 0 8.242066751318333e-11
reduced O 0 1.6750012835076156e-11
or O 0 6.282818097161011e-14
undetectable O 0 5.742684799914244e-11
in O 0 5.770608464813684e-14
the O 0 1.7469307792873645e-13
majority O 0 4.536734554108808e-14
of O 0 2.470919085659218e-12
high O 0 7.065934504169036e-09
- O 0 8.815780994098077e-09
grade O 0 6.286384746090334e-08
, O 0 2.2492763207537791e-10
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 4.5226589834301834e-11
suggesting O 0 1.045391811310692e-11
that O 0 2.879976801744427e-13
absence O 0 2.181201441686653e-09
of O 0 3.5682077292875647e-09
BRCA1 O 0 5.325176966053391e-10
may O 0 1.7706991472035694e-12
contribute O 0 2.8122307000472135e-14
to O 0 4.1537032060418033e-14
the O 0 8.944046892001012e-12
pathogenesis O 0 4.049004687090019e-09
of O 0 5.499851008644585e-12
a O 0 7.111443053355038e-13
significant O 0 3.3589023489682956e-12
percentage O 0 5.3090969120983544e-12
of O 0 1.045474054550688e-10
sporadic B-Disease 1 0.9999946355819702
breast I-Disease 1 0.9999990463256836
cancers I-Disease 1 0.9998778104782104
. O 0 1.5640740258504593e-08
. O 0 1.206524871122383e-07

